Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-05-09
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| A1BG | -0.0122052 |
| A1BG-AS1 | 0.0109188 |
| A1CF | 0.0083888 |
| A2M | -0.0224915 |
| A2M-AS1 | 0.0192998 |
| A2ML1 | -0.0845744 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 21942 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 17453 |
| num_profile_genes_not_in_sets | 4489 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 3186 |
| num_genesets_included | 7275 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM | 6 | 3.24e-05 | -0.979 | 0.0114 |
| GOBP REGULATION OF CORTICOTROPIN SECRETION | 5 | 3.97e-04 | 0.915 | 0.0634 |
| GOMF PIRNA BINDING | 5 | 5.06e-03 | -0.724 | 0.2780 |
| GOBP PREVENTION OF POLYSPERMY | 7 | 1.22e-03 | -0.706 | 0.1290 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 8.29e-03 | -0.682 | 0.3530 |
| GOBP SEMICIRCULAR CANAL MORPHOGENESIS | 7 | 3.25e-03 | 0.642 | 0.2190 |
| GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY | 5 | 1.44e-02 | -0.632 | 0.4540 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 1.50e-02 | 0.628 | 0.4610 |
| GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 5 | 1.53e-02 | 0.626 | 0.4610 |
| GOBP EGG ACTIVATION | 11 | 3.95e-04 | -0.617 | 0.0634 |
| GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 5 | 1.79e-02 | 0.612 | 0.4770 |
| GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION | 5 | 1.81e-02 | -0.611 | 0.4770 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 5.28e-03 | -0.609 | 0.2800 |
| GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 8 | 2.87e-03 | -0.609 | 0.2040 |
| GOBP REGULATION OF MESODERM DEVELOPMENT | 6 | 1.02e-02 | -0.605 | 0.3830 |
| GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT | 5 | 1.98e-02 | 0.602 | 0.4910 |
| GOMF CXCR3 CHEMOKINE RECEPTOR BINDING | 5 | 1.98e-02 | -0.601 | 0.4910 |
| GOMF CCR3 CHEMOKINE RECEPTOR BINDING | 5 | 2.03e-02 | -0.599 | 0.4940 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 6.14e-03 | -0.598 | 0.3000 |
| GOBP SPERMIDINE TRANSPORT | 5 | 2.08e-02 | 0.597 | 0.4960 |
| GOBP SOFT PALATE DEVELOPMENT | 5 | 2.10e-02 | 0.596 | 0.4960 |
| GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 6 | 1.30e-02 | -0.586 | 0.4360 |
| GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 5 | 2.42e-02 | -0.582 | 0.5170 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 7.80e-03 | 0.581 | 0.3430 |
| GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 10 | 1.58e-03 | -0.577 | 0.1510 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 2.55e-02 | 0.577 | 0.5250 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 10 | 1.67e-03 | 0.574 | 0.1570 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.59e-03 | -0.574 | 0.3580 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 2.66e-02 | 0.573 | 0.5310 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 2.74e-02 | -0.570 | 0.5370 |
| GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS | 6 | 1.58e-02 | -0.569 | 0.4660 |
| GOBP POSITIVE REGULATION OF FERTILIZATION | 5 | 2.81e-02 | 0.567 | 0.5450 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 1.65e-02 | 0.565 | 0.4680 |
| GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS | 5 | 3.00e-02 | 0.560 | 0.5540 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 3.12e-02 | 0.556 | 0.5560 |
| GOMF LACTATE DEHYDROGENASE ACTIVITY | 6 | 1.90e-02 | 0.553 | 0.4890 |
| GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION | 5 | 3.24e-02 | 0.552 | 0.5580 |
| GOBP ENDOCANNABINOID SIGNALING PATHWAY | 5 | 3.24e-02 | -0.552 | 0.5580 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 8 | 7.04e-03 | 0.550 | 0.3250 |
| GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE | 5 | 3.60e-02 | -0.542 | 0.5750 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 10 | 3.16e-03 | -0.539 | 0.2160 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 8.43e-03 | -0.538 | 0.3550 |
| GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING | 6 | 2.26e-02 | 0.538 | 0.5080 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 2.42e-02 | 0.531 | 0.5170 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 6 | 2.45e-02 | 0.530 | 0.5190 |
| GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY | 6 | 2.46e-02 | 0.530 | 0.5190 |
| GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY | 5 | 4.04e-02 | 0.529 | 0.6080 |
| GOBP CORTISOL SECRETION | 5 | 4.07e-02 | 0.528 | 0.6080 |
| GOCC TRANSLOCON COMPLEX | 5 | 4.12e-02 | 0.527 | 0.6100 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 5 | 4.14e-02 | -0.527 | 0.6100 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM | 6 | 3.24e-05 | -9.79e-01 | 1.14e-02 |
| GOBP REGULATION OF CORTICOTROPIN SECRETION | 5 | 3.97e-04 | 9.15e-01 | 6.34e-02 |
| GOMF PIRNA BINDING | 5 | 5.06e-03 | -7.24e-01 | 2.78e-01 |
| GOBP PREVENTION OF POLYSPERMY | 7 | 1.22e-03 | -7.06e-01 | 1.29e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 8.29e-03 | -6.82e-01 | 3.53e-01 |
| GOBP SEMICIRCULAR CANAL MORPHOGENESIS | 7 | 3.25e-03 | 6.42e-01 | 2.19e-01 |
| GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY | 5 | 1.44e-02 | -6.32e-01 | 4.54e-01 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 1.50e-02 | 6.28e-01 | 4.61e-01 |
| GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 5 | 1.53e-02 | 6.26e-01 | 4.61e-01 |
| GOBP EGG ACTIVATION | 11 | 3.95e-04 | -6.17e-01 | 6.34e-02 |
| GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 5 | 1.79e-02 | 6.12e-01 | 4.77e-01 |
| GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION | 5 | 1.81e-02 | -6.11e-01 | 4.77e-01 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 5.28e-03 | -6.09e-01 | 2.80e-01 |
| GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 8 | 2.87e-03 | -6.09e-01 | 2.04e-01 |
| GOBP REGULATION OF MESODERM DEVELOPMENT | 6 | 1.02e-02 | -6.05e-01 | 3.83e-01 |
| GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT | 5 | 1.98e-02 | 6.02e-01 | 4.91e-01 |
| GOMF CXCR3 CHEMOKINE RECEPTOR BINDING | 5 | 1.98e-02 | -6.01e-01 | 4.91e-01 |
| GOMF CCR3 CHEMOKINE RECEPTOR BINDING | 5 | 2.03e-02 | -5.99e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 6.14e-03 | -5.98e-01 | 3.00e-01 |
| GOBP SPERMIDINE TRANSPORT | 5 | 2.08e-02 | 5.97e-01 | 4.96e-01 |
| GOBP SOFT PALATE DEVELOPMENT | 5 | 2.10e-02 | 5.96e-01 | 4.96e-01 |
| GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 6 | 1.30e-02 | -5.86e-01 | 4.36e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 5 | 2.42e-02 | -5.82e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 7.80e-03 | 5.81e-01 | 3.43e-01 |
| GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 10 | 1.58e-03 | -5.77e-01 | 1.51e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 2.55e-02 | 5.77e-01 | 5.25e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 10 | 1.67e-03 | 5.74e-01 | 1.57e-01 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.59e-03 | -5.74e-01 | 3.58e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 2.66e-02 | 5.73e-01 | 5.31e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 2.74e-02 | -5.70e-01 | 5.37e-01 |
| GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS | 6 | 1.58e-02 | -5.69e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF FERTILIZATION | 5 | 2.81e-02 | 5.67e-01 | 5.45e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 1.65e-02 | 5.65e-01 | 4.68e-01 |
| GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS | 5 | 3.00e-02 | 5.60e-01 | 5.54e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 3.12e-02 | 5.56e-01 | 5.56e-01 |
| GOMF LACTATE DEHYDROGENASE ACTIVITY | 6 | 1.90e-02 | 5.53e-01 | 4.89e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION | 5 | 3.24e-02 | 5.52e-01 | 5.58e-01 |
| GOBP ENDOCANNABINOID SIGNALING PATHWAY | 5 | 3.24e-02 | -5.52e-01 | 5.58e-01 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 8 | 7.04e-03 | 5.50e-01 | 3.25e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE | 5 | 3.60e-02 | -5.42e-01 | 5.75e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 10 | 3.16e-03 | -5.39e-01 | 2.16e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 8.43e-03 | -5.38e-01 | 3.55e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING | 6 | 2.26e-02 | 5.38e-01 | 5.08e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 2.42e-02 | 5.31e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 6 | 2.45e-02 | 5.30e-01 | 5.19e-01 |
| GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY | 6 | 2.46e-02 | 5.30e-01 | 5.19e-01 |
| GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY | 5 | 4.04e-02 | 5.29e-01 | 6.08e-01 |
| GOBP CORTISOL SECRETION | 5 | 4.07e-02 | 5.28e-01 | 6.08e-01 |
| GOCC TRANSLOCON COMPLEX | 5 | 4.12e-02 | 5.27e-01 | 6.10e-01 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 5 | 4.14e-02 | -5.27e-01 | 6.10e-01 |
| GOBP PROTEIN LIPOYLATION | 5 | 4.17e-02 | 5.26e-01 | 6.10e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 4.19e-02 | -5.25e-01 | 6.10e-01 |
| GOBP MODULATION BY VIRUS OF HOST PROCESS | 7 | 1.62e-02 | 5.25e-01 | 4.68e-01 |
| GOBP HEAT ACCLIMATION | 5 | 4.29e-02 | -5.23e-01 | 6.14e-01 |
| GOBP ASCENDING AORTA DEVELOPMENT | 5 | 4.30e-02 | 5.23e-01 | 6.14e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 7 | 1.69e-02 | -5.21e-01 | 4.68e-01 |
| GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION | 5 | 4.40e-02 | -5.20e-01 | 6.22e-01 |
| GOBP MESODERMAL CELL MIGRATION | 5 | 4.42e-02 | -5.20e-01 | 6.22e-01 |
| GOBP CORTICOTROPIN SECRETION | 7 | 1.73e-02 | 5.19e-01 | 4.73e-01 |
| GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY | 5 | 4.54e-02 | -5.17e-01 | 6.22e-01 |
| GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY | 5 | 4.59e-02 | -5.16e-01 | 6.22e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 1.84e-02 | 5.14e-01 | 4.80e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 1.19e-02 | -5.14e-01 | 4.11e-01 |
| GOCC OTHER ORGANISM PART | 5 | 4.80e-02 | -5.11e-01 | 6.27e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 4.82e-02 | -5.10e-01 | 6.27e-01 |
| GOBP GALACTOLIPID METABOLIC PROCESS | 9 | 8.21e-03 | -5.09e-01 | 3.53e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 6 | 3.10e-02 | -5.08e-01 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION | 5 | 4.89e-02 | 5.08e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF ANOIKIS | 6 | 3.10e-02 | 5.08e-01 | 5.55e-01 |
| GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 4.92e-02 | -5.08e-01 | 6.28e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 7 | 2.02e-02 | -5.07e-01 | 4.94e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 4.97e-02 | -5.07e-01 | 6.28e-01 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 6 | 3.17e-02 | -5.06e-01 | 5.58e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 12 | 2.50e-03 | -5.04e-01 | 1.91e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 8 | 1.39e-02 | -5.02e-01 | 4.46e-01 |
| GOBP REGULATION OF FAS SIGNALING PATHWAY | 6 | 3.35e-02 | -5.01e-01 | 5.58e-01 |
| GOBP SEMICIRCULAR CANAL DEVELOPMENT | 9 | 9.40e-03 | 5.00e-01 | 3.67e-01 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 5.33e-02 | -4.99e-01 | 6.45e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL | 6 | 3.44e-02 | -4.99e-01 | 5.66e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 6 | 3.46e-02 | -4.98e-01 | 5.70e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 3.60e-02 | 4.94e-01 | 5.75e-01 |
| GOBP REGULATION OF MESONEPHROS DEVELOPMENT | 5 | 5.60e-02 | 4.93e-01 | 6.53e-01 |
| GOBP AUTOCRINE SIGNALING | 6 | 3.67e-02 | -4.93e-01 | 5.81e-01 |
| GOMF KINETOCHORE BINDING | 6 | 3.85e-02 | 4.88e-01 | 5.93e-01 |
| GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 5 | 6.03e-02 | -4.85e-01 | 6.62e-01 |
| GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION | 7 | 2.68e-02 | -4.83e-01 | 5.32e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 1.80e-02 | 4.83e-01 | 4.77e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 7 | 2.72e-02 | -4.82e-01 | 5.34e-01 |
| GOBP GALACTOLIPID BIOSYNTHETIC PROCESS | 6 | 4.11e-02 | -4.81e-01 | 6.10e-01 |
| GOMF L LACTATE DEHYDROGENASE ACTIVITY | 5 | 6.34e-02 | 4.79e-01 | 6.67e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 6.35e-02 | 4.79e-01 | 6.67e-01 |
| GOCC EGG COAT | 5 | 6.46e-02 | -4.77e-01 | 6.75e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 2.90e-02 | 4.76e-01 | 5.52e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 9 | 1.35e-02 | -4.76e-01 | 4.44e-01 |
| GOBP CELLULAR RESPONSE TO HEPARIN | 5 | 6.61e-02 | -4.75e-01 | 6.82e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR | 6 | 4.42e-02 | -4.74e-01 | 6.22e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 6.65e-02 | -4.74e-01 | 6.83e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 4.50e-02 | 4.73e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 4.51e-02 | 4.72e-01 | 6.22e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 7 | 3.05e-02 | 4.72e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 10 | 9.76e-03 | 4.72e-01 | 3.75e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 6.78e-02 | -4.72e-01 | 6.90e-01 |
| GOBP HIS PURKINJE SYSTEM DEVELOPMENT | 7 | 3.09e-02 | 4.71e-01 | 5.55e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 6 | 4.57e-02 | 4.71e-01 | 6.22e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 14 | 2.30e-03 | 4.71e-01 | 1.84e-01 |
| GOBP NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS | 5 | 6.95e-02 | 4.69e-01 | 6.94e-01 |
| GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.23e-02 | 4.67e-01 | 5.58e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 7 | 3.24e-02 | -4.67e-01 | 5.58e-01 |
| GOBP DETECTION OF BACTERIUM | 16 | 1.23e-03 | -4.67e-01 | 1.29e-01 |
| GOMF OPIOID RECEPTOR BINDING | 7 | 3.26e-02 | -4.67e-01 | 5.58e-01 |
| GOBP REGULATION OF PHENOTYPIC SWITCHING | 6 | 4.78e-02 | -4.66e-01 | 6.27e-01 |
| GOBP ADULT FEEDING BEHAVIOR | 9 | 1.54e-02 | 4.66e-01 | 4.61e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 7.12e-02 | -4.66e-01 | 6.99e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 8 | 2.27e-02 | -4.65e-01 | 5.08e-01 |
| GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX | 5 | 7.19e-02 | -4.65e-01 | 7.01e-01 |
| GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS | 8 | 2.30e-02 | -4.64e-01 | 5.12e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 7 | 3.35e-02 | -4.64e-01 | 5.58e-01 |
| GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS | 6 | 4.94e-02 | -4.63e-01 | 6.28e-01 |
| GOBP DNA METHYLATION ON CYTOSINE | 6 | 4.99e-02 | 4.62e-01 | 6.30e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS | 6 | 5.05e-02 | -4.61e-01 | 6.33e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 7 | 3.47e-02 | -4.61e-01 | 5.70e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN PARTURITION | 5 | 7.46e-02 | 4.60e-01 | 7.12e-01 |
| GOBP CORTICOSTERONE SECRETION | 5 | 7.46e-02 | -4.60e-01 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 7 | 3.51e-02 | -4.60e-01 | 5.72e-01 |
| GOBP SEROTONIN UPTAKE | 12 | 5.86e-03 | 4.59e-01 | 2.93e-01 |
| GOBP RESPONSE TO YEAST | 7 | 3.55e-02 | -4.59e-01 | 5.74e-01 |
| GOBP CELL CELL JUNCTION DISASSEMBLY | 5 | 7.57e-02 | 4.59e-01 | 7.17e-01 |
| GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS | 8 | 2.48e-02 | -4.58e-01 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN | 5 | 7.62e-02 | -4.58e-01 | 7.18e-01 |
| GOBP ENDOTHELIAL CELL MATRIX ADHESION | 8 | 2.51e-02 | -4.57e-01 | 5.21e-01 |
| GOBP FAS SIGNALING PATHWAY | 8 | 2.52e-02 | -4.57e-01 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 9 | 1.78e-02 | -4.56e-01 | 4.77e-01 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 7.80e-02 | -4.55e-01 | 7.19e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 7 | 3.70e-02 | 4.55e-01 | 5.82e-01 |
| GOBP EOSINOPHIL ACTIVATION | 8 | 2.61e-02 | -4.54e-01 | 5.28e-01 |
| GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY | 5 | 7.91e-02 | -4.53e-01 | 7.24e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 8.03e-02 | -4.52e-01 | 7.26e-01 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 14 | 3.47e-03 | -4.51e-01 | 2.25e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 10 | 1.38e-02 | -4.50e-01 | 4.46e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 6 | 5.68e-02 | -4.49e-01 | 6.57e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 11 | 1.01e-02 | -4.48e-01 | 3.83e-01 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 8.29e-02 | 4.48e-01 | 7.36e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 8.31e-02 | 4.48e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION | 5 | 8.32e-02 | 4.47e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 8.39e-02 | -4.46e-01 | 7.37e-01 |
| GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS | 6 | 5.84e-02 | -4.46e-01 | 6.58e-01 |
| GOBP ANTIMICROBIAL PEPTIDE PRODUCTION | 11 | 1.04e-02 | -4.46e-01 | 3.86e-01 |
| GOMF KERATIN FILAMENT BINDING | 6 | 5.88e-02 | -4.45e-01 | 6.60e-01 |
| GOCC BOX H ACA RNP COMPLEX | 7 | 4.13e-02 | -4.45e-01 | 6.10e-01 |
| GOMF ACROSIN BINDING | 5 | 8.52e-02 | -4.44e-01 | 7.43e-01 |
| GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 8.55e-02 | -4.44e-01 | 7.45e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 2.97e-02 | -4.44e-01 | 5.52e-01 |
| GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION | 7 | 4.21e-02 | -4.44e-01 | 6.11e-01 |
| GOBP GENERAL ADAPTATION SYNDROME | 6 | 6.03e-02 | -4.43e-01 | 6.62e-01 |
| GOMF GLYCEROL CHANNEL ACTIVITY | 5 | 8.63e-02 | -4.43e-01 | 7.47e-01 |
| GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION | 6 | 6.12e-02 | -4.41e-01 | 6.63e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 7 | 4.35e-02 | -4.41e-01 | 6.18e-01 |
| GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 6.19e-02 | 4.40e-01 | 6.63e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 6 | 6.24e-02 | 4.39e-01 | 6.63e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 5 | 8.90e-02 | 4.39e-01 | 7.52e-01 |
| GOBP MESANGIAL CELL DEVELOPMENT | 6 | 6.26e-02 | 4.39e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 8 | 3.17e-02 | 4.39e-01 | 5.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 6 | 6.33e-02 | 4.38e-01 | 6.67e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 8 | 3.21e-02 | 4.38e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 6.38e-02 | 4.37e-01 | 6.68e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 18 | 1.34e-03 | -4.37e-01 | 1.37e-01 |
| GOBP ACYLGLYCEROL TRANSPORT | 8 | 3.29e-02 | 4.35e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 7 | 4.61e-02 | 4.35e-01 | 6.22e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 8 | 3.32e-02 | -4.35e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 8 | 3.33e-02 | -4.35e-01 | 5.58e-01 |
| GOMF COMPLEMENT COMPONENT C3B BINDING | 9 | 2.40e-02 | -4.34e-01 | 5.17e-01 |
| GOBP PHENYLPROPANOID METABOLIC PROCESS | 6 | 6.54e-02 | 4.34e-01 | 6.80e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 6 | 6.55e-02 | -4.34e-01 | 6.80e-01 |
| GOBP C 5 METHYLATION OF CYTOSINE | 5 | 9.28e-02 | 4.34e-01 | 7.59e-01 |
| GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY | 6 | 6.57e-02 | -4.34e-01 | 6.81e-01 |
| GOBP URETERIC BUD FORMATION | 7 | 4.78e-02 | 4.32e-01 | 6.27e-01 |
| GOMF APOLIPOPROTEIN A I BINDING | 5 | 9.44e-02 | -4.32e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 9.47e-02 | -4.32e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 9.51e-02 | 4.31e-01 | 7.66e-01 |
| GOCC CORVET COMPLEX | 7 | 4.85e-02 | 4.31e-01 | 6.28e-01 |
| GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY | 5 | 9.60e-02 | -4.30e-01 | 7.66e-01 |
| GOBP NAD TRANSPORT | 5 | 9.60e-02 | -4.30e-01 | 7.66e-01 |
| GOBP REGULATION OF APPETITE | 19 | 1.19e-03 | 4.30e-01 | 1.29e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 10 | 1.87e-02 | -4.29e-01 | 4.85e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 9 | 2.58e-02 | 4.29e-01 | 5.28e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 9.66e-02 | -4.29e-01 | 7.66e-01 |
| GOBP RESPONSE TO HEPARIN | 7 | 4.94e-02 | -4.29e-01 | 6.28e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 9.68e-02 | 4.29e-01 | 7.66e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 6 | 6.95e-02 | -4.28e-01 | 6.94e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.65e-02 | -4.27e-01 | 5.31e-01 |
| GOCC SARCOPLASMIC RETICULUM LUMEN | 9 | 2.69e-02 | -4.26e-01 | 5.32e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 6 | 7.12e-02 | 4.25e-01 | 6.99e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 9.98e-02 | 4.25e-01 | 7.66e-01 |
| GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY | 5 | 1.01e-01 | 4.23e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 1.01e-01 | -4.23e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 5 | 1.02e-01 | 4.22e-01 | 7.66e-01 |
| GOMF PROTEIN ARGININE DEIMINASE ACTIVITY | 5 | 1.03e-01 | -4.22e-01 | 7.66e-01 |
| GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 6 | 7.45e-02 | -4.20e-01 | 7.12e-01 |
| GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.04e-01 | -4.20e-01 | 7.68e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 5.47e-02 | -4.19e-01 | 6.47e-01 |
| GOMF GABA GATED CHLORIDE ION CHANNEL ACTIVITY | 11 | 1.61e-02 | 4.19e-01 | 4.67e-01 |
| GOBP GLYCEROL TRANSMEMBRANE TRANSPORT | 7 | 5.50e-02 | -4.19e-01 | 6.48e-01 |
| GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.50e-02 | -4.19e-01 | 6.48e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 18 | 2.10e-03 | 4.19e-01 | 1.76e-01 |
| GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS | 5 | 1.05e-01 | -4.19e-01 | 7.69e-01 |
| GOCC CARDIAC MYOFIBRIL | 6 | 7.58e-02 | 4.19e-01 | 7.17e-01 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 1.05e-01 | 4.18e-01 | 7.69e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 7 | 5.56e-02 | 4.18e-01 | 6.52e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 1.67e-02 | 4.17e-01 | 4.68e-01 |
| GOBP UTERUS MORPHOGENESIS | 6 | 7.82e-02 | 4.15e-01 | 7.20e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 3.10e-02 | 4.15e-01 | 5.55e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 1.08e-01 | -4.15e-01 | 7.73e-01 |
| GOBP FOREBRAIN NEURON FATE COMMITMENT | 7 | 5.78e-02 | 4.14e-01 | 6.57e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 4.28e-02 | -4.13e-01 | 6.14e-01 |
| GOMF ROUNDABOUT BINDING | 8 | 4.36e-02 | -4.12e-01 | 6.19e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 17 | 3.28e-03 | 4.12e-01 | 2.19e-01 |
| GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME | 5 | 1.11e-01 | 4.11e-01 | 7.77e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 6 | 8.16e-02 | 4.10e-01 | 7.30e-01 |
| GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 5 | 1.13e-01 | -4.10e-01 | 7.80e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 8.26e-02 | 4.09e-01 | 7.34e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 6 | 8.29e-02 | 4.09e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 1.14e-01 | -4.09e-01 | 7.81e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 6.12e-02 | -4.09e-01 | 6.63e-01 |
| GOBP PROGESTERONE BIOSYNTHETIC PROCESS | 6 | 8.37e-02 | 4.08e-01 | 7.37e-01 |
| GOBP ENDODERMAL CELL FATE SPECIFICATION | 8 | 4.60e-02 | -4.07e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT | 13 | 1.10e-02 | -4.07e-01 | 3.96e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 6.21e-02 | -4.07e-01 | 6.63e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 8 | 4.63e-02 | -4.07e-01 | 6.22e-01 |
| GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION | 5 | 1.16e-01 | -4.06e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION | 5 | 1.16e-01 | -4.06e-01 | 7.82e-01 |
| GOBP ASPARTATE METABOLIC PROCESS | 8 | 4.70e-02 | -4.06e-01 | 6.25e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 8 | 4.71e-02 | -4.05e-01 | 6.25e-01 |
| GOMF FUCOSE BINDING | 8 | 4.73e-02 | -4.05e-01 | 6.25e-01 |
| GOBP SEROTONIN SECRETION | 9 | 3.56e-02 | 4.04e-01 | 5.75e-01 |
| GOMF METAL ION SEQUESTERING ACTIVITY | 5 | 1.17e-01 | -4.04e-01 | 7.82e-01 |
| GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION | 6 | 8.63e-02 | -4.04e-01 | 7.47e-01 |
| GOCC 9PLUS0 MOTILE CILIUM | 5 | 1.18e-01 | -4.04e-01 | 7.82e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 8 | 4.81e-02 | 4.04e-01 | 6.27e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 8 | 4.82e-02 | 4.03e-01 | 6.27e-01 |
| GOBP SYNAPTIC VESICLE UNCOATING | 6 | 8.71e-02 | 4.03e-01 | 7.51e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 10 | 2.72e-02 | -4.03e-01 | 5.34e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 9 | 3.64e-02 | -4.03e-01 | 5.79e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 12 | 1.58e-02 | -4.02e-01 | 4.66e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 1.19e-01 | 4.02e-01 | 7.87e-01 |
| GOBP QUINOLINATE METABOLIC PROCESS | 5 | 1.20e-01 | -4.02e-01 | 7.87e-01 |
| GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE | 12 | 1.61e-02 | -4.01e-01 | 4.67e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 6 | 8.88e-02 | 4.01e-01 | 7.52e-01 |
| GOBP FORMATE METABOLIC PROCESS | 6 | 8.89e-02 | -4.01e-01 | 7.52e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 12 | 1.62e-02 | -4.01e-01 | 4.68e-01 |
| GOBP HYDROCARBON METABOLIC PROCESS | 7 | 6.64e-02 | 4.01e-01 | 6.83e-01 |
| GOCC MEMBRANE ATTACK COMPLEX | 7 | 6.67e-02 | -4.00e-01 | 6.83e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 38 | 1.97e-05 | -4.00e-01 | 7.47e-03 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 6 | 9.00e-02 | -4.00e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 1.23e-01 | 3.99e-01 | 7.89e-01 |
| GOBP GALACTOSE TRANSMEMBRANE TRANSPORT | 5 | 1.23e-01 | 3.98e-01 | 7.92e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 9.23e-02 | 3.97e-01 | 7.58e-01 |
| GOBP LIPID HYDROXYLATION | 7 | 6.94e-02 | 3.96e-01 | 6.94e-01 |
| GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY | 5 | 1.25e-01 | -3.96e-01 | 7.93e-01 |
| GOBP PARATHYROID GLAND DEVELOPMENT | 7 | 6.95e-02 | 3.96e-01 | 6.94e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 1.25e-01 | 3.96e-01 | 7.93e-01 |
| GOBP THYMOCYTE MIGRATION | 6 | 9.30e-02 | -3.96e-01 | 7.59e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 9 | 3.99e-02 | -3.96e-01 | 6.03e-01 |
| GOBP RECOGNITION OF APOPTOTIC CELL | 7 | 7.01e-02 | -3.95e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 1.26e-01 | 3.95e-01 | 7.93e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX | 5 | 1.27e-01 | 3.94e-01 | 7.93e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 11 | 2.39e-02 | -3.93e-01 | 5.17e-01 |
| GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY | 5 | 1.28e-01 | 3.93e-01 | 7.93e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 9.57e-02 | 3.93e-01 | 7.66e-01 |
| GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 5 | 1.28e-01 | -3.93e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 1.29e-01 | -3.92e-01 | 7.93e-01 |
| GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR | 9 | 4.16e-02 | -3.92e-01 | 6.10e-01 |
| GOBP REGULATION OF RESPONSE TO DRUG | 15 | 8.60e-03 | -3.92e-01 | 3.58e-01 |
| GOCC OMEGASOME | 5 | 1.29e-01 | 3.92e-01 | 7.93e-01 |
| GOCC HOPS COMPLEX | 9 | 4.19e-02 | 3.92e-01 | 6.10e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 8 | 5.53e-02 | -3.91e-01 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING | 6 | 9.70e-02 | 3.91e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 4.24e-02 | 3.91e-01 | 6.13e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 1.31e-01 | 3.90e-01 | 7.94e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 19 | 3.22e-03 | -3.90e-01 | 2.18e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 1.31e-01 | -3.90e-01 | 7.94e-01 |
| GOBP ADENOHYPOPHYSIS DEVELOPMENT | 16 | 6.98e-03 | -3.90e-01 | 3.25e-01 |
| GOBP SEROTONIN TRANSPORT | 20 | 2.58e-03 | 3.89e-01 | 1.93e-01 |
| GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY | 6 | 9.92e-02 | 3.89e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 11 | 2.56e-02 | -3.89e-01 | 5.26e-01 |
| GOBP EQUILIBRIOCEPTION | 7 | 7.53e-02 | -3.88e-01 | 7.15e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 10 | 3.36e-02 | -3.88e-01 | 5.58e-01 |
| GOBP RESPONSE TO AMMONIUM ION | 6 | 9.99e-02 | -3.88e-01 | 7.66e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 8 | 5.77e-02 | -3.88e-01 | 6.57e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 1.00e-01 | 3.88e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 10 | 3.42e-02 | -3.87e-01 | 5.66e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN D | 5 | 1.35e-01 | -3.86e-01 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 12 | 2.05e-02 | -3.86e-01 | 4.96e-01 |
| GOBP NEURON GLIAL CELL SIGNALING | 5 | 1.35e-01 | -3.86e-01 | 8.06e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION | 7 | 7.77e-02 | -3.85e-01 | 7.18e-01 |
| GOCC NETWORK FORMING COLLAGEN TRIMER | 6 | 1.03e-01 | 3.85e-01 | 7.66e-01 |
| GOBP EPOXYGENASE P450 PATHWAY | 17 | 6.05e-03 | 3.85e-01 | 2.97e-01 |
| GOCC NEURONAL DENSE CORE VESICLE MEMBRANE | 5 | 1.37e-01 | -3.84e-01 | 8.06e-01 |
| GOBP CHOLINE TRANSPORT | 9 | 4.61e-02 | 3.84e-01 | 6.22e-01 |
| GOBP ANTIBACTERIAL PEPTIDE PRODUCTION | 9 | 4.61e-02 | -3.84e-01 | 6.22e-01 |
| GOBP REGULATION OF OPSONIZATION | 10 | 3.59e-02 | -3.83e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 5 | 1.38e-01 | -3.83e-01 | 8.06e-01 |
| GOMF RAGE RECEPTOR BINDING | 10 | 3.66e-02 | -3.82e-01 | 5.81e-01 |
| GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA | 5 | 1.39e-01 | -3.82e-01 | 8.06e-01 |
| GOBP HYPOTONIC RESPONSE | 13 | 1.72e-02 | -3.82e-01 | 4.71e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 10 | 3.71e-02 | -3.81e-01 | 5.82e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 2.89e-02 | -3.80e-01 | 5.52e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 2.89e-02 | -3.80e-01 | 5.52e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 2.26e-02 | 3.80e-01 | 5.08e-01 |
| GOMF TAP BINDING | 7 | 8.20e-02 | -3.80e-01 | 7.31e-01 |
| GOMF SULFATIDE BINDING | 6 | 1.08e-01 | -3.79e-01 | 7.72e-01 |
| GOCC CUTICULAR PLATE | 8 | 6.38e-02 | 3.78e-01 | 6.68e-01 |
| GOMF AMINOACYLASE ACTIVITY | 6 | 1.09e-01 | -3.78e-01 | 7.74e-01 |
| GOBP REGULATION OF SEROTONIN SECRETION | 6 | 1.09e-01 | 3.78e-01 | 7.74e-01 |
| GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY | 5 | 1.44e-01 | -3.77e-01 | 8.06e-01 |
| GOMF SOMATOSTATIN RECEPTOR ACTIVITY | 5 | 1.44e-01 | -3.77e-01 | 8.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 1.45e-01 | -3.77e-01 | 8.06e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 1.11e-01 | 3.76e-01 | 7.77e-01 |
| GOBP RIBOFLAVIN TRANSPORT | 6 | 1.11e-01 | -3.76e-01 | 7.77e-01 |
| GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.11e-01 | -3.76e-01 | 7.77e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 6 | 1.11e-01 | 3.75e-01 | 7.77e-01 |
| GOBP L ALANINE TRANSPORT | 10 | 3.99e-02 | -3.75e-01 | 6.03e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 1.46e-01 | -3.75e-01 | 8.08e-01 |
| GOCC BRCA1 A COMPLEX | 7 | 8.57e-02 | 3.75e-01 | 7.46e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 6.62e-02 | -3.75e-01 | 6.82e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 26 | 9.45e-04 | -3.75e-01 | 1.15e-01 |
| GOBP REGULATION OF LUNG BLOOD PRESSURE | 5 | 1.48e-01 | 3.73e-01 | 8.11e-01 |
| GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY | 6 | 1.14e-01 | 3.73e-01 | 7.81e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 8.77e-02 | 3.73e-01 | 7.52e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 7 | 8.77e-02 | -3.73e-01 | 7.52e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 11 | 3.24e-02 | -3.72e-01 | 5.58e-01 |
| GOBP REGULATION OF PLASMA CELL DIFFERENTIATION | 5 | 1.49e-01 | -3.72e-01 | 8.13e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 8.84e-02 | 3.72e-01 | 7.52e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 12 | 2.60e-02 | -3.71e-01 | 5.28e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 5 | 1.51e-01 | 3.71e-01 | 8.16e-01 |
| GOCC MULTIVESICULAR BODY LUMEN | 6 | 1.16e-01 | 3.71e-01 | 7.82e-01 |
| GOBP COPPER ION IMPORT | 6 | 1.16e-01 | -3.70e-01 | 7.82e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 1.16e-01 | 3.70e-01 | 7.82e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 6 | 1.17e-01 | -3.70e-01 | 7.82e-01 |
| GOMF CCR6 CHEMOKINE RECEPTOR BINDING | 5 | 1.52e-01 | -3.70e-01 | 8.17e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 11 | 3.37e-02 | 3.70e-01 | 5.59e-01 |
| GOBP OTIC VESICLE FORMATION | 8 | 7.04e-02 | -3.69e-01 | 6.96e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 14 | 1.68e-02 | 3.69e-01 | 4.68e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 13 | 2.16e-02 | -3.68e-01 | 5.02e-01 |
| GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY | 8 | 7.15e-02 | 3.68e-01 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 5 | 1.55e-01 | 3.68e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 7 | 9.25e-02 | -3.67e-01 | 7.58e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 11 | 3.50e-02 | 3.67e-01 | 5.72e-01 |
| GOCC STEREOCILIUM MEMBRANE | 6 | 1.20e-01 | -3.67e-01 | 7.87e-01 |
| GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY | 7 | 9.31e-02 | 3.67e-01 | 7.60e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 13 | 2.22e-02 | -3.66e-01 | 5.06e-01 |
| GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 1.56e-01 | 3.66e-01 | 8.17e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 1.20e-01 | 3.66e-01 | 7.89e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 9 | 5.72e-02 | -3.66e-01 | 6.57e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 14 | 1.77e-02 | -3.66e-01 | 4.77e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 9.40e-02 | 3.66e-01 | 7.64e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 7.35e-02 | 3.65e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 1.57e-01 | -3.65e-01 | 8.17e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.57e-01 | 3.65e-01 | 8.17e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 37 | 1.20e-04 | -3.65e-01 | 2.80e-02 |
| GOMF ARYL SULFOTRANSFERASE ACTIVITY | 7 | 9.42e-02 | -3.65e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 1.57e-01 | -3.65e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING | 6 | 1.22e-01 | -3.64e-01 | 7.89e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 9.52e-02 | 3.64e-01 | 7.66e-01 |
| GOMF OXYSTEROL BINDING | 8 | 7.48e-02 | -3.64e-01 | 7.12e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 9 | 5.90e-02 | -3.64e-01 | 6.61e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 12 | 2.93e-02 | 3.63e-01 | 5.52e-01 |
| GOBP TRACHEA FORMATION | 7 | 9.60e-02 | -3.63e-01 | 7.66e-01 |
| GOBP SYNAPTIC TRANSMISSION GLYCINERGIC | 5 | 1.60e-01 | -3.63e-01 | 8.20e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 12 | 2.95e-02 | 3.63e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 9 | 5.94e-02 | -3.63e-01 | 6.61e-01 |
| GOMF C X C CHEMOKINE BINDING | 5 | 1.61e-01 | -3.62e-01 | 8.21e-01 |
| GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 1.62e-01 | 3.62e-01 | 8.24e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 9 | 6.08e-02 | 3.61e-01 | 6.63e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 9 | 6.09e-02 | -3.61e-01 | 6.63e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 1.26e-01 | -3.61e-01 | 7.93e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 11 | 3.86e-02 | -3.60e-01 | 5.93e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 3.89e-02 | 3.60e-01 | 5.97e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 11 | 3.91e-02 | -3.59e-01 | 5.99e-01 |
| GOBP MEIOTIC CYTOKINESIS | 8 | 7.86e-02 | -3.59e-01 | 7.22e-01 |
| GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.28e-01 | -3.58e-01 | 7.93e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 12 | 3.16e-02 | -3.58e-01 | 5.58e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 1.29e-01 | -3.58e-01 | 7.93e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 7 | 1.01e-01 | -3.57e-01 | 7.66e-01 |
| GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION | 9 | 6.33e-02 | -3.57e-01 | 6.67e-01 |
| GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT | 6 | 1.30e-01 | 3.57e-01 | 7.93e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 8 | 8.05e-02 | -3.57e-01 | 7.26e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 1.02e-01 | -3.57e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 1.31e-01 | 3.56e-01 | 7.94e-01 |
| GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.27e-02 | 3.56e-01 | 5.58e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 3.28e-02 | 3.56e-01 | 5.58e-01 |
| GOBP EPINEPHRINE TRANSPORT | 11 | 4.11e-02 | 3.56e-01 | 6.10e-01 |
| GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY | 6 | 1.32e-01 | -3.55e-01 | 7.96e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 16 | 1.38e-02 | -3.55e-01 | 4.46e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 1.32e-01 | -3.55e-01 | 7.96e-01 |
| GOBP RIGHTING REFLEX | 8 | 8.17e-02 | -3.55e-01 | 7.30e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 11 | 4.14e-02 | -3.55e-01 | 6.10e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 1.32e-01 | 3.55e-01 | 7.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 1.04e-01 | 3.55e-01 | 7.68e-01 |
| GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION | 5 | 1.69e-01 | -3.55e-01 | 8.31e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 1.32e-01 | 3.55e-01 | 7.96e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY | 5 | 1.70e-01 | -3.54e-01 | 8.32e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 10 | 5.24e-02 | -3.54e-01 | 6.44e-01 |
| GOCC PERINUCLEOLAR COMPARTMENT | 5 | 1.70e-01 | -3.54e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 5 | 1.71e-01 | -3.54e-01 | 8.32e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 1.05e-01 | 3.54e-01 | 7.69e-01 |
| GOBP REGULATION OF CGMP MEDIATED SIGNALING | 11 | 4.27e-02 | 3.53e-01 | 6.14e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 7 | 1.07e-01 | -3.52e-01 | 7.72e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 1.73e-01 | 3.52e-01 | 8.36e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 10 | 5.40e-02 | -3.52e-01 | 6.45e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 9 | 6.79e-02 | -3.51e-01 | 6.90e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 10 | 5.49e-02 | -3.51e-01 | 6.48e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 1.75e-01 | -3.50e-01 | 8.40e-01 |
| GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX | 5 | 1.75e-01 | 3.50e-01 | 8.41e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 7 | 1.09e-01 | 3.50e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 13 | 2.90e-02 | -3.50e-01 | 5.52e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 6.94e-02 | -3.50e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 9 | 6.98e-02 | 3.49e-01 | 6.94e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 4.50e-02 | -3.49e-01 | 6.22e-01 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 1.77e-01 | 3.49e-01 | 8.41e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 5 | 1.77e-01 | -3.49e-01 | 8.41e-01 |
| GOBP RESPONSE TO OZONE | 5 | 1.77e-01 | 3.49e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 7 | 1.10e-01 | 3.48e-01 | 7.77e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 1.40e-01 | 3.48e-01 | 8.06e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 9 | 7.10e-02 | -3.48e-01 | 6.99e-01 |
| GOBP LUNG GROWTH | 6 | 1.41e-01 | -3.47e-01 | 8.06e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 1.79e-01 | 3.47e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 4.62e-02 | 3.47e-01 | 6.22e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.63e-02 | -3.47e-01 | 6.22e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 1.80e-01 | 3.46e-01 | 8.41e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 5.82e-02 | 3.46e-01 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 1.42e-01 | 3.46e-01 | 8.06e-01 |
| GOBP S SHAPED BODY MORPHOGENESIS | 7 | 1.13e-01 | 3.46e-01 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 19 | 9.11e-03 | -3.46e-01 | 3.64e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 1.81e-01 | 3.45e-01 | 8.41e-01 |
| GOMF EXTRACELLULAR MATRIX PROTEIN BINDING | 6 | 1.43e-01 | 3.45e-01 | 8.06e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 9.24e-03 | 3.45e-01 | 3.64e-01 |
| GOMF FATTY ACYL COA SYNTHASE ACTIVITY | 6 | 1.44e-01 | 3.45e-01 | 8.06e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 17 | 1.39e-02 | 3.44e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 14 | 2.60e-02 | 3.44e-01 | 5.28e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 7 | 1.15e-01 | -3.44e-01 | 7.82e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT | 5 | 1.83e-01 | -3.44e-01 | 8.42e-01 |
| GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 9.24e-02 | -3.44e-01 | 7.58e-01 |
| GOBP ADENINE TRANSPORT | 5 | 1.83e-01 | 3.44e-01 | 8.42e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 1.84e-01 | -3.43e-01 | 8.42e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 13 | 3.21e-02 | -3.43e-01 | 5.58e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 7 | 1.16e-01 | -3.43e-01 | 7.82e-01 |
| GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 7 | 1.16e-01 | -3.43e-01 | 7.82e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 1.85e-01 | 3.42e-01 | 8.43e-01 |
| GOCC CELL TIP | 5 | 1.85e-01 | 3.42e-01 | 8.43e-01 |
| GOBP SERTOLI CELL PROLIFERATION | 5 | 1.85e-01 | 3.42e-01 | 8.43e-01 |
| GOBP LEUCINE TRANSPORT | 10 | 6.17e-02 | -3.41e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING | 10 | 6.17e-02 | -3.41e-01 | 6.63e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION | 5 | 1.87e-01 | 3.41e-01 | 8.44e-01 |
| GOCC GATOR2 COMPLEX | 5 | 1.87e-01 | 3.41e-01 | 8.44e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 1.19e-01 | 3.41e-01 | 7.85e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.49e-01 | -3.40e-01 | 8.12e-01 |
| GOCC CORTICAL GRANULE | 6 | 1.49e-01 | -3.40e-01 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 9 | 7.72e-02 | -3.40e-01 | 7.18e-01 |
| GOCC SPECTRIN | 9 | 7.72e-02 | 3.40e-01 | 7.18e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 1.88e-01 | -3.40e-01 | 8.44e-01 |
| GOBP NOREPINEPHRINE UPTAKE | 8 | 9.60e-02 | 3.40e-01 | 7.66e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 1.88e-01 | 3.40e-01 | 8.44e-01 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 15 | 2.27e-02 | -3.40e-01 | 5.08e-01 |
| GOMF PYRUVATE DEHYDROGENASE LIPOAMIDE PHOSPHATASE ACTIVITY | 5 | 1.89e-01 | -3.39e-01 | 8.44e-01 |
| GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 1.90e-01 | -3.38e-01 | 8.44e-01 |
| GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS | 11 | 5.22e-02 | -3.38e-01 | 6.43e-01 |
| GOBP CANNABINOID SIGNALING PATHWAY | 9 | 7.91e-02 | -3.38e-01 | 7.24e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 9 | 7.91e-02 | -3.38e-01 | 7.24e-01 |
| GOBP MAST CELL PROLIFERATION | 7 | 1.22e-01 | -3.38e-01 | 7.89e-01 |
| GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY | 5 | 1.91e-01 | -3.38e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 5 | 1.91e-01 | 3.38e-01 | 8.44e-01 |
| GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS | 6 | 1.52e-01 | -3.38e-01 | 8.17e-01 |
| GOBP MINERALOCORTICOID SECRETION | 7 | 1.22e-01 | -3.37e-01 | 7.89e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 1.91e-01 | -3.37e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 7 | 1.22e-01 | -3.37e-01 | 7.89e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 13 | 3.52e-02 | -3.37e-01 | 5.72e-01 |
| GOCC CELL POLE | 7 | 1.23e-01 | 3.37e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 9 | 8.03e-02 | -3.37e-01 | 7.26e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 8 | 9.91e-02 | -3.37e-01 | 7.66e-01 |
| GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT | 5 | 1.92e-01 | -3.37e-01 | 8.44e-01 |
| GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 12 | 4.35e-02 | -3.37e-01 | 6.18e-01 |
| GOMF LIPOTEICHOIC ACID BINDING | 5 | 1.93e-01 | 3.36e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 8.12e-02 | -3.36e-01 | 7.29e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 1.55e-01 | -3.36e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 5 | 1.94e-01 | 3.35e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 6 | 1.55e-01 | -3.35e-01 | 8.17e-01 |
| GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 11 | 5.45e-02 | -3.35e-01 | 6.46e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 15 | 2.48e-02 | -3.35e-01 | 5.20e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 1.95e-01 | -3.35e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 1.01e-01 | -3.35e-01 | 7.66e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 10 | 6.70e-02 | 3.35e-01 | 6.85e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK | 5 | 1.96e-01 | -3.34e-01 | 8.44e-01 |
| GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.96e-01 | 3.34e-01 | 8.44e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 9 | 8.34e-02 | 3.33e-01 | 7.36e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 9 | 8.35e-02 | -3.33e-01 | 7.36e-01 |
| GOMF ALKANE 1 MONOOXYGENASE ACTIVITY | 5 | 1.97e-01 | -3.33e-01 | 8.44e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 4.60e-02 | -3.33e-01 | 6.22e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 10 | 6.96e-02 | 3.31e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 1.05e-01 | -3.31e-01 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 8 | 1.05e-01 | -3.31e-01 | 7.69e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 11 | 5.74e-02 | -3.31e-01 | 6.57e-01 |
| GOMF HEMOGLOBIN BINDING | 9 | 8.61e-02 | -3.30e-01 | 7.47e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 16 | 2.22e-02 | 3.30e-01 | 5.06e-01 |
| GOBP OVIDUCT DEVELOPMENT | 5 | 2.01e-01 | 3.30e-01 | 8.49e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 1.62e-01 | -3.30e-01 | 8.24e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 1.06e-01 | 3.30e-01 | 7.72e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 35 | 7.39e-04 | -3.30e-01 | 1.01e-01 |
| GOBP RESPONSE TO FUNGUS | 62 | 7.35e-06 | -3.29e-01 | 3.42e-03 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 13 | 4.00e-02 | -3.29e-01 | 6.03e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 52 | 4.08e-05 | -3.29e-01 | 1.35e-02 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 25 | 4.43e-03 | -3.29e-01 | 2.59e-01 |
| GOBP INTRACELLULAR WATER HOMEOSTASIS | 6 | 1.63e-01 | 3.29e-01 | 8.24e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 6.01e-02 | 3.27e-01 | 6.62e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 9 | 8.91e-02 | -3.27e-01 | 7.52e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 8 | 1.09e-01 | 3.27e-01 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 7.35e-02 | 3.27e-01 | 7.07e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 6 | 1.67e-01 | -3.26e-01 | 8.28e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 2.07e-01 | -3.26e-01 | 8.51e-01 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 2.08e-01 | 3.25e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 9 | 9.11e-02 | -3.25e-01 | 7.55e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 2.08e-01 | 3.25e-01 | 8.51e-01 |
| GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT | 8 | 1.11e-01 | -3.25e-01 | 7.77e-01 |
| GOBP REGULATION OF BILE ACID SECRETION | 6 | 1.68e-01 | -3.25e-01 | 8.31e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 6 | 1.68e-01 | -3.25e-01 | 8.31e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 1.12e-01 | 3.25e-01 | 7.77e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 23 | 7.05e-03 | -3.25e-01 | 3.25e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 7.58e-02 | -3.24e-01 | 7.17e-01 |
| GOMF RETINOL BINDING | 16 | 2.49e-02 | -3.24e-01 | 5.20e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.25e-02 | -3.24e-01 | 7.58e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 7 | 1.38e-01 | -3.24e-01 | 8.06e-01 |
| GOMF BMP RECEPTOR BINDING | 11 | 6.31e-02 | -3.24e-01 | 6.67e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 10 | 7.65e-02 | 3.23e-01 | 7.18e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 1.70e-01 | 3.23e-01 | 8.32e-01 |
| GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE | 5 | 2.11e-01 | 3.23e-01 | 8.53e-01 |
| GOBP PHENOTYPIC SWITCHING | 16 | 2.53e-02 | -3.23e-01 | 5.24e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 6 | 1.71e-01 | -3.23e-01 | 8.32e-01 |
| GOBP MESONEPHRIC TUBULE FORMATION | 10 | 7.71e-02 | 3.23e-01 | 7.18e-01 |
| GOBP HAIR CYCLE PHASE | 9 | 9.41e-02 | 3.22e-01 | 7.64e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 1.40e-01 | 3.22e-01 | 8.06e-01 |
| GOMF TRAIL BINDING | 5 | 2.12e-01 | 3.22e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 66 | 6.01e-06 | -3.22e-01 | 3.19e-03 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 8 | 1.15e-01 | 3.22e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 26 | 4.49e-03 | -3.22e-01 | 2.61e-01 |
| GOBP NORADRENERGIC NEURON DIFFERENTIATION | 10 | 7.82e-02 | 3.22e-01 | 7.20e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 10 | 7.83e-02 | -3.22e-01 | 7.20e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 12 | 5.39e-02 | 3.21e-01 | 6.45e-01 |
| GOBP COP9 SIGNALOSOME ASSEMBLY | 5 | 2.13e-01 | 3.21e-01 | 8.54e-01 |
| GOBP REFLEX | 21 | 1.08e-02 | -3.21e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 5.41e-02 | -3.21e-01 | 6.45e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 2.15e-01 | -3.20e-01 | 8.55e-01 |
| GOBP CAMP METABOLIC PROCESS | 23 | 7.80e-03 | -3.20e-01 | 3.43e-01 |
| GOBP TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE | 5 | 2.15e-01 | -3.20e-01 | 8.55e-01 |
| GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY | 17 | 2.22e-02 | 3.20e-01 | 5.06e-01 |
| GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION | 10 | 7.96e-02 | -3.20e-01 | 7.25e-01 |
| GOBP UREA TRANSMEMBRANE TRANSPORT | 9 | 9.64e-02 | -3.20e-01 | 7.66e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 1.17e-01 | 3.20e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 1.43e-01 | -3.20e-01 | 8.06e-01 |
| GOBP INTESTINAL STEM CELL HOMEOSTASIS | 6 | 1.76e-01 | -3.19e-01 | 8.41e-01 |
| GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION | 5 | 2.16e-01 | 3.19e-01 | 8.56e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 6 | 1.76e-01 | -3.19e-01 | 8.41e-01 |
| GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 1.77e-01 | -3.18e-01 | 8.41e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY | 7 | 1.45e-01 | 3.18e-01 | 8.06e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 1.19e-01 | -3.18e-01 | 7.87e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 2.18e-01 | 3.18e-01 | 8.56e-01 |
| GOBP MACROPHAGE FUSION | 6 | 1.77e-01 | -3.18e-01 | 8.41e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 2.19e-01 | 3.18e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 3.98e-02 | -3.17e-01 | 6.03e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 1.20e-01 | -3.17e-01 | 7.89e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 15 | 3.34e-02 | -3.17e-01 | 5.58e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 11 | 6.86e-02 | 3.17e-01 | 6.94e-01 |
| GOMF TELETHONIN BINDING | 7 | 1.47e-01 | -3.17e-01 | 8.08e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 9 | 1.00e-01 | 3.16e-01 | 7.66e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 10 | 8.33e-02 | 3.16e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 2.21e-01 | 3.16e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 17 | 2.41e-02 | 3.16e-01 | 5.17e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 8 | 1.22e-01 | 3.16e-01 | 7.89e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 8 | 1.22e-01 | -3.16e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 6 | 1.81e-01 | -3.16e-01 | 8.41e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 6 | 1.81e-01 | -3.15e-01 | 8.41e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 23 | 8.85e-03 | -3.15e-01 | 3.60e-01 |
| GOBP CAMP CATABOLIC PROCESS | 9 | 1.01e-01 | -3.15e-01 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS | 5 | 2.22e-01 | 3.15e-01 | 8.57e-01 |
| GOBP HARD PALATE DEVELOPMENT | 8 | 1.23e-01 | 3.15e-01 | 7.92e-01 |
| GOCC FHF COMPLEX | 5 | 2.24e-01 | 3.14e-01 | 8.57e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 2.24e-01 | -3.14e-01 | 8.57e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 1.83e-01 | 3.14e-01 | 8.42e-01 |
| GOBP INDUCTION OF BACTERIAL AGGLUTINATION | 6 | 1.84e-01 | -3.13e-01 | 8.42e-01 |
| GOCC POLE PLASM | 24 | 7.89e-03 | -3.13e-01 | 3.44e-01 |
| GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION | 5 | 2.25e-01 | 3.13e-01 | 8.59e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 19 | 1.83e-02 | -3.13e-01 | 4.77e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 8 | 1.26e-01 | 3.13e-01 | 7.93e-01 |
| GOCC STEREOCILIA COUPLING LINK | 7 | 1.52e-01 | -3.12e-01 | 8.17e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 22 | 1.12e-02 | -3.12e-01 | 4.02e-01 |
| GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 5 | 2.27e-01 | -3.12e-01 | 8.62e-01 |
| GOBP CILIARY BASAL BODY ORGANIZATION | 5 | 2.28e-01 | 3.12e-01 | 8.62e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 2.28e-01 | 3.11e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 1.28e-01 | 3.11e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 3.12e-02 | 3.11e-01 | 5.56e-01 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 12 | 6.22e-02 | -3.11e-01 | 6.63e-01 |
| GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 9 | 1.07e-01 | 3.11e-01 | 7.72e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 7 | 1.55e-01 | -3.10e-01 | 8.17e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM | 6 | 1.88e-01 | -3.10e-01 | 8.44e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 5 | 2.30e-01 | -3.10e-01 | 8.62e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 10 | 8.99e-02 | 3.10e-01 | 7.52e-01 |
| GOCC CYTOLYTIC GRANULE | 13 | 5.32e-02 | -3.10e-01 | 6.45e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 8 | 1.29e-01 | 3.10e-01 | 7.93e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 6 | 1.89e-01 | 3.09e-01 | 8.44e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 9 | 1.08e-01 | -3.09e-01 | 7.73e-01 |
| GOMF XMP 5 NUCLEOSIDASE ACTIVITY | 6 | 1.90e-01 | -3.09e-01 | 8.44e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT | 5 | 2.32e-01 | -3.09e-01 | 8.63e-01 |
| GOBP CELLULAR RESPONSE TO UV C | 5 | 2.32e-01 | 3.09e-01 | 8.63e-01 |
| GOMF PHOTORECEPTOR ACTIVITY | 13 | 5.41e-02 | 3.08e-01 | 6.45e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 1.91e-01 | 3.08e-01 | 8.44e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 6 | 1.92e-01 | 3.08e-01 | 8.44e-01 |
| GOBP SENSORY PERCEPTION OF UMAMI TASTE | 7 | 1.59e-01 | -3.08e-01 | 8.19e-01 |
| GOBP RENAL PROTEIN ABSORPTION | 7 | 1.59e-01 | 3.07e-01 | 8.19e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 1.92e-01 | 3.07e-01 | 8.44e-01 |
| GOBP MONOCYTE ACTIVATION | 12 | 6.52e-02 | -3.07e-01 | 6.80e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 2.34e-01 | -3.07e-01 | 8.64e-01 |
| GOBP MUSCLE CELL FATE COMMITMENT | 20 | 1.75e-02 | 3.07e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING | 5 | 2.35e-01 | 3.07e-01 | 8.64e-01 |
| GOMF SIALIC ACID BINDING | 22 | 1.28e-02 | -3.07e-01 | 4.32e-01 |
| GOBP HINDBRAIN MATURATION | 5 | 2.36e-01 | 3.06e-01 | 8.64e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 7 | 1.61e-01 | -3.06e-01 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 19 | 2.11e-02 | -3.06e-01 | 4.96e-01 |
| GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE | 6 | 1.95e-01 | -3.05e-01 | 8.44e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 2.37e-01 | 3.05e-01 | 8.64e-01 |
| GOBP OPTIC NERVE MORPHOGENESIS | 6 | 1.95e-01 | -3.05e-01 | 8.44e-01 |
| GOBP LUNG LOBE DEVELOPMENT | 7 | 1.62e-01 | -3.05e-01 | 8.24e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 9 | 1.13e-01 | 3.05e-01 | 7.80e-01 |
| GOBP PIRNA PROCESSING | 23 | 1.13e-02 | -3.05e-01 | 4.04e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 17 | 2.97e-02 | -3.05e-01 | 5.52e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 7 | 1.63e-01 | -3.04e-01 | 8.24e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 1.97e-01 | 3.04e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 1.97e-01 | -3.04e-01 | 8.44e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 26 | 7.28e-03 | 3.04e-01 | 3.33e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 14 | 4.89e-02 | 3.04e-01 | 6.28e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 15 | 4.15e-02 | -3.04e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 9.63e-02 | -3.04e-01 | 7.66e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 10 | 9.64e-02 | -3.04e-01 | 7.66e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 2.40e-01 | 3.03e-01 | 8.64e-01 |
| GOCC DENSE BODY | 5 | 2.40e-01 | -3.03e-01 | 8.64e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 1.65e-01 | 3.03e-01 | 8.24e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 3.05e-02 | 3.03e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 2.41e-01 | -3.03e-01 | 8.64e-01 |
| GOBP PARANODAL JUNCTION ASSEMBLY | 6 | 1.99e-01 | 3.03e-01 | 8.45e-01 |
| GOCC SEROTONIN ACTIVATED CATION SELECTIVE CHANNEL COMPLEX | 5 | 2.41e-01 | -3.03e-01 | 8.64e-01 |
| GOMF SEROTONIN GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 5 | 2.41e-01 | -3.03e-01 | 8.64e-01 |
| GOCC EARLY PHAGOSOME | 12 | 6.94e-02 | -3.03e-01 | 6.94e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 14 | 5.00e-02 | 3.03e-01 | 6.31e-01 |
| GOBP MYCOTOXIN METABOLIC PROCESS | 6 | 1.99e-01 | 3.03e-01 | 8.46e-01 |
| GOBP CMP METABOLIC PROCESS | 8 | 1.38e-01 | -3.02e-01 | 8.06e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 18 | 2.63e-02 | 3.02e-01 | 5.28e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 2.00e-01 | 3.02e-01 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 2.00e-01 | 3.02e-01 | 8.47e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 5 | 2.42e-01 | -3.02e-01 | 8.64e-01 |
| GOBP FAT PAD DEVELOPMENT | 8 | 1.39e-01 | 3.02e-01 | 8.06e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 1.39e-01 | -3.02e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 10 | 9.83e-02 | 3.02e-01 | 7.66e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 1.40e-01 | 3.01e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION | 7 | 1.67e-01 | 3.01e-01 | 8.31e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 2.43e-01 | -3.01e-01 | 8.64e-01 |
| GOBP CELLULAR RESPONSE TO AMMONIUM ION | 5 | 2.44e-01 | -3.01e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY | 9 | 1.18e-01 | -3.01e-01 | 7.82e-01 |
| GOBP DNA DEAMINATION | 13 | 6.03e-02 | 3.01e-01 | 6.62e-01 |
| GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS | 5 | 2.44e-01 | 3.01e-01 | 8.64e-01 |
| GOBP ETHANOL CATABOLIC PROCESS | 10 | 9.95e-02 | -3.01e-01 | 7.66e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 2.02e-01 | 3.01e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 7 | 1.68e-01 | 3.01e-01 | 8.31e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 7 | 1.69e-01 | 3.00e-01 | 8.31e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 2.03e-01 | 3.00e-01 | 8.51e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 10 | 1.00e-01 | -3.00e-01 | 7.66e-01 |
| GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE | 5 | 2.45e-01 | 3.00e-01 | 8.65e-01 |
| GOBP MESANGIAL CELL DIFFERENTIATION | 7 | 1.69e-01 | 3.00e-01 | 8.31e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 11 | 8.48e-02 | 3.00e-01 | 7.42e-01 |
| GOCC ELASTIC FIBER | 5 | 2.45e-01 | -3.00e-01 | 8.65e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 1.69e-01 | 3.00e-01 | 8.31e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 2.46e-01 | -3.00e-01 | 8.65e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 12 | 7.22e-02 | 3.00e-01 | 7.02e-01 |
| GOMF INTERFERON RECEPTOR ACTIVITY | 5 | 2.46e-01 | -3.00e-01 | 8.65e-01 |
| GOMF PROFILIN BINDING | 10 | 1.01e-01 | 2.99e-01 | 7.66e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 14 | 5.27e-02 | 2.99e-01 | 6.45e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 1.71e-01 | -2.99e-01 | 8.32e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 9 | 1.20e-01 | -2.99e-01 | 7.89e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 9 | 1.20e-01 | -2.99e-01 | 7.89e-01 |
| GOCC CENTRAL ELEMENT | 7 | 1.71e-01 | 2.99e-01 | 8.32e-01 |
| GOMF LIM DOMAIN BINDING | 5 | 2.48e-01 | 2.99e-01 | 8.65e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 9 | 1.21e-01 | -2.98e-01 | 7.89e-01 |
| GOCC PI BODY | 10 | 1.02e-01 | -2.98e-01 | 7.66e-01 |
| GOBP ABSCISSION | 6 | 2.06e-01 | -2.98e-01 | 8.51e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 19 | 2.46e-02 | -2.98e-01 | 5.19e-01 |
| GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY | 7 | 1.72e-01 | 2.98e-01 | 8.36e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 1.73e-01 | -2.98e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 7 | 1.73e-01 | 2.98e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 10 | 1.03e-01 | -2.97e-01 | 7.67e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 9 | 1.23e-01 | -2.97e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 8.80e-02 | 2.97e-01 | 7.52e-01 |
| GOBP REGULATION OF COA TRANSFERASE ACTIVITY | 10 | 1.04e-01 | -2.97e-01 | 7.68e-01 |
| GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY | 6 | 2.08e-01 | -2.97e-01 | 8.51e-01 |
| GOBP RRNA TRANSPORT | 5 | 2.51e-01 | -2.97e-01 | 8.65e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 2.51e-01 | 2.97e-01 | 8.65e-01 |
| GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS | 7 | 1.74e-01 | -2.97e-01 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 5 | 2.51e-01 | 2.97e-01 | 8.65e-01 |
| GOMF BUBBLE DNA BINDING | 8 | 1.46e-01 | -2.96e-01 | 8.08e-01 |
| GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX | 5 | 2.51e-01 | -2.96e-01 | 8.65e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 15 | 4.71e-02 | 2.96e-01 | 6.25e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 5 | 2.52e-01 | 2.96e-01 | 8.65e-01 |
| GOCC FACIT COLLAGEN TRIMER | 6 | 2.10e-01 | -2.96e-01 | 8.53e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 2.10e-01 | -2.96e-01 | 8.53e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 8 | 1.48e-01 | -2.96e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINE SECRETION | 6 | 2.10e-01 | 2.95e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 11 | 9.02e-02 | 2.95e-01 | 7.52e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 11 | 9.03e-02 | 2.95e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION | 5 | 2.54e-01 | 2.95e-01 | 8.65e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 6 | 2.12e-01 | 2.94e-01 | 8.54e-01 |
| GOBP INTERKINETIC NUCLEAR MIGRATION | 5 | 2.55e-01 | 2.94e-01 | 8.65e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 6 | 2.13e-01 | -2.94e-01 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 11 | 9.16e-02 | 2.94e-01 | 7.57e-01 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION | 9 | 1.27e-01 | -2.94e-01 | 7.93e-01 |
| GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY | 5 | 2.56e-01 | -2.94e-01 | 8.65e-01 |
| GOBP VESICLE UNCOATING | 8 | 1.51e-01 | 2.93e-01 | 8.15e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 1.51e-01 | 2.93e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION | 5 | 2.56e-01 | 2.93e-01 | 8.65e-01 |
| GOBP ARTICULAR CARTILAGE DEVELOPMENT | 5 | 2.56e-01 | 2.93e-01 | 8.65e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 3.14e-02 | 2.93e-01 | 5.57e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 16 | 4.25e-02 | -2.93e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 2.57e-01 | -2.93e-01 | 8.65e-01 |
| GOMF KETOSTEROID MONOOXYGENASE ACTIVITY | 5 | 2.57e-01 | -2.93e-01 | 8.65e-01 |
| GOBP RESPONSE TO L ASCORBIC ACID | 6 | 2.15e-01 | 2.92e-01 | 8.55e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 82 | 4.73e-06 | -2.92e-01 | 2.85e-03 |
| GOCC SMN COMPLEX | 9 | 1.29e-01 | 2.92e-01 | 7.93e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 1.29e-01 | 2.92e-01 | 7.93e-01 |
| GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING | 8 | 1.53e-01 | -2.92e-01 | 8.17e-01 |
| GOBP SKELETAL MUSCLE ATROPHY | 5 | 2.59e-01 | -2.92e-01 | 8.66e-01 |
| GOBP T CELL CHEMOTAXIS | 26 | 1.01e-02 | -2.91e-01 | 3.83e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 7 | 1.82e-01 | -2.91e-01 | 8.42e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL | 6 | 2.18e-01 | -2.91e-01 | 8.56e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 1.31e-01 | 2.91e-01 | 7.94e-01 |
| GOMF AMINO ACID PROTON SYMPORTER ACTIVITY | 6 | 2.18e-01 | -2.91e-01 | 8.56e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 1.55e-01 | -2.90e-01 | 8.17e-01 |
| GOBP LOOP OF HENLE DEVELOPMENT | 12 | 8.20e-02 | 2.90e-01 | 7.31e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 2.19e-01 | 2.90e-01 | 8.56e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 14 | 6.04e-02 | -2.90e-01 | 6.62e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.32e-01 | -2.90e-01 | 7.96e-01 |
| GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 2.62e-01 | -2.90e-01 | 8.67e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE FORMATION | 11 | 9.65e-02 | 2.89e-01 | 7.66e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 10 | 1.13e-01 | -2.89e-01 | 7.80e-01 |
| GOBP REGULATION OF THYROID HORMONE GENERATION | 7 | 1.85e-01 | 2.89e-01 | 8.43e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 2.63e-01 | 2.89e-01 | 8.68e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 1.14e-01 | 2.89e-01 | 7.81e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 21 | 2.19e-02 | -2.89e-01 | 5.04e-01 |
| GOMF GLUTAMATE BINDING | 8 | 1.57e-01 | -2.89e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION | 5 | 2.64e-01 | -2.88e-01 | 8.69e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 10 | 1.14e-01 | -2.88e-01 | 7.81e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 7.19e-02 | 2.88e-01 | 7.01e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 9 | 1.35e-01 | 2.88e-01 | 8.04e-01 |
| GOMF BENZODIAZEPINE RECEPTOR ACTIVITY | 9 | 1.35e-01 | 2.88e-01 | 8.05e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 94 | 1.44e-06 | -2.88e-01 | 1.23e-03 |
| GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY | 5 | 2.66e-01 | 2.88e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 28 | 8.46e-03 | -2.87e-01 | 3.55e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.23e-01 | -2.87e-01 | 8.57e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 7 | 1.88e-01 | -2.87e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 11 | 9.92e-02 | -2.87e-01 | 7.66e-01 |
| GOMF LBD DOMAIN BINDING | 6 | 2.23e-01 | -2.87e-01 | 8.57e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 17 | 4.05e-02 | -2.87e-01 | 6.08e-01 |
| GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY | 8 | 1.60e-01 | -2.87e-01 | 8.20e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 13 | 7.33e-02 | -2.87e-01 | 7.07e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 15 | 5.44e-02 | -2.87e-01 | 6.46e-01 |
| GOBP MONOCYTE AGGREGATION | 5 | 2.67e-01 | 2.87e-01 | 8.69e-01 |
| GOCC INNER ACROSOMAL MEMBRANE | 5 | 2.67e-01 | -2.87e-01 | 8.69e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 1.60e-01 | -2.87e-01 | 8.20e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 2.67e-01 | 2.87e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 17 | 4.07e-02 | 2.87e-01 | 6.08e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 31 | 5.74e-03 | -2.87e-01 | 2.92e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 18 | 3.53e-02 | -2.87e-01 | 5.73e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 26 | 1.15e-02 | -2.86e-01 | 4.05e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.90e-01 | -2.86e-01 | 8.44e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 1.00e-01 | 2.86e-01 | 7.66e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 10 | 1.17e-01 | -2.86e-01 | 7.82e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 1.18e-01 | 2.86e-01 | 7.82e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 18 | 3.59e-02 | -2.86e-01 | 5.75e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 21 | 2.34e-02 | 2.86e-01 | 5.17e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 11 | 1.01e-01 | -2.86e-01 | 7.66e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 6 | 2.26e-01 | 2.86e-01 | 8.59e-01 |
| GOBP BLEB ASSEMBLY | 11 | 1.01e-01 | -2.85e-01 | 7.66e-01 |
| GOBP MONOCYTE EXTRAVASATION | 10 | 1.18e-01 | -2.85e-01 | 7.85e-01 |
| GOBP LYSINE METABOLIC PROCESS | 8 | 1.63e-01 | -2.85e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.63e-01 | 2.85e-01 | 8.24e-01 |
| GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY | 5 | 2.70e-01 | -2.85e-01 | 8.69e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 9 | 1.39e-01 | -2.85e-01 | 8.06e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 13 | 7.58e-02 | 2.84e-01 | 7.17e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 11 | 1.02e-01 | -2.84e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 5 | 2.71e-01 | -2.84e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 2.71e-01 | 2.84e-01 | 8.69e-01 |
| GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS | 6 | 2.29e-01 | 2.84e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 22 | 2.13e-02 | -2.84e-01 | 4.98e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 11 | 1.03e-01 | 2.84e-01 | 7.67e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 4.96e-02 | 2.83e-01 | 6.28e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.65e-01 | 2.83e-01 | 8.25e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 7 | 1.94e-01 | 2.83e-01 | 8.44e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 9 | 1.41e-01 | 2.83e-01 | 8.06e-01 |
| GOMF RS DOMAIN BINDING | 5 | 2.73e-01 | -2.83e-01 | 8.69e-01 |
| GOBP HEME TRANSPORT | 9 | 1.41e-01 | 2.83e-01 | 8.06e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 12 | 8.98e-02 | -2.83e-01 | 7.52e-01 |
| GOMF CONNEXIN BINDING | 5 | 2.73e-01 | -2.83e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 8 | 1.66e-01 | -2.83e-01 | 8.27e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 2.30e-01 | 2.83e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 15 | 5.81e-02 | -2.83e-01 | 6.58e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 2.75e-01 | -2.82e-01 | 8.69e-01 |
| GOBP REGULATION OF ARACHIDONIC ACID SECRETION | 7 | 1.97e-01 | -2.82e-01 | 8.44e-01 |
| GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 1.69e-01 | 2.81e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 8 | 1.69e-01 | -2.81e-01 | 8.31e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 6 | 2.34e-01 | 2.81e-01 | 8.64e-01 |
| GOBP SEPTUM PRIMUM DEVELOPMENT | 5 | 2.77e-01 | 2.81e-01 | 8.70e-01 |
| GOBP CORNIFICATION | 9 | 1.45e-01 | -2.81e-01 | 8.06e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 22 | 2.28e-02 | -2.80e-01 | 5.08e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 1.25e-01 | -2.80e-01 | 7.93e-01 |
| GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY | 5 | 2.78e-01 | -2.80e-01 | 8.70e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 14 | 6.94e-02 | 2.80e-01 | 6.94e-01 |
| GOBP DETECTION OF CELL DENSITY | 9 | 1.45e-01 | -2.80e-01 | 8.07e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 26 | 1.34e-02 | -2.80e-01 | 4.44e-01 |
| GOBP REVERSIBLE DIFFERENTIATION | 11 | 1.08e-01 | -2.80e-01 | 7.72e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 14 | 6.95e-02 | -2.80e-01 | 6.94e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 10 | 1.25e-01 | 2.80e-01 | 7.93e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 2.79e-01 | 2.80e-01 | 8.71e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 1.71e-01 | -2.79e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 1.47e-01 | 2.79e-01 | 8.08e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 12 | 9.41e-02 | -2.79e-01 | 7.64e-01 |
| GOMF HMG BOX DOMAIN BINDING | 13 | 8.15e-02 | 2.79e-01 | 7.30e-01 |
| GOBP REGULATION OF MITOPHAGY | 15 | 6.17e-02 | 2.79e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 21 | 2.71e-02 | -2.79e-01 | 5.34e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 6 | 2.37e-01 | 2.79e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 2.37e-01 | -2.78e-01 | 8.64e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 17 | 4.68e-02 | 2.78e-01 | 6.25e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 2.38e-01 | -2.78e-01 | 8.64e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 7 | 2.03e-01 | -2.78e-01 | 8.51e-01 |
| GOBP ATRIOVENTRICULAR NODE DEVELOPMENT | 9 | 1.49e-01 | 2.78e-01 | 8.12e-01 |
| GOBP CRANIAL NERVE FORMATION | 10 | 1.28e-01 | 2.78e-01 | 7.93e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 7 | 2.04e-01 | -2.77e-01 | 8.51e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 12 | 9.65e-02 | -2.77e-01 | 7.66e-01 |
| GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 2.84e-01 | 2.77e-01 | 8.74e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 10 | 1.30e-01 | -2.77e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 1.51e-01 | -2.77e-01 | 8.15e-01 |
| GOBP REGULATION OF OSTEOCLAST PROLIFERATION | 6 | 2.41e-01 | -2.77e-01 | 8.64e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 17 | 4.84e-02 | -2.77e-01 | 6.28e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 11 | 1.12e-01 | 2.76e-01 | 7.78e-01 |
| GOCC BRISC COMPLEX | 5 | 2.84e-01 | 2.76e-01 | 8.74e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 12 | 9.73e-02 | -2.76e-01 | 7.66e-01 |
| GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT | 7 | 2.05e-01 | 2.76e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 14 | 7.35e-02 | 2.76e-01 | 7.07e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 2.06e-01 | -2.76e-01 | 8.51e-01 |
| GOBP GLUTATHIONE CATABOLIC PROCESS | 6 | 2.42e-01 | 2.76e-01 | 8.64e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE | 7 | 2.06e-01 | -2.76e-01 | 8.51e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 16 | 5.61e-02 | 2.76e-01 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 5 | 2.86e-01 | -2.76e-01 | 8.75e-01 |
| GOBP RESPONSE TO FOOD | 35 | 4.80e-03 | 2.75e-01 | 2.69e-01 |
| GOCC GLYCINERGIC SYNAPSE | 7 | 2.07e-01 | -2.75e-01 | 8.51e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 12 | 9.86e-02 | 2.75e-01 | 7.66e-01 |
| GOBP SYNAPSE PRUNING | 14 | 7.47e-02 | -2.75e-01 | 7.12e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 1.54e-01 | -2.75e-01 | 8.17e-01 |
| GOMF MYOSIN LIGHT CHAIN BINDING | 8 | 1.79e-01 | -2.74e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 6 | 2.45e-01 | 2.74e-01 | 8.65e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 10 | 1.33e-01 | 2.74e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 1.55e-01 | 2.74e-01 | 8.17e-01 |
| GOCC SPERM CONNECTING PIECE | 9 | 1.55e-01 | -2.74e-01 | 8.17e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 22 | 2.63e-02 | -2.74e-01 | 5.28e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 26 | 1.57e-02 | 2.74e-01 | 4.66e-01 |
| GOBP AMINO ACID SALVAGE | 7 | 2.10e-01 | 2.73e-01 | 8.53e-01 |
| GOMF AMINE BINDING | 11 | 1.16e-01 | 2.73e-01 | 7.82e-01 |
| GOBP OTOLITH MORPHOGENESIS | 5 | 2.90e-01 | -2.73e-01 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 15 | 6.67e-02 | -2.73e-01 | 6.83e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 4.46e-02 | -2.73e-01 | 6.22e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 1.56e-01 | -2.73e-01 | 8.17e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 21 | 3.03e-02 | 2.73e-01 | 5.54e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 17 | 5.19e-02 | -2.72e-01 | 6.42e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 12 | 1.02e-01 | 2.72e-01 | 7.66e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.48e-01 | -2.72e-01 | 8.65e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 1.82e-01 | 2.72e-01 | 8.42e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 26 | 1.64e-02 | -2.72e-01 | 4.68e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 8 | 1.83e-01 | -2.72e-01 | 8.42e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 2.93e-01 | -2.72e-01 | 8.79e-01 |
| GOBP THYROID HORMONE TRANSPORT | 10 | 1.37e-01 | 2.72e-01 | 8.06e-01 |
| GOMF U3 SNORNA BINDING | 10 | 1.37e-01 | 2.71e-01 | 8.06e-01 |
| GOBP TAURINE TRANSPORT | 8 | 1.84e-01 | 2.71e-01 | 8.42e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 17 | 5.29e-02 | -2.71e-01 | 6.45e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 6 | 2.50e-01 | -2.71e-01 | 8.65e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 9.08e-02 | 2.71e-01 | 7.54e-01 |
| GOBP R LOOP PROCESSING | 6 | 2.51e-01 | 2.71e-01 | 8.65e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 9 | 1.60e-01 | 2.71e-01 | 8.20e-01 |
| GOBP ADENOSINE TRANSPORT | 5 | 2.95e-01 | 2.71e-01 | 8.82e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE | 5 | 2.95e-01 | -2.70e-01 | 8.82e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 10 | 1.39e-01 | -2.70e-01 | 8.06e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 1.39e-01 | 2.70e-01 | 8.06e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.21e-01 | -2.70e-01 | 7.89e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 19 | 4.15e-02 | 2.70e-01 | 6.10e-01 |
| GOBP MYOBLAST MIGRATION | 13 | 9.18e-02 | 2.70e-01 | 7.57e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 8 | 1.86e-01 | 2.70e-01 | 8.44e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 21 | 3.24e-02 | 2.70e-01 | 5.58e-01 |
| GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION | 6 | 2.53e-01 | -2.70e-01 | 8.65e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 11 | 1.22e-01 | -2.70e-01 | 7.89e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 7 | 2.17e-01 | -2.70e-01 | 8.56e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 2.97e-01 | 2.69e-01 | 8.82e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 16 | 6.20e-02 | 2.69e-01 | 6.63e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 20 | 3.71e-02 | -2.69e-01 | 5.82e-01 |
| GOBP CHEMOREPULSION OF AXON | 6 | 2.54e-01 | -2.69e-01 | 8.65e-01 |
| GOCC U6 SNRNP | 8 | 1.87e-01 | 2.69e-01 | 8.44e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 6 | 2.54e-01 | 2.69e-01 | 8.65e-01 |
| GOBP PODOCYTE CELL MIGRATION | 7 | 2.19e-01 | -2.69e-01 | 8.56e-01 |
| GOMF LNCRNA BINDING | 18 | 4.89e-02 | 2.68e-01 | 6.28e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 11 | 1.24e-01 | 2.68e-01 | 7.93e-01 |
| GOCC POLAR MICROTUBULE | 5 | 2.99e-01 | 2.68e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 20 | 3.81e-02 | -2.68e-01 | 5.91e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 9 | 1.64e-01 | 2.68e-01 | 8.24e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 6 | 2.57e-01 | -2.67e-01 | 8.65e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 2.21e-01 | -2.67e-01 | 8.56e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 2.58e-01 | -2.67e-01 | 8.65e-01 |
| GOBP AGGRESSIVE BEHAVIOR | 7 | 2.22e-01 | -2.67e-01 | 8.57e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 12 | 1.10e-01 | 2.66e-01 | 7.76e-01 |
| GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION | 5 | 3.02e-01 | 2.66e-01 | 8.84e-01 |
| GOBP RHOMBOMERE DEVELOPMENT | 8 | 1.92e-01 | 2.66e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 2.60e-01 | -2.66e-01 | 8.66e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 20 | 3.97e-02 | -2.66e-01 | 6.03e-01 |
| GOBP FUSED ANTRUM STAGE | 6 | 2.60e-01 | -2.66e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY | 8 | 1.93e-01 | -2.66e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 10 | 1.46e-01 | 2.66e-01 | 8.08e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 2.60e-01 | -2.65e-01 | 8.66e-01 |
| GOBP SHORT TERM MEMORY | 10 | 1.46e-01 | -2.65e-01 | 8.08e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 12 | 1.11e-01 | 2.65e-01 | 7.77e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 12 | 1.11e-01 | 2.65e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 11 | 1.28e-01 | -2.65e-01 | 7.93e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 36 | 5.88e-03 | -2.65e-01 | 2.93e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 29 | 1.34e-02 | -2.65e-01 | 4.44e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 2.24e-01 | -2.65e-01 | 8.58e-01 |
| GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS | 8 | 1.94e-01 | 2.65e-01 | 8.44e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 8 | 1.94e-01 | -2.65e-01 | 8.44e-01 |
| GOBP BLOOD VESSEL MATURATION | 8 | 1.94e-01 | -2.65e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 34 | 7.51e-03 | 2.65e-01 | 3.39e-01 |
| GOBP URATE METABOLIC PROCESS | 12 | 1.12e-01 | -2.65e-01 | 7.78e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 1.37e-02 | 2.65e-01 | 4.46e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 18 | 5.20e-02 | -2.65e-01 | 6.43e-01 |
| GOCC POSTSYNAPTIC ENDOCYTIC ZONE | 5 | 3.06e-01 | -2.64e-01 | 8.85e-01 |
| GOBP PROTEIN REPAIR | 7 | 2.26e-01 | -2.64e-01 | 8.59e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 6 | 2.62e-01 | 2.64e-01 | 8.68e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 8 | 1.95e-01 | 2.64e-01 | 8.44e-01 |
| GOBP BIOLOGICAL PHASE | 11 | 1.29e-01 | 2.64e-01 | 7.93e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 15 | 7.66e-02 | -2.64e-01 | 7.18e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 2.63e-01 | 2.64e-01 | 8.68e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 9 | 1.71e-01 | 2.64e-01 | 8.32e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 22 | 3.23e-02 | 2.64e-01 | 5.58e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 26 | 2.00e-02 | 2.64e-01 | 4.91e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 1.71e-01 | -2.63e-01 | 8.32e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 6 | 2.64e-01 | -2.63e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF OPSONIZATION | 8 | 1.98e-01 | -2.63e-01 | 8.44e-01 |
| GOCC DYSTROGLYCAN COMPLEX | 7 | 2.29e-01 | 2.63e-01 | 8.62e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 1.50e-01 | -2.63e-01 | 8.14e-01 |
| GOCC GEMINI OF COILED BODIES | 11 | 1.31e-01 | 2.63e-01 | 7.95e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 13 | 1.01e-01 | 2.63e-01 | 7.66e-01 |
| GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS | 7 | 2.29e-01 | -2.63e-01 | 8.62e-01 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 3.09e-01 | -2.63e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 3.09e-01 | 2.63e-01 | 8.87e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 17 | 6.08e-02 | -2.63e-01 | 6.63e-01 |
| GOBP MAMMARY GLAND INVOLUTION | 8 | 1.98e-01 | -2.63e-01 | 8.44e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 23 | 2.93e-02 | 2.63e-01 | 5.52e-01 |
| GOCC COPI VESICLE COAT | 13 | 1.01e-01 | 2.63e-01 | 7.66e-01 |
| GOCC INTERSTITIAL MATRIX | 11 | 1.32e-01 | -2.62e-01 | 7.96e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 6 | 2.66e-01 | 2.62e-01 | 8.69e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 1.32e-01 | -2.62e-01 | 7.96e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 5 | 3.11e-01 | 2.62e-01 | 8.88e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 10 | 1.53e-01 | 2.61e-01 | 8.17e-01 |
| GOCC NODE OF RANVIER | 16 | 7.05e-02 | -2.61e-01 | 6.97e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 7 | 2.32e-01 | -2.61e-01 | 8.63e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 35 | 7.57e-03 | -2.61e-01 | 3.39e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 13 | 1.04e-01 | -2.61e-01 | 7.68e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 1.04e-01 | 2.61e-01 | 7.68e-01 |
| GOBP DEPYRIMIDINATION | 8 | 2.02e-01 | 2.61e-01 | 8.51e-01 |
| GOCC INO80 COMPLEX | 15 | 8.08e-02 | 2.60e-01 | 7.26e-01 |
| GOBP GRANULOCYTE ACTIVATION | 48 | 1.81e-03 | -2.60e-01 | 1.62e-01 |
| GOCC AXON INITIAL SEGMENT | 21 | 3.89e-02 | -2.60e-01 | 5.97e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 2.70e-01 | 2.60e-01 | 8.69e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 14 | 9.20e-02 | -2.60e-01 | 7.58e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 3.14e-01 | 2.60e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF PINOCYTOSIS | 5 | 3.14e-01 | -2.60e-01 | 8.90e-01 |
| GOMF ICOSANOID BINDING | 8 | 2.03e-01 | -2.60e-01 | 8.51e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 5 | 3.15e-01 | -2.60e-01 | 8.90e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 2.71e-01 | -2.59e-01 | 8.69e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 2.72e-01 | 2.59e-01 | 8.69e-01 |
| GOMF MOLYBDOPTERIN COFACTOR BINDING | 6 | 2.72e-01 | -2.59e-01 | 8.69e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 22 | 3.55e-02 | 2.59e-01 | 5.74e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 6 | 2.72e-01 | 2.59e-01 | 8.69e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 25 | 2.51e-02 | -2.59e-01 | 5.21e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 1.56e-01 | 2.59e-01 | 8.17e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 3.16e-01 | -2.59e-01 | 8.91e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 1.79e-01 | -2.59e-01 | 8.41e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 2.73e-01 | 2.58e-01 | 8.69e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 12 | 1.21e-01 | 2.58e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 13 | 1.07e-01 | -2.58e-01 | 7.72e-01 |
| GOBP OLFACTORY NERVE DEVELOPMENT | 6 | 2.73e-01 | 2.58e-01 | 8.69e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 20 | 4.56e-02 | -2.58e-01 | 6.22e-01 |
| GOCC INNER DYNEIN ARM | 5 | 3.18e-01 | 2.58e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 14 | 9.46e-02 | -2.58e-01 | 7.64e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.58e-01 | 2.58e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 12 | 1.22e-01 | 2.58e-01 | 7.89e-01 |
| GOBP MIDBODY ABSCISSION | 17 | 6.58e-02 | 2.58e-01 | 6.81e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 2.74e-01 | 2.58e-01 | 8.69e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 20 | 4.61e-02 | 2.58e-01 | 6.22e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 11 | 1.39e-01 | 2.57e-01 | 8.06e-01 |
| GOCC PREFOLDIN COMPLEX | 6 | 2.75e-01 | 2.57e-01 | 8.69e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 8 | 2.07e-01 | -2.57e-01 | 8.51e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 2.39e-01 | 2.57e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 18 | 5.88e-02 | -2.57e-01 | 6.60e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 8 | 2.08e-01 | 2.57e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 39 | 5.50e-03 | -2.57e-01 | 2.87e-01 |
| GOBP THERMOCEPTION | 8 | 2.08e-01 | 2.57e-01 | 8.52e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 1.09e-01 | -2.57e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 7 | 2.39e-01 | -2.57e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 18 | 5.93e-02 | -2.57e-01 | 6.61e-01 |
| GOBP UREA TRANSPORT | 11 | 1.41e-01 | -2.57e-01 | 8.06e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 8 | 2.09e-01 | -2.57e-01 | 8.52e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 18 | 5.95e-02 | -2.57e-01 | 6.62e-01 |
| GOBP PULMONARY ARTERY MORPHOGENESIS | 6 | 2.77e-01 | 2.56e-01 | 8.70e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 39 | 5.59e-03 | 2.56e-01 | 2.88e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 19 | 5.31e-02 | -2.56e-01 | 6.45e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 8 | 2.10e-01 | -2.56e-01 | 8.53e-01 |
| GOBP EOSINOPHIL MIGRATION | 28 | 1.91e-02 | -2.56e-01 | 4.89e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 3.22e-01 | -2.56e-01 | 8.92e-01 |
| GOMF AROMATASE ACTIVITY | 26 | 2.40e-02 | 2.56e-01 | 5.17e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 16 | 7.68e-02 | -2.55e-01 | 7.18e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 14 | 9.79e-02 | -2.55e-01 | 7.66e-01 |
| GOBP DETECTION OF LIPOPOLYSACCHARIDE | 5 | 3.23e-01 | -2.55e-01 | 8.92e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 9 | 1.85e-01 | 2.55e-01 | 8.43e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 7 | 2.42e-01 | -2.55e-01 | 8.64e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 2.79e-01 | 2.55e-01 | 8.71e-01 |
| GOBP GENOMIC IMPRINTING | 18 | 6.10e-02 | 2.55e-01 | 6.63e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 2.44e-02 | 2.55e-01 | 5.18e-01 |
| GOBP REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE | 6 | 2.80e-01 | -2.55e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 16 | 7.75e-02 | -2.55e-01 | 7.18e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 2.80e-01 | -2.55e-01 | 8.71e-01 |
| GOBP OOCYTE CONSTRUCTION | 8 | 2.12e-01 | -2.55e-01 | 8.54e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 9 | 1.86e-01 | -2.55e-01 | 8.44e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 14 | 9.93e-02 | -2.54e-01 | 7.66e-01 |
| GOCC MHC PROTEIN COMPLEX | 24 | 3.10e-02 | -2.54e-01 | 5.55e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 6 | 2.81e-01 | 2.54e-01 | 8.72e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 9 | 1.87e-01 | 2.54e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 10 | 1.64e-01 | -2.54e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 12 | 1.28e-01 | -2.54e-01 | 7.93e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 9 | 1.87e-01 | -2.54e-01 | 8.44e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 12 | 1.28e-01 | -2.54e-01 | 7.93e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 1.45e-01 | -2.54e-01 | 8.06e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 1.88e-01 | -2.54e-01 | 8.44e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.26e-01 | 2.53e-01 | 8.93e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 12 | 1.29e-01 | -2.53e-01 | 7.93e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 12 | 1.29e-01 | -2.53e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 67 | 3.37e-04 | 2.53e-01 | 5.75e-02 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 7 | 2.46e-01 | -2.53e-01 | 8.65e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 8 | 2.16e-01 | 2.53e-01 | 8.56e-01 |
| GOBP FIBROBLAST ACTIVATION | 15 | 9.00e-02 | -2.53e-01 | 7.52e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 19 | 5.66e-02 | 2.53e-01 | 6.56e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 12 | 1.30e-01 | -2.53e-01 | 7.93e-01 |
| GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION | 7 | 2.47e-01 | -2.53e-01 | 8.65e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 13 | 1.15e-01 | 2.52e-01 | 7.82e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 6 | 2.85e-01 | -2.52e-01 | 8.75e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 14 | 1.02e-01 | -2.52e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 73 | 1.98e-04 | -2.52e-01 | 3.98e-02 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 11 | 1.48e-01 | -2.52e-01 | 8.10e-01 |
| GOCC X CHROMOSOME | 11 | 1.48e-01 | 2.52e-01 | 8.10e-01 |
| GOMF INTRACELLULAR CGMP ACTIVATED CATION CHANNEL ACTIVITY | 6 | 2.86e-01 | -2.52e-01 | 8.75e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 18 | 6.46e-02 | 2.52e-01 | 6.75e-01 |
| GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY | 5 | 3.30e-01 | -2.52e-01 | 8.93e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 8 | 2.18e-01 | -2.52e-01 | 8.56e-01 |
| GOBP REACTIVE GLIOSIS | 6 | 2.86e-01 | 2.51e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 5 | 3.31e-01 | -2.51e-01 | 8.93e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 20 | 5.17e-02 | 2.51e-01 | 6.42e-01 |
| GOBP ALDITOL BIOSYNTHETIC PROCESS | 5 | 3.31e-01 | 2.51e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 31 | 1.55e-02 | -2.51e-01 | 4.63e-01 |
| GOBP LIPOPHAGY | 7 | 2.50e-01 | 2.51e-01 | 8.65e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 28 | 2.15e-02 | 2.51e-01 | 5.02e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 11 | 1.49e-01 | -2.51e-01 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION | 5 | 3.31e-01 | -2.51e-01 | 8.93e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 16 | 8.24e-02 | 2.51e-01 | 7.33e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 8 | 2.19e-01 | -2.51e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 2.51e-01 | 2.51e-01 | 8.65e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 14 | 1.04e-01 | -2.51e-01 | 7.69e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 18 | 6.58e-02 | 2.50e-01 | 6.81e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 34 | 1.15e-02 | -2.50e-01 | 4.05e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 6 | 2.88e-01 | 2.50e-01 | 8.77e-01 |
| GOCC SERINE PROTEASE INHIBITOR COMPLEX | 6 | 2.88e-01 | -2.50e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 3.32e-01 | -2.50e-01 | 8.94e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 6 | 2.88e-01 | 2.50e-01 | 8.77e-01 |
| GOMF GANGLIOSIDE BINDING | 5 | 3.33e-01 | 2.50e-01 | 8.94e-01 |
| GOBP T CELL EXTRAVASATION | 10 | 1.71e-01 | -2.50e-01 | 8.32e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 5 | 3.33e-01 | 2.50e-01 | 8.94e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 31 | 1.61e-02 | -2.50e-01 | 4.67e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 35 | 1.06e-02 | 2.50e-01 | 3.87e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 8 | 2.21e-01 | 2.50e-01 | 8.56e-01 |
| GOMF CHEMOKINE ACTIVITY | 45 | 3.77e-03 | -2.50e-01 | 2.32e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 2.90e-01 | 2.49e-01 | 8.78e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 14 | 1.06e-01 | -2.49e-01 | 7.71e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 8 | 2.22e-01 | -2.49e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 6 | 2.90e-01 | 2.49e-01 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 1.95e-01 | -2.49e-01 | 8.44e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 7 | 2.53e-01 | 2.49e-01 | 8.65e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 1.96e-01 | 2.49e-01 | 8.44e-01 |
| GOMF OPSONIN BINDING | 19 | 6.01e-02 | -2.49e-01 | 6.62e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 19 | 6.01e-02 | -2.49e-01 | 6.62e-01 |
| GOBP SERINE TRANSPORT | 9 | 1.96e-01 | -2.49e-01 | 8.44e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.96e-01 | -2.49e-01 | 8.44e-01 |
| GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS | 5 | 3.35e-01 | -2.49e-01 | 8.96e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 12 | 1.36e-01 | 2.49e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 10 | 1.74e-01 | 2.48e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 3.36e-01 | -2.48e-01 | 8.96e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 9 | 1.97e-01 | -2.48e-01 | 8.44e-01 |
| GOBP DELAMINATION | 7 | 2.55e-01 | -2.48e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 4.89e-02 | -2.48e-01 | 6.28e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 69 | 3.66e-04 | -2.48e-01 | 6.14e-02 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 12 | 1.37e-01 | 2.48e-01 | 8.06e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 3.37e-01 | 2.48e-01 | 8.96e-01 |
| GOBP SPERM EJACULATION | 5 | 3.38e-01 | -2.48e-01 | 8.96e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 17 | 7.72e-02 | 2.48e-01 | 7.18e-01 |
| GOCC POLYSOMAL RIBOSOME | 28 | 2.34e-02 | -2.48e-01 | 5.16e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 28 | 2.35e-02 | 2.47e-01 | 5.17e-01 |
| GOMF FRUCTOSE BINDING | 6 | 2.94e-01 | 2.47e-01 | 8.81e-01 |
| GOBP REGULATION OF LYMPHANGIOGENESIS | 6 | 2.95e-01 | -2.47e-01 | 8.82e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 2.26e-01 | -2.47e-01 | 8.61e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 12 | 1.39e-01 | 2.47e-01 | 8.06e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 18 | 6.98e-02 | 2.47e-01 | 6.94e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 15 | 9.80e-02 | -2.47e-01 | 7.66e-01 |
| GOBP OMEGA HYDROXYLASE P450 PATHWAY | 11 | 1.57e-01 | 2.46e-01 | 8.17e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 14 | 1.10e-01 | 2.46e-01 | 7.77e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 3.40e-01 | -2.46e-01 | 8.96e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.28e-01 | 2.46e-01 | 8.62e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 1.24e-01 | 2.46e-01 | 7.93e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 5.08e-02 | 2.46e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 1.58e-01 | 2.46e-01 | 8.17e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 2.97e-01 | -2.46e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 1.11e-01 | 2.46e-01 | 7.77e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 3.41e-01 | 2.46e-01 | 8.96e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 2.97e-01 | 2.46e-01 | 8.82e-01 |
| GOCC SAGA COMPLEX | 23 | 4.15e-02 | 2.46e-01 | 6.10e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 2.61e-01 | 2.45e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 5 | 3.42e-01 | 2.45e-01 | 8.96e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 10 | 1.79e-01 | 2.45e-01 | 8.41e-01 |
| GOBP CARDIAC MUSCLE TISSUE REGENERATION | 8 | 2.30e-01 | 2.45e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 13 | 1.26e-01 | -2.45e-01 | 7.93e-01 |
| GOBP COMPLEMENT ACTIVATION | 56 | 1.52e-03 | -2.45e-01 | 1.46e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 12 | 1.42e-01 | 2.45e-01 | 8.06e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 3.00e-01 | 2.45e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 2.63e-01 | 2.45e-01 | 8.68e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 27 | 2.80e-02 | -2.44e-01 | 5.43e-01 |
| GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY | 5 | 3.44e-01 | -2.44e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF AXON GUIDANCE | 5 | 3.44e-01 | -2.44e-01 | 8.96e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 3.45e-01 | 2.44e-01 | 8.96e-01 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 3.45e-01 | 2.44e-01 | 8.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 1.82e-01 | 2.44e-01 | 8.42e-01 |
| GOBP BRAINSTEM DEVELOPMENT | 7 | 2.64e-01 | 2.44e-01 | 8.69e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 13 | 1.28e-01 | -2.44e-01 | 7.93e-01 |
| GOBP KERATINIZATION | 75 | 2.64e-04 | -2.44e-01 | 4.76e-02 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 3.46e-01 | 2.43e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 1.83e-01 | -2.43e-01 | 8.42e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 21 | 5.37e-02 | 2.43e-01 | 6.45e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 14 | 1.15e-01 | -2.43e-01 | 7.81e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 1.03e-01 | 2.43e-01 | 7.66e-01 |
| GOBP CARBON DIOXIDE TRANSPORT | 15 | 1.03e-01 | -2.43e-01 | 7.66e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 1.29e-01 | -2.43e-01 | 7.93e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 8 | 2.34e-01 | 2.43e-01 | 8.64e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 2.66e-01 | -2.43e-01 | 8.69e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 8 | 2.34e-01 | 2.43e-01 | 8.64e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 3.47e-01 | 2.43e-01 | 8.98e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 58 | 1.40e-03 | 2.43e-01 | 1.40e-01 |
| GOMF INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC CATION CHANNEL ACTIVITY | 10 | 1.84e-01 | -2.42e-01 | 8.42e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 9 | 2.08e-01 | 2.42e-01 | 8.51e-01 |
| GOBP DRINKING BEHAVIOR | 8 | 2.35e-01 | 2.42e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 11 | 1.64e-01 | -2.42e-01 | 8.24e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 14 | 1.16e-01 | 2.42e-01 | 7.82e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 3.48e-01 | 2.42e-01 | 8.98e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 2.36e-01 | 2.42e-01 | 8.64e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 3.05e-01 | -2.42e-01 | 8.84e-01 |
| GOBP IODIDE TRANSPORT | 9 | 2.09e-01 | -2.42e-01 | 8.52e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 13 | 1.31e-01 | 2.42e-01 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 23 | 4.50e-02 | -2.41e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 2.69e-01 | 2.41e-01 | 8.69e-01 |
| GOMF IGG BINDING | 6 | 3.06e-01 | -2.41e-01 | 8.85e-01 |
| GOBP ENDOTHELIAL CELL FATE COMMITMENT | 8 | 2.37e-01 | 2.41e-01 | 8.64e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 5.63e-03 | -2.41e-01 | 2.88e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 15 | 1.07e-01 | 2.41e-01 | 7.72e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 2.39e-01 | -2.41e-01 | 8.64e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 6.95e-02 | 2.41e-01 | 6.94e-01 |
| GOBP CYTOLYSIS | 7 | 2.71e-01 | 2.40e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 8 | 2.39e-01 | 2.40e-01 | 8.64e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 13 | 1.34e-01 | -2.40e-01 | 8.01e-01 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 3.52e-01 | -2.40e-01 | 9.00e-01 |
| GOBP TRACHEA MORPHOGENESIS | 11 | 1.68e-01 | -2.40e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 3.09e-01 | 2.40e-01 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 30 | 2.29e-02 | -2.40e-01 | 5.11e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 9 | 2.13e-01 | -2.40e-01 | 8.54e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 9 | 2.13e-01 | -2.40e-01 | 8.54e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 10 | 1.89e-01 | -2.40e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 7 | 2.72e-01 | -2.40e-01 | 8.69e-01 |
| GOBP SMOOTH MUSCLE CELL MATRIX ADHESION | 6 | 3.10e-01 | -2.39e-01 | 8.87e-01 |
| GOBP HAIR FOLLICLE MATURATION | 15 | 1.09e-01 | 2.39e-01 | 7.73e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 15 | 1.09e-01 | 2.39e-01 | 7.73e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 9 | 2.14e-01 | -2.39e-01 | 8.55e-01 |
| GOCC SPERM MITOCHONDRIAL SHEATH | 5 | 3.55e-01 | 2.39e-01 | 9.02e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 19 | 7.13e-02 | 2.39e-01 | 6.99e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 3.11e-01 | 2.39e-01 | 8.89e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 8 | 2.43e-01 | 2.39e-01 | 8.64e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 7.98e-02 | -2.39e-01 | 7.25e-01 |
| GOBP GLYCINE TRANSPORT | 14 | 1.22e-01 | -2.38e-01 | 7.89e-01 |
| GOBP REGULATION OF PROTEIN KINASE C ACTIVITY | 5 | 3.56e-01 | 2.38e-01 | 9.02e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 8 | 2.43e-01 | -2.38e-01 | 8.64e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 3.57e-01 | -2.38e-01 | 9.03e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 18 | 8.06e-02 | 2.38e-01 | 7.26e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 14 | 1.23e-01 | 2.38e-01 | 7.92e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 7 | 2.76e-01 | -2.38e-01 | 8.70e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 10 | 1.93e-01 | 2.38e-01 | 8.44e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 22 | 5.38e-02 | 2.38e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS | 5 | 3.58e-01 | 2.38e-01 | 9.03e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 28 | 2.96e-02 | -2.37e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 1.94e-01 | -2.37e-01 | 8.44e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 22 | 5.39e-02 | -2.37e-01 | 6.45e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 9 | 2.18e-01 | 2.37e-01 | 8.56e-01 |
| GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY | 6 | 3.15e-01 | 2.37e-01 | 8.90e-01 |
| GOBP ENDOCARDIAL CELL DIFFERENTIATION | 6 | 3.15e-01 | 2.37e-01 | 8.90e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 21 | 6.02e-02 | 2.37e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 2.19e-01 | 2.37e-01 | 8.56e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 9 | 2.19e-01 | -2.37e-01 | 8.56e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 13 | 1.40e-01 | 2.37e-01 | 8.06e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT | 6 | 3.15e-01 | -2.37e-01 | 8.90e-01 |
| GOBP FLAVONE METABOLIC PROCESS | 6 | 3.16e-01 | 2.37e-01 | 8.90e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 2.47e-01 | 2.37e-01 | 8.65e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 10 | 1.95e-01 | 2.36e-01 | 8.44e-01 |
| GOCC COPII VESICLE COAT | 16 | 1.01e-01 | 2.36e-01 | 7.66e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 20 | 6.74e-02 | -2.36e-01 | 6.87e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 3.17e-01 | 2.36e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 11 | 1.75e-01 | -2.36e-01 | 8.40e-01 |
| GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS | 5 | 3.61e-01 | 2.36e-01 | 9.04e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 8 | 2.48e-01 | -2.36e-01 | 8.65e-01 |
| GOMF LIPASE BINDING | 7 | 2.80e-01 | -2.36e-01 | 8.71e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 17 | 9.21e-02 | -2.36e-01 | 7.58e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 2.20e-01 | -2.36e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 7 | 2.80e-01 | -2.36e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 13 | 1.41e-01 | 2.36e-01 | 8.06e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 3.17e-01 | 2.36e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 14 | 1.27e-01 | -2.36e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 2.21e-01 | -2.36e-01 | 8.56e-01 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 6 | 3.18e-01 | -2.36e-01 | 8.91e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 15 | 1.14e-01 | 2.36e-01 | 7.81e-01 |
| GOBP REGULATION OF GTP BINDING | 11 | 1.76e-01 | -2.35e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 8 | 2.49e-01 | -2.35e-01 | 8.65e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 18 | 8.38e-02 | 2.35e-01 | 7.37e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 29 | 2.83e-02 | -2.35e-01 | 5.45e-01 |
| GOBP CRANIAL GANGLION DEVELOPMENT | 5 | 3.62e-01 | 2.35e-01 | 9.06e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 12 | 1.58e-01 | 2.35e-01 | 8.19e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 7 | 2.82e-01 | -2.35e-01 | 8.73e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 51 | 3.69e-03 | -2.35e-01 | 2.31e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 10 | 1.98e-01 | 2.35e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 7 | 2.82e-01 | 2.35e-01 | 8.73e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 14 | 1.28e-01 | 2.35e-01 | 7.93e-01 |
| GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY | 7 | 2.82e-01 | 2.35e-01 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING | 5 | 3.63e-01 | 2.35e-01 | 9.06e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 2.82e-01 | 2.35e-01 | 8.73e-01 |
| GOMF U6 SNRNA BINDING | 14 | 1.28e-01 | 2.35e-01 | 7.93e-01 |
| GOCC KNL1 SPC105 COMPLEX | 6 | 3.19e-01 | 2.35e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION | 5 | 3.64e-01 | -2.34e-01 | 9.06e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 7 | 2.83e-01 | 2.34e-01 | 8.73e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 62 | 1.41e-03 | -2.34e-01 | 1.40e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 22 | 5.71e-02 | 2.34e-01 | 6.57e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 13 | 1.44e-01 | -2.34e-01 | 8.06e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 3.21e-01 | 2.34e-01 | 8.92e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 12 | 1.61e-01 | 2.34e-01 | 8.21e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 2.52e-01 | 2.34e-01 | 8.65e-01 |
| GOBP ALANINE TRANSPORT | 16 | 1.06e-01 | -2.34e-01 | 7.71e-01 |
| GOBP OXYGEN METABOLIC PROCESS | 5 | 3.66e-01 | -2.34e-01 | 9.06e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 11 | 1.80e-01 | 2.33e-01 | 8.41e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 99 | 6.00e-05 | -2.33e-01 | 1.74e-02 |
| GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY | 6 | 3.23e-01 | -2.33e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 10 | 2.02e-01 | 2.33e-01 | 8.51e-01 |
| GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT | 7 | 2.86e-01 | 2.33e-01 | 8.75e-01 |
| GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.23e-01 | -2.33e-01 | 8.93e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 12 | 1.63e-01 | 2.32e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 2.87e-01 | -2.32e-01 | 8.76e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING | 5 | 3.68e-01 | -2.32e-01 | 9.08e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 19 | 7.97e-02 | 2.32e-01 | 7.25e-01 |
| GOBP DIAPEDESIS | 6 | 3.25e-01 | -2.32e-01 | 8.93e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 2.88e-01 | 2.32e-01 | 8.77e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 23 | 5.42e-02 | -2.32e-01 | 6.45e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 10 | 2.04e-01 | -2.32e-01 | 8.51e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 14 | 1.33e-01 | -2.32e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 8 | 2.56e-01 | 2.32e-01 | 8.65e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 8.89e-02 | 2.32e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 25 | 4.50e-02 | -2.32e-01 | 6.22e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 11 | 1.84e-01 | -2.32e-01 | 8.42e-01 |
| GOBP REGULATION OF SYNAPSE PRUNING | 6 | 3.26e-01 | -2.32e-01 | 8.93e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 29 | 3.09e-02 | 2.32e-01 | 5.55e-01 |
| GOCC FLOTILLIN COMPLEX | 9 | 2.29e-01 | 2.31e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 2.57e-01 | 2.31e-01 | 8.65e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 2.57e-01 | 2.31e-01 | 8.65e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 11 | 1.84e-01 | -2.31e-01 | 8.42e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 9 | 2.30e-01 | 2.31e-01 | 8.62e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 18 | 8.95e-02 | -2.31e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 8 | 2.58e-01 | -2.31e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 3.27e-01 | 2.31e-01 | 8.93e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 17 | 9.91e-02 | -2.31e-01 | 7.66e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 10 | 2.06e-01 | -2.31e-01 | 8.51e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 9 | 2.30e-01 | 2.31e-01 | 8.62e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX | 7 | 2.90e-01 | -2.31e-01 | 8.78e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 25 | 4.58e-02 | 2.31e-01 | 6.22e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE | 6 | 3.28e-01 | -2.31e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 26 | 4.19e-02 | -2.31e-01 | 6.10e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 19 | 8.20e-02 | 2.30e-01 | 7.31e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 2.59e-01 | -2.30e-01 | 8.66e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 3.29e-01 | -2.30e-01 | 8.93e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 26 | 4.21e-02 | -2.30e-01 | 6.11e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 3.29e-01 | -2.30e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 28 | 3.50e-02 | -2.30e-01 | 5.72e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 6 | 3.29e-01 | -2.30e-01 | 8.93e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 54 | 3.45e-03 | -2.30e-01 | 2.25e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 9.11e-02 | -2.30e-01 | 7.55e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.87e-01 | -2.30e-01 | 8.44e-01 |
| GOBP PROTEIN SIALYLATION | 5 | 3.73e-01 | -2.30e-01 | 9.09e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 23 | 5.64e-02 | 2.30e-01 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE | 7 | 2.92e-01 | 2.30e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 9 | 2.33e-01 | -2.30e-01 | 8.64e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 3.30e-01 | 2.30e-01 | 8.93e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 6 | 3.31e-01 | -2.29e-01 | 8.93e-01 |
| GOBP RESPONSE TO CHEMOKINE | 93 | 1.32e-04 | -2.29e-01 | 3.00e-02 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 3.75e-01 | -2.29e-01 | 9.09e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 3.75e-01 | -2.29e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 21 | 6.92e-02 | -2.29e-01 | 6.94e-01 |
| GOMF CARBOXYLESTERASE ACTIVITY | 6 | 3.31e-01 | -2.29e-01 | 8.93e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 1.13e-01 | 2.29e-01 | 7.80e-01 |
| GOBP DETOXIFICATION OF NITROGEN COMPOUND | 5 | 3.76e-01 | -2.29e-01 | 9.09e-01 |
| GOBP LEUKOTRIENE D4 METABOLIC PROCESS | 7 | 2.94e-01 | 2.29e-01 | 8.82e-01 |
| GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION | 10 | 2.10e-01 | -2.29e-01 | 8.53e-01 |
| GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 3.76e-01 | 2.29e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 8 | 2.63e-01 | -2.29e-01 | 8.68e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 9 | 2.35e-01 | -2.29e-01 | 8.64e-01 |
| GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY | 9 | 2.35e-01 | -2.28e-01 | 8.64e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 1.39e-01 | -2.28e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 13 | 1.54e-01 | -2.28e-01 | 8.17e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 20 | 7.73e-02 | 2.28e-01 | 7.18e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 8.86e-03 | -2.28e-01 | 3.60e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 35 | 1.96e-02 | -2.28e-01 | 4.91e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 10 | 2.12e-01 | 2.28e-01 | 8.54e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.91e-01 | 2.28e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 1.91e-01 | -2.28e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY | 5 | 3.78e-01 | -2.28e-01 | 9.09e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 9 | 2.37e-01 | 2.28e-01 | 8.64e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 38 | 1.54e-02 | -2.27e-01 | 4.61e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION | 6 | 3.35e-01 | 2.27e-01 | 8.96e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 8 | 2.66e-01 | 2.27e-01 | 8.69e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 15 | 1.28e-01 | -2.27e-01 | 7.93e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 10 | 2.14e-01 | 2.27e-01 | 8.55e-01 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 13 | 1.57e-01 | -2.27e-01 | 8.17e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 14 | 1.42e-01 | 2.27e-01 | 8.06e-01 |
| GOBP COCHLEA MORPHOGENESIS | 23 | 5.99e-02 | 2.27e-01 | 6.62e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 13 | 1.57e-01 | 2.26e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 50 | 5.61e-03 | 2.26e-01 | 2.88e-01 |
| GOBP RETINAL CELL PROGRAMMED CELL DEATH | 6 | 3.37e-01 | 2.26e-01 | 8.96e-01 |
| GOBP PARTURITION | 14 | 1.43e-01 | 2.26e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 16 | 1.17e-01 | 2.26e-01 | 7.82e-01 |
| GOBP REGULATION OF DNA METHYLATION | 20 | 8.01e-02 | 2.26e-01 | 7.26e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS | 34 | 2.26e-02 | -2.26e-01 | 5.08e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 16 | 1.18e-01 | 2.26e-01 | 7.82e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 61 | 2.29e-03 | -2.26e-01 | 1.84e-01 |
| GOBP UTP METABOLIC PROCESS | 12 | 1.76e-01 | 2.26e-01 | 8.41e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 21 | 7.34e-02 | -2.26e-01 | 7.07e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION | 8 | 2.69e-01 | 2.26e-01 | 8.69e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 7 | 3.02e-01 | -2.25e-01 | 8.84e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 3.83e-01 | -2.25e-01 | 9.12e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 59 | 2.75e-03 | -2.25e-01 | 2.00e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 9 | 2.42e-01 | 2.25e-01 | 8.64e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 8.94e-02 | 2.25e-01 | 7.52e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 8 | 2.70e-01 | 2.25e-01 | 8.69e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 11 | 1.96e-01 | 2.25e-01 | 8.44e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.40e-01 | -2.25e-01 | 8.96e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 14 | 1.45e-01 | -2.25e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 14 | 1.45e-01 | -2.25e-01 | 8.06e-01 |
| GOCC TERTIARY GRANULE LUMEN | 53 | 4.62e-03 | -2.25e-01 | 2.64e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 19 | 8.97e-02 | -2.25e-01 | 7.52e-01 |
| GOBP RENAL VESICLE FORMATION | 8 | 2.71e-01 | -2.25e-01 | 8.69e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 2.71e-01 | 2.25e-01 | 8.69e-01 |
| GOBP RESPONSE TO GRAM POSITIVE BACTERIUM | 5 | 3.84e-01 | -2.25e-01 | 9.14e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 6 | 3.41e-01 | 2.25e-01 | 8.96e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 2.71e-01 | -2.25e-01 | 8.69e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 2.72e-01 | 2.24e-01 | 8.69e-01 |
| GOMF POLYSOME BINDING | 6 | 3.41e-01 | -2.24e-01 | 8.96e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 11 | 1.97e-01 | -2.24e-01 | 8.44e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 1.46e-01 | -2.24e-01 | 8.08e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 12 | 1.78e-01 | 2.24e-01 | 8.41e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 28 | 3.99e-02 | 2.24e-01 | 6.03e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 1.20e-01 | 2.24e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 2.44e-01 | 2.24e-01 | 8.65e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 17 | 1.10e-01 | 2.24e-01 | 7.75e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 8 | 2.73e-01 | 2.24e-01 | 8.69e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 33 | 2.60e-02 | -2.24e-01 | 5.28e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 18 | 1.00e-01 | -2.24e-01 | 7.66e-01 |
| GOBP RETICULOPHAGY | 18 | 1.00e-01 | 2.24e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 1.34e-01 | -2.24e-01 | 8.01e-01 |
| GOCC BBAF COMPLEX | 10 | 2.21e-01 | 2.24e-01 | 8.56e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 3.87e-01 | 2.24e-01 | 9.14e-01 |
| GOBP REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 3.87e-01 | 2.24e-01 | 9.14e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 7 | 3.06e-01 | 2.23e-01 | 8.85e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 94 | 1.85e-04 | -2.23e-01 | 3.87e-02 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 16 | 1.22e-01 | -2.23e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.81e-01 | -2.23e-01 | 8.41e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 13 | 1.64e-01 | -2.23e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 3.88e-01 | -2.23e-01 | 9.14e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 10 | 2.23e-01 | -2.23e-01 | 8.57e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 12 | 1.82e-01 | -2.23e-01 | 8.42e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 24 | 5.91e-02 | -2.23e-01 | 6.61e-01 |
| GOMF DOPAMINE BINDING | 6 | 3.45e-01 | 2.22e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 31 | 3.21e-02 | -2.22e-01 | 5.58e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 7 | 3.08e-01 | 2.22e-01 | 8.87e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 3.46e-01 | 2.22e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 10 | 2.24e-01 | 2.22e-01 | 8.57e-01 |
| GOBP ISOLEUCINE TRANSPORT | 5 | 3.90e-01 | -2.22e-01 | 9.15e-01 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 3.90e-01 | -2.22e-01 | 9.15e-01 |
| GOBP RESPONSE TO BILE ACID | 7 | 3.09e-01 | -2.22e-01 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 12 | 1.83e-01 | 2.22e-01 | 8.42e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 3.91e-01 | 2.22e-01 | 9.15e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 24 | 6.03e-02 | -2.22e-01 | 6.62e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 17 | 1.14e-01 | -2.21e-01 | 7.81e-01 |
| GOBP FEVER GENERATION | 11 | 2.03e-01 | 2.21e-01 | 8.51e-01 |
| GOBP MONOTERPENOID METABOLIC PROCESS | 6 | 3.48e-01 | 2.21e-01 | 8.98e-01 |
| GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE | 7 | 3.10e-01 | 2.21e-01 | 8.88e-01 |
| GOMF HEMOGLOBIN ALPHA BINDING | 5 | 3.92e-01 | -2.21e-01 | 9.16e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 3.92e-01 | -2.21e-01 | 9.16e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 16 | 1.26e-01 | 2.21e-01 | 7.93e-01 |
| GOMF MORPHOGEN ACTIVITY | 8 | 2.79e-01 | -2.21e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 3.11e-01 | 2.21e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 1.68e-01 | -2.21e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 27 | 4.69e-02 | -2.21e-01 | 6.25e-01 |
| GOBP RESPONSE TO FORSKOLIN | 14 | 1.52e-01 | -2.21e-01 | 8.17e-01 |
| GOBP PRIMITIVE STREAK FORMATION | 10 | 2.26e-01 | 2.21e-01 | 8.61e-01 |
| GOMF SUMO BINDING | 16 | 1.26e-01 | 2.21e-01 | 7.93e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 21 | 7.98e-02 | 2.21e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 2.27e-01 | 2.21e-01 | 8.61e-01 |
| GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 3.49e-01 | 2.21e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 3.93e-01 | -2.21e-01 | 9.17e-01 |
| GOCC SORTING ENDOSOME | 6 | 3.49e-01 | -2.21e-01 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 3.93e-01 | 2.21e-01 | 9.17e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.27e-01 | 2.21e-01 | 8.62e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 2.27e-01 | 2.21e-01 | 8.62e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 3.12e-01 | -2.21e-01 | 8.89e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 19 | 9.60e-02 | 2.21e-01 | 7.66e-01 |
| GOMF NITRITE REDUCTASE ACTIVITY | 5 | 3.93e-01 | -2.20e-01 | 9.17e-01 |
| GOBP VITAMIN D3 METABOLIC PROCESS | 6 | 3.50e-01 | 2.20e-01 | 8.99e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 1.39e-01 | 2.20e-01 | 8.06e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 28 | 4.36e-02 | -2.20e-01 | 6.19e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 9 | 2.53e-01 | 2.20e-01 | 8.65e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 7 | 3.13e-01 | -2.20e-01 | 8.90e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 12 | 1.87e-01 | 2.20e-01 | 8.44e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION | 7 | 3.13e-01 | -2.20e-01 | 8.90e-01 |
| GOBP RNA DECAPPING | 19 | 9.69e-02 | 2.20e-01 | 7.66e-01 |
| GOBP DENSE CORE GRANULE EXOCYTOSIS | 10 | 2.28e-01 | -2.20e-01 | 8.62e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 13 | 1.70e-01 | -2.20e-01 | 8.32e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 3.51e-01 | 2.20e-01 | 9.00e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 18 | 1.07e-01 | 2.20e-01 | 7.72e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 3.95e-01 | 2.20e-01 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 10 | 2.29e-01 | -2.19e-01 | 8.62e-01 |
| GOBP LYMPHOCYTE ANERGY | 7 | 3.15e-01 | 2.19e-01 | 8.90e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 2.55e-01 | -2.19e-01 | 8.65e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 3.15e-01 | -2.19e-01 | 8.90e-01 |
| GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS | 8 | 2.84e-01 | -2.19e-01 | 8.74e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 20 | 9.01e-02 | -2.19e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 18 | 1.08e-01 | -2.19e-01 | 7.73e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE | 5 | 3.97e-01 | -2.19e-01 | 9.18e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 17 | 1.19e-01 | 2.19e-01 | 7.86e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 7 | 3.17e-01 | 2.18e-01 | 8.91e-01 |
| GOBP SENSORY PERCEPTION OF SOUR TASTE | 9 | 2.57e-01 | 2.18e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 9 | 2.57e-01 | -2.18e-01 | 8.65e-01 |
| GOBP RESPONSE TO INSECTICIDE | 6 | 3.54e-01 | 2.18e-01 | 9.01e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 5 | 3.98e-01 | 2.18e-01 | 9.18e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 35 | 2.54e-02 | 2.18e-01 | 5.24e-01 |
| GOBP RESPONSE TO FOLIC ACID | 10 | 2.32e-01 | -2.18e-01 | 8.63e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 3.98e-01 | 2.18e-01 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 3.55e-01 | 2.18e-01 | 9.02e-01 |
| GOBP KINETOCHORE ORGANIZATION | 20 | 9.16e-02 | 2.18e-01 | 7.57e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 20 | 9.16e-02 | -2.18e-01 | 7.57e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 3.58e-02 | 2.18e-01 | 5.75e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 19 | 1.01e-01 | 2.18e-01 | 7.66e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 21 | 8.43e-02 | -2.18e-01 | 7.40e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 9 | 2.58e-01 | -2.18e-01 | 8.65e-01 |
| GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT | 12 | 1.92e-01 | 2.17e-01 | 8.44e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 12 | 1.92e-01 | 2.17e-01 | 8.44e-01 |
| GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 3.19e-01 | -2.17e-01 | 8.92e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 2.62e-02 | 2.17e-01 | 5.28e-01 |
| GOBP LUTEOLYSIS | 6 | 3.57e-01 | 2.17e-01 | 9.03e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 4.00e-01 | -2.17e-01 | 9.18e-01 |
| GOBP EPIDERMAL CELL FATE SPECIFICATION | 5 | 4.01e-01 | 2.17e-01 | 9.18e-01 |
| GOCC ELONGIN COMPLEX | 5 | 4.01e-01 | -2.17e-01 | 9.18e-01 |
| GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS | 6 | 3.58e-01 | -2.17e-01 | 9.03e-01 |
| GOCC KERATIN FILAMENT | 90 | 3.82e-04 | -2.17e-01 | 6.30e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 20 | 9.35e-02 | -2.17e-01 | 7.62e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 2.89e-01 | 2.17e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 31 | 3.69e-02 | -2.17e-01 | 5.82e-01 |
| GOMF NERVE GROWTH FACTOR BINDING | 6 | 3.58e-01 | -2.16e-01 | 9.03e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 26 | 5.61e-02 | -2.16e-01 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 12 | 1.94e-01 | -2.16e-01 | 8.44e-01 |
| GOBP RESPONSE TO MUSCLE INACTIVITY | 9 | 2.61e-01 | 2.16e-01 | 8.66e-01 |
| GOBP MESENCHYME MIGRATION | 5 | 4.03e-01 | 2.16e-01 | 9.20e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 3.59e-01 | 2.16e-01 | 9.04e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 2.90e-01 | 2.16e-01 | 8.78e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 2.62e-01 | 2.16e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 3.23e-01 | 2.16e-01 | 8.92e-01 |
| GOBP PML BODY ORGANIZATION | 7 | 3.23e-01 | -2.16e-01 | 8.92e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 13 | 1.78e-01 | 2.16e-01 | 8.41e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 17 | 1.24e-01 | -2.16e-01 | 7.93e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.91e-01 | 2.16e-01 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 41 | 1.70e-02 | -2.15e-01 | 4.68e-01 |
| GOBP REGULATION OF RENAL SODIUM EXCRETION | 8 | 2.92e-01 | 2.15e-01 | 8.79e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 17 | 1.24e-01 | -2.15e-01 | 7.93e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 34 | 2.98e-02 | -2.15e-01 | 5.52e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 2.92e-01 | -2.15e-01 | 8.79e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 4.05e-01 | -2.15e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING | 10 | 2.39e-01 | -2.15e-01 | 8.64e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 9 | 2.64e-01 | -2.15e-01 | 8.69e-01 |
| GOMF JUN KINASE BINDING | 11 | 2.17e-01 | 2.15e-01 | 8.56e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 11 | 2.17e-01 | -2.15e-01 | 8.56e-01 |
| GOCC 90S PRERIBOSOME | 28 | 4.90e-02 | 2.15e-01 | 6.28e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 6 | 3.62e-01 | -2.15e-01 | 9.06e-01 |
| GOMF TELOMERASE ACTIVITY | 6 | 3.62e-01 | -2.15e-01 | 9.06e-01 |
| GOBP ACETYLCHOLINE SECRETION | 5 | 4.05e-01 | 2.15e-01 | 9.21e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 15 | 1.50e-01 | -2.15e-01 | 8.14e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 34 | 3.03e-02 | 2.15e-01 | 5.54e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 26 | 5.82e-02 | 2.15e-01 | 6.58e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 29 | 4.55e-02 | -2.15e-01 | 6.22e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 12 | 1.98e-01 | -2.14e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 11 | 2.18e-01 | 2.14e-01 | 8.56e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 71 | 1.78e-03 | -2.14e-01 | 1.62e-01 |
| GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION | 7 | 3.26e-01 | -2.14e-01 | 8.93e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 3.63e-01 | 2.14e-01 | 9.06e-01 |
| GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 3.64e-01 | 2.14e-01 | 9.06e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 3.26e-01 | 2.14e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 8 | 2.94e-01 | -2.14e-01 | 8.81e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 9 | 2.66e-01 | -2.14e-01 | 8.69e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 2.19e-01 | -2.14e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 7 | 3.27e-01 | -2.14e-01 | 8.93e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 30 | 4.26e-02 | 2.14e-01 | 6.13e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 39 | 2.08e-02 | -2.14e-01 | 4.96e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 3.64e-01 | 2.14e-01 | 9.06e-01 |
| GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION | 9 | 2.67e-01 | -2.14e-01 | 8.69e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.95e-01 | -2.14e-01 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 7 | 3.28e-01 | -2.14e-01 | 8.93e-01 |
| GOCC NUCLEAR REPLICATION FORK | 32 | 3.65e-02 | 2.14e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 9 | 2.67e-01 | -2.14e-01 | 8.69e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 14 | 1.67e-01 | -2.13e-01 | 8.29e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 13 | 1.83e-01 | 2.13e-01 | 8.42e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 2.96e-01 | -2.13e-01 | 8.82e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 41 | 1.81e-02 | -2.13e-01 | 4.77e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 4.09e-01 | -2.13e-01 | 9.21e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 3.66e-01 | -2.13e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 24 | 7.06e-02 | 2.13e-01 | 6.97e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 10 | 2.43e-01 | -2.13e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 2.97e-01 | -2.13e-01 | 8.82e-01 |
| GOCC CHROMOCENTER | 13 | 1.84e-01 | 2.13e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 2.02e-01 | -2.13e-01 | 8.51e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 2.44e-01 | -2.13e-01 | 8.64e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 2.69e-01 | 2.13e-01 | 8.69e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 6 | 3.67e-01 | 2.13e-01 | 9.07e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 4.10e-01 | -2.13e-01 | 9.21e-01 |
| GOBP AMYGDALA DEVELOPMENT | 5 | 4.11e-01 | 2.13e-01 | 9.21e-01 |
| GOBP PARACRINE SIGNALING | 6 | 3.67e-01 | -2.12e-01 | 9.07e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 2.70e-01 | 2.12e-01 | 8.69e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 11 | 2.23e-01 | -2.12e-01 | 8.57e-01 |
| GOBP OPSONIZATION | 16 | 1.41e-01 | -2.12e-01 | 8.06e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 7 | 3.31e-01 | 2.12e-01 | 8.93e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 8 | 2.98e-01 | 2.12e-01 | 8.82e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 12 | 2.03e-01 | -2.12e-01 | 8.51e-01 |
| GOMF PHOSPHODIESTERASE I ACTIVITY | 5 | 4.11e-01 | 2.12e-01 | 9.21e-01 |
| GOCC CHITOSOME | 19 | 1.09e-01 | -2.12e-01 | 7.74e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 10 | 2.45e-01 | 2.12e-01 | 8.65e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 37 | 2.56e-02 | 2.12e-01 | 5.25e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 8 | 2.99e-01 | 2.12e-01 | 8.83e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 10 | 2.46e-01 | -2.12e-01 | 8.65e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 4.12e-01 | 2.12e-01 | 9.21e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 16 | 1.42e-01 | -2.12e-01 | 8.06e-01 |
| GOMF POTASSIUM ION BINDING | 13 | 1.86e-01 | -2.12e-01 | 8.44e-01 |
| GOBP BRONCHUS DEVELOPMENT | 11 | 2.24e-01 | -2.12e-01 | 8.57e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 13 | 1.86e-01 | -2.12e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 11 | 2.24e-01 | 2.12e-01 | 8.57e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 16 | 1.43e-01 | 2.12e-01 | 8.06e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 35 | 3.03e-02 | -2.12e-01 | 5.54e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 28 | 5.27e-02 | 2.12e-01 | 6.45e-01 |
| GOBP REGULATION OF ENAMEL MINERALIZATION | 7 | 3.32e-01 | -2.12e-01 | 8.94e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 2.25e-01 | 2.12e-01 | 8.58e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 1.20e-01 | -2.11e-01 | 7.89e-01 |
| GOBP DOSAGE COMPENSATION | 27 | 5.71e-02 | 2.11e-01 | 6.57e-01 |
| GOBP COMMA SHAPED BODY MORPHOGENESIS | 5 | 4.13e-01 | 2.11e-01 | 9.22e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 10 | 2.47e-01 | 2.11e-01 | 8.65e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 1.92e-02 | 2.11e-01 | 4.89e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 9 | 2.72e-01 | -2.11e-01 | 8.69e-01 |
| GOBP FUNGIFORM PAPILLA MORPHOGENESIS | 5 | 4.13e-01 | 2.11e-01 | 9.23e-01 |
| GOCC BASEMENT MEMBRANE COLLAGEN TRIMER | 6 | 3.70e-01 | 2.11e-01 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 3.33e-01 | 2.11e-01 | 8.94e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 2.05e-01 | 2.11e-01 | 8.51e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 22 | 8.65e-02 | 2.11e-01 | 7.47e-01 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 1.44e-01 | 2.11e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 18 | 1.21e-01 | 2.11e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 15 | 1.57e-01 | 2.11e-01 | 8.17e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 9 | 2.73e-01 | 2.11e-01 | 8.69e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 16 | 1.44e-01 | -2.11e-01 | 8.06e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 9 | 2.74e-01 | -2.11e-01 | 8.69e-01 |
| GOCC INTERPHOTORECEPTOR MATRIX | 6 | 3.72e-01 | -2.11e-01 | 9.09e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 12 | 2.06e-01 | -2.11e-01 | 8.51e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 9 | 2.74e-01 | 2.11e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 33 | 3.63e-02 | 2.11e-01 | 5.79e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 12 | 2.07e-01 | -2.11e-01 | 8.51e-01 |
| GOBP PEPTIDE CROSS LINKING | 26 | 6.32e-02 | -2.10e-01 | 6.67e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 4.15e-01 | 2.10e-01 | 9.23e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 2.75e-01 | 2.10e-01 | 8.69e-01 |
| GOBP MANNOSYLATION | 22 | 8.80e-02 | 2.10e-01 | 7.52e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 22 | 8.80e-02 | -2.10e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN | 16 | 1.46e-01 | -2.10e-01 | 8.08e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 3.03e-01 | 2.10e-01 | 8.84e-01 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 7 | 3.36e-01 | -2.10e-01 | 8.96e-01 |
| GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY | 8 | 3.04e-01 | 2.10e-01 | 8.84e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION | 8 | 3.04e-01 | -2.10e-01 | 8.84e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 17 | 1.34e-01 | -2.10e-01 | 8.02e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION | 5 | 4.17e-01 | -2.10e-01 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 9 | 2.76e-01 | -2.10e-01 | 8.70e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 3.74e-01 | -2.10e-01 | 9.09e-01 |
| GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX | 5 | 4.17e-01 | -2.09e-01 | 9.23e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 17 | 1.35e-01 | -2.09e-01 | 8.05e-01 |
| GOBP REGULATION OF CHLORIDE TRANSPORT | 6 | 3.74e-01 | -2.09e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 3.05e-01 | -2.09e-01 | 8.84e-01 |
| GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS | 8 | 3.05e-01 | -2.09e-01 | 8.84e-01 |
| GOCC FASCIA ADHERENS | 8 | 3.05e-01 | 2.09e-01 | 8.84e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 8 | 3.05e-01 | 2.09e-01 | 8.85e-01 |
| GOCC CLATHRIN COMPLEX | 6 | 3.75e-01 | -2.09e-01 | 9.09e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 12 | 2.10e-01 | -2.09e-01 | 8.53e-01 |
| GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT | 7 | 3.38e-01 | 2.09e-01 | 8.96e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 11 | 2.30e-01 | -2.09e-01 | 8.62e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 11 | 2.30e-01 | -2.09e-01 | 8.62e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 2.10e-01 | -2.09e-01 | 8.53e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 2.78e-01 | 2.09e-01 | 8.70e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 62 | 4.43e-03 | 2.09e-01 | 2.59e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 10 | 2.53e-01 | 2.09e-01 | 8.65e-01 |
| GOBP TRANSPORT OF VIRUS | 21 | 9.79e-02 | -2.09e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION | 5 | 4.19e-01 | 2.09e-01 | 9.24e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 17 | 1.37e-01 | -2.08e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 10 | 2.54e-01 | 2.08e-01 | 8.65e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 36 | 3.05e-02 | -2.08e-01 | 5.54e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 25 | 7.13e-02 | -2.08e-01 | 6.99e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 6 | 3.77e-01 | -2.08e-01 | 9.09e-01 |
| GOBP RNA IMPORT INTO MITOCHONDRION | 5 | 4.20e-01 | -2.08e-01 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 16 | 1.49e-01 | 2.08e-01 | 8.13e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 9 | 2.79e-01 | -2.08e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 2.54e-01 | -2.08e-01 | 8.65e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 4.20e-01 | -2.08e-01 | 9.24e-01 |
| GOMF WD40 REPEAT DOMAIN BINDING | 5 | 4.20e-01 | -2.08e-01 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 12 | 2.12e-01 | 2.08e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 14 | 1.78e-01 | 2.08e-01 | 8.41e-01 |
| GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS | 5 | 4.21e-01 | -2.08e-01 | 9.24e-01 |
| GOBP FOLATE TRANSMEMBRANE TRANSPORT | 5 | 4.21e-01 | 2.08e-01 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 2.33e-01 | -2.08e-01 | 8.63e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 7 | 3.41e-01 | -2.08e-01 | 8.96e-01 |
| GOBP CHROMOSOME SEPARATION | 81 | 1.23e-03 | 2.08e-01 | 1.29e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 10 | 2.56e-01 | -2.08e-01 | 8.65e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY | 5 | 4.22e-01 | -2.08e-01 | 9.24e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 18 | 1.28e-01 | -2.07e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 35 | 3.37e-02 | -2.07e-01 | 5.59e-01 |
| GOBP PROTEIN PALMITOYLATION | 28 | 5.76e-02 | -2.07e-01 | 6.57e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 2.56e-01 | 2.07e-01 | 8.65e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 4.22e-01 | -2.07e-01 | 9.24e-01 |
| GOMF U4 SNRNA BINDING | 6 | 3.80e-01 | 2.07e-01 | 9.10e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 9 | 2.82e-01 | -2.07e-01 | 8.73e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 39 | 2.54e-02 | -2.07e-01 | 5.24e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 13 | 1.97e-01 | 2.07e-01 | 8.44e-01 |
| GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY | 10 | 2.58e-01 | -2.07e-01 | 8.65e-01 |
| GOBP MOTOR NEURON MIGRATION | 13 | 1.97e-01 | -2.07e-01 | 8.44e-01 |
| GOBP NEPHRIC DUCT FORMATION | 5 | 4.24e-01 | 2.07e-01 | 9.24e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 24 | 7.99e-02 | 2.06e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 8 | 3.12e-01 | -2.06e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 11 | 2.36e-01 | -2.06e-01 | 8.64e-01 |
| GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION | 6 | 3.82e-01 | 2.06e-01 | 9.12e-01 |
| GOMF PRE MIRNA BINDING | 9 | 2.84e-01 | 2.06e-01 | 8.74e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.85e-01 | -2.06e-01 | 8.75e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 3.46e-01 | -2.06e-01 | 8.96e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 14 | 1.83e-01 | -2.06e-01 | 8.42e-01 |
| GOMF POLYSACCHARIDE BINDING | 21 | 1.03e-01 | -2.06e-01 | 7.66e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 9 | 2.86e-01 | 2.06e-01 | 8.75e-01 |
| GOMF INTERLEUKIN 12 RECEPTOR BINDING | 5 | 4.27e-01 | -2.05e-01 | 9.26e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 10 | 2.62e-01 | 2.05e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF ACTION POTENTIAL | 8 | 3.15e-01 | -2.05e-01 | 8.90e-01 |
| GOCC LATE ENDOSOME LUMEN | 8 | 3.15e-01 | 2.05e-01 | 8.90e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 12 | 2.19e-01 | -2.05e-01 | 8.56e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 20 | 1.13e-01 | 2.05e-01 | 7.80e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 7 | 3.48e-01 | 2.05e-01 | 8.98e-01 |
| GOCC TERTIARY GRANULE | 157 | 9.64e-06 | -2.05e-01 | 4.23e-03 |
| GOBP NUCLEOLUS ORGANIZATION | 16 | 1.57e-01 | 2.05e-01 | 8.17e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 5 | 4.28e-01 | -2.05e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 9 | 2.88e-01 | 2.05e-01 | 8.77e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 15 | 1.70e-01 | -2.04e-01 | 8.32e-01 |
| GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE | 5 | 4.29e-01 | -2.04e-01 | 9.27e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 11 | 2.40e-01 | 2.04e-01 | 8.64e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 17 | 1.45e-01 | -2.04e-01 | 8.06e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 38 | 2.93e-02 | 2.04e-01 | 5.52e-01 |
| GOCC CHYLOMICRON | 12 | 2.21e-01 | -2.04e-01 | 8.56e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 2.64e-01 | 2.04e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 15 | 1.71e-01 | 2.04e-01 | 8.32e-01 |
| GOBP ADENOSINE TO INOSINE EDITING | 7 | 3.50e-01 | 2.04e-01 | 8.99e-01 |
| GOMF REGULATORY RNA BINDING | 49 | 1.36e-02 | -2.04e-01 | 4.46e-01 |
| GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY | 5 | 4.30e-01 | 2.04e-01 | 9.27e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 10 | 2.65e-01 | 2.04e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 43 | 2.10e-02 | -2.03e-01 | 4.96e-01 |
| GOBP ADP TRANSPORT | 10 | 2.65e-01 | 2.03e-01 | 8.69e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 11 | 2.43e-01 | 2.03e-01 | 8.64e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 13 | 2.04e-01 | 2.03e-01 | 8.51e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 45 | 1.83e-02 | -2.03e-01 | 4.77e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 11 | 2.43e-01 | 2.03e-01 | 8.64e-01 |
| GOBP RESPONSE TO PHEROMONE | 7 | 3.52e-01 | -2.03e-01 | 9.00e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 7 | 3.52e-01 | 2.03e-01 | 9.00e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 8 | 3.20e-01 | 2.03e-01 | 8.92e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 4.32e-01 | -2.03e-01 | 9.27e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 12 | 2.24e-01 | 2.03e-01 | 8.57e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 3.89e-01 | 2.03e-01 | 9.15e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 7 | 3.53e-01 | 2.03e-01 | 9.00e-01 |
| GOBP GOLGI RIBBON FORMATION | 10 | 2.67e-01 | -2.03e-01 | 8.69e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 16 | 1.60e-01 | -2.03e-01 | 8.20e-01 |
| GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE | 12 | 2.24e-01 | 2.03e-01 | 8.57e-01 |
| GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT | 5 | 4.32e-01 | 2.03e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 22 | 9.98e-02 | -2.03e-01 | 7.66e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 36 | 3.54e-02 | -2.03e-01 | 5.73e-01 |
| GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX | 5 | 4.33e-01 | -2.03e-01 | 9.27e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 41 | 2.49e-02 | 2.02e-01 | 5.20e-01 |
| GOMF NOTCH BINDING | 23 | 9.28e-02 | 2.02e-01 | 7.59e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 2.93e-01 | 2.02e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 3.54e-01 | -2.02e-01 | 9.01e-01 |
| GOBP RENAL WATER ABSORPTION | 6 | 3.91e-01 | -2.02e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 6 | 3.91e-01 | 2.02e-01 | 9.15e-01 |
| GOCC DENSE CORE GRANULE MEMBRANE | 7 | 3.54e-01 | -2.02e-01 | 9.01e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 9 | 2.94e-01 | -2.02e-01 | 8.81e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 3.91e-01 | 2.02e-01 | 9.16e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 12 | 2.26e-01 | -2.02e-01 | 8.59e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 45 | 1.91e-02 | 2.02e-01 | 4.89e-01 |
| GOBP DNA METHYLATION | 47 | 1.67e-02 | 2.02e-01 | 4.68e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 13 | 2.08e-01 | -2.02e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 21 | 1.10e-01 | 2.02e-01 | 7.75e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 3.92e-01 | 2.02e-01 | 9.17e-01 |
| GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY | 13 | 2.08e-01 | -2.02e-01 | 8.52e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 5 | 4.35e-01 | 2.02e-01 | 9.27e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 20 | 1.19e-01 | 2.01e-01 | 7.86e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 1.63e-01 | 2.01e-01 | 8.24e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 78 | 2.12e-03 | -2.01e-01 | 1.76e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 3.25e-01 | -2.01e-01 | 8.93e-01 |
| GOBP PANCREATIC A CELL DIFFERENTIATION | 11 | 2.48e-01 | 2.01e-01 | 8.65e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 3.94e-01 | -2.01e-01 | 9.17e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 1.78e-01 | -2.01e-01 | 8.41e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 18 | 1.40e-01 | 2.01e-01 | 8.06e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 2.10e-01 | -2.01e-01 | 8.53e-01 |
| GOBP FOLLICLE STIMULATING HORMONE SECRETION | 8 | 3.25e-01 | 2.01e-01 | 8.93e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 3.58e-01 | -2.01e-01 | 9.03e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 10 | 2.72e-01 | -2.01e-01 | 8.69e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 8 | 3.26e-01 | -2.00e-01 | 8.93e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 34 | 4.30e-02 | -2.00e-01 | 6.14e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 4.38e-01 | 2.00e-01 | 9.28e-01 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 9 | 2.98e-01 | 2.00e-01 | 8.82e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 57 | 8.89e-03 | -2.00e-01 | 3.60e-01 |
| GOMF SPLICING FACTOR BINDING | 5 | 4.38e-01 | 2.00e-01 | 9.28e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 36 | 3.77e-02 | 2.00e-01 | 5.88e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 12 | 2.30e-01 | 2.00e-01 | 8.62e-01 |
| GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY | 8 | 3.27e-01 | -2.00e-01 | 8.93e-01 |
| GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY | 6 | 3.96e-01 | -2.00e-01 | 9.18e-01 |
| GOCC PORE COMPLEX | 24 | 9.00e-02 | -2.00e-01 | 7.52e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 20 | 1.22e-01 | -2.00e-01 | 7.89e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 4.37e-02 | 2.00e-01 | 6.19e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 28 | 6.73e-02 | -2.00e-01 | 6.87e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 38 | 3.31e-02 | -2.00e-01 | 5.58e-01 |
| GOMF HETEROTRIMERIC G PROTEIN BINDING | 5 | 4.39e-01 | 2.00e-01 | 9.29e-01 |
| GOBP VITAMIN A METABOLIC PROCESS | 8 | 3.28e-01 | -2.00e-01 | 8.93e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 4.40e-01 | -1.99e-01 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION | 5 | 4.40e-01 | 1.99e-01 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 3.29e-01 | 1.99e-01 | 8.93e-01 |
| GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY | 8 | 3.29e-01 | -1.99e-01 | 8.93e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 27 | 7.33e-02 | -1.99e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 11 | 2.53e-01 | 1.99e-01 | 8.65e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 3.30e-01 | 1.99e-01 | 8.93e-01 |
| GOCC MLL1 2 COMPLEX | 29 | 6.36e-02 | 1.99e-01 | 6.67e-01 |
| GOMF HISTONE KINASE ACTIVITY | 20 | 1.23e-01 | 1.99e-01 | 7.92e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 25 | 8.51e-02 | -1.99e-01 | 7.43e-01 |
| GOBP LIMB BUD FORMATION | 9 | 3.01e-01 | -1.99e-01 | 8.84e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 12 | 2.33e-01 | -1.99e-01 | 8.63e-01 |
| GOMF TITIN BINDING | 13 | 2.14e-01 | 1.99e-01 | 8.55e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 3.62e-01 | -1.99e-01 | 9.06e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 7 | 3.62e-01 | 1.99e-01 | 9.06e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 3.99e-01 | 1.99e-01 | 9.18e-01 |
| GOBP T CELL MIGRATION | 67 | 4.90e-03 | -1.99e-01 | 2.71e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 8 | 3.31e-01 | 1.99e-01 | 8.93e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 10 | 2.77e-01 | -1.99e-01 | 8.70e-01 |
| GOBP REGULATION OF ARTERY MORPHOGENESIS | 11 | 2.54e-01 | -1.98e-01 | 8.65e-01 |
| GOBP THALAMUS DEVELOPMENT | 11 | 2.54e-01 | -1.98e-01 | 8.65e-01 |
| GOBP AMP CATABOLIC PROCESS | 5 | 4.42e-01 | -1.98e-01 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 5 | 4.42e-01 | 1.98e-01 | 9.30e-01 |
| GOMF CORECEPTOR ACTIVITY | 47 | 1.87e-02 | -1.98e-01 | 4.85e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 8 | 3.31e-01 | -1.98e-01 | 8.93e-01 |
| GOMF CO RECEPTOR BINDING | 13 | 2.16e-01 | -1.98e-01 | 8.56e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 8 | 3.32e-01 | 1.98e-01 | 8.94e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING | 5 | 4.43e-01 | -1.98e-01 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 14 | 2.00e-01 | 1.98e-01 | 8.47e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 23 | 1.00e-01 | -1.98e-01 | 7.66e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 32 | 5.28e-02 | -1.98e-01 | 6.45e-01 |
| GOBP P BODY ASSEMBLY | 20 | 1.26e-01 | 1.98e-01 | 7.93e-01 |
| GOBP L SERINE CATABOLIC PROCESS | 5 | 4.44e-01 | 1.98e-01 | 9.30e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 21 | 1.17e-01 | -1.98e-01 | 7.82e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 4.45e-01 | -1.97e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 7 | 3.66e-01 | 1.97e-01 | 9.06e-01 |
| GOBP ETHER METABOLIC PROCESS | 26 | 8.16e-02 | 1.97e-01 | 7.30e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 3.05e-01 | 1.97e-01 | 8.85e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 17 | 1.59e-01 | -1.97e-01 | 8.19e-01 |
| GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS | 11 | 2.58e-01 | 1.97e-01 | 8.65e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 4.03e-01 | 1.97e-01 | 9.20e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 4.45e-01 | 1.97e-01 | 9.31e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 6 | 4.03e-01 | 1.97e-01 | 9.20e-01 |
| GOBP FUCOSE CATABOLIC PROCESS | 9 | 3.06e-01 | -1.97e-01 | 8.85e-01 |
| GOBP INTESTINAL HEXOSE ABSORPTION | 5 | 4.46e-01 | -1.97e-01 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 10 | 2.81e-01 | -1.97e-01 | 8.73e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 7 | 3.67e-01 | 1.97e-01 | 9.07e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 9 | 3.07e-01 | -1.97e-01 | 8.85e-01 |
| GOBP NEUROTRANSMITTER BIOSYNTHETIC PROCESS | 14 | 2.03e-01 | 1.97e-01 | 8.51e-01 |
| GOBP RESPIRATORY BURST | 32 | 5.42e-02 | -1.97e-01 | 6.45e-01 |
| GOBP NEUTROPHIL MIGRATION | 118 | 2.25e-04 | -1.97e-01 | 4.32e-02 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.47e-01 | -1.97e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 10 | 2.82e-01 | 1.97e-01 | 8.73e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 9 | 3.07e-01 | 1.97e-01 | 8.85e-01 |
| GOCC SAGA TYPE COMPLEX | 35 | 4.42e-02 | 1.96e-01 | 6.22e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 4.47e-01 | -1.96e-01 | 9.31e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 3.68e-01 | 1.96e-01 | 9.08e-01 |
| GOBP RESPONSE TO STEROL | 35 | 4.43e-02 | -1.96e-01 | 6.22e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 13 | 2.20e-01 | 1.96e-01 | 8.56e-01 |
| GOMF URATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.08e-01 | -1.96e-01 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 2.20e-01 | -1.96e-01 | 8.56e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 20 | 1.29e-01 | -1.96e-01 | 7.93e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 47 | 1.99e-02 | 1.96e-01 | 4.91e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 15 | 1.88e-01 | -1.96e-01 | 8.44e-01 |
| GOBP TRACHEA DEVELOPMENT | 18 | 1.50e-01 | -1.96e-01 | 8.13e-01 |
| GOBP CARDIAC SEPTUM CELL DIFFERENTIATION | 5 | 4.48e-01 | 1.96e-01 | 9.31e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 12 | 2.40e-01 | 1.96e-01 | 8.64e-01 |
| GOMF GLYCINE BINDING | 10 | 2.83e-01 | -1.96e-01 | 8.74e-01 |
| GOBP ANDROGEN BIOSYNTHETIC PROCESS | 10 | 2.83e-01 | -1.96e-01 | 8.74e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 2.04e-01 | -1.96e-01 | 8.51e-01 |
| GOMF ADP PHOSPHATASE ACTIVITY | 5 | 4.48e-01 | -1.96e-01 | 9.32e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 42 | 2.82e-02 | -1.96e-01 | 5.45e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 20 | 1.30e-01 | -1.96e-01 | 7.93e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 13 | 2.22e-01 | -1.96e-01 | 8.57e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 4.07e-01 | 1.96e-01 | 9.21e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 60 | 8.83e-03 | -1.95e-01 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW | 6 | 4.07e-01 | -1.95e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION | 13 | 2.23e-01 | -1.95e-01 | 8.57e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 1.31e-01 | 1.95e-01 | 7.94e-01 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 6 | 4.08e-01 | -1.95e-01 | 9.21e-01 |
| GOCC CHROMATOID BODY | 13 | 2.23e-01 | -1.95e-01 | 8.57e-01 |
| GOBP NEURAL CREST CELL FATE COMMITMENT | 6 | 4.08e-01 | 1.95e-01 | 9.21e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 18 | 1.52e-01 | -1.95e-01 | 8.17e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 26 | 8.51e-02 | -1.95e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 4.08e-01 | -1.95e-01 | 9.21e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 4.50e-01 | -1.95e-01 | 9.33e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 19 | 1.41e-01 | 1.95e-01 | 8.06e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 16 | 1.77e-01 | -1.95e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 15 | 1.91e-01 | -1.95e-01 | 8.44e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 4.50e-01 | -1.95e-01 | 9.33e-01 |
| GOBP PROTEIN NITROSYLATION | 15 | 1.92e-01 | -1.95e-01 | 8.44e-01 |
| GOCC COP9 SIGNALOSOME | 16 | 1.77e-01 | 1.95e-01 | 8.41e-01 |
| GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 3.40e-01 | -1.95e-01 | 8.96e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 9 | 3.12e-01 | 1.95e-01 | 8.89e-01 |
| GOCC MANCHETTE | 16 | 1.78e-01 | -1.95e-01 | 8.41e-01 |
| GOBP REGULATION OF EPINEPHRINE SECRETION | 7 | 3.73e-01 | 1.95e-01 | 9.09e-01 |
| GOBP POLE PLASM ASSEMBLY | 6 | 4.10e-01 | -1.94e-01 | 9.21e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 12 | 2.44e-01 | -1.94e-01 | 8.64e-01 |
| GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION | 5 | 4.52e-01 | 1.94e-01 | 9.35e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 8.66e-02 | 1.94e-01 | 7.48e-01 |
| GOCC PARANODAL JUNCTION | 8 | 3.42e-01 | -1.94e-01 | 8.96e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 23 | 1.07e-01 | 1.94e-01 | 7.72e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 15 | 1.94e-01 | 1.94e-01 | 8.44e-01 |
| GOCC KINETOCHORE MICROTUBULE | 20 | 1.33e-01 | 1.94e-01 | 8.00e-01 |
| GOMF STEROID HORMONE BINDING | 6 | 4.11e-01 | -1.94e-01 | 9.21e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 15 | 1.94e-01 | 1.94e-01 | 8.44e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 4.12e-01 | 1.94e-01 | 9.21e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 16 | 1.80e-01 | -1.94e-01 | 8.41e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 14 | 2.10e-01 | -1.93e-01 | 8.53e-01 |
| GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY | 6 | 4.12e-01 | -1.93e-01 | 9.21e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 3.15e-01 | 1.93e-01 | 8.90e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 23 | 1.09e-01 | -1.93e-01 | 7.73e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 8 | 3.44e-01 | 1.93e-01 | 8.96e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 8 | 3.44e-01 | -1.93e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 14 | 2.11e-01 | 1.93e-01 | 8.54e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 16 | 1.81e-01 | -1.93e-01 | 8.41e-01 |
| GOBP CARDIAC MUSCLE CELL FATE COMMITMENT | 11 | 2.68e-01 | 1.93e-01 | 8.69e-01 |
| GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 8 | 3.45e-01 | 1.93e-01 | 8.96e-01 |
| GOBP PONS DEVELOPMENT | 11 | 2.68e-01 | 1.93e-01 | 8.69e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 4.13e-01 | 1.93e-01 | 9.23e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 13 | 2.29e-01 | 1.93e-01 | 8.62e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 13 | 2.29e-01 | 1.93e-01 | 8.62e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 16 | 1.82e-01 | 1.93e-01 | 8.42e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 11 | 2.69e-01 | -1.93e-01 | 8.69e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 8 | 3.46e-01 | 1.93e-01 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 15 | 1.97e-01 | -1.93e-01 | 8.44e-01 |
| GOMF DEOXYRIBONUCLEOTIDE BINDING | 5 | 4.56e-01 | -1.93e-01 | 9.36e-01 |
| GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 7 | 3.78e-01 | -1.92e-01 | 9.09e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 24 | 1.03e-01 | -1.92e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION | 6 | 4.14e-01 | -1.92e-01 | 9.23e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 23 | 1.10e-01 | 1.92e-01 | 7.77e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 14 | 2.13e-01 | -1.92e-01 | 8.54e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 9 | 3.18e-01 | 1.92e-01 | 8.91e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 46 | 2.40e-02 | -1.92e-01 | 5.17e-01 |
| GOBP CELLULAR RESPONSE TO WATER STIMULUS | 6 | 4.15e-01 | 1.92e-01 | 9.23e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 13 | 2.30e-01 | 1.92e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 4.15e-01 | -1.92e-01 | 9.23e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 11 | 2.70e-01 | 1.92e-01 | 8.69e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 9 | 3.18e-01 | -1.92e-01 | 8.91e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 12 | 2.50e-01 | 1.92e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 8 | 3.47e-01 | 1.92e-01 | 8.98e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 6 | 4.16e-01 | -1.92e-01 | 9.23e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 15 | 1.99e-01 | 1.92e-01 | 8.45e-01 |
| GOMF TRACE AMINE RECEPTOR ACTIVITY | 7 | 3.80e-01 | 1.91e-01 | 9.10e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 13 | 2.32e-01 | -1.91e-01 | 8.63e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 4.59e-01 | 1.91e-01 | 9.37e-01 |
| GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT | 6 | 4.17e-01 | 1.91e-01 | 9.23e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 17 | 1.72e-01 | -1.91e-01 | 8.36e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 23 | 1.12e-01 | -1.91e-01 | 7.78e-01 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 6 | 4.17e-01 | -1.91e-01 | 9.23e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 11 | 2.72e-01 | -1.91e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 4.59e-01 | -1.91e-01 | 9.37e-01 |
| GOCC RNA POLYMERASE COMPLEX | 97 | 1.15e-03 | 1.91e-01 | 1.28e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 21 | 1.30e-01 | 1.91e-01 | 7.93e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 12 | 2.52e-01 | 1.91e-01 | 8.65e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 25 | 9.84e-02 | -1.91e-01 | 7.66e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 15 | 2.01e-01 | 1.91e-01 | 8.48e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 11 | 2.73e-01 | -1.91e-01 | 8.69e-01 |
| GOBP BRONCHIOLE DEVELOPMENT | 5 | 4.60e-01 | 1.91e-01 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 20 | 1.40e-01 | -1.91e-01 | 8.06e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 13 | 2.34e-01 | -1.91e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 4.60e-01 | 1.91e-01 | 9.37e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 2.01e-01 | 1.91e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 10 | 2.97e-01 | -1.91e-01 | 8.82e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 3.23e-01 | 1.90e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 32 | 6.25e-02 | -1.90e-01 | 6.64e-01 |
| GOBP TRICUSPID VALVE MORPHOGENESIS | 5 | 4.61e-01 | 1.90e-01 | 9.37e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 41 | 3.51e-02 | -1.90e-01 | 5.72e-01 |
| GOBP NEURON FATE DETERMINATION | 10 | 2.98e-01 | 1.90e-01 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 2.19e-01 | 1.90e-01 | 8.56e-01 |
| GOCC GROWTH CONE MEMBRANE | 8 | 3.52e-01 | -1.90e-01 | 9.00e-01 |
| GOMF BUTYRATE COA LIGASE ACTIVITY | 8 | 3.53e-01 | 1.90e-01 | 9.00e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 10 | 2.99e-01 | -1.90e-01 | 8.83e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 2.36e-01 | 1.90e-01 | 8.64e-01 |
| GOBP TRACHEA CARTILAGE DEVELOPMENT | 7 | 3.85e-01 | -1.90e-01 | 9.14e-01 |
| GOBP CELLULAR RESPONSE TO CGMP | 7 | 3.85e-01 | -1.90e-01 | 9.14e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 20 | 1.42e-01 | 1.90e-01 | 8.06e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 17 | 1.76e-01 | 1.90e-01 | 8.41e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 9 | 3.25e-01 | -1.90e-01 | 8.93e-01 |
| GOBP DECIDUALIZATION | 24 | 1.08e-01 | 1.90e-01 | 7.73e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 27 | 8.83e-02 | -1.90e-01 | 7.52e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY | 6 | 4.22e-01 | 1.89e-01 | 9.24e-01 |
| GOBP RECEPTOR TRANSACTIVATION | 5 | 4.63e-01 | 1.89e-01 | 9.37e-01 |
| GOBP PROSTATE GLAND GROWTH | 10 | 3.00e-01 | -1.89e-01 | 8.84e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 26 | 9.50e-02 | 1.89e-01 | 7.66e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 9 | 3.26e-01 | 1.89e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 6 | 4.22e-01 | 1.89e-01 | 9.24e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 41 | 3.61e-02 | -1.89e-01 | 5.77e-01 |
| GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION | 5 | 4.64e-01 | 1.89e-01 | 9.37e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 16 | 1.90e-01 | -1.89e-01 | 8.44e-01 |
| GOBP DIRECT OSSIFICATION | 7 | 3.86e-01 | -1.89e-01 | 9.14e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 27 | 8.90e-02 | -1.89e-01 | 7.52e-01 |
| GOBP HEART VALVE FORMATION | 15 | 2.05e-01 | 1.89e-01 | 8.51e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 15 | 2.05e-01 | 1.89e-01 | 8.51e-01 |
| GOMF MYOSIN V BINDING | 16 | 1.90e-01 | -1.89e-01 | 8.44e-01 |
| GOCC CONTRACTILE RING | 10 | 3.01e-01 | 1.89e-01 | 8.84e-01 |
| GOBP MOTOR LEARNING | 7 | 3.87e-01 | 1.89e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 7 | 3.87e-01 | -1.89e-01 | 9.14e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 13 | 2.38e-01 | 1.89e-01 | 8.64e-01 |
| GOBP ACUTE PHASE RESPONSE | 46 | 2.67e-02 | 1.89e-01 | 5.32e-01 |
| GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.87e-01 | 1.89e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 4.23e-01 | 1.89e-01 | 9.24e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 10 | 3.01e-01 | -1.89e-01 | 8.84e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.56e-01 | -1.89e-01 | 9.02e-01 |
| GOBP RNA STABILIZATION | 66 | 8.09e-03 | -1.88e-01 | 3.51e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 13 | 2.40e-01 | 1.88e-01 | 8.64e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 12 | 2.59e-01 | -1.88e-01 | 8.65e-01 |
| GOMF VITAMIN D BINDING | 6 | 4.24e-01 | -1.88e-01 | 9.24e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 4.66e-01 | -1.88e-01 | 9.38e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 8 | 3.56e-01 | 1.88e-01 | 9.02e-01 |
| GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY | 5 | 4.66e-01 | 1.88e-01 | 9.38e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 4.66e-01 | -1.88e-01 | 9.38e-01 |
| GOBP THYROID HORMONE GENERATION | 22 | 1.26e-01 | 1.88e-01 | 7.93e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.03e-01 | -1.88e-01 | 8.84e-01 |
| GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 7 | 3.89e-01 | 1.88e-01 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 10 | 3.03e-01 | 1.88e-01 | 8.84e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 15 | 2.07e-01 | 1.88e-01 | 8.51e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 3.49e-02 | 1.88e-01 | 5.72e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 1.79e-01 | -1.88e-01 | 8.41e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 54 | 1.68e-02 | 1.88e-01 | 4.68e-01 |
| GOMF ARGININE BINDING | 8 | 3.57e-01 | -1.88e-01 | 9.03e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 14 | 2.24e-01 | 1.88e-01 | 8.57e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.58e-01 | 1.88e-01 | 9.03e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 10 | 3.04e-01 | 1.88e-01 | 8.84e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 66 | 8.35e-03 | -1.88e-01 | 3.53e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 12 | 2.60e-01 | 1.88e-01 | 8.66e-01 |
| GOMF COMPLEMENT BINDING | 24 | 1.12e-01 | -1.88e-01 | 7.77e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 45 | 2.95e-02 | -1.87e-01 | 5.52e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 10 | 3.05e-01 | -1.87e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 21 | 1.37e-01 | -1.87e-01 | 8.06e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 2.82e-01 | 1.87e-01 | 8.73e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 22 | 1.29e-01 | -1.87e-01 | 7.93e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 3.31e-01 | -1.87e-01 | 8.93e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 13 | 2.43e-01 | -1.87e-01 | 8.64e-01 |
| GOBP UTERUS DEVELOPMENT | 23 | 1.21e-01 | 1.87e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 4.69e-01 | -1.87e-01 | 9.39e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 4.69e-01 | 1.87e-01 | 9.39e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 9 | 3.32e-01 | -1.87e-01 | 8.94e-01 |
| GOCC VARICOSITY | 8 | 3.61e-01 | 1.87e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 14 | 2.27e-01 | -1.87e-01 | 8.62e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 3.07e-01 | -1.86e-01 | 8.85e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 28 | 8.78e-02 | -1.86e-01 | 7.52e-01 |
| GOBP REGULATION OF LUTEINIZING HORMONE SECRETION | 6 | 4.30e-01 | 1.86e-01 | 9.27e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 4.71e-01 | 1.86e-01 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 2.45e-01 | 1.86e-01 | 8.65e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 98 | 1.46e-03 | -1.86e-01 | 1.42e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 3.09e-01 | -1.86e-01 | 8.87e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 2.12e-01 | -1.86e-01 | 8.54e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 8.86e-02 | 1.86e-01 | 7.52e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 15 | 2.12e-01 | 1.86e-01 | 8.54e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 27 | 9.45e-02 | -1.86e-01 | 7.64e-01 |
| GOBP FOREBRAIN NEUROBLAST DIVISION | 5 | 4.72e-01 | -1.86e-01 | 9.39e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 23 | 1.23e-01 | 1.86e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 3.95e-01 | 1.86e-01 | 9.18e-01 |
| GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX | 5 | 4.72e-01 | 1.86e-01 | 9.39e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 15 | 2.13e-01 | -1.86e-01 | 8.54e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 3.64e-01 | 1.85e-01 | 9.06e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 13 | 2.47e-01 | -1.85e-01 | 8.65e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 13 | 2.48e-01 | -1.85e-01 | 8.65e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 3.36e-01 | -1.85e-01 | 8.96e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 8 | 3.64e-01 | 1.85e-01 | 9.06e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 14 | 2.30e-01 | -1.85e-01 | 8.62e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 12 | 2.67e-01 | -1.85e-01 | 8.69e-01 |
| GOBP ROUNDABOUT SIGNALING PATHWAY | 5 | 4.74e-01 | -1.85e-01 | 9.41e-01 |
| GOBP RESPONSE TO GRAVITY | 9 | 3.36e-01 | 1.85e-01 | 8.96e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 23 | 1.25e-01 | -1.85e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 3.97e-01 | -1.85e-01 | 9.18e-01 |
| GOBP RRNA TRANSCRIPTION | 37 | 5.15e-02 | 1.85e-01 | 6.40e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 3.37e-01 | -1.85e-01 | 8.96e-01 |
| GOBP PERISTALSIS | 12 | 2.67e-01 | 1.85e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 4.74e-01 | -1.85e-01 | 9.41e-01 |
| GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE | 8 | 3.65e-01 | 1.85e-01 | 9.06e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 3.65e-01 | 1.85e-01 | 9.06e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 4.33e-01 | 1.85e-01 | 9.27e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 4.74e-01 | 1.85e-01 | 9.41e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 88 | 2.74e-03 | -1.85e-01 | 2.00e-01 |
| GOBP EXOCYST LOCALIZATION | 5 | 4.74e-01 | 1.85e-01 | 9.41e-01 |
| GOCC T TUBULE | 51 | 2.25e-02 | -1.85e-01 | 5.08e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 3.97e-01 | -1.85e-01 | 9.18e-01 |
| GOMF DIHYDROPYRIMIDINASE ACTIVITY | 6 | 4.34e-01 | -1.85e-01 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 4.75e-01 | -1.85e-01 | 9.41e-01 |
| GOBP SIRNA PROCESSING | 9 | 3.38e-01 | 1.85e-01 | 8.96e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 7 | 3.98e-01 | 1.84e-01 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 11 | 2.90e-01 | -1.84e-01 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 12 | 2.69e-01 | 1.84e-01 | 8.69e-01 |
| GOBP ANDROGEN CATABOLIC PROCESS | 5 | 4.75e-01 | -1.84e-01 | 9.41e-01 |
| GOBP MESONEPHRIC DUCT DEVELOPMENT | 8 | 3.67e-01 | 1.84e-01 | 9.06e-01 |
| GOMF EPINEPHRINE BINDING | 6 | 4.34e-01 | 1.84e-01 | 9.27e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 93 | 2.13e-03 | 1.84e-01 | 1.76e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 15 | 2.17e-01 | -1.84e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 18 | 1.76e-01 | 1.84e-01 | 8.41e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 19 | 1.65e-01 | 1.84e-01 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 14 | 2.34e-01 | 1.84e-01 | 8.64e-01 |
| GOBP AMMONIUM HOMEOSTASIS | 5 | 4.77e-01 | 1.84e-01 | 9.41e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 59 | 1.47e-02 | -1.84e-01 | 4.59e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 11 | 2.92e-01 | -1.84e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 27 | 9.90e-02 | -1.83e-01 | 7.66e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 21 | 1.46e-01 | 1.83e-01 | 8.08e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 17 | 1.91e-01 | 1.83e-01 | 8.44e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 32 | 7.30e-02 | -1.83e-01 | 7.07e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 20 | 1.56e-01 | -1.83e-01 | 8.17e-01 |
| GOBP AMYLOID BETA CLEARANCE | 39 | 4.79e-02 | -1.83e-01 | 6.27e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 12 | 2.73e-01 | -1.83e-01 | 8.69e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 8 | 3.70e-01 | 1.83e-01 | 9.09e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 4.38e-01 | 1.83e-01 | 9.28e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 18 | 1.79e-01 | 1.83e-01 | 8.41e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 16 | 2.06e-01 | -1.83e-01 | 8.51e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 3.71e-01 | 1.83e-01 | 9.09e-01 |
| GOBP VITAMIN E METABOLIC PROCESS | 6 | 4.38e-01 | -1.83e-01 | 9.28e-01 |
| GOBP DNA CATABOLIC PROCESS | 29 | 8.87e-02 | 1.83e-01 | 7.52e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 10 | 3.18e-01 | -1.83e-01 | 8.91e-01 |
| GOMF MRF BINDING | 5 | 4.80e-01 | -1.82e-01 | 9.42e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 4.39e-01 | -1.82e-01 | 9.29e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 38 | 5.18e-02 | 1.82e-01 | 6.42e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 1.08e-01 | 1.82e-01 | 7.72e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 11 | 2.95e-01 | 1.82e-01 | 8.82e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 10 | 3.19e-01 | -1.82e-01 | 8.91e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 1.94e-01 | -1.82e-01 | 8.44e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 9 | 3.44e-01 | -1.82e-01 | 8.96e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 11 | 2.96e-01 | 1.82e-01 | 8.82e-01 |
| GOCC REPLISOME | 13 | 2.56e-01 | 1.82e-01 | 8.65e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 2.96e-01 | 1.82e-01 | 8.82e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 29 | 9.00e-02 | 1.82e-01 | 7.52e-01 |
| GOBP SIALYLATION | 8 | 3.73e-01 | -1.82e-01 | 9.09e-01 |
| GOCC FC RECEPTOR COMPLEX | 5 | 4.81e-01 | -1.82e-01 | 9.42e-01 |
| GOBP COPPER ION HOMEOSTASIS | 17 | 1.95e-01 | -1.82e-01 | 8.44e-01 |
| GOMF NEUROTRANSMITTER BINDING | 16 | 2.08e-01 | -1.82e-01 | 8.52e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 13 | 2.57e-01 | 1.82e-01 | 8.65e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 20 | 1.60e-01 | -1.81e-01 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 7 | 4.06e-01 | 1.81e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 13 | 2.58e-01 | 1.81e-01 | 8.65e-01 |
| GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 11 | 2.98e-01 | -1.81e-01 | 8.82e-01 |
| GOMF U1 SNRNA BINDING | 8 | 3.75e-01 | -1.81e-01 | 9.09e-01 |
| GOBP NEGATIVE T CELL SELECTION | 13 | 2.58e-01 | 1.81e-01 | 8.65e-01 |
| GOMF C C CHEMOKINE BINDING | 23 | 1.33e-01 | -1.81e-01 | 7.99e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 4.83e-01 | 1.81e-01 | 9.43e-01 |
| GOMF GAMMA CATENIN BINDING | 12 | 2.78e-01 | 1.81e-01 | 8.70e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 11 | 2.99e-01 | 1.81e-01 | 8.83e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 9 | 3.47e-01 | 1.81e-01 | 8.98e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 25 | 1.18e-01 | 1.81e-01 | 7.82e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 41 | 4.52e-02 | -1.81e-01 | 6.22e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 10 | 3.22e-01 | 1.81e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 28 | 9.79e-02 | 1.81e-01 | 7.66e-01 |
| GOBP L SERINE TRANSPORT | 7 | 4.08e-01 | -1.81e-01 | 9.21e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.08e-01 | -1.81e-01 | 9.21e-01 |
| GOCC SPERM PRINCIPAL PIECE | 32 | 7.71e-02 | -1.81e-01 | 7.18e-01 |
| GOCC CORNIFIED ENVELOPE | 55 | 2.07e-02 | -1.80e-01 | 4.96e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 24 | 1.26e-01 | 1.80e-01 | 7.93e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 1.98e-01 | 1.80e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 11 | 3.01e-01 | 1.80e-01 | 8.84e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 8 | 3.78e-01 | -1.80e-01 | 9.09e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 93 | 2.69e-03 | -1.80e-01 | 1.98e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 7 | 4.09e-01 | 1.80e-01 | 9.21e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 6.16e-02 | 1.80e-01 | 6.63e-01 |
| GOCC ESCRT I COMPLEX | 11 | 3.01e-01 | -1.80e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 16 | 2.13e-01 | 1.80e-01 | 8.54e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 67 | 1.09e-02 | 1.80e-01 | 3.94e-01 |
| GOBP URETER MORPHOGENESIS | 7 | 4.10e-01 | 1.80e-01 | 9.21e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 2.44e-01 | -1.80e-01 | 8.64e-01 |
| GOCC BARR BODY | 7 | 4.10e-01 | 1.80e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 37 | 5.83e-02 | -1.80e-01 | 6.58e-01 |
| GOBP RESPONSE TO LEUCINE | 15 | 2.28e-01 | 1.80e-01 | 8.62e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 5 | 4.86e-01 | 1.80e-01 | 9.43e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 59 | 1.70e-02 | 1.80e-01 | 4.68e-01 |
| GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX | 7 | 4.11e-01 | -1.80e-01 | 9.21e-01 |
| GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS | 5 | 4.87e-01 | -1.80e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF MIRNA PROCESSING | 5 | 4.87e-01 | 1.79e-01 | 9.43e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 13 | 2.62e-01 | -1.79e-01 | 8.68e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 16 | 2.14e-01 | 1.79e-01 | 8.55e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 8 | 3.80e-01 | 1.79e-01 | 9.10e-01 |
| GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION | 5 | 4.88e-01 | -1.79e-01 | 9.43e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 3.03e-01 | -1.79e-01 | 8.84e-01 |
| GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.48e-01 | 1.79e-01 | 9.31e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 6.30e-02 | 1.79e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 33 | 7.52e-02 | -1.79e-01 | 7.15e-01 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 7 | 4.12e-01 | 1.79e-01 | 9.21e-01 |
| GOBP REGULATION OF GLUCAGON SECRETION | 8 | 3.81e-01 | 1.79e-01 | 9.11e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 11 | 3.04e-01 | -1.79e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 14 | 2.47e-01 | -1.79e-01 | 8.65e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 26 | 1.15e-01 | 1.79e-01 | 7.81e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 11 | 3.05e-01 | 1.79e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 13 | 2.65e-01 | -1.79e-01 | 8.69e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 4.89e-01 | -1.79e-01 | 9.43e-01 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 4.49e-01 | -1.79e-01 | 9.33e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 10 | 3.28e-01 | 1.78e-01 | 8.93e-01 |
| GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY | 6 | 4.49e-01 | 1.78e-01 | 9.33e-01 |
| GOBP REGULATION OF PHOSPHATE TRANSPORT | 6 | 4.49e-01 | -1.78e-01 | 9.33e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 42 | 4.55e-02 | -1.78e-01 | 6.22e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 3.06e-01 | -1.78e-01 | 8.85e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 15 | 2.32e-01 | 1.78e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 15 | 2.32e-01 | 1.78e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 9 | 3.55e-01 | -1.78e-01 | 9.02e-01 |
| GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY | 7 | 4.15e-01 | -1.78e-01 | 9.23e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 12 | 2.86e-01 | -1.78e-01 | 8.75e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 7 | 4.15e-01 | -1.78e-01 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 9 | 3.56e-01 | -1.78e-01 | 9.02e-01 |
| GOCC ISWI TYPE COMPLEX | 12 | 2.87e-01 | 1.78e-01 | 8.76e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 15 | 2.34e-01 | 1.77e-01 | 8.64e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 6 | 4.52e-01 | -1.77e-01 | 9.35e-01 |
| GOMF RETROMER COMPLEX BINDING | 7 | 4.17e-01 | -1.77e-01 | 9.23e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 15 | 2.35e-01 | -1.77e-01 | 8.64e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 13 | 2.69e-01 | -1.77e-01 | 8.69e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 29 | 9.92e-02 | -1.77e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 10 | 3.33e-01 | 1.77e-01 | 8.94e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 18 | 1.94e-01 | 1.77e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 15 | 2.36e-01 | 1.77e-01 | 8.64e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 11 | 3.10e-01 | 1.77e-01 | 8.87e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 15 | 2.36e-01 | -1.77e-01 | 8.64e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 37 | 6.29e-02 | 1.77e-01 | 6.67e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 8 | 3.87e-01 | 1.77e-01 | 9.14e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 28 | 1.06e-01 | 1.77e-01 | 7.71e-01 |
| GOCC MCM COMPLEX | 8 | 3.87e-01 | -1.77e-01 | 9.14e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 4.54e-01 | -1.77e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 63 | 1.54e-02 | 1.76e-01 | 4.61e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 7 | 4.19e-01 | -1.76e-01 | 9.24e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 33 | 7.95e-02 | -1.76e-01 | 7.25e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 13 | 2.71e-01 | 1.76e-01 | 8.69e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 5 | 4.95e-01 | 1.76e-01 | 9.45e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 8 | 3.88e-01 | 1.76e-01 | 9.14e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 2.53e-01 | 1.76e-01 | 8.65e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 3.35e-01 | -1.76e-01 | 8.96e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 6 | 4.55e-01 | -1.76e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 20 | 1.73e-01 | 1.76e-01 | 8.36e-01 |
| GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY | 6 | 4.55e-01 | 1.76e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 4.55e-01 | 1.76e-01 | 9.36e-01 |
| GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY | 6 | 4.55e-01 | -1.76e-01 | 9.36e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 2.54e-01 | 1.76e-01 | 8.65e-01 |
| GOBP SUCCINATE TRANSMEMBRANE TRANSPORT | 6 | 4.56e-01 | 1.76e-01 | 9.36e-01 |
| GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.56e-01 | 1.76e-01 | 9.36e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 6 | 4.56e-01 | 1.76e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION | 5 | 4.96e-01 | -1.76e-01 | 9.45e-01 |
| GOBP CILIARY BODY MORPHOGENESIS | 5 | 4.97e-01 | 1.75e-01 | 9.45e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 24 | 1.37e-01 | 1.75e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 6 | 4.57e-01 | -1.75e-01 | 9.36e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 18 | 1.98e-01 | 1.75e-01 | 8.44e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 232 | 4.27e-06 | -1.75e-01 | 2.73e-03 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 3.91e-01 | 1.75e-01 | 9.16e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 38 | 6.17e-02 | 1.75e-01 | 6.63e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 11 | 3.15e-01 | -1.75e-01 | 8.90e-01 |
| GOBP AXIAL MESODERM DEVELOPMENT | 8 | 3.92e-01 | 1.75e-01 | 9.16e-01 |
| GOMF VINCULIN BINDING | 11 | 3.15e-01 | 1.75e-01 | 8.90e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 1.99e-01 | 1.75e-01 | 8.45e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 54 | 2.63e-02 | -1.75e-01 | 5.28e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 2.12e-01 | -1.75e-01 | 8.54e-01 |
| GOBP TYPE III INTERFERON PRODUCTION | 5 | 4.99e-01 | 1.75e-01 | 9.45e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 15 | 2.42e-01 | -1.75e-01 | 8.64e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 4.59e-01 | -1.75e-01 | 9.37e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 4.24e-01 | 1.74e-01 | 9.24e-01 |
| GOBP NEUROBLAST DIVISION | 13 | 2.76e-01 | -1.74e-01 | 8.70e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 18 | 2.00e-01 | -1.74e-01 | 8.48e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 5.00e-01 | 1.74e-01 | 9.45e-01 |
| GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS | 6 | 4.60e-01 | -1.74e-01 | 9.37e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 7 | 4.24e-01 | -1.74e-01 | 9.24e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 7 | 4.24e-01 | 1.74e-01 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 1.39e-01 | 1.74e-01 | 8.06e-01 |
| GOBP SPERM DNA CONDENSATION | 17 | 2.13e-01 | -1.74e-01 | 8.54e-01 |
| GOCC U7 SNRNP | 7 | 4.25e-01 | 1.74e-01 | 9.25e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 19 | 1.89e-01 | -1.74e-01 | 8.44e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 12 | 2.96e-01 | 1.74e-01 | 8.82e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 30 | 9.88e-02 | 1.74e-01 | 7.66e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 11 | 3.17e-01 | 1.74e-01 | 8.91e-01 |
| GOBP RENAL WATER TRANSPORT | 9 | 3.66e-01 | -1.74e-01 | 9.06e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 17 | 2.14e-01 | -1.74e-01 | 8.55e-01 |
| GOCC EXOCYST | 14 | 2.60e-01 | 1.74e-01 | 8.66e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 3.18e-01 | -1.74e-01 | 8.91e-01 |
| GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE | 5 | 5.01e-01 | -1.74e-01 | 9.45e-01 |
| GOBP ANAGEN | 5 | 5.01e-01 | 1.74e-01 | 9.45e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 7 | 4.26e-01 | -1.74e-01 | 9.26e-01 |
| GOBP REGULATION OF PANCREATIC JUICE SECRETION | 7 | 4.27e-01 | -1.74e-01 | 9.26e-01 |
| GOCC ZYMOGEN GRANULE | 14 | 2.61e-01 | -1.74e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 19 | 1.91e-01 | -1.73e-01 | 8.44e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 14 | 2.62e-01 | -1.73e-01 | 8.67e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 18 | 2.03e-01 | 1.73e-01 | 8.51e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 37 | 6.83e-02 | -1.73e-01 | 6.92e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 2.46e-01 | -1.73e-01 | 8.65e-01 |
| GOBP SYMPATHETIC NEURON PROJECTION EXTENSION | 5 | 5.03e-01 | -1.73e-01 | 9.45e-01 |
| GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION | 5 | 5.03e-01 | 1.73e-01 | 9.45e-01 |
| GOMF RDNA BINDING | 10 | 3.43e-01 | 1.73e-01 | 8.96e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 4.63e-01 | -1.73e-01 | 9.37e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 40 | 5.83e-02 | -1.73e-01 | 6.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 12 | 2.99e-01 | -1.73e-01 | 8.83e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING | 8 | 3.97e-01 | -1.73e-01 | 9.18e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 3.27e-02 | 1.73e-01 | 5.58e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 6 | 4.63e-01 | -1.73e-01 | 9.37e-01 |
| GOBP TERMINAL BUTTON ORGANIZATION | 6 | 4.64e-01 | 1.73e-01 | 9.37e-01 |
| GOBP PROTEIN DEMETHYLATION | 9 | 3.69e-01 | 1.73e-01 | 9.09e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 1.61e-01 | 1.73e-01 | 8.22e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 90 | 4.64e-03 | 1.73e-01 | 2.64e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 12 | 3.00e-01 | -1.73e-01 | 8.84e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 5.04e-01 | 1.73e-01 | 9.45e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 8 | 3.98e-01 | 1.72e-01 | 9.18e-01 |
| GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 15 | 2.48e-01 | -1.72e-01 | 8.65e-01 |
| GOBP STRIATUM DEVELOPMENT | 20 | 1.82e-01 | -1.72e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 2.82e-01 | 1.72e-01 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.99e-01 | -1.72e-01 | 9.18e-01 |
| GOMF COPPER ION BINDING | 58 | 2.33e-02 | -1.72e-01 | 5.16e-01 |
| GOBP AMELOBLAST DIFFERENTIATION | 5 | 5.05e-01 | 1.72e-01 | 9.45e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 60 | 2.11e-02 | -1.72e-01 | 4.96e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 22 | 1.62e-01 | 1.72e-01 | 8.24e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 1.72e-01 | 1.72e-01 | 8.36e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 9 | 3.72e-01 | -1.72e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 12 | 3.03e-01 | 1.72e-01 | 8.84e-01 |
| GOMF THIOESTERASE BINDING | 9 | 3.72e-01 | -1.72e-01 | 9.09e-01 |
| GOMF PORIN ACTIVITY | 6 | 4.66e-01 | -1.72e-01 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 4.31e-01 | -1.72e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 29 | 1.10e-01 | 1.72e-01 | 7.75e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 9.84e-02 | -1.72e-01 | 7.66e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 8 | 4.01e-01 | -1.72e-01 | 9.18e-01 |
| GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.67e-01 | 1.71e-01 | 9.38e-01 |
| GOCC METHYLOSOME | 13 | 2.84e-01 | -1.71e-01 | 8.74e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 37 | 7.11e-02 | -1.71e-01 | 6.99e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 16 | 2.35e-01 | 1.71e-01 | 8.64e-01 |
| GOBP ALKALOID METABOLIC PROCESS | 7 | 4.32e-01 | 1.71e-01 | 9.27e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 22 | 1.64e-01 | 1.71e-01 | 8.24e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 54 | 2.94e-02 | -1.71e-01 | 5.52e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 25 | 1.38e-01 | -1.71e-01 | 8.06e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION | 6 | 4.67e-01 | -1.71e-01 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 17 | 2.22e-01 | 1.71e-01 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 24 | 1.47e-01 | 1.71e-01 | 8.08e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 3.74e-01 | -1.71e-01 | 9.09e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 3.05e-01 | 1.71e-01 | 8.84e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 6 | 4.68e-01 | 1.71e-01 | 9.39e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 16 | 2.36e-01 | -1.71e-01 | 8.64e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 18 | 2.09e-01 | 1.71e-01 | 8.53e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 15 | 2.52e-01 | -1.71e-01 | 8.65e-01 |
| GOMF MITOCHONDRION TARGETING SEQUENCE BINDING | 5 | 5.08e-01 | 1.71e-01 | 9.46e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 14 | 2.69e-01 | 1.71e-01 | 8.69e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 1.98e-01 | 1.71e-01 | 8.44e-01 |
| GOMF OLIGOSACCHARIDE BINDING | 15 | 2.52e-01 | -1.71e-01 | 8.65e-01 |
| GOBP NEUROBLAST MIGRATION | 6 | 4.69e-01 | 1.71e-01 | 9.39e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 7 | 4.34e-01 | 1.71e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING | 5 | 5.09e-01 | 1.71e-01 | 9.46e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 4.04e-01 | 1.71e-01 | 9.20e-01 |
| GOMF MICROFIBRIL BINDING | 5 | 5.09e-01 | -1.71e-01 | 9.46e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 4.70e-01 | 1.70e-01 | 9.39e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 68 | 1.51e-02 | -1.70e-01 | 4.61e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 37 | 7.28e-02 | 1.70e-01 | 7.06e-01 |
| GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY | 7 | 4.35e-01 | 1.70e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 12 | 3.07e-01 | 1.70e-01 | 8.85e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 11 | 3.28e-01 | 1.70e-01 | 8.93e-01 |
| GOMF INHIBITORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 3.28e-01 | 1.70e-01 | 8.93e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 7 | 4.35e-01 | -1.70e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 15 | 2.54e-01 | -1.70e-01 | 8.65e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 4.71e-01 | 1.70e-01 | 9.39e-01 |
| GOBP PINOCYTOSIS | 22 | 1.68e-01 | -1.70e-01 | 8.31e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 34 | 8.67e-02 | -1.70e-01 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 18 | 2.12e-01 | -1.70e-01 | 8.54e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 9 | 3.78e-01 | 1.70e-01 | 9.09e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 6 | 4.71e-01 | 1.70e-01 | 9.39e-01 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 5.11e-01 | -1.70e-01 | 9.46e-01 |
| GOBP WNT PROTEIN SECRETION | 5 | 5.11e-01 | -1.70e-01 | 9.46e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 122 | 1.21e-03 | -1.70e-01 | 1.29e-01 |
| GOCC FILTRATION DIAPHRAGM | 8 | 4.06e-01 | 1.70e-01 | 9.21e-01 |
| GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY | 6 | 4.72e-01 | -1.70e-01 | 9.39e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 4.37e-01 | -1.70e-01 | 9.28e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 28 | 1.21e-01 | -1.69e-01 | 7.89e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 2.26e-01 | -1.69e-01 | 8.61e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 59 | 2.44e-02 | -1.69e-01 | 5.18e-01 |
| GOBP RESPONSE TO X RAY | 28 | 1.21e-01 | 1.69e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 25 | 1.43e-01 | -1.69e-01 | 8.06e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 11 | 3.31e-01 | -1.69e-01 | 8.93e-01 |
| GOCC AZUROPHIL GRANULE | 151 | 3.32e-04 | -1.69e-01 | 5.75e-02 |
| GOBP ACETATE ESTER TRANSPORT | 9 | 3.80e-01 | 1.69e-01 | 9.10e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 40 | 6.41e-02 | 1.69e-01 | 6.71e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 18 | 2.14e-01 | -1.69e-01 | 8.55e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 16 | 2.42e-01 | 1.69e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 19 | 2.02e-01 | -1.69e-01 | 8.51e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 5.13e-01 | 1.69e-01 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE | 7 | 4.39e-01 | -1.69e-01 | 9.29e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 25 | 1.44e-01 | -1.69e-01 | 8.06e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 21 | 1.80e-01 | 1.69e-01 | 8.41e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 36 | 7.95e-02 | -1.69e-01 | 7.25e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 64 | 1.95e-02 | -1.69e-01 | 4.91e-01 |
| GOMF FILAMIN BINDING | 14 | 2.74e-01 | -1.69e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 3.55e-01 | 1.69e-01 | 9.02e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 9 | 3.81e-01 | -1.69e-01 | 9.11e-01 |
| GOBP ANTERIOR COMMISSURE MORPHOGENESIS | 7 | 4.40e-01 | -1.69e-01 | 9.29e-01 |
| GOBP LYMPHOCYTE MIGRATION | 114 | 1.87e-03 | -1.69e-01 | 1.62e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 26 | 1.37e-01 | -1.69e-01 | 8.06e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 17 | 2.29e-01 | -1.69e-01 | 8.62e-01 |
| GOBP STEM CELL FATE COMMITMENT | 10 | 3.56e-01 | 1.69e-01 | 9.02e-01 |
| GOBP VAGINA DEVELOPMENT | 10 | 3.56e-01 | -1.68e-01 | 9.02e-01 |
| GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION | 5 | 5.14e-01 | 1.68e-01 | 9.46e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 48 | 4.35e-02 | -1.68e-01 | 6.18e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 6 | 4.75e-01 | 1.68e-01 | 9.41e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 17 | 2.29e-01 | -1.68e-01 | 8.62e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 67 | 1.71e-02 | 1.68e-01 | 4.70e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 4.41e-01 | 1.68e-01 | 9.29e-01 |
| GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 6 | 4.75e-01 | 1.68e-01 | 9.41e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 47 | 4.60e-02 | -1.68e-01 | 6.22e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 9 | 3.82e-01 | 1.68e-01 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 31 | 1.05e-01 | -1.68e-01 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 9 | 3.82e-01 | -1.68e-01 | 9.12e-01 |
| GOMF CATECHOLAMINE BINDING | 12 | 3.13e-01 | 1.68e-01 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 5.15e-01 | 1.68e-01 | 9.46e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 67 | 1.74e-02 | -1.68e-01 | 4.75e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 8 | 4.11e-01 | 1.68e-01 | 9.21e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 16 | 2.45e-01 | 1.68e-01 | 8.65e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 7 | 4.42e-01 | -1.68e-01 | 9.30e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 14 | 2.78e-01 | 1.68e-01 | 8.70e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 11 | 3.36e-01 | -1.68e-01 | 8.96e-01 |
| GOBP PROTEIN UNFOLDING | 5 | 5.16e-01 | -1.68e-01 | 9.46e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 23 | 1.64e-01 | -1.67e-01 | 8.24e-01 |
| GOMF O PALMITOYLTRANSFERASE ACTIVITY | 5 | 5.17e-01 | 1.67e-01 | 9.46e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 25 | 1.47e-01 | -1.67e-01 | 8.08e-01 |
| GOMF GALACTOSYLCERAMIDASE ACTIVITY | 5 | 5.17e-01 | 1.67e-01 | 9.46e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 2.78e-01 | -1.67e-01 | 8.71e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 18 | 2.19e-01 | -1.67e-01 | 8.56e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 13 | 2.96e-01 | -1.67e-01 | 8.82e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 49 | 4.28e-02 | 1.67e-01 | 6.14e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 5.17e-01 | -1.67e-01 | 9.47e-01 |
| GOMF DYSTROGLYCAN BINDING | 10 | 3.60e-01 | 1.67e-01 | 9.04e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 47 | 4.76e-02 | -1.67e-01 | 6.27e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 4.44e-01 | 1.67e-01 | 9.30e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 27 | 1.33e-01 | -1.67e-01 | 8.00e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 11 | 3.38e-01 | 1.67e-01 | 8.96e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 7 | 4.44e-01 | 1.67e-01 | 9.30e-01 |
| GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 5.18e-01 | -1.67e-01 | 9.47e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 5.18e-01 | 1.67e-01 | 9.47e-01 |
| GOBP PROLINE METABOLIC PROCESS | 10 | 3.61e-01 | -1.67e-01 | 9.04e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 16 | 2.48e-01 | 1.67e-01 | 8.65e-01 |
| GOBP RESPONSE TO BLUE LIGHT | 6 | 4.79e-01 | -1.67e-01 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 24 | 1.57e-01 | 1.67e-01 | 8.17e-01 |
| GOMF PHOSPHOLIPASE BINDING | 20 | 1.97e-01 | 1.67e-01 | 8.44e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 12 | 3.17e-01 | -1.67e-01 | 8.91e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 32 | 1.03e-01 | -1.67e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 48 | 4.57e-02 | -1.67e-01 | 6.22e-01 |
| GOBP NADH OXIDATION | 6 | 4.80e-01 | 1.67e-01 | 9.42e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 6 | 4.80e-01 | 1.67e-01 | 9.42e-01 |
| GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY | 6 | 4.80e-01 | 1.67e-01 | 9.42e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 7 | 4.45e-01 | 1.67e-01 | 9.31e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 77 | 1.15e-02 | -1.67e-01 | 4.05e-01 |
| GOBP REGULATION OF PROSTATIC BUD FORMATION | 5 | 5.19e-01 | 1.67e-01 | 9.47e-01 |
| GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 5 | 5.19e-01 | -1.66e-01 | 9.47e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 10 | 3.62e-01 | -1.66e-01 | 9.06e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 1.03e-01 | 1.66e-01 | 7.67e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 57 | 2.98e-02 | 1.66e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 35 | 8.87e-02 | -1.66e-01 | 7.52e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 11 | 3.40e-01 | -1.66e-01 | 8.96e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 5.20e-01 | -1.66e-01 | 9.47e-01 |
| GOBP ADULT HEART DEVELOPMENT | 13 | 3.00e-01 | -1.66e-01 | 8.84e-01 |
| GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY | 5 | 5.20e-01 | 1.66e-01 | 9.47e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 10 | 3.63e-01 | -1.66e-01 | 9.06e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 18 | 2.23e-01 | 1.66e-01 | 8.57e-01 |
| GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY | 6 | 4.82e-01 | 1.66e-01 | 9.42e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 7 | 4.47e-01 | -1.66e-01 | 9.31e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 3.41e-01 | -1.66e-01 | 8.96e-01 |
| GOBP VESICLE TARGETING | 65 | 2.08e-02 | 1.66e-01 | 4.96e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 32 | 1.04e-01 | 1.66e-01 | 7.69e-01 |
| GOBP GLYCOSIDE TRANSPORT | 5 | 5.21e-01 | 1.66e-01 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 6 | 4.82e-01 | -1.66e-01 | 9.43e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 12 | 3.21e-01 | -1.66e-01 | 8.92e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 23 | 1.69e-01 | -1.66e-01 | 8.31e-01 |
| GOCC SYNAPTIC CLEFT | 21 | 1.89e-01 | -1.65e-01 | 8.44e-01 |
| GOBP LIPOXYGENASE PATHWAY | 11 | 3.42e-01 | -1.65e-01 | 8.96e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 20 | 2.00e-01 | -1.65e-01 | 8.48e-01 |
| GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY | 8 | 4.18e-01 | 1.65e-01 | 9.24e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 12 | 3.21e-01 | 1.65e-01 | 8.92e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 13 | 3.02e-01 | 1.65e-01 | 8.84e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 49 | 4.54e-02 | 1.65e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 6 | 4.83e-01 | -1.65e-01 | 9.43e-01 |
| GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION | 10 | 3.66e-01 | -1.65e-01 | 9.06e-01 |
| GOMF MHC PROTEIN BINDING | 32 | 1.06e-01 | -1.65e-01 | 7.71e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 15 | 2.68e-01 | -1.65e-01 | 8.69e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 28 | 1.31e-01 | 1.65e-01 | 7.94e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 34 | 9.60e-02 | 1.65e-01 | 7.66e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 2.69e-01 | 1.65e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 63 | 2.36e-02 | -1.65e-01 | 5.17e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 15 | 2.69e-01 | -1.65e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 11 | 3.44e-01 | -1.65e-01 | 8.96e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 16 | 2.54e-01 | 1.65e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 34 | 9.65e-02 | -1.65e-01 | 7.66e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 16 | 2.55e-01 | -1.64e-01 | 8.65e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 44 | 5.92e-02 | 1.64e-01 | 6.61e-01 |
| GOMF OLFACTORY RECEPTOR ACTIVITY | 337 | 2.13e-07 | -1.64e-01 | 2.72e-04 |
| GOBP HISTONE DEACETYLATION | 19 | 2.15e-01 | 1.64e-01 | 8.55e-01 |
| GOBP COMMON BILE DUCT DEVELOPMENT | 5 | 5.25e-01 | -1.64e-01 | 9.47e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 14 | 2.87e-01 | -1.64e-01 | 8.76e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 8 | 4.21e-01 | -1.64e-01 | 9.24e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 2.71e-01 | -1.64e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 146 | 6.14e-04 | -1.64e-01 | 8.98e-02 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 8 | 4.21e-01 | -1.64e-01 | 9.24e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 7 | 4.52e-01 | 1.64e-01 | 9.35e-01 |
| GOBP FOLIC ACID TRANSPORT | 10 | 3.69e-01 | 1.64e-01 | 9.08e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 27 | 1.40e-01 | -1.64e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 10 | 3.69e-01 | -1.64e-01 | 9.09e-01 |
| GOCC CBM COMPLEX | 5 | 5.26e-01 | 1.64e-01 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 12 | 3.26e-01 | 1.64e-01 | 8.93e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 40 | 7.29e-02 | -1.64e-01 | 7.07e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 4.53e-01 | -1.64e-01 | 9.35e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 4.53e-01 | 1.64e-01 | 9.35e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 2.16e-01 | 1.64e-01 | 8.56e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 44 | 6.02e-02 | 1.64e-01 | 6.62e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 25 | 1.56e-01 | -1.64e-01 | 8.17e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 8 | 4.23e-01 | -1.64e-01 | 9.24e-01 |
| GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY | 11 | 3.47e-01 | 1.64e-01 | 8.98e-01 |
| GOBP LIVER MORPHOGENESIS | 25 | 1.57e-01 | -1.64e-01 | 8.17e-01 |
| GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION | 5 | 5.26e-01 | -1.64e-01 | 9.47e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 5.26e-01 | 1.64e-01 | 9.47e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 2.73e-01 | -1.64e-01 | 8.69e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 4.54e-01 | -1.64e-01 | 9.36e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 19 | 2.17e-01 | -1.63e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 1.95e-01 | -1.63e-01 | 8.44e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 89 | 7.69e-03 | 1.63e-01 | 3.42e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 5.27e-01 | -1.63e-01 | 9.48e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 18 | 2.30e-01 | -1.63e-01 | 8.62e-01 |
| GOBP HEAT GENERATION | 17 | 2.44e-01 | 1.63e-01 | 8.64e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 5.27e-01 | -1.63e-01 | 9.48e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 27 | 1.42e-01 | -1.63e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 5.28e-01 | -1.63e-01 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 26 | 1.50e-01 | -1.63e-01 | 8.14e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 34 | 9.98e-02 | 1.63e-01 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 15 | 2.74e-01 | -1.63e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF ACROSOME REACTION | 11 | 3.49e-01 | -1.63e-01 | 8.99e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 7 | 4.55e-01 | -1.63e-01 | 9.36e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 10 | 3.72e-01 | -1.63e-01 | 9.09e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 21 | 1.97e-01 | -1.63e-01 | 8.44e-01 |
| GOMF ACETYLCHOLINE BINDING | 10 | 3.73e-01 | -1.63e-01 | 9.09e-01 |
| GOCC BLOC COMPLEX | 14 | 2.92e-01 | -1.63e-01 | 8.79e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 69 | 1.96e-02 | 1.62e-01 | 4.91e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 22 | 1.87e-01 | -1.62e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 65 | 2.36e-02 | -1.62e-01 | 5.17e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 26 | 1.52e-01 | 1.62e-01 | 8.17e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 10 | 3.74e-01 | 1.62e-01 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 27 | 1.45e-01 | -1.62e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 3.99e-01 | 1.62e-01 | 9.18e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 17 | 2.47e-01 | -1.62e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 5.30e-01 | 1.62e-01 | 9.48e-01 |
| GOBP CELL KILLING | 212 | 4.78e-05 | -1.62e-01 | 1.53e-02 |
| GOMF TYPE I INTERFERON RECEPTOR BINDING | 13 | 3.12e-01 | -1.62e-01 | 8.89e-01 |
| GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR | 6 | 4.92e-01 | -1.62e-01 | 9.45e-01 |
| GOCC CAJAL BODY | 77 | 1.41e-02 | 1.62e-01 | 4.49e-01 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 15 | 2.78e-01 | 1.62e-01 | 8.70e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 20 | 2.10e-01 | -1.62e-01 | 8.53e-01 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 5.31e-01 | -1.62e-01 | 9.48e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 8 | 4.29e-01 | 1.62e-01 | 9.27e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 5 | 5.32e-01 | 1.62e-01 | 9.48e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 1.80e-01 | 1.62e-01 | 8.41e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 23 | 1.80e-01 | 1.61e-01 | 8.41e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 26 | 1.54e-01 | 1.61e-01 | 8.17e-01 |
| GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY | 5 | 5.32e-01 | 1.61e-01 | 9.48e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 35 | 9.85e-02 | 1.61e-01 | 7.66e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 4.94e-01 | -1.61e-01 | 9.45e-01 |
| GOCC AXOLEMMA | 15 | 2.80e-01 | 1.61e-01 | 8.71e-01 |
| GOMF VIRION BINDING | 13 | 3.14e-01 | -1.61e-01 | 8.90e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 3.55e-01 | 1.61e-01 | 9.02e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 10 | 3.78e-01 | -1.61e-01 | 9.09e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 14 | 2.97e-01 | 1.61e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 3.15e-01 | 1.61e-01 | 8.90e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 3.34e-01 | 1.61e-01 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 32 | 1.15e-01 | -1.61e-01 | 7.81e-01 |
| GOBP DNA MODIFICATION | 99 | 5.63e-03 | 1.61e-01 | 2.88e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 68 | 2.17e-02 | -1.61e-01 | 5.03e-01 |
| GOCC PRC1 COMPLEX | 16 | 2.65e-01 | 1.61e-01 | 8.69e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 34 | 1.05e-01 | -1.61e-01 | 7.69e-01 |
| GOBP REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 5 | 5.34e-01 | -1.61e-01 | 9.49e-01 |
| GOBP TOXIN METABOLIC PROCESS | 14 | 2.98e-01 | 1.61e-01 | 8.82e-01 |
| GOBP REGULATION OF INTESTINAL LIPID ABSORPTION | 10 | 3.79e-01 | 1.61e-01 | 9.10e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 15 | 2.82e-01 | -1.60e-01 | 8.73e-01 |
| GOCC RSC TYPE COMPLEX | 15 | 2.83e-01 | 1.60e-01 | 8.74e-01 |
| GOMF PRE MRNA 5 SPLICE SITE BINDING | 6 | 4.97e-01 | -1.60e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 17 | 2.53e-01 | -1.60e-01 | 8.65e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 47 | 5.77e-02 | -1.60e-01 | 6.57e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 363 | 1.64e-07 | -1.60e-01 | 2.39e-04 |
| GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE | 8 | 4.33e-01 | -1.60e-01 | 9.27e-01 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 7 | 4.64e-01 | 1.60e-01 | 9.37e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 4.34e-01 | 1.60e-01 | 9.27e-01 |
| GOBP PEPTIDYL LYSINE OXIDATION | 5 | 5.36e-01 | -1.60e-01 | 9.49e-01 |
| GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY | 5 | 5.36e-01 | -1.60e-01 | 9.49e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 23 | 1.85e-01 | 1.60e-01 | 8.43e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 13 | 3.19e-01 | 1.60e-01 | 8.92e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 71 | 2.01e-02 | 1.60e-01 | 4.94e-01 |
| GOCC DNA POLYMERASE COMPLEX | 18 | 2.41e-01 | 1.59e-01 | 8.64e-01 |
| GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 6 | 4.99e-01 | -1.59e-01 | 9.45e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 3.39e-01 | -1.59e-01 | 8.96e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 20 | 2.17e-01 | -1.59e-01 | 8.56e-01 |
| GOBP CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION | 5 | 5.37e-01 | 1.59e-01 | 9.49e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 122 | 2.37e-03 | -1.59e-01 | 1.87e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 15 | 2.86e-01 | -1.59e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 4.66e-01 | 1.59e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 216 | 5.58e-05 | -1.59e-01 | 1.68e-02 |
| GOBP CYTOPLASMIC TRANSLATION | 142 | 1.07e-03 | -1.59e-01 | 1.23e-01 |
| GOCC U2 SNRNP | 24 | 1.77e-01 | 1.59e-01 | 8.41e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 3.03e-01 | 1.59e-01 | 8.84e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 53 | 4.53e-02 | -1.59e-01 | 6.22e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 13 | 3.21e-01 | -1.59e-01 | 8.92e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 24 | 1.78e-01 | 1.59e-01 | 8.41e-01 |
| GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 5.00e-01 | 1.59e-01 | 9.45e-01 |
| GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.38e-01 | -1.59e-01 | 9.49e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 78 | 1.53e-02 | -1.59e-01 | 4.61e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 15 | 2.87e-01 | 1.59e-01 | 8.76e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 4.67e-01 | 1.59e-01 | 9.38e-01 |
| GOCC NSL COMPLEX | 9 | 4.10e-01 | 1.59e-01 | 9.21e-01 |
| GOCC COLLAGEN TRIMER | 83 | 1.24e-02 | -1.59e-01 | 4.25e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 22 | 1.98e-01 | -1.59e-01 | 8.44e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 3.42e-01 | 1.59e-01 | 8.96e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 61 | 3.22e-02 | -1.59e-01 | 5.58e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 9 | 4.10e-01 | -1.58e-01 | 9.21e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 17 | 2.58e-01 | -1.58e-01 | 8.65e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 1.88e-01 | 1.58e-01 | 8.44e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 3.05e-01 | 1.58e-01 | 8.84e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 3.63e-01 | 1.58e-01 | 9.06e-01 |
| GOBP PROTEIN TRIMERIZATION | 17 | 2.58e-01 | -1.58e-01 | 8.65e-01 |
| GOBP EMBRYONIC CLEAVAGE | 8 | 4.38e-01 | 1.58e-01 | 9.28e-01 |
| GOMF INSULIN BINDING | 5 | 5.40e-01 | -1.58e-01 | 9.49e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 20 | 2.20e-01 | -1.58e-01 | 8.56e-01 |
| GOBP DETECTION OF VIRUS | 6 | 5.02e-01 | 1.58e-01 | 9.45e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 3.42e-01 | 1.58e-01 | 8.96e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 9 | 4.11e-01 | -1.58e-01 | 9.21e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 2.88e-01 | -1.58e-01 | 8.77e-01 |
| GOCC PIP BODY | 5 | 5.40e-01 | -1.58e-01 | 9.49e-01 |
| GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY | 6 | 5.02e-01 | -1.58e-01 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 3.87e-01 | -1.58e-01 | 9.14e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 38 | 9.17e-02 | 1.58e-01 | 7.57e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 27 | 1.55e-01 | -1.58e-01 | 8.17e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 48 | 5.83e-02 | 1.58e-01 | 6.58e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 54 | 4.47e-02 | -1.58e-01 | 6.22e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.44e-01 | -1.58e-01 | 8.96e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 28 | 1.48e-01 | -1.58e-01 | 8.10e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 24 | 1.81e-01 | 1.58e-01 | 8.41e-01 |
| GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 5.03e-01 | -1.58e-01 | 9.45e-01 |
| GOMF U2 SNRNA BINDING | 6 | 5.03e-01 | -1.58e-01 | 9.45e-01 |
| GOCC CYTOSOLIC RIBOSOME | 107 | 4.81e-03 | -1.58e-01 | 2.69e-01 |
| GOBP DORSAL ROOT GANGLION DEVELOPMENT | 7 | 4.70e-01 | 1.58e-01 | 9.39e-01 |
| GOBP RESPONSE TO PROTOZOAN | 31 | 1.29e-01 | -1.58e-01 | 7.93e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 6 | 5.04e-01 | -1.58e-01 | 9.45e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 38 | 9.29e-02 | 1.58e-01 | 7.59e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 5.42e-01 | 1.58e-01 | 9.49e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 13 | 3.25e-01 | -1.57e-01 | 8.93e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 25 | 1.73e-01 | 1.57e-01 | 8.36e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 5.05e-01 | -1.57e-01 | 9.45e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 9 | 4.14e-01 | 1.57e-01 | 9.23e-01 |
| GOCC CHOLINERGIC SYNAPSE | 11 | 3.67e-01 | 1.57e-01 | 9.06e-01 |
| GOBP REGULATION OF XENOPHAGY | 9 | 4.14e-01 | 1.57e-01 | 9.23e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 29 | 1.43e-01 | 1.57e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 26 | 1.65e-01 | -1.57e-01 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 4.72e-01 | -1.57e-01 | 9.39e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 5 | 5.43e-01 | 1.57e-01 | 9.49e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 5.05e-01 | -1.57e-01 | 9.45e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 33 | 1.19e-01 | 1.57e-01 | 7.85e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 11 | 3.67e-01 | 1.57e-01 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 18 | 2.49e-01 | -1.57e-01 | 8.65e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 52 | 5.03e-02 | -1.57e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 11 | 3.68e-01 | 1.57e-01 | 9.07e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 25 | 1.75e-01 | -1.57e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 78 | 1.67e-02 | -1.57e-01 | 4.68e-01 |
| GOCC REPLICATION FORK | 64 | 3.01e-02 | 1.57e-01 | 5.54e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 16 | 2.78e-01 | -1.57e-01 | 8.70e-01 |
| GOBP REGULATION OF POTASSIUM ION IMPORT | 5 | 5.44e-01 | 1.57e-01 | 9.49e-01 |
| GOBP PLATELET DEGRANULATION | 7 | 4.73e-01 | -1.57e-01 | 9.41e-01 |
| GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX | 5 | 5.45e-01 | -1.56e-01 | 9.49e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 30 | 1.38e-01 | 1.56e-01 | 8.06e-01 |
| GOMF CHANNEL ACTIVATOR ACTIVITY | 6 | 5.07e-01 | -1.56e-01 | 9.46e-01 |
| GOBP RIG I SIGNALING PATHWAY | 28 | 1.52e-01 | 1.56e-01 | 8.17e-01 |
| GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.45e-01 | -1.56e-01 | 9.49e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 29 | 1.45e-01 | 1.56e-01 | 8.07e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 4.44e-01 | 1.56e-01 | 9.30e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 10 | 3.93e-01 | 1.56e-01 | 9.17e-01 |
| GOBP AXON MIDLINE CHOICE POINT RECOGNITION | 5 | 5.46e-01 | 1.56e-01 | 9.49e-01 |
| GOBP RESPONSE TO WATER DEPRIVATION | 5 | 5.46e-01 | 1.56e-01 | 9.49e-01 |
| GOBP GLUTATHIONE TRANSPORT | 9 | 4.18e-01 | -1.56e-01 | 9.23e-01 |
| GOCC CHECKPOINT CLAMP COMPLEX | 5 | 5.46e-01 | -1.56e-01 | 9.49e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 23 | 1.95e-01 | -1.56e-01 | 8.44e-01 |
| GOBP MATURATION OF SSU RRNA | 51 | 5.40e-02 | 1.56e-01 | 6.45e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 21 | 2.16e-01 | -1.56e-01 | 8.56e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 23 | 1.96e-01 | -1.56e-01 | 8.44e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 4.18e-01 | 1.56e-01 | 9.24e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 26 | 1.69e-01 | -1.56e-01 | 8.31e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 17 | 2.66e-01 | -1.56e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 30 | 1.40e-01 | 1.56e-01 | 8.06e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 16 | 2.81e-01 | -1.56e-01 | 8.72e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 7 | 4.76e-01 | 1.56e-01 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 18 | 2.53e-01 | 1.56e-01 | 8.65e-01 |
| GOBP MICROTUBULE NUCLEATION | 43 | 7.76e-02 | 1.56e-01 | 7.18e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 7 | 4.76e-01 | 1.55e-01 | 9.41e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 4.46e-01 | -1.55e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 9 | 4.19e-01 | -1.55e-01 | 9.24e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 18 | 2.54e-01 | -1.55e-01 | 8.65e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 22 | 2.07e-01 | -1.55e-01 | 8.51e-01 |
| GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT | 8 | 4.47e-01 | 1.55e-01 | 9.31e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 12 | 3.52e-01 | -1.55e-01 | 9.00e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.52e-01 | -1.55e-01 | 9.00e-01 |
| GOBP INSEMINATION | 12 | 3.52e-01 | -1.55e-01 | 9.00e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 13 | 3.33e-01 | -1.55e-01 | 8.94e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 10 | 3.96e-01 | -1.55e-01 | 9.18e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 81 | 1.59e-02 | -1.55e-01 | 4.67e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 2.42e-01 | 1.55e-01 | 8.64e-01 |
| GOBP URATE TRANSPORT | 11 | 3.74e-01 | -1.55e-01 | 9.09e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 12 | 3.53e-01 | -1.55e-01 | 9.00e-01 |
| GOBP RESPONSE TO THYROXINE | 5 | 5.49e-01 | -1.55e-01 | 9.49e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 27 | 1.64e-01 | 1.55e-01 | 8.24e-01 |
| GOMF I SMAD BINDING | 16 | 2.83e-01 | 1.55e-01 | 8.74e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 33 | 1.24e-01 | 1.55e-01 | 7.93e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 8 | 4.48e-01 | 1.55e-01 | 9.32e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 22 | 2.09e-01 | -1.55e-01 | 8.53e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 11 | 3.74e-01 | -1.55e-01 | 9.09e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 10 | 3.97e-01 | -1.55e-01 | 9.18e-01 |
| GOCC PINOSOME | 7 | 4.79e-01 | 1.55e-01 | 9.42e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 110 | 5.10e-03 | -1.55e-01 | 2.78e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 9 | 4.22e-01 | -1.54e-01 | 9.24e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 18 | 2.57e-01 | 1.54e-01 | 8.65e-01 |
| GOCC AXON HILLOCK | 7 | 4.79e-01 | -1.54e-01 | 9.42e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 7 | 4.79e-01 | -1.54e-01 | 9.42e-01 |
| GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.50e-01 | 1.54e-01 | 9.49e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 4.50e-01 | 1.54e-01 | 9.33e-01 |
| GOCC DENDRITE TERMINUS | 12 | 3.55e-01 | 1.54e-01 | 9.02e-01 |
| GOMF INTRACELLULAR CAMP ACTIVATED CATION CHANNEL ACTIVITY | 8 | 4.50e-01 | -1.54e-01 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 21 | 2.21e-01 | -1.54e-01 | 8.56e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 27 | 1.65e-01 | -1.54e-01 | 8.25e-01 |
| GOBP KETONE BODY BIOSYNTHETIC PROCESS | 6 | 5.13e-01 | -1.54e-01 | 9.46e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 30 | 1.44e-01 | -1.54e-01 | 8.06e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 4.50e-01 | -1.54e-01 | 9.33e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 8 | 4.50e-01 | 1.54e-01 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE | 6 | 5.13e-01 | 1.54e-01 | 9.46e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 11 | 3.76e-01 | 1.54e-01 | 9.09e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 31 | 1.38e-01 | -1.54e-01 | 8.06e-01 |
| GOMF ALKALINE PHOSPHATASE ACTIVITY | 6 | 5.14e-01 | 1.54e-01 | 9.46e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 17 | 2.72e-01 | 1.54e-01 | 8.69e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 16 | 2.87e-01 | -1.54e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 5.52e-01 | -1.54e-01 | 9.49e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 6 | 5.14e-01 | -1.54e-01 | 9.46e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 6 | 5.14e-01 | 1.54e-01 | 9.46e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 41 | 8.86e-02 | -1.54e-01 | 7.52e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 11 | 3.77e-01 | 1.54e-01 | 9.09e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 121 | 3.51e-03 | -1.54e-01 | 2.26e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 36 | 1.11e-01 | -1.54e-01 | 7.77e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 131 | 2.40e-03 | -1.54e-01 | 1.87e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 18 | 2.59e-01 | -1.54e-01 | 8.66e-01 |
| GOBP REGULATION OF ANOIKIS | 24 | 1.93e-01 | 1.54e-01 | 8.44e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 31 | 1.39e-01 | 1.54e-01 | 8.06e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 45 | 7.48e-02 | -1.54e-01 | 7.12e-01 |
| GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY | 8 | 4.52e-01 | 1.53e-01 | 9.35e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 51 | 5.81e-02 | 1.53e-01 | 6.58e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 116 | 4.32e-03 | -1.53e-01 | 2.58e-01 |
| GOBP CARDIOLIPIN ACYL CHAIN REMODELING | 5 | 5.53e-01 | -1.53e-01 | 9.49e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 31 | 1.39e-01 | 1.53e-01 | 8.06e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 12 | 3.58e-01 | 1.53e-01 | 9.03e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 73 | 2.36e-02 | -1.53e-01 | 5.17e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 5.53e-01 | -1.53e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 3.21e-01 | 1.53e-01 | 8.92e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 17 | 2.75e-01 | -1.53e-01 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 18 | 2.61e-01 | -1.53e-01 | 8.66e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 3.80e-01 | -1.53e-01 | 9.10e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 45 | 7.59e-02 | 1.53e-01 | 7.17e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 5.54e-01 | 1.53e-01 | 9.49e-01 |
| GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY | 5 | 5.54e-01 | 1.53e-01 | 9.49e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 25 | 1.86e-01 | 1.53e-01 | 8.44e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 8 | 4.54e-01 | 1.53e-01 | 9.36e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 8 | 4.54e-01 | 1.53e-01 | 9.36e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 3.22e-01 | 1.53e-01 | 8.92e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 9 | 4.28e-01 | -1.53e-01 | 9.27e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 11 | 3.81e-01 | -1.53e-01 | 9.11e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 44 | 8.03e-02 | -1.52e-01 | 7.26e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 43 | 8.38e-02 | -1.52e-01 | 7.37e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 6 | 5.18e-01 | -1.52e-01 | 9.47e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 14 | 3.24e-01 | 1.52e-01 | 8.93e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 42 | 8.78e-02 | -1.52e-01 | 7.52e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 7 | 4.86e-01 | 1.52e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 17 | 2.78e-01 | -1.52e-01 | 8.70e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 9 | 4.29e-01 | 1.52e-01 | 9.27e-01 |
| GOCC ESC E Z COMPLEX | 9 | 4.30e-01 | 1.52e-01 | 9.27e-01 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 7 | 4.86e-01 | -1.52e-01 | 9.43e-01 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 7 | 4.86e-01 | -1.52e-01 | 9.43e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 23 | 2.07e-01 | -1.52e-01 | 8.51e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 63 | 3.71e-02 | 1.52e-01 | 5.82e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 1.98e-01 | 1.52e-01 | 8.44e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 3.83e-01 | -1.52e-01 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 29 | 1.57e-01 | 1.52e-01 | 8.17e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 4.87e-01 | -1.52e-01 | 9.43e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 12 | 3.63e-01 | 1.52e-01 | 9.06e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 5.20e-01 | -1.52e-01 | 9.47e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 3.44e-01 | 1.52e-01 | 8.96e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 118 | 4.43e-03 | 1.52e-01 | 2.59e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 5.57e-01 | -1.52e-01 | 9.49e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY | 5 | 5.57e-01 | 1.52e-01 | 9.49e-01 |
| GOMF BITTER TASTE RECEPTOR ACTIVITY | 23 | 2.08e-01 | 1.52e-01 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 3.63e-01 | -1.52e-01 | 9.06e-01 |
| GOBP REGULATION OF ASYMMETRIC CELL DIVISION | 5 | 5.57e-01 | 1.52e-01 | 9.49e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 29 | 1.58e-01 | 1.51e-01 | 8.19e-01 |
| GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE | 5 | 5.58e-01 | -1.51e-01 | 9.49e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 21 | 2.30e-01 | -1.51e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 4.88e-01 | 1.51e-01 | 9.43e-01 |
| GOBP PRONEPHROS DEVELOPMENT | 9 | 4.33e-01 | 1.51e-01 | 9.27e-01 |
| GOMF VASOPRESSIN RECEPTOR ACTIVITY | 6 | 5.22e-01 | -1.51e-01 | 9.47e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 6 | 5.22e-01 | 1.51e-01 | 9.47e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 11 | 3.86e-01 | -1.51e-01 | 9.14e-01 |
| GOBP CEREBELLAR GRANULAR LAYER FORMATION | 6 | 5.22e-01 | 1.51e-01 | 9.47e-01 |
| GOBP DCMP CATABOLIC PROCESS | 6 | 5.22e-01 | -1.51e-01 | 9.47e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 5.22e-01 | -1.51e-01 | 9.47e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 10 | 4.09e-01 | -1.51e-01 | 9.21e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 10 | 4.09e-01 | -1.51e-01 | 9.21e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 11 | 3.86e-01 | 1.51e-01 | 9.14e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 10 | 4.09e-01 | -1.51e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 25 | 1.92e-01 | -1.51e-01 | 8.44e-01 |
| GOBP ZYMOGEN ACTIVATION | 57 | 4.89e-02 | -1.51e-01 | 6.28e-01 |
| GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 5.59e-01 | -1.51e-01 | 9.49e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 10 | 4.09e-01 | 1.51e-01 | 9.21e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 44 | 8.37e-02 | -1.51e-01 | 7.37e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.09e-01 | -1.51e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 15 | 3.13e-01 | 1.50e-01 | 8.90e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 44 | 8.43e-02 | 1.50e-01 | 7.40e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 39 | 1.04e-01 | 1.50e-01 | 7.68e-01 |
| GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY | 7 | 4.91e-01 | -1.50e-01 | 9.45e-01 |
| GOBP RETINAL CONE CELL DEVELOPMENT | 11 | 3.88e-01 | 1.50e-01 | 9.14e-01 |
| GOBP HEART VALVE DEVELOPMENT | 72 | 2.75e-02 | 1.50e-01 | 5.37e-01 |
| GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION | 9 | 4.35e-01 | 1.50e-01 | 9.27e-01 |
| GOMF CHLORIDE ION BINDING | 10 | 4.11e-01 | 1.50e-01 | 9.21e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 5.24e-01 | 1.50e-01 | 9.47e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 92 | 1.28e-02 | -1.50e-01 | 4.32e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 8 | 4.62e-01 | -1.50e-01 | 9.37e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 4.12e-01 | 1.50e-01 | 9.21e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 4.12e-01 | 1.50e-01 | 9.21e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 2.58e-01 | 1.50e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION | 9 | 4.36e-01 | -1.50e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 7 | 4.93e-01 | -1.50e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 29 | 1.63e-01 | -1.50e-01 | 8.24e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 3.50e-01 | -1.50e-01 | 8.99e-01 |
| GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 6 | 5.26e-01 | 1.50e-01 | 9.47e-01 |
| GOBP CELLULAR EXTRAVASATION | 71 | 2.92e-02 | -1.50e-01 | 5.52e-01 |
| GOMF DEMETHYLASE ACTIVITY | 35 | 1.26e-01 | 1.50e-01 | 7.93e-01 |
| GOBP GTP METABOLIC PROCESS | 24 | 2.05e-01 | 1.49e-01 | 8.51e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 5 | 5.63e-01 | 1.49e-01 | 9.49e-01 |
| GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING | 6 | 5.26e-01 | 1.49e-01 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 49 | 7.06e-02 | -1.49e-01 | 6.97e-01 |
| GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION | 9 | 4.38e-01 | -1.49e-01 | 9.28e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 26 | 1.88e-01 | -1.49e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 11 | 3.92e-01 | -1.49e-01 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 7 | 4.95e-01 | -1.49e-01 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 4.95e-01 | 1.49e-01 | 9.45e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 11 | 3.92e-01 | -1.49e-01 | 9.16e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 5.64e-01 | -1.49e-01 | 9.50e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 27 | 1.80e-01 | -1.49e-01 | 8.41e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 18 | 2.74e-01 | -1.49e-01 | 8.69e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 17 | 2.88e-01 | -1.49e-01 | 8.77e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 23 | 2.17e-01 | 1.49e-01 | 8.56e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 4.96e-01 | 1.49e-01 | 9.45e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 13 | 3.54e-01 | 1.49e-01 | 9.01e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 2.62e-01 | 1.49e-01 | 8.68e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 117 | 5.49e-03 | -1.49e-01 | 2.87e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 3.93e-01 | 1.49e-01 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 5.29e-01 | -1.49e-01 | 9.48e-01 |
| GOBP BILE ACID SECRETION | 12 | 3.73e-01 | -1.48e-01 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 9 | 4.41e-01 | 1.48e-01 | 9.29e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 16 | 3.05e-01 | -1.48e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 15 | 3.21e-01 | -1.48e-01 | 8.92e-01 |
| GOCC B WICH COMPLEX | 7 | 4.97e-01 | 1.48e-01 | 9.45e-01 |
| GOBP PLASMINOGEN ACTIVATION | 26 | 1.91e-01 | -1.48e-01 | 8.44e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS | 7 | 4.98e-01 | 1.48e-01 | 9.45e-01 |
| GOMF 11 CIS RETINAL BINDING | 7 | 4.98e-01 | -1.48e-01 | 9.45e-01 |
| GOCC VESICLE TETHERING COMPLEX | 56 | 5.54e-02 | 1.48e-01 | 6.51e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 15 | 3.21e-01 | -1.48e-01 | 8.92e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 14 | 3.38e-01 | 1.48e-01 | 8.96e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 34 | 1.36e-01 | -1.48e-01 | 8.06e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.42e-01 | 1.48e-01 | 9.30e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 4.69e-01 | -1.48e-01 | 9.39e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 4.69e-01 | -1.48e-01 | 9.39e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 13 | 3.56e-01 | 1.48e-01 | 9.02e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 62 | 4.42e-02 | -1.48e-01 | 6.22e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 20 | 2.53e-01 | -1.48e-01 | 8.65e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 232 | 1.06e-04 | -1.48e-01 | 2.65e-02 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 3.76e-01 | 1.48e-01 | 9.09e-01 |
| GOBP CATECHOLAMINE UPTAKE | 18 | 2.78e-01 | 1.48e-01 | 8.71e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 34 | 1.37e-01 | -1.48e-01 | 8.06e-01 |
| GOMF TROPOMYOSIN BINDING | 15 | 3.23e-01 | -1.48e-01 | 8.92e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 36 | 1.26e-01 | -1.48e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 11 | 3.97e-01 | 1.47e-01 | 9.18e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 9 | 4.44e-01 | 1.47e-01 | 9.30e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 13 | 3.58e-01 | -1.47e-01 | 9.03e-01 |
| GOMF MIRNA BINDING | 39 | 1.11e-01 | -1.47e-01 | 7.77e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 22 | 2.32e-01 | 1.47e-01 | 8.63e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 84 | 1.97e-02 | 1.47e-01 | 4.91e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 36 | 1.26e-01 | -1.47e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 3.78e-01 | 1.47e-01 | 9.09e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 31 | 1.56e-01 | 1.47e-01 | 8.17e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 11 | 3.98e-01 | -1.47e-01 | 9.18e-01 |
| GOCC HETEROCHROMATIN | 76 | 2.68e-02 | 1.47e-01 | 5.32e-01 |
| GOMF ALKANESULFONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.70e-01 | 1.47e-01 | 9.51e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 29 | 1.71e-01 | -1.47e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 20 | 2.56e-01 | -1.47e-01 | 8.65e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 37 | 1.23e-01 | 1.47e-01 | 7.89e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 18 | 2.81e-01 | 1.47e-01 | 8.73e-01 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 8 | 4.73e-01 | -1.47e-01 | 9.40e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 5.02e-01 | -1.47e-01 | 9.45e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 22 | 2.34e-01 | 1.46e-01 | 8.64e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 4.01e-01 | 1.46e-01 | 9.18e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 5.02e-01 | 1.46e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY | 6 | 5.35e-01 | -1.46e-01 | 9.49e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 34 | 1.40e-01 | -1.46e-01 | 8.06e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 5.71e-01 | 1.46e-01 | 9.51e-01 |
| GOBP LENS FIBER CELL MORPHOGENESIS | 6 | 5.35e-01 | -1.46e-01 | 9.49e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 13 | 3.62e-01 | -1.46e-01 | 9.06e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 12 | 3.81e-01 | 1.46e-01 | 9.11e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 4.48e-01 | -1.46e-01 | 9.32e-01 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 5.72e-01 | 1.46e-01 | 9.51e-01 |
| GOBP LIMB JOINT MORPHOGENESIS | 5 | 5.72e-01 | -1.46e-01 | 9.51e-01 |
| GOCC DENDRITE MEMBRANE | 36 | 1.30e-01 | 1.46e-01 | 7.93e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 18 | 2.84e-01 | -1.46e-01 | 8.74e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 13 | 3.63e-01 | -1.46e-01 | 9.06e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 15 | 3.29e-01 | -1.46e-01 | 8.93e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 11 | 4.03e-01 | 1.46e-01 | 9.20e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 60 | 5.11e-02 | 1.46e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 8 | 4.76e-01 | -1.46e-01 | 9.41e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 40 | 1.11e-01 | 1.46e-01 | 7.77e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 37 | 1.25e-01 | -1.46e-01 | 7.93e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 35 | 1.36e-01 | -1.46e-01 | 8.06e-01 |
| GOBP LUTEINIZATION | 12 | 3.83e-01 | -1.46e-01 | 9.12e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 19 | 2.73e-01 | -1.45e-01 | 8.69e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 5.74e-01 | 1.45e-01 | 9.51e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION | 6 | 5.38e-01 | -1.45e-01 | 9.49e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 7 | 5.06e-01 | 1.45e-01 | 9.45e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 28 | 1.84e-01 | 1.45e-01 | 8.42e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 9 | 4.51e-01 | 1.45e-01 | 9.35e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 29 | 1.77e-01 | 1.45e-01 | 8.41e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 38 | 1.22e-01 | -1.45e-01 | 7.89e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 8 | 4.78e-01 | 1.45e-01 | 9.42e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 34 | 1.44e-01 | 1.45e-01 | 8.06e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 11 | 4.05e-01 | 1.45e-01 | 9.21e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 64 | 4.51e-02 | 1.45e-01 | 6.22e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 74 | 3.13e-02 | -1.45e-01 | 5.57e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 23 | 2.29e-01 | -1.45e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 4.28e-01 | -1.45e-01 | 9.27e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 21 | 2.51e-01 | -1.45e-01 | 8.65e-01 |
| GOBP GRANULOCYTE MIGRATION | 145 | 2.63e-03 | -1.45e-01 | 1.95e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 37 | 1.28e-01 | -1.45e-01 | 7.93e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 4.53e-01 | 1.45e-01 | 9.35e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 5.76e-01 | -1.45e-01 | 9.51e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 5.40e-01 | -1.45e-01 | 9.49e-01 |
| GOBP MEMBRANE INVAGINATION | 62 | 4.91e-02 | -1.44e-01 | 6.28e-01 |
| GOBP DENDRITIC CELL MIGRATION | 32 | 1.57e-01 | -1.44e-01 | 8.17e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 11 | 4.07e-01 | 1.44e-01 | 9.21e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 4.53e-01 | -1.44e-01 | 9.35e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 32 | 1.57e-01 | 1.44e-01 | 8.17e-01 |
| GOMF DEAMINASE ACTIVITY | 33 | 1.51e-01 | 1.44e-01 | 8.16e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 44 | 9.76e-02 | -1.44e-01 | 7.66e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 12 | 3.87e-01 | -1.44e-01 | 9.14e-01 |
| GOBP NK T CELL ACTIVATION | 12 | 3.87e-01 | -1.44e-01 | 9.14e-01 |
| GOBP LYMPHANGIOGENESIS | 18 | 2.90e-01 | 1.44e-01 | 8.78e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 5.10e-01 | -1.44e-01 | 9.46e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 44 | 9.86e-02 | 1.44e-01 | 7.66e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 7 | 5.10e-01 | -1.44e-01 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 22 | 2.43e-01 | 1.44e-01 | 8.64e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 13 | 3.69e-01 | -1.44e-01 | 9.09e-01 |
| GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY | 8 | 4.81e-01 | -1.44e-01 | 9.42e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 88 | 1.97e-02 | 1.44e-01 | 4.91e-01 |
| GOBP OVULATION FROM OVARIAN FOLLICLE | 8 | 4.81e-01 | 1.44e-01 | 9.42e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 37 | 1.30e-01 | 1.44e-01 | 7.94e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 7 | 5.10e-01 | 1.44e-01 | 9.46e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 4.82e-01 | 1.44e-01 | 9.42e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 33 | 1.53e-01 | -1.44e-01 | 8.17e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 9 | 4.56e-01 | 1.44e-01 | 9.36e-01 |
| GOBP MRNA POLYADENYLATION | 24 | 2.23e-01 | -1.44e-01 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 9 | 4.56e-01 | -1.44e-01 | 9.36e-01 |
| GOMF IGE BINDING | 5 | 5.78e-01 | -1.44e-01 | 9.52e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 2.67e-01 | 1.44e-01 | 8.69e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 61 | 5.26e-02 | 1.43e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 15 | 3.36e-01 | 1.43e-01 | 8.96e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 25 | 2.15e-01 | -1.43e-01 | 8.55e-01 |
| GOBP CELLULAR GLUCURONIDATION | 18 | 2.93e-01 | 1.43e-01 | 8.79e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 3.37e-01 | 1.43e-01 | 8.96e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 14 | 3.53e-01 | -1.43e-01 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 9 | 4.57e-01 | -1.43e-01 | 9.36e-01 |
| GOBP FLAVONOID METABOLIC PROCESS | 11 | 4.11e-01 | 1.43e-01 | 9.21e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 2.15e-01 | -1.43e-01 | 8.56e-01 |
| GOBP RESPONSE TO ETHER | 11 | 4.11e-01 | -1.43e-01 | 9.21e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION | 5 | 5.79e-01 | 1.43e-01 | 9.53e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 29 | 1.82e-01 | 1.43e-01 | 8.42e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 6 | 5.44e-01 | 1.43e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 27 | 1.98e-01 | 1.43e-01 | 8.44e-01 |
| GOBP RESPONSE TO COPPER ION | 35 | 1.43e-01 | -1.43e-01 | 8.06e-01 |
| GOBP EOSINOPHIL DIFFERENTIATION | 6 | 5.44e-01 | 1.43e-01 | 9.49e-01 |
| GOBP ISOPRENOID CATABOLIC PROCESS | 10 | 4.34e-01 | 1.43e-01 | 9.27e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 19 | 2.81e-01 | 1.43e-01 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 7 | 5.13e-01 | -1.43e-01 | 9.46e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 10 | 4.34e-01 | 1.43e-01 | 9.27e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 15 | 3.38e-01 | -1.43e-01 | 8.96e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 139 | 3.66e-03 | 1.43e-01 | 2.31e-01 |
| GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY | 7 | 5.14e-01 | 1.43e-01 | 9.46e-01 |
| GOBP DETECTION OF CALCIUM ION | 13 | 3.74e-01 | -1.42e-01 | 9.09e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 5.81e-01 | -1.42e-01 | 9.53e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 15 | 3.40e-01 | 1.42e-01 | 8.96e-01 |
| GOBP REPLACEMENT OSSIFICATION | 30 | 1.77e-01 | -1.42e-01 | 8.41e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 11 | 4.14e-01 | -1.42e-01 | 9.23e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 12 | 3.93e-01 | 1.42e-01 | 9.17e-01 |
| GOBP TONGUE MORPHOGENESIS | 10 | 4.36e-01 | 1.42e-01 | 9.27e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 6 | 5.46e-01 | -1.42e-01 | 9.49e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 10 | 4.36e-01 | 1.42e-01 | 9.27e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 45 | 9.89e-02 | -1.42e-01 | 7.66e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 13 | 3.75e-01 | -1.42e-01 | 9.09e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 4.87e-01 | 1.42e-01 | 9.43e-01 |
| GOBP OTOLITH DEVELOPMENT | 10 | 4.37e-01 | -1.42e-01 | 9.28e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME | 7 | 5.15e-01 | 1.42e-01 | 9.46e-01 |
| GOBP TNFSF11 MEDIATED SIGNALING PATHWAY | 5 | 5.82e-01 | 1.42e-01 | 9.53e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 21 | 2.60e-01 | -1.42e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 27 | 2.02e-01 | -1.42e-01 | 8.51e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 26 | 2.11e-01 | 1.42e-01 | 8.53e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 21 | 2.61e-01 | 1.42e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 21 | 2.61e-01 | -1.42e-01 | 8.66e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 51 | 7.98e-02 | -1.42e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 3.42e-01 | -1.42e-01 | 8.96e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 3.95e-01 | 1.42e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 89 | 2.09e-02 | 1.42e-01 | 4.96e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 5.16e-01 | 1.42e-01 | 9.46e-01 |
| GOCC GOLGI LUMEN | 96 | 1.65e-02 | -1.42e-01 | 4.68e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 5.48e-01 | -1.42e-01 | 9.49e-01 |
| GOMF CHEMOKINE BINDING | 31 | 1.72e-01 | -1.42e-01 | 8.36e-01 |
| GOBP PENILE ERECTION | 7 | 5.17e-01 | -1.42e-01 | 9.46e-01 |
| GOBP VESICLE COATING | 38 | 1.31e-01 | 1.42e-01 | 7.94e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 26 | 2.11e-01 | -1.42e-01 | 8.54e-01 |
| GOBP MICROVILLUS ORGANIZATION | 28 | 1.95e-01 | -1.42e-01 | 8.44e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING | 9 | 4.62e-01 | 1.42e-01 | 9.37e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 188 | 8.19e-04 | 1.42e-01 | 1.07e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 20 | 2.73e-01 | -1.41e-01 | 8.69e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 29 | 1.87e-01 | -1.41e-01 | 8.44e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 3.97e-01 | -1.41e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 6 | 5.49e-01 | 1.41e-01 | 9.49e-01 |
| GOBP NEURAL CREST FORMATION | 15 | 3.43e-01 | 1.41e-01 | 8.96e-01 |
| GOBP AMACRINE CELL DIFFERENTIATION | 12 | 3.97e-01 | 1.41e-01 | 9.18e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 4.40e-01 | 1.41e-01 | 9.29e-01 |
| GOBP RESPONSE TO SYMBIONT | 6 | 5.50e-01 | -1.41e-01 | 9.49e-01 |
| GOCC SWR1 COMPLEX | 13 | 3.79e-01 | 1.41e-01 | 9.09e-01 |
| GOMF NF KAPPAB BINDING | 28 | 1.96e-01 | 1.41e-01 | 8.44e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 17 | 3.14e-01 | 1.41e-01 | 8.90e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 27 | 2.05e-01 | -1.41e-01 | 8.51e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 11 | 4.18e-01 | 1.41e-01 | 9.24e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 15 | 3.45e-01 | 1.41e-01 | 8.96e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 24 | 2.33e-01 | 1.41e-01 | 8.63e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 12 | 3.99e-01 | -1.41e-01 | 9.18e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 10 | 4.41e-01 | -1.41e-01 | 9.29e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 7 | 5.19e-01 | -1.41e-01 | 9.47e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 19 | 2.89e-01 | -1.41e-01 | 8.77e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 17 | 3.16e-01 | -1.41e-01 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 23 | 2.43e-01 | -1.41e-01 | 8.64e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 18 | 3.02e-01 | 1.40e-01 | 8.84e-01 |
| GOBP RIBOSOME DISASSEMBLY | 12 | 3.99e-01 | 1.40e-01 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 4.92e-01 | -1.40e-01 | 9.45e-01 |
| GOBP POST EMBRYONIC EYE MORPHOGENESIS | 7 | 5.20e-01 | -1.40e-01 | 9.47e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 46 | 9.94e-02 | -1.40e-01 | 7.66e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 23 | 2.44e-01 | 1.40e-01 | 8.64e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 16 | 3.31e-01 | -1.40e-01 | 8.93e-01 |
| GOBP MALE MATING BEHAVIOR | 6 | 5.52e-01 | -1.40e-01 | 9.49e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 5.87e-01 | 1.40e-01 | 9.54e-01 |
| GOBP DEDIFFERENTIATION | 11 | 4.20e-01 | -1.40e-01 | 9.24e-01 |
| GOBP BONE MARROW DEVELOPMENT | 9 | 4.66e-01 | -1.40e-01 | 9.38e-01 |
| GOBP OTIC VESICLE MORPHOGENESIS | 10 | 4.42e-01 | -1.40e-01 | 9.30e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 37 | 1.40e-01 | -1.40e-01 | 8.06e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 125 | 6.83e-03 | 1.40e-01 | 3.24e-01 |
| GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 5 | 5.88e-01 | 1.40e-01 | 9.54e-01 |
| GOBP ERBB4 ERBB4 SIGNALING PATHWAY | 6 | 5.52e-01 | -1.40e-01 | 9.49e-01 |
| GOBP FATTY ACID BETA OXIDATION | 74 | 3.73e-02 | 1.40e-01 | 5.83e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 3.64e-01 | 1.40e-01 | 9.06e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 13 | 3.82e-01 | -1.40e-01 | 9.12e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 65 | 5.09e-02 | -1.40e-01 | 6.36e-01 |
| GOBP REGULATION OF EOSINOPHIL MIGRATION | 6 | 5.53e-01 | 1.40e-01 | 9.49e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 12 | 4.01e-01 | 1.40e-01 | 9.19e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 14 | 3.65e-01 | 1.40e-01 | 9.06e-01 |
| GOMF T CELL RECEPTOR BINDING | 11 | 4.22e-01 | 1.40e-01 | 9.24e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 2.91e-01 | 1.40e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 5.88e-01 | 1.40e-01 | 9.54e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 35 | 1.52e-01 | -1.40e-01 | 8.17e-01 |
| GOMF DEACETYLASE ACTIVITY | 36 | 1.47e-01 | 1.40e-01 | 8.08e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 242 | 1.82e-04 | 1.40e-01 | 3.87e-02 |
| GOBP RENAL SODIUM EXCRETION | 11 | 4.23e-01 | 1.40e-01 | 9.24e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 5.54e-01 | -1.40e-01 | 9.49e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 4.69e-01 | 1.39e-01 | 9.39e-01 |
| GOCC TORC1 COMPLEX | 6 | 5.54e-01 | 1.39e-01 | 9.49e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 1.86e-01 | 1.39e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 48 | 9.47e-02 | -1.39e-01 | 7.64e-01 |
| GOMF ALL TRANS RETINAL BINDING | 5 | 5.89e-01 | -1.39e-01 | 9.54e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 7 | 5.23e-01 | -1.39e-01 | 9.47e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 17 | 3.20e-01 | -1.39e-01 | 8.92e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 21 | 2.69e-01 | 1.39e-01 | 8.69e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 55 | 7.40e-02 | -1.39e-01 | 7.10e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 9 | 4.69e-01 | -1.39e-01 | 9.39e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 5.23e-01 | 1.39e-01 | 9.47e-01 |
| GOBP ARGININE METABOLIC PROCESS | 19 | 2.93e-01 | -1.39e-01 | 8.80e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 5.90e-01 | 1.39e-01 | 9.54e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 54 | 7.69e-02 | 1.39e-01 | 7.18e-01 |
| GOBP PROSTAGLANDIN SECRETION | 17 | 3.21e-01 | 1.39e-01 | 8.92e-01 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 6 | 5.56e-01 | -1.39e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 10 | 4.47e-01 | 1.39e-01 | 9.31e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 24 | 2.39e-01 | 1.39e-01 | 8.64e-01 |
| GOCC SPECIFIC GRANULE | 155 | 2.85e-03 | -1.39e-01 | 2.04e-01 |
| GOBP CENTRIOLE ASSEMBLY | 47 | 9.96e-02 | 1.39e-01 | 7.66e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 33 | 1.68e-01 | 1.39e-01 | 8.31e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 4.97e-01 | -1.39e-01 | 9.45e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 8 | 4.97e-01 | 1.39e-01 | 9.45e-01 |
| GOBP HISTIDINE CATABOLIC PROCESS | 8 | 4.97e-01 | -1.39e-01 | 9.45e-01 |
| GOMF BETA 2 ADRENERGIC RECEPTOR BINDING | 6 | 5.56e-01 | -1.39e-01 | 9.49e-01 |
| GOBP AORTA DEVELOPMENT | 65 | 5.31e-02 | 1.39e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 13 | 3.87e-01 | -1.39e-01 | 9.14e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 4.72e-01 | -1.39e-01 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 34 | 1.62e-01 | -1.38e-01 | 8.24e-01 |
| GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY | 8 | 4.98e-01 | 1.38e-01 | 9.45e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 6 | 5.57e-01 | -1.38e-01 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 23 | 2.51e-01 | -1.38e-01 | 8.65e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 11 | 4.27e-01 | 1.38e-01 | 9.26e-01 |
| GOCC INNER KINETOCHORE | 17 | 3.23e-01 | 1.38e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 59 | 6.61e-02 | -1.38e-01 | 6.82e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 5.26e-01 | -1.38e-01 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 8 | 4.98e-01 | -1.38e-01 | 9.45e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 8 | 4.98e-01 | 1.38e-01 | 9.45e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 8 | 4.98e-01 | -1.38e-01 | 9.45e-01 |
| GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS | 7 | 5.27e-01 | -1.38e-01 | 9.48e-01 |
| GOMF D LOOP DNA BINDING | 5 | 5.93e-01 | 1.38e-01 | 9.54e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 25 | 2.32e-01 | -1.38e-01 | 8.63e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 14 | 3.71e-01 | 1.38e-01 | 9.09e-01 |
| GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 5.93e-01 | -1.38e-01 | 9.54e-01 |
| GOCC AMPHISOME MEMBRANE | 11 | 4.28e-01 | 1.38e-01 | 9.27e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 4.50e-01 | 1.38e-01 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 8 | 5.00e-01 | -1.38e-01 | 9.45e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 25 | 2.33e-01 | -1.38e-01 | 8.64e-01 |
| GOCC ROD PHOTORECEPTOR OUTER SEGMENT | 5 | 5.94e-01 | 1.38e-01 | 9.54e-01 |
| GOBP GLIAL CELL FATE SPECIFICATION | 7 | 5.28e-01 | -1.38e-01 | 9.48e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 27 | 2.16e-01 | -1.38e-01 | 8.56e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 5.59e-01 | 1.38e-01 | 9.49e-01 |
| GOBP PEROXISOME FISSION | 9 | 4.75e-01 | 1.38e-01 | 9.41e-01 |
| GOBP COCHLEA DEVELOPMENT | 46 | 1.07e-01 | 1.38e-01 | 7.72e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 19 | 2.99e-01 | 1.37e-01 | 8.83e-01 |
| GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS | 7 | 5.29e-01 | 1.37e-01 | 9.48e-01 |
| GOBP MESODERMAL CELL FATE SPECIFICATION | 12 | 4.10e-01 | 1.37e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 5.60e-01 | -1.37e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 24 | 2.44e-01 | 1.37e-01 | 8.65e-01 |
| GOBP INTRACELLULAR NITROGEN HOMEOSTASIS | 5 | 5.95e-01 | -1.37e-01 | 9.54e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 24 | 2.45e-01 | 1.37e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 25 | 2.35e-01 | 1.37e-01 | 8.64e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 12 | 4.11e-01 | 1.37e-01 | 9.21e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 12 | 4.11e-01 | 1.37e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 10 | 4.53e-01 | -1.37e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 8 | 5.02e-01 | -1.37e-01 | 9.45e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 31 | 1.87e-01 | -1.37e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 48 | 1.01e-01 | 1.37e-01 | 7.66e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 171 | 2.04e-03 | 1.37e-01 | 1.74e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 8 | 5.03e-01 | -1.37e-01 | 9.45e-01 |
| GOBP RNA 5 END PROCESSING | 21 | 2.78e-01 | 1.37e-01 | 8.71e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 32 | 1.81e-01 | -1.37e-01 | 8.41e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 38 | 1.45e-01 | -1.37e-01 | 8.06e-01 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 8 | 5.04e-01 | -1.37e-01 | 9.45e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 17 | 3.30e-01 | 1.37e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 4.33e-01 | 1.37e-01 | 9.27e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 22 | 2.68e-01 | -1.37e-01 | 8.69e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 196 | 9.80e-04 | -1.37e-01 | 1.18e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 133 | 6.55e-03 | -1.37e-01 | 3.18e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 64 | 5.90e-02 | -1.36e-01 | 6.61e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 2.38e-01 | 1.36e-01 | 8.64e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 24 | 2.47e-01 | -1.36e-01 | 8.65e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.04e-01 | -1.36e-01 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 22 | 2.69e-01 | 1.36e-01 | 8.69e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 14 | 3.78e-01 | 1.36e-01 | 9.09e-01 |
| GOBP L CYSTINE TRANSPORT | 6 | 5.64e-01 | 1.36e-01 | 9.50e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 146 | 4.51e-03 | 1.36e-01 | 2.61e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 29 | 2.04e-01 | -1.36e-01 | 8.51e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 7 | 5.33e-01 | 1.36e-01 | 9.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 14 | 3.78e-01 | -1.36e-01 | 9.09e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 10 | 4.56e-01 | -1.36e-01 | 9.36e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 12 | 4.15e-01 | 1.36e-01 | 9.23e-01 |
| GOCC BASAL CORTEX | 5 | 5.99e-01 | 1.36e-01 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 20 | 2.93e-01 | -1.36e-01 | 8.79e-01 |
| GOCC FIBRILLAR COLLAGEN TRIMER | 12 | 4.15e-01 | -1.36e-01 | 9.23e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 16 | 3.47e-01 | -1.36e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 14 | 3.79e-01 | 1.36e-01 | 9.09e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 3.96e-01 | 1.36e-01 | 9.18e-01 |
| GOBP PROSTATIC BUD FORMATION | 8 | 5.06e-01 | 1.36e-01 | 9.45e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 8 | 5.06e-01 | 1.36e-01 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 36 | 1.59e-01 | -1.36e-01 | 8.19e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 5.99e-01 | -1.36e-01 | 9.55e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 5 | 5.99e-01 | -1.36e-01 | 9.55e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 16 | 3.48e-01 | -1.36e-01 | 8.98e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 152 | 3.92e-03 | -1.36e-01 | 2.37e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 23 | 2.61e-01 | -1.35e-01 | 8.66e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 12 | 4.17e-01 | -1.35e-01 | 9.23e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 36 | 1.60e-01 | -1.35e-01 | 8.20e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 42 | 1.29e-01 | 1.35e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 5.36e-01 | 1.35e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 39 | 1.44e-01 | -1.35e-01 | 8.06e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 160 | 3.17e-03 | -1.35e-01 | 2.16e-01 |
| GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE | 7 | 5.36e-01 | -1.35e-01 | 9.49e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 4.60e-01 | -1.35e-01 | 9.37e-01 |
| GOBP VIRAL TRANSCRIPTION | 50 | 9.86e-02 | 1.35e-01 | 7.66e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 6 | 5.67e-01 | -1.35e-01 | 9.50e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 6 | 5.67e-01 | 1.35e-01 | 9.50e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 45 | 1.17e-01 | 1.35e-01 | 7.82e-01 |
| GOCC ATAC COMPLEX | 13 | 4.00e-01 | 1.35e-01 | 9.18e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 28 | 2.17e-01 | 1.35e-01 | 8.56e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 27 | 2.25e-01 | -1.35e-01 | 8.59e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 25 | 2.43e-01 | 1.35e-01 | 8.64e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 12 | 4.19e-01 | 1.35e-01 | 9.24e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 7 | 5.37e-01 | 1.35e-01 | 9.49e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 4.61e-01 | 1.35e-01 | 9.37e-01 |
| GOCC ENDONUCLEASE COMPLEX | 37 | 1.56e-01 | 1.35e-01 | 8.17e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 34 | 1.74e-01 | -1.35e-01 | 8.37e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 19 | 3.10e-01 | -1.35e-01 | 8.87e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 129 | 8.29e-03 | 1.35e-01 | 3.53e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 84 | 3.30e-02 | 1.35e-01 | 5.58e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 18 | 3.23e-01 | 1.35e-01 | 8.92e-01 |
| GOBP EXOCRINE PANCREAS DEVELOPMENT | 7 | 5.38e-01 | 1.35e-01 | 9.49e-01 |
| GOBP REGULATION OF ASTROCYTE ACTIVATION | 8 | 5.10e-01 | -1.35e-01 | 9.46e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 34 | 1.75e-01 | 1.35e-01 | 8.39e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 28 | 2.18e-01 | 1.34e-01 | 8.56e-01 |
| GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX | 6 | 5.68e-01 | 1.34e-01 | 9.51e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 20 | 2.98e-01 | -1.34e-01 | 8.82e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 32 | 1.88e-01 | -1.34e-01 | 8.44e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 51 | 9.68e-02 | -1.34e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS | 5 | 6.03e-01 | 1.34e-01 | 9.55e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 156 | 3.78e-03 | -1.34e-01 | 2.32e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 4.62e-01 | 1.34e-01 | 9.37e-01 |
| GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY | 11 | 4.41e-01 | -1.34e-01 | 9.29e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 6.03e-01 | 1.34e-01 | 9.55e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 451 | 1.02e-06 | -1.34e-01 | 9.45e-04 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 56 | 8.23e-02 | -1.34e-01 | 7.33e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 126 | 9.28e-03 | 1.34e-01 | 3.64e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.04e-01 | 1.34e-01 | 8.51e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 35 | 1.70e-01 | -1.34e-01 | 8.32e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 19 | 3.12e-01 | -1.34e-01 | 8.89e-01 |
| GOMF COBALAMIN BINDING | 9 | 4.86e-01 | -1.34e-01 | 9.43e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 70 | 5.29e-02 | 1.34e-01 | 6.45e-01 |
| GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT | 11 | 4.42e-01 | -1.34e-01 | 9.30e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 14 | 3.86e-01 | -1.34e-01 | 9.14e-01 |
| GOBP CELLULAR RESPONSE TO HISTAMINE | 7 | 5.40e-01 | -1.34e-01 | 9.49e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 5.40e-01 | -1.34e-01 | 9.49e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 6.05e-01 | 1.34e-01 | 9.55e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 15 | 3.70e-01 | -1.34e-01 | 9.09e-01 |
| GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 6 | 5.71e-01 | -1.34e-01 | 9.51e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 6.05e-01 | -1.34e-01 | 9.55e-01 |
| GOBP EYE PIGMENTATION | 5 | 6.05e-01 | -1.34e-01 | 9.55e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 21 | 2.90e-01 | 1.33e-01 | 8.78e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 12 | 4.23e-01 | -1.33e-01 | 9.24e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 5.41e-01 | 1.33e-01 | 9.49e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 9 | 4.89e-01 | 1.33e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 13 | 4.05e-01 | 1.33e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 56 | 8.47e-02 | -1.33e-01 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 41 | 1.40e-01 | -1.33e-01 | 8.06e-01 |
| GOMF CASPASE BINDING | 13 | 4.06e-01 | -1.33e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 39 | 1.51e-01 | 1.33e-01 | 8.15e-01 |
| GOBP NADPH OXIDATION | 5 | 6.06e-01 | -1.33e-01 | 9.55e-01 |
| GOMF ADRENERGIC RECEPTOR ACTIVITY | 9 | 4.90e-01 | -1.33e-01 | 9.43e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 23 | 2.69e-01 | 1.33e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 3.16e-01 | -1.33e-01 | 8.90e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 16 | 3.57e-01 | 1.33e-01 | 9.03e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 3.29e-01 | 1.33e-01 | 8.93e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 12 | 4.25e-01 | 1.33e-01 | 9.26e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 6 | 5.73e-01 | 1.33e-01 | 9.51e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 15 | 3.73e-01 | -1.33e-01 | 9.09e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 8 | 5.16e-01 | -1.33e-01 | 9.46e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 12 | 4.26e-01 | 1.33e-01 | 9.26e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 18 | 3.30e-01 | -1.33e-01 | 8.93e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 5.43e-01 | 1.33e-01 | 9.49e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 24 | 2.61e-01 | 1.33e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 14 | 3.91e-01 | 1.32e-01 | 9.16e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 69 | 5.73e-02 | -1.32e-01 | 6.57e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 9 | 4.92e-01 | 1.32e-01 | 9.45e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 89 | 3.09e-02 | 1.32e-01 | 5.55e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 18 | 3.31e-01 | -1.32e-01 | 8.93e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 9 | 4.92e-01 | 1.32e-01 | 9.45e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 15 | 3.75e-01 | 1.32e-01 | 9.09e-01 |
| GOBP PHAGOCYTOSIS | 228 | 5.82e-04 | -1.32e-01 | 8.64e-02 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 17 | 3.45e-01 | 1.32e-01 | 8.96e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 17 | 3.46e-01 | -1.32e-01 | 8.96e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 1.43e-01 | -1.32e-01 | 8.06e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 10 | 4.70e-01 | -1.32e-01 | 9.39e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 23 | 2.73e-01 | 1.32e-01 | 8.69e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 19 | 3.19e-01 | -1.32e-01 | 8.92e-01 |
| GOBP HISTONE METHYLATION | 35 | 1.77e-01 | 1.32e-01 | 8.41e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 14 | 3.93e-01 | 1.32e-01 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 5.18e-01 | 1.32e-01 | 9.47e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 12 | 4.29e-01 | 1.32e-01 | 9.27e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 80 | 4.16e-02 | -1.32e-01 | 6.10e-01 |
| GOBP RESPONSE TO CORTISOL | 6 | 5.76e-01 | -1.32e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 24 | 2.64e-01 | 1.32e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 4.30e-01 | -1.32e-01 | 9.27e-01 |
| GOMF ALPHA TUBULIN BINDING | 37 | 1.66e-01 | 1.32e-01 | 8.25e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 15 | 3.77e-01 | -1.32e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 14 | 3.94e-01 | -1.32e-01 | 9.17e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 26 | 2.45e-01 | 1.32e-01 | 8.65e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 4.11e-01 | 1.32e-01 | 9.21e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 4.11e-01 | -1.32e-01 | 9.21e-01 |
| GOBP TRNA 5 END PROCESSING | 15 | 3.78e-01 | 1.32e-01 | 9.09e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 19 | 3.21e-01 | -1.32e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 51 | 1.04e-01 | -1.32e-01 | 7.68e-01 |
| GOBP HISTONE MODIFICATION | 106 | 1.93e-02 | 1.32e-01 | 4.91e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 39 | 1.55e-01 | 1.32e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 28 | 2.28e-01 | 1.31e-01 | 8.62e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 18 | 3.35e-01 | 1.31e-01 | 8.96e-01 |
| GOBP REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY | 5 | 6.11e-01 | 1.31e-01 | 9.59e-01 |
| GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY | 5 | 6.11e-01 | -1.31e-01 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 14 | 3.95e-01 | -1.31e-01 | 9.18e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 6.12e-01 | 1.31e-01 | 9.59e-01 |
| GOBP AMINO ACID ACTIVATION | 43 | 1.37e-01 | 1.31e-01 | 8.06e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 6.12e-01 | 1.31e-01 | 9.59e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 10 | 4.73e-01 | 1.31e-01 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 3.11e-01 | -1.31e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 60 | 7.95e-02 | -1.31e-01 | 7.25e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I | 5 | 6.12e-01 | 1.31e-01 | 9.59e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 4.97e-01 | 1.31e-01 | 9.45e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 4.14e-01 | 1.31e-01 | 9.23e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 11 | 4.53e-01 | -1.31e-01 | 9.35e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 9 | 4.97e-01 | -1.31e-01 | 9.45e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 41 | 1.48e-01 | -1.31e-01 | 8.09e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 188 | 2.01e-03 | 1.31e-01 | 1.73e-01 |
| GOBP ANOIKIS | 33 | 1.94e-01 | 1.31e-01 | 8.44e-01 |
| GOCC CELL TRAILING EDGE | 13 | 4.15e-01 | -1.31e-01 | 9.23e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 9 | 4.98e-01 | -1.31e-01 | 9.45e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 48 | 1.18e-01 | -1.31e-01 | 7.82e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 66 | 6.67e-02 | 1.31e-01 | 6.83e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 91 | 3.14e-02 | 1.30e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 29 | 2.24e-01 | 1.30e-01 | 8.57e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 169 | 3.43e-03 | -1.30e-01 | 2.25e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 19 | 3.25e-01 | -1.30e-01 | 8.93e-01 |
| GOBP RESPONSE TO VITAMIN E | 8 | 5.23e-01 | -1.30e-01 | 9.47e-01 |
| GOBP RETINAL METABOLIC PROCESS | 18 | 3.38e-01 | 1.30e-01 | 8.96e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 43 | 1.39e-01 | 1.30e-01 | 8.06e-01 |
| GOBP RESPONSE TO GLUCAGON | 20 | 3.13e-01 | 1.30e-01 | 8.90e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 55 | 9.44e-02 | -1.30e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 3.99e-01 | 1.30e-01 | 9.18e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 12 | 4.35e-01 | -1.30e-01 | 9.27e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 76 | 4.97e-02 | -1.30e-01 | 6.28e-01 |
| GOBP COPULATION | 19 | 3.26e-01 | -1.30e-01 | 8.93e-01 |
| GOBP INTRACELLULAR PH ELEVATION | 7 | 5.51e-01 | 1.30e-01 | 9.49e-01 |
| GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY | 5 | 6.14e-01 | 1.30e-01 | 9.59e-01 |
| GOCC HOST CELLULAR COMPONENT | 9 | 4.99e-01 | -1.30e-01 | 9.45e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 30 | 2.17e-01 | -1.30e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 16 | 3.68e-01 | 1.30e-01 | 9.07e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 4.77e-01 | -1.30e-01 | 9.41e-01 |
| GOBP DOPAMINE SECRETION | 41 | 1.50e-01 | -1.30e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 31 | 2.10e-01 | -1.30e-01 | 8.53e-01 |
| GOBP PERICENTRIC HETEROCHROMATIN FORMATION | 5 | 6.15e-01 | 1.30e-01 | 9.60e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 62 | 7.70e-02 | -1.30e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 26 | 2.52e-01 | -1.30e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 14 | 4.01e-01 | -1.30e-01 | 9.18e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 4.78e-01 | 1.30e-01 | 9.42e-01 |
| GOMF ALKALI METAL ION BINDING | 19 | 3.28e-01 | -1.30e-01 | 8.93e-01 |
| GOCC SEX CHROMOSOME | 33 | 1.98e-01 | 1.30e-01 | 8.44e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 11 | 4.57e-01 | -1.29e-01 | 9.36e-01 |
| GOBP HISTAMINE TRANSPORT | 15 | 3.85e-01 | 1.29e-01 | 9.14e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 22 | 2.93e-01 | -1.29e-01 | 8.80e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 13 | 4.19e-01 | -1.29e-01 | 9.24e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 26 | 2.53e-01 | 1.29e-01 | 8.65e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 28 | 2.36e-01 | 1.29e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 11 | 4.58e-01 | -1.29e-01 | 9.37e-01 |
| GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY | 11 | 4.58e-01 | 1.29e-01 | 9.37e-01 |
| GOMF CYTOKINE ACTIVITY | 223 | 8.85e-04 | -1.29e-01 | 1.12e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 6.17e-01 | 1.29e-01 | 9.61e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 131 | 1.07e-02 | 1.29e-01 | 3.90e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 14 | 4.03e-01 | -1.29e-01 | 9.20e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 62 | 7.87e-02 | -1.29e-01 | 7.22e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 6 | 5.84e-01 | 1.29e-01 | 9.54e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 4.20e-01 | 1.29e-01 | 9.24e-01 |
| GOBP FIBRINOLYSIS | 27 | 2.46e-01 | -1.29e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 121 | 1.42e-02 | -1.29e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 30 | 2.21e-01 | -1.29e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 8 | 5.28e-01 | -1.29e-01 | 9.48e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 233 | 6.94e-04 | -1.29e-01 | 9.74e-02 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 3.44e-01 | 1.29e-01 | 8.96e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 104 | 2.31e-02 | 1.29e-01 | 5.13e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 12 | 4.40e-01 | 1.29e-01 | 9.29e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 17 | 3.58e-01 | -1.29e-01 | 9.03e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 1.87e-01 | -1.29e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 32 | 2.08e-01 | -1.29e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 19 | 3.32e-01 | 1.29e-01 | 8.94e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 77 | 5.10e-02 | -1.29e-01 | 6.36e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 7 | 5.56e-01 | -1.29e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 15 | 3.89e-01 | 1.29e-01 | 9.14e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 8 | 5.29e-01 | 1.28e-01 | 9.48e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 230 | 7.87e-04 | -1.28e-01 | 1.05e-01 |
| GOBP MUCOCILIARY CLEARANCE | 8 | 5.29e-01 | -1.28e-01 | 9.48e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 4.23e-01 | -1.28e-01 | 9.24e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 6.19e-01 | 1.28e-01 | 9.61e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX | 5 | 6.19e-01 | -1.28e-01 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 8 | 5.30e-01 | 1.28e-01 | 9.48e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 3.09e-01 | 1.28e-01 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 37 | 1.77e-01 | 1.28e-01 | 8.41e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 67 | 6.93e-02 | 1.28e-01 | 6.94e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 27 | 2.49e-01 | 1.28e-01 | 8.65e-01 |
| GOCC NPBAF COMPLEX | 14 | 4.06e-01 | 1.28e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 5.87e-01 | -1.28e-01 | 9.54e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 3.09e-01 | 1.28e-01 | 8.87e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 9 | 5.06e-01 | 1.28e-01 | 9.45e-01 |
| GOCC VESICLE LUMEN | 311 | 1.01e-04 | -1.28e-01 | 2.65e-02 |
| GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 5.87e-01 | 1.28e-01 | 9.54e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 60 | 8.63e-02 | -1.28e-01 | 7.47e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 13 | 4.24e-01 | 1.28e-01 | 9.24e-01 |
| GOBP CARNITINE TRANSPORT | 8 | 5.31e-01 | 1.28e-01 | 9.48e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 10 | 4.84e-01 | -1.28e-01 | 9.43e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 11 | 4.63e-01 | 1.28e-01 | 9.37e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 281 | 2.25e-04 | -1.28e-01 | 4.32e-02 |
| GOBP PHOSPHATE ION TRANSPORT | 28 | 2.42e-01 | -1.28e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 12 | 4.43e-01 | 1.28e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 16 | 3.76e-01 | -1.28e-01 | 9.09e-01 |
| GOMF STEROID BINDING | 97 | 2.96e-02 | -1.28e-01 | 5.52e-01 |
| GOMF CD4 RECEPTOR BINDING | 8 | 5.31e-01 | -1.28e-01 | 9.48e-01 |
| GOBP COPII COATED VESICLE BUDDING | 42 | 1.52e-01 | 1.28e-01 | 8.17e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 10 | 4.84e-01 | -1.28e-01 | 9.43e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 20 | 3.23e-01 | -1.28e-01 | 8.92e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 17 | 3.62e-01 | 1.28e-01 | 9.06e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 24 | 2.79e-01 | 1.28e-01 | 8.71e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 6 | 5.89e-01 | -1.28e-01 | 9.54e-01 |
| GOMF PROTEIN KINASE B BINDING | 10 | 4.85e-01 | -1.28e-01 | 9.43e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 10 | 4.85e-01 | 1.28e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 14 | 4.09e-01 | 1.27e-01 | 9.21e-01 |
| GOCC GOLGI CIS CISTERNA | 14 | 4.09e-01 | 1.27e-01 | 9.21e-01 |
| GOCC PCG PROTEIN COMPLEX | 35 | 1.92e-01 | 1.27e-01 | 8.44e-01 |
| GOCC PERINEURONAL NET | 10 | 4.85e-01 | -1.27e-01 | 9.43e-01 |
| GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY | 6 | 5.89e-01 | -1.27e-01 | 9.54e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 33 | 2.05e-01 | -1.27e-01 | 8.51e-01 |
| GOBP IMP METABOLIC PROCESS | 17 | 3.63e-01 | -1.27e-01 | 9.06e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 29 | 2.35e-01 | -1.27e-01 | 8.64e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 158 | 5.76e-03 | 1.27e-01 | 2.92e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 58 | 9.38e-02 | -1.27e-01 | 7.64e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 7 | 5.60e-01 | -1.27e-01 | 9.49e-01 |
| GOCC PODOSOME | 31 | 2.20e-01 | -1.27e-01 | 8.56e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 4.10e-01 | 1.27e-01 | 9.21e-01 |
| GOBP MACROPHAGE MIGRATION | 61 | 8.60e-02 | -1.27e-01 | 7.47e-01 |
| GOCC GID COMPLEX | 5 | 6.23e-01 | 1.27e-01 | 9.61e-01 |
| GOMF THYROID HORMONE BINDING | 6 | 5.90e-01 | -1.27e-01 | 9.54e-01 |
| GOMF PRIMARY MIRNA BINDING | 9 | 5.09e-01 | 1.27e-01 | 9.46e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 10 | 4.87e-01 | 1.27e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 6.23e-01 | -1.27e-01 | 9.61e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 19 | 3.38e-01 | -1.27e-01 | 8.96e-01 |
| GOBP REGULATION OF NOREPINEPHRINE SECRETION | 13 | 4.29e-01 | 1.27e-01 | 9.27e-01 |
| GOBP ASTROCYTE ACTIVATION | 25 | 2.72e-01 | -1.27e-01 | 8.69e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 21 | 3.15e-01 | -1.27e-01 | 8.90e-01 |
| GOBP SULFATION | 20 | 3.27e-01 | -1.27e-01 | 8.93e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 16 | 3.80e-01 | 1.27e-01 | 9.10e-01 |
| GOBP REGULATION OF GASTRIC ACID SECRETION | 6 | 5.91e-01 | 1.27e-01 | 9.54e-01 |
| GOMF SYNDECAN BINDING | 5 | 6.24e-01 | -1.27e-01 | 9.61e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 11 | 4.67e-01 | 1.27e-01 | 9.38e-01 |
| GOMF DIACYLGLYCEROL BINDING | 13 | 4.30e-01 | -1.26e-01 | 9.27e-01 |
| GOBP REGULATION OF OOCYTE MATURATION | 7 | 5.62e-01 | 1.26e-01 | 9.49e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 72 | 6.36e-02 | -1.26e-01 | 6.67e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 10 | 4.89e-01 | 1.26e-01 | 9.43e-01 |
| GOBP V D J RECOMBINATION | 19 | 3.40e-01 | 1.26e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 65 | 7.79e-02 | -1.26e-01 | 7.19e-01 |
| GOBP EPIBOLY | 37 | 1.83e-01 | 1.26e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 50 | 1.22e-01 | -1.26e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 7 | 5.62e-01 | 1.26e-01 | 9.49e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 3.53e-01 | 1.26e-01 | 9.01e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 9 | 5.12e-01 | -1.26e-01 | 9.46e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 70 | 6.78e-02 | 1.26e-01 | 6.90e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 5.92e-01 | 1.26e-01 | 9.54e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 8 | 5.37e-01 | 1.26e-01 | 9.49e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 21 | 3.17e-01 | -1.26e-01 | 8.91e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 11 | 4.69e-01 | 1.26e-01 | 9.39e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 12 | 4.49e-01 | -1.26e-01 | 9.33e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 82 | 4.84e-02 | -1.26e-01 | 6.28e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 5.93e-01 | -1.26e-01 | 9.54e-01 |
| GOCC PRP19 COMPLEX | 12 | 4.50e-01 | 1.26e-01 | 9.33e-01 |
| GOBP CHITIN METABOLIC PROCESS | 6 | 5.93e-01 | 1.26e-01 | 9.54e-01 |
| GOMF CHITINASE ACTIVITY | 6 | 5.93e-01 | 1.26e-01 | 9.54e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 5.93e-01 | -1.26e-01 | 9.54e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 23 | 2.96e-01 | 1.26e-01 | 8.82e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 31 | 2.25e-01 | -1.26e-01 | 8.59e-01 |
| GOBP AGGREPHAGY | 10 | 4.91e-01 | -1.26e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 61 | 8.91e-02 | 1.26e-01 | 7.52e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 9 | 5.13e-01 | -1.26e-01 | 9.46e-01 |
| GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY | 16 | 3.84e-01 | 1.26e-01 | 9.14e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 23 | 2.96e-01 | -1.26e-01 | 8.82e-01 |
| GOBP SKIN MORPHOGENESIS | 13 | 4.32e-01 | -1.26e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS | 5 | 6.26e-01 | -1.26e-01 | 9.61e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 5.65e-01 | 1.26e-01 | 9.50e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.70e-01 | -1.26e-01 | 9.39e-01 |
| GOBP CENTROSOME DUPLICATION | 74 | 6.16e-02 | 1.26e-01 | 6.63e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 6.26e-01 | -1.26e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 14 | 4.16e-01 | -1.26e-01 | 9.23e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 16 | 3.84e-01 | -1.26e-01 | 9.14e-01 |
| GOMF PRE MRNA BINDING | 39 | 1.75e-01 | -1.26e-01 | 8.39e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 5.94e-01 | 1.26e-01 | 9.54e-01 |
| GOBP PANCREATIC JUICE SECRETION | 11 | 4.71e-01 | -1.26e-01 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 5.65e-01 | -1.26e-01 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 26 | 2.68e-01 | -1.26e-01 | 8.69e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 10 | 4.92e-01 | 1.26e-01 | 9.45e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 22 | 3.09e-01 | 1.25e-01 | 8.87e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 9 | 5.15e-01 | -1.25e-01 | 9.46e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 15 | 4.01e-01 | 1.25e-01 | 9.18e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 6 | 5.95e-01 | -1.25e-01 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 13 | 4.34e-01 | 1.25e-01 | 9.27e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 19 | 3.45e-01 | 1.25e-01 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY | 8 | 5.40e-01 | 1.25e-01 | 9.49e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 56 | 1.05e-01 | -1.25e-01 | 7.69e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 13 | 4.35e-01 | 1.25e-01 | 9.27e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 8 | 5.40e-01 | 1.25e-01 | 9.49e-01 |
| GOBP LEUKOTRIENE B4 METABOLIC PROCESS | 5 | 6.28e-01 | -1.25e-01 | 9.61e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 230 | 1.08e-03 | -1.25e-01 | 1.23e-01 |
| GOBP CARTILAGE CONDENSATION | 19 | 3.46e-01 | 1.25e-01 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 21 | 3.21e-01 | -1.25e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 59 | 9.68e-02 | -1.25e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 10 | 4.94e-01 | 1.25e-01 | 9.45e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 20 | 3.33e-01 | -1.25e-01 | 8.94e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 36 | 1.94e-01 | 1.25e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 5.16e-01 | 1.25e-01 | 9.46e-01 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 10 | 4.94e-01 | -1.25e-01 | 9.45e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 30 | 2.37e-01 | 1.25e-01 | 8.64e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 66 | 7.95e-02 | 1.25e-01 | 7.25e-01 |
| GOCC GROWTH FACTOR COMPLEX | 8 | 5.41e-01 | 1.25e-01 | 9.49e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 23 | 3.00e-01 | -1.25e-01 | 8.84e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 34 | 2.08e-01 | 1.25e-01 | 8.51e-01 |
| GOBP PEXOPHAGY | 6 | 5.97e-01 | -1.25e-01 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 23 | 3.00e-01 | -1.25e-01 | 8.84e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 37 | 1.89e-01 | 1.25e-01 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 47 | 1.39e-01 | 1.25e-01 | 8.06e-01 |
| GOBP EXCRETION | 29 | 2.45e-01 | -1.25e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 6.29e-01 | -1.25e-01 | 9.61e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 9 | 5.18e-01 | -1.25e-01 | 9.47e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 16 | 3.89e-01 | 1.24e-01 | 9.14e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 9 | 5.18e-01 | -1.24e-01 | 9.47e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 29 | 2.46e-01 | 1.24e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 6 | 5.98e-01 | 1.24e-01 | 9.55e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 15 | 4.04e-01 | 1.24e-01 | 9.21e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 7 | 5.69e-01 | 1.24e-01 | 9.51e-01 |
| GOBP VACUOLE FUSION | 12 | 4.57e-01 | 1.24e-01 | 9.36e-01 |
| GOBP VOCALIZATION BEHAVIOR | 15 | 4.05e-01 | -1.24e-01 | 9.21e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 7 | 5.70e-01 | -1.24e-01 | 9.51e-01 |
| GOCC SIN3 TYPE COMPLEX | 20 | 3.37e-01 | 1.24e-01 | 8.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 6 | 5.99e-01 | 1.24e-01 | 9.55e-01 |
| GOCC PHAGOCYTIC CUP | 28 | 2.56e-01 | -1.24e-01 | 8.65e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 7 | 5.70e-01 | -1.24e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 9 | 5.19e-01 | -1.24e-01 | 9.47e-01 |
| GOCC ASTROCYTE PROJECTION | 19 | 3.49e-01 | -1.24e-01 | 8.99e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 9 | 5.20e-01 | 1.24e-01 | 9.47e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 8 | 5.44e-01 | -1.24e-01 | 9.49e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 8 | 5.44e-01 | -1.24e-01 | 9.49e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 19 | 3.50e-01 | 1.24e-01 | 8.99e-01 |
| GOMF FIBRONECTIN BINDING | 29 | 2.48e-01 | -1.24e-01 | 8.65e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 25 | 2.84e-01 | 1.24e-01 | 8.74e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 6.32e-01 | 1.24e-01 | 9.61e-01 |
| GOBP SPINDLE ASSEMBLY | 125 | 1.68e-02 | 1.24e-01 | 4.68e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 5.45e-01 | -1.24e-01 | 9.49e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 131 | 1.45e-02 | -1.24e-01 | 4.54e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 41 | 1.71e-01 | 1.24e-01 | 8.32e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 26 | 2.75e-01 | 1.24e-01 | 8.69e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 6 | 6.00e-01 | -1.24e-01 | 9.55e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 99 | 3.36e-02 | 1.24e-01 | 5.58e-01 |
| GOBP GLOMERULUS VASCULATURE MORPHOGENESIS | 6 | 6.01e-01 | 1.23e-01 | 9.55e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 19 | 3.52e-01 | 1.23e-01 | 9.00e-01 |
| GOMF NEUROTROPHIN BINDING | 10 | 4.99e-01 | -1.23e-01 | 9.45e-01 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 8 | 5.46e-01 | 1.23e-01 | 9.49e-01 |
| GOBP MELANOCYTE PROLIFERATION | 5 | 6.33e-01 | -1.23e-01 | 9.61e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 11 | 4.79e-01 | -1.23e-01 | 9.42e-01 |
| GOBP TRUNK SEGMENTATION | 5 | 6.33e-01 | 1.23e-01 | 9.61e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 302 | 2.29e-04 | -1.23e-01 | 4.32e-02 |
| GOBP REGULATION OF HEAT GENERATION | 12 | 4.60e-01 | 1.23e-01 | 9.37e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 6 | 6.01e-01 | 1.23e-01 | 9.55e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING | 7 | 5.73e-01 | -1.23e-01 | 9.51e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 6.33e-01 | 1.23e-01 | 9.61e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 9 | 5.22e-01 | 1.23e-01 | 9.47e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 18 | 3.66e-01 | -1.23e-01 | 9.06e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 438 | 9.93e-06 | -1.23e-01 | 4.23e-03 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 45 | 1.53e-01 | -1.23e-01 | 8.17e-01 |
| GOMF CARD DOMAIN BINDING | 16 | 3.94e-01 | 1.23e-01 | 9.17e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 8 | 5.47e-01 | -1.23e-01 | 9.49e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 23 | 3.07e-01 | 1.23e-01 | 8.85e-01 |
| GOCC BBSOME | 8 | 5.47e-01 | -1.23e-01 | 9.49e-01 |
| GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 6.02e-01 | 1.23e-01 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 21 | 3.29e-01 | 1.23e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 14 | 4.26e-01 | -1.23e-01 | 9.26e-01 |
| GOBP TRANSFERRIN TRANSPORT | 10 | 5.01e-01 | 1.23e-01 | 9.45e-01 |
| GOBP RRNA METHYLATION | 24 | 2.97e-01 | 1.23e-01 | 8.82e-01 |
| GOBP INTRACILIARY TRANSPORT | 45 | 1.54e-01 | 1.23e-01 | 8.17e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 26 | 2.79e-01 | -1.23e-01 | 8.71e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 6 | 6.03e-01 | -1.23e-01 | 9.55e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 16 | 3.96e-01 | 1.23e-01 | 9.18e-01 |
| GOBP SPINDLE ORGANIZATION | 192 | 3.39e-03 | 1.23e-01 | 2.24e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 5 | 6.35e-01 | -1.23e-01 | 9.61e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 37 | 1.97e-01 | 1.22e-01 | 8.44e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 15 | 4.12e-01 | -1.22e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS | 7 | 5.75e-01 | 1.22e-01 | 9.51e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 60 | 1.01e-01 | 1.22e-01 | 7.66e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 6.04e-01 | 1.22e-01 | 9.55e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 29 | 2.54e-01 | -1.22e-01 | 8.65e-01 |
| GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY | 6 | 6.04e-01 | -1.22e-01 | 9.55e-01 |
| GOCC STEREOCILIUM BASE | 5 | 6.36e-01 | -1.22e-01 | 9.61e-01 |
| GOBP RESPONSE TO LEPTIN | 21 | 3.32e-01 | 1.22e-01 | 8.94e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 9 | 5.26e-01 | -1.22e-01 | 9.47e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 86 | 5.02e-02 | -1.22e-01 | 6.32e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 1.08e-01 | 1.22e-01 | 7.72e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 4.64e-01 | -1.22e-01 | 9.37e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 6 | 6.05e-01 | 1.22e-01 | 9.55e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 6.36e-01 | 1.22e-01 | 9.61e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 6.37e-01 | 1.22e-01 | 9.61e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 19 | 3.57e-01 | -1.22e-01 | 9.03e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 24 | 3.01e-01 | 1.22e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 34 | 2.18e-01 | 1.22e-01 | 8.56e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 97 | 3.79e-02 | 1.22e-01 | 5.90e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 7 | 5.76e-01 | 1.22e-01 | 9.51e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 2.40e-01 | -1.22e-01 | 8.64e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 31 | 2.40e-01 | 1.22e-01 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 44 | 1.62e-01 | 1.22e-01 | 8.24e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 4.84e-01 | -1.22e-01 | 9.43e-01 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 8 | 5.51e-01 | -1.22e-01 | 9.49e-01 |
| GOBP BONE TRABECULA FORMATION | 10 | 5.05e-01 | -1.22e-01 | 9.45e-01 |
| GOMF QUINONE BINDING | 15 | 4.14e-01 | -1.22e-01 | 9.23e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 10 | 5.05e-01 | -1.22e-01 | 9.45e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 46 | 1.53e-01 | 1.22e-01 | 8.17e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 29 | 2.57e-01 | -1.22e-01 | 8.65e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 11 | 4.85e-01 | 1.22e-01 | 9.43e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 4.00e-01 | 1.22e-01 | 9.18e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 16 | 4.00e-01 | 1.22e-01 | 9.18e-01 |
| GOCC VACUOLAR LUMEN | 167 | 6.73e-03 | -1.22e-01 | 3.20e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 10 | 5.06e-01 | 1.22e-01 | 9.45e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 10 | 5.06e-01 | 1.22e-01 | 9.45e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 45 | 1.59e-01 | -1.21e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 8 | 5.52e-01 | 1.21e-01 | 9.49e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 8 | 5.52e-01 | 1.21e-01 | 9.49e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 5.52e-01 | -1.21e-01 | 9.49e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 4.32e-01 | -1.21e-01 | 9.27e-01 |
| GOBP REGULATION OF HAIR CYCLE | 27 | 2.75e-01 | 1.21e-01 | 8.69e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 209 | 2.51e-03 | 1.21e-01 | 1.91e-01 |
| GOBP LUTEINIZING HORMONE SECRETION | 10 | 5.07e-01 | 1.21e-01 | 9.45e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 19 | 3.60e-01 | 1.21e-01 | 9.04e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 11 | 4.86e-01 | -1.21e-01 | 9.43e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 50 | 1.38e-01 | 1.21e-01 | 8.06e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 9 | 5.29e-01 | -1.21e-01 | 9.48e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 125 | 1.93e-02 | 1.21e-01 | 4.91e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 3.48e-01 | -1.21e-01 | 8.98e-01 |
| GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT | 5 | 6.39e-01 | 1.21e-01 | 9.62e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 17 | 3.88e-01 | 1.21e-01 | 9.14e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 25 | 2.95e-01 | 1.21e-01 | 8.82e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 6.39e-01 | 1.21e-01 | 9.62e-01 |
| GOMF APOLIPOPROTEIN BINDING | 17 | 3.88e-01 | -1.21e-01 | 9.14e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 16 | 4.02e-01 | 1.21e-01 | 9.19e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 20 | 3.49e-01 | -1.21e-01 | 8.99e-01 |
| GOBP GOLGI ORGANIZATION | 139 | 1.39e-02 | 1.21e-01 | 4.46e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 54 | 1.25e-01 | -1.21e-01 | 7.93e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 85 | 5.42e-02 | 1.21e-01 | 6.45e-01 |
| GOBP CELL CHEMOTAXIS | 304 | 2.92e-04 | -1.21e-01 | 5.15e-02 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 57 | 1.15e-01 | -1.21e-01 | 7.81e-01 |
| GOBP PROTEIN ACETYLATION | 97 | 3.99e-02 | 1.21e-01 | 6.03e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 118 | 2.37e-02 | -1.21e-01 | 5.17e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 8 | 5.55e-01 | -1.21e-01 | 9.49e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 12 | 4.70e-01 | 1.21e-01 | 9.39e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 9 | 5.31e-01 | 1.20e-01 | 9.48e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 4.52e-01 | -1.20e-01 | 9.35e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 11 | 4.89e-01 | -1.20e-01 | 9.43e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 7 | 5.81e-01 | -1.20e-01 | 9.53e-01 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 13 | 4.53e-01 | 1.20e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 14 | 4.36e-01 | -1.20e-01 | 9.27e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 2.98e-01 | 1.20e-01 | 8.82e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 58 | 1.13e-01 | 1.20e-01 | 7.80e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 13 | 4.53e-01 | 1.20e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 33 | 2.32e-01 | -1.20e-01 | 8.63e-01 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 9 | 5.32e-01 | -1.20e-01 | 9.48e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 6.10e-01 | -1.20e-01 | 9.58e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 44 | 1.68e-01 | 1.20e-01 | 8.31e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 44 | 1.68e-01 | -1.20e-01 | 8.31e-01 |
| GOBP POSTREPLICATION REPAIR | 33 | 2.33e-01 | 1.20e-01 | 8.63e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 7 | 5.82e-01 | -1.20e-01 | 9.53e-01 |
| GOBP ACTIVATION OF MEIOSIS | 6 | 6.11e-01 | 1.20e-01 | 9.58e-01 |
| GOBP METANEPHRIC TUBULE FORMATION | 6 | 6.11e-01 | -1.20e-01 | 9.58e-01 |
| GOBP REGULATION OF BONE DEVELOPMENT | 9 | 5.33e-01 | -1.20e-01 | 9.49e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 28 | 2.72e-01 | 1.20e-01 | 8.69e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 47 | 1.55e-01 | -1.20e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 4.91e-01 | 1.20e-01 | 9.45e-01 |
| GOMF RETINAL BINDING | 19 | 3.66e-01 | -1.20e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 90 | 4.94e-02 | -1.20e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 18 | 3.79e-01 | 1.20e-01 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 5.83e-01 | -1.20e-01 | 9.54e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 9 | 5.34e-01 | -1.20e-01 | 9.49e-01 |
| GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE | 6 | 6.12e-01 | 1.20e-01 | 9.59e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 16 | 4.07e-01 | 1.20e-01 | 9.21e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 2.14e-01 | -1.20e-01 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 45 | 1.65e-01 | 1.20e-01 | 8.25e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 13 | 4.56e-01 | 1.19e-01 | 9.36e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 5.13e-01 | -1.19e-01 | 9.46e-01 |
| GOMF GLUCOSE BINDING | 10 | 5.13e-01 | 1.19e-01 | 9.46e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 24 | 3.12e-01 | 1.19e-01 | 8.89e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 3.94e-01 | 1.19e-01 | 9.18e-01 |
| GOBP RESPONSE TO VITAMIN A | 15 | 4.24e-01 | -1.19e-01 | 9.24e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 19 | 3.68e-01 | -1.19e-01 | 9.08e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 10 | 5.14e-01 | 1.19e-01 | 9.46e-01 |
| GOMF ALPHA CATENIN BINDING | 10 | 5.14e-01 | 1.19e-01 | 9.46e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 20 | 3.57e-01 | -1.19e-01 | 9.03e-01 |
| GOMF NEUROLIGIN FAMILY PROTEIN BINDING | 5 | 6.45e-01 | -1.19e-01 | 9.63e-01 |
| GOCC MRNA EDITING COMPLEX | 15 | 4.25e-01 | 1.19e-01 | 9.25e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 8 | 5.60e-01 | -1.19e-01 | 9.49e-01 |
| GOBP DENDRITE ARBORIZATION | 10 | 5.15e-01 | -1.19e-01 | 9.46e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 14 | 4.41e-01 | -1.19e-01 | 9.29e-01 |
| GOBP CARDIAC CONDUCTION | 94 | 4.64e-02 | -1.19e-01 | 6.22e-01 |
| GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY | 5 | 6.45e-01 | -1.19e-01 | 9.63e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 16 | 4.11e-01 | 1.19e-01 | 9.21e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 44 | 1.73e-01 | 1.19e-01 | 8.36e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE FORMATION | 5 | 6.46e-01 | 1.19e-01 | 9.63e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 16 | 4.11e-01 | 1.19e-01 | 9.21e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 3.71e-01 | -1.19e-01 | 9.09e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 87 | 5.60e-02 | 1.19e-01 | 6.53e-01 |
| GOBP GLUCOCORTICOID SECRETION | 12 | 4.77e-01 | 1.18e-01 | 9.41e-01 |
| GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 5 | 6.46e-01 | -1.18e-01 | 9.63e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 130 | 1.97e-02 | -1.18e-01 | 4.91e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 16 | 4.12e-01 | -1.18e-01 | 9.21e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 8 | 5.62e-01 | -1.18e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 141 | 1.52e-02 | -1.18e-01 | 4.61e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 6.16e-01 | -1.18e-01 | 9.60e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 53 | 1.36e-01 | 1.18e-01 | 8.06e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 17 | 3.99e-01 | -1.18e-01 | 9.18e-01 |
| GOBP REGULATION OF SOMITOGENESIS | 6 | 6.16e-01 | 1.18e-01 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 14 | 4.44e-01 | 1.18e-01 | 9.30e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 32 | 2.47e-01 | -1.18e-01 | 8.65e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 8 | 5.63e-01 | 1.18e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 42 | 1.85e-01 | -1.18e-01 | 8.44e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 172 | 7.54e-03 | 1.18e-01 | 3.39e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 14 | 4.44e-01 | -1.18e-01 | 9.30e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 2.14e-01 | -1.18e-01 | 8.55e-01 |
| GOCC AMPHISOME | 13 | 4.61e-01 | 1.18e-01 | 9.37e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 17 | 4.00e-01 | 1.18e-01 | 9.18e-01 |
| GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX | 12 | 4.79e-01 | -1.18e-01 | 9.42e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 6.17e-01 | -1.18e-01 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 7 | 5.89e-01 | 1.18e-01 | 9.54e-01 |
| GOBP NEURON MATURATION | 47 | 1.62e-01 | -1.18e-01 | 8.24e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 6.48e-01 | -1.18e-01 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 9 | 5.41e-01 | -1.18e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 33 | 2.42e-01 | -1.18e-01 | 8.64e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.90e-01 | -1.18e-01 | 9.54e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 16 | 4.15e-01 | -1.18e-01 | 9.23e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 104 | 3.81e-02 | -1.18e-01 | 5.91e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 30 | 2.65e-01 | 1.18e-01 | 8.69e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 48 | 1.58e-01 | -1.18e-01 | 8.19e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 5.90e-01 | 1.18e-01 | 9.54e-01 |
| GOCC RETROMER COMPLEX | 11 | 4.99e-01 | -1.18e-01 | 9.45e-01 |
| GOBP LACTATE METABOLIC PROCESS | 18 | 3.88e-01 | 1.18e-01 | 9.14e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 5.42e-01 | 1.18e-01 | 9.49e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 4.31e-01 | -1.17e-01 | 9.27e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 13 | 4.63e-01 | -1.17e-01 | 9.37e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 41 | 1.93e-01 | 1.17e-01 | 8.44e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 45 | 1.73e-01 | 1.17e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 36 | 2.23e-01 | 1.17e-01 | 8.57e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 21 | 3.52e-01 | 1.17e-01 | 9.00e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 57 | 1.26e-01 | 1.17e-01 | 7.93e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 13 | 4.64e-01 | -1.17e-01 | 9.37e-01 |
| GOBP LUNG MORPHOGENESIS | 54 | 1.36e-01 | -1.17e-01 | 8.06e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 3.30e-01 | -1.17e-01 | 8.93e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 34 | 2.37e-01 | -1.17e-01 | 8.64e-01 |
| GOBP NEURON FATE COMMITMENT | 73 | 8.33e-02 | 1.17e-01 | 7.36e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 180 | 6.68e-03 | -1.17e-01 | 3.20e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 9 | 5.43e-01 | 1.17e-01 | 9.49e-01 |
| GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY | 5 | 6.50e-01 | -1.17e-01 | 9.64e-01 |
| GOCC BASEMENT MEMBRANE | 85 | 6.19e-02 | -1.17e-01 | 6.63e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 269 | 9.42e-04 | 1.17e-01 | 1.15e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 18 | 3.90e-01 | -1.17e-01 | 9.15e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 2.52e-01 | 1.17e-01 | 8.65e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 27 | 2.92e-01 | 1.17e-01 | 8.79e-01 |
| GOMF MRNA 3 UTR BINDING | 230 | 2.24e-03 | -1.17e-01 | 1.83e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 13 | 4.65e-01 | 1.17e-01 | 9.38e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 46 | 1.70e-01 | -1.17e-01 | 8.32e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 15 | 4.33e-01 | -1.17e-01 | 9.27e-01 |
| GOMF GABA RECEPTOR BINDING | 18 | 3.91e-01 | 1.17e-01 | 9.15e-01 |
| GOBP GAS TRANSPORT | 22 | 3.43e-01 | -1.17e-01 | 8.96e-01 |
| GOMF DNA POLYMERASE BINDING | 22 | 3.43e-01 | -1.17e-01 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 9 | 5.44e-01 | -1.17e-01 | 9.49e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 17 | 4.04e-01 | 1.17e-01 | 9.21e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 177 | 7.36e-03 | 1.17e-01 | 3.35e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 193 | 5.18e-03 | -1.17e-01 | 2.78e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 28 | 2.85e-01 | 1.17e-01 | 8.75e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 26 | 3.03e-01 | 1.17e-01 | 8.84e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 86 | 6.17e-02 | -1.17e-01 | 6.63e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 11 | 5.03e-01 | -1.17e-01 | 9.45e-01 |
| GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT | 6 | 6.21e-01 | 1.17e-01 | 9.61e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 21 | 3.55e-01 | 1.17e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 112 | 3.33e-02 | 1.16e-01 | 5.58e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 4.67e-01 | 1.16e-01 | 9.38e-01 |
| GOBP AMYLIN RECEPTOR SIGNALING PATHWAY | 6 | 6.22e-01 | 1.16e-01 | 9.61e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 8 | 5.69e-01 | -1.16e-01 | 9.51e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 32 | 2.55e-01 | -1.16e-01 | 8.65e-01 |
| GOBP DETECTION OF STIMULUS | 571 | 2.02e-06 | -1.16e-01 | 1.38e-03 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 54 | 1.39e-01 | 1.16e-01 | 8.06e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 24 | 3.24e-01 | 1.16e-01 | 8.93e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 28 | 2.87e-01 | -1.16e-01 | 8.76e-01 |
| GOCC GINS COMPLEX | 5 | 6.53e-01 | -1.16e-01 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 26 | 3.05e-01 | 1.16e-01 | 8.84e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 5.46e-01 | 1.16e-01 | 9.49e-01 |
| GOBP SOMATIC MOTOR NEURON DIFFERENTIATION | 5 | 6.53e-01 | 1.16e-01 | 9.64e-01 |
| GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY | 5 | 6.53e-01 | -1.16e-01 | 9.64e-01 |
| GOBP REGULATION OF GASTRULATION | 16 | 4.21e-01 | 1.16e-01 | 9.24e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 36 | 2.28e-01 | 1.16e-01 | 8.62e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 5.95e-01 | -1.16e-01 | 9.54e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 99 | 4.60e-02 | -1.16e-01 | 6.22e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 12 | 4.87e-01 | 1.16e-01 | 9.43e-01 |
| GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 5 | 6.54e-01 | 1.16e-01 | 9.64e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 9 | 5.47e-01 | -1.16e-01 | 9.49e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 27 | 2.98e-01 | 1.16e-01 | 8.82e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 4.23e-01 | 1.16e-01 | 9.24e-01 |
| GOBP SEQUESTERING OF METAL ION | 10 | 5.26e-01 | -1.16e-01 | 9.47e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 295 | 6.32e-04 | -1.16e-01 | 9.11e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 25 | 3.17e-01 | -1.16e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 9 | 5.48e-01 | -1.16e-01 | 9.49e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 67 | 1.02e-01 | 1.16e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 4.54e-01 | -1.16e-01 | 9.36e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 6.55e-01 | -1.16e-01 | 9.65e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 128 | 2.40e-02 | 1.15e-01 | 5.17e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 4.10e-01 | -1.15e-01 | 9.21e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 7 | 5.97e-01 | -1.15e-01 | 9.55e-01 |
| GOMF DELTA CATENIN BINDING | 9 | 5.49e-01 | -1.15e-01 | 9.49e-01 |
| GOBP SNRNA MODIFICATION | 6 | 6.25e-01 | 1.15e-01 | 9.61e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 5.72e-01 | -1.15e-01 | 9.51e-01 |
| GOBP ATP TRANSPORT | 17 | 4.10e-01 | 1.15e-01 | 9.21e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 4.10e-01 | 1.15e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 3.97e-01 | -1.15e-01 | 9.18e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 18 | 3.97e-01 | 1.15e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 8 | 5.73e-01 | -1.15e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 39 | 2.13e-01 | -1.15e-01 | 8.54e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 6 | 6.25e-01 | -1.15e-01 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 16 | 4.26e-01 | -1.15e-01 | 9.26e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 16 | 4.26e-01 | -1.15e-01 | 9.26e-01 |
| GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION | 8 | 5.73e-01 | 1.15e-01 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 51 | 1.55e-01 | -1.15e-01 | 8.17e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 180 | 7.81e-03 | 1.15e-01 | 3.43e-01 |
| GOBP REGULATION OF SARCOMERE ORGANIZATION | 9 | 5.51e-01 | 1.15e-01 | 9.49e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 70 | 9.65e-02 | -1.15e-01 | 7.66e-01 |
| GOCC CENTRIOLE | 151 | 1.48e-02 | 1.15e-01 | 4.61e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 50 | 1.60e-01 | 1.15e-01 | 8.20e-01 |
| GOBP TRANSPOSITION | 38 | 2.21e-01 | -1.15e-01 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 23 | 3.41e-01 | -1.15e-01 | 8.96e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 45 | 1.83e-01 | 1.15e-01 | 8.42e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 27 | 3.02e-01 | -1.15e-01 | 8.84e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 23 | 3.41e-01 | -1.15e-01 | 8.96e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 29 | 2.86e-01 | -1.15e-01 | 8.75e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 5.75e-01 | -1.14e-01 | 9.51e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 6.00e-01 | 1.14e-01 | 9.55e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 19 | 3.88e-01 | 1.14e-01 | 9.14e-01 |
| GOBP RESPONSE TO AMINE | 45 | 1.84e-01 | 1.14e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 8 | 5.75e-01 | 1.14e-01 | 9.51e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 117 | 3.25e-02 | -1.14e-01 | 5.58e-01 |
| GOMF MANNOSE BINDING | 24 | 3.32e-01 | -1.14e-01 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 21 | 3.64e-01 | -1.14e-01 | 9.06e-01 |
| GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW | 8 | 5.75e-01 | -1.14e-01 | 9.51e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 5.75e-01 | 1.14e-01 | 9.51e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 10 | 5.31e-01 | 1.14e-01 | 9.48e-01 |
| GOBP MEMBRANE REPOLARIZATION | 52 | 1.54e-01 | -1.14e-01 | 8.17e-01 |
| GOMF SNORNA BINDING | 31 | 2.71e-01 | 1.14e-01 | 8.69e-01 |
| GOCC SPERM HEAD PLASMA MEMBRANE | 6 | 6.28e-01 | 1.14e-01 | 9.61e-01 |
| GOBP RESPONSE TO ESTRADIOL | 109 | 3.95e-02 | 1.14e-01 | 6.03e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 27 | 3.05e-01 | -1.14e-01 | 8.84e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 21 | 3.65e-01 | 1.14e-01 | 9.06e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 24 | 3.33e-01 | 1.14e-01 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 15 | 4.44e-01 | 1.14e-01 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 46 | 1.81e-01 | -1.14e-01 | 8.41e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 15 | 4.45e-01 | -1.14e-01 | 9.30e-01 |
| GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 6 | 6.29e-01 | -1.14e-01 | 9.61e-01 |
| GOCC OUTER KINETOCHORE | 20 | 3.77e-01 | 1.14e-01 | 9.09e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 93 | 5.74e-02 | -1.14e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 3.66e-01 | -1.14e-01 | 9.06e-01 |
| GOBP FUCOSYLATION | 17 | 4.16e-01 | -1.14e-01 | 9.23e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 5.54e-01 | 1.14e-01 | 9.49e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 37 | 2.31e-01 | -1.14e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 52 | 1.55e-01 | -1.14e-01 | 8.17e-01 |
| GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS | 5 | 6.59e-01 | -1.14e-01 | 9.66e-01 |
| GOCC MYELIN SHEATH ADAXONAL REGION | 6 | 6.29e-01 | 1.14e-01 | 9.61e-01 |
| GOMF STEROL BINDING | 61 | 1.24e-01 | -1.14e-01 | 7.93e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 5.77e-01 | 1.14e-01 | 9.52e-01 |
| GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY | 5 | 6.60e-01 | 1.14e-01 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 65 | 1.13e-01 | -1.14e-01 | 7.80e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 6.60e-01 | -1.14e-01 | 9.66e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 6.30e-01 | 1.14e-01 | 9.61e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 7 | 6.03e-01 | 1.14e-01 | 9.55e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 6.60e-01 | 1.14e-01 | 9.66e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 15 | 4.47e-01 | 1.14e-01 | 9.31e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 5.34e-01 | -1.13e-01 | 9.49e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 29 | 2.90e-01 | -1.13e-01 | 8.78e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 13 | 4.79e-01 | 1.13e-01 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 7 | 6.03e-01 | -1.13e-01 | 9.55e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 53 | 1.53e-01 | -1.13e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 15 | 4.47e-01 | 1.13e-01 | 9.31e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 119 | 3.26e-02 | 1.13e-01 | 5.58e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 12 | 4.97e-01 | -1.13e-01 | 9.45e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 102 | 4.80e-02 | -1.13e-01 | 6.27e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 47 | 1.79e-01 | -1.13e-01 | 8.41e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 2.91e-01 | 1.13e-01 | 8.79e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 45 | 1.89e-01 | 1.13e-01 | 8.44e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 6.61e-01 | 1.13e-01 | 9.66e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 13 | 4.80e-01 | -1.13e-01 | 9.42e-01 |
| GOCC SMAD PROTEIN COMPLEX | 9 | 5.57e-01 | 1.13e-01 | 9.49e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 8 | 5.80e-01 | 1.13e-01 | 9.53e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 5.36e-01 | -1.13e-01 | 9.49e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 24 | 3.38e-01 | 1.13e-01 | 8.96e-01 |
| GOBP UREA CYCLE | 10 | 5.36e-01 | -1.13e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 10 | 5.36e-01 | 1.13e-01 | 9.49e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 21 | 3.71e-01 | 1.13e-01 | 9.09e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 12 | 4.98e-01 | -1.13e-01 | 9.45e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 125 | 2.93e-02 | -1.13e-01 | 5.52e-01 |
| GOCC DENDRITIC GROWTH CONE | 8 | 5.80e-01 | 1.13e-01 | 9.53e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 6.32e-01 | -1.13e-01 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 25 | 3.29e-01 | -1.13e-01 | 8.93e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 14 | 4.65e-01 | 1.13e-01 | 9.38e-01 |
| GOBP CELL PROLIFERATION IN MIDBRAIN | 8 | 5.81e-01 | -1.13e-01 | 9.53e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 12 | 4.99e-01 | -1.13e-01 | 9.45e-01 |
| GOBP MRNA MODIFICATION | 31 | 2.77e-01 | 1.13e-01 | 8.70e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 128 | 2.77e-02 | 1.13e-01 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 33 | 2.63e-01 | -1.13e-01 | 8.68e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 6.06e-01 | 1.13e-01 | 9.55e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 42 | 2.07e-01 | -1.13e-01 | 8.51e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 6.06e-01 | 1.13e-01 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 5 | 6.63e-01 | -1.12e-01 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC | 6 | 6.33e-01 | -1.12e-01 | 9.61e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 63 | 1.23e-01 | -1.12e-01 | 7.89e-01 |
| GOMF CADMIUM ION BINDING | 5 | 6.63e-01 | -1.12e-01 | 9.67e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 13 | 4.83e-01 | -1.12e-01 | 9.43e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 22 | 3.61e-01 | 1.12e-01 | 9.05e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 6.07e-01 | 1.12e-01 | 9.55e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 55 | 1.49e-01 | 1.12e-01 | 8.13e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 25 | 3.31e-01 | 1.12e-01 | 8.93e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 6 | 6.34e-01 | -1.12e-01 | 9.61e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 13 | 4.83e-01 | 1.12e-01 | 9.43e-01 |
| GOBP POLYAMINE TRANSPORT | 16 | 4.37e-01 | 1.12e-01 | 9.28e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 31 | 2.79e-01 | -1.12e-01 | 8.71e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 11 | 5.19e-01 | -1.12e-01 | 9.47e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 11 | 5.20e-01 | 1.12e-01 | 9.47e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 35 | 2.51e-01 | 1.12e-01 | 8.65e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 13 | 4.84e-01 | 1.12e-01 | 9.43e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 18 | 4.10e-01 | 1.12e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 11 | 5.20e-01 | -1.12e-01 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 27 | 3.13e-01 | -1.12e-01 | 8.90e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 50 | 1.70e-01 | -1.12e-01 | 8.32e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 7 | 6.08e-01 | 1.12e-01 | 9.56e-01 |
| GOBP RESPONSE TO AXON INJURY | 79 | 8.53e-02 | -1.12e-01 | 7.43e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 6 | 6.35e-01 | -1.12e-01 | 9.61e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 18 | 4.11e-01 | -1.12e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 6 | 6.35e-01 | -1.12e-01 | 9.61e-01 |
| GOBP MYELOID DENDRITIC CELL CHEMOTAXIS | 5 | 6.65e-01 | -1.12e-01 | 9.67e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 36 | 2.45e-01 | -1.12e-01 | 8.65e-01 |
| GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 6.35e-01 | -1.12e-01 | 9.61e-01 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 7 | 6.08e-01 | 1.12e-01 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 27 | 3.15e-01 | -1.12e-01 | 8.90e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 11 | 5.21e-01 | 1.12e-01 | 9.47e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 34 | 2.59e-01 | -1.12e-01 | 8.66e-01 |
| GOBP NEPHRON TUBULE FORMATION | 20 | 3.87e-01 | 1.12e-01 | 9.14e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 38 | 2.33e-01 | -1.12e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 28 | 3.06e-01 | -1.12e-01 | 8.85e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 24 | 3.43e-01 | -1.12e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 26 | 3.24e-01 | -1.12e-01 | 8.93e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 21 | 3.76e-01 | -1.12e-01 | 9.09e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 15 | 4.54e-01 | 1.12e-01 | 9.36e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 55 | 1.52e-01 | -1.12e-01 | 8.17e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 11 | 5.22e-01 | 1.12e-01 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 9 | 5.62e-01 | -1.12e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 31 | 2.82e-01 | -1.12e-01 | 8.73e-01 |
| GOCC SECRETORY GRANULE | 855 | 3.04e-08 | -1.12e-01 | 8.45e-05 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 25 | 3.35e-01 | -1.11e-01 | 8.96e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 30 | 2.91e-01 | -1.11e-01 | 8.78e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 26 | 3.25e-01 | 1.11e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 6.66e-01 | -1.11e-01 | 9.67e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 73 | 1.00e-01 | -1.11e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 21 | 3.77e-01 | -1.11e-01 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 16 | 4.41e-01 | 1.11e-01 | 9.29e-01 |
| GOMF NEUROTROPHIN RECEPTOR ACTIVITY | 5 | 6.67e-01 | 1.11e-01 | 9.67e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 10 | 5.43e-01 | 1.11e-01 | 9.49e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 17 | 4.28e-01 | 1.11e-01 | 9.27e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 8 | 5.86e-01 | -1.11e-01 | 9.54e-01 |
| GOBP RESPONSE TO ZINC ION | 48 | 1.83e-01 | -1.11e-01 | 8.42e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 38 | 2.36e-01 | 1.11e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 29 | 3.01e-01 | 1.11e-01 | 8.84e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 4.15e-01 | 1.11e-01 | 9.23e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 21 | 3.79e-01 | 1.11e-01 | 9.09e-01 |
| GOMF GPI ANCHOR BINDING | 7 | 6.11e-01 | 1.11e-01 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 8 | 5.87e-01 | -1.11e-01 | 9.54e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 8 | 5.87e-01 | -1.11e-01 | 9.54e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 25 | 3.37e-01 | -1.11e-01 | 8.96e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 26 | 3.28e-01 | -1.11e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 18 | 4.16e-01 | 1.11e-01 | 9.23e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.68e-01 | 1.11e-01 | 9.67e-01 |
| GOBP DNA DEALKYLATION | 37 | 2.43e-01 | 1.11e-01 | 8.64e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 6.12e-01 | 1.11e-01 | 9.59e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 5.06e-01 | -1.11e-01 | 9.45e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 5.25e-01 | -1.11e-01 | 9.47e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 11 | 5.25e-01 | 1.11e-01 | 9.47e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 26 | 3.29e-01 | 1.11e-01 | 8.93e-01 |
| GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING | 6 | 6.39e-01 | 1.11e-01 | 9.62e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 331 | 5.41e-04 | -1.11e-01 | 8.14e-02 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 3.59e-01 | 1.11e-01 | 9.03e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 6.12e-01 | -1.11e-01 | 9.59e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 10 | 5.45e-01 | 1.11e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 5 | 6.69e-01 | 1.11e-01 | 9.67e-01 |
| GOBP GANGLION DEVELOPMENT | 17 | 4.30e-01 | 1.10e-01 | 9.27e-01 |
| GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY | 6 | 6.39e-01 | 1.10e-01 | 9.62e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 17 | 4.31e-01 | -1.10e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 192 | 8.33e-03 | -1.10e-01 | 3.53e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 54 | 1.61e-01 | 1.10e-01 | 8.21e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 5.27e-01 | -1.10e-01 | 9.47e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 6.69e-01 | 1.10e-01 | 9.67e-01 |
| GOCC MEIOTIC SPINDLE | 15 | 4.60e-01 | -1.10e-01 | 9.37e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 56 | 1.54e-01 | -1.10e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 16 | 4.45e-01 | 1.10e-01 | 9.31e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 4.92e-01 | 1.10e-01 | 9.45e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 10 | 5.47e-01 | -1.10e-01 | 9.49e-01 |
| GOBP MOTOR BEHAVIOR | 22 | 3.71e-01 | 1.10e-01 | 9.09e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 150 | 2.00e-02 | 1.10e-01 | 4.91e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 13 | 4.92e-01 | -1.10e-01 | 9.45e-01 |
| GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION | 9 | 5.68e-01 | 1.10e-01 | 9.51e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 15 | 4.61e-01 | -1.10e-01 | 9.37e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 38 | 2.41e-01 | 1.10e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 6.41e-01 | 1.10e-01 | 9.62e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 37 | 2.47e-01 | -1.10e-01 | 8.65e-01 |
| GOBP MEMBRANE DOCKING | 91 | 7.01e-02 | -1.10e-01 | 6.96e-01 |
| GOMF ALCOHOL BINDING | 87 | 7.66e-02 | -1.10e-01 | 7.18e-01 |
| GOBP CELL RECOGNITION | 152 | 1.94e-02 | -1.10e-01 | 4.91e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 5.28e-01 | -1.10e-01 | 9.48e-01 |
| GOBP TERPENOID CATABOLIC PROCESS | 8 | 5.91e-01 | 1.10e-01 | 9.54e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 104 | 5.33e-02 | 1.10e-01 | 6.45e-01 |
| GOBP ER TO GOLGI CERAMIDE TRANSPORT | 5 | 6.71e-01 | -1.10e-01 | 9.68e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 54 | 1.64e-01 | -1.10e-01 | 8.24e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 22 | 3.74e-01 | 1.10e-01 | 9.09e-01 |
| GOCC BRAHMA COMPLEX | 14 | 4.78e-01 | 1.10e-01 | 9.42e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 64 | 1.30e-01 | 1.10e-01 | 7.93e-01 |
| GOBP MIRNA PROCESSING | 45 | 2.04e-01 | 1.10e-01 | 8.51e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 4.78e-01 | -1.09e-01 | 9.42e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 4.35e-01 | 1.09e-01 | 9.27e-01 |
| GOCC SECRETORY VESICLE | 1019 | 3.42e-09 | -1.09e-01 | 3.50e-05 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 18 | 4.22e-01 | -1.09e-01 | 9.24e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 42 | 2.20e-01 | 1.09e-01 | 8.56e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 45 | 2.04e-01 | -1.09e-01 | 8.51e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 5.92e-01 | 1.09e-01 | 9.54e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 83 | 8.49e-02 | -1.09e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 5.12e-01 | -1.09e-01 | 9.46e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 6 | 6.43e-01 | -1.09e-01 | 9.63e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 10 | 5.49e-01 | 1.09e-01 | 9.49e-01 |
| GOBP PRESYNAPTIC MEMBRANE ORGANIZATION | 6 | 6.43e-01 | -1.09e-01 | 9.63e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 50 | 1.81e-01 | -1.09e-01 | 8.41e-01 |
| GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY | 16 | 4.49e-01 | 1.09e-01 | 9.33e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 165 | 1.54e-02 | -1.09e-01 | 4.61e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 38 | 2.44e-01 | 1.09e-01 | 8.64e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 17 | 4.36e-01 | -1.09e-01 | 9.27e-01 |
| GOMF HYALURONIC ACID BINDING | 24 | 3.54e-01 | -1.09e-01 | 9.01e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 6.43e-01 | 1.09e-01 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 61 | 1.40e-01 | -1.09e-01 | 8.06e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 5.13e-01 | -1.09e-01 | 9.46e-01 |
| GOBP HISTONE H4 ACETYLATION | 11 | 5.31e-01 | 1.09e-01 | 9.48e-01 |
| GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 10 | 5.50e-01 | 1.09e-01 | 9.49e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 49 | 1.87e-01 | -1.09e-01 | 8.44e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 18 | 4.23e-01 | -1.09e-01 | 9.24e-01 |
| GOBP REGULATION OF METANEPHROS DEVELOPMENT | 5 | 6.73e-01 | -1.09e-01 | 9.68e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 6.44e-01 | 1.09e-01 | 9.63e-01 |
| GOBP PROTEIN SULFATION | 6 | 6.44e-01 | 1.09e-01 | 9.63e-01 |
| GOBP STOMACH DEVELOPMENT | 5 | 6.73e-01 | 1.09e-01 | 9.68e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 39 | 2.39e-01 | -1.09e-01 | 8.64e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 5.51e-01 | -1.09e-01 | 9.49e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 1.55e-01 | 1.09e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 92 | 7.11e-02 | 1.09e-01 | 6.99e-01 |
| GOBP PYROPTOSIS | 36 | 2.58e-01 | -1.09e-01 | 8.65e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 8 | 5.94e-01 | 1.09e-01 | 9.54e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 5.94e-01 | -1.09e-01 | 9.54e-01 |
| GOBP OXALATE TRANSPORT | 12 | 5.14e-01 | -1.09e-01 | 9.46e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 8 | 5.94e-01 | -1.09e-01 | 9.54e-01 |
| GOBP RESPONSE TO COCAINE | 47 | 1.97e-01 | 1.09e-01 | 8.44e-01 |
| GOBP EXIT FROM MITOSIS | 31 | 2.95e-01 | 1.09e-01 | 8.82e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 29 | 3.11e-01 | -1.09e-01 | 8.89e-01 |
| GOBP VISUAL BEHAVIOR | 55 | 1.64e-01 | -1.09e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 24 | 3.57e-01 | 1.09e-01 | 9.03e-01 |
| GOCC SEX CHROMATIN | 6 | 6.45e-01 | 1.09e-01 | 9.63e-01 |
| GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING | 6 | 6.45e-01 | -1.08e-01 | 9.63e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 43 | 2.19e-01 | 1.08e-01 | 8.56e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 12 | 5.16e-01 | -1.08e-01 | 9.46e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 13 | 4.99e-01 | -1.08e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION | 5 | 6.75e-01 | 1.08e-01 | 9.68e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 18 | 4.26e-01 | -1.08e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 59 | 1.51e-01 | 1.08e-01 | 8.15e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 61 | 1.44e-01 | -1.08e-01 | 8.06e-01 |
| GOBP SISTER CHROMATID COHESION | 52 | 1.77e-01 | 1.08e-01 | 8.41e-01 |
| GOBP REGULATION OF GAP JUNCTION ASSEMBLY | 9 | 5.74e-01 | 1.08e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 22 | 3.80e-01 | -1.08e-01 | 9.10e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 18 | 4.27e-01 | -1.08e-01 | 9.27e-01 |
| GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 10 | 5.54e-01 | -1.08e-01 | 9.49e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 17 | 4.41e-01 | -1.08e-01 | 9.29e-01 |
| GOBP VESICLE DOCKING | 64 | 1.36e-01 | -1.08e-01 | 8.06e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 250 | 3.33e-03 | -1.08e-01 | 2.21e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 57 | 1.59e-01 | -1.08e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 71 | 1.16e-01 | -1.08e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 33 | 2.84e-01 | 1.08e-01 | 8.74e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 35 | 2.70e-01 | -1.08e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 40 | 2.38e-01 | 1.08e-01 | 8.64e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 93 | 7.26e-02 | -1.08e-01 | 7.06e-01 |
| GOMF FRIZZLED BINDING | 36 | 2.63e-01 | -1.08e-01 | 8.69e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 61 | 1.46e-01 | -1.08e-01 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 26 | 3.42e-01 | -1.08e-01 | 8.96e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 7 | 6.22e-01 | 1.08e-01 | 9.61e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 14 | 4.86e-01 | -1.08e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 71 | 1.17e-01 | -1.08e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 8 | 5.98e-01 | 1.08e-01 | 9.55e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 7 | 6.22e-01 | 1.08e-01 | 9.61e-01 |
| GOMF NUCLEOSIDE BINDING | 8 | 5.98e-01 | 1.08e-01 | 9.55e-01 |
| GOBP DIACYLGLYCEROL CATABOLIC PROCESS | 5 | 6.77e-01 | -1.08e-01 | 9.68e-01 |
| GOBP ELASTIN CATABOLIC PROCESS | 5 | 6.77e-01 | 1.07e-01 | 9.68e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 24 | 3.62e-01 | -1.07e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 5.37e-01 | -1.07e-01 | 9.49e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 6.49e-01 | -1.07e-01 | 9.63e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 76 | 1.05e-01 | -1.07e-01 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 10 | 5.57e-01 | -1.07e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 33 | 2.86e-01 | -1.07e-01 | 8.75e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 4.87e-01 | 1.07e-01 | 9.43e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 26 | 3.44e-01 | -1.07e-01 | 8.96e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 6.24e-01 | 1.07e-01 | 9.61e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 5.78e-01 | -1.07e-01 | 9.52e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 6.24e-01 | -1.07e-01 | 9.61e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 26 | 3.46e-01 | -1.07e-01 | 8.96e-01 |
| GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING | 9 | 5.79e-01 | 1.07e-01 | 9.53e-01 |
| GOBP SINOATRIAL NODE CELL DIFFERENTIATION | 6 | 6.50e-01 | -1.07e-01 | 9.64e-01 |
| GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION | 5 | 6.79e-01 | 1.07e-01 | 9.68e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 44 | 2.21e-01 | -1.07e-01 | 8.56e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 507 | 3.90e-05 | -1.07e-01 | 1.33e-02 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 44 | 2.21e-01 | 1.07e-01 | 8.56e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 16 | 4.60e-01 | -1.07e-01 | 9.37e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 191 | 1.10e-02 | -1.07e-01 | 3.96e-01 |
| GOBP REGULATION OF FEVER GENERATION | 9 | 5.80e-01 | 1.07e-01 | 9.53e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 57 | 1.64e-01 | -1.07e-01 | 8.24e-01 |
| GOBP GLIAL CELL PROLIFERATION | 53 | 1.79e-01 | 1.07e-01 | 8.41e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT | 5 | 6.80e-01 | -1.07e-01 | 9.68e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 5.60e-01 | 1.07e-01 | 9.49e-01 |
| GOBP RESPONSE TO MANGANESE ION | 17 | 4.47e-01 | -1.07e-01 | 9.31e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 31 | 3.05e-01 | -1.06e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 124 | 4.06e-02 | 1.06e-01 | 6.08e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 13 | 5.07e-01 | -1.06e-01 | 9.45e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 6.81e-01 | 1.06e-01 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 41 | 2.39e-01 | -1.06e-01 | 8.64e-01 |
| GOBP ECTODERM DEVELOPMENT | 21 | 3.99e-01 | 1.06e-01 | 9.18e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 82 | 9.61e-02 | -1.06e-01 | 7.66e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 15 | 4.76e-01 | -1.06e-01 | 9.41e-01 |
| GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE | 6 | 6.52e-01 | -1.06e-01 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 7 | 6.26e-01 | 1.06e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 33 | 2.91e-01 | -1.06e-01 | 8.78e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 14 | 4.92e-01 | 1.06e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 22 | 3.89e-01 | -1.06e-01 | 9.15e-01 |
| GOBP PODOSOME ASSEMBLY | 19 | 4.23e-01 | -1.06e-01 | 9.24e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 190 | 1.17e-02 | -1.06e-01 | 4.10e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 26 | 3.49e-01 | 1.06e-01 | 8.99e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 6.27e-01 | 1.06e-01 | 9.61e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 29 | 3.23e-01 | -1.06e-01 | 8.92e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 18 | 4.36e-01 | -1.06e-01 | 9.27e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 5.25e-01 | 1.06e-01 | 9.47e-01 |
| GOBP REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY | 7 | 6.27e-01 | 1.06e-01 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 6.27e-01 | 1.06e-01 | 9.61e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 16 | 4.63e-01 | 1.06e-01 | 9.37e-01 |
| GOMF HORMONE BINDING | 83 | 9.53e-02 | -1.06e-01 | 7.66e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 21 | 4.01e-01 | 1.06e-01 | 9.18e-01 |
| GOBP CHOLESTEROL EFFLUX | 73 | 1.18e-01 | -1.06e-01 | 7.82e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 1.56e-01 | 1.06e-01 | 8.17e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 30 | 3.16e-01 | 1.06e-01 | 8.91e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 14 | 4.93e-01 | 1.06e-01 | 9.45e-01 |
| GOCC EXOCYTIC VESICLE | 222 | 6.62e-03 | -1.06e-01 | 3.19e-01 |
| GOBP GLYCINE BIOSYNTHETIC PROCESS | 7 | 6.28e-01 | -1.06e-01 | 9.61e-01 |
| GOBP TRNA MODIFICATION | 87 | 8.83e-02 | 1.06e-01 | 7.52e-01 |
| GOBP REGULATION OF CELL KILLING | 110 | 5.55e-02 | -1.06e-01 | 6.51e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 24 | 3.70e-01 | 1.06e-01 | 9.09e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 10 | 5.63e-01 | 1.06e-01 | 9.49e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 52 | 1.88e-01 | -1.06e-01 | 8.44e-01 |
| GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION | 5 | 6.83e-01 | -1.06e-01 | 9.68e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 7 | 6.29e-01 | -1.06e-01 | 9.61e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 6.29e-01 | 1.06e-01 | 9.61e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 6.54e-01 | 1.06e-01 | 9.64e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 42 | 2.37e-01 | -1.06e-01 | 8.64e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 6.83e-01 | 1.06e-01 | 9.68e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 130 | 3.77e-02 | 1.06e-01 | 5.88e-01 |
| GOMF HEPARIN BINDING | 169 | 1.79e-02 | -1.06e-01 | 4.77e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 20 | 4.14e-01 | -1.05e-01 | 9.23e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 40 | 2.49e-01 | 1.05e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.10e-01 | -1.05e-01 | 8.87e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 7 | 6.29e-01 | 1.05e-01 | 9.61e-01 |
| GOMF MYOSIN II BINDING | 12 | 5.28e-01 | -1.05e-01 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 27 | 3.44e-01 | -1.05e-01 | 8.96e-01 |
| GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 12 | 5.28e-01 | -1.05e-01 | 9.48e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 12 | 5.28e-01 | -1.05e-01 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 5.12e-01 | 1.05e-01 | 9.46e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 5.12e-01 | 1.05e-01 | 9.46e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 2.75e-01 | -1.05e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION | 8 | 6.07e-01 | 1.05e-01 | 9.55e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 15 | 4.81e-01 | 1.05e-01 | 9.42e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 39 | 2.56e-01 | 1.05e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 51 | 1.94e-01 | 1.05e-01 | 8.44e-01 |
| GOBP INNERVATION | 26 | 3.54e-01 | -1.05e-01 | 9.01e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 7 | 6.31e-01 | -1.05e-01 | 9.61e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 6.85e-01 | 1.05e-01 | 9.68e-01 |
| GOBP SEGMENT SPECIFICATION | 16 | 4.68e-01 | 1.05e-01 | 9.39e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 10 | 5.66e-01 | -1.05e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 8 | 6.08e-01 | -1.05e-01 | 9.56e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 20 | 4.17e-01 | -1.05e-01 | 9.23e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 15 | 4.82e-01 | -1.05e-01 | 9.43e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 5.86e-01 | 1.05e-01 | 9.54e-01 |
| GOBP TRANSLESION SYNTHESIS | 25 | 3.65e-01 | 1.05e-01 | 9.06e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.85e-01 | -1.05e-01 | 9.68e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 13 | 5.14e-01 | -1.05e-01 | 9.46e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 9 | 5.87e-01 | 1.05e-01 | 9.54e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 24 | 3.75e-01 | -1.05e-01 | 9.09e-01 |
| GOBP AMELOGENESIS | 24 | 3.76e-01 | -1.04e-01 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 38 | 2.65e-01 | 1.04e-01 | 8.69e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 22 | 3.96e-01 | -1.04e-01 | 9.18e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 6.58e-01 | -1.04e-01 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 24 | 3.76e-01 | 1.04e-01 | 9.09e-01 |
| GOBP DNA LIGATION | 16 | 4.70e-01 | 1.04e-01 | 9.39e-01 |
| GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING | 5 | 6.86e-01 | 1.04e-01 | 9.68e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 38 | 2.66e-01 | 1.04e-01 | 8.69e-01 |
| GOBP PH REDUCTION | 6 | 6.58e-01 | -1.04e-01 | 9.66e-01 |
| GOMF BMP RECEPTOR ACTIVITY | 7 | 6.33e-01 | -1.04e-01 | 9.61e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 7 | 6.33e-01 | -1.04e-01 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 18 | 4.44e-01 | -1.04e-01 | 9.30e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 221 | 7.59e-03 | 1.04e-01 | 3.39e-01 |
| GOBP CGMP MEDIATED SIGNALING | 30 | 3.23e-01 | 1.04e-01 | 8.92e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 2.03e-01 | 1.04e-01 | 8.51e-01 |
| GOCC CALCITONIN FAMILY RECEPTOR COMPLEX | 5 | 6.87e-01 | -1.04e-01 | 9.68e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 20 | 4.20e-01 | 1.04e-01 | 9.24e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 9 | 5.89e-01 | 1.04e-01 | 9.54e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 15 | 4.85e-01 | 1.04e-01 | 9.43e-01 |
| GOBP MUSCULAR SEPTUM MORPHOGENESIS | 5 | 6.87e-01 | 1.04e-01 | 9.68e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 39 | 2.61e-01 | 1.04e-01 | 8.66e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 7 | 6.34e-01 | -1.04e-01 | 9.61e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 6.34e-01 | -1.04e-01 | 9.61e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 17 | 4.58e-01 | 1.04e-01 | 9.37e-01 |
| GOBP TAXIS | 442 | 1.80e-04 | -1.04e-01 | 3.87e-02 |
| GOCC FEMALE GERM CELL NUCLEUS | 17 | 4.58e-01 | -1.04e-01 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 43 | 2.38e-01 | -1.04e-01 | 8.64e-01 |
| GOBP LIPID OXIDATION | 112 | 5.76e-02 | 1.04e-01 | 6.57e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 16 | 4.72e-01 | -1.04e-01 | 9.39e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 60 | 1.64e-01 | 1.04e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 19 | 4.33e-01 | 1.04e-01 | 9.27e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 10 | 5.70e-01 | -1.04e-01 | 9.51e-01 |
| GOBP RRNA BASE METHYLATION | 9 | 5.90e-01 | 1.04e-01 | 9.54e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 10 | 5.70e-01 | 1.04e-01 | 9.51e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION | 11 | 5.51e-01 | 1.04e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 28 | 3.43e-01 | 1.04e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 6.12e-01 | 1.04e-01 | 9.59e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 6 | 6.61e-01 | -1.04e-01 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 15 | 4.88e-01 | -1.04e-01 | 9.43e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 16 | 4.74e-01 | 1.03e-01 | 9.41e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 36 | 2.83e-01 | -1.03e-01 | 8.73e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 236 | 6.19e-03 | -1.03e-01 | 3.02e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 38 | 2.70e-01 | 1.03e-01 | 8.69e-01 |
| GOBP OOCYTE MATURATION | 33 | 3.04e-01 | 1.03e-01 | 8.84e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 18 | 4.48e-01 | -1.03e-01 | 9.31e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 6 | 6.61e-01 | 1.03e-01 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 11 | 5.54e-01 | 1.03e-01 | 9.49e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 49 | 2.12e-01 | 1.03e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 104 | 6.94e-02 | 1.03e-01 | 6.94e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 29 | 3.37e-01 | -1.03e-01 | 8.96e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 5.54e-01 | 1.03e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 35 | 2.92e-01 | -1.03e-01 | 8.79e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 22 | 4.03e-01 | -1.03e-01 | 9.20e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 35 | 2.92e-01 | -1.03e-01 | 8.79e-01 |
| GOBP L AMINO ACID TRANSPORT | 84 | 1.03e-01 | -1.03e-01 | 7.67e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 5 | 6.90e-01 | -1.03e-01 | 9.69e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 15 | 4.91e-01 | 1.03e-01 | 9.45e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 25 | 3.74e-01 | 1.03e-01 | 9.09e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 9 | 5.94e-01 | -1.03e-01 | 9.54e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 291 | 2.57e-03 | 1.03e-01 | 1.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 90 | 9.23e-02 | 1.03e-01 | 7.58e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 97 | 8.07e-02 | 1.03e-01 | 7.26e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 59 | 1.73e-01 | 1.03e-01 | 8.36e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 2.34e-01 | -1.03e-01 | 8.64e-01 |
| GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION | 12 | 5.38e-01 | -1.03e-01 | 9.49e-01 |
| GOBP REGULATION OF TOOTH MINERALIZATION | 10 | 5.74e-01 | -1.03e-01 | 9.51e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 88 | 9.64e-02 | 1.03e-01 | 7.66e-01 |
| GOCC COPI COATED VESICLE | 25 | 3.75e-01 | 1.02e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 6.64e-01 | 1.02e-01 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF CILIUM MOVEMENT | 11 | 5.56e-01 | -1.02e-01 | 9.49e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 34 | 3.01e-01 | 1.02e-01 | 8.84e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 81 | 1.11e-01 | 1.02e-01 | 7.77e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 13 | 5.23e-01 | -1.02e-01 | 9.47e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 11 | 5.56e-01 | -1.02e-01 | 9.49e-01 |
| GOMF MAP KINASE ACTIVITY | 16 | 4.78e-01 | 1.02e-01 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 3.24e-01 | 1.02e-01 | 8.93e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 6 | 6.64e-01 | -1.02e-01 | 9.67e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 27 | 3.58e-01 | -1.02e-01 | 9.03e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 10 | 5.75e-01 | -1.02e-01 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 15 | 4.93e-01 | 1.02e-01 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 121 | 5.21e-02 | 1.02e-01 | 6.43e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 27 | 3.58e-01 | -1.02e-01 | 9.03e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 31 | 3.25e-01 | 1.02e-01 | 8.93e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 59 | 1.75e-01 | -1.02e-01 | 8.39e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 20 | 4.29e-01 | -1.02e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 39 | 2.70e-01 | -1.02e-01 | 8.69e-01 |
| GOBP INORGANIC ANION TRANSPORT | 162 | 2.49e-02 | -1.02e-01 | 5.20e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 272 | 3.75e-03 | -1.02e-01 | 2.32e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 6 | 6.65e-01 | -1.02e-01 | 9.67e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 38 | 2.76e-01 | -1.02e-01 | 8.70e-01 |
| GOMF ARYLESTERASE ACTIVITY | 6 | 6.65e-01 | 1.02e-01 | 9.67e-01 |
| GOMF RNA POLYMERASE BINDING | 57 | 1.83e-01 | 1.02e-01 | 8.42e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 45 | 2.37e-01 | -1.02e-01 | 8.64e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 23 | 3.97e-01 | -1.02e-01 | 9.18e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING | 6 | 6.66e-01 | -1.02e-01 | 9.67e-01 |
| GOBP FORMATION OF ANATOMICAL BOUNDARY | 7 | 6.41e-01 | 1.02e-01 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 14 | 5.10e-01 | -1.02e-01 | 9.46e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 28 | 3.51e-01 | -1.02e-01 | 9.00e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 11 | 5.59e-01 | 1.02e-01 | 9.49e-01 |
| GOBP CARDIAC VENTRICLE FORMATION | 8 | 6.18e-01 | 1.02e-01 | 9.61e-01 |
| GOBP CHLORIDE TRANSPORT | 116 | 5.84e-02 | -1.02e-01 | 6.58e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 19 | 4.43e-01 | 1.02e-01 | 9.30e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 42 | 2.54e-01 | 1.02e-01 | 8.65e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 11 | 5.60e-01 | 1.02e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 27 | 3.61e-01 | -1.02e-01 | 9.04e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 44 | 2.44e-01 | -1.02e-01 | 8.64e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 13 | 5.26e-01 | 1.01e-01 | 9.47e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 12 | 5.43e-01 | -1.01e-01 | 9.49e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 31 | 3.28e-01 | -1.01e-01 | 8.93e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 604 | 2.07e-05 | -1.01e-01 | 7.55e-03 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 5.98e-01 | -1.01e-01 | 9.55e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 49 | 2.20e-01 | -1.01e-01 | 8.56e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 34 | 3.07e-01 | 1.01e-01 | 8.85e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 10 | 5.79e-01 | 1.01e-01 | 9.53e-01 |
| GOBP INTERNEURON MIGRATION | 14 | 5.12e-01 | 1.01e-01 | 9.46e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 204 | 1.27e-02 | 1.01e-01 | 4.32e-01 |
| GOMF PROTEASOME BINDING | 17 | 4.70e-01 | -1.01e-01 | 9.39e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 56 | 1.91e-01 | 1.01e-01 | 8.44e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 29 | 3.46e-01 | 1.01e-01 | 8.96e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 6.00e-01 | -1.01e-01 | 9.55e-01 |
| GOCC CYTOCHROME COMPLEX | 34 | 3.08e-01 | 1.01e-01 | 8.86e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 24 | 3.91e-01 | -1.01e-01 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 12 | 5.45e-01 | -1.01e-01 | 9.49e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 34 | 3.08e-01 | -1.01e-01 | 8.87e-01 |
| GOMF BH DOMAIN BINDING | 9 | 6.00e-01 | 1.01e-01 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 34 | 3.08e-01 | -1.01e-01 | 8.87e-01 |
| GOCC CILIARY BASE | 44 | 2.47e-01 | 1.01e-01 | 8.65e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 6.69e-01 | -1.01e-01 | 9.67e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 88 | 1.02e-01 | -1.01e-01 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 8 | 6.21e-01 | -1.01e-01 | 9.61e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 173 | 2.20e-02 | -1.01e-01 | 5.05e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 71 | 1.42e-01 | 1.01e-01 | 8.06e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 3.16e-01 | 1.01e-01 | 8.91e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 5.63e-01 | -1.01e-01 | 9.49e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 16 | 4.85e-01 | 1.01e-01 | 9.43e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 27 | 3.65e-01 | -1.01e-01 | 9.06e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 46 | 2.37e-01 | -1.01e-01 | 8.64e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 6.69e-01 | 1.01e-01 | 9.67e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 13 | 5.30e-01 | -1.01e-01 | 9.48e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 18 | 4.60e-01 | 1.01e-01 | 9.37e-01 |
| GOCC SEROTONIN RECEPTOR COMPLEX | 8 | 6.22e-01 | 1.01e-01 | 9.61e-01 |
| GOCC CILIARY ROOTLET | 15 | 5.00e-01 | -1.01e-01 | 9.45e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 17 | 4.73e-01 | -1.01e-01 | 9.40e-01 |
| GOBP SALIVA SECRETION | 13 | 5.30e-01 | -1.01e-01 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 83 | 1.13e-01 | 1.01e-01 | 7.80e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 62 | 1.71e-01 | -1.00e-01 | 8.32e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 210 | 1.21e-02 | 1.00e-01 | 4.16e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 65 | 1.62e-01 | 1.00e-01 | 8.24e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 6.02e-01 | 1.00e-01 | 9.55e-01 |
| GOBP DEMETHYLATION | 51 | 2.15e-01 | 1.00e-01 | 8.56e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 10 | 5.83e-01 | 1.00e-01 | 9.54e-01 |
| GOBP RRNA METABOLIC PROCESS | 253 | 6.04e-03 | 1.00e-01 | 2.97e-01 |
| GOMF GLYCOLIPID BINDING | 28 | 3.59e-01 | -1.00e-01 | 9.03e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 1.31e-01 | 1.00e-01 | 7.94e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 33 | 3.19e-01 | -1.00e-01 | 8.92e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 17 | 4.74e-01 | -1.00e-01 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 6 | 6.71e-01 | 1.00e-01 | 9.68e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 17 | 4.75e-01 | 1.00e-01 | 9.41e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 92 | 9.70e-02 | 1.00e-01 | 7.66e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 10 | 5.84e-01 | 1.00e-01 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 16 | 4.88e-01 | -1.00e-01 | 9.43e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 32 | 3.27e-01 | 1.00e-01 | 8.93e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 102 | 8.08e-02 | 1.00e-01 | 7.26e-01 |
| GOBP REGULATION OF DNA REPAIR | 205 | 1.35e-02 | 1.00e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 28 | 3.60e-01 | -1.00e-01 | 9.04e-01 |
| GOMF CLATHRIN BINDING | 68 | 1.54e-01 | -1.00e-01 | 8.17e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 6.25e-01 | 9.99e-02 | 9.61e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 57 | 1.92e-01 | 9.98e-02 | 8.44e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 5.66e-01 | -9.98e-02 | 9.50e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 29 | 3.52e-01 | 9.98e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 11 | 5.67e-01 | 9.98e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 6.99e-01 | -9.98e-02 | 9.70e-01 |
| GOBP ASSOCIATIVE LEARNING | 84 | 1.14e-01 | -9.98e-02 | 7.81e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 13 | 5.33e-01 | -9.97e-02 | 9.49e-01 |
| GOCC CHROMOSOMAL REGION | 379 | 8.58e-04 | 9.97e-02 | 1.10e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 12 | 5.50e-01 | 9.97e-02 | 9.49e-01 |
| GOBP THYMIC T CELL SELECTION | 23 | 4.08e-01 | 9.97e-02 | 9.21e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 17 | 4.77e-01 | 9.96e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 189 | 1.82e-02 | 9.96e-02 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 107 | 7.51e-02 | 9.96e-02 | 7.15e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.05e-01 | 9.95e-02 | 9.55e-01 |
| GOBP INOSINE METABOLIC PROCESS | 5 | 7.00e-01 | 9.95e-02 | 9.70e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 8 | 6.26e-01 | -9.94e-02 | 9.61e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 285 | 3.87e-03 | -9.94e-02 | 2.36e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 5.51e-01 | -9.94e-02 | 9.49e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 132 | 4.87e-02 | -9.94e-02 | 6.28e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 73 | 1.42e-01 | -9.94e-02 | 8.06e-01 |
| GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN | 16 | 4.92e-01 | 9.93e-02 | 9.45e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 11 | 5.69e-01 | -9.93e-02 | 9.51e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 5.35e-01 | -9.93e-02 | 9.49e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 5.87e-01 | -9.93e-02 | 9.54e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 21 | 4.31e-01 | 9.93e-02 | 9.27e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.39e-01 | -9.92e-02 | 8.96e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 369 | 1.06e-03 | -9.92e-02 | 1.23e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 11 | 5.69e-01 | -9.91e-02 | 9.51e-01 |
| GOMF SODIUM ION BINDING | 8 | 6.27e-01 | -9.91e-02 | 9.61e-01 |
| GOBP URETERIC BUD ELONGATION | 8 | 6.28e-01 | 9.90e-02 | 9.61e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 5.53e-01 | 9.89e-02 | 9.49e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 54 | 2.08e-01 | -9.89e-02 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 14 | 5.22e-01 | -9.89e-02 | 9.47e-01 |
| GOMF ANTIGEN BINDING | 66 | 1.65e-01 | -9.89e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 24 | 4.02e-01 | 9.89e-02 | 9.19e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 34 | 3.18e-01 | 9.89e-02 | 8.91e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 7 | 6.51e-01 | 9.88e-02 | 9.64e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 20 | 4.44e-01 | 9.88e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 6.75e-01 | 9.88e-02 | 9.68e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 161 | 3.06e-02 | -9.88e-02 | 5.54e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 6 | 6.75e-01 | 9.88e-02 | 9.68e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 7.02e-01 | -9.87e-02 | 9.71e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 5.71e-01 | 9.87e-02 | 9.51e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 32 | 3.34e-01 | 9.87e-02 | 8.94e-01 |
| GOCC FILOPODIUM MEMBRANE | 17 | 4.81e-01 | 9.87e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 16 | 4.94e-01 | -9.87e-02 | 9.45e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 65 | 1.69e-01 | 9.86e-02 | 8.31e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 79 | 1.30e-01 | -9.86e-02 | 7.93e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 11 | 5.71e-01 | -9.86e-02 | 9.51e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 6.52e-01 | -9.85e-02 | 9.64e-01 |
| GOBP INTEGRIN ACTIVATION | 26 | 3.85e-01 | -9.85e-02 | 9.14e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 18 | 4.70e-01 | -9.85e-02 | 9.39e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 37 | 3.00e-01 | -9.85e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 6.76e-01 | -9.85e-02 | 9.68e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 26 | 3.85e-01 | -9.84e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 39 | 2.87e-01 | 9.84e-02 | 8.76e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 10 | 5.90e-01 | -9.84e-02 | 9.54e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 39 | 2.88e-01 | 9.84e-02 | 8.77e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 60 | 1.88e-01 | 9.83e-02 | 8.44e-01 |
| GOBP HEART GROWTH | 94 | 9.95e-02 | -9.83e-02 | 7.66e-01 |
| GOBP EPOXIDE METABOLIC PROCESS | 5 | 7.04e-01 | 9.83e-02 | 9.71e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 8 | 6.30e-01 | 9.82e-02 | 9.61e-01 |
| GOMF COLLAGEN RECEPTOR ACTIVITY | 5 | 7.04e-01 | -9.82e-02 | 9.71e-01 |
| GOBP MEMBRANE BIOGENESIS | 59 | 1.92e-01 | 9.82e-02 | 8.44e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 5.10e-01 | 9.82e-02 | 9.46e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 5.91e-01 | -9.81e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 5.57e-01 | 9.80e-02 | 9.49e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 90 | 1.08e-01 | 9.80e-02 | 7.73e-01 |
| GOCC PSEUDOPODIUM | 16 | 4.97e-01 | -9.80e-02 | 9.45e-01 |
| GOCC SPINDLE MICROTUBULE | 76 | 1.40e-01 | 9.79e-02 | 8.06e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 6.54e-01 | 9.79e-02 | 9.64e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 31 | 3.46e-01 | 9.79e-02 | 8.96e-01 |
| GOMF DNA BINDING BENDING | 16 | 4.98e-01 | -9.79e-02 | 9.45e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 6.54e-01 | -9.78e-02 | 9.64e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 5 | 7.05e-01 | 9.78e-02 | 9.71e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 5.12e-01 | -9.78e-02 | 9.46e-01 |
| GOBP SUCKLING BEHAVIOR | 12 | 5.58e-01 | 9.77e-02 | 9.49e-01 |
| GOCC CILIARY TIP | 45 | 2.57e-01 | 9.77e-02 | 8.65e-01 |
| GOBP LACTATION | 37 | 3.04e-01 | -9.77e-02 | 8.84e-01 |
| GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 6.79e-01 | 9.77e-02 | 9.68e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 31 | 3.47e-01 | -9.77e-02 | 8.97e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 6 | 6.79e-01 | -9.77e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 179 | 2.42e-02 | -9.77e-02 | 5.17e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 240 | 9.18e-03 | -9.76e-02 | 3.64e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 101 | 9.00e-02 | 9.76e-02 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 11 | 5.75e-01 | 9.75e-02 | 9.51e-01 |
| GOBP RESPONSE TO CADMIUM ION | 56 | 2.07e-01 | -9.75e-02 | 8.51e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 10 | 5.93e-01 | 9.75e-02 | 9.54e-01 |
| GOBP PROTEIN DE ADP RIBOSYLATION | 5 | 7.06e-01 | -9.75e-02 | 9.71e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 37 | 3.05e-01 | 9.75e-02 | 8.84e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 9 | 6.13e-01 | -9.74e-02 | 9.59e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 10 | 5.94e-01 | 9.74e-02 | 9.54e-01 |
| GOMF S100 PROTEIN BINDING | 14 | 5.28e-01 | -9.74e-02 | 9.48e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 56 | 2.07e-01 | -9.74e-02 | 8.51e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 89 | 1.12e-01 | -9.74e-02 | 7.78e-01 |
| GOBP RESPONSE TO REDOX STATE | 14 | 5.28e-01 | -9.74e-02 | 9.48e-01 |
| GOBP RESPONSE TO WATER | 13 | 5.43e-01 | 9.74e-02 | 9.49e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 33 | 3.33e-01 | 9.74e-02 | 8.94e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 6.34e-01 | -9.73e-02 | 9.61e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 72 | 1.53e-01 | -9.73e-02 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 39 | 2.93e-01 | 9.73e-02 | 8.80e-01 |
| GOBP CORTISOL BIOSYNTHETIC PROCESS | 10 | 5.94e-01 | -9.73e-02 | 9.54e-01 |
| GOBP REGULATION OF SALIVA SECRETION | 7 | 6.56e-01 | 9.73e-02 | 9.65e-01 |
| GOCC SPERMATOPROTEASOME COMPLEX | 5 | 7.06e-01 | -9.73e-02 | 9.71e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 10 | 5.94e-01 | -9.72e-02 | 9.54e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 5.01e-01 | 9.72e-02 | 9.45e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 503 | 1.90e-04 | -9.72e-02 | 3.89e-02 |
| GOBP LATERAL SPROUTING FROM AN EPITHELIUM | 10 | 5.95e-01 | 9.72e-02 | 9.54e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 4.20e-01 | 9.72e-02 | 9.24e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 6.14e-01 | 9.71e-02 | 9.59e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 5.95e-01 | 9.71e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 65 | 1.76e-01 | 9.71e-02 | 8.41e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 6 | 6.80e-01 | 9.71e-02 | 9.68e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 9 | 6.14e-01 | -9.71e-02 | 9.59e-01 |
| GOBP GLIAL CELL MIGRATION | 57 | 2.05e-01 | -9.70e-02 | 8.51e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 6.81e-01 | 9.70e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 38 | 3.01e-01 | -9.70e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 8 | 6.35e-01 | 9.69e-02 | 9.61e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 22 | 4.31e-01 | -9.69e-02 | 9.27e-01 |
| GOBP VESICLE TETHERING | 31 | 3.50e-01 | 9.69e-02 | 8.99e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 10 | 5.96e-01 | -9.69e-02 | 9.55e-01 |
| GOBP CHIASMA ASSEMBLY | 6 | 6.81e-01 | 9.68e-02 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 218 | 1.38e-02 | -9.68e-02 | 4.46e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 1.15e-01 | 9.68e-02 | 7.81e-01 |
| GOBP MAST CELL MIGRATION | 13 | 5.46e-01 | -9.68e-02 | 9.49e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 9 | 6.15e-01 | -9.68e-02 | 9.60e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 5.78e-01 | 9.68e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 6 | 6.82e-01 | 9.68e-02 | 9.68e-01 |
| GOBP LEUKOCYTE MIGRATION | 380 | 1.20e-03 | -9.67e-02 | 1.29e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 8 | 6.36e-01 | 9.67e-02 | 9.61e-01 |
| GOCC ACROSOMAL MEMBRANE | 32 | 3.44e-01 | -9.66e-02 | 8.96e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 9 | 6.16e-01 | 9.66e-02 | 9.60e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 26 | 3.94e-01 | 9.66e-02 | 9.17e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 5.63e-01 | 9.65e-02 | 9.49e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 25 | 4.04e-01 | -9.65e-02 | 9.20e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 42 | 2.79e-01 | 9.65e-02 | 8.71e-01 |
| GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT | 6 | 6.82e-01 | -9.65e-02 | 9.68e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 369 | 1.46e-03 | -9.65e-02 | 1.42e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 8 | 6.37e-01 | 9.64e-02 | 9.61e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 119 | 6.92e-02 | -9.64e-02 | 6.94e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION | 6 | 6.83e-01 | -9.64e-02 | 9.68e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 78 | 1.41e-01 | -9.64e-02 | 8.06e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 210 | 1.61e-02 | 9.64e-02 | 4.67e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 27 | 3.86e-01 | 9.63e-02 | 9.14e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 18 | 4.79e-01 | 9.63e-02 | 9.42e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 12 | 5.64e-01 | -9.62e-02 | 9.50e-01 |
| GOMF GATED CHANNEL ACTIVITY | 308 | 3.68e-03 | -9.62e-02 | 2.31e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 6.83e-01 | -9.62e-02 | 9.68e-01 |
| GOBP BONE MINERALIZATION | 116 | 7.35e-02 | -9.62e-02 | 7.07e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 46 | 2.59e-01 | -9.61e-02 | 8.66e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 6.38e-01 | 9.61e-02 | 9.62e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 3.18e-01 | 9.61e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 75 | 1.50e-01 | -9.61e-02 | 8.14e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 142 | 4.82e-02 | -9.60e-02 | 6.27e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 31 | 3.55e-01 | -9.59e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 143 | 4.77e-02 | -9.59e-02 | 6.27e-01 |
| GOBP MITOPHAGY | 34 | 3.33e-01 | 9.59e-02 | 8.94e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 38 | 3.06e-01 | 9.59e-02 | 8.85e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 16 | 5.07e-01 | -9.59e-02 | 9.45e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 38 | 3.07e-01 | 9.58e-02 | 8.85e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 51 | 2.36e-01 | -9.58e-02 | 8.64e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 96 | 1.05e-01 | -9.58e-02 | 7.69e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 232 | 1.19e-02 | 9.58e-02 | 4.13e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 9 | 6.19e-01 | 9.58e-02 | 9.61e-01 |
| GOCC U4 SNRNP | 10 | 6.00e-01 | 9.58e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 6.39e-01 | -9.57e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 11 | 5.83e-01 | 9.57e-02 | 9.53e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 15 | 5.21e-01 | 9.57e-02 | 9.47e-01 |
| GOCC APICAL CORTEX | 8 | 6.39e-01 | -9.57e-02 | 9.62e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 17 | 4.95e-01 | -9.56e-02 | 9.45e-01 |
| GOBP FEAR RESPONSE | 43 | 2.78e-01 | 9.56e-02 | 8.70e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 17 | 4.95e-01 | -9.56e-02 | 9.45e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 10 | 6.01e-01 | 9.56e-02 | 9.55e-01 |
| GOMF PROTEIN KINASE C BINDING | 50 | 2.42e-01 | 9.56e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 6.85e-01 | -9.56e-02 | 9.68e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 41 | 2.90e-01 | -9.56e-02 | 8.78e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 5.51e-01 | -9.55e-02 | 9.49e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 86 | 1.26e-01 | -9.55e-02 | 7.93e-01 |
| GOBP SECONDARY HEART FIELD SPECIFICATION | 11 | 5.84e-01 | -9.55e-02 | 9.54e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 239 | 1.10e-02 | 9.54e-02 | 3.96e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 77 | 1.48e-01 | 9.54e-02 | 8.09e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 39 | 3.02e-01 | -9.54e-02 | 8.84e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 84 | 1.31e-01 | 9.54e-02 | 7.94e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 13 | 5.51e-01 | 9.54e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 6 | 6.86e-01 | -9.54e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 43 | 2.79e-01 | -9.54e-02 | 8.71e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 9 | 6.20e-01 | -9.53e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 5.84e-01 | 9.53e-02 | 9.54e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 18 | 4.84e-01 | -9.52e-02 | 9.43e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 26 | 4.01e-01 | -9.52e-02 | 9.18e-01 |
| GOBP REGULATION OF VESICLE SIZE | 19 | 4.72e-01 | 9.52e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 249 | 9.73e-03 | 9.51e-02 | 3.75e-01 |
| GOMF DOUBLE STRANDED METHYLATED DNA BINDING | 5 | 7.13e-01 | 9.51e-02 | 9.71e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 17 | 4.97e-01 | 9.51e-02 | 9.45e-01 |
| GOBP METHYLATION | 260 | 8.32e-03 | 9.50e-02 | 3.53e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 150 | 4.46e-02 | -9.50e-02 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 307 | 4.20e-03 | 9.50e-02 | 2.53e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 20 | 4.62e-01 | -9.50e-02 | 9.37e-01 |
| GOBP TISSUE MIGRATION | 364 | 1.86e-03 | -9.50e-02 | 1.62e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 6.03e-01 | 9.49e-02 | 9.55e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 5.69e-01 | 9.49e-02 | 9.51e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 48 | 2.55e-01 | -9.49e-02 | 8.65e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 13 | 5.54e-01 | -9.49e-02 | 9.49e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY | 5 | 7.13e-01 | -9.48e-02 | 9.72e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 254 | 9.25e-03 | -9.48e-02 | 3.64e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 220 | 1.53e-02 | -9.48e-02 | 4.61e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 11 | 5.86e-01 | 9.48e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 10 | 6.04e-01 | 9.48e-02 | 9.55e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 20 | 4.63e-01 | 9.48e-02 | 9.37e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 1133 | 7.49e-08 | -9.47e-02 | 1.28e-04 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 29 | 3.77e-01 | 9.47e-02 | 9.09e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 82 | 1.38e-01 | 9.46e-02 | 8.06e-01 |
| GOBP SEGMENTATION | 99 | 1.04e-01 | 9.46e-02 | 7.68e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 57 | 2.17e-01 | -9.45e-02 | 8.56e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 29 | 3.78e-01 | -9.45e-02 | 9.09e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 217 | 1.64e-02 | -9.45e-02 | 4.68e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 12 | 5.71e-01 | 9.45e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 24 | 4.23e-01 | 9.45e-02 | 9.24e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 5.56e-01 | -9.43e-02 | 9.49e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 36 | 3.28e-01 | 9.43e-02 | 8.93e-01 |
| GOBP CHONDROBLAST DIFFERENTIATION | 5 | 7.15e-01 | 9.43e-02 | 9.72e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 25 | 4.15e-01 | 9.43e-02 | 9.23e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 54 | 2.31e-01 | 9.42e-02 | 8.63e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 5.42e-01 | 9.42e-02 | 9.49e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 10 | 6.06e-01 | 9.42e-02 | 9.55e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 13 | 5.57e-01 | 9.42e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 31 | 3.64e-01 | -9.42e-02 | 9.06e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 10 | 6.06e-01 | 9.41e-02 | 9.55e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 26 | 4.06e-01 | 9.41e-02 | 9.21e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 8 | 6.45e-01 | -9.41e-02 | 9.63e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 5.89e-01 | 9.40e-02 | 9.54e-01 |
| GOMF ENONE REDUCTASE ACTIVITY | 5 | 7.16e-01 | -9.40e-02 | 9.72e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 17 | 5.02e-01 | 9.39e-02 | 9.45e-01 |
| GOCC CATION CHANNEL COMPLEX | 188 | 2.63e-02 | -9.39e-02 | 5.28e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 9 | 6.26e-01 | -9.39e-02 | 9.61e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 56 | 2.24e-01 | 9.39e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 5.58e-01 | -9.39e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 5.73e-01 | 9.39e-02 | 9.51e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 6 | 6.91e-01 | 9.38e-02 | 9.69e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 741 | 1.37e-05 | -9.38e-02 | 5.38e-03 |
| GOCC POLYSOME | 60 | 2.09e-01 | -9.38e-02 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 255 | 9.89e-03 | -9.38e-02 | 3.78e-01 |
| GOCC MICOS COMPLEX | 6 | 6.91e-01 | 9.38e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 12 | 5.74e-01 | -9.38e-02 | 9.51e-01 |
| GOBP TRNA METABOLIC PROCESS | 188 | 2.66e-02 | 9.38e-02 | 5.31e-01 |
| GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING | 7 | 6.68e-01 | -9.37e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 15 | 5.30e-01 | -9.37e-02 | 9.48e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 23 | 4.37e-01 | -9.37e-02 | 9.27e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 11 | 5.90e-01 | -9.37e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 16 | 5.16e-01 | 9.37e-02 | 9.46e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 12 | 5.74e-01 | -9.37e-02 | 9.51e-01 |
| GOBP IMP CATABOLIC PROCESS | 5 | 7.17e-01 | 9.37e-02 | 9.72e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 18 | 4.92e-01 | -9.36e-02 | 9.45e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 6.68e-01 | -9.36e-02 | 9.67e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 6.68e-01 | 9.36e-02 | 9.67e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 1357 | 7.17e-09 | -9.36e-02 | 3.67e-05 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 9 | 6.27e-01 | -9.36e-02 | 9.61e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 220 | 1.68e-02 | -9.35e-02 | 4.68e-01 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 14 | 5.45e-01 | 9.35e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 8 | 6.47e-01 | 9.35e-02 | 9.63e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 12 | 5.75e-01 | -9.34e-02 | 9.51e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 65 | 1.93e-01 | -9.34e-02 | 8.44e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 6.69e-01 | -9.34e-02 | 9.67e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 6.69e-01 | -9.34e-02 | 9.67e-01 |
| GOCC SPERM HEAD | 17 | 5.05e-01 | -9.33e-02 | 9.45e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 17 | 5.06e-01 | 9.32e-02 | 9.45e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 74 | 1.65e-01 | -9.32e-02 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 6.48e-01 | 9.32e-02 | 9.63e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 24 | 4.29e-01 | -9.32e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 9 | 6.28e-01 | -9.32e-02 | 9.61e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 35 | 3.40e-01 | -9.32e-02 | 8.96e-01 |
| GOMF CHOLESTEROL BINDING | 51 | 2.50e-01 | -9.32e-02 | 8.65e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 18 | 4.94e-01 | -9.32e-02 | 9.45e-01 |
| GOBP FLAVONOID GLUCURONIDATION | 5 | 7.18e-01 | 9.31e-02 | 9.72e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 103 | 1.03e-01 | -9.31e-02 | 7.66e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 18 | 4.94e-01 | -9.30e-02 | 9.45e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 10 | 6.10e-01 | 9.30e-02 | 9.58e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 16 | 5.19e-01 | -9.30e-02 | 9.47e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 21 | 4.61e-01 | 9.30e-02 | 9.37e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 10 | 6.11e-01 | -9.29e-02 | 9.58e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 90 | 1.28e-01 | -9.29e-02 | 7.93e-01 |
| GOCC CONDENSED CHROMOSOME | 265 | 9.25e-03 | 9.29e-02 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 13 | 5.62e-01 | -9.29e-02 | 9.49e-01 |
| GOCC ACTOMYOSIN | 76 | 1.62e-01 | -9.28e-02 | 8.24e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 13 | 5.62e-01 | 9.28e-02 | 9.49e-01 |
| GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING | 8 | 6.49e-01 | 9.28e-02 | 9.64e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 19 | 4.84e-01 | -9.28e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 32 | 3.64e-01 | -9.28e-02 | 9.06e-01 |
| GOMF ANKYRIN BINDING | 19 | 4.84e-01 | -9.28e-02 | 9.43e-01 |
| GOBP ORGANELLE DISASSEMBLY | 137 | 6.08e-02 | 9.28e-02 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 38 | 3.23e-01 | -9.27e-02 | 8.92e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 10 | 6.12e-01 | 9.27e-02 | 9.59e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 6.71e-01 | 9.26e-02 | 9.68e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 15 | 5.35e-01 | 9.26e-02 | 9.49e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 35 | 3.43e-01 | -9.26e-02 | 8.96e-01 |
| GOCC COMPACT MYELIN | 14 | 5.49e-01 | -9.26e-02 | 9.49e-01 |
| GOBP RNA MODIFICATION | 168 | 3.84e-02 | 9.26e-02 | 5.93e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 26 | 4.14e-01 | 9.26e-02 | 9.23e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 12 | 5.79e-01 | 9.26e-02 | 9.52e-01 |
| GOBP ORGANIC CATION TRANSPORT | 62 | 2.07e-01 | 9.26e-02 | 8.51e-01 |
| GOCC PHAGOCYTIC VESICLE | 131 | 6.73e-02 | -9.26e-02 | 6.87e-01 |
| GOBP D AMINO ACID TRANSPORT | 6 | 6.95e-01 | -9.25e-02 | 9.69e-01 |
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 11 | 5.96e-01 | -9.24e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 6.51e-01 | 9.24e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 6.72e-01 | 9.24e-02 | 9.68e-01 |
| GOBP REGULATION OF G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 5 | 7.21e-01 | 9.23e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 7 | 6.73e-01 | 9.23e-02 | 9.68e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 178 | 3.38e-02 | -9.22e-02 | 5.59e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 21 | 4.65e-01 | -9.22e-02 | 9.38e-01 |
| GOMF TRNA BINDING | 73 | 1.73e-01 | 9.22e-02 | 8.36e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 6.52e-01 | -9.22e-02 | 9.64e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 179 | 3.34e-02 | 9.22e-02 | 5.58e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 164 | 4.17e-02 | 9.21e-02 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 17 | 5.11e-01 | 9.21e-02 | 9.46e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 48 | 2.70e-01 | -9.21e-02 | 8.69e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 22 | 4.55e-01 | 9.21e-02 | 9.36e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 13 | 5.65e-01 | 9.21e-02 | 9.50e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 19 | 4.87e-01 | -9.21e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 35 | 3.46e-01 | -9.21e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 14 | 5.51e-01 | 9.20e-02 | 9.49e-01 |
| GOBP XENOBIOTIC TRANSPORT | 59 | 2.21e-01 | -9.20e-02 | 8.56e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 65 | 1.99e-01 | -9.20e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 102 | 1.08e-01 | -9.20e-02 | 7.73e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 8 | 6.52e-01 | 9.20e-02 | 9.64e-01 |
| GOCC U1 SNRNP | 19 | 4.88e-01 | -9.20e-02 | 9.43e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 7.22e-01 | 9.19e-02 | 9.73e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 5.98e-01 | 9.19e-02 | 9.55e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 4.00e-01 | -9.19e-02 | 9.18e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 27 | 4.09e-01 | 9.18e-02 | 9.21e-01 |
| GOCC RECYCLING ENDOSOME | 194 | 2.75e-02 | -9.18e-02 | 5.37e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 26 | 4.18e-01 | 9.18e-02 | 9.24e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 793 | 1.11e-05 | 9.17e-02 | 4.56e-03 |
| GOBP BLOOD VESSEL REMODELING | 46 | 2.82e-01 | -9.17e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE | 6 | 6.97e-01 | 9.17e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 154 | 4.96e-02 | 9.17e-02 | 6.28e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 49 | 2.67e-01 | 9.17e-02 | 8.69e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 82 | 1.52e-01 | 9.16e-02 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 3.85e-01 | -9.16e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 24 | 4.38e-01 | 9.15e-02 | 9.28e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 11 | 5.99e-01 | -9.15e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 31 | 3.78e-01 | 9.15e-02 | 9.09e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 6.98e-01 | -9.15e-02 | 9.70e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 101 | 1.12e-01 | -9.15e-02 | 7.78e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 46 | 2.83e-01 | -9.15e-02 | 8.74e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 38 | 3.29e-01 | -9.15e-02 | 8.93e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 9 | 6.35e-01 | -9.15e-02 | 9.61e-01 |
| GOCC PLATELET DENSE GRANULE | 20 | 4.79e-01 | -9.14e-02 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 49 | 2.68e-01 | -9.14e-02 | 8.69e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 6 | 6.98e-01 | 9.14e-02 | 9.70e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 4.20e-01 | 9.13e-02 | 9.24e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 53 | 2.50e-01 | 9.13e-02 | 8.65e-01 |
| GOMF MYOSIN BINDING | 71 | 1.83e-01 | -9.13e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 14 | 5.55e-01 | -9.12e-02 | 9.49e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 6.99e-01 | 9.11e-02 | 9.70e-01 |
| GOBP SOMITOGENESIS | 64 | 2.07e-01 | 9.11e-02 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 5.41e-01 | -9.11e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 323 | 4.87e-03 | -9.11e-02 | 2.71e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 31 | 3.80e-01 | 9.11e-02 | 9.10e-01 |
| GOMF APOLIPOPROTEIN RECEPTOR BINDING | 7 | 6.77e-01 | 9.11e-02 | 9.68e-01 |
| GOBP PROTEIN OXIDATION | 13 | 5.70e-01 | -9.11e-02 | 9.51e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 48 | 2.75e-01 | 9.11e-02 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 9 | 6.36e-01 | -9.11e-02 | 9.61e-01 |
| GOBP CHROMOSOME SEGREGATION | 406 | 1.65e-03 | 9.10e-02 | 1.56e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 24 | 4.40e-01 | -9.10e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 21 | 4.71e-01 | -9.10e-02 | 9.39e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 21 | 4.71e-01 | -9.09e-02 | 9.39e-01 |
| GOCC DENTATE GYRUS MOSSY FIBER | 6 | 7.00e-01 | 9.09e-02 | 9.70e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 11 | 6.02e-01 | -9.09e-02 | 9.55e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 23 | 4.50e-01 | -9.09e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 12 | 5.86e-01 | -9.09e-02 | 9.54e-01 |
| GOBP APOPTOTIC PROCESS IN BONE MARROW CELL | 6 | 7.00e-01 | 9.09e-02 | 9.70e-01 |
| GOCC STEREOCILIUM BUNDLE | 60 | 2.24e-01 | -9.08e-02 | 8.57e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 270 | 1.02e-02 | -9.08e-02 | 3.83e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 7 | 6.77e-01 | 9.08e-02 | 9.68e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 20 | 4.82e-01 | -9.08e-02 | 9.43e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 48 | 2.77e-01 | -9.07e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 18 | 5.05e-01 | -9.07e-02 | 9.45e-01 |
| GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION | 5 | 7.26e-01 | -9.07e-02 | 9.75e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 20 | 4.83e-01 | -9.07e-02 | 9.43e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 46 | 2.87e-01 | -9.07e-02 | 8.76e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 48 | 2.77e-01 | 9.07e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 26 | 4.24e-01 | -9.05e-02 | 9.24e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 4.95e-01 | -9.05e-02 | 9.45e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 17 | 5.19e-01 | 9.04e-02 | 9.47e-01 |
| GOBP METANEPHROS DEVELOPMENT | 91 | 1.36e-01 | 9.04e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 8 | 6.58e-01 | 9.04e-02 | 9.66e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 17 | 5.19e-01 | -9.03e-02 | 9.47e-01 |
| GOBP STRAND INVASION | 6 | 7.02e-01 | 9.03e-02 | 9.71e-01 |
| GOCC CALCINEURIN COMPLEX | 6 | 7.02e-01 | 9.03e-02 | 9.71e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 7.27e-01 | 9.02e-02 | 9.75e-01 |
| GOBP THIAMINE TRANSPORT | 8 | 6.59e-01 | -9.02e-02 | 9.66e-01 |
| GOBP LIPID GLYCOSYLATION | 12 | 5.88e-01 | 9.02e-02 | 9.54e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 25 | 4.35e-01 | -9.02e-02 | 9.27e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 35 | 3.56e-01 | 9.02e-02 | 9.02e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 407 | 1.80e-03 | -9.02e-02 | 1.62e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 4.64e-01 | -9.01e-02 | 9.37e-01 |
| GOBP MALE SEX DIFFERENTIATION | 163 | 4.71e-02 | 9.01e-02 | 6.25e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.59e-01 | 9.01e-02 | 9.66e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 6.22e-01 | -9.01e-02 | 9.61e-01 |
| GOBP FEEDING BEHAVIOR | 102 | 1.16e-01 | 9.00e-02 | 7.82e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 48 | 2.81e-01 | -9.00e-02 | 8.72e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 50 | 2.71e-01 | -8.99e-02 | 8.69e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 25 | 4.36e-01 | 8.99e-02 | 9.27e-01 |
| GOBP PROTEIN DESTABILIZATION | 46 | 2.92e-01 | 8.99e-02 | 8.79e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 54 | 2.53e-01 | -8.99e-02 | 8.65e-01 |
| GOCC HAUS COMPLEX | 7 | 6.80e-01 | 8.99e-02 | 9.68e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 83 | 1.57e-01 | -8.99e-02 | 8.17e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 12 | 5.90e-01 | 8.99e-02 | 9.54e-01 |
| GOCC MICROFIBRIL | 13 | 5.75e-01 | -8.99e-02 | 9.51e-01 |
| GOBP REGULATION OF GLOMERULUS DEVELOPMENT | 5 | 7.28e-01 | -8.98e-02 | 9.75e-01 |
| GOBP REGULATION OF HOMOPHILIC CELL ADHESION | 5 | 7.28e-01 | 8.98e-02 | 9.75e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.03e-01 | -8.98e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 19 | 4.98e-01 | 8.98e-02 | 9.45e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 45 | 2.97e-01 | 8.98e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 22 | 4.66e-01 | -8.98e-02 | 9.38e-01 |
| GOBP REGULATION OF FEMALE RECEPTIVITY | 7 | 6.81e-01 | -8.97e-02 | 9.68e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 16 | 5.34e-01 | 8.97e-02 | 9.49e-01 |
| GOMF CO SMAD BINDING | 9 | 6.41e-01 | 8.97e-02 | 9.62e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 36 | 3.52e-01 | -8.96e-02 | 9.00e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 27 | 4.20e-01 | 8.96e-02 | 9.24e-01 |
| GOBP DNA INTEGRATION | 8 | 6.61e-01 | 8.96e-02 | 9.66e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 46 | 2.93e-01 | -8.95e-02 | 8.80e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 19 | 4.99e-01 | -8.95e-02 | 9.45e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 35 | 3.59e-01 | -8.95e-02 | 9.04e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 41 | 3.21e-01 | -8.95e-02 | 8.92e-01 |
| GOBP RESPONSE TO INACTIVITY | 12 | 5.91e-01 | 8.95e-02 | 9.54e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 92 | 1.38e-01 | 8.95e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 26 | 4.30e-01 | -8.94e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 52 | 2.65e-01 | -8.94e-02 | 8.69e-01 |
| GOMF FERROUS IRON BINDING | 24 | 4.48e-01 | 8.94e-02 | 9.32e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 16 | 5.36e-01 | 8.94e-02 | 9.49e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 19 | 5.00e-01 | 8.93e-02 | 9.45e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 51 | 2.70e-01 | -8.93e-02 | 8.69e-01 |
| GOBP O GLYCAN PROCESSING | 42 | 3.17e-01 | -8.93e-02 | 8.91e-01 |
| GOBP RENAL TUBULAR SECRETION | 19 | 5.00e-01 | -8.93e-02 | 9.45e-01 |
| GOBP RNA SURVEILLANCE | 17 | 5.24e-01 | 8.93e-02 | 9.47e-01 |
| GOBP HYALOID VASCULAR PLEXUS REGRESSION | 7 | 6.83e-01 | 8.93e-02 | 9.68e-01 |
| GOBP REGULATION OF HEART GROWTH | 68 | 2.04e-01 | -8.91e-02 | 8.51e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 38 | 3.42e-01 | -8.91e-02 | 8.96e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 86 | 1.53e-01 | -8.91e-02 | 8.17e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 12 | 5.93e-01 | 8.91e-02 | 9.54e-01 |
| GOBP ACTION POTENTIAL | 139 | 6.98e-02 | -8.91e-02 | 6.94e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 41 | 3.24e-01 | 8.91e-02 | 8.93e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 10 | 6.26e-01 | -8.90e-02 | 9.61e-01 |
| GOCC SPERM FIBROUS SHEATH | 6 | 7.06e-01 | -8.90e-02 | 9.71e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 12 | 5.93e-01 | 8.90e-02 | 9.54e-01 |
| GOBP BONE MORPHOGENESIS | 98 | 1.28e-01 | -8.90e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 18 | 5.13e-01 | -8.90e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 7 | 6.84e-01 | 8.90e-02 | 9.68e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 6.44e-01 | 8.89e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 28 | 4.16e-01 | -8.89e-02 | 9.23e-01 |
| GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION | 5 | 7.31e-01 | 8.89e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 72 | 1.92e-01 | 8.89e-02 | 8.44e-01 |
| GOBP SNRNA TRANSPORT | 6 | 7.06e-01 | -8.89e-02 | 9.71e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 34 | 3.70e-01 | -8.89e-02 | 9.09e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 106 | 1.14e-01 | 8.88e-02 | 7.81e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 16 | 5.38e-01 | 8.88e-02 | 9.49e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 5.38e-01 | -8.88e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 34 | 3.70e-01 | 8.88e-02 | 9.09e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 5.65e-01 | 8.88e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 31 | 3.92e-01 | 8.88e-02 | 9.16e-01 |
| GOBP L SERINE METABOLIC PROCESS | 12 | 5.94e-01 | 8.88e-02 | 9.54e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 5.52e-01 | 8.88e-02 | 9.49e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 286 | 9.80e-03 | 8.88e-02 | 3.75e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 46 | 2.98e-01 | 8.87e-02 | 8.82e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 6 | 7.07e-01 | -8.87e-02 | 9.71e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 9 | 6.45e-01 | -8.87e-02 | 9.63e-01 |
| GOMF LAMININ BINDING | 28 | 4.17e-01 | -8.86e-02 | 9.23e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 54 | 2.60e-01 | -8.86e-02 | 8.66e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 63 | 2.24e-01 | -8.86e-02 | 8.57e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 87 | 1.53e-01 | 8.86e-02 | 8.17e-01 |
| GOCC COHESIN COMPLEX | 8 | 6.64e-01 | 8.86e-02 | 9.67e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 6.46e-01 | 8.85e-02 | 9.63e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 9 | 6.46e-01 | -8.85e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 16 | 5.40e-01 | 8.85e-02 | 9.49e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 19 | 5.04e-01 | -8.85e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 32 | 3.87e-01 | -8.84e-02 | 9.14e-01 |
| GOBP REGULATION OF URINE VOLUME | 20 | 4.94e-01 | 8.84e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 7.08e-01 | 8.84e-02 | 9.71e-01 |
| GOBP BONE MATURATION | 25 | 4.44e-01 | -8.84e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 31 | 3.95e-01 | -8.83e-02 | 9.18e-01 |
| GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS | 6 | 7.08e-01 | 8.83e-02 | 9.71e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 13 | 5.81e-01 | 8.83e-02 | 9.53e-01 |
| GOMF FATTY ACID BINDING | 47 | 2.95e-01 | -8.83e-02 | 8.82e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 122 | 9.22e-02 | -8.83e-02 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 19 | 5.05e-01 | -8.82e-02 | 9.45e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 89 | 1.50e-01 | 8.82e-02 | 8.14e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 27 | 4.28e-01 | 8.81e-02 | 9.27e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 13 | 5.82e-01 | -8.81e-02 | 9.53e-01 |
| GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY | 6 | 7.09e-01 | -8.81e-02 | 9.71e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 7.33e-01 | 8.81e-02 | 9.76e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 9 | 6.47e-01 | -8.81e-02 | 9.63e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 341 | 5.18e-03 | 8.81e-02 | 2.78e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 73 | 1.93e-01 | -8.81e-02 | 8.44e-01 |
| GOBP PHOTORECEPTOR CELL MORPHOGENESIS | 5 | 7.33e-01 | 8.80e-02 | 9.76e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 34 | 3.74e-01 | 8.80e-02 | 9.09e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 7 | 6.87e-01 | 8.80e-02 | 9.68e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 7 | 6.87e-01 | 8.80e-02 | 9.68e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I | 5 | 7.33e-01 | -8.79e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 41 | 3.30e-01 | -8.79e-02 | 8.93e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 27 | 4.29e-01 | 8.79e-02 | 9.27e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 6.87e-01 | -8.79e-02 | 9.68e-01 |
| GOCC RIBBON SYNAPSE | 15 | 5.56e-01 | -8.79e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 233 | 2.09e-02 | -8.78e-02 | 4.96e-01 |
| GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY | 6 | 7.09e-01 | -8.78e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 12 | 5.98e-01 | 8.78e-02 | 9.55e-01 |
| GOBP XENOPHAGY | 14 | 5.70e-01 | 8.78e-02 | 9.51e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 40 | 3.37e-01 | 8.77e-02 | 8.96e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 15 | 5.56e-01 | -8.77e-02 | 9.49e-01 |
| GOBP NEURON FATE SPECIFICATION | 34 | 3.76e-01 | 8.77e-02 | 9.09e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 58 | 2.48e-01 | 8.77e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 52 | 2.74e-01 | -8.77e-02 | 8.69e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 478 | 1.03e-03 | -8.76e-02 | 1.22e-01 |
| GOMF ANNEALING ACTIVITY | 8 | 6.68e-01 | -8.76e-02 | 9.67e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 13 | 5.84e-01 | 8.76e-02 | 9.54e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 6 | 7.10e-01 | -8.76e-02 | 9.71e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 282 | 1.14e-02 | -8.76e-02 | 4.04e-01 |
| GOBP GERM CELL MIGRATION | 8 | 6.68e-01 | 8.75e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 38 | 3.51e-01 | -8.75e-02 | 8.99e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 7.11e-01 | 8.75e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 31 | 3.99e-01 | 8.75e-02 | 9.18e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 235 | 2.09e-02 | -8.75e-02 | 4.96e-01 |
| GOBP ENTRY INTO HOST | 157 | 5.86e-02 | -8.74e-02 | 6.60e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 48 | 2.95e-01 | -8.74e-02 | 8.82e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 144 | 7.03e-02 | -8.74e-02 | 6.96e-01 |
| GOBP AXIS ELONGATION | 27 | 4.32e-01 | -8.74e-02 | 9.27e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 18 | 5.22e-01 | -8.72e-02 | 9.47e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 28 | 4.25e-01 | -8.71e-02 | 9.25e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 19 | 5.11e-01 | -8.71e-02 | 9.46e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 7.12e-01 | -8.71e-02 | 9.71e-01 |
| GOCC CELL BODY FIBER | 7 | 6.90e-01 | 8.70e-02 | 9.69e-01 |
| GOBP NUCLEOSIDE SALVAGE | 8 | 6.70e-01 | -8.70e-02 | 9.67e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 4.80e-01 | 8.70e-02 | 9.42e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 57 | 2.56e-01 | 8.70e-02 | 8.65e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 203 | 3.28e-02 | 8.69e-02 | 5.58e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 11 | 6.18e-01 | 8.69e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 98 | 1.37e-01 | -8.69e-02 | 8.06e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 115 | 1.07e-01 | -8.69e-02 | 7.72e-01 |
| GOMF FOLIC ACID BINDING | 13 | 5.88e-01 | 8.69e-02 | 9.54e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 13 | 5.88e-01 | -8.69e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 8 | 6.71e-01 | -8.69e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 15 | 5.61e-01 | 8.68e-02 | 9.49e-01 |
| GOCC EMC COMPLEX | 9 | 6.52e-01 | 8.67e-02 | 9.64e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 18 | 5.24e-01 | -8.67e-02 | 9.47e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 7 | 6.91e-01 | -8.67e-02 | 9.69e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 12 | 6.03e-01 | -8.66e-02 | 9.55e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 7 | 6.91e-01 | 8.66e-02 | 9.69e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 7 | 6.91e-01 | -8.66e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 17 | 5.37e-01 | -8.66e-02 | 9.49e-01 |
| GOBP ENDOSOME ORGANIZATION | 92 | 1.51e-01 | 8.65e-02 | 8.17e-01 |
| GOMF GLYCOGEN BINDING | 7 | 6.92e-01 | -8.65e-02 | 9.69e-01 |
| GOBP FOREGUT MORPHOGENESIS | 10 | 6.36e-01 | 8.65e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 94 | 1.48e-01 | -8.64e-02 | 8.09e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 7.14e-01 | 8.64e-02 | 9.72e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 72 | 2.05e-01 | 8.64e-02 | 8.51e-01 |
| GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.38e-01 | -8.64e-02 | 9.77e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 15 | 5.63e-01 | 8.63e-02 | 9.49e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 215 | 2.92e-02 | -8.63e-02 | 5.52e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 24 | 4.65e-01 | -8.62e-02 | 9.38e-01 |
| GOMF ERBB 3 CLASS RECEPTOR BINDING | 5 | 7.39e-01 | 8.62e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 71 | 2.09e-01 | 8.62e-02 | 8.53e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 203 | 3.44e-02 | -8.61e-02 | 5.66e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 37 | 3.65e-01 | 8.61e-02 | 9.06e-01 |
| GOBP ZINC ION TRANSPORT | 28 | 4.30e-01 | -8.61e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 142 | 7.65e-02 | 8.61e-02 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 16 | 5.51e-01 | 8.61e-02 | 9.49e-01 |
| GOCC GLIAL CELL PROJECTION | 36 | 3.72e-01 | -8.61e-02 | 9.09e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 91 | 1.56e-01 | -8.60e-02 | 8.17e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 15 | 5.64e-01 | -8.60e-02 | 9.50e-01 |
| GOBP REGULATION OF TUBE SIZE | 142 | 7.69e-02 | -8.60e-02 | 7.18e-01 |
| GOBP PARENTAL BEHAVIOR | 10 | 6.38e-01 | -8.60e-02 | 9.62e-01 |
| GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS | 5 | 7.39e-01 | 8.59e-02 | 9.77e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 11 | 6.22e-01 | 8.59e-02 | 9.61e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 7 | 6.94e-01 | 8.58e-02 | 9.69e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 7.16e-01 | -8.58e-02 | 9.72e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 12 | 6.07e-01 | -8.58e-02 | 9.55e-01 |
| GOCC ASTER | 10 | 6.39e-01 | 8.57e-02 | 9.62e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 46 | 3.15e-01 | -8.57e-02 | 8.90e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 19 | 5.18e-01 | 8.57e-02 | 9.47e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 36 | 3.74e-01 | 8.57e-02 | 9.09e-01 |
| GOBP G1 TO G0 TRANSITION | 19 | 5.18e-01 | 8.56e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 317 | 8.75e-03 | 8.56e-02 | 3.60e-01 |
| GOCC SPINDLE POLE | 166 | 5.70e-02 | 8.56e-02 | 6.57e-01 |
| GOBP BLASTOCYST FORMATION | 45 | 3.21e-01 | 8.56e-02 | 8.92e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 83 | 1.78e-01 | -8.56e-02 | 8.41e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 8 | 6.75e-01 | 8.56e-02 | 9.68e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 2.33e-01 | 8.55e-02 | 8.64e-01 |
| GOMF GDP BINDING | 69 | 2.19e-01 | -8.55e-02 | 8.56e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 130 | 9.23e-02 | -8.55e-02 | 7.58e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 101 | 1.38e-01 | -8.55e-02 | 8.06e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 6.24e-01 | 8.55e-02 | 9.61e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 13 | 5.94e-01 | -8.54e-02 | 9.54e-01 |
| GOBP RESPONSE TO HYPEROXIA | 18 | 5.30e-01 | 8.54e-02 | 9.48e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 23 | 4.78e-01 | 8.54e-02 | 9.42e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 20 | 5.09e-01 | -8.54e-02 | 9.46e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 123 | 1.02e-01 | -8.54e-02 | 7.66e-01 |
| GOBP SPINDLE LOCALIZATION | 62 | 2.45e-01 | 8.54e-02 | 8.65e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 15 | 5.67e-01 | -8.54e-02 | 9.50e-01 |
| GOBP TISSUE REGENERATION | 73 | 2.08e-01 | 8.53e-02 | 8.51e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 12 | 6.09e-01 | 8.53e-02 | 9.57e-01 |
| GOBP CGMP CATABOLIC PROCESS | 5 | 7.41e-01 | -8.53e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 7.41e-01 | -8.52e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 75 | 2.02e-01 | -8.52e-02 | 8.51e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 14 | 5.81e-01 | 8.52e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 5.32e-01 | -8.51e-02 | 9.48e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 39 | 3.58e-01 | -8.51e-02 | 9.03e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 62 | 2.46e-01 | -8.51e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 146 | 7.61e-02 | 8.51e-02 | 7.17e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 6.59e-01 | 8.50e-02 | 9.66e-01 |
| GOBP RESPONSE TO UV A | 13 | 5.96e-01 | 8.50e-02 | 9.55e-01 |
| GOBP SOMITE DEVELOPMENT | 82 | 1.83e-01 | 8.50e-02 | 8.42e-01 |
| GOCC CILIARY BASAL BODY | 158 | 6.53e-02 | 8.50e-02 | 6.80e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 11 | 6.26e-01 | -8.50e-02 | 9.61e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 37 | 3.71e-01 | -8.49e-02 | 9.09e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 11 | 6.26e-01 | -8.49e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 177 | 5.13e-02 | -8.49e-02 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 6 | 7.19e-01 | -8.49e-02 | 9.72e-01 |
| GOCC VESICLE COAT | 61 | 2.51e-01 | 8.49e-02 | 8.65e-01 |
| GOBP LIPID DIGESTION | 21 | 5.01e-01 | 8.49e-02 | 9.45e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 101 | 1.40e-01 | -8.49e-02 | 8.06e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 55 | 2.76e-01 | -8.49e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 8 | 6.78e-01 | 8.49e-02 | 9.68e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 90 | 1.64e-01 | 8.48e-02 | 8.24e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 147 | 7.59e-02 | 8.48e-02 | 7.17e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 7 | 6.98e-01 | -8.48e-02 | 9.70e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 437 | 2.38e-03 | 8.48e-02 | 1.87e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 43 | 3.36e-01 | 8.48e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 5 | 7.43e-01 | -8.47e-02 | 9.77e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 28 | 4.38e-01 | 8.47e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 11 | 6.27e-01 | -8.47e-02 | 9.61e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 29 | 4.30e-01 | -8.47e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION | 7 | 6.98e-01 | -8.46e-02 | 9.70e-01 |
| GOCC R2TP COMPLEX | 5 | 7.43e-01 | 8.46e-02 | 9.77e-01 |
| GOBP PHOTOTRANSDUCTION | 42 | 3.43e-01 | 8.46e-02 | 8.96e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 6.98e-01 | 8.46e-02 | 9.70e-01 |
| GOBP NUCLEAR MIGRATION | 25 | 4.64e-01 | 8.46e-02 | 9.37e-01 |
| GOBP HEMOSTASIS | 220 | 3.06e-02 | -8.46e-02 | 5.54e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 78 | 1.96e-01 | -8.46e-02 | 8.44e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 17 | 5.46e-01 | -8.46e-02 | 9.49e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 29 | 4.31e-01 | 8.45e-02 | 9.27e-01 |
| GOCC TIGHT JUNCTION | 122 | 1.07e-01 | -8.45e-02 | 7.72e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 16 | 5.59e-01 | -8.45e-02 | 9.49e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 56 | 2.74e-01 | 8.45e-02 | 8.69e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 93 | 1.59e-01 | 8.44e-02 | 8.19e-01 |
| GOBP REGULATION OF HEART MORPHOGENESIS | 10 | 6.44e-01 | -8.44e-02 | 9.63e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 21 | 5.03e-01 | 8.44e-02 | 9.45e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 46 | 3.22e-01 | 8.44e-02 | 8.92e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 44 | 3.33e-01 | -8.44e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 11 | 6.28e-01 | -8.44e-02 | 9.61e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 34 | 3.95e-01 | -8.43e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 108 | 1.30e-01 | -8.43e-02 | 7.93e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 20 | 5.14e-01 | -8.43e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 7 | 6.99e-01 | -8.43e-02 | 9.70e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 17 | 5.48e-01 | -8.43e-02 | 9.49e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 9 | 6.62e-01 | -8.43e-02 | 9.66e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 28 | 4.40e-01 | -8.42e-02 | 9.29e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 34 | 3.95e-01 | -8.42e-02 | 9.18e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 18 | 5.36e-01 | -8.42e-02 | 9.49e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 201 | 3.97e-02 | -8.41e-02 | 6.03e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 41 | 3.51e-01 | -8.41e-02 | 9.00e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 121 | 1.10e-01 | -8.41e-02 | 7.77e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 6 | 7.21e-01 | 8.41e-02 | 9.73e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 11 | 6.29e-01 | -8.41e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 14 | 5.86e-01 | 8.41e-02 | 9.54e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 42 | 3.46e-01 | -8.40e-02 | 8.96e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 92 | 1.64e-01 | 8.40e-02 | 8.24e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 29 | 4.34e-01 | -8.40e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 38 | 3.70e-01 | 8.40e-02 | 9.09e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 64 | 2.45e-01 | -8.40e-02 | 8.65e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 32 | 4.11e-01 | 8.40e-02 | 9.21e-01 |
| GOCC NUCLEOSOME | 114 | 1.21e-01 | 8.40e-02 | 7.89e-01 |
| GOBP CELLULAR PIGMENTATION | 60 | 2.60e-01 | -8.40e-02 | 8.66e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 14 | 5.86e-01 | 8.40e-02 | 9.54e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 7.45e-01 | -8.40e-02 | 9.78e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 595 | 4.67e-04 | 8.40e-02 | 7.18e-02 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 183 | 5.02e-02 | 8.39e-02 | 6.32e-01 |
| GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD | 8 | 6.81e-01 | 8.39e-02 | 9.68e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 17 | 5.50e-01 | -8.38e-02 | 9.49e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 16 | 5.62e-01 | -8.38e-02 | 9.49e-01 |
| GOBP CELL CELL RECOGNITION | 72 | 2.19e-01 | -8.38e-02 | 8.56e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 3.05e-01 | 8.38e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 166 | 6.24e-02 | -8.38e-02 | 6.63e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 110 | 1.29e-01 | -8.38e-02 | 7.93e-01 |
| GOBP GLIAL CELL FATE COMMITMENT | 13 | 6.01e-01 | -8.37e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 6.82e-01 | 8.37e-02 | 9.68e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 8 | 6.82e-01 | -8.37e-02 | 9.68e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 6.16e-01 | 8.37e-02 | 9.60e-01 |
| GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN | 6 | 7.23e-01 | -8.37e-02 | 9.74e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 29 | 4.36e-01 | 8.36e-02 | 9.27e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1135 | 2.01e-06 | 8.36e-02 | 1.38e-03 |
| GOBP NEUROTRANSMITTER SECRETION | 138 | 9.00e-02 | -8.36e-02 | 7.52e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 7.23e-01 | 8.36e-02 | 9.74e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 24 | 4.78e-01 | -8.36e-02 | 9.42e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 22 | 4.97e-01 | -8.36e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 108 | 1.34e-01 | -8.35e-02 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 44 | 3.38e-01 | 8.35e-02 | 8.96e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 6.83e-01 | 8.35e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 18 | 5.40e-01 | 8.35e-02 | 9.49e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 91 | 1.69e-01 | 8.35e-02 | 8.31e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 10 | 6.48e-01 | 8.34e-02 | 9.63e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 482 | 1.72e-03 | -8.34e-02 | 1.58e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 746 | 1.06e-04 | 8.33e-02 | 2.65e-02 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 26 | 4.62e-01 | -8.33e-02 | 9.37e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 223 | 3.20e-02 | -8.33e-02 | 5.58e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 7.24e-01 | 8.33e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 170 | 6.09e-02 | -8.33e-02 | 6.63e-01 |
| GOBP INTERFERON BETA PRODUCTION | 56 | 2.81e-01 | 8.33e-02 | 8.72e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 7 | 7.03e-01 | -8.33e-02 | 9.71e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 34 | 4.01e-01 | -8.33e-02 | 9.18e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 11 | 6.33e-01 | -8.33e-02 | 9.61e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 49 | 3.13e-01 | 8.33e-02 | 8.90e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 13 | 6.03e-01 | 8.33e-02 | 9.55e-01 |
| GOBP MACROMOLECULE DEACYLATION | 63 | 2.53e-01 | 8.32e-02 | 8.65e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION | 6 | 7.24e-01 | 8.32e-02 | 9.74e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 76 | 2.10e-01 | -8.32e-02 | 8.53e-01 |
| GOBP MUSCLE HYPERTROPHY | 103 | 1.45e-01 | -8.32e-02 | 8.06e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 46 | 3.29e-01 | 8.32e-02 | 8.93e-01 |
| GOBP RESPONSE TO UV C | 14 | 5.90e-01 | -8.32e-02 | 9.54e-01 |
| GOBP ANTERIOR POSTERIOR AXON GUIDANCE | 7 | 7.03e-01 | 8.32e-02 | 9.71e-01 |
| GOCC ATPASE COMPLEX | 140 | 8.94e-02 | 8.31e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 35 | 3.95e-01 | 8.31e-02 | 9.18e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 13 | 6.04e-01 | -8.31e-02 | 9.55e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 15 | 5.78e-01 | -8.30e-02 | 9.52e-01 |
| GOBP HEART TRABECULA FORMATION | 15 | 5.78e-01 | -8.30e-02 | 9.52e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 6.49e-01 | 8.30e-02 | 9.64e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 7.25e-01 | 8.30e-02 | 9.75e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 68 | 2.37e-01 | 8.30e-02 | 8.64e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 52 | 3.01e-01 | 8.30e-02 | 8.84e-01 |
| GOMF OXYGEN SENSOR ACTIVITY | 5 | 7.48e-01 | -8.30e-02 | 9.79e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 15 | 5.78e-01 | 8.29e-02 | 9.52e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 5.21e-01 | -8.29e-02 | 9.47e-01 |
| GOCC NUCLEAR CHROMOSOME | 213 | 3.71e-02 | 8.29e-02 | 5.82e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 127 | 1.07e-01 | -8.28e-02 | 7.72e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 12 | 6.19e-01 | 8.28e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 10 | 6.50e-01 | 8.28e-02 | 9.64e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 58 | 2.76e-01 | 8.28e-02 | 8.70e-01 |
| GOCC CILIARY TRANSITION FIBER | 8 | 6.85e-01 | 8.28e-02 | 9.68e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 13 | 6.06e-01 | 8.27e-02 | 9.55e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 14 | 5.92e-01 | -8.27e-02 | 9.54e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 85 | 1.88e-01 | -8.26e-02 | 8.44e-01 |
| GOBP NECROPTOTIC PROCESS | 45 | 3.38e-01 | 8.26e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 14 | 5.93e-01 | 8.26e-02 | 9.54e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 10 | 6.51e-01 | 8.26e-02 | 9.64e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 20 | 5.23e-01 | 8.25e-02 | 9.47e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 83 | 1.94e-01 | -8.25e-02 | 8.44e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 25 | 4.75e-01 | 8.25e-02 | 9.41e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 8 | 6.86e-01 | 8.25e-02 | 9.68e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 538 | 1.07e-03 | -8.24e-02 | 1.23e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 75 | 2.17e-01 | 8.24e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 60 | 2.69e-01 | -8.24e-02 | 8.69e-01 |
| GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY | 5 | 7.50e-01 | -8.24e-02 | 9.80e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 7 | 7.06e-01 | -8.24e-02 | 9.71e-01 |
| GOBP BEHAVIORAL RESPONSE TO NICOTINE | 9 | 6.69e-01 | -8.23e-02 | 9.67e-01 |
| GOBP QUINONE METABOLIC PROCESS | 39 | 3.74e-01 | 8.23e-02 | 9.09e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 6.69e-01 | 8.23e-02 | 9.67e-01 |
| GOCC MYOSIN FILAMENT | 24 | 4.86e-01 | 8.22e-02 | 9.43e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 51 | 3.10e-01 | -8.22e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 65 | 2.52e-01 | 8.22e-02 | 8.65e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 15 | 5.82e-01 | -8.21e-02 | 9.53e-01 |
| GOMF OLFACTORY RECEPTOR BINDING | 6 | 7.27e-01 | 8.21e-02 | 9.75e-01 |
| GOBP PROTEIN IMPORT | 7 | 7.07e-01 | -8.21e-02 | 9.71e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 11 | 6.37e-01 | -8.21e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 57 | 2.84e-01 | -8.21e-02 | 8.74e-01 |
| GOMF CHROMATIN DNA BINDING | 110 | 1.37e-01 | 8.21e-02 | 8.06e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 9 | 6.70e-01 | -8.21e-02 | 9.67e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY | 9 | 6.70e-01 | -8.21e-02 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 12 | 6.23e-01 | -8.20e-02 | 9.61e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 24 | 4.87e-01 | -8.20e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 82 | 1.99e-01 | 8.20e-02 | 8.45e-01 |
| GOBP XENOBIOTIC GLUCURONIDATION | 6 | 7.28e-01 | -8.20e-02 | 9.75e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 17 | 5.58e-01 | -8.20e-02 | 9.49e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 38 | 3.82e-01 | -8.20e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 108 | 1.41e-01 | -8.20e-02 | 8.06e-01 |
| GOBP CHROMATIN REMODELING | 577 | 7.69e-04 | 8.19e-02 | 1.04e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 27 | 4.61e-01 | -8.19e-02 | 9.37e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 24 | 4.88e-01 | 8.19e-02 | 9.43e-01 |
| GOMF HSP70 PROTEIN BINDING | 50 | 3.17e-01 | 8.18e-02 | 8.91e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 43 | 3.53e-01 | 8.18e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 21 | 5.16e-01 | -8.18e-02 | 9.46e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 16 | 5.71e-01 | 8.18e-02 | 9.51e-01 |
| GOBP RRNA CATABOLIC PROCESS | 21 | 5.17e-01 | 8.18e-02 | 9.46e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 2.90e-01 | 8.17e-02 | 8.78e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 17 | 5.60e-01 | -8.17e-02 | 9.49e-01 |
| GOCC HEMOGLOBIN COMPLEX | 12 | 6.24e-01 | -8.17e-02 | 9.61e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 64 | 2.58e-01 | -8.17e-02 | 8.65e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 12 | 6.24e-01 | -8.17e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 17 | 5.60e-01 | 8.17e-02 | 9.49e-01 |
| GOBP REGULATION OF CELL MATURATION | 20 | 5.27e-01 | -8.17e-02 | 9.48e-01 |
| GOMF NADP BINDING | 50 | 3.18e-01 | -8.17e-02 | 8.91e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 15 | 5.84e-01 | -8.16e-02 | 9.54e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 10 | 6.55e-01 | -8.16e-02 | 9.65e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 14 | 5.98e-01 | -8.15e-02 | 9.55e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 28 | 4.56e-01 | -8.15e-02 | 9.36e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 33 | 4.18e-01 | 8.14e-02 | 9.24e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 28 | 4.56e-01 | 8.14e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 65 | 2.57e-01 | 8.14e-02 | 8.65e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 101 | 1.58e-01 | 8.13e-02 | 8.18e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 162 | 7.42e-02 | 8.13e-02 | 7.11e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 7 | 7.10e-01 | -8.13e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 65 | 2.57e-01 | 8.13e-02 | 8.65e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 5.74e-01 | 8.13e-02 | 9.51e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 22 | 5.09e-01 | 8.13e-02 | 9.46e-01 |
| GOBP LOCOMOTOR RHYTHM | 15 | 5.86e-01 | 8.12e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 286 | 1.81e-02 | 8.12e-02 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 9 | 6.73e-01 | -8.12e-02 | 9.68e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 12 | 6.27e-01 | 8.11e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 32 | 4.27e-01 | -8.11e-02 | 9.27e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 6.91e-01 | -8.11e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 25 | 4.83e-01 | -8.11e-02 | 9.43e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 73 | 2.31e-01 | 8.11e-02 | 8.63e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 26 | 4.75e-01 | -8.10e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 23 | 5.01e-01 | 8.10e-02 | 9.45e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 22 | 5.11e-01 | -8.10e-02 | 9.46e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 46 | 3.42e-01 | 8.09e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 44 | 3.53e-01 | 8.09e-02 | 9.00e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 11 | 6.42e-01 | 8.09e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 18 | 5.53e-01 | 8.09e-02 | 9.49e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 28 | 4.59e-01 | 8.08e-02 | 9.37e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 6.28e-01 | -8.08e-02 | 9.61e-01 |
| GOBP INTERCELLULAR TRANSPORT | 10 | 6.58e-01 | 8.08e-02 | 9.66e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 9 | 6.75e-01 | 8.07e-02 | 9.68e-01 |
| GOCC PROTEIN DNA COMPLEX | 1325 | 8.15e-07 | 8.07e-02 | 8.34e-04 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 26 | 4.77e-01 | -8.06e-02 | 9.41e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 6.75e-01 | -8.06e-02 | 9.68e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 54 | 3.05e-01 | 8.06e-02 | 8.85e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 26 | 4.77e-01 | -8.06e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 587 | 8.50e-04 | -8.06e-02 | 1.10e-01 |
| GOBP FORELIMB MORPHOGENESIS | 39 | 3.84e-01 | 8.06e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 17 | 5.66e-01 | -8.05e-02 | 9.50e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 52 | 3.16e-01 | -8.05e-02 | 8.90e-01 |
| GOCC PIGMENT GRANULE | 109 | 1.47e-01 | -8.04e-02 | 8.08e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 42 | 3.67e-01 | 8.04e-02 | 9.07e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 94 | 1.78e-01 | -8.04e-02 | 8.41e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 15 | 5.90e-01 | 8.03e-02 | 9.54e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 22 | 5.14e-01 | 8.03e-02 | 9.46e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 74 | 2.32e-01 | -8.03e-02 | 8.63e-01 |
| GOMF BETA GLUCOSIDASE ACTIVITY | 6 | 7.34e-01 | 8.02e-02 | 9.76e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 81 | 2.12e-01 | 8.02e-02 | 8.54e-01 |
| GOBP TRANSITION BETWEEN FAST AND SLOW FIBER | 9 | 6.77e-01 | 8.02e-02 | 9.68e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 71 | 2.43e-01 | -8.02e-02 | 8.64e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 27 | 4.71e-01 | 8.01e-02 | 9.39e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 202 | 4.97e-02 | -8.01e-02 | 6.28e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 20 | 5.35e-01 | -8.01e-02 | 9.49e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.31e-01 | -8.01e-02 | 9.61e-01 |
| GOBP MATURATION OF LSU RRNA | 27 | 4.72e-01 | 8.00e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATURATION | 8 | 6.95e-01 | -8.00e-02 | 9.69e-01 |
| GOBP RESPONSE TO HEAT | 99 | 1.69e-01 | 7.99e-02 | 8.31e-01 |
| GOBP INSULIN SECRETION | 193 | 5.56e-02 | 7.99e-02 | 6.52e-01 |
| GOMF HISTONE READER ACTIVITY | 12 | 6.32e-01 | 7.99e-02 | 9.61e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 24 | 4.98e-01 | 7.99e-02 | 9.45e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 6.32e-01 | 7.99e-02 | 9.61e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 11 | 6.47e-01 | -7.98e-02 | 9.63e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 7.35e-01 | -7.98e-02 | 9.77e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 18 | 5.58e-01 | 7.98e-02 | 9.49e-01 |
| GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 5 | 7.57e-01 | -7.98e-02 | 9.82e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 6.47e-01 | 7.98e-02 | 9.63e-01 |
| GOMF P53 BINDING | 64 | 2.70e-01 | 7.98e-02 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 5 | 7.57e-01 | 7.98e-02 | 9.82e-01 |
| GOBP PRENYLATION | 11 | 6.47e-01 | 7.98e-02 | 9.63e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 34 | 4.21e-01 | -7.98e-02 | 9.24e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 103 | 1.62e-01 | 7.97e-02 | 8.24e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 19 | 5.47e-01 | -7.97e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 68 | 2.56e-01 | 7.97e-02 | 8.65e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 6.79e-01 | -7.97e-02 | 9.68e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 113 | 1.43e-01 | 7.97e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 16 | 5.81e-01 | -7.96e-02 | 9.53e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 48 | 3.40e-01 | 7.96e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 12 | 6.33e-01 | 7.96e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 35 | 4.15e-01 | -7.96e-02 | 9.23e-01 |
| GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION | 5 | 7.58e-01 | -7.96e-02 | 9.82e-01 |
| GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 6.63e-01 | 7.96e-02 | 9.67e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 8 | 6.97e-01 | 7.95e-02 | 9.70e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 7.58e-01 | -7.95e-02 | 9.82e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 7.58e-01 | -7.95e-02 | 9.82e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 7.16e-01 | 7.95e-02 | 9.72e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 27 | 4.75e-01 | -7.95e-02 | 9.41e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 1138 | 6.20e-06 | 7.94e-02 | 3.19e-03 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 15 | 5.94e-01 | -7.94e-02 | 9.54e-01 |
| GOCC ZONULA ADHERENS | 8 | 6.97e-01 | 7.94e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 18 | 5.60e-01 | 7.93e-02 | 9.49e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 58 | 2.96e-01 | 7.93e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 12 | 6.34e-01 | 7.93e-02 | 9.61e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 32 | 4.38e-01 | 7.92e-02 | 9.28e-01 |
| GOBP CHOLINE METABOLIC PROCESS | 6 | 7.37e-01 | -7.92e-02 | 9.77e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 6.98e-01 | -7.92e-02 | 9.70e-01 |
| GOBP STEROL HOMEOSTASIS | 99 | 1.74e-01 | -7.91e-02 | 8.37e-01 |
| GOBP FILOPODIUM ASSEMBLY | 65 | 2.70e-01 | -7.91e-02 | 8.69e-01 |
| GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 5 | 7.59e-01 | 7.91e-02 | 9.82e-01 |
| GOBP CHROMOSOME LOCALIZATION | 117 | 1.40e-01 | 7.91e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 13 | 6.22e-01 | -7.90e-02 | 9.61e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 18 | 5.62e-01 | 7.90e-02 | 9.49e-01 |
| GOBP MALATE METABOLIC PROCESS | 9 | 6.81e-01 | 7.90e-02 | 9.68e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 33 | 4.32e-01 | 7.90e-02 | 9.27e-01 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 10 | 6.65e-01 | -7.90e-02 | 9.67e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 80 | 2.22e-01 | -7.90e-02 | 8.57e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 49 | 3.39e-01 | -7.89e-02 | 8.96e-01 |
| GOCC CLATHRIN COATED PIT | 73 | 2.44e-01 | -7.89e-02 | 8.64e-01 |
| GOBP RESPONSE TO CALCIUM ION | 139 | 1.08e-01 | -7.89e-02 | 7.73e-01 |
| GOBP ENDOCARDIAL CUSHION FUSION | 5 | 7.60e-01 | 7.89e-02 | 9.82e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 563 | 1.38e-03 | -7.89e-02 | 1.40e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 155 | 9.03e-02 | 7.88e-02 | 7.52e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 7.38e-01 | 7.88e-02 | 9.77e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 20 | 5.42e-01 | 7.88e-02 | 9.49e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 28 | 4.71e-01 | -7.88e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 43 | 3.72e-01 | 7.87e-02 | 9.09e-01 |
| GOBP MITOTIC CELL CYCLE | 898 | 6.30e-05 | 7.87e-02 | 1.74e-02 |
| GOBP ESTROUS CYCLE | 16 | 5.86e-01 | -7.87e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 26 | 4.88e-01 | 7.86e-02 | 9.43e-01 |
| GOBP TOLERANCE INDUCTION | 29 | 4.64e-01 | -7.86e-02 | 9.37e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 37 | 4.08e-01 | 7.86e-02 | 9.21e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 376 | 8.86e-03 | -7.86e-02 | 3.60e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 7.19e-01 | -7.86e-02 | 9.72e-01 |
| GOBP ACID SECRETION | 43 | 3.73e-01 | -7.86e-02 | 9.09e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 41 | 3.84e-01 | -7.85e-02 | 9.14e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 30 | 4.57e-01 | 7.85e-02 | 9.36e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 197 | 5.76e-02 | 7.85e-02 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION | 9 | 6.84e-01 | 7.85e-02 | 9.68e-01 |
| GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION | 6 | 7.39e-01 | -7.85e-02 | 9.77e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 18 | 5.64e-01 | -7.85e-02 | 9.50e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 6.68e-01 | 7.84e-02 | 9.67e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 56 | 3.10e-01 | 7.84e-02 | 8.88e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 114 | 1.48e-01 | -7.84e-02 | 8.11e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 445 | 4.60e-03 | 7.84e-02 | 2.64e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 7.20e-01 | -7.83e-02 | 9.73e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 6.53e-01 | -7.83e-02 | 9.64e-01 |
| GOCC CIA COMPLEX | 5 | 7.62e-01 | 7.83e-02 | 9.82e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 6 | 7.40e-01 | 7.83e-02 | 9.77e-01 |
| GOBP REGULATION OF OSSIFICATION | 116 | 1.45e-01 | -7.83e-02 | 8.07e-01 |
| GOBP ALPHA KETOGLUTARATE TRANSPORT | 7 | 7.20e-01 | 7.82e-02 | 9.73e-01 |
| GOCC CHROMOSOME | 1811 | 3.30e-08 | 7.82e-02 | 8.45e-05 |
| GOBP GOLGI LOCALIZATION | 14 | 6.12e-01 | 7.82e-02 | 9.59e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 7 | 7.20e-01 | 7.82e-02 | 9.73e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 49 | 3.44e-01 | -7.82e-02 | 8.96e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 39 | 3.98e-01 | -7.82e-02 | 9.18e-01 |
| GOMF DEATH RECEPTOR BINDING | 19 | 5.55e-01 | -7.81e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 7.62e-01 | -7.81e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 336 | 1.39e-02 | 7.81e-02 | 4.46e-01 |
| GOBP WALKING BEHAVIOR | 35 | 4.24e-01 | -7.81e-02 | 9.24e-01 |
| GOMF LYSOZYME ACTIVITY | 9 | 6.85e-01 | 7.81e-02 | 9.68e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 353 | 1.18e-02 | -7.80e-02 | 4.11e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 8 | 7.02e-01 | -7.80e-02 | 9.71e-01 |
| GOBP GLIAL CELL ACTIVATION | 57 | 3.08e-01 | -7.80e-02 | 8.87e-01 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 6 | 7.41e-01 | 7.80e-02 | 9.77e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 14 | 6.14e-01 | 7.79e-02 | 9.59e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 42 | 3.83e-01 | -7.79e-02 | 9.12e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 19 | 5.57e-01 | 7.78e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 42 | 3.83e-01 | 7.78e-02 | 9.13e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 60 | 2.98e-01 | -7.77e-02 | 8.82e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 15 | 6.02e-01 | -7.77e-02 | 9.55e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 136 | 1.18e-01 | 7.77e-02 | 7.82e-01 |
| GOBP NEURAL FOLD FORMATION | 7 | 7.22e-01 | -7.77e-02 | 9.73e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 36 | 4.20e-01 | -7.77e-02 | 9.24e-01 |
| GOBP RESPONSE TO BACTERIUM | 660 | 6.64e-04 | -7.77e-02 | 9.44e-02 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 27 | 4.85e-01 | 7.76e-02 | 9.43e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 16 | 5.91e-01 | 7.76e-02 | 9.54e-01 |
| GOBP INTESTINE SMOOTH MUSCLE CONTRACTION | 8 | 7.04e-01 | 7.76e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 74 | 2.48e-01 | -7.76e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 39 | 4.02e-01 | -7.76e-02 | 9.19e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 44 | 3.73e-01 | -7.76e-02 | 9.09e-01 |
| GOBP PLATELET AGGREGATION | 71 | 2.58e-01 | -7.76e-02 | 8.65e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 6.56e-01 | 7.76e-02 | 9.65e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 507 | 2.80e-03 | 7.75e-02 | 2.02e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 96 | 1.89e-01 | 7.75e-02 | 8.44e-01 |
| GOBP SPINDLE ELONGATION | 13 | 6.29e-01 | -7.75e-02 | 9.61e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 278 | 2.62e-02 | -7.75e-02 | 5.28e-01 |
| GOBP RESPONSE TO ESTROGEN | 66 | 2.77e-01 | 7.75e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 30 | 4.63e-01 | -7.74e-02 | 9.37e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 30 | 4.63e-01 | -7.74e-02 | 9.37e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 11 | 6.57e-01 | -7.74e-02 | 9.66e-01 |
| GOBP SENSORY PERCEPTION | 862 | 1.15e-04 | -7.74e-02 | 2.73e-02 |
| GOBP RESPONSE TO DEXAMETHASONE | 38 | 4.09e-01 | 7.73e-02 | 9.21e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 182 | 7.20e-02 | 7.73e-02 | 7.01e-01 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 8 | 7.05e-01 | -7.73e-02 | 9.71e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 54 | 3.26e-01 | 7.73e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 13 | 6.29e-01 | -7.73e-02 | 9.61e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 38 | 4.10e-01 | -7.73e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 32 | 4.50e-01 | 7.72e-02 | 9.33e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 306 | 2.03e-02 | 7.71e-02 | 4.94e-01 |
| GOCC MKS COMPLEX | 13 | 6.30e-01 | 7.71e-02 | 9.61e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1821 | 4.83e-08 | 7.71e-02 | 9.88e-05 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 20 | 5.51e-01 | -7.71e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 37 | 4.17e-01 | -7.71e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF GASTRULATION | 6 | 7.44e-01 | -7.71e-02 | 9.77e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 39 | 4.05e-01 | 7.70e-02 | 9.21e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 450 | 5.08e-03 | 7.70e-02 | 2.78e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 29 | 4.73e-01 | 7.70e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 7.65e-01 | 7.70e-02 | 9.82e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 95 | 1.95e-01 | -7.70e-02 | 8.44e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 12 | 6.44e-01 | 7.70e-02 | 9.63e-01 |
| GOBP CHEMOKINE PRODUCTION | 101 | 1.81e-01 | -7.70e-02 | 8.41e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 102 | 1.80e-01 | 7.69e-02 | 8.41e-01 |
| GOBP SULFATE TRANSPORT | 17 | 5.83e-01 | -7.69e-02 | 9.54e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 12 | 6.45e-01 | 7.69e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 43 | 3.83e-01 | 7.68e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 65 | 2.84e-01 | 7.68e-02 | 8.74e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 1361 | 2.00e-06 | 7.68e-02 | 1.38e-03 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 24 | 5.15e-01 | 7.68e-02 | 9.46e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 7.25e-01 | -7.68e-02 | 9.75e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 61 | 3.00e-01 | 7.68e-02 | 8.84e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 8 | 7.07e-01 | -7.68e-02 | 9.71e-01 |
| GOCC ASTROCYTE END FOOT | 9 | 6.90e-01 | -7.67e-02 | 9.69e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 30 | 4.67e-01 | 7.67e-02 | 9.38e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 24 | 5.15e-01 | -7.67e-02 | 9.46e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 13 | 6.32e-01 | -7.67e-02 | 9.61e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 77 | 2.45e-01 | 7.66e-02 | 8.65e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 28 | 4.83e-01 | 7.66e-02 | 9.43e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 6.91e-01 | -7.66e-02 | 9.69e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 175 | 8.04e-02 | 7.66e-02 | 7.26e-01 |
| GOBP TONGUE DEVELOPMENT | 20 | 5.53e-01 | -7.66e-02 | 9.49e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 37 | 4.20e-01 | -7.66e-02 | 9.24e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 40 | 4.02e-01 | 7.66e-02 | 9.19e-01 |
| GOBP ACROSOME REACTION | 40 | 4.02e-01 | -7.66e-02 | 9.19e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 42 | 3.91e-01 | 7.66e-02 | 9.15e-01 |
| GOBP PHAGOSOME MATURATION | 28 | 4.83e-01 | -7.66e-02 | 9.43e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 52 | 3.40e-01 | -7.65e-02 | 8.96e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 323 | 1.81e-02 | -7.65e-02 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 15 | 6.08e-01 | -7.65e-02 | 9.56e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 49 | 3.54e-01 | -7.65e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 33 | 4.47e-01 | -7.65e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 94 | 2.00e-01 | -7.64e-02 | 8.48e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 18 | 5.75e-01 | -7.64e-02 | 9.51e-01 |
| GOBP RESPONSE TO LECTIN | 21 | 5.45e-01 | -7.64e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 11 | 6.61e-01 | 7.64e-02 | 9.66e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 8 | 7.08e-01 | 7.63e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 5.65e-01 | 7.63e-02 | 9.50e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 18 | 5.76e-01 | 7.62e-02 | 9.51e-01 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 6 | 7.47e-01 | 7.62e-02 | 9.79e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 85 | 2.25e-01 | 7.62e-02 | 8.59e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 29 | 4.78e-01 | 7.61e-02 | 9.42e-01 |
| GOBP GERMINAL CENTER FORMATION | 14 | 6.22e-01 | -7.61e-02 | 9.61e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 57 | 3.20e-01 | -7.61e-02 | 8.92e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 72 | 2.64e-01 | 7.61e-02 | 8.69e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 25 | 5.10e-01 | 7.60e-02 | 9.46e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 52 | 3.43e-01 | -7.60e-02 | 8.96e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 70 | 2.71e-01 | 7.60e-02 | 8.69e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 8 | 7.10e-01 | 7.60e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 461 | 5.18e-03 | -7.60e-02 | 2.78e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 105 | 1.79e-01 | -7.60e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 32 | 4.57e-01 | 7.59e-02 | 9.36e-01 |
| GOMF LIPOPEPTIDE BINDING | 10 | 6.78e-01 | 7.59e-02 | 9.68e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 53 | 3.39e-01 | 7.59e-02 | 8.96e-01 |
| GOCC CATENIN COMPLEX | 31 | 4.65e-01 | 7.59e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 72 | 2.66e-01 | -7.58e-02 | 8.69e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 31 | 4.65e-01 | 7.58e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 10 | 6.78e-01 | -7.58e-02 | 9.68e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 387 | 1.05e-02 | 7.58e-02 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT | 5 | 7.69e-01 | 7.58e-02 | 9.82e-01 |
| GOBP TORC1 SIGNALING | 95 | 2.02e-01 | 7.57e-02 | 8.51e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 13 | 6.36e-01 | -7.57e-02 | 9.61e-01 |
| GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS | 10 | 6.78e-01 | 7.57e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 7.69e-01 | 7.57e-02 | 9.82e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 8 | 7.11e-01 | -7.57e-02 | 9.71e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 71 | 2.70e-01 | 7.57e-02 | 8.69e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 42 | 3.96e-01 | -7.56e-02 | 9.18e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 6.64e-01 | 7.56e-02 | 9.67e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 549 | 2.44e-03 | 7.56e-02 | 1.89e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 91 | 2.13e-01 | 7.56e-02 | 8.54e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 7.70e-01 | 7.56e-02 | 9.82e-01 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 10 | 6.79e-01 | 7.55e-02 | 9.68e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 170 | 8.93e-02 | -7.55e-02 | 7.52e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 75 | 2.58e-01 | -7.55e-02 | 8.65e-01 |
| GOCC P BODY | 98 | 1.97e-01 | 7.55e-02 | 8.44e-01 |
| GOCC ACTIN FILAMENT | 105 | 1.81e-01 | -7.55e-02 | 8.41e-01 |
| GOBP LOCOMOTION | 1260 | 6.60e-06 | -7.55e-02 | 3.21e-03 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 8 | 7.12e-01 | -7.55e-02 | 9.71e-01 |
| GOBP NADPH REGENERATION | 21 | 5.49e-01 | 7.55e-02 | 9.49e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 61 | 3.08e-01 | -7.55e-02 | 8.87e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1562 | 6.39e-07 | 7.55e-02 | 7.26e-04 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 108 | 1.76e-01 | 7.54e-02 | 8.41e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN | 6 | 7.49e-01 | 7.54e-02 | 9.80e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 14 | 6.25e-01 | -7.54e-02 | 9.61e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 25 | 5.14e-01 | 7.54e-02 | 9.46e-01 |
| GOBP REGULATION OF NEURON MATURATION | 8 | 7.12e-01 | -7.54e-02 | 9.71e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 219 | 5.47e-02 | -7.53e-02 | 6.47e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 13 | 6.38e-01 | -7.53e-02 | 9.62e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 37 | 4.28e-01 | -7.53e-02 | 9.27e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 47 | 3.72e-01 | -7.53e-02 | 9.09e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 20 | 5.60e-01 | 7.52e-02 | 9.49e-01 |
| GOBP NOTOCHORD MORPHOGENESIS | 8 | 7.13e-01 | 7.52e-02 | 9.71e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 217 | 5.63e-02 | -7.52e-02 | 6.53e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 7.13e-01 | 7.52e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 17 | 5.92e-01 | -7.52e-02 | 9.54e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 7.71e-01 | 7.52e-02 | 9.82e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 65 | 2.95e-01 | 7.51e-02 | 8.82e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 14 | 6.27e-01 | -7.51e-02 | 9.61e-01 |
| GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY | 7 | 7.31e-01 | -7.51e-02 | 9.76e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 9 | 6.97e-01 | -7.51e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 19 | 5.71e-01 | -7.50e-02 | 9.51e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 29 | 4.84e-01 | -7.50e-02 | 9.43e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 5.72e-01 | -7.50e-02 | 9.51e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 13 | 6.40e-01 | -7.49e-02 | 9.62e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 12 | 6.53e-01 | -7.49e-02 | 9.64e-01 |
| GOCC DENDRITE CYTOPLASM | 26 | 5.09e-01 | 7.48e-02 | 9.46e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 13 | 6.40e-01 | 7.48e-02 | 9.62e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 22 | 5.44e-01 | -7.48e-02 | 9.49e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 109 | 1.77e-01 | -7.48e-02 | 8.41e-01 |
| GOBP FUNGIFORM PAPILLA DEVELOPMENT | 6 | 7.51e-01 | 7.47e-02 | 9.80e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 24 | 5.26e-01 | 7.47e-02 | 9.47e-01 |
| GOBP MACROMOLECULE METHYLATION | 195 | 7.21e-02 | 7.47e-02 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 50 | 3.61e-01 | -7.47e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 54 | 3.42e-01 | 7.47e-02 | 8.96e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 235 | 4.90e-02 | -7.45e-02 | 6.28e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 711 | 7.07e-04 | 7.45e-02 | 9.78e-02 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 11 | 6.69e-01 | -7.45e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE | 5 | 7.73e-01 | -7.45e-02 | 9.82e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 15 | 6.18e-01 | -7.44e-02 | 9.61e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 21 | 5.55e-01 | -7.44e-02 | 9.49e-01 |
| GOCC KINOCILIUM | 9 | 6.99e-01 | 7.44e-02 | 9.70e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 47 | 3.78e-01 | 7.44e-02 | 9.09e-01 |
| GOBP CAMP MEDIATED SIGNALING | 53 | 3.49e-01 | -7.43e-02 | 8.99e-01 |
| GOMF SYNTAXIN BINDING | 65 | 3.00e-01 | -7.43e-02 | 8.84e-01 |
| GOBP PROTEIN TETRAMERIZATION | 88 | 2.28e-01 | 7.43e-02 | 8.62e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 7.00e-01 | -7.43e-02 | 9.70e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 5.65e-01 | -7.42e-02 | 9.50e-01 |
| GOBP MUSCLE ADAPTATION | 117 | 1.66e-01 | -7.42e-02 | 8.25e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 21 | 5.56e-01 | 7.42e-02 | 9.49e-01 |
| GOMF METHYL CPG BINDING | 24 | 5.29e-01 | -7.42e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 21 | 5.56e-01 | -7.41e-02 | 9.49e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 7.00e-01 | 7.41e-02 | 9.70e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 14 | 6.31e-01 | -7.41e-02 | 9.61e-01 |
| GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 7.74e-01 | 7.41e-02 | 9.82e-01 |
| GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 7.74e-01 | -7.41e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 37 | 4.36e-01 | -7.40e-02 | 9.27e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 44 | 3.96e-01 | -7.40e-02 | 9.18e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 54 | 3.47e-01 | -7.40e-02 | 8.97e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 61 | 3.18e-01 | -7.40e-02 | 8.91e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 25 | 5.22e-01 | 7.40e-02 | 9.47e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 88 | 2.30e-01 | -7.40e-02 | 8.62e-01 |
| GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION | 5 | 7.75e-01 | -7.39e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 12 | 6.57e-01 | -7.39e-02 | 9.66e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 27 | 5.06e-01 | 7.39e-02 | 9.45e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 14 | 6.32e-01 | 7.39e-02 | 9.61e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 24 | 5.31e-01 | 7.39e-02 | 9.48e-01 |
| GOBP ACTIN NUCLEATION | 53 | 3.52e-01 | -7.39e-02 | 9.00e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 11 | 6.71e-01 | -7.39e-02 | 9.68e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 14 | 6.32e-01 | -7.39e-02 | 9.61e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 92 | 2.21e-01 | -7.39e-02 | 8.56e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 15 | 6.21e-01 | 7.38e-02 | 9.61e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 36 | 4.43e-01 | 7.38e-02 | 9.30e-01 |
| GOBP BASE EXCISION REPAIR | 42 | 4.08e-01 | 7.38e-02 | 9.21e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 5 | 7.75e-01 | -7.38e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 6.86e-01 | 7.38e-02 | 9.68e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 21 | 5.58e-01 | 7.38e-02 | 9.49e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 161 | 1.06e-01 | 7.38e-02 | 7.72e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 34 | 4.57e-01 | -7.37e-02 | 9.36e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 109 | 1.84e-01 | -7.37e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF ODONTOGENESIS | 7 | 7.36e-01 | 7.36e-02 | 9.77e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 80 | 2.55e-01 | -7.36e-02 | 8.65e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 7.36e-01 | -7.35e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 118 | 1.68e-01 | -7.35e-02 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 32 | 4.72e-01 | -7.35e-02 | 9.39e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 7.36e-01 | -7.35e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 59 | 3.29e-01 | 7.34e-02 | 8.93e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 29 | 4.94e-01 | 7.34e-02 | 9.45e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 10 | 6.88e-01 | 7.34e-02 | 9.69e-01 |
| GOBP HEART MORPHOGENESIS | 262 | 4.09e-02 | 7.34e-02 | 6.09e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 20 | 5.70e-01 | -7.34e-02 | 9.51e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 11 | 6.74e-01 | 7.34e-02 | 9.68e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 18 | 5.90e-01 | -7.34e-02 | 9.54e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 17 | 6.01e-01 | -7.34e-02 | 9.55e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 11 | 6.74e-01 | -7.33e-02 | 9.68e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 19 | 5.80e-01 | -7.33e-02 | 9.53e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 7.03e-01 | -7.33e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 27 | 5.10e-01 | 7.33e-02 | 9.46e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 7.20e-01 | 7.33e-02 | 9.73e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 23 | 5.43e-01 | -7.33e-02 | 9.49e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 24 | 5.34e-01 | 7.33e-02 | 9.49e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 140 | 1.35e-01 | 7.33e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 60 | 3.27e-01 | 7.32e-02 | 8.93e-01 |
| GOBP MITOTIC CYTOKINESIS | 85 | 2.44e-01 | 7.31e-02 | 8.64e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 50 | 3.71e-01 | -7.31e-02 | 9.09e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 7.21e-01 | -7.30e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 92 | 2.26e-01 | -7.30e-02 | 8.60e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 13 | 6.48e-01 | 7.30e-02 | 9.63e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 31 | 4.82e-01 | 7.30e-02 | 9.42e-01 |
| GOBP DENDRITIC TRANSPORT | 12 | 6.61e-01 | 7.30e-02 | 9.66e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 5.54e-01 | -7.29e-02 | 9.49e-01 |
| GOBP SKIN DEVELOPMENT | 306 | 2.83e-02 | -7.29e-02 | 5.45e-01 |
| GOBP RNA SPLICING | 420 | 1.04e-02 | 7.29e-02 | 3.86e-01 |
| GOBP NADH METABOLIC PROCESS | 11 | 6.76e-01 | 7.29e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 5.37e-01 | 7.28e-02 | 9.49e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 12 | 6.62e-01 | 7.28e-02 | 9.66e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.76e-01 | -7.27e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 27 | 5.13e-01 | -7.27e-02 | 9.46e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 34 | 4.63e-01 | -7.27e-02 | 9.37e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 89 | 2.36e-01 | -7.27e-02 | 8.64e-01 |
| GOCC BASAL DENDRITE | 6 | 7.58e-01 | -7.27e-02 | 9.82e-01 |
| GOBP LIPID MODIFICATION | 185 | 8.84e-02 | 7.26e-02 | 7.52e-01 |
| GOBP REGULATION OF FERTILIZATION | 17 | 6.04e-01 | -7.26e-02 | 9.55e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 24 | 5.38e-01 | -7.26e-02 | 9.49e-01 |
| GOBP REGULATION OF DNA BINDING | 82 | 2.56e-01 | 7.25e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 45 | 4.00e-01 | 7.25e-02 | 9.18e-01 |
| GOBP ENDOCYTOSIS | 681 | 1.26e-03 | -7.25e-02 | 1.30e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CHROMATIN | 78 | 2.69e-01 | 7.24e-02 | 8.69e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 7 | 7.40e-01 | 7.24e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 11 | 6.78e-01 | 7.24e-02 | 9.68e-01 |
| GOMF CHROMATIN BINDING | 551 | 3.67e-03 | 7.24e-02 | 2.31e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 17 | 6.05e-01 | 7.24e-02 | 9.55e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 23 | 5.48e-01 | 7.24e-02 | 9.49e-01 |
| GOCC INTEGRIN COMPLEX | 30 | 4.93e-01 | -7.23e-02 | 9.45e-01 |
| GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX | 5 | 7.79e-01 | 7.23e-02 | 9.83e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 15 | 6.28e-01 | 7.23e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 39 | 4.35e-01 | -7.22e-02 | 9.27e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 21 | 5.67e-01 | 7.22e-02 | 9.50e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 10 | 6.93e-01 | 7.22e-02 | 9.69e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 48 | 3.87e-01 | -7.21e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 10 | 6.93e-01 | 7.21e-02 | 9.69e-01 |
| GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING | 5 | 7.80e-01 | -7.21e-02 | 9.83e-01 |
| GOBP REGULATION OF CELL CYCLE | 1068 | 6.95e-05 | 7.20e-02 | 1.87e-02 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 18 | 5.97e-01 | -7.20e-02 | 9.55e-01 |
| GOMF RIBOSOME BINDING | 101 | 2.11e-01 | 7.20e-02 | 8.54e-01 |
| GOCC MEMBRANE COAT | 93 | 2.30e-01 | 7.20e-02 | 8.62e-01 |
| GOBP TELOMERE CAPPING | 39 | 4.37e-01 | 7.20e-02 | 9.27e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 28 | 5.10e-01 | 7.20e-02 | 9.46e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 7.60e-01 | -7.20e-02 | 9.82e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 11 | 6.79e-01 | -7.19e-02 | 9.68e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 44 | 4.09e-01 | -7.19e-02 | 9.21e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 89 | 2.41e-01 | 7.19e-02 | 8.64e-01 |
| GOCC PHAGOLYSOSOME | 5 | 7.81e-01 | 7.19e-02 | 9.83e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 60 | 3.35e-01 | -7.19e-02 | 8.96e-01 |
| GOCC PARANODE REGION OF AXON | 12 | 6.66e-01 | -7.19e-02 | 9.67e-01 |
| GOBP ICOSANOID CATABOLIC PROCESS | 9 | 7.09e-01 | -7.19e-02 | 9.71e-01 |
| GOBP ORGANELLE FISSION | 478 | 7.17e-03 | 7.18e-02 | 3.29e-01 |
| GOCC CELL SURFACE | 838 | 4.17e-04 | -7.18e-02 | 6.56e-02 |
| GOBP TRNA PROCESSING | 126 | 1.64e-01 | 7.17e-02 | 8.24e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 351 | 2.10e-02 | -7.17e-02 | 4.96e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 4.22e-01 | -7.17e-02 | 9.24e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 80 | 2.68e-01 | -7.16e-02 | 8.69e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 66 | 3.15e-01 | 7.16e-02 | 8.90e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 107 | 2.01e-01 | 7.16e-02 | 8.49e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 58 | 3.46e-01 | -7.15e-02 | 8.96e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 29 | 5.06e-01 | 7.14e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 9 | 7.11e-01 | 7.14e-02 | 9.71e-01 |
| GOBP VASOCONSTRICTION | 80 | 2.69e-01 | -7.14e-02 | 8.69e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 7.82e-01 | -7.14e-02 | 9.83e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 11 | 6.82e-01 | -7.14e-02 | 9.68e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 49 | 3.87e-01 | -7.14e-02 | 9.14e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 12 | 6.69e-01 | 7.14e-02 | 9.67e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 23 | 5.54e-01 | 7.14e-02 | 9.49e-01 |
| GOBP NAIL DEVELOPMENT | 11 | 6.82e-01 | -7.13e-02 | 9.68e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 5 | 7.82e-01 | 7.13e-02 | 9.83e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 51 | 3.78e-01 | 7.13e-02 | 9.09e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 249 | 5.30e-02 | 7.12e-02 | 6.45e-01 |
| GOBP BODY MORPHOGENESIS | 46 | 4.03e-01 | 7.12e-02 | 9.20e-01 |
| GOBP BLASTODERM SEGMENTATION | 24 | 5.46e-01 | 7.12e-02 | 9.49e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 36 | 4.60e-01 | -7.12e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 39 | 4.42e-01 | 7.12e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 460 | 8.89e-03 | -7.12e-02 | 3.60e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 5.63e-01 | -7.12e-02 | 9.50e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 89 | 2.46e-01 | 7.11e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 10 | 6.97e-01 | -7.11e-02 | 9.70e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 20 | 5.82e-01 | 7.11e-02 | 9.53e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 5.73e-01 | -7.11e-02 | 9.51e-01 |
| GOBP SYNAPSE MATURATION | 33 | 4.80e-01 | -7.11e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 10 | 6.97e-01 | -7.11e-02 | 9.70e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 49 | 3.90e-01 | -7.10e-02 | 9.15e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 7.28e-01 | -7.10e-02 | 9.75e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 6.45e-01 | -7.10e-02 | 9.63e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 1.40e-01 | -7.10e-02 | 8.06e-01 |
| GOCC TERMINAL BOUTON | 43 | 4.20e-01 | -7.10e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT | 8 | 7.28e-01 | -7.10e-02 | 9.75e-01 |
| GOBP CRISTAE FORMATION | 15 | 6.34e-01 | 7.10e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 126 | 1.69e-01 | -7.10e-02 | 8.31e-01 |
| GOBP ENDODERM FORMATION | 57 | 3.54e-01 | -7.10e-02 | 9.01e-01 |
| GOBP T TUBULE ORGANIZATION | 6 | 7.64e-01 | -7.09e-02 | 9.82e-01 |
| GOMF KINESIN BINDING | 43 | 4.21e-01 | 7.09e-02 | 9.24e-01 |
| GOBP VIRAL BUDDING | 25 | 5.40e-01 | 7.08e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 307 | 3.29e-02 | -7.08e-02 | 5.58e-01 |
| GOBP POTASSIUM ION TRANSPORT | 234 | 6.22e-02 | -7.08e-02 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 12 | 6.71e-01 | 7.08e-02 | 9.68e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 37 | 4.56e-01 | 7.08e-02 | 9.36e-01 |
| GOCC CENTROSOME | 607 | 2.94e-03 | 7.07e-02 | 2.08e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 3.87e-01 | 7.07e-02 | 9.14e-01 |
| GOBP PROTEIN SUMOYLATION | 64 | 3.29e-01 | 7.06e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 19 | 5.94e-01 | 7.06e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 7.46e-01 | -7.06e-02 | 9.79e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 7.14e-01 | -7.05e-02 | 9.72e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 149 | 1.38e-01 | -7.05e-02 | 8.06e-01 |
| GOBP CEREBRAL CORTEX REGIONALIZATION | 7 | 7.47e-01 | 7.04e-02 | 9.79e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 506 | 6.71e-03 | 7.04e-02 | 3.20e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 41 | 4.35e-01 | -7.04e-02 | 9.27e-01 |
| GOBP RESPONSE TO ALKALOID | 90 | 2.49e-01 | 7.04e-02 | 8.65e-01 |
| GOMF METAL ION SENSOR ACTIVITY | 5 | 7.85e-01 | 7.03e-02 | 9.84e-01 |
| GOMF AMMONIA LYASE ACTIVITY | 5 | 7.86e-01 | 7.02e-02 | 9.84e-01 |
| GOBP PIGMENTATION | 108 | 2.07e-01 | -7.02e-02 | 8.51e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 102 | 2.21e-01 | -7.02e-02 | 8.56e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 294 | 3.84e-02 | -7.02e-02 | 5.93e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 23 | 5.60e-01 | -7.01e-02 | 9.49e-01 |
| GOCC GTPASE COMPLEX | 38 | 4.54e-01 | -7.01e-02 | 9.36e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 271 | 4.69e-02 | 7.01e-02 | 6.25e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 43 | 4.26e-01 | 7.01e-02 | 9.26e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 36 | 4.67e-01 | -7.01e-02 | 9.38e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 78 | 2.85e-01 | 7.01e-02 | 8.74e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 7.66e-01 | 7.01e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 7.66e-01 | 7.01e-02 | 9.82e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 8 | 7.32e-01 | 7.01e-02 | 9.76e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 32 | 4.93e-01 | -7.00e-02 | 9.45e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 57 | 3.60e-01 | -7.00e-02 | 9.04e-01 |
| GOMF HISTAMINE RECEPTOR ACTIVITY | 6 | 7.67e-01 | -6.99e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 110 | 2.06e-01 | 6.98e-02 | 8.51e-01 |
| GOBP MAST CELL CHEMOTAXIS | 10 | 7.02e-01 | -6.98e-02 | 9.71e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 33 | 4.88e-01 | -6.98e-02 | 9.43e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 129 | 1.71e-01 | 6.98e-02 | 8.32e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 8 | 7.32e-01 | -6.98e-02 | 9.76e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 11 | 6.88e-01 | -6.98e-02 | 9.69e-01 |
| GOBP NEURON PROJECTION REGENERATION | 54 | 3.75e-01 | -6.98e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 20 | 5.89e-01 | 6.98e-02 | 9.54e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 6.63e-01 | 6.98e-02 | 9.67e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 37 | 4.63e-01 | -6.97e-02 | 9.37e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 6.89e-01 | -6.97e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 10 | 7.03e-01 | -6.97e-02 | 9.71e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 32 | 4.95e-01 | 6.97e-02 | 9.45e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 418 | 1.45e-02 | -6.97e-02 | 4.54e-01 |
| GOBP REGULATION OF AXON EXTENSION | 85 | 2.67e-01 | -6.97e-02 | 8.69e-01 |
| GOBP PANCREAS DEVELOPMENT | 78 | 2.88e-01 | 6.97e-02 | 8.76e-01 |
| GOBP ARTERY DEVELOPMENT | 111 | 2.05e-01 | 6.96e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 24 | 5.55e-01 | 6.96e-02 | 9.49e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 5.55e-01 | -6.96e-02 | 9.49e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 40 | 4.46e-01 | 6.96e-02 | 9.31e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 6 | 7.68e-01 | -6.96e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 7.18e-01 | -6.96e-02 | 9.72e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 27 | 5.32e-01 | -6.96e-02 | 9.48e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 11 | 6.90e-01 | 6.96e-02 | 9.69e-01 |
| GOBP TRNA METHYLATION | 38 | 4.58e-01 | 6.95e-02 | 9.37e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 15 | 6.41e-01 | -6.95e-02 | 9.62e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 30 | 5.10e-01 | -6.95e-02 | 9.46e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 17 | 6.20e-01 | 6.95e-02 | 9.61e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 9 | 7.18e-01 | 6.94e-02 | 9.72e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 181 | 1.07e-01 | -6.94e-02 | 7.72e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 7 | 7.51e-01 | 6.94e-02 | 9.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 46 | 4.16e-01 | 6.94e-02 | 9.23e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 23 | 5.65e-01 | -6.94e-02 | 9.50e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 4.72e-01 | 6.93e-02 | 9.39e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 88 | 2.61e-01 | -6.93e-02 | 8.66e-01 |
| GOBP PROLINE TRANSPORT | 11 | 6.91e-01 | -6.93e-02 | 9.69e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC | 8 | 7.34e-01 | -6.93e-02 | 9.77e-01 |
| GOMF FLOPPASE ACTIVITY | 15 | 6.43e-01 | -6.92e-02 | 9.63e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 52 | 3.88e-01 | 6.92e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 66 | 3.31e-01 | 6.92e-02 | 8.93e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 195 | 9.59e-02 | 6.92e-02 | 7.66e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 134 | 1.67e-01 | -6.91e-02 | 8.30e-01 |
| GOBP CYTOPLASM ORGANIZATION | 15 | 6.43e-01 | -6.91e-02 | 9.63e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 67 | 3.28e-01 | -6.91e-02 | 8.93e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 108 | 2.15e-01 | 6.91e-02 | 8.55e-01 |
| GOMF CAMP BINDING | 22 | 5.75e-01 | -6.91e-02 | 9.51e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 72 | 3.11e-01 | 6.91e-02 | 8.88e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 8 | 7.35e-01 | 6.91e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 891 | 4.70e-04 | 6.91e-02 | 7.18e-02 |
| GOMF LRR DOMAIN BINDING | 16 | 6.33e-01 | 6.90e-02 | 9.61e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 5.35e-01 | 6.90e-02 | 9.49e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 34 | 4.86e-01 | -6.90e-02 | 9.43e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 13 | 6.67e-01 | 6.89e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 37 | 4.68e-01 | 6.89e-02 | 9.39e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 42 | 4.40e-01 | 6.89e-02 | 9.29e-01 |
| GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE | 6 | 7.70e-01 | 6.89e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 51 | 3.95e-01 | -6.89e-02 | 9.18e-01 |
| GOBP AMINO ACID TRANSPORT | 142 | 1.56e-01 | -6.89e-02 | 8.17e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 4.19e-01 | 6.89e-02 | 9.24e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 127 | 1.80e-01 | 6.89e-02 | 8.41e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 11 | 6.93e-01 | -6.88e-02 | 9.69e-01 |
| GOBP EXOCYTIC PROCESS | 82 | 2.81e-01 | -6.88e-02 | 8.73e-01 |
| GOBP NUCLEOPHAGY | 18 | 6.13e-01 | -6.88e-02 | 9.59e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 92 | 2.54e-01 | 6.88e-02 | 8.65e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 39 | 4.57e-01 | -6.88e-02 | 9.36e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 11 | 6.93e-01 | 6.88e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 12 | 6.80e-01 | -6.88e-02 | 9.68e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 12 | 6.80e-01 | 6.88e-02 | 9.68e-01 |
| GOBP RRNA MODIFICATION | 32 | 5.01e-01 | 6.87e-02 | 9.45e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 178 | 1.14e-01 | 6.87e-02 | 7.81e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 14 | 6.56e-01 | -6.87e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 27 | 5.37e-01 | -6.87e-02 | 9.49e-01 |
| GOBP AEROBIC RESPIRATION | 170 | 1.22e-01 | 6.87e-02 | 7.89e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 406 | 1.76e-02 | -6.86e-02 | 4.76e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 17 | 6.24e-01 | 6.86e-02 | 9.61e-01 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT | 6 | 7.71e-01 | -6.86e-02 | 9.82e-01 |
| GOCC SCAR COMPLEX | 12 | 6.81e-01 | 6.86e-02 | 9.68e-01 |
| GOCC MICROTUBULE BUNDLE | 6 | 7.71e-01 | 6.86e-02 | 9.82e-01 |
| GOBP STRESS FIBER ASSEMBLY | 108 | 2.18e-01 | -6.86e-02 | 8.56e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 13 | 6.68e-01 | -6.86e-02 | 9.67e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 153 | 1.43e-01 | -6.86e-02 | 8.06e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 22 | 5.78e-01 | -6.85e-02 | 9.52e-01 |
| GOMF ACETYLESTERASE ACTIVITY | 5 | 7.91e-01 | -6.85e-02 | 9.84e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 176 | 1.17e-01 | -6.85e-02 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 74 | 3.08e-01 | 6.85e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 191 | 1.03e-01 | -6.85e-02 | 7.66e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 27 | 5.38e-01 | -6.85e-02 | 9.49e-01 |
| GOCC CATSPER COMPLEX | 14 | 6.57e-01 | -6.85e-02 | 9.66e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 46 | 4.22e-01 | -6.85e-02 | 9.24e-01 |
| GOBP VACUOLAR TRANSPORT | 163 | 1.32e-01 | 6.84e-02 | 7.96e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 27 | 5.38e-01 | 6.84e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 241 | 6.73e-02 | 6.84e-02 | 6.87e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 32 | 5.03e-01 | -6.84e-02 | 9.45e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 31 | 5.10e-01 | -6.84e-02 | 9.46e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 16 | 6.36e-01 | 6.83e-02 | 9.61e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 319 | 3.59e-02 | -6.83e-02 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION | 11 | 6.95e-01 | 6.83e-02 | 9.69e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 7 | 7.54e-01 | -6.83e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 63 | 3.49e-01 | -6.83e-02 | 8.99e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 64 | 3.45e-01 | -6.83e-02 | 8.96e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 29 | 5.25e-01 | 6.83e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 71 | 3.20e-01 | -6.82e-02 | 8.92e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 74 | 3.10e-01 | -6.82e-02 | 8.88e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 239 | 6.95e-02 | -6.82e-02 | 6.94e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 129 | 1.81e-01 | -6.82e-02 | 8.41e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 164 | 1.32e-01 | 6.81e-02 | 7.96e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 449 | 1.34e-02 | 6.81e-02 | 4.44e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 51 | 4.00e-01 | -6.81e-02 | 9.18e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 47 | 4.19e-01 | -6.81e-02 | 9.24e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 14 | 6.59e-01 | -6.81e-02 | 9.66e-01 |
| GOMF MACROLIDE BINDING | 12 | 6.83e-01 | -6.81e-02 | 9.68e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.09e-01 | 6.81e-02 | 9.71e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 3.92e-01 | 6.80e-02 | 9.16e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 6.38e-01 | 6.80e-02 | 9.62e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 197 | 9.97e-02 | -6.80e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 31 | 5.12e-01 | 6.80e-02 | 9.46e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 184 | 1.12e-01 | 6.80e-02 | 7.77e-01 |
| GOBP HYDROGEN SULFIDE METABOLIC PROCESS | 6 | 7.73e-01 | -6.80e-02 | 9.82e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 70 | 3.25e-01 | 6.80e-02 | 8.93e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 33 | 4.99e-01 | -6.79e-02 | 9.45e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 8 | 7.39e-01 | 6.79e-02 | 9.77e-01 |
| GOMF E BOX BINDING | 58 | 3.71e-01 | 6.79e-02 | 9.09e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 182 | 1.14e-01 | -6.79e-02 | 7.81e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 11 | 6.97e-01 | 6.79e-02 | 9.70e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 132 | 1.78e-01 | 6.78e-02 | 8.41e-01 |
| GOCC RUFFLE MEMBRANE | 99 | 2.44e-01 | -6.78e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 12 | 6.84e-01 | -6.78e-02 | 9.68e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 56 | 3.80e-01 | -6.78e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 60 | 3.64e-01 | -6.78e-02 | 9.06e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 24 | 5.65e-01 | 6.78e-02 | 9.50e-01 |
| GOMF NEUROPEPTIDE BINDING | 31 | 5.14e-01 | 6.78e-02 | 9.46e-01 |
| GOBP DIGESTION | 128 | 1.85e-01 | -6.78e-02 | 8.44e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 16 | 6.39e-01 | -6.77e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 391 | 2.15e-02 | 6.77e-02 | 5.02e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 166 | 1.32e-01 | -6.77e-02 | 7.96e-01 |
| GOMF VITAMIN B6 BINDING | 54 | 3.90e-01 | 6.77e-02 | 9.15e-01 |
| GOBP AXIS SPECIFICATION | 91 | 2.65e-01 | 6.77e-02 | 8.69e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 19 | 6.10e-01 | 6.76e-02 | 9.58e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 239 | 7.17e-02 | -6.76e-02 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 24 | 5.66e-01 | -6.76e-02 | 9.50e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 18 | 6.19e-01 | 6.76e-02 | 9.61e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 21 | 5.92e-01 | -6.76e-02 | 9.54e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 5.75e-01 | -6.76e-02 | 9.51e-01 |
| GOCC CATALYTIC COMPLEX | 1609 | 6.24e-06 | 6.75e-02 | 3.19e-03 |
| GOBP GLUTAMINE TRANSPORT | 9 | 7.26e-01 | -6.75e-02 | 9.75e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 5.59e-01 | -6.75e-02 | 9.49e-01 |
| GOBP REGULATION OF LOCOMOTION | 1080 | 1.79e-04 | -6.75e-02 | 3.87e-02 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 20 | 6.01e-01 | 6.75e-02 | 9.55e-01 |
| GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING | 7 | 7.57e-01 | -6.74e-02 | 9.82e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 158 | 1.44e-01 | 6.74e-02 | 8.06e-01 |
| GOBP MUCUS SECRETION | 18 | 6.21e-01 | 6.74e-02 | 9.61e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 101 | 2.42e-01 | -6.74e-02 | 8.64e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 23 | 5.76e-01 | -6.74e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 8 | 7.42e-01 | 6.73e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 81 | 2.95e-01 | -6.73e-02 | 8.82e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 7 | 7.58e-01 | 6.72e-02 | 9.82e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 295 | 4.72e-02 | -6.72e-02 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 19 | 6.12e-01 | -6.72e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 181 | 1.19e-01 | -6.71e-02 | 7.87e-01 |
| GOBP N GLYCAN PROCESSING | 17 | 6.32e-01 | 6.71e-02 | 9.61e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 57 | 3.81e-01 | 6.71e-02 | 9.11e-01 |
| GOBP VASCULAR WOUND HEALING | 22 | 5.86e-01 | 6.71e-02 | 9.54e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 21 | 5.95e-01 | 6.71e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 27 | 5.46e-01 | 6.71e-02 | 9.49e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 262 | 6.18e-02 | 6.70e-02 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 202 | 1.01e-01 | -6.70e-02 | 7.66e-01 |
| GOCC MEMBRANE MICRODOMAIN | 279 | 5.42e-02 | -6.70e-02 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 78 | 3.07e-01 | -6.70e-02 | 8.85e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 111 | 2.23e-01 | 6.69e-02 | 8.57e-01 |
| GOBP MATING BEHAVIOR | 36 | 4.87e-01 | -6.69e-02 | 9.43e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 11 | 7.01e-01 | 6.69e-02 | 9.70e-01 |
| GOMF R SMAD BINDING | 25 | 5.62e-01 | 6.69e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 15 | 6.54e-01 | -6.69e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 24 | 5.71e-01 | -6.69e-02 | 9.51e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 95 | 2.60e-01 | 6.68e-02 | 8.66e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 7.77e-01 | -6.68e-02 | 9.83e-01 |
| GOCC SPINDLE | 404 | 2.12e-02 | 6.68e-02 | 4.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 11 | 7.01e-01 | -6.68e-02 | 9.71e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 16 | 6.44e-01 | -6.68e-02 | 9.63e-01 |
| GOCC TRANSPORT VESICLE | 408 | 2.09e-02 | -6.66e-02 | 4.96e-01 |
| GOBP GROOMING BEHAVIOR | 17 | 6.34e-01 | -6.66e-02 | 9.61e-01 |
| GOBP SELECTIVE AUTOPHAGY | 92 | 2.70e-01 | 6.66e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 88 | 2.80e-01 | -6.66e-02 | 8.72e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 11 | 7.02e-01 | -6.66e-02 | 9.71e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 166 | 1.39e-01 | -6.65e-02 | 8.06e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 66 | 3.50e-01 | 6.65e-02 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 24 | 5.73e-01 | -6.65e-02 | 9.51e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 10 | 7.16e-01 | 6.65e-02 | 9.72e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 34 | 5.02e-01 | -6.65e-02 | 9.45e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY | 7 | 7.61e-01 | 6.65e-02 | 9.82e-01 |
| GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS | 5 | 7.97e-01 | 6.65e-02 | 9.84e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 137 | 1.80e-01 | 6.64e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 82 | 2.99e-01 | 6.64e-02 | 8.83e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 71 | 3.34e-01 | -6.64e-02 | 8.94e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 36 | 4.91e-01 | 6.63e-02 | 9.45e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 100 | 2.52e-01 | -6.63e-02 | 8.65e-01 |
| GOBP COPPER ION TRANSPORT | 15 | 6.57e-01 | -6.63e-02 | 9.66e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 7 | 7.61e-01 | -6.63e-02 | 9.82e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 134 | 1.85e-01 | 6.63e-02 | 8.44e-01 |
| GOCC RUFFLE | 178 | 1.28e-01 | -6.62e-02 | 7.93e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 9 | 7.31e-01 | 6.62e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 62 | 3.68e-01 | -6.62e-02 | 9.07e-01 |
| GOBP REGULATION OF GLIOGENESIS | 106 | 2.39e-01 | 6.61e-02 | 8.64e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 165 | 1.43e-01 | -6.61e-02 | 8.06e-01 |
| GOBP CALCIUM ION IMPORT | 46 | 4.38e-01 | -6.61e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 6.28e-01 | 6.60e-02 | 9.61e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 207 | 1.01e-01 | -6.60e-02 | 7.66e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 85 | 2.93e-01 | -6.60e-02 | 8.79e-01 |
| GOCC CEREBELLAR MOSSY FIBER | 7 | 7.62e-01 | -6.60e-02 | 9.82e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 118 | 2.15e-01 | 6.60e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 139 | 1.79e-01 | -6.60e-02 | 8.41e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 13 | 6.80e-01 | 6.60e-02 | 9.68e-01 |
| GOCC DENDRITIC SPINE HEAD | 7 | 7.62e-01 | 6.60e-02 | 9.82e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 14 | 6.69e-01 | -6.60e-02 | 9.67e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 47 | 4.34e-01 | 6.60e-02 | 9.27e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 47 | 4.34e-01 | 6.60e-02 | 9.27e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 25 | 5.68e-01 | -6.60e-02 | 9.51e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 7.18e-01 | 6.60e-02 | 9.72e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 27 | 5.53e-01 | -6.60e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 11 | 7.05e-01 | 6.59e-02 | 9.71e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 430 | 1.90e-02 | -6.59e-02 | 4.89e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 31 | 5.25e-01 | -6.59e-02 | 9.47e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 8 | 7.47e-01 | 6.59e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 93 | 2.72e-01 | 6.59e-02 | 8.69e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 16 | 6.48e-01 | -6.59e-02 | 9.63e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 99 | 2.57e-01 | -6.59e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 1211 | 1.13e-04 | 6.59e-02 | 2.73e-02 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 12 | 6.93e-01 | 6.59e-02 | 9.69e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 16 | 6.48e-01 | 6.59e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 17 | 6.38e-01 | 6.58e-02 | 9.62e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 57 | 3.90e-01 | 6.58e-02 | 9.15e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 9 | 7.32e-01 | 6.58e-02 | 9.76e-01 |
| GOCC EXCITATORY SYNAPSE | 57 | 3.90e-01 | -6.58e-02 | 9.15e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 6.59e-01 | -6.58e-02 | 9.66e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 117 | 2.19e-01 | 6.58e-02 | 8.56e-01 |
| GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN | 5 | 7.99e-01 | 6.58e-02 | 9.85e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 17 | 6.39e-01 | 6.58e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 13 | 6.81e-01 | 6.58e-02 | 9.68e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 46 | 4.40e-01 | 6.57e-02 | 9.29e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 86 | 2.92e-01 | -6.57e-02 | 8.79e-01 |
| GOCC PERIKARYON | 142 | 1.77e-01 | -6.57e-02 | 8.41e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 7.33e-01 | 6.57e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 29 | 5.41e-01 | -6.56e-02 | 9.49e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 7.19e-01 | 6.56e-02 | 9.73e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 10 | 7.19e-01 | 6.56e-02 | 9.73e-01 |
| GOBP REGULATION OF PIGMENTATION | 17 | 6.40e-01 | 6.56e-02 | 9.62e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 48 | 4.32e-01 | -6.56e-02 | 9.27e-01 |
| GOBP TYPE II PNEUMOCYTE DIFFERENTIATION | 6 | 7.81e-01 | -6.56e-02 | 9.83e-01 |
| GOBP CELL FATE SPECIFICATION | 107 | 2.41e-01 | 6.56e-02 | 8.64e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 59 | 3.85e-01 | 6.54e-02 | 9.14e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 30 | 5.35e-01 | -6.54e-02 | 9.49e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 5.03e-01 | 6.54e-02 | 9.45e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 261 | 6.89e-02 | -6.54e-02 | 6.94e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 81 | 3.09e-01 | -6.54e-02 | 8.87e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 73 | 3.34e-01 | 6.54e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE | 5 | 8.00e-01 | -6.54e-02 | 9.85e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 6.72e-01 | -6.54e-02 | 9.68e-01 |
| GOMF CYTOKINE BINDING | 133 | 1.93e-01 | -6.53e-02 | 8.44e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 7.21e-01 | -6.53e-02 | 9.73e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 9 | 7.34e-01 | 6.53e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 6.95e-01 | -6.53e-02 | 9.69e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 39 | 4.80e-01 | -6.53e-02 | 9.42e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 28 | 5.50e-01 | -6.53e-02 | 9.49e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 30 | 5.36e-01 | -6.53e-02 | 9.49e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 12 | 6.95e-01 | -6.53e-02 | 9.69e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 11 | 7.08e-01 | -6.52e-02 | 9.71e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 68 | 3.52e-01 | -6.52e-02 | 9.00e-01 |
| GOBP AXONEME ASSEMBLY | 92 | 2.79e-01 | -6.52e-02 | 8.71e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 18 | 6.32e-01 | -6.52e-02 | 9.61e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 108 | 2.42e-01 | 6.52e-02 | 8.64e-01 |
| GOCC I BAND | 141 | 1.82e-01 | -6.52e-02 | 8.42e-01 |
| GOBP PENETRATION OF ZONA PELLUCIDA | 9 | 7.35e-01 | 6.52e-02 | 9.77e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 460 | 1.66e-02 | 6.51e-02 | 4.68e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 89 | 2.88e-01 | -6.51e-02 | 8.77e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 6 | 7.82e-01 | 6.51e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 21 | 6.06e-01 | -6.51e-02 | 9.55e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL | 5 | 8.01e-01 | 6.50e-02 | 9.85e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 27 | 5.59e-01 | 6.50e-02 | 9.49e-01 |
| GOBP INSULIN PROCESSING | 8 | 7.50e-01 | -6.50e-02 | 9.80e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 16 | 6.53e-01 | -6.50e-02 | 9.64e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 30 | 5.38e-01 | 6.50e-02 | 9.49e-01 |
| GOBP STEM CELL DIVISION | 30 | 5.38e-01 | -6.50e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 7.66e-01 | 6.50e-02 | 9.82e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 85 | 3.01e-01 | 6.49e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 26 | 5.67e-01 | 6.49e-02 | 9.50e-01 |
| GOBP SYNAPSE ORGANIZATION | 446 | 1.88e-02 | -6.49e-02 | 4.85e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 9 | 7.36e-01 | 6.49e-02 | 9.77e-01 |
| GOMF POLY G BINDING | 7 | 7.66e-01 | -6.49e-02 | 9.82e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 42 | 4.67e-01 | -6.49e-02 | 9.38e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 71 | 3.45e-01 | 6.49e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 151 | 1.69e-01 | -6.49e-02 | 8.31e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 271 | 6.62e-02 | 6.48e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 7.83e-01 | -6.48e-02 | 9.84e-01 |
| GOMF HELICASE ACTIVITY | 148 | 1.74e-01 | 6.48e-02 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 120 | 2.20e-01 | -6.48e-02 | 8.56e-01 |
| GOBP REGULATED EXOCYTOSIS | 214 | 1.03e-01 | -6.47e-02 | 7.66e-01 |
| GOBP ICOSANOID TRANSPORT | 63 | 3.74e-01 | 6.47e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 118 | 2.25e-01 | -6.46e-02 | 8.59e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 58 | 3.95e-01 | 6.46e-02 | 9.18e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 1396 | 5.16e-05 | -6.46e-02 | 1.60e-02 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 59 | 3.91e-01 | -6.46e-02 | 9.15e-01 |
| GOCC WASH COMPLEX | 8 | 7.52e-01 | -6.46e-02 | 9.80e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 17 | 6.45e-01 | -6.46e-02 | 9.63e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 298 | 5.52e-02 | -6.46e-02 | 6.50e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 481 | 1.53e-02 | 6.45e-02 | 4.61e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 24 | 5.84e-01 | -6.45e-02 | 9.54e-01 |
| GOBP DIOL METABOLIC PROCESS | 30 | 5.41e-01 | -6.45e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 22 | 6.01e-01 | -6.45e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT | 5 | 8.03e-01 | 6.44e-02 | 9.85e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 7.85e-01 | -6.44e-02 | 9.84e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 150 | 1.73e-01 | 6.44e-02 | 8.37e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 24 | 5.85e-01 | 6.44e-02 | 9.54e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 12 | 6.99e-01 | 6.44e-02 | 9.70e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 35 | 5.10e-01 | -6.44e-02 | 9.46e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 13 | 6.88e-01 | 6.44e-02 | 9.69e-01 |
| GOBP DUMP METABOLIC PROCESS | 7 | 7.68e-01 | -6.44e-02 | 9.82e-01 |
| GOBP REGULATION OF PRIMARY MIRNA PROCESSING | 5 | 8.03e-01 | 6.44e-02 | 9.85e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 59 | 3.92e-01 | 6.44e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 17 | 6.46e-01 | 6.44e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 9 | 7.38e-01 | -6.44e-02 | 9.77e-01 |
| GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING | 6 | 7.85e-01 | -6.43e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 122 | 2.20e-01 | 6.43e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 7.85e-01 | 6.43e-02 | 9.84e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 49 | 4.36e-01 | -6.43e-02 | 9.27e-01 |
| GOBP MYELIN ASSEMBLY | 24 | 5.86e-01 | 6.43e-02 | 9.54e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 127 | 2.11e-01 | 6.43e-02 | 8.54e-01 |
| GOBP IMPORT INTO CELL | 897 | 1.10e-03 | -6.43e-02 | 1.23e-01 |
| GOBP DNA RECOMBINATION | 318 | 4.88e-02 | 6.42e-02 | 6.28e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 7.85e-01 | -6.42e-02 | 9.84e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 559 | 9.45e-03 | -6.42e-02 | 3.68e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 7.25e-01 | -6.42e-02 | 9.75e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 41 | 4.77e-01 | -6.42e-02 | 9.41e-01 |
| GOMF CYCLIN BINDING | 34 | 5.18e-01 | -6.41e-02 | 9.47e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 126 | 2.14e-01 | 6.41e-02 | 8.55e-01 |
| GOBP TRABECULA FORMATION | 26 | 5.72e-01 | -6.40e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 148 | 1.79e-01 | -6.40e-02 | 8.41e-01 |
| GOBP GERM CELL PROLIFERATION | 10 | 7.26e-01 | -6.40e-02 | 9.75e-01 |
| GOBP STEM CELL DEVELOPMENT | 87 | 3.02e-01 | 6.40e-02 | 8.84e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 6.78e-01 | 6.40e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 51 | 4.29e-01 | -6.40e-02 | 9.27e-01 |
| GOBP REGULATION OF LIPID STORAGE | 54 | 4.16e-01 | -6.40e-02 | 9.23e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 23 | 5.95e-01 | -6.40e-02 | 9.55e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 80 | 3.23e-01 | -6.40e-02 | 8.92e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 142 | 1.88e-01 | 6.39e-02 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 6 | 7.86e-01 | -6.39e-02 | 9.84e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 57 | 4.04e-01 | -6.39e-02 | 9.21e-01 |
| GOMF NADPH BINDING | 15 | 6.69e-01 | 6.39e-02 | 9.67e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 5.88e-01 | 6.38e-02 | 9.54e-01 |
| GOMF RRNA BINDING | 62 | 3.85e-01 | -6.38e-02 | 9.14e-01 |
| GOBP IP 10 PRODUCTION | 5 | 8.05e-01 | -6.38e-02 | 9.87e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 16 | 6.58e-01 | -6.38e-02 | 9.66e-01 |
| GOBP AORTA MORPHOGENESIS | 38 | 4.96e-01 | 6.38e-02 | 9.45e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 32 | 5.32e-01 | 6.38e-02 | 9.48e-01 |
| GOBP CELLULAR RESPIRATION | 216 | 1.06e-01 | 6.38e-02 | 7.72e-01 |
| GOMF FMN BINDING | 15 | 6.69e-01 | 6.37e-02 | 9.67e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 290 | 6.18e-02 | -6.37e-02 | 6.63e-01 |
| GOBP MEMBRANE FISSION | 42 | 4.75e-01 | 6.37e-02 | 9.41e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 13 | 6.91e-01 | 6.37e-02 | 9.69e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 10 | 7.27e-01 | 6.37e-02 | 9.75e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 20 | 6.22e-01 | 6.37e-02 | 9.61e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 207 | 1.14e-01 | 6.36e-02 | 7.81e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 102 | 2.67e-01 | 6.36e-02 | 8.69e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 7.28e-01 | -6.36e-02 | 9.75e-01 |
| GOCC RIPOPTOSOME | 6 | 7.87e-01 | 6.35e-02 | 9.84e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 7 | 7.71e-01 | 6.35e-02 | 9.82e-01 |
| GOBP PHOTOPERIODISM | 28 | 5.61e-01 | 6.35e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 6 | 7.88e-01 | 6.35e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 197 | 1.24e-01 | -6.35e-02 | 7.93e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 79 | 3.29e-01 | -6.35e-02 | 8.93e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 7.88e-01 | -6.35e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 165 | 1.59e-01 | -6.35e-02 | 8.19e-01 |
| GOBP NEURON CELL CELL ADHESION | 13 | 6.92e-01 | -6.35e-02 | 9.69e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 22 | 6.06e-01 | -6.34e-02 | 9.55e-01 |
| GOBP HINDBRAIN TANGENTIAL CELL MIGRATION | 5 | 8.06e-01 | -6.34e-02 | 9.87e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 8 | 7.56e-01 | -6.34e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 139 | 1.97e-01 | 6.34e-02 | 8.44e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR II BINDING | 8 | 7.56e-01 | -6.34e-02 | 9.82e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 851 | 1.68e-03 | 6.34e-02 | 1.57e-01 |
| GOCC NEUROFILAMENT | 9 | 7.42e-01 | 6.34e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 65 | 3.77e-01 | 6.34e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 13 | 6.92e-01 | 6.34e-02 | 9.69e-01 |
| GOBP CENTROSOME SEPARATION | 15 | 6.71e-01 | 6.34e-02 | 9.68e-01 |
| GOBP MALE SEX DETERMINATION | 11 | 7.16e-01 | -6.33e-02 | 9.72e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 45 | 4.62e-01 | -6.33e-02 | 9.37e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 81 | 3.24e-01 | -6.33e-02 | 8.93e-01 |
| GOBP VESICLE LOCALIZATION | 208 | 1.15e-01 | 6.33e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 8 | 7.57e-01 | -6.33e-02 | 9.82e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 7 | 7.72e-01 | 6.33e-02 | 9.82e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 31 | 5.42e-01 | -6.33e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 11 | 7.16e-01 | 6.33e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 32 | 5.36e-01 | -6.32e-02 | 9.49e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 13 | 6.93e-01 | 6.32e-02 | 9.69e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 23 | 6.00e-01 | 6.31e-02 | 9.55e-01 |
| GOBP NEPHRIC DUCT MORPHOGENESIS | 10 | 7.30e-01 | 6.31e-02 | 9.76e-01 |
| GOMF GROWTH FACTOR BINDING | 130 | 2.14e-01 | -6.31e-02 | 8.55e-01 |
| GOBP VACUOLAR LOCALIZATION | 82 | 3.23e-01 | 6.31e-02 | 8.92e-01 |
| GOBP ERBB SIGNALING PATHWAY | 122 | 2.29e-01 | -6.31e-02 | 8.62e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 99 | 2.78e-01 | 6.31e-02 | 8.70e-01 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.30e-01 | -6.31e-02 | 9.76e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 38 | 5.01e-01 | 6.31e-02 | 9.45e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 10 | 7.30e-01 | -6.31e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 107 | 2.60e-01 | -6.31e-02 | 8.66e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 5.64e-01 | 6.31e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 8.07e-01 | -6.30e-02 | 9.87e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 54 | 4.23e-01 | -6.30e-02 | 9.24e-01 |
| GOMF CARDIOLIPIN BINDING | 11 | 7.17e-01 | -6.30e-02 | 9.72e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 27 | 5.71e-01 | -6.30e-02 | 9.51e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 15 | 6.73e-01 | 6.30e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 6.53e-01 | 6.30e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN | 6 | 7.90e-01 | -6.29e-02 | 9.84e-01 |
| GOBP TYROSINE CATABOLIC PROCESS | 6 | 7.90e-01 | -6.29e-02 | 9.84e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 33 | 5.32e-01 | 6.28e-02 | 9.48e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 5 | 8.08e-01 | -6.28e-02 | 9.87e-01 |
| GOBP RESPONSE TO METAL ION | 344 | 4.53e-02 | -6.28e-02 | 6.22e-01 |
| GOMF PROLINE SODIUM SYMPORTER ACTIVITY | 5 | 8.08e-01 | -6.28e-02 | 9.87e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 7.58e-01 | 6.28e-02 | 9.82e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 28 | 5.65e-01 | 6.28e-02 | 9.50e-01 |
| GOBP BRUSH BORDER ASSEMBLY | 7 | 7.74e-01 | -6.28e-02 | 9.82e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 90 | 3.03e-01 | 6.28e-02 | 8.84e-01 |
| GOCC LAMIN FILAMENT | 5 | 8.08e-01 | 6.28e-02 | 9.87e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 28 | 5.66e-01 | 6.27e-02 | 9.50e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 5 | 8.08e-01 | -6.26e-02 | 9.87e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 96 | 2.89e-01 | 6.26e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 120 | 2.36e-01 | -6.26e-02 | 8.64e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 5.53e-01 | 6.26e-02 | 9.49e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 8 | 7.59e-01 | 6.25e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 8 | 7.59e-01 | -6.25e-02 | 9.82e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 21 | 6.20e-01 | 6.25e-02 | 9.61e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 14 | 6.86e-01 | 6.25e-02 | 9.68e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 41 | 4.89e-01 | -6.25e-02 | 9.43e-01 |
| GOMF DAMAGED DNA BINDING | 70 | 3.66e-01 | 6.25e-02 | 9.06e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 32 | 5.41e-01 | 6.25e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 182 | 1.46e-01 | -6.25e-02 | 8.08e-01 |
| GOBP ORGAN INDUCTION | 22 | 6.12e-01 | 6.24e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 10 | 7.33e-01 | 6.24e-02 | 9.76e-01 |
| GOBP RNA METHYLATION | 84 | 3.23e-01 | 6.24e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 45 | 4.69e-01 | -6.24e-02 | 9.39e-01 |
| GOMF PDZ DOMAIN BINDING | 84 | 3.23e-01 | -6.24e-02 | 8.92e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 73 | 3.57e-01 | -6.24e-02 | 9.03e-01 |
| GOBP DUMP CATABOLIC PROCESS | 6 | 7.91e-01 | 6.23e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 9 | 7.46e-01 | 6.23e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 18 | 6.47e-01 | 6.23e-02 | 9.63e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 15 | 6.76e-01 | -6.23e-02 | 9.68e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 33 | 5.37e-01 | 6.22e-02 | 9.49e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 78 | 3.43e-01 | 6.22e-02 | 8.96e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 9 | 7.47e-01 | 6.21e-02 | 9.79e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 43 | 4.81e-01 | -6.21e-02 | 9.42e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 11 | 7.21e-01 | 6.21e-02 | 9.73e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 6.39e-01 | 6.21e-02 | 9.62e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 157 | 1.79e-01 | 6.21e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION | 7 | 7.76e-01 | -6.21e-02 | 9.82e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 17 | 6.58e-01 | 6.20e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 37 | 5.14e-01 | 6.20e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 124 | 2.33e-01 | -6.20e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 466 | 2.19e-02 | -6.20e-02 | 5.04e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS | 5 | 8.10e-01 | 6.20e-02 | 9.87e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 61 | 4.03e-01 | -6.19e-02 | 9.20e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 81 | 3.35e-01 | 6.19e-02 | 8.96e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 27 | 5.77e-01 | -6.19e-02 | 9.52e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 7.93e-01 | -6.19e-02 | 9.84e-01 |
| GOCC CHROMOSOME CENTROMERIC CORE DOMAIN | 17 | 6.59e-01 | 6.19e-02 | 9.66e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 65 | 3.88e-01 | -6.19e-02 | 9.14e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 43 | 4.83e-01 | -6.19e-02 | 9.43e-01 |
| GOBP KERATINOCYTE MIGRATION | 20 | 6.32e-01 | -6.18e-02 | 9.61e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 74 | 3.58e-01 | -6.17e-02 | 9.03e-01 |
| GOCC RESPIRASOME | 85 | 3.25e-01 | 6.17e-02 | 8.93e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 147 | 1.96e-01 | -6.17e-02 | 8.44e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 91 | 3.09e-01 | -6.17e-02 | 8.87e-01 |
| GOMF CYCLASE ACTIVITY | 21 | 6.25e-01 | -6.17e-02 | 9.61e-01 |
| GOCC MICROTUBULE PLUS END | 24 | 6.01e-01 | 6.17e-02 | 9.55e-01 |
| GOCC FEMALE PRONUCLEUS | 10 | 7.36e-01 | -6.17e-02 | 9.77e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 7.12e-01 | -6.17e-02 | 9.71e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 126 | 2.32e-01 | 6.16e-02 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 72 | 3.66e-01 | -6.16e-02 | 9.06e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 8 | 7.63e-01 | -6.16e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 18 | 6.51e-01 | -6.16e-02 | 9.64e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 54 | 4.34e-01 | 6.16e-02 | 9.27e-01 |
| GOCC PHOSPHATASE COMPLEX | 51 | 4.47e-01 | 6.16e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION | 5 | 8.11e-01 | -6.16e-02 | 9.87e-01 |
| GOMF CUPRIC ION BINDING | 5 | 8.12e-01 | 6.16e-02 | 9.87e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 9 | 7.49e-01 | -6.16e-02 | 9.80e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 6.42e-01 | 6.15e-02 | 9.63e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 13 | 7.01e-01 | 6.15e-02 | 9.70e-01 |
| GOBP CELL CYCLE PROCESS | 1242 | 2.65e-04 | 6.15e-02 | 4.76e-02 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 183 | 1.51e-01 | -6.15e-02 | 8.16e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 55 | 4.30e-01 | 6.15e-02 | 9.27e-01 |
| GOCC CONNEXIN COMPLEX | 19 | 6.43e-01 | -6.14e-02 | 9.63e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 24 | 6.02e-01 | 6.14e-02 | 9.55e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 143 | 2.05e-01 | -6.14e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 40 | 5.02e-01 | 6.13e-02 | 9.45e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 22 | 6.19e-01 | 6.13e-02 | 9.61e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 10 | 7.37e-01 | -6.12e-02 | 9.77e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 183 | 1.53e-01 | -6.12e-02 | 8.17e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 7.95e-01 | -6.12e-02 | 9.84e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 749 | 4.34e-03 | -6.12e-02 | 2.58e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 8.13e-01 | 6.12e-02 | 9.87e-01 |
| GOBP TOOTH ERUPTION | 5 | 8.13e-01 | -6.12e-02 | 9.87e-01 |
| GOBP RESPONSE TO ACIDIC PH | 28 | 5.75e-01 | -6.12e-02 | 9.51e-01 |
| GOBP CELL FATE DETERMINATION | 42 | 4.93e-01 | 6.11e-02 | 9.45e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 15 | 6.82e-01 | -6.11e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 43 | 4.88e-01 | 6.11e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 327 | 5.75e-02 | -6.11e-02 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 7.95e-01 | -6.11e-02 | 9.84e-01 |
| GOBP DETECTION OF MUSCLE STRETCH | 7 | 7.80e-01 | -6.11e-02 | 9.83e-01 |
| GOBP MANCHETTE ASSEMBLY | 6 | 7.96e-01 | -6.11e-02 | 9.84e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 24 | 6.05e-01 | 6.10e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 49 | 4.60e-01 | -6.10e-02 | 9.37e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 43 | 4.89e-01 | -6.10e-02 | 9.43e-01 |
| GOBP NCRNA PROCESSING | 415 | 3.30e-02 | 6.10e-02 | 5.58e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 113 | 2.63e-01 | 6.10e-02 | 8.68e-01 |
| GOBP L LYSINE TRANSPORT | 7 | 7.80e-01 | -6.09e-02 | 9.83e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.80e-01 | -6.09e-02 | 9.83e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 278 | 8.05e-02 | -6.09e-02 | 7.26e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 8 | 7.66e-01 | 6.09e-02 | 9.82e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 83 | 3.38e-01 | 6.09e-02 | 8.96e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 7 | 7.80e-01 | -6.09e-02 | 9.83e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 198 | 1.40e-01 | -6.09e-02 | 8.06e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 14 | 6.94e-01 | -6.08e-02 | 9.69e-01 |
| GOBP PLATELET ACTIVATION | 128 | 2.35e-01 | -6.08e-02 | 8.64e-01 |
| GOCC SYMMETRIC SYNAPSE | 8 | 7.66e-01 | 6.08e-02 | 9.82e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 1036 | 9.47e-04 | -6.07e-02 | 1.15e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 13 | 7.05e-01 | -6.07e-02 | 9.71e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 62 | 4.08e-01 | 6.07e-02 | 9.21e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 32 | 5.53e-01 | -6.06e-02 | 9.49e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 99 | 2.97e-01 | 6.06e-02 | 8.82e-01 |
| GOMF RETINYL PALMITATE ESTERASE ACTIVITY | 6 | 7.97e-01 | 6.06e-02 | 9.84e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 42 | 4.97e-01 | 6.06e-02 | 9.45e-01 |
| GOBP ANTERIOR HEAD DEVELOPMENT | 7 | 7.81e-01 | 6.06e-02 | 9.83e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 31 | 5.60e-01 | -6.06e-02 | 9.49e-01 |
| GOMF INTERLEUKIN 2 RECEPTOR BINDING | 5 | 8.15e-01 | 6.05e-02 | 9.87e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 143 | 2.11e-01 | -6.05e-02 | 8.54e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 37 | 5.24e-01 | 6.05e-02 | 9.47e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 5.74e-01 | -6.04e-02 | 9.51e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 7 | 7.82e-01 | 6.04e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 7.06e-01 | -6.03e-02 | 9.71e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 29 | 5.74e-01 | -6.03e-02 | 9.51e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 7.82e-01 | 6.03e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 37 | 5.25e-01 | 6.03e-02 | 9.47e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 10 | 7.41e-01 | 6.03e-02 | 9.77e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 19 | 6.49e-01 | -6.03e-02 | 9.64e-01 |
| GOMF FERRIC IRON BINDING | 9 | 7.54e-01 | -6.03e-02 | 9.81e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 24 | 6.09e-01 | 6.02e-02 | 9.57e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 31 | 5.62e-01 | 6.02e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX | 22 | 6.25e-01 | -6.02e-02 | 9.61e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 7 | 7.83e-01 | -6.01e-02 | 9.84e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 127 | 2.42e-01 | 6.01e-02 | 8.64e-01 |
| GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY | 13 | 7.07e-01 | -6.01e-02 | 9.71e-01 |
| GOBP CELL SUBSTRATE ADHESION | 342 | 5.62e-02 | -6.01e-02 | 6.53e-01 |
| GOBP ATP METABOLIC PROCESS | 124 | 2.48e-01 | 6.01e-02 | 8.65e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 183 | 1.61e-01 | 6.00e-02 | 8.24e-01 |
| GOMF CARBOHYDRATE BINDING | 260 | 9.57e-02 | -6.00e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 26 | 5.96e-01 | -6.00e-02 | 9.55e-01 |
| GOBP RESPONSE TO IRON ION | 28 | 5.83e-01 | 6.00e-02 | 9.53e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 8.16e-01 | 6.00e-02 | 9.87e-01 |
| GOMF PHOSPHOLIPID BINDING | 456 | 2.83e-02 | -5.99e-02 | 5.45e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 14 | 6.98e-01 | -5.99e-02 | 9.70e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 5 | 8.17e-01 | 5.99e-02 | 9.87e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 330 | 6.16e-02 | 5.99e-02 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 5 | 8.17e-01 | 5.99e-02 | 9.87e-01 |
| GOBP MRNA PROCESSING | 449 | 2.97e-02 | 5.99e-02 | 5.52e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 231 | 1.17e-01 | 5.98e-02 | 7.82e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 65 | 4.06e-01 | -5.97e-02 | 9.21e-01 |
| GOBP MYELIN MAINTENANCE | 17 | 6.70e-01 | -5.96e-02 | 9.67e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 249 | 1.05e-01 | 5.96e-02 | 7.69e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 579 | 1.42e-02 | -5.96e-02 | 4.50e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 5.31e-01 | -5.95e-02 | 9.48e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 48 | 4.76e-01 | 5.95e-02 | 9.41e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 42 | 5.05e-01 | -5.95e-02 | 9.45e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 8 | 7.71e-01 | 5.95e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 44 | 4.95e-01 | 5.95e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 7.21e-01 | 5.95e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 67 | 4.00e-01 | -5.95e-02 | 9.18e-01 |
| GOMF SYNTAXIN 1 BINDING | 19 | 6.54e-01 | 5.95e-02 | 9.64e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 7.00e-01 | -5.95e-02 | 9.70e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 23 | 6.22e-01 | 5.94e-02 | 9.61e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 7.33e-01 | 5.94e-02 | 9.76e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 9 | 7.58e-01 | 5.94e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 53 | 4.55e-01 | -5.93e-02 | 9.36e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 359 | 5.34e-02 | -5.93e-02 | 6.45e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION | 9 | 7.58e-01 | -5.93e-02 | 9.82e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 41 | 5.11e-01 | -5.93e-02 | 9.46e-01 |
| GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX | 10 | 7.45e-01 | 5.93e-02 | 9.78e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 32 | 5.61e-01 | 5.93e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 47 | 4.82e-01 | -5.93e-02 | 9.42e-01 |
| GOCC CORE MEDIATOR COMPLEX | 25 | 6.08e-01 | 5.93e-02 | 9.56e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 95 | 3.18e-01 | 5.93e-02 | 8.91e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 7.86e-01 | -5.92e-02 | 9.84e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 75 | 3.75e-01 | 5.92e-02 | 9.09e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 6 | 8.02e-01 | 5.92e-02 | 9.85e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 865 | 3.12e-03 | -5.92e-02 | 2.16e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 17 | 6.73e-01 | -5.92e-02 | 9.68e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 9 | 7.59e-01 | 5.92e-02 | 9.82e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 24 | 6.16e-01 | -5.91e-02 | 9.60e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 15 | 6.92e-01 | -5.91e-02 | 9.69e-01 |
| GOBP SPERM EGG RECOGNITION | 51 | 4.65e-01 | -5.91e-02 | 9.38e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 44 | 4.98e-01 | -5.91e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 42 | 5.08e-01 | 5.91e-02 | 9.46e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 8.19e-01 | -5.91e-02 | 9.87e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 43 | 5.03e-01 | -5.91e-02 | 9.45e-01 |
| GOBP NCRNA METABOLIC PROCESS | 603 | 1.33e-02 | 5.90e-02 | 4.44e-01 |
| GOBP NAD METABOLIC PROCESS | 42 | 5.08e-01 | -5.90e-02 | 9.46e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 19 | 6.56e-01 | 5.90e-02 | 9.65e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 156 | 2.03e-01 | 5.90e-02 | 8.51e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 20 | 6.48e-01 | 5.90e-02 | 9.63e-01 |
| GOBP RIBOSOME BIOGENESIS | 303 | 7.74e-02 | 5.90e-02 | 7.18e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 163 | 1.94e-01 | -5.89e-02 | 8.44e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 150 | 2.13e-01 | 5.89e-02 | 8.54e-01 |
| GOCC JUNCTIONAL MEMBRANE COMPLEX | 6 | 8.03e-01 | -5.89e-02 | 9.85e-01 |
| GOCC FILOPODIUM | 103 | 3.02e-01 | -5.89e-02 | 8.84e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 7.73e-01 | 5.89e-02 | 9.82e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 155 | 2.06e-01 | -5.89e-02 | 8.51e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 63 | 4.19e-01 | 5.88e-02 | 9.24e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 47 | 4.85e-01 | -5.88e-02 | 9.43e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 5.90e-01 | 5.88e-02 | 9.54e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 31 | 5.71e-01 | -5.88e-02 | 9.51e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 7.60e-01 | 5.88e-02 | 9.82e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 69 | 3.99e-01 | 5.87e-02 | 9.18e-01 |
| GOCC CYTOSOLIC REGION | 19 | 6.58e-01 | 5.87e-02 | 9.66e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 20 | 6.49e-01 | -5.87e-02 | 9.64e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 19 | 6.58e-01 | -5.87e-02 | 9.66e-01 |
| GOBP OSSIFICATION | 424 | 3.82e-02 | -5.87e-02 | 5.92e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 12 | 7.25e-01 | -5.86e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 71 | 3.93e-01 | -5.86e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 71 | 3.93e-01 | 5.86e-02 | 9.17e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 165 | 1.94e-01 | 5.86e-02 | 8.44e-01 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 6 | 8.04e-01 | -5.86e-02 | 9.86e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 6.67e-01 | -5.86e-02 | 9.67e-01 |
| GOBP CAVEOLA ASSEMBLY | 5 | 8.20e-01 | -5.86e-02 | 9.87e-01 |
| GOCC MITOCHONDRIAL MATRIX | 466 | 3.02e-02 | 5.86e-02 | 5.54e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 102 | 3.07e-01 | 5.86e-02 | 8.85e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 41 | 5.17e-01 | 5.85e-02 | 9.46e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 99 | 3.14e-01 | 5.85e-02 | 8.90e-01 |
| GOMF ADP BINDING | 35 | 5.49e-01 | -5.85e-02 | 9.49e-01 |
| GOBP EAR MORPHOGENESIS | 123 | 2.63e-01 | 5.85e-02 | 8.68e-01 |
| GOMF LIPID BINDING | 808 | 4.73e-03 | -5.85e-02 | 2.67e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 263 | 1.03e-01 | 5.84e-02 | 7.66e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 713 | 7.85e-03 | -5.84e-02 | 3.43e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 10 | 7.49e-01 | -5.84e-02 | 9.80e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 32 | 5.67e-01 | -5.84e-02 | 9.50e-01 |
| GOCC ANKYRIN 1 COMPLEX | 7 | 7.89e-01 | -5.84e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 395 | 4.64e-02 | -5.84e-02 | 6.22e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 18 | 6.68e-01 | -5.84e-02 | 9.67e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 68 | 4.05e-01 | 5.84e-02 | 9.21e-01 |
| GOBP STARTLE RESPONSE | 26 | 6.06e-01 | -5.84e-02 | 9.55e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 50 | 4.76e-01 | -5.83e-02 | 9.41e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 23 | 6.28e-01 | -5.83e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 65 | 4.17e-01 | -5.83e-02 | 9.23e-01 |
| GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 22 | 6.36e-01 | -5.82e-02 | 9.61e-01 |
| GOBP RNA CAPPING | 35 | 5.51e-01 | 5.82e-02 | 9.49e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 101 | 3.12e-01 | -5.82e-02 | 8.89e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 370 | 5.45e-02 | -5.82e-02 | 6.46e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 14 | 7.06e-01 | -5.82e-02 | 9.71e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 16 | 6.87e-01 | 5.82e-02 | 9.68e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 18 | 6.69e-01 | -5.81e-02 | 9.67e-01 |
| GOBP CELL MOTILITY | 1713 | 6.30e-05 | -5.81e-02 | 1.74e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 61 | 4.33e-01 | -5.81e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 7.76e-01 | -5.81e-02 | 9.82e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 312 | 7.76e-02 | -5.81e-02 | 7.18e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 19 | 6.61e-01 | 5.81e-02 | 9.66e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 53 | 4.65e-01 | -5.81e-02 | 9.38e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 20 | 6.53e-01 | 5.80e-02 | 9.64e-01 |
| GOCC SECONDARY LYSOSOME | 16 | 6.88e-01 | 5.80e-02 | 9.69e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 52 | 4.69e-01 | 5.80e-02 | 9.39e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 42 | 5.15e-01 | -5.80e-02 | 9.46e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 20 | 6.54e-01 | -5.79e-02 | 9.64e-01 |
| GOBP PRE MIRNA PROCESSING | 17 | 6.79e-01 | 5.79e-02 | 9.68e-01 |
| GOBP TISSUE HOMEOSTASIS | 264 | 1.05e-01 | -5.79e-02 | 7.69e-01 |
| GOCC FILAMENTOUS ACTIN | 28 | 5.96e-01 | 5.79e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 70 | 4.02e-01 | -5.79e-02 | 9.20e-01 |
| GOBP TELOMERE LOCALIZATION | 12 | 7.29e-01 | -5.79e-02 | 9.75e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 10 | 7.51e-01 | 5.78e-02 | 9.80e-01 |
| GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION | 7 | 7.91e-01 | -5.78e-02 | 9.84e-01 |
| GOBP PROTEIN ACYLATION | 134 | 2.48e-01 | 5.78e-02 | 8.65e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 7 | 7.91e-01 | 5.78e-02 | 9.84e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 45 | 5.02e-01 | 5.78e-02 | 9.45e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 50 | 4.80e-01 | 5.78e-02 | 9.42e-01 |
| GOCC SPERM PLASMA MEMBRANE | 14 | 7.08e-01 | -5.78e-02 | 9.71e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 14 | 7.08e-01 | 5.78e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 26 | 6.10e-01 | -5.77e-02 | 9.58e-01 |
| GOMF UBIQUINONE BINDING | 5 | 8.23e-01 | -5.77e-02 | 9.88e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 13 | 7.19e-01 | -5.77e-02 | 9.72e-01 |
| GOCC SPERM MIDPIECE | 51 | 4.76e-01 | -5.77e-02 | 9.41e-01 |
| GOCC VACUOLE | 809 | 5.28e-03 | -5.77e-02 | 2.80e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 129 | 2.58e-01 | 5.77e-02 | 8.65e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 82 | 3.67e-01 | -5.77e-02 | 9.06e-01 |
| GOCC TRANSFERASE COMPLEX | 789 | 5.88e-03 | 5.77e-02 | 2.93e-01 |
| GOBP TORC2 SIGNALING | 12 | 7.29e-01 | -5.77e-02 | 9.76e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 45 | 5.03e-01 | -5.76e-02 | 9.45e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 468 | 3.27e-02 | -5.76e-02 | 5.58e-01 |
| GOCC DENSE CORE GRANULE | 38 | 5.39e-01 | -5.76e-02 | 9.49e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 10 | 7.53e-01 | 5.76e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 8.24e-01 | -5.76e-02 | 9.88e-01 |
| GOBP UREA METABOLIC PROCESS | 12 | 7.30e-01 | -5.76e-02 | 9.76e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 47 | 4.95e-01 | -5.75e-02 | 9.45e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 16 | 6.90e-01 | -5.75e-02 | 9.69e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 7.09e-01 | -5.75e-02 | 9.71e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 544 | 2.18e-02 | -5.75e-02 | 5.04e-01 |
| GOBP BONE DEVELOPMENT | 203 | 1.58e-01 | -5.75e-02 | 8.19e-01 |
| GOBP MANGANESE ION TRANSPORT | 11 | 7.41e-01 | 5.74e-02 | 9.77e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 19 | 6.65e-01 | 5.74e-02 | 9.67e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 7.66e-01 | 5.74e-02 | 9.82e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 14 | 7.10e-01 | -5.74e-02 | 9.71e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 14 | 7.10e-01 | 5.74e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 140 | 2.41e-01 | -5.74e-02 | 8.64e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 87 | 3.55e-01 | -5.73e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 14 | 7.11e-01 | -5.73e-02 | 9.71e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 17 | 6.83e-01 | 5.73e-02 | 9.68e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 55 | 4.63e-01 | 5.72e-02 | 9.37e-01 |
| GOBP BICARBONATE TRANSPORT | 35 | 5.58e-01 | -5.72e-02 | 9.49e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY | 5 | 8.25e-01 | -5.72e-02 | 9.88e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 658 | 1.23e-02 | 5.72e-02 | 4.23e-01 |
| GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE | 9 | 7.67e-01 | -5.71e-02 | 9.82e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 438 | 4.05e-02 | -5.71e-02 | 6.08e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 441 | 3.99e-02 | -5.71e-02 | 6.03e-01 |
| GOBP TRICUSPID VALVE DEVELOPMENT | 6 | 8.09e-01 | 5.70e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 142 | 2.41e-01 | 5.70e-02 | 8.64e-01 |
| GOBP MUSCLE CONTRACTION | 338 | 7.16e-02 | -5.70e-02 | 7.00e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 39 | 5.38e-01 | -5.70e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 354 | 6.55e-02 | -5.70e-02 | 6.80e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 9 | 7.67e-01 | 5.69e-02 | 9.82e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 13 | 7.22e-01 | -5.69e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 26 | 6.15e-01 | -5.69e-02 | 9.60e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 806 | 6.02e-03 | 5.69e-02 | 2.97e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 63 | 4.35e-01 | -5.69e-02 | 9.27e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 28 | 6.02e-01 | 5.69e-02 | 9.55e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 71 | 4.07e-01 | 5.69e-02 | 9.21e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 50 | 4.87e-01 | -5.69e-02 | 9.43e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 6.52e-01 | -5.69e-02 | 9.64e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 84 | 3.68e-01 | -5.68e-02 | 9.07e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 158 | 2.18e-01 | -5.68e-02 | 8.56e-01 |
| GOBP RESPONSE TO CGMP | 8 | 7.81e-01 | -5.68e-02 | 9.83e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 37 | 5.50e-01 | -5.68e-02 | 9.49e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 7 | 7.95e-01 | 5.68e-02 | 9.84e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 8.26e-01 | 5.68e-02 | 9.88e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 35 | 5.61e-01 | 5.68e-02 | 9.49e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 337 | 7.34e-02 | -5.67e-02 | 7.07e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 70 | 4.12e-01 | 5.67e-02 | 9.21e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 39 | 5.40e-01 | 5.67e-02 | 9.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 42 | 5.25e-01 | 5.66e-02 | 9.47e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 9 | 7.69e-01 | -5.66e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 15 | 7.04e-01 | -5.66e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 66 | 4.26e-01 | -5.66e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 15 | 7.04e-01 | 5.66e-02 | 9.71e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 22 | 6.46e-01 | 5.66e-02 | 9.63e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 8.10e-01 | -5.66e-02 | 9.87e-01 |
| GOCC PROTEIN LIPID COMPLEX | 38 | 5.46e-01 | -5.66e-02 | 9.49e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 18 | 6.78e-01 | 5.65e-02 | 9.68e-01 |
| GOBP STEROL METABOLIC PROCESS | 149 | 2.34e-01 | 5.65e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 17 | 6.87e-01 | 5.65e-02 | 9.68e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 29 | 5.99e-01 | -5.65e-02 | 9.55e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 18 | 6.78e-01 | 5.65e-02 | 9.68e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 30 | 5.93e-01 | 5.64e-02 | 9.54e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 13 | 7.25e-01 | 5.64e-02 | 9.75e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 34 | 5.69e-01 | 5.64e-02 | 9.51e-01 |
| GOBP TRANSLATIONAL TERMINATION | 15 | 7.05e-01 | -5.64e-02 | 9.71e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 25 | 6.25e-01 | -5.64e-02 | 9.61e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 46 | 5.08e-01 | -5.64e-02 | 9.46e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 34 | 5.69e-01 | -5.64e-02 | 9.51e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 7.15e-01 | -5.64e-02 | 9.72e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 9 | 7.70e-01 | -5.63e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 8 | 7.83e-01 | -5.63e-02 | 9.84e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 54 | 4.74e-01 | -5.63e-02 | 9.41e-01 |
| GOCC TRANSPORTER COMPLEX | 391 | 5.60e-02 | -5.63e-02 | 6.53e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 14 | 7.15e-01 | 5.63e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 56 | 4.66e-01 | 5.63e-02 | 9.38e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 52 | 4.83e-01 | -5.63e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 8.28e-01 | 5.63e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 106 | 3.17e-01 | -5.63e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 27 | 6.13e-01 | 5.62e-02 | 9.59e-01 |
| GOBP GLYCOSYLATION | 214 | 1.56e-01 | 5.62e-02 | 8.17e-01 |
| GOMF SNRNP BINDING | 9 | 7.70e-01 | 5.62e-02 | 9.82e-01 |
| GOBP CHROMATIN LOOPING | 11 | 7.47e-01 | 5.62e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 7 | 7.97e-01 | -5.62e-02 | 9.84e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 21 | 6.56e-01 | -5.62e-02 | 9.65e-01 |
| GOCC BRUSH BORDER MEMBRANE | 57 | 4.63e-01 | -5.62e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 31 | 5.88e-01 | 5.62e-02 | 9.54e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 45 | 5.15e-01 | 5.61e-02 | 9.46e-01 |
| GOBP LIPOXIN METABOLIC PROCESS | 5 | 8.28e-01 | 5.61e-02 | 9.88e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 36 | 5.60e-01 | 5.61e-02 | 9.49e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 9 | 7.71e-01 | 5.61e-02 | 9.82e-01 |
| GOBP ADULT BEHAVIOR | 141 | 2.50e-01 | 5.61e-02 | 8.65e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 8.28e-01 | -5.61e-02 | 9.88e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 454 | 4.07e-02 | 5.60e-02 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 100 | 3.33e-01 | -5.60e-02 | 8.94e-01 |
| GOBP RESPONSE TO ACTIVITY | 72 | 4.11e-01 | 5.60e-02 | 9.21e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 83 | 3.78e-01 | 5.60e-02 | 9.09e-01 |
| GOBP MAPK CASCADE | 737 | 9.63e-03 | -5.60e-02 | 3.73e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 498 | 3.24e-02 | -5.60e-02 | 5.58e-01 |
| GOMF C X3 C CHEMOKINE BINDING | 5 | 8.28e-01 | -5.60e-02 | 9.88e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 39 | 5.46e-01 | 5.59e-02 | 9.49e-01 |
| GOBP EPITHELIAL CELL MATURATION | 24 | 6.35e-01 | 5.59e-02 | 9.61e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 24 | 6.35e-01 | 5.59e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 14 | 7.17e-01 | 5.59e-02 | 9.72e-01 |
| GOMF WW DOMAIN BINDING | 22 | 6.50e-01 | -5.59e-02 | 9.64e-01 |
| GOCC NUCLEAR BODY | 812 | 6.91e-03 | 5.58e-02 | 3.25e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 514 | 3.05e-02 | -5.58e-02 | 5.54e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 5 | 8.29e-01 | 5.58e-02 | 9.88e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 734 | 1.01e-02 | -5.57e-02 | 3.83e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 25 | 6.30e-01 | 5.57e-02 | 9.61e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 17 | 6.91e-01 | -5.57e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 70 | 4.20e-01 | -5.57e-02 | 9.24e-01 |
| GOBP TISSUE REMODELING | 179 | 1.99e-01 | -5.57e-02 | 8.45e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 188 | 1.88e-01 | 5.57e-02 | 8.44e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 69 | 4.24e-01 | -5.57e-02 | 9.24e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 26 | 6.23e-01 | -5.57e-02 | 9.61e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 7.28e-01 | -5.57e-02 | 9.75e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 177 | 2.02e-01 | -5.56e-02 | 8.51e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 75 | 4.05e-01 | -5.56e-02 | 9.21e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 30 | 5.98e-01 | -5.56e-02 | 9.55e-01 |
| GOBP RESPONSE TO VASOPRESSIN | 8 | 7.85e-01 | 5.56e-02 | 9.84e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 42 | 5.33e-01 | -5.56e-02 | 9.49e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 7.73e-01 | -5.56e-02 | 9.82e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 33 | 5.81e-01 | -5.56e-02 | 9.53e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.73e-01 | -5.55e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 46 | 5.15e-01 | -5.55e-02 | 9.46e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 39 | 5.48e-01 | 5.55e-02 | 9.49e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 163 | 2.21e-01 | -5.55e-02 | 8.56e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 89 | 3.65e-01 | 5.55e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 7.61e-01 | 5.55e-02 | 9.82e-01 |
| GOBP SEX DIFFERENTIATION | 266 | 1.19e-01 | 5.55e-02 | 7.87e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 175 | 2.06e-01 | -5.55e-02 | 8.51e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 6 | 8.14e-01 | -5.54e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 18 | 6.84e-01 | -5.54e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 17 | 6.93e-01 | -5.54e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 12 | 7.40e-01 | -5.54e-02 | 9.77e-01 |
| GOCC RIBOSOME | 224 | 1.53e-01 | -5.54e-02 | 8.17e-01 |
| GOBP TAURINE METABOLIC PROCESS | 9 | 7.74e-01 | -5.54e-02 | 9.82e-01 |
| GOCC ENDOCYTIC VESICLE | 325 | 8.63e-02 | -5.54e-02 | 7.47e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 66 | 4.37e-01 | 5.53e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 11 | 7.51e-01 | 5.53e-02 | 9.80e-01 |
| GOMF GABA RECEPTOR ACTIVITY | 19 | 6.76e-01 | 5.53e-02 | 9.68e-01 |
| GOBP OVULATION | 15 | 7.11e-01 | 5.53e-02 | 9.71e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 115 | 3.06e-01 | 5.53e-02 | 8.85e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 75 | 4.08e-01 | 5.53e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 72 | 4.18e-01 | -5.53e-02 | 9.23e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 11 | 7.51e-01 | -5.52e-02 | 9.80e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 6.93e-01 | 5.52e-02 | 9.69e-01 |
| GOBP FATTY ACID OMEGA OXIDATION | 5 | 8.31e-01 | 5.52e-02 | 9.88e-01 |
| GOMF HSP90 PROTEIN BINDING | 40 | 5.46e-01 | 5.52e-02 | 9.49e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 87 | 3.74e-01 | -5.52e-02 | 9.09e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 11 | 7.51e-01 | 5.52e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 13 | 7.31e-01 | -5.52e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 8.31e-01 | 5.51e-02 | 9.88e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 45 | 5.23e-01 | -5.50e-02 | 9.47e-01 |
| GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM | 5 | 8.31e-01 | 5.50e-02 | 9.88e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 93 | 3.59e-01 | -5.50e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 21 | 6.63e-01 | 5.50e-02 | 9.67e-01 |
| GOBP NEURON RECOGNITION | 45 | 5.23e-01 | -5.50e-02 | 9.47e-01 |
| GOBP VITAMIN TRANSPORT | 52 | 4.93e-01 | -5.50e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 21 | 6.63e-01 | -5.49e-02 | 9.67e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 80 | 3.96e-01 | -5.49e-02 | 9.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 54 | 4.85e-01 | -5.49e-02 | 9.43e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 271 | 1.20e-01 | 5.49e-02 | 7.88e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 9 | 7.76e-01 | -5.49e-02 | 9.82e-01 |
| GOCC FIBRILLAR CENTER | 144 | 2.56e-01 | 5.48e-02 | 8.65e-01 |
| GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY | 5 | 8.32e-01 | 5.48e-02 | 9.88e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 21 | 6.64e-01 | 5.48e-02 | 9.67e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 203 | 1.78e-01 | -5.48e-02 | 8.41e-01 |
| GOCC A BAND | 33 | 5.86e-01 | 5.48e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 7.88e-01 | -5.48e-02 | 9.84e-01 |
| GOCC PRESPLICEOSOME | 16 | 7.04e-01 | 5.48e-02 | 9.71e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 176 | 2.11e-01 | -5.47e-02 | 8.53e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 14 | 7.23e-01 | -5.47e-02 | 9.74e-01 |
| GOMF ODORANT BINDING | 100 | 3.44e-01 | -5.47e-02 | 8.96e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 160 | 2.32e-01 | -5.47e-02 | 8.63e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 16 | 7.05e-01 | -5.47e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 33 | 5.87e-01 | -5.47e-02 | 9.54e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 144 | 2.58e-01 | -5.46e-02 | 8.65e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 5.76e-01 | -5.46e-02 | 9.51e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 126 | 2.90e-01 | -5.46e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 693 | 1.43e-02 | -5.46e-02 | 4.50e-01 |
| GOBP MEIOTIC CELL CYCLE | 275 | 1.19e-01 | 5.46e-02 | 7.86e-01 |
| GOBP B CELL DIFFERENTIATION | 142 | 2.61e-01 | -5.46e-02 | 8.67e-01 |
| GOBP DNA METABOLIC PROCESS | 982 | 3.79e-03 | 5.46e-02 | 2.32e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 19 | 6.81e-01 | -5.46e-02 | 9.68e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 103 | 3.39e-01 | -5.45e-02 | 8.96e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 24 | 6.44e-01 | -5.45e-02 | 9.63e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 19 | 6.81e-01 | -5.45e-02 | 9.68e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 8.33e-01 | -5.45e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 8.17e-01 | 5.45e-02 | 9.87e-01 |
| GOMF SNARE BINDING | 104 | 3.37e-01 | -5.44e-02 | 8.96e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 7.66e-01 | 5.44e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 44 | 5.32e-01 | -5.44e-02 | 9.48e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 9 | 7.77e-01 | 5.44e-02 | 9.83e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 37 | 5.67e-01 | -5.44e-02 | 9.50e-01 |
| GOBP REGULATION OF AUTOPHAGY | 337 | 8.62e-02 | 5.44e-02 | 7.47e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 1081 | 2.53e-03 | -5.44e-02 | 1.92e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 21 | 6.66e-01 | 5.44e-02 | 9.67e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 10 | 7.66e-01 | 5.43e-02 | 9.82e-01 |
| GOBP D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 8.33e-01 | -5.43e-02 | 9.88e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 16 | 7.07e-01 | 5.43e-02 | 9.71e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 157 | 2.40e-01 | -5.43e-02 | 8.64e-01 |
| GOMF TAU PROTEIN BINDING | 42 | 5.43e-01 | 5.43e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 26 | 6.32e-01 | -5.43e-02 | 9.61e-01 |
| GOBP MICROTUBULE SEVERING | 8 | 7.90e-01 | -5.43e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 8.34e-01 | 5.43e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 10 | 7.66e-01 | 5.42e-02 | 9.82e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 52 | 4.99e-01 | -5.42e-02 | 9.45e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 15 | 7.16e-01 | -5.42e-02 | 9.72e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 13 | 7.35e-01 | -5.42e-02 | 9.77e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 75 | 4.17e-01 | -5.42e-02 | 9.23e-01 |
| GOBP OBSERVATIONAL LEARNING | 7 | 8.04e-01 | -5.42e-02 | 9.86e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 15 | 7.16e-01 | 5.42e-02 | 9.72e-01 |
| GOBP DNA REPLICATION | 272 | 1.24e-01 | 5.42e-02 | 7.93e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 34 | 5.85e-01 | -5.42e-02 | 9.54e-01 |
| GOBP VASODILATION | 46 | 5.25e-01 | -5.42e-02 | 9.47e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 165 | 2.30e-01 | -5.42e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 100 | 3.50e-01 | 5.41e-02 | 8.99e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 248 | 1.42e-01 | 5.41e-02 | 8.06e-01 |
| GOBP TOR SIGNALING | 157 | 2.42e-01 | 5.41e-02 | 8.64e-01 |
| GOCC MICROBODY LUMEN | 51 | 5.04e-01 | 5.41e-02 | 9.45e-01 |
| GOBP RESPONSE TO ALCOHOL | 246 | 1.44e-01 | -5.41e-02 | 8.06e-01 |
| GOBP MAMMARY GLAND FORMATION | 7 | 8.04e-01 | -5.41e-02 | 9.86e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 155 | 2.46e-01 | -5.40e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 22 | 6.61e-01 | 5.40e-02 | 9.66e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 16 | 7.09e-01 | -5.39e-02 | 9.71e-01 |
| GOBP VITAMIN CATABOLIC PROCESS | 14 | 7.27e-01 | 5.39e-02 | 9.75e-01 |
| GOBP CELL DIVISION | 613 | 2.26e-02 | 5.39e-02 | 5.08e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 8.19e-01 | 5.39e-02 | 9.87e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 8.19e-01 | 5.39e-02 | 9.87e-01 |
| GOCC MIDBODY | 196 | 1.93e-01 | 5.39e-02 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 31 | 6.04e-01 | 5.38e-02 | 9.55e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 61 | 4.67e-01 | 5.38e-02 | 9.38e-01 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 9 | 7.80e-01 | -5.38e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 35 | 5.82e-01 | -5.38e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 69 | 4.40e-01 | -5.37e-02 | 9.29e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 8.20e-01 | -5.37e-02 | 9.87e-01 |
| GOBP MELANIN METABOLIC PROCESS | 24 | 6.49e-01 | -5.37e-02 | 9.64e-01 |
| GOBP NEURAL TUBE FORMATION | 103 | 3.47e-01 | 5.36e-02 | 8.97e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 8.35e-01 | -5.36e-02 | 9.89e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 69 | 4.41e-01 | -5.36e-02 | 9.29e-01 |
| GOBP RECOMBINATIONAL REPAIR | 169 | 2.29e-01 | 5.36e-02 | 8.62e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 27 | 6.30e-01 | -5.36e-02 | 9.61e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 16 | 7.10e-01 | 5.36e-02 | 9.71e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 48 | 5.20e-01 | -5.36e-02 | 9.47e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 43 | 5.43e-01 | -5.36e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 27 | 6.30e-01 | -5.36e-02 | 9.61e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 37 | 5.73e-01 | -5.35e-02 | 9.51e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 25 | 6.43e-01 | 5.35e-02 | 9.63e-01 |
| GOBP SPERM MOTILITY | 127 | 2.98e-01 | -5.35e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 14 | 7.29e-01 | 5.35e-02 | 9.75e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 422 | 5.94e-02 | -5.35e-02 | 6.61e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 20 | 6.79e-01 | -5.35e-02 | 9.68e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 107 | 3.39e-01 | -5.35e-02 | 8.96e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 7.11e-01 | 5.35e-02 | 9.71e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 15 | 7.20e-01 | -5.35e-02 | 9.73e-01 |
| GOBP EMBRYO IMPLANTATION | 57 | 4.85e-01 | -5.34e-02 | 9.43e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 34 | 5.90e-01 | -5.34e-02 | 9.54e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 107 | 3.40e-01 | -5.34e-02 | 8.96e-01 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 7 | 8.07e-01 | -5.34e-02 | 9.87e-01 |
| GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO | 6 | 8.21e-01 | -5.34e-02 | 9.87e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 135 | 2.85e-01 | -5.33e-02 | 8.74e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 140 | 2.76e-01 | 5.33e-02 | 8.70e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 93 | 3.75e-01 | -5.33e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 62 | 4.68e-01 | -5.32e-02 | 9.39e-01 |
| GOMF RNA CAP BINDING | 20 | 6.80e-01 | -5.32e-02 | 9.68e-01 |
| GOBP CELL CYCLE | 1732 | 2.32e-04 | 5.32e-02 | 4.32e-02 |
| GOCC LATERAL PART OF CELL | 5 | 8.37e-01 | 5.32e-02 | 9.89e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 400 | 6.79e-02 | -5.32e-02 | 6.90e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 10 | 7.71e-01 | 5.32e-02 | 9.82e-01 |
| GOBP PROPIONATE METABOLIC PROCESS | 5 | 8.37e-01 | 5.32e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 27 | 6.33e-01 | 5.32e-02 | 9.61e-01 |
| GOBP TOOTH MINERALIZATION | 28 | 6.27e-01 | -5.31e-02 | 9.61e-01 |
| GOBP IRON IMPORT INTO CELL | 10 | 7.71e-01 | 5.31e-02 | 9.82e-01 |
| GOBP REGULATION OF AXONOGENESIS | 145 | 2.70e-01 | -5.31e-02 | 8.69e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 336 | 9.47e-02 | -5.31e-02 | 7.64e-01 |
| GOCC GRANULAR COMPONENT | 7 | 8.08e-01 | -5.30e-02 | 9.87e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 115 | 3.26e-01 | -5.30e-02 | 8.93e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 57 | 4.89e-01 | -5.30e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 56 | 4.93e-01 | 5.30e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 37 | 5.77e-01 | -5.30e-02 | 9.52e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 30 | 6.16e-01 | -5.29e-02 | 9.60e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 8.38e-01 | 5.29e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 55 | 4.97e-01 | -5.29e-02 | 9.45e-01 |
| GOMF NAD BINDING | 55 | 4.97e-01 | -5.29e-02 | 9.45e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 8.38e-01 | -5.29e-02 | 9.89e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 11 | 7.61e-01 | -5.29e-02 | 9.82e-01 |
| GOMF HORMONE ACTIVITY | 119 | 3.19e-01 | -5.29e-02 | 8.92e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 10 | 7.72e-01 | 5.29e-02 | 9.82e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 279 | 1.29e-01 | -5.29e-02 | 7.93e-01 |
| GOCC APICAL JUNCTION COMPLEX | 140 | 2.81e-01 | -5.28e-02 | 8.72e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 143 | 2.76e-01 | -5.28e-02 | 8.70e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 217 | 1.80e-01 | 5.28e-02 | 8.41e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 57 | 4.91e-01 | 5.28e-02 | 9.45e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 64 | 4.66e-01 | 5.27e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 7 | 8.09e-01 | -5.27e-02 | 9.87e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 8 | 7.96e-01 | -5.27e-02 | 9.84e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 7 | 8.09e-01 | 5.27e-02 | 9.87e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 32 | 6.06e-01 | -5.27e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 52 | 5.11e-01 | -5.26e-02 | 9.46e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.97e-01 | 5.26e-02 | 9.84e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 8.09e-01 | -5.26e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 60 | 4.81e-01 | -5.26e-02 | 9.42e-01 |
| GOCC KINESIN COMPLEX | 46 | 5.37e-01 | -5.26e-02 | 9.49e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 713 | 1.68e-02 | -5.26e-02 | 4.68e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 108 | 3.45e-01 | 5.26e-02 | 8.96e-01 |
| GOBP FEMALE MEIOSIS I | 13 | 7.43e-01 | -5.25e-02 | 9.77e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 27 | 6.37e-01 | 5.25e-02 | 9.61e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 9 | 7.85e-01 | -5.25e-02 | 9.84e-01 |
| GOBP REGULATION OF DNA REPLICATION | 121 | 3.18e-01 | 5.25e-02 | 8.91e-01 |
| GOBP REGULATION OF COAGULATION | 73 | 4.38e-01 | -5.25e-02 | 9.28e-01 |
| GOMF 5S RRNA BINDING | 9 | 7.85e-01 | -5.25e-02 | 9.84e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 13 | 7.43e-01 | 5.25e-02 | 9.77e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 37 | 5.81e-01 | 5.25e-02 | 9.53e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 8.10e-01 | -5.24e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 7.25e-01 | 5.24e-02 | 9.75e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 50 | 5.22e-01 | -5.24e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 8.39e-01 | -5.24e-02 | 9.89e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 7.98e-01 | 5.24e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 30 | 6.20e-01 | -5.23e-02 | 9.61e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 5.98e-01 | 5.23e-02 | 9.55e-01 |
| GOMF ACTIVIN BINDING | 11 | 7.64e-01 | -5.23e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 5 | 8.40e-01 | 5.22e-02 | 9.89e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 684 | 1.99e-02 | -5.22e-02 | 4.91e-01 |
| GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT | 5 | 8.40e-01 | 5.22e-02 | 9.89e-01 |
| GOBP VIRION ASSEMBLY | 34 | 5.99e-01 | 5.22e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 66 | 4.64e-01 | -5.22e-02 | 9.37e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 248 | 1.57e-01 | -5.21e-02 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 7.75e-01 | 5.21e-02 | 9.82e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 780 | 1.33e-02 | -5.21e-02 | 4.44e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 6.65e-01 | 5.21e-02 | 9.67e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 93 | 3.85e-01 | -5.21e-02 | 9.14e-01 |
| GOBP ACETATE ESTER METABOLIC PROCESS | 6 | 8.25e-01 | -5.21e-02 | 9.88e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 31 | 6.16e-01 | -5.21e-02 | 9.60e-01 |
| GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL | 7 | 8.12e-01 | 5.20e-02 | 9.87e-01 |
| GOBP RHYTHMIC BEHAVIOR | 44 | 5.51e-01 | 5.20e-02 | 9.49e-01 |
| GOBP INTESTINAL ABSORPTION | 41 | 5.65e-01 | 5.20e-02 | 9.50e-01 |
| GOBP CARTILAGE MORPHOGENESIS | 10 | 7.76e-01 | -5.20e-02 | 9.82e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 9 | 7.87e-01 | -5.20e-02 | 9.84e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 7 | 8.12e-01 | -5.20e-02 | 9.87e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 251 | 1.56e-01 | -5.20e-02 | 8.17e-01 |
| GOBP RESPONSE TO ATP | 31 | 6.17e-01 | 5.19e-02 | 9.61e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 25 | 6.53e-01 | -5.19e-02 | 9.64e-01 |
| GOBP INFLAMMATORY RESPONSE | 844 | 1.04e-02 | -5.19e-02 | 3.86e-01 |
| GOCC PRONUCLEUS | 14 | 7.37e-01 | 5.19e-02 | 9.77e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 24 | 6.60e-01 | -5.19e-02 | 9.66e-01 |
| GOBP CELL MATURATION | 191 | 2.16e-01 | -5.19e-02 | 8.56e-01 |
| GOCC MLL3 4 COMPLEX | 10 | 7.76e-01 | 5.19e-02 | 9.83e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 73 | 4.44e-01 | -5.19e-02 | 9.30e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 113 | 3.41e-01 | 5.18e-02 | 8.96e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 7 | 8.12e-01 | 5.18e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 8.13e-01 | 5.18e-02 | 9.87e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 294 | 1.27e-01 | 5.18e-02 | 7.93e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 221 | 1.85e-01 | -5.18e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 7.88e-01 | 5.17e-02 | 9.84e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 271 | 1.43e-01 | -5.17e-02 | 8.06e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 387 | 8.09e-02 | 5.17e-02 | 7.26e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 42 | 5.63e-01 | -5.16e-02 | 9.49e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 15 | 7.29e-01 | 5.16e-02 | 9.76e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 13 | 7.47e-01 | -5.16e-02 | 9.79e-01 |
| GOBP RESPONSE TO FATTY ACID | 55 | 5.08e-01 | 5.16e-02 | 9.46e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 39 | 5.77e-01 | -5.16e-02 | 9.52e-01 |
| GOCC TRANS GOLGI NETWORK | 246 | 1.64e-01 | -5.16e-02 | 8.24e-01 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 9 | 7.89e-01 | -5.15e-02 | 9.84e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 14 | 7.39e-01 | -5.15e-02 | 9.77e-01 |
| GOBP MALE MEIOSIS I | 27 | 6.43e-01 | 5.15e-02 | 9.63e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 122 | 3.26e-01 | 5.15e-02 | 8.93e-01 |
| GOMF MONOSACCHARIDE BINDING | 73 | 4.47e-01 | 5.15e-02 | 9.31e-01 |
| GOCC VESICLE MEMBRANE | 1170 | 3.01e-03 | -5.15e-02 | 2.09e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 78 | 4.32e-01 | 5.15e-02 | 9.27e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 456 | 5.97e-02 | 5.15e-02 | 6.62e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 7 | 8.14e-01 | -5.14e-02 | 9.87e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 62 | 4.84e-01 | 5.14e-02 | 9.43e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 10 | 7.78e-01 | 5.14e-02 | 9.83e-01 |
| GOBP BLASTOCYST GROWTH | 21 | 6.83e-01 | -5.14e-02 | 9.68e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 68 | 4.63e-01 | 5.14e-02 | 9.37e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 38 | 5.84e-01 | 5.14e-02 | 9.54e-01 |
| GOBP CHORION DEVELOPMENT | 10 | 7.78e-01 | 5.14e-02 | 9.83e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 73 | 4.48e-01 | -5.14e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 10 | 7.79e-01 | 5.13e-02 | 9.83e-01 |
| GOCC CDC73 PAF1 COMPLEX | 7 | 8.14e-01 | -5.13e-02 | 9.87e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 8.42e-01 | -5.13e-02 | 9.89e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 7.40e-01 | 5.13e-02 | 9.77e-01 |
| GOBP ORGANELLE FUSION | 156 | 2.69e-01 | 5.12e-02 | 8.69e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 45 | 5.52e-01 | 5.12e-02 | 9.49e-01 |
| GOCC MITOCHONDRIAL CRISTA | 8 | 8.02e-01 | -5.12e-02 | 9.85e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 245 | 1.68e-01 | 5.11e-02 | 8.31e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 20 | 6.92e-01 | 5.11e-02 | 9.69e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 82 | 4.24e-01 | -5.11e-02 | 9.24e-01 |
| GOBP HEART FORMATION | 33 | 6.11e-01 | 5.11e-02 | 9.59e-01 |
| GOBP POSITIVE T CELL SELECTION | 39 | 5.81e-01 | 5.11e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 7 | 8.15e-01 | -5.11e-02 | 9.87e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 261 | 1.56e-01 | 5.11e-02 | 8.17e-01 |
| GOMF HEXOKINASE ACTIVITY | 5 | 8.43e-01 | 5.10e-02 | 9.89e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 15 | 7.32e-01 | 5.10e-02 | 9.76e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 7 | 8.15e-01 | -5.10e-02 | 9.87e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 11 | 7.70e-01 | 5.10e-02 | 9.82e-01 |
| GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE | 7 | 8.15e-01 | -5.10e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 201 | 2.12e-01 | -5.10e-02 | 8.54e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 9 | 7.91e-01 | 5.10e-02 | 9.84e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 15 | 7.32e-01 | -5.10e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 14 | 7.41e-01 | -5.10e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 8.03e-01 | -5.10e-02 | 9.85e-01 |
| GOBP SEQUESTERING OF IRON ION | 6 | 8.29e-01 | -5.10e-02 | 9.88e-01 |
| GOBP EXOCYTOSIS | 329 | 1.12e-01 | -5.10e-02 | 7.78e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 209 | 2.04e-01 | 5.10e-02 | 8.51e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 11 | 7.70e-01 | 5.09e-02 | 9.82e-01 |
| GOBP VIRAL LIFE CYCLE | 307 | 1.25e-01 | -5.09e-02 | 7.93e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 43 | 5.64e-01 | -5.08e-02 | 9.50e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 418 | 7.47e-02 | 5.08e-02 | 7.12e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 53 | 5.22e-01 | -5.08e-02 | 9.47e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 10 | 7.81e-01 | 5.08e-02 | 9.83e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 8.29e-01 | 5.08e-02 | 9.88e-01 |
| GOCC NUCLEAR PERIPHERY | 142 | 2.96e-01 | 5.08e-02 | 8.82e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 2.91e-01 | 5.08e-02 | 8.79e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 29 | 6.36e-01 | -5.08e-02 | 9.61e-01 |
| GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 7 | 8.16e-01 | -5.08e-02 | 9.87e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 12 | 7.61e-01 | -5.07e-02 | 9.82e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 20 | 6.95e-01 | -5.07e-02 | 9.69e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 102 | 3.76e-01 | -5.07e-02 | 9.09e-01 |
| GOBP RESPONSE TO VITAMIN | 82 | 4.28e-01 | -5.07e-02 | 9.27e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 12 | 7.61e-01 | 5.06e-02 | 9.82e-01 |
| GOBP GONADOTROPIN SECRETION | 17 | 7.18e-01 | 5.06e-02 | 9.72e-01 |
| GOCC U5 SNRNP | 22 | 6.81e-01 | 5.06e-02 | 9.68e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 7 | 8.17e-01 | -5.06e-02 | 9.87e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 30 | 6.31e-01 | 5.06e-02 | 9.61e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 24 | 6.68e-01 | 5.06e-02 | 9.67e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 13 | 7.52e-01 | 5.06e-02 | 9.81e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 142 | 2.98e-01 | -5.06e-02 | 8.82e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 14 | 7.43e-01 | -5.05e-02 | 9.77e-01 |
| GOBP LIPID HOMEOSTASIS | 169 | 2.57e-01 | -5.05e-02 | 8.65e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 8.05e-01 | 5.05e-02 | 9.86e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 9 | 7.93e-01 | -5.05e-02 | 9.84e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 36 | 6.00e-01 | -5.05e-02 | 9.55e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 451 | 6.62e-02 | 5.05e-02 | 6.82e-01 |
| GOCC CELL BODY MEMBRANE | 32 | 6.21e-01 | 5.05e-02 | 9.61e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 27 | 6.50e-01 | -5.04e-02 | 9.64e-01 |
| GOMF LIPID KINASE ACTIVITY | 40 | 5.81e-01 | -5.04e-02 | 9.53e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 51 | 5.33e-01 | 5.04e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 8.17e-01 | 5.04e-02 | 9.87e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 24 | 6.69e-01 | 5.03e-02 | 9.67e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 7.12e-01 | 5.03e-02 | 9.71e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 14 | 7.44e-01 | 5.03e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 30 | 6.33e-01 | -5.03e-02 | 9.61e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 91 | 4.07e-01 | -5.03e-02 | 9.21e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 19 | 7.04e-01 | -5.03e-02 | 9.71e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 132 | 3.19e-01 | 5.03e-02 | 8.91e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 18 | 7.12e-01 | -5.03e-02 | 9.71e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 67 | 4.77e-01 | 5.03e-02 | 9.41e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 8.06e-01 | -5.03e-02 | 9.87e-01 |
| GOMF LAMININ 1 BINDING | 7 | 8.18e-01 | 5.02e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 14 | 7.45e-01 | -5.02e-02 | 9.78e-01 |
| GOBP EYE MORPHOGENESIS | 159 | 2.74e-01 | 5.02e-02 | 8.69e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 128 | 3.26e-01 | -5.02e-02 | 8.93e-01 |
| GOBP NEUROBLAST DIFFERENTIATION | 8 | 8.06e-01 | -5.02e-02 | 9.87e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 53 | 5.27e-01 | 5.02e-02 | 9.48e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 169 | 2.60e-01 | -5.02e-02 | 8.66e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 23 | 6.77e-01 | -5.02e-02 | 9.68e-01 |
| GOCC GOLGI CISTERNA | 97 | 3.93e-01 | -5.01e-02 | 9.17e-01 |
| GOBP MRNA CATABOLIC PROCESS | 294 | 1.39e-01 | -5.01e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 48 | 5.48e-01 | -5.01e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 34 | 6.13e-01 | 5.01e-02 | 9.59e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 8.06e-01 | 5.01e-02 | 9.87e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 40 | 5.84e-01 | 5.01e-02 | 9.54e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 22 | 6.84e-01 | -5.01e-02 | 9.68e-01 |
| GOMF INSULIN RECEPTOR BINDING | 21 | 6.91e-01 | -5.01e-02 | 9.69e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 27 | 6.53e-01 | 5.00e-02 | 9.64e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 17 | 7.21e-01 | 5.00e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 8.46e-01 | -5.00e-02 | 9.90e-01 |
| GOBP COLLATERAL SPROUTING | 26 | 6.59e-01 | -5.00e-02 | 9.66e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 232 | 1.90e-01 | -4.99e-02 | 8.44e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 51 | 5.37e-01 | -4.99e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 591 | 3.81e-02 | -4.99e-02 | 5.91e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 35 | 6.09e-01 | 4.99e-02 | 9.57e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 9 | 7.96e-01 | 4.99e-02 | 9.84e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 570 | 4.20e-02 | 4.98e-02 | 6.10e-01 |
| GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE | 5 | 8.47e-01 | 4.98e-02 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 320 | 1.26e-01 | -4.98e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 49 | 5.47e-01 | 4.98e-02 | 9.49e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 46 | 5.59e-01 | 4.98e-02 | 9.49e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 80 | 4.41e-01 | -4.98e-02 | 9.29e-01 |
| GOMF UNIPORTER ACTIVITY | 8 | 8.07e-01 | -4.98e-02 | 9.87e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 35 | 6.10e-01 | 4.98e-02 | 9.58e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 169 | 2.64e-01 | 4.98e-02 | 8.69e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 125 | 3.37e-01 | 4.98e-02 | 8.96e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 54 | 5.27e-01 | 4.97e-02 | 9.48e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 7 | 8.20e-01 | 4.97e-02 | 9.87e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 16 | 7.31e-01 | 4.97e-02 | 9.76e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 14 | 7.47e-01 | -4.97e-02 | 9.79e-01 |
| GOCC TOR COMPLEX | 11 | 7.75e-01 | 4.97e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 46 | 5.60e-01 | 4.97e-02 | 9.49e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 7.96e-01 | -4.97e-02 | 9.84e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 32 | 6.27e-01 | -4.97e-02 | 9.61e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 573 | 4.22e-02 | -4.96e-02 | 6.11e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 94 | 4.06e-01 | -4.96e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 46 | 5.61e-01 | -4.96e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 26 | 6.62e-01 | 4.96e-02 | 9.66e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 6 | 8.33e-01 | 4.96e-02 | 9.88e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 28 | 6.50e-01 | -4.96e-02 | 9.64e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 88 | 4.21e-01 | -4.96e-02 | 9.24e-01 |
| GOBP RECEPTOR CLUSTERING | 53 | 5.32e-01 | 4.96e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 23 | 6.81e-01 | -4.96e-02 | 9.68e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 19 | 7.08e-01 | -4.95e-02 | 9.71e-01 |
| GOCC KATANIN COMPLEX | 5 | 8.48e-01 | -4.94e-02 | 9.91e-01 |
| GOBP CYTOKINE PRODUCTION | 835 | 1.54e-02 | -4.94e-02 | 4.61e-01 |
| GOBP RESPONSE TO DSRNA | 52 | 5.38e-01 | -4.93e-02 | 9.49e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 14 | 7.49e-01 | -4.93e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 97 | 4.01e-01 | -4.93e-02 | 9.19e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 39 | 5.94e-01 | -4.93e-02 | 9.54e-01 |
| GOBP ISOPRENOID TRANSPORT | 5 | 8.49e-01 | 4.93e-02 | 9.91e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 341 | 1.18e-01 | -4.93e-02 | 7.82e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 74 | 4.64e-01 | 4.93e-02 | 9.37e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 978 | 9.12e-03 | -4.92e-02 | 3.64e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 21 | 6.96e-01 | 4.92e-02 | 9.69e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 13 | 7.59e-01 | -4.92e-02 | 9.82e-01 |
| GOBP GROWTH HORMONE SECRETION | 13 | 7.59e-01 | 4.92e-02 | 9.82e-01 |
| GOBP ORGAN GROWTH | 168 | 2.71e-01 | -4.92e-02 | 8.69e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 27 | 6.58e-01 | 4.92e-02 | 9.66e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 18 | 7.18e-01 | 4.91e-02 | 9.72e-01 |
| GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION | 5 | 8.49e-01 | 4.91e-02 | 9.91e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 169 | 2.71e-01 | -4.91e-02 | 8.69e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 12 | 7.68e-01 | 4.91e-02 | 9.82e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 8.49e-01 | 4.91e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 104 | 3.87e-01 | -4.91e-02 | 9.14e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 89 | 4.24e-01 | 4.91e-02 | 9.24e-01 |
| GOCC CLATHRIN COAT | 47 | 5.60e-01 | -4.91e-02 | 9.49e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 17 | 7.26e-01 | -4.91e-02 | 9.75e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 10 | 7.88e-01 | -4.91e-02 | 9.84e-01 |
| GOBP ERK5 CASCADE | 5 | 8.49e-01 | -4.91e-02 | 9.91e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 38 | 6.01e-01 | 4.90e-02 | 9.55e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 33 | 6.26e-01 | -4.90e-02 | 9.61e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 99 | 3.99e-01 | -4.90e-02 | 9.18e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 7 | 8.22e-01 | 4.90e-02 | 9.88e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 1381 | 2.27e-03 | -4.90e-02 | 1.84e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 6 | 8.35e-01 | 4.90e-02 | 9.89e-01 |
| GOCC SITE OF DNA DAMAGE | 113 | 3.69e-01 | 4.90e-02 | 9.08e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 426 | 8.31e-02 | -4.90e-02 | 7.36e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 305 | 1.41e-01 | 4.90e-02 | 8.06e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 452 | 7.44e-02 | 4.90e-02 | 7.12e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 14 | 7.51e-01 | 4.89e-02 | 9.80e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 139 | 3.19e-01 | -4.89e-02 | 8.92e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 70 | 4.79e-01 | 4.89e-02 | 9.42e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 62 | 5.05e-01 | -4.89e-02 | 9.45e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 18 | 7.19e-01 | -4.89e-02 | 9.73e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 16 | 7.35e-01 | -4.89e-02 | 9.77e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 7.89e-01 | 4.89e-02 | 9.84e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 124 | 3.48e-01 | -4.88e-02 | 8.98e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 6 | 8.36e-01 | 4.88e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 60 | 5.13e-01 | 4.88e-02 | 9.46e-01 |
| GOBP T CELL SELECTION | 52 | 5.42e-01 | 4.88e-02 | 9.49e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 101 | 3.97e-01 | -4.88e-02 | 9.18e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 8.11e-01 | 4.88e-02 | 9.87e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 31 | 6.38e-01 | -4.88e-02 | 9.62e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 8.11e-01 | -4.88e-02 | 9.87e-01 |
| GOCC CLEAVAGE FURROW | 51 | 5.47e-01 | -4.88e-02 | 9.49e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 9 | 8.00e-01 | -4.87e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 351 | 1.17e-01 | -4.87e-02 | 7.82e-01 |
| GOBP CELL ADHESION | 1462 | 1.84e-03 | -4.87e-02 | 1.62e-01 |
| GOCC ANCHORING JUNCTION | 863 | 1.52e-02 | -4.87e-02 | 4.61e-01 |
| GOCC LATERAL ELEMENT | 14 | 7.53e-01 | 4.87e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1430 | 2.06e-03 | 4.86e-02 | 1.75e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 12 | 7.71e-01 | 4.86e-02 | 9.82e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 33 | 6.29e-01 | 4.86e-02 | 9.61e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 196 | 2.41e-01 | -4.86e-02 | 8.64e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 7 | 8.24e-01 | -4.85e-02 | 9.88e-01 |
| GOMF PEPTIDE HORMONE BINDING | 48 | 5.61e-01 | -4.85e-02 | 9.49e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 10 | 7.90e-01 | 4.85e-02 | 9.84e-01 |
| GOBP INTERLEUKIN 21 PRODUCTION | 5 | 8.51e-01 | -4.85e-02 | 9.91e-01 |
| GOBP PROTEIN PROCESSING | 233 | 2.02e-01 | -4.85e-02 | 8.51e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 39 | 6.00e-01 | -4.85e-02 | 9.55e-01 |
| GOBP OVULATION CYCLE | 72 | 4.77e-01 | -4.85e-02 | 9.41e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 32 | 6.35e-01 | -4.85e-02 | 9.61e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 101 | 4.00e-01 | -4.85e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 7.37e-01 | 4.85e-02 | 9.77e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 131 | 3.38e-01 | -4.85e-02 | 8.96e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 127 | 3.45e-01 | 4.85e-02 | 8.96e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 16 | 7.37e-01 | -4.85e-02 | 9.77e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 33 | 6.30e-01 | -4.84e-02 | 9.61e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 8.37e-01 | 4.84e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 17 | 7.30e-01 | -4.84e-02 | 9.76e-01 |
| GOMF ACYL COA BINDING | 19 | 7.15e-01 | 4.84e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 214 | 2.23e-01 | -4.84e-02 | 8.57e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 8 | 8.13e-01 | -4.83e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 21 | 7.02e-01 | 4.83e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 212 | 2.26e-01 | -4.83e-02 | 8.59e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 198 | 2.41e-01 | 4.83e-02 | 8.64e-01 |
| GOBP MUSCLE ATROPHY | 10 | 7.91e-01 | -4.83e-02 | 9.84e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 6.76e-01 | 4.83e-02 | 9.68e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 118 | 3.65e-01 | -4.83e-02 | 9.06e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 603 | 4.31e-02 | 4.82e-02 | 6.14e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 8.52e-01 | 4.82e-02 | 9.91e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 28 | 6.59e-01 | 4.81e-02 | 9.66e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 19 | 7.17e-01 | 4.81e-02 | 9.72e-01 |
| GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS | 6 | 8.38e-01 | 4.81e-02 | 9.89e-01 |
| GOBP NITRIC OXIDE TRANSPORT | 5 | 8.52e-01 | 4.81e-02 | 9.91e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 9 | 8.03e-01 | 4.81e-02 | 9.85e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 44 | 5.81e-01 | -4.81e-02 | 9.53e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 6.60e-01 | 4.81e-02 | 9.66e-01 |
| GOBP SYNAPSE ASSEMBLY | 184 | 2.61e-01 | -4.81e-02 | 8.66e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 6 | 8.38e-01 | 4.80e-02 | 9.89e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 7 | 8.26e-01 | 4.80e-02 | 9.88e-01 |
| GOBP HORMONE TRANSPORT | 311 | 1.46e-01 | 4.80e-02 | 8.08e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 12 | 7.74e-01 | 4.80e-02 | 9.82e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 5 | 8.53e-01 | -4.79e-02 | 9.91e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 17 | 7.32e-01 | -4.79e-02 | 9.76e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 14 | 7.56e-01 | 4.79e-02 | 9.82e-01 |
| GOMF NUCLEOSOME BINDING | 67 | 4.98e-01 | 4.79e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 44 | 5.83e-01 | -4.79e-02 | 9.53e-01 |
| GOBP TRIGEMINAL NERVE DEVELOPMENT | 10 | 7.93e-01 | -4.79e-02 | 9.84e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 10 | 7.93e-01 | -4.79e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 148 | 3.15e-01 | -4.79e-02 | 8.90e-01 |
| GOBP OOCYTE DIFFERENTIATION | 64 | 5.08e-01 | 4.78e-02 | 9.46e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 9 | 8.04e-01 | 4.78e-02 | 9.86e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 86 | 4.44e-01 | -4.78e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 1007 | 1.03e-02 | -4.78e-02 | 3.85e-01 |
| GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING | 5 | 8.53e-01 | -4.78e-02 | 9.91e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 11 | 7.84e-01 | -4.77e-02 | 9.84e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 26 | 6.74e-01 | -4.77e-02 | 9.68e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 304 | 1.53e-01 | -4.77e-02 | 8.17e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 39 | 6.07e-01 | -4.76e-02 | 9.55e-01 |
| GOBP MRNA METHYLATION | 17 | 7.34e-01 | -4.76e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 27 | 6.68e-01 | 4.76e-02 | 9.67e-01 |
| GOBP FATTY ACID ELONGATION | 12 | 7.75e-01 | -4.76e-02 | 9.82e-01 |
| GOCC SEPTIN CYTOSKELETON | 14 | 7.58e-01 | 4.76e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 15 | 7.50e-01 | -4.76e-02 | 9.80e-01 |
| GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 8.54e-01 | -4.75e-02 | 9.91e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 1131 | 7.05e-03 | -4.75e-02 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 8.54e-01 | 4.75e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 22 | 7.00e-01 | 4.75e-02 | 9.70e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 64 | 5.11e-01 | -4.75e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 8.40e-01 | -4.75e-02 | 9.89e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 16 | 7.42e-01 | -4.74e-02 | 9.77e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 27 | 6.70e-01 | -4.74e-02 | 9.67e-01 |
| GOBP RETINAL CELL APOPTOTIC PROCESS | 7 | 8.28e-01 | -4.74e-02 | 9.88e-01 |
| GOBP VESICLE CARGO LOADING | 29 | 6.59e-01 | 4.74e-02 | 9.66e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS | 7 | 8.28e-01 | 4.74e-02 | 9.88e-01 |
| GOBP SELF PROTEOLYSIS | 12 | 7.76e-01 | 4.73e-02 | 9.83e-01 |
| GOBP CATECHOLAMINE SECRETION | 60 | 5.26e-01 | -4.73e-02 | 9.47e-01 |
| GOBP RNA CATABOLIC PROCESS | 348 | 1.30e-01 | -4.73e-02 | 7.93e-01 |
| GOBP PLASMA MEMBRANE FUSION | 30 | 6.54e-01 | -4.73e-02 | 9.64e-01 |
| GOBP RESPONSE TO CAMP | 81 | 4.62e-01 | -4.73e-02 | 9.37e-01 |
| GOCC GBAF COMPLEX | 14 | 7.59e-01 | -4.73e-02 | 9.82e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 34 | 6.33e-01 | 4.73e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 9 | 8.06e-01 | 4.72e-02 | 9.87e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 12 | 7.77e-01 | 4.71e-02 | 9.83e-01 |
| GOMF GAMMA TUBULIN BINDING | 30 | 6.55e-01 | -4.71e-02 | 9.65e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 44 | 5.89e-01 | 4.71e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 8 | 8.18e-01 | -4.71e-02 | 9.87e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 57 | 5.40e-01 | 4.70e-02 | 9.49e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 15 | 7.53e-01 | -4.70e-02 | 9.81e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 6 | 8.42e-01 | 4.70e-02 | 9.89e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 560 | 5.77e-02 | -4.69e-02 | 6.57e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 53 | 5.55e-01 | -4.69e-02 | 9.49e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 25 | 6.85e-01 | 4.69e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS | 6 | 8.42e-01 | -4.69e-02 | 9.89e-01 |
| GOBP RESPONSE TO HISTAMINE | 11 | 7.88e-01 | -4.69e-02 | 9.84e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 8.30e-01 | -4.69e-02 | 9.88e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 21 | 7.10e-01 | -4.69e-02 | 9.71e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 8 | 8.18e-01 | -4.69e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 34 | 6.36e-01 | -4.68e-02 | 9.61e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 219 | 2.33e-01 | -4.68e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 83 | 4.62e-01 | -4.67e-02 | 9.37e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 10 | 7.98e-01 | -4.67e-02 | 9.84e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 260 | 1.94e-01 | 4.67e-02 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 10 | 7.98e-01 | -4.67e-02 | 9.84e-01 |
| GOCC GERM CELL NUCLEUS | 68 | 5.05e-01 | -4.67e-02 | 9.45e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 49 | 5.72e-01 | -4.67e-02 | 9.51e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 37 | 6.23e-01 | 4.67e-02 | 9.61e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 10 | 7.98e-01 | -4.67e-02 | 9.85e-01 |
| GOMF MANGANESE ION BINDING | 63 | 5.22e-01 | -4.67e-02 | 9.47e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 62 | 5.25e-01 | -4.67e-02 | 9.47e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 83 | 4.63e-01 | -4.66e-02 | 9.37e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 22 | 7.05e-01 | 4.66e-02 | 9.71e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 37 | 6.24e-01 | 4.66e-02 | 9.61e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 24 | 6.93e-01 | -4.66e-02 | 9.69e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 21 | 7.12e-01 | 4.66e-02 | 9.71e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 102 | 4.16e-01 | -4.66e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 16 | 7.47e-01 | 4.66e-02 | 9.79e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 63 | 5.23e-01 | 4.66e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 86 | 4.56e-01 | -4.65e-02 | 9.36e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 55 | 5.51e-01 | -4.65e-02 | 9.49e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 29 | 6.65e-01 | 4.65e-02 | 9.67e-01 |
| GOBP REGULATION OF NODAL SIGNALING PATHWAY | 9 | 8.09e-01 | 4.65e-02 | 9.87e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 305 | 1.63e-01 | 4.65e-02 | 8.24e-01 |
| GOMF ISOMERASE ACTIVITY | 154 | 3.20e-01 | 4.65e-02 | 8.92e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 93 | 4.39e-01 | 4.65e-02 | 9.29e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 13 | 7.72e-01 | 4.64e-02 | 9.82e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 8 | 8.20e-01 | -4.64e-02 | 9.87e-01 |
| GOBP CELLULAR HOMEOSTASIS | 779 | 2.77e-02 | -4.64e-02 | 5.39e-01 |
| GOCC CLATHRIN VESICLE COAT | 33 | 6.45e-01 | -4.63e-02 | 9.63e-01 |
| GOBP CELL FATE COMMITMENT | 279 | 1.83e-01 | 4.63e-02 | 8.42e-01 |
| GOCC CMG COMPLEX | 11 | 7.90e-01 | -4.63e-02 | 9.84e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 13 | 7.73e-01 | 4.63e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 81 | 4.72e-01 | 4.62e-02 | 9.39e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 7.91e-01 | -4.62e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 853 | 2.20e-02 | -4.62e-02 | 5.05e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 8 | 8.21e-01 | 4.62e-02 | 9.87e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 7 | 8.32e-01 | 4.62e-02 | 9.88e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 11 | 7.91e-01 | 4.62e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 118 | 3.86e-01 | 4.62e-02 | 9.14e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 9 | 8.11e-01 | 4.61e-02 | 9.87e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.62e-01 | -4.61e-02 | 9.66e-01 |
| GOBP DOPAMINE TRANSPORT | 55 | 5.54e-01 | -4.61e-02 | 9.49e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 200 | 2.61e-01 | 4.61e-02 | 8.67e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 139 | 3.48e-01 | -4.61e-02 | 8.98e-01 |
| GOBP CITRATE TRANSPORT | 5 | 8.58e-01 | 4.61e-02 | 9.92e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 28 | 6.73e-01 | 4.60e-02 | 9.68e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 43 | 6.02e-01 | -4.60e-02 | 9.55e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 242 | 2.18e-01 | 4.60e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 460 | 9.09e-02 | -4.60e-02 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 310 | 1.64e-01 | -4.60e-02 | 8.24e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 17 | 7.43e-01 | -4.60e-02 | 9.77e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 6 | 8.45e-01 | -4.60e-02 | 9.90e-01 |
| GOBP MONOAMINE TRANSPORT | 86 | 4.61e-01 | 4.60e-02 | 9.37e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 20 | 7.22e-01 | -4.59e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 7.29e-01 | 4.59e-02 | 9.76e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 12 | 7.83e-01 | 4.59e-02 | 9.84e-01 |
| GOCC INTERCALATED DISC | 49 | 5.78e-01 | -4.59e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 8.02e-01 | 4.59e-02 | 9.85e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 12 | 7.83e-01 | -4.58e-02 | 9.84e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 169 | 3.04e-01 | 4.58e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 370 | 1.30e-01 | -4.58e-02 | 7.94e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 13 | 7.75e-01 | -4.58e-02 | 9.82e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 7.59e-01 | -4.58e-02 | 9.82e-01 |
| GOMF DEATH DOMAIN BINDING | 11 | 7.93e-01 | -4.58e-02 | 9.84e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 124 | 3.79e-01 | 4.58e-02 | 9.09e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 54 | 5.61e-01 | 4.58e-02 | 9.49e-01 |
| GOMF SH2 DOMAIN BINDING | 40 | 6.17e-01 | 4.57e-02 | 9.61e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 9 | 8.12e-01 | -4.57e-02 | 9.87e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 151 | 3.32e-01 | -4.57e-02 | 8.94e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 16 | 7.52e-01 | 4.57e-02 | 9.80e-01 |
| GOCC BASAL PART OF CELL | 291 | 1.80e-01 | -4.57e-02 | 8.41e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 8.23e-01 | -4.57e-02 | 9.88e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 10 | 8.03e-01 | 4.57e-02 | 9.85e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 298 | 1.75e-01 | -4.56e-02 | 8.41e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 342 | 1.47e-01 | 4.56e-02 | 8.08e-01 |
| GOBP ENDOCARDIUM MORPHOGENESIS | 6 | 8.47e-01 | 4.56e-02 | 9.90e-01 |
| GOBP CELLULAR RESPONSE TO PH | 26 | 6.87e-01 | 4.56e-02 | 9.69e-01 |
| GOBP PROTEIN AUTOPROCESSING | 28 | 6.77e-01 | 4.55e-02 | 9.68e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 40 | 6.19e-01 | -4.55e-02 | 9.61e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 7.94e-01 | 4.55e-02 | 9.84e-01 |
| GOBP PEPTIDE MODIFICATION | 5 | 8.60e-01 | 4.54e-02 | 9.93e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 22 | 7.12e-01 | 4.54e-02 | 9.71e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 7.94e-01 | 4.54e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 107 | 4.17e-01 | -4.54e-02 | 9.23e-01 |
| GOCC MYOSIN COMPLEX | 56 | 5.57e-01 | -4.54e-02 | 9.49e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 137 | 3.59e-01 | 4.54e-02 | 9.03e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 194 | 2.76e-01 | -4.54e-02 | 8.70e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 36 | 6.38e-01 | -4.54e-02 | 9.62e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 341 | 1.50e-01 | 4.54e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 6 | 8.47e-01 | 4.54e-02 | 9.90e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER | 5 | 8.61e-01 | 4.54e-02 | 9.93e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 9 | 8.14e-01 | 4.53e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 44 | 6.03e-01 | 4.53e-02 | 9.55e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 51 | 5.76e-01 | 4.53e-02 | 9.51e-01 |
| GOBP REGULATION OF TRANSPORT | 1706 | 1.87e-03 | -4.53e-02 | 1.62e-01 |
| GOBP CARDIAC PACEMAKER CELL DEVELOPMENT | 9 | 8.14e-01 | 4.53e-02 | 9.87e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 7.54e-01 | 4.53e-02 | 9.81e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 8.14e-01 | -4.53e-02 | 9.87e-01 |
| GOBP B CELL PROLIFERATION | 96 | 4.44e-01 | -4.52e-02 | 9.30e-01 |
| GOCC CHROMAFFIN GRANULE | 13 | 7.78e-01 | -4.52e-02 | 9.83e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 26 | 6.90e-01 | 4.52e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 974 | 1.69e-02 | -4.52e-02 | 4.68e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 993 | 1.59e-02 | 4.52e-02 | 4.67e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 91 | 4.56e-01 | -4.52e-02 | 9.36e-01 |
| GOMF METAL CLUSTER BINDING | 66 | 5.26e-01 | 4.52e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 6 | 8.48e-01 | 4.51e-02 | 9.91e-01 |
| GOCC BLEB | 9 | 8.15e-01 | 4.51e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 22 | 7.14e-01 | -4.51e-02 | 9.72e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 23 | 7.08e-01 | 4.51e-02 | 9.71e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 77 | 4.94e-01 | 4.51e-02 | 9.45e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 46 | 5.96e-01 | 4.51e-02 | 9.55e-01 |
| GOCC ALVEOLAR LAMELLAR BODY | 7 | 8.36e-01 | -4.51e-02 | 9.89e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 28 | 6.80e-01 | -4.51e-02 | 9.68e-01 |
| GOCC TRAPP COMPLEX | 16 | 7.55e-01 | -4.50e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 8 | 8.26e-01 | -4.50e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 23 | 7.09e-01 | 4.50e-02 | 9.71e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 9 | 8.15e-01 | 4.50e-02 | 9.87e-01 |
| GOCC AGGRESOME | 33 | 6.55e-01 | 4.50e-02 | 9.65e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 111 | 4.13e-01 | -4.50e-02 | 9.23e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 40 | 6.23e-01 | 4.49e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 7.63e-01 | -4.49e-02 | 9.82e-01 |
| GOCC GABA RECEPTOR COMPLEX | 18 | 7.42e-01 | 4.49e-02 | 9.77e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 289 | 1.89e-01 | 4.49e-02 | 8.44e-01 |
| GOBP LEUKOTRIENE CATABOLIC PROCESS | 6 | 8.49e-01 | -4.49e-02 | 9.91e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 286 | 1.92e-01 | -4.48e-02 | 8.44e-01 |
| GOMF ACTININ BINDING | 35 | 6.47e-01 | -4.48e-02 | 9.63e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 92 | 4.58e-01 | -4.48e-02 | 9.37e-01 |
| GOBP NUCLEUS LOCALIZATION | 33 | 6.56e-01 | 4.48e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 161 | 3.27e-01 | -4.48e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 15 | 7.64e-01 | -4.48e-02 | 9.82e-01 |
| GOBP LIPID PHOSPHORYLATION | 10 | 8.07e-01 | 4.47e-02 | 9.87e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 10 | 8.07e-01 | 4.47e-02 | 9.87e-01 |
| GOMF WNT PROTEIN BINDING | 31 | 6.67e-01 | -4.47e-02 | 9.67e-01 |
| GOBP ENDOCRINE PROCESS | 87 | 4.71e-01 | 4.47e-02 | 9.39e-01 |
| GOCC LYSOSOMAL LUMEN | 91 | 4.62e-01 | -4.46e-02 | 9.37e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 168 | 3.19e-01 | 4.46e-02 | 8.91e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 29 | 6.78e-01 | 4.46e-02 | 9.68e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 259 | 2.17e-01 | -4.46e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 855 | 2.69e-02 | -4.46e-02 | 5.32e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 11 | 7.98e-01 | -4.46e-02 | 9.84e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 58 | 5.57e-01 | 4.45e-02 | 9.49e-01 |
| GOMF LIGASE ACTIVITY | 159 | 3.33e-01 | 4.45e-02 | 8.94e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 65 | 5.35e-01 | -4.45e-02 | 9.49e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 142 | 3.60e-01 | 4.45e-02 | 9.04e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 190 | 2.90e-01 | 4.45e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 14 | 7.73e-01 | -4.45e-02 | 9.82e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 38 | 6.35e-01 | -4.45e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 30 | 6.73e-01 | 4.45e-02 | 9.68e-01 |
| GOMF PH DOMAIN BINDING | 8 | 8.28e-01 | 4.45e-02 | 9.88e-01 |
| GOBP CHROMOSOME ORGANIZATION | 604 | 6.21e-02 | 4.44e-02 | 6.63e-01 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 19 | 7.37e-01 | 4.44e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 8.28e-01 | -4.44e-02 | 9.88e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 38 | 6.36e-01 | -4.44e-02 | 9.61e-01 |
| GOBP NEPHRON MORPHOGENESIS | 77 | 5.00e-01 | 4.44e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 951 | 2.03e-02 | -4.44e-02 | 4.94e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 58 | 5.59e-01 | 4.44e-02 | 9.49e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 51 | 5.83e-01 | 4.44e-02 | 9.54e-01 |
| GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 5 | 8.64e-01 | 4.44e-02 | 9.93e-01 |
| GOBP REGULATION OF EATING BEHAVIOR | 7 | 8.39e-01 | 4.44e-02 | 9.89e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 8 | 8.28e-01 | -4.44e-02 | 9.88e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 165 | 3.26e-01 | 4.44e-02 | 8.93e-01 |
| GOBP INNATE IMMUNE RESPONSE | 896 | 2.43e-02 | -4.43e-02 | 5.18e-01 |
| GOBP IRON ION TRANSPORT | 53 | 5.77e-01 | 4.43e-02 | 9.52e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 28 | 6.85e-01 | 4.43e-02 | 9.68e-01 |
| GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 7.91e-01 | 4.43e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 21 | 7.26e-01 | -4.43e-02 | 9.75e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 21 | 7.26e-01 | -4.42e-02 | 9.75e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID IMPORT | 6 | 8.51e-01 | -4.42e-02 | 9.91e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 7.08e-01 | -4.42e-02 | 9.71e-01 |
| GOBP SNRNA PROCESSING | 25 | 7.02e-01 | 4.42e-02 | 9.71e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 33 | 6.61e-01 | -4.42e-02 | 9.66e-01 |
| GOCC SET1C COMPASS COMPLEX | 14 | 7.75e-01 | 4.42e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 52 | 5.82e-01 | -4.42e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS | 5 | 8.64e-01 | -4.41e-02 | 9.93e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 25 | 7.03e-01 | -4.41e-02 | 9.71e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 134 | 3.78e-01 | -4.41e-02 | 9.09e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 23 | 7.14e-01 | -4.41e-02 | 9.72e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 83 | 4.88e-01 | -4.40e-02 | 9.43e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 11 | 8.00e-01 | 4.40e-02 | 9.85e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 19 | 7.40e-01 | 4.40e-02 | 9.77e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 9 | 8.19e-01 | -4.40e-02 | 9.87e-01 |
| GOBP ANIMAL ORGAN MATURATION | 29 | 6.82e-01 | -4.40e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 152 | 3.49e-01 | 4.40e-02 | 8.99e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 106 | 4.34e-01 | -4.39e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 55 | 5.73e-01 | -4.39e-02 | 9.51e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 16 | 7.61e-01 | -4.39e-02 | 9.82e-01 |
| GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.20e-01 | 4.39e-02 | 9.87e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 206 | 2.77e-01 | -4.39e-02 | 8.70e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 98 | 4.53e-01 | 4.39e-02 | 9.35e-01 |
| GOBP BONE RESORPTION | 65 | 5.41e-01 | -4.39e-02 | 9.49e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 88 | 4.77e-01 | -4.38e-02 | 9.41e-01 |
| GOMF HYDRO LYASE ACTIVITY | 57 | 5.67e-01 | 4.38e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 10 | 8.11e-01 | -4.38e-02 | 9.87e-01 |
| GOMF PROTEOGLYCAN BINDING | 36 | 6.49e-01 | -4.38e-02 | 9.64e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 8.53e-01 | -4.38e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 33 | 6.63e-01 | -4.38e-02 | 9.67e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 7.69e-01 | 4.38e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 19 | 7.41e-01 | 4.37e-02 | 9.77e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 512 | 9.03e-02 | 4.37e-02 | 7.52e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 58 | 5.65e-01 | -4.37e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 61 | 5.55e-01 | -4.37e-02 | 9.49e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 28 | 6.89e-01 | 4.37e-02 | 9.69e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 55 | 5.75e-01 | 4.37e-02 | 9.51e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 443 | 1.15e-01 | -4.37e-02 | 7.81e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 67 | 5.37e-01 | 4.37e-02 | 9.49e-01 |
| GOBP PROTEASOME ASSEMBLY | 11 | 8.02e-01 | -4.37e-02 | 9.85e-01 |
| GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 5 | 8.66e-01 | -4.36e-02 | 9.93e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 22 | 7.23e-01 | 4.36e-02 | 9.74e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 7.94e-01 | 4.36e-02 | 9.84e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 26 | 7.00e-01 | -4.36e-02 | 9.70e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 7.23e-01 | 4.36e-02 | 9.74e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 20 | 7.36e-01 | -4.36e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 26 | 7.01e-01 | -4.36e-02 | 9.70e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 17 | 7.56e-01 | -4.35e-02 | 9.82e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 8.66e-01 | -4.35e-02 | 9.93e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 15 | 7.71e-01 | 4.34e-02 | 9.82e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 57 | 5.71e-01 | 4.34e-02 | 9.51e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 49 | 5.99e-01 | 4.34e-02 | 9.55e-01 |
| GOCC NUCLEAR LAMINA | 10 | 8.12e-01 | 4.34e-02 | 9.87e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 973 | 2.21e-02 | -4.33e-02 | 5.05e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 7 | 8.43e-01 | -4.33e-02 | 9.89e-01 |
| GOCC RECEPTOR COMPLEX | 380 | 1.47e-01 | -4.33e-02 | 8.08e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 50 | 5.96e-01 | 4.33e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 5 | 8.67e-01 | -4.33e-02 | 9.93e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 61 | 5.59e-01 | 4.33e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 72 | 5.26e-01 | -4.33e-02 | 9.47e-01 |
| GOMF ORGANIC ACID BINDING | 207 | 2.83e-01 | -4.33e-02 | 8.74e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 197 | 2.95e-01 | -4.33e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 49 | 6.01e-01 | -4.32e-02 | 9.55e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 65 | 5.47e-01 | 4.32e-02 | 9.49e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 70 | 5.32e-01 | -4.32e-02 | 9.48e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 7.87e-01 | -4.32e-02 | 9.84e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 63 | 5.53e-01 | 4.32e-02 | 9.49e-01 |
| GOBP DETOXIFICATION | 152 | 3.58e-01 | -4.32e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 67 | 5.41e-01 | 4.32e-02 | 9.49e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 33 | 6.68e-01 | 4.32e-02 | 9.67e-01 |
| GOCC MICROVILLUS | 94 | 4.70e-01 | -4.31e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 24 | 7.15e-01 | 4.31e-02 | 9.72e-01 |
| GOBP DEFENSE RESPONSE | 1720 | 2.98e-03 | -4.31e-02 | 2.09e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 29 | 6.88e-01 | -4.31e-02 | 9.69e-01 |
| GOBP SPROUTING ANGIOGENESIS | 183 | 3.15e-01 | -4.31e-02 | 8.90e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 50 | 5.98e-01 | 4.31e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 22 | 7.27e-01 | -4.30e-02 | 9.75e-01 |
| GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE | 8 | 8.33e-01 | 4.30e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION | 5 | 8.68e-01 | 4.30e-02 | 9.93e-01 |
| GOCC CILIARY MEMBRANE | 72 | 5.28e-01 | 4.30e-02 | 9.48e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 12 | 7.97e-01 | -4.29e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 32 | 6.74e-01 | 4.29e-02 | 9.68e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 431 | 1.27e-01 | -4.29e-02 | 7.93e-01 |
| GOBP VIRAL GENE EXPRESSION | 99 | 4.61e-01 | 4.29e-02 | 9.37e-01 |
| GOBP PARAXIAL MESODERM FORMATION | 7 | 8.44e-01 | 4.29e-02 | 9.90e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 8.34e-01 | 4.29e-02 | 9.88e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 112 | 4.34e-01 | 4.28e-02 | 9.27e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 37 | 6.52e-01 | 4.28e-02 | 9.64e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 11 | 8.06e-01 | -4.28e-02 | 9.87e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 7.74e-01 | 4.28e-02 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 68 | 5.42e-01 | 4.28e-02 | 9.49e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 116 | 4.26e-01 | 4.28e-02 | 9.26e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER | 5 | 8.68e-01 | -4.28e-02 | 9.93e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 8.56e-01 | 4.27e-02 | 9.92e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 8.06e-01 | 4.27e-02 | 9.87e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 39 | 6.45e-01 | -4.27e-02 | 9.63e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 8.25e-01 | -4.27e-02 | 9.88e-01 |
| GOBP COBALAMIN TRANSPORT | 8 | 8.35e-01 | -4.27e-02 | 9.88e-01 |
| GOMF COA HYDROLASE ACTIVITY | 21 | 7.35e-01 | -4.26e-02 | 9.77e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 7.75e-01 | 4.26e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 171 | 3.37e-01 | -4.26e-02 | 8.96e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 172 | 3.36e-01 | 4.26e-02 | 8.96e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 12 | 7.99e-01 | -4.25e-02 | 9.85e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 23 | 7.24e-01 | 4.25e-02 | 9.74e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 15 | 7.76e-01 | 4.25e-02 | 9.82e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 32 | 6.78e-01 | -4.25e-02 | 9.68e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 76 | 5.22e-01 | -4.24e-02 | 9.47e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 8.08e-01 | -4.24e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 46 | 6.19e-01 | 4.24e-02 | 9.61e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 13 | 7.92e-01 | -4.23e-02 | 9.84e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 95 | 4.76e-01 | 4.23e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 9 | 8.26e-01 | 4.23e-02 | 9.88e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 7.92e-01 | 4.23e-02 | 9.84e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 11 | 8.08e-01 | 4.23e-02 | 9.87e-01 |
| GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT | 5 | 8.70e-01 | 4.23e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 8.70e-01 | 4.23e-02 | 9.93e-01 |
| GOMF HISTONE BINDING | 220 | 2.80e-01 | 4.22e-02 | 8.72e-01 |
| GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION | 6 | 8.58e-01 | 4.22e-02 | 9.92e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 476 | 1.14e-01 | -4.22e-02 | 7.81e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 26 | 7.09e-01 | 4.22e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 263 | 2.39e-01 | -4.22e-02 | 8.64e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 8.58e-01 | -4.22e-02 | 9.92e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 102 | 4.62e-01 | -4.22e-02 | 9.37e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 94 | 4.80e-01 | 4.22e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 8.58e-01 | -4.22e-02 | 9.92e-01 |
| GOBP GLUTAMATE SECRETION | 28 | 6.99e-01 | -4.21e-02 | 9.70e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 164 | 3.52e-01 | 4.21e-02 | 9.00e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 189 | 3.18e-01 | 4.21e-02 | 8.91e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 7.38e-01 | 4.21e-02 | 9.77e-01 |
| GOCC CIS GOLGI NETWORK | 55 | 5.89e-01 | 4.21e-02 | 9.54e-01 |
| GOCC SWI SNF COMPLEX | 30 | 6.90e-01 | 4.21e-02 | 9.69e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 31 | 6.85e-01 | 4.21e-02 | 9.68e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 8.18e-01 | 4.21e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 335 | 1.86e-01 | -4.20e-02 | 8.44e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 45 | 6.26e-01 | -4.20e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 16 | 7.71e-01 | -4.20e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION | 5 | 8.71e-01 | -4.20e-02 | 9.93e-01 |
| GOCC INTERCELLULAR BRIDGE | 90 | 4.91e-01 | 4.20e-02 | 9.45e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 56 | 5.87e-01 | 4.20e-02 | 9.54e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 422 | 1.39e-01 | -4.20e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 1128 | 1.76e-02 | -4.19e-02 | 4.76e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 78 | 5.23e-01 | 4.19e-02 | 9.47e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 254 | 2.51e-01 | -4.18e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 170 | 3.47e-01 | -4.18e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 111 | 4.46e-01 | -4.18e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 15 | 7.79e-01 | 4.18e-02 | 9.83e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 23 | 7.29e-01 | 4.18e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 376 | 1.64e-01 | -4.18e-02 | 8.24e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 40 | 6.48e-01 | 4.18e-02 | 9.63e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 153 | 3.73e-01 | -4.18e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 114 | 4.41e-01 | 4.17e-02 | 9.29e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 8.72e-01 | -4.17e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 25 | 7.18e-01 | 4.17e-02 | 9.72e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 216 | 2.91e-01 | -4.17e-02 | 8.78e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 82 | 5.14e-01 | 4.17e-02 | 9.46e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 18 | 7.59e-01 | -4.17e-02 | 9.82e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 10 | 8.19e-01 | 4.17e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 157 | 3.68e-01 | -4.17e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 418 | 1.44e-01 | -4.16e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 8.03e-01 | -4.16e-02 | 9.85e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 28 | 7.03e-01 | -4.16e-02 | 9.71e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 53 | 6.00e-01 | -4.16e-02 | 9.55e-01 |
| GOBP OTIC VESICLE DEVELOPMENT | 15 | 7.80e-01 | 4.16e-02 | 9.83e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 117 | 4.37e-01 | -4.16e-02 | 9.28e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 11 | 8.12e-01 | 4.15e-02 | 9.87e-01 |
| GOBP HISTAMINE METABOLIC PROCESS | 6 | 8.60e-01 | 4.15e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 8.72e-01 | 4.15e-02 | 9.93e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 48 | 6.19e-01 | 4.15e-02 | 9.61e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 34 | 6.75e-01 | -4.15e-02 | 9.68e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 18 | 7.61e-01 | -4.15e-02 | 9.82e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 380 | 1.65e-01 | -4.15e-02 | 8.25e-01 |
| GOCC PLASMA MEMBRANE RAFT | 112 | 4.49e-01 | -4.14e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 44 | 6.35e-01 | 4.14e-02 | 9.61e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 41 | 6.47e-01 | -4.14e-02 | 9.63e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 7.55e-01 | -4.14e-02 | 9.82e-01 |
| GOMF FAD BINDING | 39 | 6.55e-01 | 4.14e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 46 | 6.27e-01 | -4.14e-02 | 9.61e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 27 | 7.10e-01 | -4.13e-02 | 9.71e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 78 | 5.28e-01 | 4.13e-02 | 9.48e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 36 | 6.68e-01 | 4.13e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 6 | 8.61e-01 | 4.13e-02 | 9.93e-01 |
| GOBP URETER DEVELOPMENT | 18 | 7.62e-01 | 4.13e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 8.50e-01 | -4.13e-02 | 9.91e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 27 | 7.11e-01 | 4.12e-02 | 9.71e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 233 | 2.78e-01 | 4.12e-02 | 8.71e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 245 | 2.67e-01 | -4.12e-02 | 8.69e-01 |
| GOBP RENAL FILTRATION | 25 | 7.22e-01 | 4.12e-02 | 9.73e-01 |
| GOBP RESPONSE TO WOUNDING | 538 | 1.02e-01 | -4.12e-02 | 7.66e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 771 | 5.18e-02 | -4.12e-02 | 6.42e-01 |
| GOBP ICOSANOID SECRETION | 46 | 6.29e-01 | 4.11e-02 | 9.61e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 150 | 3.85e-01 | 4.11e-02 | 9.14e-01 |
| GOBP MEMBRANE FUSION | 174 | 3.50e-01 | 4.11e-02 | 8.99e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 88 | 5.05e-01 | -4.11e-02 | 9.45e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 808 | 4.72e-02 | -4.11e-02 | 6.25e-01 |
| GOBP GDP METABOLIC PROCESS | 9 | 8.31e-01 | 4.10e-02 | 9.88e-01 |
| GOBP SYNCYTIUM FORMATION | 65 | 5.67e-01 | -4.10e-02 | 9.50e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 160 | 3.71e-01 | 4.10e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 591 | 8.86e-02 | -4.10e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 89 | 5.04e-01 | -4.10e-02 | 9.45e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS | 6 | 8.62e-01 | 4.10e-02 | 9.93e-01 |
| GOBP HEAD MORPHOGENESIS | 35 | 6.75e-01 | 4.10e-02 | 9.68e-01 |
| GOMF TRANSPORTER ACTIVITY | 1171 | 1.81e-02 | -4.10e-02 | 4.77e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 10 | 8.22e-01 | 4.10e-02 | 9.88e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 34 | 6.79e-01 | -4.10e-02 | 9.68e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 22 | 7.39e-01 | 4.10e-02 | 9.77e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 23 | 7.34e-01 | 4.09e-02 | 9.77e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 8.51e-01 | 4.09e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 23 | 7.34e-01 | 4.09e-02 | 9.77e-01 |
| GOMF SULFUR COMPOUND BINDING | 263 | 2.53e-01 | -4.09e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 208 | 3.09e-01 | -4.09e-02 | 8.87e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 50 | 6.17e-01 | -4.09e-02 | 9.61e-01 |
| GOCC ENDOSOME | 986 | 2.98e-02 | -4.09e-02 | 5.52e-01 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 12 | 8.06e-01 | -4.09e-02 | 9.87e-01 |
| GOBP REGULATION OF CELL SHAPE | 134 | 4.14e-01 | -4.09e-02 | 9.23e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 7 | 8.51e-01 | -4.09e-02 | 9.91e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 42 | 6.47e-01 | 4.09e-02 | 9.63e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 8.41e-01 | 4.08e-02 | 9.89e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 44 | 6.39e-01 | -4.08e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 474 | 1.28e-01 | -4.08e-02 | 7.93e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 76 | 5.39e-01 | -4.08e-02 | 9.49e-01 |
| GOCC RIBOSOMAL SUBUNIT | 177 | 3.49e-01 | -4.08e-02 | 8.99e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 5 | 8.75e-01 | 4.08e-02 | 9.93e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 46 | 6.33e-01 | 4.08e-02 | 9.61e-01 |
| GOCC PROTEASOME COMPLEX | 59 | 5.88e-01 | 4.07e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 43 | 6.44e-01 | 4.07e-02 | 9.63e-01 |
| GOCC CELL CELL CONTACT ZONE | 70 | 5.56e-01 | -4.07e-02 | 9.49e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 44 | 6.40e-01 | -4.07e-02 | 9.62e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 84 | 5.19e-01 | -4.07e-02 | 9.47e-01 |
| GOBP CELL CELL ADHESION | 918 | 3.68e-02 | -4.06e-02 | 5.82e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 64 | 5.74e-01 | -4.06e-02 | 9.51e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 172 | 3.58e-01 | -4.06e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION | 12 | 8.08e-01 | -4.06e-02 | 9.87e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 9 | 8.33e-01 | -4.06e-02 | 9.88e-01 |
| GOBP UMP CATABOLIC PROCESS | 5 | 8.75e-01 | -4.06e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 9 | 8.33e-01 | 4.05e-02 | 9.88e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 539 | 1.07e-01 | -4.05e-02 | 7.72e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 7.72e-01 | 4.05e-02 | 9.82e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 17 | 7.72e-01 | -4.05e-02 | 9.82e-01 |
| GOBP DNA REPAIR | 561 | 1.01e-01 | 4.05e-02 | 7.66e-01 |
| GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.64e-01 | -4.05e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 313 | 2.18e-01 | 4.05e-02 | 8.56e-01 |
| GOBP ARTERY MORPHOGENESIS | 81 | 5.29e-01 | 4.05e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 14 | 7.93e-01 | -4.04e-02 | 9.84e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 169 | 3.64e-01 | -4.04e-02 | 9.06e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 16 | 7.80e-01 | 4.04e-02 | 9.83e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 102 | 4.81e-01 | 4.04e-02 | 9.42e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 120 | 4.45e-01 | -4.04e-02 | 9.31e-01 |
| GOMF MRNA BINDING | 540 | 1.09e-01 | -4.03e-02 | 7.73e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 127 | 4.33e-01 | -4.03e-02 | 9.27e-01 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.76e-01 | -4.03e-02 | 9.93e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 813 | 5.09e-02 | -4.03e-02 | 6.36e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 45 | 6.40e-01 | 4.03e-02 | 9.62e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 19 | 7.61e-01 | -4.03e-02 | 9.82e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 42 | 6.52e-01 | 4.03e-02 | 9.64e-01 |
| GOMF BILE ACID SODIUM SYMPORTER ACTIVITY | 5 | 8.76e-01 | 4.03e-02 | 9.93e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 36 | 6.76e-01 | 4.02e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 7 | 8.54e-01 | -4.02e-02 | 9.91e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 77 | 5.42e-01 | -4.02e-02 | 9.49e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 21 | 7.50e-01 | 4.02e-02 | 9.80e-01 |
| GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING | 10 | 8.26e-01 | 4.01e-02 | 9.88e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 17 | 7.75e-01 | -4.01e-02 | 9.82e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 155 | 3.89e-01 | -4.01e-02 | 9.15e-01 |
| GOBP RESPONSE TO CAFFEINE | 15 | 7.88e-01 | 4.01e-02 | 9.84e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.26e-01 | -4.00e-02 | 9.88e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 7.95e-01 | 4.00e-02 | 9.84e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 57 | 6.01e-01 | -4.00e-02 | 9.55e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 16 | 7.82e-01 | -4.00e-02 | 9.83e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 32 | 6.96e-01 | -4.00e-02 | 9.69e-01 |
| GOBP RESPONSE TO ETHANOL | 117 | 4.56e-01 | -3.99e-02 | 9.36e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 8.45e-01 | -3.99e-02 | 9.90e-01 |
| GOBP P38MAPK CASCADE | 57 | 6.02e-01 | -3.99e-02 | 9.55e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 31 | 7.01e-01 | -3.99e-02 | 9.70e-01 |
| GOBP B CELL HOMEOSTASIS | 31 | 7.01e-01 | -3.99e-02 | 9.70e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 8.45e-01 | -3.99e-02 | 9.90e-01 |
| GOCC MALE GERM CELL NUCLEUS | 52 | 6.19e-01 | -3.99e-02 | 9.61e-01 |
| GOMF SNRNA BINDING | 48 | 6.33e-01 | 3.99e-02 | 9.61e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 32 | 6.96e-01 | -3.99e-02 | 9.70e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 61 | 5.90e-01 | 3.98e-02 | 9.54e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 50 | 6.26e-01 | -3.98e-02 | 9.61e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 88 | 5.19e-01 | 3.98e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 53 | 6.16e-01 | 3.98e-02 | 9.60e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 46 | 6.41e-01 | 3.97e-02 | 9.62e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 35 | 6.84e-01 | -3.97e-02 | 9.68e-01 |
| GOCC MIB COMPLEX | 11 | 8.20e-01 | 3.96e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 123 | 4.48e-01 | -3.96e-02 | 9.31e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 9 | 8.37e-01 | 3.96e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1672 | 7.00e-03 | -3.96e-02 | 3.25e-01 |
| GOBP REGULATION OF CELL ADHESION | 771 | 6.13e-02 | -3.96e-02 | 6.63e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 14 | 7.98e-01 | -3.96e-02 | 9.84e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 42 | 6.57e-01 | 3.96e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 49 | 6.32e-01 | -3.96e-02 | 9.61e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 95 | 5.05e-01 | -3.96e-02 | 9.45e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION | 11 | 8.20e-01 | 3.96e-02 | 9.87e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 120 | 4.54e-01 | -3.95e-02 | 9.36e-01 |
| GOCC MAIN AXON | 67 | 5.76e-01 | -3.95e-02 | 9.51e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 29 | 7.12e-01 | 3.95e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 14 | 7.98e-01 | 3.95e-02 | 9.84e-01 |
| GOMF BIOTIN BINDING | 5 | 8.78e-01 | 3.95e-02 | 9.93e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 35 | 6.86e-01 | -3.95e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 14 | 7.98e-01 | 3.95e-02 | 9.84e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 198 | 3.38e-01 | 3.95e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1805 | 5.35e-03 | 3.95e-02 | 2.82e-01 |
| GOBP RETINA LAYER FORMATION | 23 | 7.43e-01 | -3.95e-02 | 9.77e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 10 | 8.29e-01 | -3.95e-02 | 9.88e-01 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 8.79e-01 | 3.95e-02 | 9.93e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 8.57e-01 | 3.95e-02 | 9.92e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 84 | 5.32e-01 | 3.94e-02 | 9.48e-01 |
| GOMF GALACTOSIDASE ACTIVITY | 6 | 8.67e-01 | 3.94e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 7 | 8.57e-01 | -3.94e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 7 | 8.57e-01 | 3.94e-02 | 9.92e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 257 | 2.77e-01 | 3.94e-02 | 8.70e-01 |
| GOBP KIDNEY MORPHOGENESIS | 94 | 5.09e-01 | 3.94e-02 | 9.46e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 111 | 4.74e-01 | -3.94e-02 | 9.41e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 7.67e-01 | 3.94e-02 | 9.82e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 114 | 4.68e-01 | -3.93e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 24 | 7.39e-01 | 3.93e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 8.30e-01 | 3.93e-02 | 9.88e-01 |
| GOBP DENDRITE DEVELOPMENT | 218 | 3.17e-01 | -3.93e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 14 | 7.99e-01 | -3.93e-02 | 9.85e-01 |
| GOBP CIRCADIAN RHYTHM | 196 | 3.43e-01 | 3.92e-02 | 8.96e-01 |
| GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY | 10 | 8.30e-01 | 3.92e-02 | 9.88e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 8.57e-01 | 3.92e-02 | 9.92e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 12 | 8.14e-01 | -3.92e-02 | 9.87e-01 |
| GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 8 | 8.48e-01 | 3.92e-02 | 9.91e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 8.68e-01 | -3.91e-02 | 9.93e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 8.58e-01 | 3.91e-02 | 9.92e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 9 | 8.39e-01 | -3.91e-02 | 9.89e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 31 | 7.06e-01 | 3.91e-02 | 9.71e-01 |
| GOMF TETRAPYRROLE BINDING | 143 | 4.19e-01 | 3.91e-02 | 9.24e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 135 | 4.33e-01 | 3.91e-02 | 9.27e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1605 | 8.99e-03 | -3.91e-02 | 3.62e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 67 | 5.80e-01 | -3.91e-02 | 9.53e-01 |
| GOBP MESENCHYME DEVELOPMENT | 310 | 2.37e-01 | 3.91e-02 | 8.64e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 61 | 5.98e-01 | -3.91e-02 | 9.55e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 7 | 8.58e-01 | -3.91e-02 | 9.92e-01 |
| GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER | 5 | 8.80e-01 | 3.91e-02 | 9.93e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 12 | 8.15e-01 | -3.91e-02 | 9.87e-01 |
| GOCC NEURON SPINE | 168 | 3.82e-01 | -3.91e-02 | 9.12e-01 |
| GOBP SODIUM ION TRANSPORT | 235 | 3.03e-01 | -3.90e-02 | 8.84e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 8.39e-01 | -3.90e-02 | 9.89e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 7 | 8.58e-01 | 3.90e-02 | 9.92e-01 |
| GOCC DYNEIN COMPLEX | 53 | 6.24e-01 | 3.90e-02 | 9.61e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 8 | 8.49e-01 | 3.89e-02 | 9.91e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 478 | 1.45e-01 | 3.89e-02 | 8.06e-01 |
| GOMF FIBRINOGEN BINDING | 5 | 8.80e-01 | -3.89e-02 | 9.93e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 34 | 6.95e-01 | -3.89e-02 | 9.69e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 45 | 6.52e-01 | 3.89e-02 | 9.64e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 365 | 2.02e-01 | -3.89e-02 | 8.51e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 19 | 7.69e-01 | 3.89e-02 | 9.82e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 121 | 4.61e-01 | 3.88e-02 | 9.37e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 15 | 7.95e-01 | -3.88e-02 | 9.84e-01 |
| GOMF PROTEASE BINDING | 139 | 4.29e-01 | -3.88e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 8.40e-01 | -3.88e-02 | 9.89e-01 |
| GOCC LAMININ COMPLEX | 9 | 8.40e-01 | -3.88e-02 | 9.89e-01 |
| GOBP TELENCEPHALON REGIONALIZATION | 13 | 8.09e-01 | 3.88e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 36 | 6.87e-01 | 3.88e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 42 | 6.64e-01 | -3.88e-02 | 9.67e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 1478 | 1.28e-02 | -3.87e-02 | 4.32e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 30 | 7.14e-01 | 3.87e-02 | 9.72e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 19 | 7.70e-01 | 3.87e-02 | 9.82e-01 |
| GOCC PRERIBOSOME | 104 | 4.96e-01 | 3.87e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 24 | 7.43e-01 | -3.87e-02 | 9.77e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 12 | 8.17e-01 | -3.87e-02 | 9.87e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 85 | 5.38e-01 | -3.86e-02 | 9.49e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 25 | 7.38e-01 | -3.86e-02 | 9.77e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 56 | 6.17e-01 | -3.86e-02 | 9.61e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 230 | 3.13e-01 | -3.86e-02 | 8.90e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 8.81e-01 | -3.85e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 60 | 6.06e-01 | 3.85e-02 | 9.55e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 30 | 7.15e-01 | -3.85e-02 | 9.72e-01 |
| GOMF SMAD BINDING | 75 | 5.64e-01 | -3.85e-02 | 9.50e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 8.60e-01 | 3.85e-02 | 9.93e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 485 | 1.47e-01 | -3.85e-02 | 8.08e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 77 | 5.60e-01 | 3.85e-02 | 9.49e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 106 | 4.94e-01 | -3.84e-02 | 9.45e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 30 | 7.16e-01 | -3.84e-02 | 9.72e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 380 | 1.99e-01 | -3.84e-02 | 8.45e-01 |
| GOCC COATED VESICLE MEMBRANE | 191 | 3.60e-01 | 3.84e-02 | 9.04e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 6.74e-01 | -3.84e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 12 | 8.18e-01 | -3.84e-02 | 9.87e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 731 | 7.77e-02 | -3.83e-02 | 7.18e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 84 | 5.44e-01 | 3.83e-02 | 9.49e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 8.71e-01 | -3.83e-02 | 9.93e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 8.51e-01 | -3.83e-02 | 9.91e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 27 | 7.31e-01 | 3.83e-02 | 9.76e-01 |
| GOBP MESENCHYMAL CELL DEVELOPMENT | 6 | 8.71e-01 | 3.82e-02 | 9.93e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 370 | 2.07e-01 | -3.82e-02 | 8.51e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 8 | 8.52e-01 | -3.82e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 19 | 7.74e-01 | 3.81e-02 | 9.82e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 89 | 5.34e-01 | 3.81e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 8.27e-01 | 3.81e-02 | 9.88e-01 |
| GOBP SPERMATID DIFFERENTIATION | 201 | 3.53e-01 | -3.80e-02 | 9.00e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 8.72e-01 | 3.80e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 8.27e-01 | -3.80e-02 | 9.88e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 93 | 5.26e-01 | -3.80e-02 | 9.47e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 468 | 1.59e-01 | 3.80e-02 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 8.72e-01 | -3.80e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 158 | 4.10e-01 | -3.80e-02 | 9.21e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 17 | 7.86e-01 | -3.80e-02 | 9.84e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 22 | 7.58e-01 | -3.79e-02 | 9.82e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 52 | 6.36e-01 | 3.79e-02 | 9.61e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 255 | 2.97e-01 | 3.79e-02 | 8.82e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 20 | 7.69e-01 | -3.79e-02 | 9.82e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 173 | 3.90e-01 | 3.79e-02 | 9.15e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 8 | 8.53e-01 | -3.79e-02 | 9.91e-01 |
| GOMF BETA GALACTOSIDASE ACTIVITY | 5 | 8.84e-01 | 3.78e-02 | 9.93e-01 |
| GOBP LYSOSOMAL TRANSPORT | 128 | 4.60e-01 | 3.78e-02 | 9.37e-01 |
| GOBP NEURAL TUBE PATTERNING | 39 | 6.83e-01 | -3.78e-02 | 9.68e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 16 | 7.94e-01 | -3.78e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 66 | 5.96e-01 | 3.77e-02 | 9.55e-01 |
| GOMF SPHINGOLIPID BINDING | 28 | 7.30e-01 | -3.77e-02 | 9.76e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 8.36e-01 | -3.77e-02 | 9.89e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 110 | 4.95e-01 | 3.77e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 13 | 8.14e-01 | 3.77e-02 | 9.87e-01 |
| GOMF INTERLEUKIN 1 BINDING | 9 | 8.45e-01 | -3.77e-02 | 9.90e-01 |
| GOBP PEPTIDE TRANSPORT | 254 | 3.02e-01 | 3.76e-02 | 8.84e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 266 | 2.91e-01 | -3.76e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 139 | 4.44e-01 | -3.76e-02 | 9.30e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 7.04e-01 | 3.76e-02 | 9.71e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 27 | 7.35e-01 | -3.76e-02 | 9.77e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 114 | 4.88e-01 | 3.76e-02 | 9.43e-01 |
| GOBP CONVERGENT EXTENSION | 15 | 8.01e-01 | -3.75e-02 | 9.85e-01 |
| GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.64e-01 | -3.75e-02 | 9.93e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 23 | 7.56e-01 | 3.75e-02 | 9.82e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 8.46e-01 | -3.75e-02 | 9.90e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 7 | 8.64e-01 | 3.75e-02 | 9.93e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 7 | 8.64e-01 | -3.74e-02 | 9.93e-01 |
| GOBP PROTEIN C LINKED GLYCOSYLATION | 5 | 8.85e-01 | 3.74e-02 | 9.93e-01 |
| GOBP WOUND HEALING | 407 | 1.95e-01 | -3.74e-02 | 8.44e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 393 | 2.03e-01 | 3.74e-02 | 8.51e-01 |
| GOBP LUNG VASCULATURE DEVELOPMENT | 8 | 8.55e-01 | -3.74e-02 | 9.91e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 8.74e-01 | 3.74e-02 | 9.93e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 52 | 6.41e-01 | -3.74e-02 | 9.62e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 666 | 9.98e-02 | 3.74e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 8.74e-01 | 3.73e-02 | 9.93e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1297 | 2.40e-02 | 3.73e-02 | 5.17e-01 |
| GOBP WATER TRANSPORT | 28 | 7.33e-01 | -3.73e-02 | 9.76e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 115 | 4.90e-01 | 3.73e-02 | 9.44e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 7.90e-01 | -3.73e-02 | 9.84e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY | 7 | 8.65e-01 | -3.72e-02 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 191 | 3.75e-01 | -3.72e-02 | 9.09e-01 |
| GOBP MACROAUTOPHAGY | 317 | 2.54e-01 | 3.72e-02 | 8.65e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 198 | 3.67e-01 | 3.72e-02 | 9.06e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 111 | 4.98e-01 | -3.72e-02 | 9.45e-01 |
| GOBP CILIUM MOVEMENT | 194 | 3.72e-01 | -3.72e-02 | 9.09e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 61 | 6.16e-01 | -3.72e-02 | 9.60e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 10 | 8.39e-01 | -3.72e-02 | 9.89e-01 |
| GOBP RESPONSE TO VITAMIN D | 36 | 7.00e-01 | -3.71e-02 | 9.70e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 208 | 3.56e-01 | -3.71e-02 | 9.02e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 348 | 2.34e-01 | -3.71e-02 | 8.64e-01 |
| GOBP AXONAL FASCICULATION | 21 | 7.69e-01 | 3.71e-02 | 9.82e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 17 | 7.91e-01 | -3.71e-02 | 9.84e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 345 | 2.37e-01 | -3.71e-02 | 8.64e-01 |
| GOBP DEVELOPMENTAL MATURATION | 317 | 2.57e-01 | -3.70e-02 | 8.65e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 17 | 7.92e-01 | 3.70e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 39 | 6.89e-01 | -3.70e-02 | 9.69e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 18 | 7.86e-01 | 3.70e-02 | 9.84e-01 |
| GOMF PRERIBOSOME BINDING | 6 | 8.75e-01 | -3.70e-02 | 9.93e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 18 | 7.86e-01 | 3.70e-02 | 9.84e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 119 | 4.86e-01 | -3.70e-02 | 9.43e-01 |
| GOCC WNT SIGNALOSOME | 13 | 8.17e-01 | -3.70e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 898 | 6.04e-02 | -3.69e-02 | 6.62e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 44 | 6.72e-01 | -3.69e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 28 | 7.35e-01 | -3.69e-02 | 9.77e-01 |
| GOMF MELANOCORTIN RECEPTOR ACTIVITY | 6 | 8.76e-01 | -3.69e-02 | 9.93e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 14 | 8.11e-01 | 3.69e-02 | 9.87e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 12 | 8.25e-01 | -3.69e-02 | 9.88e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 159 | 4.22e-01 | -3.69e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 98 | 5.28e-01 | -3.69e-02 | 9.48e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 10 | 8.40e-01 | 3.69e-02 | 9.89e-01 |
| GOBP REGULATION OF WOUND HEALING | 129 | 4.70e-01 | -3.68e-02 | 9.39e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 652 | 1.09e-01 | -3.68e-02 | 7.73e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 6 | 8.76e-01 | -3.68e-02 | 9.93e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 63 | 6.13e-01 | 3.68e-02 | 9.59e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 23 | 7.60e-01 | 3.68e-02 | 9.82e-01 |
| GOBP SPERM CAPACITATION | 30 | 7.27e-01 | -3.68e-02 | 9.75e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 27 | 7.41e-01 | -3.67e-02 | 9.77e-01 |
| GOCC INTERCELLULAR CANALICULUS | 6 | 8.76e-01 | -3.67e-02 | 9.93e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 112 | 5.02e-01 | 3.67e-02 | 9.45e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 992 | 5.05e-02 | -3.67e-02 | 6.33e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 189 | 3.85e-01 | -3.67e-02 | 9.14e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 6 | 8.76e-01 | 3.67e-02 | 9.93e-01 |
| GOCC NEURON PROJECTION TERMINUS | 123 | 4.83e-01 | -3.67e-02 | 9.43e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1705 | 1.19e-02 | -3.66e-02 | 4.11e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 25 | 7.51e-01 | -3.66e-02 | 9.80e-01 |
| GOBP GLYCOLYTIC PROCESS | 85 | 5.59e-01 | -3.66e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 96 | 5.35e-01 | -3.66e-02 | 9.49e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 8.77e-01 | -3.66e-02 | 9.93e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 11 | 8.34e-01 | -3.66e-02 | 9.88e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 47 | 6.65e-01 | 3.66e-02 | 9.67e-01 |
| GOCC ENDOLYSOSOME | 26 | 7.47e-01 | 3.66e-02 | 9.79e-01 |
| GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 8.00e-01 | -3.65e-02 | 9.85e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 54 | 6.42e-01 | 3.65e-02 | 9.63e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 7 | 8.67e-01 | 3.65e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 8.88e-01 | -3.65e-02 | 9.93e-01 |
| GOCC CELL CELL JUNCTION | 485 | 1.69e-01 | -3.64e-02 | 8.31e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 126 | 4.80e-01 | -3.64e-02 | 9.42e-01 |
| GOCC CALYX OF HELD | 19 | 7.84e-01 | -3.64e-02 | 9.84e-01 |
| GOBP LUNG SECRETORY CELL DIFFERENTIATION | 11 | 8.34e-01 | -3.64e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 149 | 4.44e-01 | 3.64e-02 | 9.30e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 8.59e-01 | 3.63e-02 | 9.92e-01 |
| GOBP CELL ACTIVATION | 1058 | 4.59e-02 | -3.63e-02 | 6.22e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 18 | 7.90e-01 | 3.63e-02 | 9.84e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 115 | 5.02e-01 | 3.63e-02 | 9.45e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 31 | 7.27e-01 | -3.63e-02 | 9.75e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 165 | 4.22e-01 | 3.63e-02 | 9.24e-01 |
| GOBP PROTEIN REFOLDING | 27 | 7.44e-01 | 3.62e-02 | 9.78e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 21 | 7.74e-01 | -3.62e-02 | 9.82e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 38 | 6.99e-01 | -3.62e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 8.78e-01 | 3.61e-02 | 9.93e-01 |
| GOBP MAST CELL DIFFERENTIATION | 6 | 8.78e-01 | -3.61e-02 | 9.93e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 20 | 7.80e-01 | -3.61e-02 | 9.83e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 34 | 7.16e-01 | -3.61e-02 | 9.72e-01 |
| GOBP ERBB3 SIGNALING PATHWAY | 5 | 8.89e-01 | 3.61e-02 | 9.93e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 27 | 7.46e-01 | -3.61e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 54 | 6.47e-01 | 3.60e-02 | 9.63e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 6.59e-01 | -3.60e-02 | 9.66e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 27 | 7.46e-01 | 3.60e-02 | 9.78e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 11 | 8.36e-01 | -3.60e-02 | 9.89e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 11 | 8.36e-01 | 3.60e-02 | 9.89e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 92 | 5.51e-01 | 3.60e-02 | 9.49e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 218 | 3.60e-01 | 3.60e-02 | 9.04e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 7.91e-01 | 3.60e-02 | 9.84e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 9 | 8.52e-01 | -3.60e-02 | 9.91e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 70 | 6.03e-01 | -3.60e-02 | 9.55e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 257 | 3.21e-01 | -3.60e-02 | 8.92e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 23 | 7.65e-01 | -3.60e-02 | 9.82e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 35 | 7.13e-01 | 3.59e-02 | 9.71e-01 |
| GOCC NUCLEAR SPECK | 395 | 2.20e-01 | 3.59e-02 | 8.56e-01 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 17 | 7.98e-01 | 3.59e-02 | 9.84e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 24 | 7.61e-01 | 3.59e-02 | 9.82e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 167 | 4.23e-01 | 3.59e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 91 | 5.54e-01 | 3.59e-02 | 9.49e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 14 | 8.16e-01 | 3.59e-02 | 9.87e-01 |
| GOCC FLEMMING BODY | 34 | 7.17e-01 | -3.59e-02 | 9.72e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 364 | 2.40e-01 | 3.59e-02 | 8.64e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 252 | 3.27e-01 | -3.59e-02 | 8.93e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 8.23e-01 | -3.58e-02 | 9.88e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 129 | 4.82e-01 | -3.58e-02 | 9.43e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 43 | 6.84e-01 | 3.58e-02 | 9.68e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 70 | 6.05e-01 | -3.58e-02 | 9.55e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 5.41e-01 | 3.58e-02 | 9.49e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 65 | 6.19e-01 | 3.57e-02 | 9.61e-01 |
| GOCC SIDE OF MEMBRANE | 674 | 1.14e-01 | -3.57e-02 | 7.81e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 72 | 6.01e-01 | 3.57e-02 | 9.55e-01 |
| GOBP REGULATION OF MELANOCYTE DIFFERENTIATION | 6 | 8.80e-01 | 3.56e-02 | 9.93e-01 |
| GOMF NFAT PROTEIN BINDING | 5 | 8.90e-01 | -3.56e-02 | 9.93e-01 |
| GOBP T CELL ACTIVATION | 537 | 1.59e-01 | -3.55e-02 | 8.19e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 25 | 7.58e-01 | -3.55e-02 | 9.82e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 201 | 3.85e-01 | 3.55e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 8 | 8.62e-01 | -3.55e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 8.91e-01 | 3.55e-02 | 9.93e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 8 | 8.62e-01 | -3.55e-02 | 9.93e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 626 | 1.30e-01 | -3.55e-02 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 52 | 6.58e-01 | -3.55e-02 | 9.66e-01 |
| GOBP RNA DESTABILIZATION | 162 | 4.36e-01 | -3.55e-02 | 9.27e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 128 | 4.89e-01 | -3.54e-02 | 9.43e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 71 | 6.06e-01 | -3.54e-02 | 9.55e-01 |
| GOBP RESPONSE TO COLD | 43 | 6.88e-01 | -3.53e-02 | 9.69e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 18 | 7.95e-01 | -3.53e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 41 | 6.96e-01 | 3.53e-02 | 9.69e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 29 | 7.42e-01 | 3.53e-02 | 9.77e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 11 | 8.39e-01 | 3.53e-02 | 9.89e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 7.95e-01 | 3.53e-02 | 9.84e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 8.81e-01 | 3.53e-02 | 9.93e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 32 | 7.30e-01 | 3.53e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ACTION POTENTIAL | 6 | 8.81e-01 | -3.53e-02 | 9.93e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 37 | 7.11e-01 | -3.52e-02 | 9.71e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 93 | 5.58e-01 | -3.52e-02 | 9.49e-01 |
| GOBP ORGANELLE LOCALIZATION | 588 | 1.45e-01 | 3.52e-02 | 8.06e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 119 | 5.08e-01 | -3.52e-02 | 9.46e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 44 | 6.87e-01 | -3.52e-02 | 9.68e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 7 | 8.72e-01 | 3.51e-02 | 9.93e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 7 | 8.72e-01 | 3.51e-02 | 9.93e-01 |
| GOCC ADHERENS JUNCTION | 179 | 4.18e-01 | -3.51e-02 | 9.23e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 8.92e-01 | -3.51e-02 | 9.93e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 11 | 8.40e-01 | -3.51e-02 | 9.89e-01 |
| GOBP SNRNA 3 END PROCESSING | 20 | 7.86e-01 | 3.51e-02 | 9.84e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 329 | 2.74e-01 | -3.51e-02 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 29 | 7.44e-01 | -3.51e-02 | 9.77e-01 |
| GOMF MAGNESIUM ION BINDING | 212 | 3.79e-01 | 3.50e-02 | 9.10e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 16 | 8.08e-01 | -3.50e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 66 | 6.23e-01 | -3.50e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 6 | 8.82e-01 | 3.50e-02 | 9.93e-01 |
| GOBP VASCULOGENESIS | 81 | 5.87e-01 | -3.49e-02 | 9.54e-01 |
| GOBP PROTEIN NEDDYLATION | 28 | 7.49e-01 | -3.49e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 15 | 8.15e-01 | -3.49e-02 | 9.87e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 21 | 7.82e-01 | -3.49e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 88 | 5.72e-01 | -3.49e-02 | 9.51e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 89 | 5.70e-01 | 3.49e-02 | 9.51e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 46 | 6.83e-01 | 3.49e-02 | 9.68e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1735 | 1.59e-02 | -3.48e-02 | 4.67e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 546 | 1.64e-01 | 3.48e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF FEAR RESPONSE | 6 | 8.83e-01 | 3.48e-02 | 9.93e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 84 | 5.82e-01 | -3.48e-02 | 9.53e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 152 | 4.59e-01 | -3.48e-02 | 9.37e-01 |
| GOCC SNARE COMPLEX | 47 | 6.81e-01 | -3.47e-02 | 9.68e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 49 | 6.74e-01 | -3.47e-02 | 9.68e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 11 | 8.42e-01 | -3.47e-02 | 9.89e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 84 | 5.83e-01 | 3.47e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 21 | 7.83e-01 | -3.47e-02 | 9.84e-01 |
| GOBP RESPONSE TO ERYTHROPOIETIN | 7 | 8.74e-01 | 3.47e-02 | 9.93e-01 |
| GOBP EMBRYO DEVELOPMENT | 1091 | 5.34e-02 | 3.46e-02 | 6.45e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 177 | 4.27e-01 | -3.46e-02 | 9.26e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 44 | 6.91e-01 | 3.46e-02 | 9.69e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 37 | 7.16e-01 | -3.46e-02 | 9.72e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 8 | 8.65e-01 | 3.46e-02 | 9.93e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 14 | 8.23e-01 | -3.46e-02 | 9.88e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 62 | 6.38e-01 | 3.46e-02 | 9.62e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 24 | 7.70e-01 | -3.45e-02 | 9.82e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 109 | 5.33e-01 | 3.45e-02 | 9.49e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 20 | 7.89e-01 | 3.45e-02 | 9.84e-01 |
| GOMF CERAMIDE BINDING | 19 | 7.95e-01 | 3.45e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 22 | 7.80e-01 | -3.45e-02 | 9.83e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 7 | 8.75e-01 | 3.45e-02 | 9.93e-01 |
| GOCC STEREOCILIUM TIP | 19 | 7.95e-01 | -3.44e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 15 | 8.17e-01 | 3.44e-02 | 9.87e-01 |
| GOBP REGULATION OF BONE REMODELING | 49 | 6.77e-01 | 3.44e-02 | 9.68e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 8.94e-01 | 3.44e-02 | 9.93e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 113 | 5.28e-01 | 3.44e-02 | 9.48e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 1147 | 4.95e-02 | -3.44e-02 | 6.28e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 11 | 8.43e-01 | 3.44e-02 | 9.89e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 72 | 6.14e-01 | -3.44e-02 | 9.59e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 45 | 6.90e-01 | -3.43e-02 | 9.69e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 8.67e-01 | -3.43e-02 | 9.93e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 488 | 1.94e-01 | -3.43e-02 | 8.44e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 115 | 5.26e-01 | 3.43e-02 | 9.47e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 103 | 5.48e-01 | 3.43e-02 | 9.49e-01 |
| GOBP DNA DAMAGE RESPONSE | 831 | 9.34e-02 | 3.43e-02 | 7.62e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 422 | 2.28e-01 | 3.42e-02 | 8.62e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 8.95e-01 | -3.42e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 28 | 7.54e-01 | 3.42e-02 | 9.81e-01 |
| GOCC BRUSH BORDER | 103 | 5.49e-01 | -3.42e-02 | 9.49e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 9 | 8.59e-01 | -3.42e-02 | 9.92e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 46 | 6.88e-01 | -3.42e-02 | 9.69e-01 |
| GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 8.67e-01 | -3.41e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 17 | 8.08e-01 | -3.41e-02 | 9.87e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 11 | 8.45e-01 | 3.41e-02 | 9.90e-01 |
| GOBP DESMOSOME ORGANIZATION | 10 | 8.52e-01 | 3.41e-02 | 9.91e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 8.32e-01 | 3.40e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 8.19e-01 | -3.40e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 7.87e-01 | 3.40e-02 | 9.84e-01 |
| GOBP LIPID IMPORT INTO CELL | 20 | 7.92e-01 | 3.40e-02 | 9.84e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 26 | 7.64e-01 | -3.40e-02 | 9.82e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 33 | 7.35e-01 | -3.40e-02 | 9.77e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 1148 | 5.24e-02 | 3.40e-02 | 6.44e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 40 | 7.10e-01 | 3.39e-02 | 9.71e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 8.86e-01 | -3.39e-02 | 9.93e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 8.53e-01 | -3.39e-02 | 9.91e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 31 | 7.44e-01 | 3.39e-02 | 9.77e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 15 | 8.20e-01 | 3.39e-02 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 67 | 6.31e-01 | -3.39e-02 | 9.61e-01 |
| GOBP CILIUM ORGANIZATION | 408 | 2.41e-01 | 3.39e-02 | 8.64e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 13 | 8.33e-01 | 3.38e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 14 | 8.27e-01 | 3.38e-02 | 9.88e-01 |
| GOBP PIGMENT ACCUMULATION | 11 | 8.46e-01 | -3.38e-02 | 9.90e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 8.46e-01 | -3.38e-02 | 9.90e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 71 | 6.22e-01 | 3.38e-02 | 9.61e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 522 | 1.86e-01 | 3.38e-02 | 8.44e-01 |
| GOBP MEMBRANE DISASSEMBLY | 11 | 8.46e-01 | -3.38e-02 | 9.90e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 8.86e-01 | 3.38e-02 | 9.93e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 15 | 8.21e-01 | 3.38e-02 | 9.87e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 79 | 6.04e-01 | -3.38e-02 | 9.55e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 32 | 7.41e-01 | -3.38e-02 | 9.77e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 150 | 4.75e-01 | -3.38e-02 | 9.41e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 7.45e-01 | 3.37e-02 | 9.78e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 8.61e-01 | -3.37e-02 | 9.93e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 8.00e-01 | -3.36e-02 | 9.85e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 9 | 8.61e-01 | 3.36e-02 | 9.93e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 25 | 7.71e-01 | 3.36e-02 | 9.82e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 8.78e-01 | 3.36e-02 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 7 | 8.78e-01 | -3.36e-02 | 9.93e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 888 | 8.94e-02 | -3.36e-02 | 7.52e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 42 | 7.07e-01 | 3.36e-02 | 9.71e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 41 | 7.10e-01 | -3.36e-02 | 9.71e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 28 | 7.59e-01 | 3.35e-02 | 9.82e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 126 | 5.15e-01 | -3.35e-02 | 9.46e-01 |
| GOBP REGULATION OF RESTING MEMBRANE POTENTIAL | 10 | 8.55e-01 | -3.35e-02 | 9.91e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 7 | 8.78e-01 | 3.35e-02 | 9.93e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 10 | 8.55e-01 | 3.35e-02 | 9.91e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 8.97e-01 | -3.35e-02 | 9.94e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 996 | 7.39e-02 | -3.35e-02 | 7.10e-01 |
| GOBP FACE MORPHOGENESIS | 30 | 7.51e-01 | 3.34e-02 | 9.80e-01 |
| GOMF ATPASE BINDING | 82 | 6.01e-01 | -3.34e-02 | 9.55e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 17 | 8.12e-01 | 3.34e-02 | 9.87e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 64 | 6.44e-01 | -3.34e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 479 | 2.11e-01 | -3.34e-02 | 8.53e-01 |
| GOBP LIPID DROPLET FORMATION | 13 | 8.35e-01 | -3.33e-02 | 9.89e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 9 | 8.63e-01 | 3.33e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 128 | 5.16e-01 | -3.33e-02 | 9.46e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 8.63e-01 | 3.33e-02 | 9.93e-01 |
| GOCC ENDOSOME MEMBRANE | 524 | 1.93e-01 | -3.33e-02 | 8.44e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR | 5 | 8.98e-01 | 3.32e-02 | 9.94e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 568 | 1.76e-01 | -3.32e-02 | 8.41e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 8.63e-01 | 3.32e-02 | 9.93e-01 |
| GOCC VACUOLAR MEMBRANE | 463 | 2.21e-01 | -3.32e-02 | 8.56e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 146 | 4.88e-01 | -3.32e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 49 | 6.88e-01 | -3.32e-02 | 9.69e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 13 | 8.36e-01 | 3.32e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 8.79e-01 | -3.32e-02 | 9.93e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 47 | 6.94e-01 | 3.32e-02 | 9.69e-01 |
| GOBP T CELL PROLIFERATION | 202 | 4.16e-01 | -3.32e-02 | 9.23e-01 |
| GOBP AMINE METABOLIC PROCESS | 107 | 5.53e-01 | -3.32e-02 | 9.49e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 8.42e-01 | 3.31e-02 | 9.89e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 753 | 1.22e-01 | -3.31e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 1191 | 5.41e-02 | 3.31e-02 | 6.45e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 68 | 6.37e-01 | 3.31e-02 | 9.61e-01 |
| GOMF ISOPRENOID BINDING | 44 | 7.04e-01 | -3.31e-02 | 9.71e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 143 | 4.94e-01 | 3.31e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 80 | 6.09e-01 | -3.31e-02 | 9.57e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 7.98e-01 | 3.31e-02 | 9.84e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 98 | 5.72e-01 | 3.30e-02 | 9.51e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 130 | 5.16e-01 | 3.30e-02 | 9.46e-01 |
| GOBP STEM CELL DIFFERENTIATION | 240 | 3.79e-01 | 3.30e-02 | 9.09e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 8.98e-01 | -3.30e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 22 | 7.89e-01 | 3.30e-02 | 9.84e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 8.43e-01 | 3.29e-02 | 9.89e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 46 | 6.99e-01 | 3.29e-02 | 9.70e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 31 | 7.51e-01 | -3.29e-02 | 9.80e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 50 | 6.87e-01 | 3.29e-02 | 9.69e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 335 | 3.01e-01 | 3.29e-02 | 8.84e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 259 | 3.63e-01 | -3.29e-02 | 9.06e-01 |
| GOMF PEPTIDE BINDING | 302 | 3.27e-01 | -3.28e-02 | 8.93e-01 |
| GOCC DESMOSOME | 25 | 7.77e-01 | 3.28e-02 | 9.83e-01 |
| GOCC AUTOPHAGOSOME | 110 | 5.53e-01 | 3.28e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 7 | 8.81e-01 | 3.27e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 44 | 7.07e-01 | 3.27e-02 | 9.71e-01 |
| GOMF POLY A BINDING | 23 | 7.86e-01 | 3.27e-02 | 9.84e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 1019 | 7.75e-02 | 3.27e-02 | 7.18e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 22 | 7.91e-01 | 3.27e-02 | 9.84e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 123 | 5.32e-01 | -3.26e-02 | 9.48e-01 |
| GOMF AMINO ACID BINDING | 47 | 6.99e-01 | -3.26e-02 | 9.70e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 49 | 6.93e-01 | 3.26e-02 | 9.69e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 13 | 8.39e-01 | -3.26e-02 | 9.89e-01 |
| GOMF KINASE BINDING | 737 | 1.32e-01 | 3.26e-02 | 7.96e-01 |
| GOCC PLASMA MEMBRANE REGION | 1248 | 5.30e-02 | -3.26e-02 | 6.45e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 247 | 3.78e-01 | -3.26e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 12 | 8.45e-01 | -3.26e-02 | 9.90e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 198 | 4.30e-01 | -3.25e-02 | 9.27e-01 |
| GOCC LEWY BODY | 8 | 8.74e-01 | -3.25e-02 | 9.93e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 7.74e-01 | 3.25e-02 | 9.82e-01 |
| GOCC DENDRITIC SHAFT | 40 | 7.22e-01 | -3.25e-02 | 9.74e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 102 | 5.71e-01 | 3.24e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 297 | 3.36e-01 | -3.24e-02 | 8.96e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 16 | 8.22e-01 | 3.24e-02 | 9.88e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 31 | 7.55e-01 | -3.24e-02 | 9.82e-01 |
| GOBP REGULATION OF GONADOTROPIN SECRETION | 11 | 8.52e-01 | 3.24e-02 | 9.91e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 13 | 8.40e-01 | -3.24e-02 | 9.89e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 21 | 7.97e-01 | -3.24e-02 | 9.84e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 155 | 4.87e-01 | -3.24e-02 | 9.43e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 8.82e-01 | 3.23e-02 | 9.93e-01 |
| GOBP EXPLORATION BEHAVIOR | 28 | 7.67e-01 | 3.23e-02 | 9.82e-01 |
| GOBP AMP METABOLIC PROCESS | 22 | 7.93e-01 | -3.23e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 132 | 5.22e-01 | -3.23e-02 | 9.47e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 140 | 5.09e-01 | 3.23e-02 | 9.46e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 320 | 3.21e-01 | 3.23e-02 | 8.92e-01 |
| GOMF EXONUCLEASE ACTIVITY | 81 | 6.15e-01 | 3.23e-02 | 9.60e-01 |
| GOBP SINOATRIAL NODE DEVELOPMENT | 12 | 8.47e-01 | 3.23e-02 | 9.90e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 204 | 4.27e-01 | 3.22e-02 | 9.27e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 658 | 1.58e-01 | -3.22e-02 | 8.19e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 90 | 5.98e-01 | -3.22e-02 | 9.55e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 92 | 5.94e-01 | -3.22e-02 | 9.54e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 115 | 5.51e-01 | -3.22e-02 | 9.49e-01 |
| GOBP STEROID HORMONE SECRETION | 27 | 7.72e-01 | -3.21e-02 | 9.82e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 60 | 6.67e-01 | 3.21e-02 | 9.67e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 63 | 6.59e-01 | -3.21e-02 | 9.66e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 551 | 1.97e-01 | 3.21e-02 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 482 | 2.28e-01 | -3.20e-02 | 8.62e-01 |
| GOCC CONTRACTILE FIBER | 238 | 3.95e-01 | -3.20e-02 | 9.18e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 135 | 5.21e-01 | -3.20e-02 | 9.47e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 48 | 7.02e-01 | 3.20e-02 | 9.71e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 865 | 1.11e-01 | 3.20e-02 | 7.77e-01 |
| GOMF NETRIN RECEPTOR ACTIVITY | 5 | 9.02e-01 | -3.20e-02 | 9.95e-01 |
| GOBP ERBB2 ERBB4 SIGNALING PATHWAY | 5 | 9.02e-01 | -3.19e-02 | 9.95e-01 |
| GOBP NUCLEUS ORGANIZATION | 142 | 5.11e-01 | 3.19e-02 | 9.46e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 32 | 7.55e-01 | -3.19e-02 | 9.81e-01 |
| GOCC CORTICAL CYTOSKELETON | 101 | 5.80e-01 | 3.19e-02 | 9.53e-01 |
| GOCC TROPONIN COMPLEX | 9 | 8.69e-01 | -3.18e-02 | 9.93e-01 |
| GOBP SENSORY PERCEPTION OF SWEET TASTE | 7 | 8.84e-01 | 3.18e-02 | 9.93e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 298 | 3.45e-01 | 3.18e-02 | 8.96e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 8 | 8.76e-01 | 3.18e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 35 | 7.45e-01 | 3.18e-02 | 9.78e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 15 | 8.31e-01 | -3.18e-02 | 9.88e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 8.84e-01 | -3.18e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1187 | 6.52e-02 | -3.18e-02 | 6.80e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 655 | 1.66e-01 | -3.18e-02 | 8.25e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 127 | 5.37e-01 | 3.18e-02 | 9.49e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION | 5 | 9.02e-01 | -3.18e-02 | 9.95e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 131 | 5.30e-01 | -3.18e-02 | 9.48e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 177 | 4.66e-01 | -3.17e-02 | 9.38e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 98 | 5.87e-01 | 3.17e-02 | 9.54e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 100 | 5.84e-01 | 3.17e-02 | 9.54e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 183 | 4.60e-01 | -3.17e-02 | 9.37e-01 |
| GOBP IRIS MORPHOGENESIS | 10 | 8.62e-01 | 3.17e-02 | 9.93e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 33 | 7.53e-01 | 3.17e-02 | 9.81e-01 |
| GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.93e-01 | -3.17e-02 | 9.93e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 38 | 7.36e-01 | 3.16e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 195 | 4.46e-01 | -3.16e-02 | 9.31e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 68 | 6.52e-01 | -3.16e-02 | 9.64e-01 |
| GOBP B CELL ACTIVATION | 261 | 3.79e-01 | -3.16e-02 | 9.10e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 15 | 8.32e-01 | 3.16e-02 | 9.88e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 8.77e-01 | -3.16e-02 | 9.93e-01 |
| GOCC BORC COMPLEX | 8 | 8.77e-01 | -3.16e-02 | 9.93e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 382 | 2.89e-01 | 3.16e-02 | 8.78e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 46 | 7.11e-01 | 3.15e-02 | 9.71e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 551 | 2.06e-01 | 3.15e-02 | 8.51e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 81 | 6.24e-01 | -3.15e-02 | 9.61e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 330 | 3.25e-01 | -3.15e-02 | 8.93e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 7 | 8.85e-01 | 3.15e-02 | 9.93e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 16 | 8.27e-01 | 3.15e-02 | 9.88e-01 |
| GOMF PHOSPHATASE ACTIVITY | 255 | 3.87e-01 | 3.15e-02 | 9.14e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 212 | 4.29e-01 | -3.15e-02 | 9.27e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 19 | 8.12e-01 | -3.15e-02 | 9.87e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 507 | 2.25e-01 | -3.15e-02 | 8.59e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 35 | 7.47e-01 | 3.14e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 8.94e-01 | 3.14e-02 | 9.93e-01 |
| GOCC ACROSOMAL VESICLE | 138 | 5.24e-01 | -3.14e-02 | 9.47e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 319 | 3.35e-01 | -3.14e-02 | 8.96e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 8 | 8.78e-01 | 3.14e-02 | 9.93e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 8.86e-01 | 3.14e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 499 | 2.30e-01 | -3.14e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 41 | 7.29e-01 | -3.13e-02 | 9.75e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 18 | 8.18e-01 | 3.13e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION | 6 | 8.94e-01 | -3.13e-02 | 9.93e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 11 | 8.57e-01 | -3.13e-02 | 9.92e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 458 | 2.52e-01 | -3.13e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 8 | 8.78e-01 | 3.12e-02 | 9.93e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 59 | 6.78e-01 | -3.12e-02 | 9.68e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 107 | 5.77e-01 | 3.12e-02 | 9.52e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 8.64e-01 | -3.12e-02 | 9.93e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 44 | 7.21e-01 | 3.12e-02 | 9.73e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 338 | 3.25e-01 | -3.12e-02 | 8.93e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 8.95e-01 | -3.12e-02 | 9.93e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 8.65e-01 | -3.11e-02 | 9.93e-01 |
| GOCC PEPTIDASE COMPLEX | 116 | 5.63e-01 | 3.11e-02 | 9.49e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 128 | 5.43e-01 | -3.11e-02 | 9.49e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 29 | 7.72e-01 | 3.11e-02 | 9.82e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 14 | 8.40e-01 | 3.11e-02 | 9.89e-01 |
| GOBP MIRNA METABOLIC PROCESS | 101 | 5.90e-01 | -3.11e-02 | 9.54e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 7.97e-01 | 3.11e-02 | 9.84e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 63 | 6.70e-01 | 3.11e-02 | 9.67e-01 |
| GOBP CARDIAC CHAMBER FORMATION | 12 | 8.52e-01 | 3.10e-02 | 9.91e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 7.92e-01 | -3.10e-02 | 9.84e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 286 | 3.67e-01 | -3.10e-02 | 9.06e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 8.41e-01 | -3.10e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 1306 | 5.97e-02 | -3.10e-02 | 6.62e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1451 | 4.80e-02 | -3.10e-02 | 6.27e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 63 | 6.70e-01 | -3.10e-02 | 9.67e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 927 | 1.10e-01 | -3.10e-02 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 141 | 5.25e-01 | -3.10e-02 | 9.47e-01 |
| GOBP RESPONSE TO PAIN | 34 | 7.55e-01 | -3.10e-02 | 9.81e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 130 | 5.42e-01 | 3.10e-02 | 9.49e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 74 | 6.45e-01 | 3.10e-02 | 9.63e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 47 | 7.13e-01 | 3.10e-02 | 9.72e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 518 | 2.28e-01 | 3.09e-02 | 8.62e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 9.05e-01 | 3.09e-02 | 9.96e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 9.05e-01 | 3.09e-02 | 9.96e-01 |
| GOMF IRON ION BINDING | 145 | 5.20e-01 | 3.09e-02 | 9.47e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 14 | 8.41e-01 | -3.09e-02 | 9.89e-01 |
| GOMF TELOMERIC DNA BINDING | 38 | 7.42e-01 | 3.09e-02 | 9.77e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 20 | 8.11e-01 | 3.09e-02 | 9.87e-01 |
| GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION | 11 | 8.59e-01 | 3.09e-02 | 9.92e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 10 | 8.66e-01 | 3.09e-02 | 9.93e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 7.94e-01 | 3.09e-02 | 9.84e-01 |
| GOCC PML BODY | 104 | 5.87e-01 | 3.08e-02 | 9.54e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 77 | 6.40e-01 | -3.08e-02 | 9.62e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 9.05e-01 | 3.08e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 33 | 7.59e-01 | -3.08e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF FEVER GENERATION | 7 | 8.88e-01 | 3.08e-02 | 9.93e-01 |
| GOBP MACROPHAGE PROLIFERATION | 12 | 8.53e-01 | 3.08e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 274 | 3.80e-01 | 3.08e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 139 | 5.31e-01 | 3.08e-02 | 9.48e-01 |
| GOMF CUPROUS ION BINDING | 8 | 8.80e-01 | -3.08e-02 | 9.93e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 61 | 6.78e-01 | -3.07e-02 | 9.68e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 87 | 6.20e-01 | 3.07e-02 | 9.61e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 1323 | 6.11e-02 | -3.07e-02 | 6.63e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 74 | 6.48e-01 | 3.07e-02 | 9.63e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 6 | 8.97e-01 | -3.06e-02 | 9.94e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 180 | 4.78e-01 | -3.06e-02 | 9.42e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 24 | 7.95e-01 | -3.06e-02 | 9.84e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 9 | 8.74e-01 | 3.06e-02 | 9.93e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 35 | 7.54e-01 | -3.06e-02 | 9.81e-01 |
| GOBP ACINAR CELL DIFFERENTIATION | 5 | 9.06e-01 | 3.06e-02 | 9.96e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 7 | 8.89e-01 | -3.06e-02 | 9.93e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 7 | 8.89e-01 | -3.06e-02 | 9.93e-01 |
| GOBP GASTRIC MOTILITY | 5 | 9.06e-01 | -3.06e-02 | 9.96e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 17 | 8.28e-01 | 3.05e-02 | 9.88e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 9 | 8.74e-01 | -3.05e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 216 | 4.40e-01 | -3.05e-02 | 9.29e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 8 | 8.81e-01 | 3.05e-02 | 9.93e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 19 | 8.18e-01 | -3.05e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 339 | 3.35e-01 | -3.05e-02 | 8.96e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 11 | 8.61e-01 | 3.05e-02 | 9.93e-01 |
| GOCC M BAND | 21 | 8.09e-01 | -3.05e-02 | 9.87e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 19 | 8.18e-01 | -3.04e-02 | 9.87e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 48 | 7.15e-01 | 3.04e-02 | 9.72e-01 |
| GOMF ALPHA ACTININ BINDING | 28 | 7.81e-01 | -3.04e-02 | 9.83e-01 |
| GOBP MESENDODERM DEVELOPMENT | 9 | 8.75e-01 | 3.04e-02 | 9.93e-01 |
| GOBP MACROPHAGE ACTIVATION | 108 | 5.86e-01 | -3.04e-02 | 9.54e-01 |
| GOBP REGULATION OF RNA SPLICING | 163 | 5.04e-01 | 3.03e-02 | 9.45e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 32 | 7.66e-01 | -3.03e-02 | 9.82e-01 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 8.82e-01 | -3.03e-02 | 9.93e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 21 | 8.10e-01 | -3.03e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 43 | 7.31e-01 | -3.03e-02 | 9.76e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 21 | 8.10e-01 | -3.03e-02 | 9.87e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 9.07e-01 | 3.03e-02 | 9.96e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 116 | 5.74e-01 | 3.03e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 72 | 6.57e-01 | -3.03e-02 | 9.66e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 624 | 1.97e-01 | 3.02e-02 | 8.44e-01 |
| GOBP PROTEIN FOLDING | 208 | 4.53e-01 | 3.02e-02 | 9.35e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 242 | 4.19e-01 | -3.02e-02 | 9.24e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 780 | 1.52e-01 | -3.01e-02 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 166 | 5.03e-01 | -3.01e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 27 | 7.87e-01 | -3.01e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 147 | 5.29e-01 | 3.01e-02 | 9.48e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 23 | 8.03e-01 | -3.01e-02 | 9.85e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 6 | 8.98e-01 | 3.01e-02 | 9.94e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 483 | 2.58e-01 | -3.01e-02 | 8.65e-01 |
| GOBP GOLGI VESICLE FUSION TO TARGET MEMBRANE | 5 | 9.07e-01 | 3.00e-02 | 9.96e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 19 | 8.21e-01 | -3.00e-02 | 9.87e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 105 | 5.95e-01 | 3.00e-02 | 9.54e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 19 | 8.21e-01 | 3.00e-02 | 9.87e-01 |
| GOBP HOMEOSTATIC PROCESS | 1655 | 4.19e-02 | -3.00e-02 | 6.10e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 41 | 7.40e-01 | -3.00e-02 | 9.77e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 24 | 7.99e-01 | -3.00e-02 | 9.85e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 168 | 5.02e-01 | -3.00e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 26 | 7.91e-01 | -3.00e-02 | 9.84e-01 |
| GOCC GAP JUNCTION | 29 | 7.80e-01 | 3.00e-02 | 9.83e-01 |
| GOCC PRESYNAPSE | 539 | 2.35e-01 | -2.99e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 34 | 7.63e-01 | -2.99e-02 | 9.82e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 155 | 5.21e-01 | 2.99e-02 | 9.47e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 1243 | 7.64e-02 | -2.99e-02 | 7.18e-01 |
| GOBP NEURAL PLATE REGIONALIZATION | 6 | 8.99e-01 | 2.99e-02 | 9.95e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 406 | 3.02e-01 | 2.98e-02 | 8.84e-01 |
| GOBP REGULATION OF CELL SIZE | 176 | 4.95e-01 | -2.98e-02 | 9.45e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 100 | 6.07e-01 | -2.98e-02 | 9.55e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 139 | 5.44e-01 | -2.98e-02 | 9.49e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 268 | 4.01e-01 | 2.98e-02 | 9.18e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 8.64e-01 | 2.98e-02 | 9.93e-01 |
| GOBP APPENDAGE DEVELOPMENT | 177 | 4.95e-01 | 2.97e-02 | 9.45e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 225 | 4.42e-01 | -2.97e-02 | 9.30e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 19 | 8.23e-01 | 2.97e-02 | 9.88e-01 |
| GOBP POSITIVE CHEMOTAXIS | 61 | 6.89e-01 | -2.96e-02 | 9.69e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 11 | 8.65e-01 | -2.96e-02 | 9.93e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY | 6 | 9.00e-01 | 2.96e-02 | 9.95e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 7 | 8.92e-01 | 2.95e-02 | 9.93e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 9.00e-01 | -2.95e-02 | 9.95e-01 |
| GOMF CGMP BINDING | 15 | 8.43e-01 | -2.95e-02 | 9.89e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 9.00e-01 | 2.95e-02 | 9.95e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 13 | 8.54e-01 | -2.95e-02 | 9.91e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 115 | 5.85e-01 | -2.95e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 45 | 7.32e-01 | -2.95e-02 | 9.76e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 33 | 7.70e-01 | 2.94e-02 | 9.82e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 225 | 4.47e-01 | -2.94e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 24 | 8.03e-01 | 2.94e-02 | 9.85e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 42 | 7.42e-01 | -2.94e-02 | 9.77e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 12 | 8.60e-01 | 2.94e-02 | 9.93e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 7 | 8.93e-01 | -2.94e-02 | 9.93e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 175 | 5.03e-01 | 2.94e-02 | 9.45e-01 |
| GOBP INNER EAR MORPHOGENESIS | 103 | 6.07e-01 | 2.93e-02 | 9.56e-01 |
| GOBP SPLEEN DEVELOPMENT | 38 | 7.55e-01 | 2.93e-02 | 9.81e-01 |
| GOBP RESPONSE TO PH | 41 | 7.46e-01 | -2.93e-02 | 9.78e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 32 | 7.75e-01 | -2.92e-02 | 9.82e-01 |
| GOBP CHROMOSOME CONDENSATION | 46 | 7.32e-01 | 2.92e-02 | 9.76e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 27 | 7.93e-01 | -2.92e-02 | 9.84e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 106 | 6.04e-01 | -2.92e-02 | 9.55e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 564 | 2.37e-01 | 2.92e-02 | 8.64e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 19 | 8.26e-01 | -2.92e-02 | 9.88e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 136 | 5.57e-01 | -2.91e-02 | 9.49e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 677 | 1.96e-01 | 2.91e-02 | 8.44e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 19 | 8.26e-01 | 2.91e-02 | 9.88e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 7 | 8.94e-01 | -2.91e-02 | 9.93e-01 |
| GOCC CENTRIOLAR SATELLITE | 107 | 6.03e-01 | 2.91e-02 | 9.55e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 306 | 3.82e-01 | -2.91e-02 | 9.12e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 1194 | 9.07e-02 | -2.91e-02 | 7.54e-01 |
| GOBP MYOBLAST PROLIFERATION | 34 | 7.69e-01 | -2.91e-02 | 9.82e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 21 | 8.18e-01 | 2.91e-02 | 9.87e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 10 | 8.74e-01 | -2.90e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 9.02e-01 | -2.90e-02 | 9.95e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 80 | 6.53e-01 | 2.90e-02 | 9.64e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 40 | 7.51e-01 | -2.90e-02 | 9.80e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 12 | 8.62e-01 | 2.90e-02 | 9.93e-01 |
| GOCC CILIARY TRANSITION ZONE | 71 | 6.72e-01 | -2.90e-02 | 9.68e-01 |
| GOBP EXPORT FROM CELL | 867 | 1.47e-01 | -2.90e-02 | 8.08e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 1202 | 9.04e-02 | -2.90e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 53 | 7.15e-01 | -2.90e-02 | 9.72e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 121 | 5.82e-01 | -2.90e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 7.28e-01 | 2.90e-02 | 9.75e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 325 | 3.69e-01 | -2.90e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 495 | 2.70e-01 | 2.89e-02 | 8.69e-01 |
| GOBP RESPONSE TO FUNGICIDE | 7 | 8.95e-01 | 2.89e-02 | 9.93e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 8 | 8.87e-01 | 2.89e-02 | 9.93e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 129 | 5.70e-01 | 2.89e-02 | 9.51e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 74 | 6.67e-01 | -2.89e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 314 | 3.79e-01 | -2.89e-02 | 9.09e-01 |
| GOBP RETINAL BLOOD VESSEL MORPHOGENESIS | 5 | 9.11e-01 | 2.89e-02 | 9.96e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 69 | 6.78e-01 | 2.89e-02 | 9.68e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 8.88e-01 | 2.89e-02 | 9.93e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 43 | 7.43e-01 | -2.89e-02 | 9.77e-01 |
| GOBP CHOLESTEROL IMPORT | 9 | 8.81e-01 | 2.89e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 38 | 7.58e-01 | 2.88e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 109 | 6.03e-01 | -2.88e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 48 | 7.30e-01 | -2.88e-02 | 9.76e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 17 | 8.37e-01 | 2.88e-02 | 9.89e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 467 | 2.87e-01 | -2.87e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 18 | 8.33e-01 | 2.87e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 127 | 5.76e-01 | 2.87e-02 | 9.51e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 9.11e-01 | -2.87e-02 | 9.96e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 1076 | 1.12e-01 | -2.87e-02 | 7.78e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 8.75e-01 | 2.87e-02 | 9.93e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 92 | 6.35e-01 | -2.86e-02 | 9.61e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 8.48e-01 | -2.86e-02 | 9.91e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 135 | 5.66e-01 | 2.86e-02 | 9.50e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 18 | 8.34e-01 | -2.86e-02 | 9.88e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 128 | 5.77e-01 | 2.86e-02 | 9.52e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 94 | 6.32e-01 | -2.85e-02 | 9.61e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 155 | 5.40e-01 | 2.85e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 38 | 7.61e-01 | 2.85e-02 | 9.82e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 101 | 6.21e-01 | -2.85e-02 | 9.61e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 5.64e-01 | 2.84e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE | 6 | 9.04e-01 | 2.84e-02 | 9.96e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 36 | 7.68e-01 | -2.84e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 692 | 2.03e-01 | -2.84e-02 | 8.51e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 65 | 6.92e-01 | -2.84e-02 | 9.69e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 337 | 3.71e-01 | -2.84e-02 | 9.09e-01 |
| GOBP RECEPTOR INTERNALIZATION | 122 | 5.89e-01 | -2.83e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 6 | 9.04e-01 | -2.83e-02 | 9.96e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 175 | 5.19e-01 | 2.83e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 68 | 6.87e-01 | -2.83e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1615 | 5.83e-02 | -2.83e-02 | 6.58e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 357 | 3.59e-01 | -2.82e-02 | 9.04e-01 |
| GOBP G0 TO G1 TRANSITION | 36 | 7.69e-01 | 2.82e-02 | 9.82e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 47 | 7.38e-01 | -2.82e-02 | 9.77e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 38 | 7.63e-01 | -2.82e-02 | 9.82e-01 |
| GOBP NADP METABOLIC PROCESS | 41 | 7.55e-01 | 2.82e-02 | 9.81e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 145 | 5.58e-01 | 2.82e-02 | 9.49e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 40 | 7.58e-01 | -2.82e-02 | 9.82e-01 |
| GOBP REGULATION OF INTESTINAL ABSORPTION | 12 | 8.66e-01 | 2.82e-02 | 9.93e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 226 | 4.66e-01 | 2.81e-02 | 9.38e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 8.90e-01 | -2.81e-02 | 9.93e-01 |
| GOBP MRNA METABOLIC PROCESS | 741 | 1.92e-01 | 2.81e-02 | 8.44e-01 |
| GOBP REGULATION OF GROWTH RATE | 5 | 9.13e-01 | -2.81e-02 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 9.13e-01 | -2.81e-02 | 9.96e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 36 | 7.71e-01 | -2.81e-02 | 9.82e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 7.12e-01 | 2.81e-02 | 9.71e-01 |
| GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM | 8 | 8.91e-01 | -2.81e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 36 | 7.71e-01 | -2.80e-02 | 9.82e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 14 | 8.56e-01 | -2.80e-02 | 9.92e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 298 | 4.05e-01 | -2.80e-02 | 9.21e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 8 | 8.91e-01 | -2.80e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MUCUS SECRETION | 5 | 9.14e-01 | 2.80e-02 | 9.96e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 8.98e-01 | -2.80e-02 | 9.94e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 803 | 1.77e-01 | -2.80e-02 | 8.41e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 18 | 8.37e-01 | -2.80e-02 | 9.89e-01 |
| GOBP CELLULAR SENESCENCE | 106 | 6.19e-01 | -2.80e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 39 | 7.63e-01 | 2.80e-02 | 9.82e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 52 | 7.28e-01 | -2.79e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 10 | 8.79e-01 | -2.79e-02 | 9.93e-01 |
| GOCC BOX C D RNP COMPLEX | 6 | 9.06e-01 | -2.79e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 31 | 7.88e-01 | -2.79e-02 | 9.84e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 94 | 6.40e-01 | 2.79e-02 | 9.62e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 16 | 8.47e-01 | 2.78e-02 | 9.90e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 86 | 6.56e-01 | 2.78e-02 | 9.65e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1521 | 7.03e-02 | 2.78e-02 | 6.96e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 516 | 2.81e-01 | -2.78e-02 | 8.72e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 232 | 4.67e-01 | -2.77e-02 | 9.38e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 108 | 6.19e-01 | 2.77e-02 | 9.61e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 36 | 7.74e-01 | 2.77e-02 | 9.82e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 8.80e-01 | -2.77e-02 | 9.93e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 8.18e-01 | -2.76e-02 | 9.87e-01 |
| GOBP TRABECULA MORPHOGENESIS | 47 | 7.43e-01 | 2.76e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 67 | 6.96e-01 | -2.76e-02 | 9.69e-01 |
| GOBP LIPID LOCALIZATION | 495 | 2.93e-01 | -2.76e-02 | 8.79e-01 |
| GOBP ETHANOL OXIDATION | 9 | 8.86e-01 | 2.76e-02 | 9.93e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 40 | 7.63e-01 | -2.76e-02 | 9.82e-01 |
| GOBP REGULATION OF KIDNEY SIZE | 5 | 9.15e-01 | 2.76e-02 | 9.97e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 93 | 6.46e-01 | 2.76e-02 | 9.63e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 613 | 2.44e-01 | 2.76e-02 | 8.64e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 558 | 2.66e-01 | -2.76e-02 | 8.69e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 106 | 6.24e-01 | -2.75e-02 | 9.61e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 101 | 6.33e-01 | -2.75e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 37 | 7.72e-01 | 2.75e-02 | 9.82e-01 |
| GOBP BRAIN MORPHOGENESIS | 37 | 7.72e-01 | 2.75e-02 | 9.82e-01 |
| GOBP FERTILIZATION | 194 | 5.09e-01 | 2.75e-02 | 9.46e-01 |
| GOBP AMINE CATABOLIC PROCESS | 15 | 8.54e-01 | -2.75e-02 | 9.91e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 66 | 7.00e-01 | -2.74e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 65 | 7.02e-01 | -2.74e-02 | 9.71e-01 |
| GOBP GLAND MORPHOGENESIS | 119 | 6.05e-01 | -2.74e-02 | 9.55e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 52 | 7.33e-01 | -2.74e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 14 | 8.59e-01 | -2.74e-02 | 9.92e-01 |
| GOBP MICROTUBULE BASED PROCESS | 897 | 1.65e-01 | 2.74e-02 | 8.24e-01 |
| GOCC NEUROFIBRILLARY TANGLE | 5 | 9.16e-01 | -2.73e-02 | 9.97e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 33 | 7.86e-01 | -2.73e-02 | 9.84e-01 |
| GOBP BODY FLUID SECRETION | 87 | 6.60e-01 | -2.73e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 556 | 2.72e-01 | -2.73e-02 | 8.69e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 28 | 8.03e-01 | -2.72e-02 | 9.85e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 121 | 6.05e-01 | 2.72e-02 | 9.55e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 50 | 7.40e-01 | -2.72e-02 | 9.77e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 8 | 8.94e-01 | 2.72e-02 | 9.93e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 44 | 7.55e-01 | -2.72e-02 | 9.82e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 254 | 4.56e-01 | -2.72e-02 | 9.36e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 110 | 6.23e-01 | 2.72e-02 | 9.61e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 194 | 5.14e-01 | 2.71e-02 | 9.46e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 15 | 8.56e-01 | 2.71e-02 | 9.92e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 382 | 3.63e-01 | 2.71e-02 | 9.06e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 133 | 5.89e-01 | -2.71e-02 | 9.54e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 41 | 7.64e-01 | -2.71e-02 | 9.82e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 109 | 6.26e-01 | -2.70e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 125 | 6.02e-01 | -2.70e-02 | 9.55e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 9.09e-01 | -2.70e-02 | 9.96e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 71 | 6.95e-01 | -2.70e-02 | 9.69e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 461 | 3.21e-01 | -2.69e-02 | 8.92e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 89 | 6.60e-01 | -2.69e-02 | 9.66e-01 |
| GOMF LAMIN BINDING | 15 | 8.57e-01 | -2.69e-02 | 9.92e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 976 | 1.54e-01 | -2.69e-02 | 8.17e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 1196 | 1.17e-01 | -2.69e-02 | 7.82e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 772 | 2.03e-01 | 2.69e-02 | 8.51e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 12 | 8.72e-01 | -2.69e-02 | 9.93e-01 |
| GOBP RESPONSE TO LIPID | 890 | 1.73e-01 | -2.69e-02 | 8.37e-01 |
| GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY | 6 | 9.09e-01 | -2.69e-02 | 9.96e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 27 | 8.09e-01 | -2.69e-02 | 9.87e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 11 | 8.77e-01 | -2.69e-02 | 9.93e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 284 | 4.36e-01 | -2.69e-02 | 9.27e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 8.72e-01 | -2.69e-02 | 9.93e-01 |
| GOCC CASPASE COMPLEX | 10 | 8.83e-01 | -2.68e-02 | 9.93e-01 |
| GOBP REGULATION OF BEHAVIOR | 73 | 6.92e-01 | 2.68e-02 | 9.69e-01 |
| GOBP NCRNA TRANSCRIPTION | 134 | 5.92e-01 | 2.68e-02 | 9.54e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 15 | 8.57e-01 | -2.68e-02 | 9.92e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 20 | 8.36e-01 | 2.68e-02 | 9.89e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 105 | 6.36e-01 | 2.68e-02 | 9.61e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 36 | 7.81e-01 | -2.68e-02 | 9.83e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 541 | 2.87e-01 | -2.68e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 6 | 9.10e-01 | -2.67e-02 | 9.96e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 9 | 8.90e-01 | 2.67e-02 | 9.93e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 331 | 4.03e-01 | -2.67e-02 | 9.20e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 45 | 7.56e-01 | -2.67e-02 | 9.82e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 25 | 8.17e-01 | -2.67e-02 | 9.87e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 31 | 7.97e-01 | 2.67e-02 | 9.84e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL | 5 | 9.18e-01 | 2.67e-02 | 9.97e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 148 | 5.75e-01 | 2.67e-02 | 9.51e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRANSPORT | 6 | 9.10e-01 | -2.67e-02 | 9.96e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 224 | 4.92e-01 | 2.66e-02 | 9.45e-01 |
| GOMF BETA CATENIN BINDING | 80 | 6.81e-01 | 2.66e-02 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 587 | 2.70e-01 | -2.66e-02 | 8.69e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 14 | 8.63e-01 | 2.66e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 7 | 9.03e-01 | -2.66e-02 | 9.95e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 325 | 4.09e-01 | -2.66e-02 | 9.21e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 34 | 7.88e-01 | 2.66e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 8.96e-01 | 2.66e-02 | 9.94e-01 |
| GOCC SYNAPSE | 1375 | 9.81e-02 | -2.66e-02 | 7.66e-01 |
| GOBP GLUCOSE IMPORT | 75 | 6.90e-01 | 2.66e-02 | 9.69e-01 |
| GOBP KETONE CATABOLIC PROCESS | 14 | 8.63e-01 | -2.66e-02 | 9.93e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 18 | 8.45e-01 | -2.66e-02 | 9.90e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 88 | 6.67e-01 | -2.66e-02 | 9.67e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 79 | 6.83e-01 | -2.66e-02 | 9.68e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 8 | 8.97e-01 | 2.65e-02 | 9.94e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 260 | 4.61e-01 | -2.65e-02 | 9.37e-01 |
| GOBP RENAL SYSTEM PROCESS | 117 | 6.21e-01 | -2.65e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 452 | 3.35e-01 | -2.64e-02 | 8.96e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 1129 | 1.34e-01 | -2.64e-02 | 8.03e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 91 | 6.63e-01 | -2.64e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 22 | 8.30e-01 | -2.64e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 14 | 8.64e-01 | -2.64e-02 | 9.93e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 7 | 9.04e-01 | -2.64e-02 | 9.96e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 304 | 4.29e-01 | 2.64e-02 | 9.27e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 54 | 7.38e-01 | 2.63e-02 | 9.77e-01 |
| GOBP VESICLE ORGANIZATION | 350 | 3.98e-01 | 2.63e-02 | 9.18e-01 |
| GOMF LIPASE ACTIVITY | 132 | 6.02e-01 | -2.63e-02 | 9.55e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 447 | 3.41e-01 | -2.63e-02 | 8.96e-01 |
| GOBP CYTOSOLIC TRANSPORT | 174 | 5.50e-01 | -2.63e-02 | 9.49e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 594 | 2.74e-01 | -2.62e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 426 | 3.53e-01 | -2.62e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 27 | 8.13e-01 | 2.62e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 42 | 7.69e-01 | -2.62e-02 | 9.82e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 26 | 8.17e-01 | -2.62e-02 | 9.87e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 39 | 7.77e-01 | -2.62e-02 | 9.83e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 9.19e-01 | 2.62e-02 | 9.97e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 56 | 7.35e-01 | 2.62e-02 | 9.77e-01 |
| GOBP ANIMAL ORGAN FORMATION | 66 | 7.13e-01 | 2.62e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 101 | 6.50e-01 | -2.62e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 62 | 7.22e-01 | 2.61e-02 | 9.73e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 379 | 3.82e-01 | 2.61e-02 | 9.12e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 23 | 8.28e-01 | 2.61e-02 | 9.88e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 31 | 8.01e-01 | -2.61e-02 | 9.85e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 46 | 7.60e-01 | 2.61e-02 | 9.82e-01 |
| GOMF KINASE ACTIVITY | 706 | 2.38e-01 | 2.61e-02 | 8.64e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 9.12e-01 | 2.60e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 8 | 8.99e-01 | 2.60e-02 | 9.94e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 54 | 7.41e-01 | 2.60e-02 | 9.77e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 192 | 5.34e-01 | 2.60e-02 | 9.49e-01 |
| GOMF DYNACTIN BINDING | 12 | 8.76e-01 | 2.60e-02 | 9.93e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 9 | 8.93e-01 | 2.60e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 9 | 8.93e-01 | 2.60e-02 | 9.93e-01 |
| GOMF AMYLOID BETA BINDING | 82 | 6.84e-01 | -2.60e-02 | 9.68e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 54 | 7.41e-01 | 2.60e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 14 | 8.66e-01 | 2.60e-02 | 9.93e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 392 | 3.78e-01 | -2.60e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 31 | 8.03e-01 | 2.59e-02 | 9.85e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 13 | 8.71e-01 | -2.59e-02 | 9.93e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 26 | 8.19e-01 | -2.59e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 44 | 7.66e-01 | 2.59e-02 | 9.82e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 9 | 8.93e-01 | 2.59e-02 | 9.93e-01 |
| GOBP BONE REMODELING | 89 | 6.73e-01 | -2.59e-02 | 9.68e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 8.87e-01 | 2.59e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 55 | 7.40e-01 | 2.59e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 8.77e-01 | -2.58e-02 | 9.93e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 6 | 9.13e-01 | -2.58e-02 | 9.96e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 208 | 5.21e-01 | -2.58e-02 | 9.47e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 95 | 6.64e-01 | 2.58e-02 | 9.67e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 50 | 7.52e-01 | -2.58e-02 | 9.81e-01 |
| GOMF LYASE ACTIVITY | 190 | 5.40e-01 | 2.58e-02 | 9.49e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 80 | 6.90e-01 | -2.58e-02 | 9.69e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 106 | 6.47e-01 | 2.58e-02 | 9.63e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 8.24e-01 | 2.58e-02 | 9.88e-01 |
| GOCC CELL CORTEX REGION | 38 | 7.84e-01 | -2.58e-02 | 9.84e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 8.88e-01 | -2.57e-02 | 9.93e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 178 | 5.54e-01 | -2.57e-02 | 9.49e-01 |
| GOBP TOXIN TRANSPORT | 11 | 8.83e-01 | 2.57e-02 | 9.93e-01 |
| GOCC MICROTUBULE END | 34 | 7.95e-01 | 2.57e-02 | 9.84e-01 |
| GOBP RESPONSE TO COBALT ION | 9 | 8.94e-01 | -2.57e-02 | 9.93e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 41 | 7.76e-01 | -2.57e-02 | 9.82e-01 |
| GOBP RUFFLE ASSEMBLY | 45 | 7.66e-01 | -2.57e-02 | 9.82e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 12 | 8.78e-01 | -2.57e-02 | 9.93e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1430 | 1.05e-01 | -2.56e-02 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 59 | 7.34e-01 | -2.56e-02 | 9.76e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 60 | 7.31e-01 | -2.56e-02 | 9.76e-01 |
| GOBP ENAMEL MINERALIZATION | 19 | 8.47e-01 | -2.56e-02 | 9.90e-01 |
| GOCC OUTER DYNEIN ARM | 11 | 8.83e-01 | -2.56e-02 | 9.93e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 68 | 7.15e-01 | -2.56e-02 | 9.72e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 131 | 6.13e-01 | 2.56e-02 | 9.59e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 49 | 7.57e-01 | -2.56e-02 | 9.82e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 54 | 7.45e-01 | 2.56e-02 | 9.78e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 185 | 5.49e-01 | -2.56e-02 | 9.49e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 10 | 8.89e-01 | -2.55e-02 | 9.93e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 51 | 7.53e-01 | -2.55e-02 | 9.81e-01 |
| GOBP HEART DEVELOPMENT | 598 | 2.87e-01 | 2.55e-02 | 8.76e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 8.79e-01 | 2.55e-02 | 9.93e-01 |
| GOBP DAMP METABOLIC PROCESS | 7 | 9.07e-01 | 2.55e-02 | 9.96e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 9.01e-01 | 2.55e-02 | 9.95e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 24 | 8.29e-01 | 2.55e-02 | 9.88e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 509 | 3.26e-01 | 2.54e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 90 | 6.77e-01 | -2.54e-02 | 9.68e-01 |
| GOBP REGULATION OF VESICLE FUSION | 24 | 8.29e-01 | 2.54e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 8.95e-01 | 2.54e-02 | 9.93e-01 |
| GOBP MUSCLE CELL MIGRATION | 100 | 6.61e-01 | -2.54e-02 | 9.66e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY | 7 | 9.07e-01 | 2.54e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 179 | 5.58e-01 | -2.54e-02 | 9.49e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 309 | 4.44e-01 | -2.53e-02 | 9.30e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE | 8 | 9.01e-01 | -2.53e-02 | 9.95e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 8.90e-01 | 2.53e-02 | 9.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 24 | 8.30e-01 | 2.53e-02 | 9.88e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 63 | 7.29e-01 | 2.53e-02 | 9.75e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 376 | 4.01e-01 | -2.52e-02 | 9.18e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 679 | 2.62e-01 | -2.52e-02 | 8.68e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 24 | 8.31e-01 | 2.52e-02 | 9.88e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 8.31e-01 | -2.52e-02 | 9.88e-01 |
| GOCC SARCOPLASM | 90 | 6.80e-01 | 2.52e-02 | 9.68e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 48 | 7.63e-01 | -2.52e-02 | 9.82e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 17 | 8.57e-01 | -2.52e-02 | 9.92e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 11 | 8.85e-01 | -2.52e-02 | 9.93e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 8 | 9.02e-01 | -2.51e-02 | 9.95e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 82 | 6.94e-01 | 2.51e-02 | 9.69e-01 |
| GOMF CALCIUM ION BINDING | 675 | 2.66e-01 | -2.51e-02 | 8.69e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 33 | 8.03e-01 | 2.51e-02 | 9.85e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 163 | 5.81e-01 | 2.50e-02 | 9.53e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 314 | 4.46e-01 | -2.50e-02 | 9.31e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 25 | 8.29e-01 | 2.50e-02 | 9.88e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 240 | 5.05e-01 | 2.50e-02 | 9.45e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 10 | 8.91e-01 | 2.50e-02 | 9.93e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 47 | 7.67e-01 | -2.50e-02 | 9.82e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 24 | 8.32e-01 | -2.50e-02 | 9.88e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 240 | 5.05e-01 | -2.50e-02 | 9.45e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 25 | 8.29e-01 | -2.49e-02 | 9.88e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 35 | 7.99e-01 | -2.49e-02 | 9.85e-01 |
| GOCC MYELIN SHEATH | 42 | 7.80e-01 | -2.49e-02 | 9.83e-01 |
| GOBP LIPID CATABOLIC PROCESS | 328 | 4.39e-01 | 2.49e-02 | 9.29e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 32 | 8.08e-01 | 2.48e-02 | 9.87e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 21 | 8.44e-01 | -2.48e-02 | 9.90e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 76 | 7.09e-01 | -2.48e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 23 | 8.37e-01 | -2.48e-02 | 9.89e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 25 | 8.30e-01 | -2.48e-02 | 9.88e-01 |
| GOBP SINOATRIAL NODE CELL DEVELOPMENT | 5 | 9.24e-01 | 2.48e-02 | 9.98e-01 |
| GOBP PROTEIN STABILIZATION | 202 | 5.44e-01 | 2.47e-02 | 9.49e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 11 | 8.87e-01 | 2.47e-02 | 9.93e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 186 | 5.61e-01 | -2.47e-02 | 9.49e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 23 | 8.37e-01 | -2.47e-02 | 9.89e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 9.17e-01 | 2.47e-02 | 9.97e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1459 | 1.15e-01 | -2.47e-02 | 7.81e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 12 | 8.83e-01 | -2.46e-02 | 9.93e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 10 | 8.93e-01 | 2.46e-02 | 9.93e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 7 | 9.10e-01 | 2.46e-02 | 9.96e-01 |
| GOCC GOLGI APPARATUS | 1535 | 1.08e-01 | -2.46e-02 | 7.72e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 32 | 8.10e-01 | -2.46e-02 | 9.87e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 73 | 7.17e-01 | -2.46e-02 | 9.72e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 11 | 8.88e-01 | 2.46e-02 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 85 | 6.96e-01 | -2.45e-02 | 9.69e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 14 | 8.74e-01 | 2.45e-02 | 9.93e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 8 | 9.05e-01 | -2.45e-02 | 9.96e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 747 | 2.55e-01 | 2.45e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 52 | 7.61e-01 | -2.44e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 71 | 7.22e-01 | -2.44e-02 | 9.73e-01 |
| GOBP CGMP METABOLIC PROCESS | 16 | 8.66e-01 | 2.44e-02 | 9.93e-01 |
| GOBP NEPHRON DEVELOPMENT | 152 | 6.03e-01 | 2.44e-02 | 9.55e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 106 | 6.64e-01 | 2.44e-02 | 9.67e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 8.75e-01 | -2.44e-02 | 9.93e-01 |
| GOMF INTEGRIN BINDING | 150 | 6.07e-01 | -2.44e-02 | 9.55e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 40 | 7.90e-01 | 2.43e-02 | 9.84e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 22 | 8.43e-01 | 2.43e-02 | 9.89e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 576 | 3.18e-01 | 2.43e-02 | 8.91e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 9.11e-01 | -2.43e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 80 | 7.07e-01 | 2.43e-02 | 9.71e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 45 | 7.78e-01 | 2.43e-02 | 9.83e-01 |
| GOMF ACTIN BINDING | 415 | 3.97e-01 | -2.42e-02 | 9.18e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 86 | 6.98e-01 | -2.42e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 25 | 8.34e-01 | 2.42e-02 | 9.88e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 614 | 3.06e-01 | -2.42e-02 | 8.85e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 194 | 5.62e-01 | -2.42e-02 | 9.49e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 15 | 8.71e-01 | -2.42e-02 | 9.93e-01 |
| GOBP RESPONSE TO LUTEINIZING HORMONE | 7 | 9.12e-01 | 2.41e-02 | 9.96e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 175 | 5.82e-01 | 2.41e-02 | 9.53e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 14 | 8.76e-01 | -2.41e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 143 | 6.19e-01 | -2.41e-02 | 9.61e-01 |
| GOCC INHIBITORY SYNAPSE | 14 | 8.76e-01 | -2.41e-02 | 9.93e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 103 | 6.73e-01 | -2.41e-02 | 9.68e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 403 | 4.07e-01 | -2.41e-02 | 9.21e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 25 | 8.35e-01 | -2.41e-02 | 9.89e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 20 | 8.52e-01 | 2.40e-02 | 9.91e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 83 | 7.05e-01 | 2.40e-02 | 9.71e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 76 | 7.17e-01 | 2.40e-02 | 9.72e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 83 | 7.05e-01 | -2.40e-02 | 9.71e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 14 | 8.77e-01 | 2.40e-02 | 9.93e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 402 | 4.09e-01 | -2.40e-02 | 9.21e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 31 | 8.17e-01 | 2.40e-02 | 9.87e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1417 | 1.31e-01 | -2.40e-02 | 7.94e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 180 | 5.80e-01 | 2.39e-02 | 9.53e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 26 | 8.33e-01 | -2.39e-02 | 9.88e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 8.33e-01 | 2.39e-02 | 9.88e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 45 | 7.82e-01 | -2.39e-02 | 9.83e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 140 | 6.26e-01 | 2.39e-02 | 9.61e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 20 | 8.54e-01 | 2.38e-02 | 9.91e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 197 | 5.64e-01 | 2.38e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 15 | 8.73e-01 | 2.38e-02 | 9.93e-01 |
| GOMF SPECTRIN BINDING | 26 | 8.34e-01 | -2.38e-02 | 9.88e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 8.47e-01 | 2.38e-02 | 9.90e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 63 | 7.44e-01 | -2.38e-02 | 9.78e-01 |
| GOBP FAT CELL DIFFERENTIATION | 243 | 5.23e-01 | -2.38e-02 | 9.47e-01 |
| GOBP IMPORT INTO NUCLEUS | 162 | 6.02e-01 | 2.38e-02 | 9.55e-01 |
| GOCC AUTOLYSOSOME | 11 | 8.92e-01 | 2.37e-02 | 9.93e-01 |
| GOBP RESPONSE TO NICOTINE | 49 | 7.74e-01 | -2.37e-02 | 9.82e-01 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 8 | 9.07e-01 | 2.37e-02 | 9.96e-01 |
| GOBP LIVER REGENERATION | 28 | 8.28e-01 | -2.37e-02 | 9.88e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 30 | 8.22e-01 | -2.37e-02 | 9.88e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 19 | 8.58e-01 | 2.37e-02 | 9.92e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 200 | 5.63e-01 | 2.37e-02 | 9.49e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 17 | 8.66e-01 | 2.37e-02 | 9.93e-01 |
| GOBP RESPONSE TO TUMOR CELL | 42 | 7.91e-01 | -2.37e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 9.27e-01 | 2.37e-02 | 9.98e-01 |
| GOBP CELL MATRIX ADHESION | 231 | 5.36e-01 | -2.36e-02 | 9.49e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 249 | 5.21e-01 | -2.36e-02 | 9.47e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 21 | 8.51e-01 | 2.36e-02 | 9.91e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 74 | 7.25e-01 | 2.36e-02 | 9.75e-01 |
| GOBP TUBE FORMATION | 149 | 6.19e-01 | 2.36e-02 | 9.61e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 32 | 8.18e-01 | 2.36e-02 | 9.87e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 34 | 8.12e-01 | 2.36e-02 | 9.87e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 6.33e-01 | 2.35e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 458 | 3.88e-01 | 2.35e-02 | 9.14e-01 |
| GOBP ORNITHINE TRANSPORT | 6 | 9.21e-01 | 2.35e-02 | 9.98e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 74 | 7.27e-01 | -2.35e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 13 | 8.83e-01 | -2.35e-02 | 9.93e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 91 | 6.99e-01 | -2.35e-02 | 9.70e-01 |
| GOCC MICROVILLUS MEMBRANE | 32 | 8.18e-01 | 2.35e-02 | 9.87e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 72 | 7.31e-01 | -2.35e-02 | 9.76e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 52 | 7.70e-01 | 2.34e-02 | 9.82e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 23 | 8.46e-01 | -2.34e-02 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 21 | 8.53e-01 | 2.34e-02 | 9.91e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 321 | 4.71e-01 | 2.34e-02 | 9.39e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 117 | 6.62e-01 | 2.34e-02 | 9.66e-01 |
| GOMF SYMPORTER ACTIVITY | 146 | 6.26e-01 | -2.33e-02 | 9.61e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 101 | 6.86e-01 | -2.33e-02 | 9.68e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 20 | 8.57e-01 | 2.33e-02 | 9.92e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 23 | 8.47e-01 | 2.33e-02 | 9.90e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 8 | 9.09e-01 | -2.33e-02 | 9.96e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 7.72e-01 | 2.33e-02 | 9.82e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 22 | 8.50e-01 | -2.32e-02 | 9.91e-01 |
| GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 9.28e-01 | -2.32e-02 | 9.98e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 234 | 5.41e-01 | 2.32e-02 | 9.49e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 8.57e-01 | -2.32e-02 | 9.92e-01 |
| GOBP STEROID METABOLIC PROCESS | 310 | 4.82e-01 | -2.32e-02 | 9.43e-01 |
| GOBP RESPONSE TO BMP | 170 | 6.02e-01 | -2.32e-02 | 9.55e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 36 | 8.10e-01 | -2.32e-02 | 9.87e-01 |
| GOMF MELANOCORTIN RECEPTOR BINDING | 5 | 9.29e-01 | -2.32e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 1396 | 1.47e-01 | -2.32e-02 | 8.08e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 8.65e-01 | -2.31e-02 | 9.93e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1438 | 1.43e-01 | -2.31e-02 | 8.06e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 25 | 8.42e-01 | 2.31e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 6 | 9.22e-01 | -2.31e-02 | 9.98e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 68 | 7.42e-01 | -2.31e-02 | 9.77e-01 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 8.21e-01 | -2.30e-02 | 9.87e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 53 | 7.72e-01 | 2.30e-02 | 9.82e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 9.00e-01 | 2.30e-02 | 9.95e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 71 | 7.38e-01 | 2.30e-02 | 9.77e-01 |
| GOBP TRANSCYTOSIS | 20 | 8.59e-01 | -2.30e-02 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 26 | 8.40e-01 | -2.29e-02 | 9.89e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 935 | 2.35e-01 | -2.29e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 26 | 8.40e-01 | -2.29e-02 | 9.89e-01 |
| GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 11 | 8.95e-01 | -2.29e-02 | 9.93e-01 |
| GOBP AMINE TRANSPORT | 106 | 6.84e-01 | -2.29e-02 | 9.68e-01 |
| GOBP HEPOXILIN METABOLIC PROCESS | 9 | 9.06e-01 | 2.28e-02 | 9.96e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 44 | 7.93e-01 | -2.28e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 161 | 6.18e-01 | -2.28e-02 | 9.61e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 8.13e-01 | -2.28e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 887 | 2.50e-01 | -2.27e-02 | 8.65e-01 |
| GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY | 10 | 9.01e-01 | 2.27e-02 | 9.95e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 89 | 7.11e-01 | 2.27e-02 | 9.71e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 64 | 7.53e-01 | 2.27e-02 | 9.81e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 143 | 6.39e-01 | 2.27e-02 | 9.62e-01 |
| GOBP FIBROBLAST MIGRATION | 52 | 7.77e-01 | -2.27e-02 | 9.83e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 173 | 6.07e-01 | 2.27e-02 | 9.55e-01 |
| GOMF BMP BINDING | 19 | 8.64e-01 | -2.27e-02 | 9.93e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 587 | 3.48e-01 | -2.27e-02 | 8.98e-01 |
| GOBP VASCULATURE DEVELOPMENT | 794 | 2.78e-01 | -2.26e-02 | 8.70e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 26 | 8.42e-01 | 2.26e-02 | 9.89e-01 |
| GOBP RESPONSE TO RADIATION | 410 | 4.32e-01 | 2.26e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 36 | 8.14e-01 | -2.26e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 15 | 8.79e-01 | -2.26e-02 | 9.93e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 217 | 5.66e-01 | -2.26e-02 | 9.50e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 38 | 8.10e-01 | -2.26e-02 | 9.87e-01 |
| GOMF SELENIUM BINDING | 9 | 9.07e-01 | 2.26e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 15 | 8.80e-01 | 2.26e-02 | 9.93e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 18 | 8.68e-01 | -2.26e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 16 | 8.76e-01 | -2.26e-02 | 9.93e-01 |
| GOBP RESPONSE TO MERCURY ION | 10 | 9.02e-01 | -2.26e-02 | 9.95e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 23 | 8.51e-01 | 2.26e-02 | 9.91e-01 |
| GOMF ZINC ION BINDING | 774 | 2.86e-01 | 2.26e-02 | 8.75e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 15 | 8.80e-01 | -2.25e-02 | 9.93e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 113 | 6.79e-01 | -2.25e-02 | 9.68e-01 |
| GOBP RHYTHMIC PROCESS | 287 | 5.12e-01 | 2.25e-02 | 9.46e-01 |
| GOCC SARCOPLASMIC RETICULUM | 72 | 7.41e-01 | 2.25e-02 | 9.77e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 18 | 8.69e-01 | -2.25e-02 | 9.93e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 7 | 9.18e-01 | 2.25e-02 | 9.97e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION | 6 | 9.24e-01 | -2.25e-02 | 9.98e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 20 | 8.62e-01 | -2.25e-02 | 9.93e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 62 | 7.60e-01 | -2.24e-02 | 9.82e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 114 | 6.79e-01 | -2.24e-02 | 9.68e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 7.80e-01 | -2.24e-02 | 9.83e-01 |
| GOCC NUCLEAR MEMBRANE | 296 | 5.08e-01 | 2.24e-02 | 9.46e-01 |
| GOBP RIBOSOME ASSEMBLY | 58 | 7.68e-01 | -2.24e-02 | 9.82e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 39 | 8.09e-01 | -2.24e-02 | 9.87e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 74 | 7.40e-01 | 2.24e-02 | 9.77e-01 |
| GOBP ODONTOGENESIS | 126 | 6.65e-01 | -2.23e-02 | 9.67e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 34 | 8.22e-01 | 2.23e-02 | 9.88e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 185 | 6.00e-01 | -2.23e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 33 | 8.24e-01 | -2.23e-02 | 9.88e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 20 | 8.63e-01 | 2.23e-02 | 9.93e-01 |
| GOBP REGULATION OF FEMALE GONAD DEVELOPMENT | 7 | 9.19e-01 | -2.23e-02 | 9.97e-01 |
| GOCC NEURON PROJECTION | 1246 | 1.86e-01 | -2.23e-02 | 8.44e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 47 | 7.91e-01 | -2.23e-02 | 9.84e-01 |
| GOBP RESPONSE TO VIRUS | 419 | 4.34e-01 | 2.23e-02 | 9.27e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 38 | 8.12e-01 | -2.23e-02 | 9.87e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 302 | 5.06e-01 | 2.22e-02 | 9.45e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 132 | 6.59e-01 | 2.22e-02 | 9.66e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 42 | 8.03e-01 | -2.22e-02 | 9.85e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 129 | 6.63e-01 | 2.22e-02 | 9.67e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 541 | 3.77e-01 | 2.22e-02 | 9.09e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 9.25e-01 | -2.22e-02 | 9.98e-01 |
| GOMF PHOSPHATASE BINDING | 184 | 6.03e-01 | -2.22e-02 | 9.55e-01 |
| GOBP GENITALIA MORPHOGENESIS | 11 | 8.99e-01 | 2.22e-02 | 9.94e-01 |
| GOMF GTPASE BINDING | 297 | 5.10e-01 | -2.22e-02 | 9.46e-01 |
| GOMF CYCLASE INHIBITOR ACTIVITY | 5 | 9.31e-01 | 2.22e-02 | 9.98e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 15 | 8.82e-01 | 2.22e-02 | 9.93e-01 |
| GOBP REGULATION OF BINDING | 253 | 5.43e-01 | 2.22e-02 | 9.49e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 233 | 5.60e-01 | -2.22e-02 | 9.49e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 9.25e-01 | 2.22e-02 | 9.98e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 29 | 8.36e-01 | -2.22e-02 | 9.89e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 8.51e-01 | -2.22e-02 | 9.91e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 11 | 8.99e-01 | 2.21e-02 | 9.94e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 15 | 8.82e-01 | 2.21e-02 | 9.93e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 9.14e-01 | 2.21e-02 | 9.96e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 53 | 7.81e-01 | -2.21e-02 | 9.83e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 225 | 5.68e-01 | -2.21e-02 | 9.51e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 181 | 6.08e-01 | 2.21e-02 | 9.56e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 93 | 7.13e-01 | 2.20e-02 | 9.72e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 9.04e-01 | 2.20e-02 | 9.96e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 70 | 7.50e-01 | -2.20e-02 | 9.80e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 47 | 7.94e-01 | -2.20e-02 | 9.84e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 83 | 7.29e-01 | -2.20e-02 | 9.75e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 220 | 5.74e-01 | 2.20e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 25 | 8.49e-01 | 2.20e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 166 | 6.25e-01 | -2.20e-02 | 9.61e-01 |
| GOBP INSULIN METABOLIC PROCESS | 16 | 8.79e-01 | 2.20e-02 | 9.93e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 363 | 4.72e-01 | 2.20e-02 | 9.39e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT | 5 | 9.32e-01 | -2.19e-02 | 9.98e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 1422 | 1.66e-01 | -2.19e-02 | 8.27e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 35 | 8.23e-01 | -2.19e-02 | 9.88e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 9 | 9.09e-01 | 2.19e-02 | 9.96e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 41 | 8.09e-01 | 2.19e-02 | 9.87e-01 |
| GOBP PEROXISOME ORGANIZATION | 34 | 8.26e-01 | 2.18e-02 | 9.88e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 21 | 8.63e-01 | -2.18e-02 | 9.93e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 243 | 5.58e-01 | -2.18e-02 | 9.49e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 392 | 4.59e-01 | 2.18e-02 | 9.37e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 47 | 7.96e-01 | -2.18e-02 | 9.84e-01 |
| GOBP MYOBLAST FUSION | 47 | 7.96e-01 | -2.18e-02 | 9.84e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 16 | 8.80e-01 | 2.18e-02 | 9.93e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 54 | 7.82e-01 | -2.18e-02 | 9.83e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 92 | 7.19e-01 | -2.17e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 9 | 9.10e-01 | 2.17e-02 | 9.96e-01 |
| GOBP MITOTIC DNA REPLICATION | 15 | 8.84e-01 | 2.17e-02 | 9.93e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 9.05e-01 | -2.17e-02 | 9.96e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 208 | 5.90e-01 | -2.17e-02 | 9.54e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 15 | 8.84e-01 | 2.17e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 155 | 6.41e-01 | -2.17e-02 | 9.62e-01 |
| GOBP MYOBLAST FATE COMMITMENT | 6 | 9.27e-01 | -2.17e-02 | 9.98e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 51 | 7.89e-01 | 2.16e-02 | 9.84e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 170 | 6.26e-01 | 2.16e-02 | 9.61e-01 |
| GOBP MRNA 3 END PROCESSING | 49 | 7.93e-01 | 2.16e-02 | 9.84e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 103 | 7.05e-01 | -2.16e-02 | 9.71e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 56 | 7.80e-01 | 2.16e-02 | 9.83e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 38 | 8.18e-01 | 2.16e-02 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 329 | 5.01e-01 | -2.16e-02 | 9.45e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 20 | 8.67e-01 | -2.16e-02 | 9.93e-01 |
| GOBP NUCLEAR TRANSPORT | 312 | 5.12e-01 | 2.16e-02 | 9.46e-01 |
| GOBP LEARNING | 145 | 6.54e-01 | -2.16e-02 | 9.64e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 96 | 7.15e-01 | 2.16e-02 | 9.72e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 158 | 6.40e-01 | 2.16e-02 | 9.62e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE | 5 | 9.34e-01 | -2.15e-02 | 9.98e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 19 | 8.71e-01 | 2.15e-02 | 9.93e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 32 | 8.33e-01 | 2.15e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 91 | 7.23e-01 | 2.15e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 20 | 8.68e-01 | -2.15e-02 | 9.93e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 74 | 7.49e-01 | 2.15e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 630 | 3.58e-01 | -2.14e-02 | 9.03e-01 |
| GOMF FK506 BINDING | 10 | 9.07e-01 | -2.14e-02 | 9.96e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 68 | 7.60e-01 | -2.14e-02 | 9.82e-01 |
| GOCC MYOFILAMENT | 26 | 8.50e-01 | -2.14e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 27 | 8.48e-01 | -2.14e-02 | 9.91e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 14 | 8.90e-01 | -2.13e-02 | 9.93e-01 |
| GOBP SEXUAL REPRODUCTION | 985 | 2.58e-01 | 2.13e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 22 | 8.63e-01 | 2.13e-02 | 9.93e-01 |
| GOBP FACE DEVELOPMENT | 49 | 7.97e-01 | 2.12e-02 | 9.84e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 21 | 8.66e-01 | -2.12e-02 | 9.93e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 85 | 7.35e-01 | 2.12e-02 | 9.77e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 67 | 7.64e-01 | 2.12e-02 | 9.82e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 700 | 3.38e-01 | -2.12e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 102 | 7.11e-01 | -2.12e-02 | 9.71e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 73 | 7.54e-01 | 2.12e-02 | 9.81e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 682 | 3.45e-01 | 2.12e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 86 | 7.34e-01 | -2.12e-02 | 9.77e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 11 | 9.03e-01 | -2.12e-02 | 9.96e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 292 | 5.34e-01 | 2.12e-02 | 9.49e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 8.91e-01 | -2.12e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 8.95e-01 | -2.11e-02 | 9.93e-01 |
| GOBP T CELL HOMEOSTASIS | 44 | 8.08e-01 | 2.11e-02 | 9.87e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 67 | 7.65e-01 | -2.11e-02 | 9.82e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 57 | 7.83e-01 | -2.11e-02 | 9.84e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 194 | 6.13e-01 | 2.11e-02 | 9.59e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 149 | 6.57e-01 | 2.11e-02 | 9.66e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 9.08e-01 | -2.10e-02 | 9.96e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 11 | 9.04e-01 | 2.10e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 461 | 4.40e-01 | -2.10e-02 | 9.29e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 27 | 8.50e-01 | 2.10e-02 | 9.91e-01 |
| GOBP CELL CELL SIGNALING | 1625 | 1.59e-01 | -2.10e-02 | 8.19e-01 |
| GOBP NERVE DEVELOPMENT | 94 | 7.25e-01 | 2.10e-02 | 9.75e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 14 | 8.92e-01 | -2.10e-02 | 9.93e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 21 | 8.68e-01 | -2.10e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 1065 | 2.48e-01 | -2.10e-02 | 8.65e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 84 | 7.40e-01 | -2.09e-02 | 9.77e-01 |
| GOCC AXON CYTOPLASM | 60 | 7.79e-01 | 2.09e-02 | 9.83e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 1143 | 2.33e-01 | 2.09e-02 | 8.63e-01 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 9.35e-01 | 2.09e-02 | 9.98e-01 |
| GOBP TRNA TRANSPORT | 6 | 9.29e-01 | 2.09e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 229 | 5.87e-01 | -2.09e-02 | 9.54e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 132 | 6.79e-01 | 2.09e-02 | 9.68e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 136 | 6.75e-01 | 2.09e-02 | 9.68e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 8.85e-01 | 2.08e-02 | 9.93e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 14 | 8.93e-01 | -2.08e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 34 | 8.33e-01 | -2.08e-02 | 9.88e-01 |
| GOBP MALE GAMETE GENERATION | 568 | 3.97e-01 | -2.08e-02 | 9.18e-01 |
| GOBP STEROL TRANSPORT | 141 | 6.70e-01 | -2.08e-02 | 9.67e-01 |
| GOBP MOLTING CYCLE | 112 | 7.04e-01 | -2.08e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 8 | 9.19e-01 | -2.08e-02 | 9.97e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 99 | 7.22e-01 | 2.07e-02 | 9.73e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 6 | 9.30e-01 | 2.07e-02 | 9.98e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 21 | 8.70e-01 | 2.07e-02 | 9.93e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 246 | 5.76e-01 | 2.07e-02 | 9.51e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 70 | 7.65e-01 | 2.07e-02 | 9.82e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 31 | 8.42e-01 | 2.07e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 158 | 6.54e-01 | -2.07e-02 | 9.64e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 79 | 7.51e-01 | -2.07e-02 | 9.80e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 19 | 8.76e-01 | 2.06e-02 | 9.93e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 43 | 8.15e-01 | 2.06e-02 | 9.87e-01 |
| GOBP CD40 SIGNALING PATHWAY | 15 | 8.90e-01 | -2.06e-02 | 9.93e-01 |
| GOBP PROTEIN METHYLATION | 75 | 7.58e-01 | 2.06e-02 | 9.82e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 47 | 8.07e-01 | 2.05e-02 | 9.87e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 8 | 9.20e-01 | -2.05e-02 | 9.98e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 38 | 8.27e-01 | 2.05e-02 | 9.88e-01 |
| GOBP RECEPTOR RECYCLING | 46 | 8.10e-01 | -2.05e-02 | 9.87e-01 |
| GOCC GOLGI MEMBRANE | 640 | 3.77e-01 | -2.05e-02 | 9.09e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 11 | 9.07e-01 | -2.04e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 51 | 8.01e-01 | -2.04e-02 | 9.85e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 34 | 8.37e-01 | -2.04e-02 | 9.89e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 9.25e-01 | 2.04e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 283 | 5.55e-01 | -2.04e-02 | 9.49e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 15 | 8.91e-01 | 2.04e-02 | 9.93e-01 |
| GOCC GOLGI STACK | 128 | 6.91e-01 | -2.04e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 139 | 6.79e-01 | -2.04e-02 | 9.68e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 20 | 8.75e-01 | 2.03e-02 | 9.93e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 16 | 8.88e-01 | 2.03e-02 | 9.93e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 146 | 6.72e-01 | -2.03e-02 | 9.68e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 21 | 8.72e-01 | -2.03e-02 | 9.93e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 73 | 7.65e-01 | 2.02e-02 | 9.82e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 132 | 6.89e-01 | -2.02e-02 | 9.69e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 21 | 8.73e-01 | -2.02e-02 | 9.93e-01 |
| GOBP GASTRIC ACID SECRETION | 13 | 9.00e-01 | 2.02e-02 | 9.95e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 8 | 9.21e-01 | -2.02e-02 | 9.98e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 9.12e-01 | 2.01e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 16 | 8.89e-01 | 2.01e-02 | 9.93e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 77 | 7.60e-01 | 2.01e-02 | 9.82e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 8.59e-01 | 2.01e-02 | 9.92e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 945 | 2.96e-01 | -2.00e-02 | 8.82e-01 |
| GOMF SH3 DOMAIN BINDING | 114 | 7.12e-01 | -2.00e-02 | 9.71e-01 |
| GOBP RNA PROCESSING | 1248 | 2.34e-01 | 2.00e-02 | 8.64e-01 |
| GOCC ENVELOPE | 1183 | 2.46e-01 | 2.00e-02 | 8.65e-01 |
| GOBP LACRIMAL GLAND DEVELOPMENT | 7 | 9.27e-01 | 2.00e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 16 | 8.90e-01 | -2.00e-02 | 9.93e-01 |
| GOBP RESPONSE TO HORMONE | 838 | 3.25e-01 | -2.00e-02 | 8.93e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 31 | 8.47e-01 | 2.00e-02 | 9.90e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 64 | 7.82e-01 | -2.00e-02 | 9.83e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 13 | 9.01e-01 | -2.00e-02 | 9.95e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 18 | 8.83e-01 | -2.00e-02 | 9.93e-01 |
| GOBP REGULATION OF EXCRETION | 11 | 9.09e-01 | -2.00e-02 | 9.96e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 487 | 4.51e-01 | -2.00e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 61 | 7.88e-01 | -1.99e-02 | 9.84e-01 |
| GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION | 8 | 9.22e-01 | 1.99e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 267 | 5.75e-01 | -1.99e-02 | 9.51e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 90 | 7.44e-01 | 1.99e-02 | 9.78e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 27 | 8.58e-01 | 1.99e-02 | 9.92e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 22 | 8.72e-01 | -1.99e-02 | 9.93e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 177 | 6.48e-01 | -1.99e-02 | 9.63e-01 |
| GOBP POLYOL METABOLIC PROCESS | 103 | 7.27e-01 | 1.99e-02 | 9.75e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 23 | 8.69e-01 | 1.99e-02 | 9.93e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 1011 | 2.85e-01 | 1.99e-02 | 8.75e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 35 | 8.39e-01 | 1.99e-02 | 9.89e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1694 | 1.74e-01 | -1.99e-02 | 8.37e-01 |
| GOMF G PROTEIN ACTIVITY | 42 | 8.24e-01 | 1.98e-02 | 9.88e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 7 | 9.28e-01 | -1.98e-02 | 9.98e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 64 | 7.84e-01 | 1.98e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 7.89e-01 | 1.98e-02 | 9.84e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 133 | 6.94e-01 | 1.98e-02 | 9.69e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 9 | 9.18e-01 | 1.98e-02 | 9.97e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 9.10e-01 | -1.98e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 18 | 8.85e-01 | -1.98e-02 | 9.93e-01 |
| GOCC SARCOLEMMA | 136 | 6.91e-01 | -1.98e-02 | 9.69e-01 |
| GOBP CELL MORPHOGENESIS | 911 | 3.12e-01 | -1.98e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 17 | 8.88e-01 | 1.98e-02 | 9.93e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 110 | 7.20e-01 | 1.97e-02 | 9.73e-01 |
| GOBP REPRODUCTION | 1408 | 2.15e-01 | 1.97e-02 | 8.56e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 109 | 7.22e-01 | 1.97e-02 | 9.74e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 278 | 5.73e-01 | -1.96e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 9.28e-01 | -1.96e-02 | 9.98e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 387 | 5.07e-01 | 1.96e-02 | 9.46e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 26 | 8.63e-01 | -1.96e-02 | 9.93e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 28 | 8.58e-01 | -1.96e-02 | 9.92e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 148 | 6.81e-01 | -1.96e-02 | 9.68e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 104 | 7.31e-01 | -1.95e-02 | 9.76e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 18 | 8.86e-01 | -1.95e-02 | 9.93e-01 |
| GOBP ENDODERM DEVELOPMENT | 81 | 7.62e-01 | -1.95e-02 | 9.82e-01 |
| GOBP ERYTHROCYTE MATURATION | 17 | 8.89e-01 | 1.95e-02 | 9.93e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 44 | 8.23e-01 | -1.94e-02 | 9.88e-01 |
| GOCC EARLY ENDOSOME | 412 | 4.99e-01 | -1.94e-02 | 9.45e-01 |
| GOMF MICROTUBULE BINDING | 261 | 5.89e-01 | 1.94e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 9.29e-01 | -1.94e-02 | 9.98e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 8 | 9.24e-01 | -1.94e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 203 | 6.34e-01 | 1.94e-02 | 9.61e-01 |
| GOBP REGULATION OF CELL GROWTH | 397 | 5.08e-01 | -1.94e-02 | 9.46e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 18 | 8.87e-01 | 1.94e-02 | 9.93e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 25 | 8.67e-01 | -1.94e-02 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 318 | 5.53e-01 | -1.93e-02 | 9.49e-01 |
| GOBP FAT CELL PROLIFERATION | 14 | 9.00e-01 | -1.93e-02 | 9.95e-01 |
| GOBP ORGANIC ANION TRANSPORT | 428 | 4.93e-01 | -1.93e-02 | 9.45e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 16 | 8.94e-01 | 1.93e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 41 | 8.31e-01 | -1.93e-02 | 9.88e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 81 | 7.65e-01 | 1.93e-02 | 9.82e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 18 | 8.88e-01 | 1.92e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 19 | 8.85e-01 | -1.92e-02 | 9.93e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 58 | 8.00e-01 | 1.92e-02 | 9.85e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 412 | 5.03e-01 | -1.92e-02 | 9.45e-01 |
| GOCC MITOCHONDRION | 1569 | 2.04e-01 | 1.92e-02 | 8.51e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 8.98e-01 | 1.92e-02 | 9.94e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 163 | 6.72e-01 | 1.92e-02 | 9.68e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 959 | 3.14e-01 | -1.92e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 7 | 9.30e-01 | 1.91e-02 | 9.98e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 37 | 8.40e-01 | -1.91e-02 | 9.89e-01 |
| GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT | 5 | 9.41e-01 | 1.91e-02 | 9.98e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 26 | 8.66e-01 | -1.91e-02 | 9.93e-01 |
| GOBP GASTRULATION | 188 | 6.52e-01 | -1.91e-02 | 9.64e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 77 | 7.73e-01 | -1.90e-02 | 9.82e-01 |
| GOCC COATED VESICLE | 296 | 5.73e-01 | 1.90e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 18 | 8.89e-01 | -1.90e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 24 | 8.72e-01 | -1.90e-02 | 9.93e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 20 | 8.83e-01 | 1.90e-02 | 9.93e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY | 5 | 9.41e-01 | -1.90e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 669 | 4.03e-01 | -1.90e-02 | 9.20e-01 |
| GOCC MALE PRONUCLEUS | 8 | 9.26e-01 | 1.90e-02 | 9.98e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 117 | 7.23e-01 | 1.89e-02 | 9.74e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 8 | 9.26e-01 | -1.89e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 30 | 8.58e-01 | -1.89e-02 | 9.92e-01 |
| GOMF GLUTATHIONE BINDING | 10 | 9.18e-01 | 1.89e-02 | 9.97e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 180 | 6.62e-01 | 1.89e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 38 | 8.40e-01 | 1.89e-02 | 9.89e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 139 | 7.01e-01 | 1.89e-02 | 9.70e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 72 | 7.82e-01 | -1.89e-02 | 9.83e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 59 | 8.02e-01 | -1.89e-02 | 9.85e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 75 | 7.78e-01 | 1.89e-02 | 9.83e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 32 | 8.53e-01 | 1.89e-02 | 9.91e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 17 | 8.93e-01 | -1.88e-02 | 9.93e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 9.36e-01 | -1.88e-02 | 9.98e-01 |
| GOCC LATE ENDOSOME | 296 | 5.78e-01 | -1.88e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 190 | 6.55e-01 | 1.88e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 772 | 3.75e-01 | 1.88e-02 | 9.09e-01 |
| GOBP VACUOLE ORGANIZATION | 219 | 6.32e-01 | 1.88e-02 | 9.61e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 44 | 8.30e-01 | -1.88e-02 | 9.88e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 216 | 6.35e-01 | -1.87e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 61 | 8.00e-01 | 1.87e-02 | 9.85e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 183 | 6.62e-01 | -1.87e-02 | 9.66e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 72 | 7.84e-01 | 1.87e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 6 | 9.37e-01 | 1.87e-02 | 9.98e-01 |
| GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION | 13 | 9.07e-01 | 1.87e-02 | 9.96e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 60 | 8.02e-01 | 1.87e-02 | 9.85e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 139 | 7.04e-01 | -1.87e-02 | 9.71e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 45 | 8.29e-01 | 1.87e-02 | 9.88e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 127 | 7.17e-01 | -1.86e-02 | 9.72e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 9.32e-01 | 1.86e-02 | 9.98e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 914 | 3.41e-01 | 1.86e-02 | 8.96e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 24 | 8.75e-01 | 1.86e-02 | 9.93e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 9.43e-01 | -1.86e-02 | 9.98e-01 |
| GOCC MYOSIN II COMPLEX | 26 | 8.70e-01 | -1.85e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 18 | 8.92e-01 | 1.85e-02 | 9.93e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 18 | 8.92e-01 | -1.85e-02 | 9.93e-01 |
| GOBP REGULATION OF T CELL COSTIMULATION | 5 | 9.43e-01 | -1.85e-02 | 9.98e-01 |
| GOBP REPLICATIVE SENESCENCE | 17 | 8.95e-01 | -1.85e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 5 | 9.43e-01 | 1.85e-02 | 9.98e-01 |
| GOBP HISTAMINE SECRETION | 12 | 9.12e-01 | 1.85e-02 | 9.96e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 33 | 8.54e-01 | -1.85e-02 | 9.91e-01 |
| GOCC FILOPODIUM TIP | 18 | 8.92e-01 | -1.85e-02 | 9.93e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 9 | 9.24e-01 | -1.85e-02 | 9.98e-01 |
| GOBP RESPONSE TO STARVATION | 208 | 6.46e-01 | -1.85e-02 | 9.63e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 561 | 4.55e-01 | 1.85e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 70 | 7.89e-01 | -1.85e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 8 | 9.28e-01 | -1.84e-02 | 9.98e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 66 | 7.96e-01 | -1.84e-02 | 9.84e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 200 | 6.54e-01 | -1.84e-02 | 9.64e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 22 | 8.81e-01 | -1.84e-02 | 9.93e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 290 | 5.90e-01 | 1.84e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 19 | 8.90e-01 | 1.84e-02 | 9.93e-01 |
| GOBP RESPONSE TO DOPAMINE | 70 | 7.91e-01 | 1.84e-02 | 9.84e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 168 | 6.81e-01 | 1.84e-02 | 9.68e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 141 | 7.07e-01 | 1.83e-02 | 9.71e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 53 | 8.17e-01 | -1.83e-02 | 9.87e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 9.38e-01 | 1.83e-02 | 9.98e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 10 | 9.20e-01 | 1.83e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 9 | 9.24e-01 | 1.83e-02 | 9.98e-01 |
| GOBP NEUROMUSCULAR PROCESS | 159 | 6.91e-01 | 1.83e-02 | 9.69e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 310 | 5.80e-01 | 1.83e-02 | 9.53e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 8 | 9.29e-01 | -1.83e-02 | 9.98e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 6 | 9.38e-01 | -1.83e-02 | 9.98e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 38 | 8.46e-01 | 1.82e-02 | 9.90e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 9.21e-01 | 1.82e-02 | 9.98e-01 |
| GOBP NUCLEAR EXPORT | 156 | 6.95e-01 | 1.82e-02 | 9.69e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 12 | 9.13e-01 | 1.82e-02 | 9.96e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 83 | 7.74e-01 | -1.82e-02 | 9.82e-01 |
| GOBP REGULATION OF GROWTH | 585 | 4.52e-01 | -1.82e-02 | 9.35e-01 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 17 | 8.97e-01 | 1.82e-02 | 9.94e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 9.39e-01 | -1.82e-02 | 9.98e-01 |
| GOMF 7S RNA BINDING | 7 | 9.34e-01 | -1.81e-02 | 9.98e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 96 | 7.59e-01 | -1.81e-02 | 9.82e-01 |
| GOBP OVULATION CYCLE PROCESS | 50 | 8.25e-01 | -1.81e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 7 | 9.34e-01 | 1.81e-02 | 9.98e-01 |
| GOCC CILIARY PLASM | 158 | 6.95e-01 | -1.81e-02 | 9.69e-01 |
| GOCC GABA ERGIC SYNAPSE | 73 | 7.90e-01 | 1.81e-02 | 9.84e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 165 | 6.90e-01 | -1.80e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 9.45e-01 | -1.80e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 222 | 6.45e-01 | -1.80e-02 | 9.63e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 46 | 8.34e-01 | 1.79e-02 | 9.88e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 138 | 7.16e-01 | -1.79e-02 | 9.72e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 460 | 5.11e-01 | -1.79e-02 | 9.46e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 17 | 8.99e-01 | -1.79e-02 | 9.94e-01 |
| GOBP CHOLESTEROL STORAGE | 25 | 8.77e-01 | -1.78e-02 | 9.93e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 79 | 7.84e-01 | -1.78e-02 | 9.84e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 349 | 5.67e-01 | -1.78e-02 | 9.50e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 49 | 8.29e-01 | 1.78e-02 | 9.88e-01 |
| GOBP UV PROTECTION | 12 | 9.15e-01 | -1.78e-02 | 9.97e-01 |
| GOBP AMIDE METABOLIC PROCESS | 1219 | 2.96e-01 | -1.78e-02 | 8.82e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 10 | 9.22e-01 | -1.78e-02 | 9.98e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 42 | 8.42e-01 | -1.78e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 22 | 8.85e-01 | -1.78e-02 | 9.93e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 199 | 6.66e-01 | -1.78e-02 | 9.67e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1507 | 2.49e-01 | 1.78e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 9.31e-01 | 1.77e-02 | 9.98e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 9 | 9.27e-01 | 1.77e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 126 | 7.32e-01 | -1.77e-02 | 9.76e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 26 | 8.76e-01 | -1.77e-02 | 9.93e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 67 | 8.02e-01 | -1.77e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 31 | 8.65e-01 | 1.77e-02 | 9.93e-01 |
| GOBP NEURON MIGRATION | 166 | 6.94e-01 | -1.77e-02 | 9.69e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 43 | 8.41e-01 | 1.77e-02 | 9.89e-01 |
| GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION | 8 | 9.31e-01 | 1.77e-02 | 9.98e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 155 | 7.04e-01 | 1.77e-02 | 9.71e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 265 | 6.21e-01 | 1.77e-02 | 9.61e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 121 | 7.38e-01 | 1.76e-02 | 9.77e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 9 | 9.27e-01 | -1.76e-02 | 9.98e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 69 | 8.01e-01 | -1.76e-02 | 9.85e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 85 | 7.79e-01 | -1.76e-02 | 9.83e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 8.89e-01 | 1.75e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 6 | 9.41e-01 | -1.75e-02 | 9.98e-01 |
| GOCC AXONEMAL MICROTUBULE | 38 | 8.52e-01 | 1.75e-02 | 9.91e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 91 | 7.73e-01 | -1.75e-02 | 9.82e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 7 | 9.36e-01 | 1.75e-02 | 9.98e-01 |
| GOBP MATURATION OF 5 8S RRNA | 35 | 8.58e-01 | 1.75e-02 | 9.92e-01 |
| GOMF HAPTOGLOBIN BINDING | 10 | 9.24e-01 | -1.75e-02 | 9.98e-01 |
| GOBP SECRETION | 923 | 3.68e-01 | -1.75e-02 | 9.08e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 82 | 7.85e-01 | 1.75e-02 | 9.84e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 16 | 9.04e-01 | -1.75e-02 | 9.96e-01 |
| GOMF BILE ACID BINDING | 10 | 9.24e-01 | -1.74e-02 | 9.98e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 8.64e-01 | 1.74e-02 | 9.93e-01 |
| GOBP SECRETION BY TISSUE | 44 | 8.41e-01 | -1.74e-02 | 9.89e-01 |
| GOCC NADPH OXIDASE COMPLEX | 13 | 9.13e-01 | 1.74e-02 | 9.96e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 24 | 8.83e-01 | -1.74e-02 | 9.93e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 542 | 4.88e-01 | -1.74e-02 | 9.43e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 658 | 4.46e-01 | -1.74e-02 | 9.31e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 26 | 8.78e-01 | -1.74e-02 | 9.93e-01 |
| GOBP ORGANELLE ASSEMBLY | 957 | 3.63e-01 | 1.74e-02 | 9.06e-01 |
| GOBP CARTILAGE DEVELOPMENT | 199 | 6.73e-01 | -1.73e-02 | 9.68e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 15 | 9.07e-01 | -1.73e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 9 | 9.28e-01 | -1.73e-02 | 9.98e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 715 | 4.30e-01 | 1.73e-02 | 9.27e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 7 | 9.37e-01 | 1.73e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 114 | 7.49e-01 | 1.73e-02 | 9.80e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 9 | 9.28e-01 | -1.73e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 398 | 5.54e-01 | -1.73e-02 | 9.49e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 54 | 8.26e-01 | -1.73e-02 | 9.88e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 54 | 8.26e-01 | -1.73e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 9.11e-01 | 1.73e-02 | 9.96e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 9.21e-01 | -1.72e-02 | 9.98e-01 |
| GOBP SLEEP | 22 | 8.89e-01 | -1.72e-02 | 9.93e-01 |
| GOBP RIBOFLAVIN METABOLIC PROCESS | 5 | 9.47e-01 | 1.72e-02 | 9.99e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 342 | 5.85e-01 | 1.72e-02 | 9.54e-01 |
| GOBP VIRAL PROCESS | 412 | 5.49e-01 | -1.72e-02 | 9.49e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 60 | 8.18e-01 | 1.72e-02 | 9.87e-01 |
| GOCC MOTILE CILIUM | 248 | 6.42e-01 | -1.71e-02 | 9.63e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 459 | 5.29e-01 | -1.71e-02 | 9.48e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 49 | 8.36e-01 | -1.71e-02 | 9.89e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 597 | 4.75e-01 | -1.71e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 10 | 9.25e-01 | 1.71e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 24 | 8.85e-01 | 1.71e-02 | 9.93e-01 |
| GOBP OLFACTORY BEHAVIOR | 10 | 9.25e-01 | 1.71e-02 | 9.98e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 9.38e-01 | 1.71e-02 | 9.98e-01 |
| GOMF CHITIN BINDING | 8 | 9.33e-01 | 1.71e-02 | 9.98e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.29e-01 | -1.71e-02 | 9.98e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 9 | 9.29e-01 | -1.71e-02 | 9.98e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 123 | 7.43e-01 | -1.71e-02 | 9.77e-01 |
| GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS | 11 | 9.22e-01 | 1.71e-02 | 9.98e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 80 | 7.92e-01 | -1.71e-02 | 9.84e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 12 | 9.18e-01 | -1.71e-02 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 66 | 8.10e-01 | -1.71e-02 | 9.87e-01 |
| GOMF DIOXYGENASE ACTIVITY | 86 | 7.84e-01 | 1.71e-02 | 9.84e-01 |
| GOCC CAVEOLA | 81 | 7.91e-01 | -1.71e-02 | 9.84e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH | 6 | 9.42e-01 | 1.70e-02 | 9.98e-01 |
| GOBP DNA REPLICATION INITIATION | 35 | 8.62e-01 | -1.70e-02 | 9.93e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 338 | 5.91e-01 | -1.70e-02 | 9.54e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 45 | 8.44e-01 | -1.70e-02 | 9.89e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 9.26e-01 | -1.70e-02 | 9.98e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 12 | 9.19e-01 | 1.70e-02 | 9.97e-01 |
| GOCC MEDIATOR COMPLEX | 34 | 8.64e-01 | 1.70e-02 | 9.93e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 9.12e-01 | 1.70e-02 | 9.96e-01 |
| GOBP RESPONSE TO KETONE | 197 | 6.82e-01 | -1.70e-02 | 9.68e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 508 | 5.13e-01 | 1.69e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 5 | 9.48e-01 | -1.69e-02 | 9.99e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 540 | 5.02e-01 | 1.69e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 14 | 9.13e-01 | -1.69e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 46 | 8.43e-01 | 1.69e-02 | 9.89e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 28 | 8.77e-01 | -1.69e-02 | 9.93e-01 |
| GOBP MITOCHONDRIAL FISSION | 40 | 8.54e-01 | -1.68e-02 | 9.91e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 102 | 7.69e-01 | -1.68e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 304 | 6.14e-01 | 1.68e-02 | 9.59e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 102 | 7.70e-01 | 1.67e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 12 | 9.20e-01 | -1.67e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 96 | 7.77e-01 | -1.67e-02 | 9.83e-01 |
| GOBP SMOOTH MUSCLE ADAPTATION | 5 | 9.48e-01 | 1.67e-02 | 9.99e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 23 | 8.90e-01 | -1.67e-02 | 9.93e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 687 | 4.56e-01 | 1.67e-02 | 9.36e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 9.31e-01 | -1.67e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 123 | 7.50e-01 | 1.66e-02 | 9.80e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 20 | 8.97e-01 | 1.66e-02 | 9.94e-01 |
| GOBP COGNITION | 303 | 6.18e-01 | -1.66e-02 | 9.61e-01 |
| GOCC NUCLEAR ENVELOPE | 464 | 5.39e-01 | 1.66e-02 | 9.49e-01 |
| GOCC ENDOSOME LUMEN | 37 | 8.61e-01 | -1.66e-02 | 9.93e-01 |
| GOBP GABAERGIC NEURON DIFFERENTIATION | 19 | 9.00e-01 | 1.66e-02 | 9.95e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 325 | 6.07e-01 | 1.66e-02 | 9.56e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 8 | 9.35e-01 | 1.66e-02 | 9.98e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 282 | 6.32e-01 | -1.66e-02 | 9.61e-01 |
| GOBP BONE GROWTH | 32 | 8.71e-01 | -1.66e-02 | 9.93e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 24 | 8.88e-01 | -1.66e-02 | 9.93e-01 |
| GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION | 7 | 9.40e-01 | 1.65e-02 | 9.98e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 15 | 9.12e-01 | 1.65e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 9.49e-01 | -1.65e-02 | 9.99e-01 |
| GOBP HYPERSENSITIVITY | 10 | 9.28e-01 | 1.65e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 9.49e-01 | 1.65e-02 | 9.99e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 262 | 6.46e-01 | -1.65e-02 | 9.63e-01 |
| GOBP DENDRITE EXTENSION | 34 | 8.68e-01 | -1.65e-02 | 9.93e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 17 | 9.06e-01 | -1.65e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 28 | 8.80e-01 | -1.64e-02 | 9.93e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 70 | 8.12e-01 | -1.64e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 122 | 7.54e-01 | -1.64e-02 | 9.81e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 199 | 6.89e-01 | -1.64e-02 | 9.69e-01 |
| GOBP GENITALIA DEVELOPMENT | 46 | 8.47e-01 | -1.64e-02 | 9.90e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 23 | 8.92e-01 | 1.64e-02 | 9.93e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 9.45e-01 | 1.64e-02 | 9.98e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 9.45e-01 | 1.64e-02 | 9.98e-01 |
| GOBP AXON DEVELOPMENT | 480 | 5.39e-01 | 1.64e-02 | 9.49e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 91 | 7.87e-01 | -1.64e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 36 | 8.65e-01 | 1.63e-02 | 9.93e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 12 | 9.22e-01 | 1.63e-02 | 9.98e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 9.22e-01 | -1.63e-02 | 9.98e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 17 | 9.07e-01 | -1.63e-02 | 9.96e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 9.13e-01 | -1.63e-02 | 9.96e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1566 | 2.83e-01 | 1.63e-02 | 8.74e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 17 | 9.08e-01 | -1.62e-02 | 9.96e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 27 | 8.84e-01 | 1.62e-02 | 9.93e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 74 | 8.09e-01 | -1.62e-02 | 9.87e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 30 | 8.78e-01 | -1.62e-02 | 9.93e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 13 | 9.19e-01 | -1.62e-02 | 9.98e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 10 | 9.29e-01 | 1.62e-02 | 9.98e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 1004 | 3.86e-01 | -1.62e-02 | 9.14e-01 |
| GOCC APICAL DENDRITE | 15 | 9.14e-01 | 1.62e-02 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 16 | 9.11e-01 | -1.61e-02 | 9.96e-01 |
| GOMF AMIDE BINDING | 381 | 5.89e-01 | -1.61e-02 | 9.54e-01 |
| GOCC CILIUM | 704 | 4.66e-01 | -1.61e-02 | 9.38e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 223 | 6.78e-01 | 1.61e-02 | 9.68e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 90 | 7.92e-01 | -1.61e-02 | 9.84e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1345 | 3.22e-01 | -1.61e-02 | 8.92e-01 |
| GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS | 11 | 9.26e-01 | -1.61e-02 | 9.98e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 24 | 8.92e-01 | -1.61e-02 | 9.93e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 101 | 7.80e-01 | 1.60e-02 | 9.83e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 8 | 9.37e-01 | -1.60e-02 | 9.98e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 9 | 9.34e-01 | 1.60e-02 | 9.98e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 21 | 8.99e-01 | -1.59e-02 | 9.95e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 113 | 7.70e-01 | -1.59e-02 | 9.82e-01 |
| GOBP DEPHOSPHORYLATION | 286 | 6.43e-01 | -1.59e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 1207 | 3.52e-01 | -1.59e-02 | 9.00e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 23 | 8.95e-01 | -1.59e-02 | 9.93e-01 |
| GOBP NODAL SIGNALING PATHWAY | 16 | 9.12e-01 | -1.59e-02 | 9.96e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 66 | 8.24e-01 | -1.59e-02 | 9.88e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 16 | 9.13e-01 | -1.59e-02 | 9.96e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 1175 | 3.60e-01 | -1.58e-02 | 9.04e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 66 | 8.24e-01 | -1.58e-02 | 9.88e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 229 | 6.80e-01 | -1.58e-02 | 9.68e-01 |
| GOBP DORSAL SPINAL CORD DEVELOPMENT | 20 | 9.03e-01 | 1.58e-02 | 9.95e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 9.24e-01 | -1.58e-02 | 9.98e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 216 | 6.89e-01 | -1.58e-02 | 9.69e-01 |
| GOCC PROTEIN KINASE COMPLEX | 135 | 7.52e-01 | -1.58e-02 | 9.80e-01 |
| GOBP MOLTING CYCLE PROCESS | 92 | 7.94e-01 | -1.58e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 8.92e-01 | 1.57e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 17 | 9.11e-01 | -1.57e-02 | 9.96e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 360 | 6.09e-01 | -1.57e-02 | 9.57e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 27 | 8.88e-01 | 1.57e-02 | 9.93e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 28 | 8.86e-01 | -1.57e-02 | 9.93e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 298 | 6.42e-01 | -1.56e-02 | 9.63e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 60 | 8.34e-01 | 1.56e-02 | 9.88e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 68 | 8.24e-01 | 1.56e-02 | 9.88e-01 |
| GOMF SIRNA BINDING | 7 | 9.43e-01 | -1.56e-02 | 9.98e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 318 | 6.33e-01 | 1.56e-02 | 9.61e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 729 | 4.74e-01 | -1.56e-02 | 9.41e-01 |
| GOCC NURD COMPLEX | 15 | 9.17e-01 | 1.56e-02 | 9.97e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 27 | 8.89e-01 | -1.56e-02 | 9.93e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 12 | 9.26e-01 | -1.55e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 59 | 8.37e-01 | -1.55e-02 | 9.89e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 86 | 8.04e-01 | -1.55e-02 | 9.86e-01 |
| GOBP PLACENTA DEVELOPMENT | 146 | 7.47e-01 | 1.55e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 66 | 8.28e-01 | 1.55e-02 | 9.88e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 11 | 9.29e-01 | 1.55e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1720 | 2.86e-01 | -1.55e-02 | 8.75e-01 |
| GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS | 6 | 9.48e-01 | 1.55e-02 | 9.99e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 10 | 9.33e-01 | 1.55e-02 | 9.98e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 170 | 7.28e-01 | -1.55e-02 | 9.75e-01 |
| GOBP CELL AGGREGATION | 23 | 8.98e-01 | -1.54e-02 | 9.94e-01 |
| GOCC INCLUSION BODY | 69 | 8.25e-01 | 1.54e-02 | 9.88e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 21 | 9.03e-01 | -1.54e-02 | 9.95e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 10 | 9.33e-01 | 1.54e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 198 | 7.09e-01 | -1.54e-02 | 9.71e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 117 | 7.74e-01 | -1.54e-02 | 9.82e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 80 | 8.12e-01 | 1.54e-02 | 9.87e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 46 | 8.57e-01 | 1.54e-02 | 9.92e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 42 | 8.63e-01 | -1.53e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 12 | 9.27e-01 | 1.53e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 9.53e-01 | -1.53e-02 | 9.99e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 61 | 8.36e-01 | -1.53e-02 | 9.89e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 33 | 8.79e-01 | -1.53e-02 | 9.93e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 17 | 9.13e-01 | -1.53e-02 | 9.96e-01 |
| GOCC COSTAMERE | 16 | 9.16e-01 | -1.53e-02 | 9.97e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1888 | 2.73e-01 | 1.52e-02 | 8.69e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1758 | 2.89e-01 | -1.52e-02 | 8.78e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 8 | 9.41e-01 | 1.52e-02 | 9.98e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 12 | 9.27e-01 | -1.52e-02 | 9.98e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 57 | 8.43e-01 | -1.52e-02 | 9.89e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 198 | 7.13e-01 | -1.52e-02 | 9.71e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 10 | 9.34e-01 | 1.52e-02 | 9.98e-01 |
| GOMF HORMONE RECEPTOR BINDING | 29 | 8.88e-01 | 1.52e-02 | 9.93e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 206 | 7.08e-01 | -1.51e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 325 | 6.40e-01 | -1.51e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 689 | 5.00e-01 | 1.51e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 6 | 9.49e-01 | -1.51e-02 | 9.99e-01 |
| GOBP LIPID STORAGE | 93 | 8.02e-01 | -1.51e-02 | 9.85e-01 |
| GOBP REGULATION OF JNK CASCADE | 127 | 7.69e-01 | -1.51e-02 | 9.82e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 265 | 6.73e-01 | -1.51e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 18 | 9.12e-01 | -1.50e-02 | 9.96e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 9.34e-01 | 1.50e-02 | 9.98e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 311 | 6.49e-01 | -1.50e-02 | 9.64e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 8 | 9.41e-01 | -1.50e-02 | 9.98e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 13 | 9.25e-01 | 1.50e-02 | 9.98e-01 |
| GOCC CLATHRIN COATED VESICLE | 201 | 7.15e-01 | 1.50e-02 | 9.72e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 14 | 9.23e-01 | -1.50e-02 | 9.98e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 370 | 6.22e-01 | 1.49e-02 | 9.61e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 10 | 9.35e-01 | -1.49e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 21 | 9.06e-01 | -1.49e-02 | 9.96e-01 |
| GOBP RESPONSE TO PEPTIDE | 498 | 5.71e-01 | -1.48e-02 | 9.51e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 86 | 8.12e-01 | 1.48e-02 | 9.87e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 42 | 8.68e-01 | 1.48e-02 | 9.93e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 11 | 9.32e-01 | -1.48e-02 | 9.98e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 159 | 7.48e-01 | 1.48e-02 | 9.79e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 33 | 8.83e-01 | 1.48e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 9.09e-01 | 1.47e-02 | 9.96e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 8 | 9.42e-01 | 1.47e-02 | 9.98e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 240 | 6.94e-01 | -1.47e-02 | 9.69e-01 |
| GOCC CELL LEADING EDGE | 408 | 6.11e-01 | -1.47e-02 | 9.58e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 45 | 8.65e-01 | -1.47e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 141 | 7.63e-01 | -1.47e-02 | 9.82e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 140 | 7.64e-01 | -1.47e-02 | 9.82e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 31 | 8.88e-01 | -1.47e-02 | 9.93e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 63 | 8.41e-01 | -1.46e-02 | 9.89e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 201 | 7.21e-01 | -1.46e-02 | 9.73e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 1026 | 4.29e-01 | -1.46e-02 | 9.27e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 112 | 7.90e-01 | -1.46e-02 | 9.84e-01 |
| GOCC LEADING EDGE MEMBRANE | 174 | 7.41e-01 | -1.45e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 89 | 8.13e-01 | 1.45e-02 | 9.87e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 13 | 9.28e-01 | 1.45e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION | 6 | 9.51e-01 | -1.45e-02 | 9.99e-01 |
| GOBP TENDON DEVELOPMENT | 5 | 9.55e-01 | 1.45e-02 | 9.99e-01 |
| GOBP CRANIAL SUTURE MORPHOGENESIS | 8 | 9.43e-01 | -1.45e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 189 | 7.31e-01 | -1.45e-02 | 9.76e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 92 | 8.10e-01 | -1.45e-02 | 9.87e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 9.40e-01 | -1.44e-02 | 9.98e-01 |
| GOBP BONE CELL DEVELOPMENT | 17 | 9.18e-01 | -1.44e-02 | 9.97e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 9 | 9.41e-01 | -1.44e-02 | 9.98e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 9.34e-01 | 1.44e-02 | 9.98e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 38 | 8.78e-01 | 1.44e-02 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO UV | 87 | 8.17e-01 | -1.43e-02 | 9.87e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 256 | 6.93e-01 | -1.43e-02 | 9.69e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 57 | 8.52e-01 | -1.43e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 7 | 9.48e-01 | 1.43e-02 | 9.99e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 220 | 7.15e-01 | 1.43e-02 | 9.72e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 13 | 9.29e-01 | -1.42e-02 | 9.98e-01 |
| GOBP ENERGY HOMEOSTASIS | 76 | 8.31e-01 | -1.42e-02 | 9.88e-01 |
| GOCC LIPID DROPLET | 93 | 8.13e-01 | -1.42e-02 | 9.87e-01 |
| GOBP PROTEIN TARGETING | 316 | 6.65e-01 | -1.42e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 18 | 9.17e-01 | -1.41e-02 | 9.97e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 40 | 8.77e-01 | 1.41e-02 | 9.93e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 12 | 9.32e-01 | -1.41e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION | 6 | 9.52e-01 | -1.41e-02 | 9.99e-01 |
| GOBP NEURON DEVELOPMENT | 1086 | 4.32e-01 | -1.41e-02 | 9.27e-01 |
| GOCC AXON | 618 | 5.49e-01 | -1.41e-02 | 9.49e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 357 | 6.47e-01 | 1.41e-02 | 9.63e-01 |
| GOMF PHOSPHATE ION BINDING | 11 | 9.36e-01 | -1.41e-02 | 9.98e-01 |
| GOMF L ASCORBIC ACID BINDING | 20 | 9.13e-01 | -1.41e-02 | 9.96e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 13 | 9.30e-01 | 1.41e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 9.11e-01 | -1.40e-02 | 9.96e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 86 | 8.22e-01 | 1.40e-02 | 9.88e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 360 | 6.48e-01 | -1.40e-02 | 9.63e-01 |
| GOBP HIPPO SIGNALING | 42 | 8.75e-01 | -1.40e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 31 | 8.93e-01 | 1.40e-02 | 9.93e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 44 | 8.72e-01 | 1.40e-02 | 9.93e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 8 | 9.45e-01 | 1.40e-02 | 9.99e-01 |
| GOBP RETINOL METABOLIC PROCESS | 50 | 8.64e-01 | -1.40e-02 | 9.93e-01 |
| GOBP RESPONSE TO SALT | 350 | 6.54e-01 | -1.40e-02 | 9.64e-01 |
| GOCC AXONAL GROWTH CONE | 25 | 9.04e-01 | -1.40e-02 | 9.96e-01 |
| GOBP RESPONSE TO STILBENOID | 8 | 9.46e-01 | -1.39e-02 | 9.99e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 9.36e-01 | -1.39e-02 | 9.98e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 9.49e-01 | -1.39e-02 | 9.99e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 9 | 9.42e-01 | 1.39e-02 | 9.98e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 19 | 9.16e-01 | 1.39e-02 | 9.97e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 57 | 8.56e-01 | -1.39e-02 | 9.92e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 309 | 6.75e-01 | -1.39e-02 | 9.68e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 117 | 7.96e-01 | 1.38e-02 | 9.84e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 407 | 6.33e-01 | 1.38e-02 | 9.61e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 21 | 9.13e-01 | 1.38e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 683 | 5.40e-01 | 1.37e-02 | 9.49e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 18 | 9.20e-01 | 1.37e-02 | 9.98e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 8 | 9.46e-01 | -1.37e-02 | 9.99e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 8.93e-01 | -1.37e-02 | 9.93e-01 |
| GOCC LAMELLAR BODY | 17 | 9.22e-01 | -1.37e-02 | 9.98e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 8 | 9.47e-01 | 1.37e-02 | 9.99e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 454 | 6.17e-01 | 1.37e-02 | 9.61e-01 |
| GOBP FATTY ACID TRANSPORT | 114 | 8.02e-01 | 1.36e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 36 | 8.88e-01 | -1.36e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 28 | 9.01e-01 | -1.36e-02 | 9.95e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 29 | 9.00e-01 | 1.35e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 32 | 8.95e-01 | -1.35e-02 | 9.93e-01 |
| GOMF PEROXISOME TARGETING SEQUENCE BINDING | 5 | 9.58e-01 | 1.35e-02 | 9.99e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 15 | 9.28e-01 | 1.35e-02 | 9.98e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 5 | 9.58e-01 | 1.35e-02 | 9.99e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 16 | 9.26e-01 | -1.35e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 47 | 8.73e-01 | 1.35e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 58 | 8.59e-01 | -1.35e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 9.36e-01 | 1.34e-02 | 9.98e-01 |
| GOBP STEM CELL PROLIFERATION | 120 | 8.00e-01 | -1.34e-02 | 9.85e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 204 | 7.42e-01 | 1.34e-02 | 9.77e-01 |
| GOBP RNA 3 URIDYLATION | 5 | 9.59e-01 | -1.34e-02 | 9.99e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 26 | 9.06e-01 | -1.34e-02 | 9.96e-01 |
| GOBP MAST CELL ACTIVATION | 66 | 8.51e-01 | 1.34e-02 | 9.91e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 8 | 9.48e-01 | 1.34e-02 | 9.99e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 7 | 9.51e-01 | 1.33e-02 | 9.99e-01 |
| GOCC RADIAL SPOKE | 5 | 9.59e-01 | -1.33e-02 | 9.99e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 121 | 8.00e-01 | 1.33e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 91 | 8.26e-01 | 1.33e-02 | 9.88e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 11 | 9.39e-01 | -1.33e-02 | 9.98e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 211 | 7.40e-01 | 1.33e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 41 | 8.83e-01 | -1.33e-02 | 9.93e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 79 | 8.39e-01 | 1.32e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 7 | 9.52e-01 | -1.32e-02 | 9.99e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 24 | 9.11e-01 | 1.32e-02 | 9.96e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 27 | 9.06e-01 | 1.31e-02 | 9.96e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 42 | 8.83e-01 | 1.31e-02 | 9.93e-01 |
| GOMF OXYGEN BINDING | 38 | 8.89e-01 | -1.31e-02 | 9.93e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 19 | 9.22e-01 | -1.31e-02 | 9.98e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 77 | 8.44e-01 | 1.30e-02 | 9.89e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 153 | 7.82e-01 | -1.30e-02 | 9.83e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 561 | 6.00e-01 | -1.30e-02 | 9.55e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 132 | 7.97e-01 | -1.29e-02 | 9.84e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 10 | 9.44e-01 | 1.29e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1554 | 3.95e-01 | -1.29e-02 | 9.18e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 19 | 9.22e-01 | 1.29e-02 | 9.98e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 50 | 8.75e-01 | 1.29e-02 | 9.93e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 100 | 8.24e-01 | -1.29e-02 | 9.88e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 97 | 8.27e-01 | -1.29e-02 | 9.88e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 29 | 9.05e-01 | 1.28e-02 | 9.96e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 26 | 9.10e-01 | -1.28e-02 | 9.96e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 58 | 8.66e-01 | -1.28e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 9 | 9.47e-01 | -1.28e-02 | 9.99e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 179 | 7.67e-01 | 1.28e-02 | 9.82e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 25 | 9.12e-01 | -1.28e-02 | 9.96e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 11 | 9.41e-01 | 1.28e-02 | 9.98e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 14 | 9.34e-01 | -1.28e-02 | 9.98e-01 |
| GOBP PREPULSE INHIBITION | 13 | 9.36e-01 | 1.28e-02 | 9.98e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 22 | 9.18e-01 | -1.27e-02 | 9.97e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 66 | 8.58e-01 | 1.27e-02 | 9.92e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 541 | 6.13e-01 | 1.27e-02 | 9.59e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 413 | 6.58e-01 | -1.27e-02 | 9.66e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 12 | 9.39e-01 | 1.27e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 58 | 8.67e-01 | 1.27e-02 | 9.93e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 322 | 6.96e-01 | -1.27e-02 | 9.69e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 227 | 7.43e-01 | -1.27e-02 | 9.77e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 24 | 9.15e-01 | 1.26e-02 | 9.97e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 35 | 8.97e-01 | 1.26e-02 | 9.94e-01 |
| GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION | 7 | 9.54e-01 | -1.26e-02 | 9.99e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 66 | 8.59e-01 | -1.26e-02 | 9.92e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 302 | 7.07e-01 | -1.26e-02 | 9.71e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 40 | 8.91e-01 | 1.25e-02 | 9.93e-01 |
| GOBP RESPONSE TO LEAD ION | 19 | 9.25e-01 | 1.25e-02 | 9.98e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 96 | 8.32e-01 | 1.25e-02 | 9.88e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 18 | 9.27e-01 | 1.25e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 527 | 6.24e-01 | -1.25e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 6 | 9.58e-01 | 1.25e-02 | 9.99e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 28 | 9.09e-01 | 1.25e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR | 6 | 9.58e-01 | 1.24e-02 | 9.99e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 913 | 5.24e-01 | -1.24e-02 | 9.47e-01 |
| GOMF PEPTIDASE ACTIVITY | 561 | 6.15e-01 | -1.24e-02 | 9.60e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 9.52e-01 | 1.24e-02 | 9.99e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 140 | 8.00e-01 | 1.24e-02 | 9.85e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 274 | 7.24e-01 | -1.24e-02 | 9.74e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 9.62e-01 | -1.24e-02 | 9.99e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 46 | 8.85e-01 | 1.24e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 31 | 9.05e-01 | 1.23e-02 | 9.96e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 499 | 6.38e-01 | -1.23e-02 | 9.62e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 156 | 7.91e-01 | 1.23e-02 | 9.84e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 11 | 9.44e-01 | -1.23e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 112 | 8.22e-01 | 1.23e-02 | 9.88e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 423 | 6.65e-01 | 1.23e-02 | 9.67e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 161 | 7.88e-01 | -1.23e-02 | 9.84e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 290 | 7.19e-01 | 1.23e-02 | 9.73e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 118 | 8.18e-01 | -1.23e-02 | 9.87e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 163 | 7.87e-01 | 1.23e-02 | 9.84e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 41 | 8.92e-01 | -1.22e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 33 | 9.03e-01 | 1.22e-02 | 9.96e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 8 | 9.52e-01 | -1.22e-02 | 9.99e-01 |
| GOBP MICROGLIAL CELL PROLIFERATION | 8 | 9.52e-01 | -1.22e-02 | 9.99e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 103 | 8.31e-01 | 1.22e-02 | 9.88e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 967 | 5.22e-01 | 1.22e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 9.63e-01 | 1.21e-02 | 9.99e-01 |
| GOCC PARASPECKLES | 7 | 9.56e-01 | 1.21e-02 | 9.99e-01 |
| GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 5 | 9.63e-01 | -1.21e-02 | 9.99e-01 |
| GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 5 | 9.63e-01 | -1.21e-02 | 9.99e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 871 | 5.45e-01 | -1.21e-02 | 9.49e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 9.42e-01 | 1.21e-02 | 9.98e-01 |
| GOMF CALMODULIN BINDING | 197 | 7.70e-01 | -1.21e-02 | 9.82e-01 |
| GOCC DEUTEROSOME | 6 | 9.59e-01 | -1.21e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 48 | 8.86e-01 | -1.20e-02 | 9.93e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 9.19e-01 | -1.20e-02 | 9.97e-01 |
| GOBP ACROSOME ASSEMBLY | 27 | 9.14e-01 | -1.20e-02 | 9.96e-01 |
| GOBP CALCIUM ION TRANSPORT | 426 | 6.71e-01 | -1.20e-02 | 9.68e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 8.80e-01 | 1.20e-02 | 9.93e-01 |
| GOBP LOBAR BRONCHUS DEVELOPMENT | 6 | 9.59e-01 | -1.20e-02 | 9.99e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 257 | 7.41e-01 | -1.20e-02 | 9.77e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 577 | 6.24e-01 | -1.20e-02 | 9.61e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 73 | 8.60e-01 | -1.19e-02 | 9.93e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 31 | 9.08e-01 | 1.19e-02 | 9.96e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 84 | 8.50e-01 | -1.19e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 96 | 8.40e-01 | -1.19e-02 | 9.89e-01 |
| GOCC APICAL PART OF CELL | 450 | 6.66e-01 | -1.19e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 93 | 8.43e-01 | -1.19e-02 | 9.89e-01 |
| GOMF DNA HELICASE ACTIVITY | 57 | 8.77e-01 | 1.19e-02 | 9.93e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 126 | 8.19e-01 | 1.18e-02 | 9.87e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1414 | 4.56e-01 | 1.18e-02 | 9.36e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 16 | 9.35e-01 | 1.18e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 28 | 9.14e-01 | -1.18e-02 | 9.96e-01 |
| GOBP T CELL DIFFERENTIATION | 300 | 7.26e-01 | -1.18e-02 | 9.75e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 26 | 9.17e-01 | 1.18e-02 | 9.97e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 146 | 8.06e-01 | -1.18e-02 | 9.87e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 155 | 8.01e-01 | 1.17e-02 | 9.85e-01 |
| GOCC CELL DIVISION SITE | 70 | 8.65e-01 | 1.17e-02 | 9.93e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 9.64e-01 | -1.17e-02 | 9.99e-01 |
| GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE | 7 | 9.57e-01 | -1.17e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 52 | 8.84e-01 | 1.17e-02 | 9.93e-01 |
| GOMF NUCLEASE ACTIVITY | 206 | 7.72e-01 | 1.17e-02 | 9.82e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 8.90e-01 | -1.17e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 36 | 9.03e-01 | 1.17e-02 | 9.96e-01 |
| GOBP PROTEIN DEGLUTAMYLATION | 6 | 9.61e-01 | 1.17e-02 | 9.99e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 61 | 8.75e-01 | -1.17e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 272 | 7.41e-01 | 1.17e-02 | 9.77e-01 |
| GOBP GLAND DEVELOPMENT | 428 | 6.80e-01 | 1.16e-02 | 9.68e-01 |
| GOCC EUCHROMATIN | 56 | 8.80e-01 | -1.16e-02 | 9.93e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 245 | 7.55e-01 | 1.16e-02 | 9.81e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 384 | 6.97e-01 | 1.16e-02 | 9.70e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 50 | 8.87e-01 | 1.16e-02 | 9.93e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 76 | 8.62e-01 | 1.16e-02 | 9.93e-01 |
| GOBP FIBROBLAST PROLIFERATION | 104 | 8.39e-01 | -1.15e-02 | 9.89e-01 |
| GOBP RNA 3 END PROCESSING | 90 | 8.50e-01 | 1.15e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 59 | 8.78e-01 | -1.15e-02 | 9.93e-01 |
| GOCC NUCLEOID | 43 | 8.96e-01 | -1.15e-02 | 9.94e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 599 | 6.30e-01 | -1.15e-02 | 9.61e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 88 | 8.52e-01 | -1.15e-02 | 9.91e-01 |
| GOBP SYNAPTIC SIGNALING | 746 | 5.93e-01 | -1.15e-02 | 9.54e-01 |
| GOBP OOGENESIS | 108 | 8.37e-01 | -1.15e-02 | 9.89e-01 |
| GOBP SPINAL CORD PATTERNING | 21 | 9.28e-01 | -1.15e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 74 | 8.65e-01 | 1.14e-02 | 9.93e-01 |
| GOBP RESPONSE TO LITHIUM ION | 15 | 9.39e-01 | -1.14e-02 | 9.98e-01 |
| GOMF RETINOIC ACID BINDING | 26 | 9.20e-01 | 1.14e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 9.41e-01 | 1.14e-02 | 9.98e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 9.65e-01 | -1.14e-02 | 9.99e-01 |
| GOCC TRAMP COMPLEX | 5 | 9.65e-01 | -1.14e-02 | 9.99e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 218 | 7.74e-01 | -1.13e-02 | 9.82e-01 |
| GOMF BETA TUBULIN BINDING | 35 | 9.08e-01 | -1.13e-02 | 9.96e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 366 | 7.11e-01 | -1.13e-02 | 9.71e-01 |
| GOBP CORTISOL METABOLIC PROCESS | 12 | 9.46e-01 | -1.12e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 15 | 9.40e-01 | -1.12e-02 | 9.98e-01 |
| GOBP TISSUE MORPHOGENESIS | 618 | 6.34e-01 | 1.12e-02 | 9.61e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 24 | 9.24e-01 | -1.12e-02 | 9.98e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 9.56e-01 | 1.12e-02 | 9.99e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 13 | 9.44e-01 | 1.12e-02 | 9.98e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 6 | 9.62e-01 | -1.12e-02 | 9.99e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 68 | 8.74e-01 | 1.12e-02 | 9.93e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 7 | 9.59e-01 | -1.11e-02 | 9.99e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 17 | 9.37e-01 | -1.11e-02 | 9.98e-01 |
| GOBP DNA CONFORMATION CHANGE | 87 | 8.58e-01 | 1.11e-02 | 9.92e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 9.43e-01 | 1.11e-02 | 9.98e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 53 | 8.89e-01 | -1.11e-02 | 9.93e-01 |
| GOBP TRANSDIFFERENTIATION | 7 | 9.60e-01 | 1.11e-02 | 9.99e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 50 | 8.92e-01 | -1.11e-02 | 9.93e-01 |
| GOMF VITAMIN BINDING | 144 | 8.19e-01 | 1.10e-02 | 9.87e-01 |
| GOBP REGULATION OF HEART RATE | 99 | 8.50e-01 | 1.10e-02 | 9.91e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 18 | 9.36e-01 | 1.10e-02 | 9.98e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 118 | 8.36e-01 | 1.10e-02 | 9.89e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 34 | 9.12e-01 | -1.10e-02 | 9.96e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 51 | 8.92e-01 | 1.10e-02 | 9.93e-01 |
| GOBP RESPONSE TO NUTRIENT | 147 | 8.18e-01 | 1.10e-02 | 9.87e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 18 | 9.36e-01 | 1.10e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 1211 | 5.21e-01 | -1.09e-02 | 9.47e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 33 | 9.13e-01 | -1.09e-02 | 9.96e-01 |
| GOCC PLATELET ALPHA GRANULE | 82 | 8.64e-01 | 1.09e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 9 | 9.55e-01 | 1.09e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 35 | 9.11e-01 | 1.09e-02 | 9.96e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 9.44e-01 | -1.09e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 9.46e-01 | -1.08e-02 | 9.99e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 30 | 9.18e-01 | -1.08e-02 | 9.97e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 84 | 8.64e-01 | 1.08e-02 | 9.93e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 38 | 9.08e-01 | 1.08e-02 | 9.96e-01 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 10 | 9.53e-01 | 1.08e-02 | 9.99e-01 |
| GOCC ESCRT COMPLEX | 27 | 9.23e-01 | -1.08e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 134 | 8.29e-01 | 1.08e-02 | 9.88e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 9.64e-01 | -1.08e-02 | 9.99e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 76 | 8.72e-01 | 1.07e-02 | 9.93e-01 |
| GOBP EATING BEHAVIOR | 37 | 9.10e-01 | -1.07e-02 | 9.96e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 21 | 9.32e-01 | 1.07e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 163 | 8.14e-01 | 1.07e-02 | 9.87e-01 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 9.67e-01 | 1.07e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 42 | 9.05e-01 | -1.07e-02 | 9.96e-01 |
| GOBP MICROTUBULE ANCHORING | 23 | 9.30e-01 | 1.07e-02 | 9.98e-01 |
| GOBP NEURON PROJECTION EXTENSION | 167 | 8.12e-01 | -1.07e-02 | 9.87e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 11 | 9.51e-01 | 1.06e-02 | 9.99e-01 |
| GOBP GLIOGENESIS | 327 | 7.41e-01 | 1.06e-02 | 9.77e-01 |
| GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING | 6 | 9.64e-01 | 1.06e-02 | 9.99e-01 |
| GOBP STEM CELL FATE SPECIFICATION | 6 | 9.64e-01 | -1.06e-02 | 9.99e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 23 | 9.30e-01 | -1.06e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 17 | 9.40e-01 | 1.06e-02 | 9.98e-01 |
| GOCC SPINDLE MIDZONE | 35 | 9.14e-01 | -1.06e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 9.67e-01 | -1.06e-02 | 9.99e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 366 | 7.29e-01 | -1.06e-02 | 9.75e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 121 | 8.42e-01 | -1.05e-02 | 9.89e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 299 | 7.55e-01 | 1.05e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 33 | 9.17e-01 | 1.05e-02 | 9.97e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 108 | 8.51e-01 | -1.05e-02 | 9.91e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 18 | 9.39e-01 | 1.05e-02 | 9.98e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 53 | 8.95e-01 | -1.05e-02 | 9.93e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 755 | 6.25e-01 | 1.05e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 60 | 8.89e-01 | -1.05e-02 | 9.93e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 9.16e-01 | -1.04e-02 | 9.97e-01 |
| GOCC MITOTIC SPINDLE | 174 | 8.13e-01 | 1.04e-02 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 17 | 9.41e-01 | 1.04e-02 | 9.98e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 68 | 8.82e-01 | 1.04e-02 | 9.93e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 83 | 8.70e-01 | -1.04e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 209 | 7.96e-01 | -1.04e-02 | 9.84e-01 |
| GOMF ACTIN MONOMER BINDING | 24 | 9.30e-01 | 1.04e-02 | 9.98e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 101 | 8.57e-01 | 1.03e-02 | 9.92e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 28 | 9.25e-01 | -1.03e-02 | 9.98e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 70 | 8.82e-01 | -1.03e-02 | 9.93e-01 |
| GOBP LIPID EXPORT FROM CELL | 47 | 9.03e-01 | 1.03e-02 | 9.95e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 166 | 8.19e-01 | -1.03e-02 | 9.87e-01 |
| GOBP TRANSLATIONAL INITIATION | 110 | 8.52e-01 | 1.03e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION | 10 | 9.55e-01 | 1.03e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 132 | 8.40e-01 | -1.02e-02 | 9.89e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 169 | 8.19e-01 | -1.02e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 71 | 8.82e-01 | 1.02e-02 | 9.93e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 50 | 9.01e-01 | 1.01e-02 | 9.95e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 8.83e-01 | 1.01e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 183 | 8.13e-01 | -1.01e-02 | 9.87e-01 |
| GOMF TUBULIN BINDING | 357 | 7.42e-01 | 1.01e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 26 | 9.29e-01 | -1.01e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 913 | 6.05e-01 | 1.01e-02 | 9.55e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 12 | 9.52e-01 | 1.01e-02 | 9.99e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 6 | 9.66e-01 | 1.00e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 380 | 7.37e-01 | 1.00e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 9 | 9.59e-01 | 1.00e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 9.56e-01 | 1.00e-02 | 9.99e-01 |
| GOBP CHORIO ALLANTOIC FUSION | 7 | 9.63e-01 | 1.00e-02 | 9.99e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 9.56e-01 | 1.00e-02 | 9.99e-01 |
| GOBP MEMORY | 120 | 8.50e-01 | -1.00e-02 | 9.91e-01 |
| GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY | 6 | 9.66e-01 | 9.97e-03 | 9.99e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 17 | 9.43e-01 | 9.96e-03 | 9.98e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 174 | 8.21e-01 | 9.95e-03 | 9.87e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 13 | 9.50e-01 | 9.94e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 145 | 8.36e-01 | -9.93e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 11 | 9.55e-01 | -9.93e-03 | 9.99e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 181 | 8.18e-01 | -9.92e-03 | 9.87e-01 |
| GOCC FIBRINOGEN COMPLEX | 8 | 9.61e-01 | 9.92e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 276 | 7.78e-01 | -9.88e-03 | 9.83e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 441 | 7.22e-01 | -9.87e-03 | 9.74e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 11 | 9.55e-01 | -9.86e-03 | 9.99e-01 |
| GOBP CARDIAC CELL FATE COMMITMENT | 16 | 9.46e-01 | -9.85e-03 | 9.99e-01 |
| GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.64e-01 | -9.83e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 111 | 8.58e-01 | -9.80e-03 | 9.92e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 8 | 9.62e-01 | -9.79e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 340 | 7.56e-01 | -9.79e-03 | 9.82e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 323 | 7.63e-01 | 9.78e-03 | 9.82e-01 |
| GOBP MESODERM DEVELOPMENT | 124 | 8.51e-01 | 9.76e-03 | 9.91e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 57 | 8.99e-01 | 9.73e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 11 | 9.55e-01 | -9.72e-03 | 9.99e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 75 | 8.84e-01 | -9.71e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 7 | 9.65e-01 | -9.71e-03 | 9.99e-01 |
| GOBP STEROID CATABOLIC PROCESS | 24 | 9.34e-01 | -9.70e-03 | 9.98e-01 |
| GOBP REGULATION OF CHONDROCYTE DEVELOPMENT | 6 | 9.67e-01 | 9.69e-03 | 9.99e-01 |
| GOBP AMIDE TRANSPORT | 344 | 7.58e-01 | 9.68e-03 | 9.82e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 9.54e-01 | 9.67e-03 | 9.99e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 9.54e-01 | -9.67e-03 | 9.99e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 26 | 9.32e-01 | 9.61e-03 | 9.98e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 187 | 8.21e-01 | -9.59e-03 | 9.87e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 9.60e-01 | -9.59e-03 | 9.99e-01 |
| GOCC MICROTUBULE | 441 | 7.30e-01 | 9.58e-03 | 9.76e-01 |
| GOMF CADHERIN BINDING | 329 | 7.66e-01 | -9.56e-03 | 9.82e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 15 | 9.49e-01 | 9.56e-03 | 9.99e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 112 | 8.61e-01 | -9.55e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 83 | 8.81e-01 | 9.54e-03 | 9.93e-01 |
| GOCC HEMIDESMOSOME | 8 | 9.63e-01 | -9.53e-03 | 9.99e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 751 | 6.57e-01 | 9.53e-03 | 9.66e-01 |
| GOCC DISTAL AXON | 261 | 7.91e-01 | -9.51e-03 | 9.84e-01 |
| GOMF NADPLUS BINDING | 18 | 9.44e-01 | 9.50e-03 | 9.98e-01 |
| GOMF NEUREGULIN BINDING | 5 | 9.71e-01 | 9.49e-03 | 9.99e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 25 | 9.35e-01 | 9.47e-03 | 9.98e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 27 | 9.32e-01 | -9.46e-03 | 9.98e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 302 | 7.78e-01 | -9.44e-03 | 9.83e-01 |
| GOBP REGENERATION | 181 | 8.27e-01 | -9.40e-03 | 9.88e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 15 | 9.50e-01 | -9.39e-03 | 9.99e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 59 | 9.01e-01 | 9.37e-03 | 9.95e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 36 | 9.23e-01 | -9.34e-03 | 9.98e-01 |
| GOBP OXYGEN TRANSPORT | 15 | 9.50e-01 | -9.33e-03 | 9.99e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 14 | 9.52e-01 | -9.33e-03 | 9.99e-01 |
| GOBP HEAD DEVELOPMENT | 721 | 6.70e-01 | -9.31e-03 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 19 | 9.44e-01 | -9.30e-03 | 9.98e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 41 | 9.18e-01 | 9.29e-03 | 9.97e-01 |
| GOBP PROTEIN MATURATION | 515 | 7.18e-01 | -9.29e-03 | 9.72e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 116 | 8.63e-01 | 9.27e-03 | 9.93e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 10 | 9.60e-01 | -9.27e-03 | 9.99e-01 |
| GOBP TRNA 3 END PROCESSING | 6 | 9.69e-01 | -9.25e-03 | 9.99e-01 |
| GOBP PROLACTIN SECRETION | 5 | 9.71e-01 | 9.25e-03 | 9.99e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 66 | 8.97e-01 | 9.24e-03 | 9.94e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 26 | 9.35e-01 | -9.23e-03 | 9.98e-01 |
| GOBP REGULATION OF NEUROGENESIS | 373 | 7.59e-01 | 9.23e-03 | 9.82e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 131 | 8.56e-01 | -9.21e-03 | 9.92e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 70 | 8.94e-01 | 9.17e-03 | 9.93e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 132 | 8.56e-01 | 9.15e-03 | 9.92e-01 |
| GOBP RESPONSE TO IRON II ION | 6 | 9.69e-01 | 9.13e-03 | 9.99e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 20 | 9.44e-01 | 9.08e-03 | 9.98e-01 |
| GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING | 5 | 9.72e-01 | 9.07e-03 | 9.99e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 102 | 8.74e-01 | 9.06e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 19 | 9.46e-01 | -9.06e-03 | 9.99e-01 |
| GOMF FATZ BINDING | 5 | 9.72e-01 | -9.05e-03 | 9.99e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 7 | 9.67e-01 | 9.01e-03 | 9.99e-01 |
| GOBP FERMENTATION | 5 | 9.72e-01 | -8.98e-03 | 9.99e-01 |
| GOBP THYMUS DEVELOPMENT | 49 | 9.13e-01 | 8.97e-03 | 9.96e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 9 | 9.63e-01 | -8.97e-03 | 9.99e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 7 | 9.67e-01 | -8.97e-03 | 9.99e-01 |
| GOBP RESPONSE TO NEMATODE | 7 | 9.67e-01 | 8.96e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 24 | 9.39e-01 | 8.95e-03 | 9.98e-01 |
| GOBP HEART FIELD SPECIFICATION | 17 | 9.49e-01 | 8.93e-03 | 9.99e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 12 | 9.57e-01 | -8.93e-03 | 9.99e-01 |
| GOBP SARCOMERE ORGANIZATION | 45 | 9.18e-01 | 8.91e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 9.65e-01 | 8.90e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 26 | 9.37e-01 | -8.89e-03 | 9.98e-01 |
| GOCC NON MOTILE CILIUM | 152 | 8.50e-01 | -8.88e-03 | 9.91e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 19 | 9.47e-01 | -8.85e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 50 | 9.14e-01 | -8.84e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 62 | 9.04e-01 | -8.82e-03 | 9.96e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 12 | 9.58e-01 | -8.80e-03 | 9.99e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 21 | 9.44e-01 | -8.80e-03 | 9.98e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 105 | 8.76e-01 | 8.79e-03 | 9.93e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 22 | 9.43e-01 | 8.78e-03 | 9.98e-01 |
| GOCC POSTSYNAPSE | 614 | 7.11e-01 | -8.76e-03 | 9.71e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 31 | 9.33e-01 | 8.75e-03 | 9.98e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 153 | 8.52e-01 | -8.75e-03 | 9.91e-01 |
| GOMF POLY PURINE TRACT BINDING | 28 | 9.36e-01 | 8.74e-03 | 9.98e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 230 | 8.20e-01 | 8.73e-03 | 9.87e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 117 | 8.71e-01 | 8.68e-03 | 9.93e-01 |
| GOBP NEURON REMODELING | 15 | 9.54e-01 | 8.68e-03 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 626 | 7.11e-01 | 8.67e-03 | 9.71e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 7 | 9.68e-01 | -8.66e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 61 | 9.07e-01 | 8.64e-03 | 9.96e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 9.61e-01 | 8.61e-03 | 9.99e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 362 | 7.79e-01 | -8.57e-03 | 9.83e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 165 | 8.49e-01 | -8.57e-03 | 9.91e-01 |
| GOBP GROWTH | 881 | 6.66e-01 | -8.56e-03 | 9.67e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 123 | 8.70e-01 | 8.55e-03 | 9.93e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 59 | 9.10e-01 | -8.52e-03 | 9.96e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 20 | 9.48e-01 | -8.50e-03 | 9.99e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 16 | 9.53e-01 | 8.47e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 752 | 6.93e-01 | 8.46e-03 | 9.69e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 98 | 8.85e-01 | 8.45e-03 | 9.93e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 10 | 9.63e-01 | -8.42e-03 | 9.99e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 9.37e-01 | -8.40e-03 | 9.98e-01 |
| GOBP MRNA TRANSPORT | 112 | 8.78e-01 | -8.39e-03 | 9.93e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 14 | 9.57e-01 | -8.38e-03 | 9.99e-01 |
| GOBP REGULATION OF PRE MIRNA PROCESSING | 6 | 9.72e-01 | -8.36e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 271 | 8.13e-01 | 8.36e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 7 | 9.69e-01 | 8.36e-03 | 9.99e-01 |
| GOBP MEMBRANE ORGANIZATION | 773 | 6.93e-01 | 8.35e-03 | 9.69e-01 |
| GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 9.74e-01 | 8.32e-03 | 9.99e-01 |
| GOCC ACTIN CYTOSKELETON | 484 | 7.54e-01 | -8.32e-03 | 9.81e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 223 | 8.31e-01 | -8.31e-03 | 9.88e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 29 | 9.38e-01 | -8.30e-03 | 9.98e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1668 | 5.74e-01 | 8.27e-03 | 9.51e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 9.72e-01 | -8.27e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 9.75e-01 | -8.25e-03 | 9.99e-01 |
| GOCC CELL PROJECTION MEMBRANE | 338 | 7.94e-01 | -8.25e-03 | 9.84e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 55 | 9.16e-01 | 8.24e-03 | 9.97e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 43 | 9.26e-01 | -8.22e-03 | 9.98e-01 |
| GOMF PROLINE RICH REGION BINDING | 17 | 9.53e-01 | 8.21e-03 | 9.99e-01 |
| GOBP HINDGUT DEVELOPMENT | 8 | 9.68e-01 | 8.20e-03 | 9.99e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 55 | 9.16e-01 | 8.19e-03 | 9.97e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 445 | 7.67e-01 | 8.19e-03 | 9.82e-01 |
| GOBP HORMONE METABOLIC PROCESS | 229 | 8.31e-01 | -8.18e-03 | 9.88e-01 |
| GOBP TUBE DEVELOPMENT | 1120 | 6.44e-01 | -8.17e-03 | 9.63e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 51 | 9.20e-01 | 8.16e-03 | 9.98e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 104 | 8.86e-01 | -8.13e-03 | 9.93e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 27 | 9.42e-01 | -8.13e-03 | 9.98e-01 |
| GOBP REGULATION OF CORE PROMOTER BINDING | 5 | 9.75e-01 | -8.12e-03 | 9.99e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 85 | 8.97e-01 | 8.12e-03 | 9.94e-01 |
| GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION | 6 | 9.73e-01 | 8.08e-03 | 9.99e-01 |
| GOBP ORGANIC ACID TRANSPORT | 340 | 7.98e-01 | -8.08e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 9.69e-01 | -8.05e-03 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 72 | 9.06e-01 | 8.03e-03 | 9.96e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 9.65e-01 | -7.97e-03 | 9.99e-01 |
| GOBP TUBE MORPHOGENESIS | 914 | 6.83e-01 | -7.96e-03 | 9.68e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 9.56e-01 | 7.95e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 12 | 9.62e-01 | -7.93e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 9.73e-01 | -7.92e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 19 | 9.52e-01 | 7.91e-03 | 9.99e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 39 | 9.32e-01 | 7.91e-03 | 9.98e-01 |
| GOCC PROTEASOME CORE COMPLEX | 20 | 9.51e-01 | 7.89e-03 | 9.99e-01 |
| GOBP NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION | 5 | 9.76e-01 | 7.87e-03 | 9.99e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 23 | 9.48e-01 | 7.86e-03 | 9.99e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 9.69e-01 | 7.82e-03 | 9.99e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 38 | 9.34e-01 | 7.81e-03 | 9.98e-01 |
| GOBP RESPONSE TO ISCHEMIA | 62 | 9.15e-01 | -7.81e-03 | 9.97e-01 |
| GOBP RESPONSE TO PROGESTERONE | 40 | 9.32e-01 | -7.80e-03 | 9.98e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.70e-01 | 7.80e-03 | 9.99e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 16 | 9.57e-01 | 7.79e-03 | 9.99e-01 |
| GOBP PROTEIN POLYMERIZATION | 271 | 8.25e-01 | -7.78e-03 | 9.88e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 83 | 9.02e-01 | 7.78e-03 | 9.95e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 980 | 6.81e-01 | 7.77e-03 | 9.68e-01 |
| GOCC CELL BODY | 529 | 7.60e-01 | -7.76e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 9.72e-01 | -7.74e-03 | 9.99e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 36 | 9.36e-01 | 7.74e-03 | 9.98e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 15 | 9.59e-01 | -7.73e-03 | 9.99e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 1213 | 6.51e-01 | -7.72e-03 | 9.64e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 30 | 9.42e-01 | -7.71e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 85 | 9.02e-01 | 7.69e-03 | 9.95e-01 |
| GOBP NEUROBLAST PROLIFERATION | 80 | 9.05e-01 | -7.68e-03 | 9.96e-01 |
| GOBP GLUTAMATE REUPTAKE | 6 | 9.74e-01 | -7.67e-03 | 9.99e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 54 | 9.22e-01 | 7.67e-03 | 9.98e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 42 | 9.32e-01 | 7.64e-03 | 9.98e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 36 | 9.37e-01 | -7.63e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 32 | 9.41e-01 | 7.55e-03 | 9.98e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 12 | 9.64e-01 | 7.55e-03 | 9.99e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 72 | 9.12e-01 | 7.49e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 9.75e-01 | -7.46e-03 | 9.99e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS | 6 | 9.75e-01 | -7.45e-03 | 9.99e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 47 | 9.30e-01 | 7.44e-03 | 9.98e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 9.71e-01 | 7.43e-03 | 9.99e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 67 | 9.16e-01 | -7.42e-03 | 9.97e-01 |
| GOBP RESPONSE TO SELENIUM ION | 8 | 9.71e-01 | 7.42e-03 | 9.99e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 9.77e-01 | -7.39e-03 | 9.99e-01 |
| GOMF LIPID ANTIGEN BINDING | 5 | 9.77e-01 | -7.39e-03 | 9.99e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 82 | 9.08e-01 | 7.37e-03 | 9.96e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 302 | 8.26e-01 | -7.36e-03 | 9.88e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 37 | 9.38e-01 | -7.36e-03 | 9.98e-01 |
| GOBP CELL GROWTH | 474 | 7.84e-01 | -7.35e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 17 | 9.58e-01 | 7.35e-03 | 9.99e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 9.58e-01 | -7.34e-03 | 9.99e-01 |
| GOBP NOSE DEVELOPMENT | 16 | 9.59e-01 | 7.34e-03 | 9.99e-01 |
| GOBP FEMALE GAMETE GENERATION | 158 | 8.74e-01 | 7.33e-03 | 9.93e-01 |
| GOBP REGULATION OF CELL DIVISION | 176 | 8.67e-01 | -7.31e-03 | 9.93e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 14 | 9.62e-01 | 7.28e-03 | 9.99e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 55 | 9.26e-01 | 7.26e-03 | 9.98e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 25 | 9.50e-01 | 7.25e-03 | 9.99e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 248 | 8.45e-01 | 7.23e-03 | 9.90e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 8 | 9.72e-01 | -7.23e-03 | 9.99e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 18 | 9.58e-01 | 7.22e-03 | 9.99e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 60 | 9.23e-01 | -7.21e-03 | 9.98e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 21 | 9.54e-01 | -7.21e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 1463 | 6.44e-01 | -7.21e-03 | 9.63e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 967 | 7.05e-01 | 7.20e-03 | 9.71e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 137 | 8.85e-01 | -7.18e-03 | 9.93e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 219 | 8.55e-01 | -7.18e-03 | 9.91e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 23 | 9.52e-01 | -7.18e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 148 | 8.80e-01 | 7.17e-03 | 9.93e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 64 | 9.21e-01 | -7.17e-03 | 9.98e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 16 | 9.61e-01 | 7.13e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 68 | 9.19e-01 | -7.12e-03 | 9.97e-01 |
| GOBP GERM CELL DEVELOPMENT | 344 | 8.21e-01 | 7.12e-03 | 9.87e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 35 | 9.42e-01 | 7.11e-03 | 9.98e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 37 | 9.40e-01 | -7.10e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 18 | 9.59e-01 | 7.06e-03 | 9.99e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 122 | 8.93e-01 | -7.06e-03 | 9.93e-01 |
| GOCC MICROBODY MEMBRANE | 62 | 9.23e-01 | -7.06e-03 | 9.98e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 799 | 7.35e-01 | 7.06e-03 | 9.77e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 57 | 9.27e-01 | 7.05e-03 | 9.98e-01 |
| GOBP APOPTOTIC PROCESS | 1853 | 6.18e-01 | 7.00e-03 | 9.61e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 618 | 7.67e-01 | 6.98e-03 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 7 | 9.75e-01 | 6.96e-03 | 9.99e-01 |
| GOMF STRUCTURAL CONSTITUENT OF PRESYNAPTIC ACTIVE ZONE | 5 | 9.79e-01 | -6.92e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 88 | 9.11e-01 | -6.91e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 23 | 9.54e-01 | -6.91e-03 | 9.99e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 27 | 9.51e-01 | 6.89e-03 | 9.99e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 18 | 9.60e-01 | 6.88e-03 | 9.99e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 18 | 9.60e-01 | 6.88e-03 | 9.99e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 25 | 9.53e-01 | -6.88e-03 | 9.99e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 16 | 9.62e-01 | 6.87e-03 | 9.99e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 10 | 9.70e-01 | 6.87e-03 | 9.99e-01 |
| GOBP GMP METABOLIC PROCESS | 25 | 9.53e-01 | -6.86e-03 | 9.99e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 54 | 9.31e-01 | -6.86e-03 | 9.98e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 9.65e-01 | 6.85e-03 | 9.99e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 37 | 9.43e-01 | -6.84e-03 | 9.98e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 12 | 9.67e-01 | -6.81e-03 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 684 | 7.63e-01 | -6.78e-03 | 9.82e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 23 | 9.55e-01 | -6.76e-03 | 9.99e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 97 | 9.09e-01 | -6.73e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 11 | 9.69e-01 | -6.73e-03 | 9.99e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 36 | 9.44e-01 | -6.72e-03 | 9.98e-01 |
| GOCC XY BODY | 15 | 9.64e-01 | 6.70e-03 | 9.99e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 81 | 9.17e-01 | -6.70e-03 | 9.97e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1539 | 6.61e-01 | -6.69e-03 | 9.66e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 7 | 9.76e-01 | 6.69e-03 | 9.99e-01 |
| GOCC TORC2 COMPLEX | 9 | 9.72e-01 | 6.65e-03 | 9.99e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 188 | 8.76e-01 | 6.62e-03 | 9.93e-01 |
| GOBP LEUKOCYTE AGGREGATION | 12 | 9.68e-01 | 6.60e-03 | 9.99e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 142 | 8.93e-01 | -6.55e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 133 | 8.97e-01 | 6.53e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 17 | 9.63e-01 | -6.52e-03 | 9.99e-01 |
| GOCC CYTOPLASMIC REGION | 277 | 8.52e-01 | -6.50e-03 | 9.91e-01 |
| GOMF UBIQUITIN BINDING | 99 | 9.11e-01 | 6.50e-03 | 9.96e-01 |
| GOBP STRIATED MUSCLE ATROPHY | 7 | 9.76e-01 | -6.49e-03 | 9.99e-01 |
| GOBP PERICARDIUM MORPHOGENESIS | 8 | 9.75e-01 | 6.49e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 300 | 8.47e-01 | -6.48e-03 | 9.90e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 17 | 9.63e-01 | 6.46e-03 | 9.99e-01 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION | 10 | 9.72e-01 | -6.43e-03 | 9.99e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 11 | 9.71e-01 | 6.40e-03 | 9.99e-01 |
| GOBP TELOMERE ORGANIZATION | 178 | 8.83e-01 | 6.39e-03 | 9.93e-01 |
| GOCC SITE OF POLARIZED GROWTH | 162 | 8.88e-01 | 6.38e-03 | 9.93e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 162 | 8.89e-01 | 6.38e-03 | 9.93e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 32 | 9.50e-01 | 6.37e-03 | 9.99e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 21 | 9.60e-01 | -6.33e-03 | 9.99e-01 |
| GOBP DEVELOPMENTAL GROWTH | 629 | 7.86e-01 | -6.33e-03 | 9.84e-01 |
| GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 12 | 9.70e-01 | 6.31e-03 | 9.99e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 9.63e-01 | -6.25e-03 | 9.99e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 20 | 9.61e-01 | -6.25e-03 | 9.99e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 28 | 9.54e-01 | -6.24e-03 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 717 | 7.77e-01 | 6.21e-03 | 9.83e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 11 | 9.72e-01 | -6.20e-03 | 9.99e-01 |
| GOBP CYTOKINETIC PROCESS | 42 | 9.45e-01 | 6.19e-03 | 9.98e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 24 | 9.58e-01 | 6.18e-03 | 9.99e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 405 | 8.31e-01 | -6.17e-03 | 9.88e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 58 | 9.35e-01 | 6.15e-03 | 9.98e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 77 | 9.26e-01 | 6.13e-03 | 9.98e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 401 | 8.34e-01 | 6.10e-03 | 9.88e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 24 | 9.59e-01 | 6.09e-03 | 9.99e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 39 | 9.48e-01 | -6.09e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 203 | 8.82e-01 | -6.04e-03 | 9.93e-01 |
| GOBP AXON CHOICE POINT RECOGNITION | 7 | 9.78e-01 | 6.04e-03 | 9.99e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 9.80e-01 | -6.02e-03 | 9.99e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 9.78e-01 | 6.01e-03 | 9.99e-01 |
| GOMF PROTEIN KINASE A BINDING | 49 | 9.42e-01 | -5.99e-03 | 9.98e-01 |
| GOBP LONG TERM MEMORY | 36 | 9.50e-01 | 5.99e-03 | 9.99e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 40 | 9.48e-01 | -5.99e-03 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 21 | 9.62e-01 | 5.98e-03 | 9.99e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 885 | 7.63e-01 | 5.97e-03 | 9.82e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1268 | 7.21e-01 | -5.96e-03 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 12 | 9.72e-01 | -5.93e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 33 | 9.53e-01 | -5.92e-03 | 9.99e-01 |
| GOBP MITOTIC RECOMBINATION | 25 | 9.59e-01 | 5.91e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 58 | 9.38e-01 | -5.91e-03 | 9.98e-01 |
| GOMF TRANSITION METAL ION BINDING | 1035 | 7.48e-01 | 5.91e-03 | 9.79e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 516 | 8.19e-01 | 5.89e-03 | 9.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR | 6 | 9.80e-01 | 5.84e-03 | 9.99e-01 |
| GOBP PALLIUM DEVELOPMENT | 180 | 8.93e-01 | 5.81e-03 | 9.93e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 205 | 8.86e-01 | -5.81e-03 | 9.93e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 110 | 9.16e-01 | -5.80e-03 | 9.97e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 107 | 9.17e-01 | -5.80e-03 | 9.97e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 11 | 9.73e-01 | -5.79e-03 | 9.99e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 30 | 9.56e-01 | -5.79e-03 | 9.99e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 9.82e-01 | -5.79e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 35 | 9.53e-01 | 5.78e-03 | 9.99e-01 |
| GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 9.82e-01 | 5.75e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 135 | 9.09e-01 | 5.72e-03 | 9.96e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 66 | 9.36e-01 | 5.71e-03 | 9.98e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 9.76e-01 | 5.70e-03 | 9.99e-01 |
| GOBP DENTINOGENESIS | 6 | 9.81e-01 | -5.70e-03 | 9.99e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 69 | 9.35e-01 | 5.69e-03 | 9.98e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS | 8 | 9.78e-01 | 5.69e-03 | 9.99e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 55 | 9.42e-01 | -5.68e-03 | 9.98e-01 |
| GOBP RNA LOCALIZATION | 182 | 8.95e-01 | -5.67e-03 | 9.93e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 41 | 9.50e-01 | 5.65e-03 | 9.99e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 436 | 8.40e-01 | -5.64e-03 | 9.89e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 37 | 9.53e-01 | 5.64e-03 | 9.99e-01 |
| GOMF PATCHED BINDING | 8 | 9.78e-01 | 5.61e-03 | 9.99e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1773 | 6.96e-01 | 5.59e-03 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 27 | 9.60e-01 | 5.58e-03 | 9.99e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 18 | 9.67e-01 | 5.56e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 17 | 9.68e-01 | 5.53e-03 | 9.99e-01 |
| GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 6 | 9.81e-01 | -5.53e-03 | 9.99e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 24 | 9.63e-01 | -5.49e-03 | 9.99e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 11 | 9.75e-01 | -5.48e-03 | 9.99e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 128 | 9.15e-01 | -5.48e-03 | 9.97e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 9.81e-01 | -5.47e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 9.65e-01 | 5.47e-03 | 9.99e-01 |
| GOBP REGULATION OF CYTOKINESIS | 86 | 9.30e-01 | 5.46e-03 | 9.98e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 28 | 9.60e-01 | -5.45e-03 | 9.99e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 205 | 8.93e-01 | -5.45e-03 | 9.93e-01 |
| GOCC LAMELLIPODIUM | 194 | 8.96e-01 | -5.45e-03 | 9.94e-01 |
| GOBP ADP METABOLIC PROCESS | 8 | 9.79e-01 | 5.45e-03 | 9.99e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 9 | 9.77e-01 | 5.45e-03 | 9.99e-01 |
| GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS | 5 | 9.83e-01 | 5.41e-03 | 9.99e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 36 | 9.55e-01 | -5.39e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 1244 | 7.49e-01 | 5.39e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 112 | 9.22e-01 | -5.38e-03 | 9.98e-01 |
| GOBP AXON EXTENSION | 111 | 9.22e-01 | -5.38e-03 | 9.98e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 577 | 8.26e-01 | -5.37e-03 | 9.88e-01 |
| GOBP SIGNAL RELEASE | 467 | 8.43e-01 | 5.35e-03 | 9.89e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 16 | 9.71e-01 | 5.32e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 23 | 9.65e-01 | -5.31e-03 | 9.99e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 9.72e-01 | 5.31e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 5 | 9.84e-01 | 5.30e-03 | 9.99e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 10 | 9.77e-01 | 5.29e-03 | 9.99e-01 |
| GOBP PERICYTE CELL DIFFERENTIATION | 11 | 9.76e-01 | 5.29e-03 | 9.99e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 70 | 9.39e-01 | 5.25e-03 | 9.98e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 9.72e-01 | -5.25e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 73 | 9.38e-01 | 5.25e-03 | 9.98e-01 |
| GOBP MESODERM MORPHOGENESIS | 76 | 9.37e-01 | -5.24e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 86 | 9.33e-01 | 5.24e-03 | 9.98e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 50 | 9.49e-01 | -5.22e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 100 | 9.28e-01 | -5.22e-03 | 9.98e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 63 | 9.43e-01 | 5.21e-03 | 9.98e-01 |
| GOBP RENAL ABSORPTION | 32 | 9.59e-01 | 5.20e-03 | 9.99e-01 |
| GOMF CLATHRIN LIGHT CHAIN BINDING | 7 | 9.81e-01 | 5.13e-03 | 9.99e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 125 | 9.21e-01 | -5.12e-03 | 9.98e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 118 | 9.24e-01 | 5.11e-03 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 26 | 9.64e-01 | -5.10e-03 | 9.99e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 61 | 9.45e-01 | 5.09e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 94 | 9.32e-01 | -5.08e-03 | 9.98e-01 |
| GOBP MIDGUT DEVELOPMENT | 10 | 9.78e-01 | -5.07e-03 | 9.99e-01 |
| GOCC DENDRITIC TREE | 589 | 8.34e-01 | -5.05e-03 | 9.88e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 29 | 9.63e-01 | 5.04e-03 | 9.99e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 30 | 9.62e-01 | -5.02e-03 | 9.99e-01 |
| GOBP GAMETE GENERATION | 721 | 8.19e-01 | 5.02e-03 | 9.87e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT | 11 | 9.77e-01 | -5.01e-03 | 9.99e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1466 | 7.48e-01 | 5.01e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 9.85e-01 | 5.01e-03 | 9.99e-01 |
| GOBP EAR DEVELOPMENT | 217 | 9.00e-01 | 4.97e-03 | 9.95e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 85 | 9.37e-01 | -4.96e-03 | 9.98e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 21 | 9.69e-01 | -4.95e-03 | 9.99e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 928 | 7.99e-01 | 4.93e-03 | 9.85e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 284 | 8.86e-01 | 4.93e-03 | 9.93e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 24 | 9.67e-01 | -4.90e-03 | 9.99e-01 |
| GOBP LIPID METABOLIC PROCESS | 1343 | 7.64e-01 | -4.89e-03 | 9.82e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 49 | 9.53e-01 | -4.88e-03 | 9.99e-01 |
| GOBP REGULATION OF PH | 95 | 9.35e-01 | 4.87e-03 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 139 | 9.21e-01 | 4.87e-03 | 9.98e-01 |
| GOCC CELL CORTEX | 296 | 8.85e-01 | -4.87e-03 | 9.93e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 83 | 9.39e-01 | 4.86e-03 | 9.98e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 14 | 9.75e-01 | -4.85e-03 | 9.99e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 29 | 9.64e-01 | 4.84e-03 | 9.99e-01 |
| GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.84e-01 | -4.83e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 9.73e-01 | -4.82e-03 | 9.99e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 51 | 9.53e-01 | -4.81e-03 | 9.99e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 26 | 9.66e-01 | 4.79e-03 | 9.99e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 96 | 9.36e-01 | -4.75e-03 | 9.98e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 107 | 9.33e-01 | -4.72e-03 | 9.98e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 25 | 9.67e-01 | -4.71e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 150 | 9.21e-01 | 4.71e-03 | 9.98e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 10 | 9.80e-01 | 4.68e-03 | 9.99e-01 |
| GOBP NUCLEOBASE TRANSPORT | 12 | 9.78e-01 | -4.67e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 43 | 9.58e-01 | -4.66e-03 | 9.99e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 102 | 9.35e-01 | 4.65e-03 | 9.98e-01 |
| GOCC PROXIMAL DENDRITE | 6 | 9.84e-01 | 4.63e-03 | 9.99e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 394 | 8.75e-01 | -4.63e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 21 | 9.71e-01 | -4.63e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 107 | 9.35e-01 | 4.56e-03 | 9.98e-01 |
| GOCC SYNAPTIC MEMBRANE | 368 | 8.81e-01 | -4.55e-03 | 9.93e-01 |
| GOBP CYTOKINESIS | 177 | 9.17e-01 | 4.55e-03 | 9.97e-01 |
| GOMF GTPASE ACTIVITY | 305 | 8.92e-01 | -4.54e-03 | 9.93e-01 |
| GOBP VASCULAR TRANSPORT | 84 | 9.43e-01 | 4.53e-03 | 9.98e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 60 | 9.52e-01 | -4.53e-03 | 9.99e-01 |
| GOBP REGULATION OF MALE GONAD DEVELOPMENT | 8 | 9.82e-01 | -4.50e-03 | 9.99e-01 |
| GOBP REGULATION OF NAD P H OXIDASE ACTIVITY | 7 | 9.84e-01 | 4.47e-03 | 9.99e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 28 | 9.67e-01 | -4.47e-03 | 9.99e-01 |
| GOBP PROTEOLYSIS | 1550 | 7.69e-01 | -4.47e-03 | 9.82e-01 |
| GOBP PYRUVATE TRANSPORT | 7 | 9.84e-01 | -4.45e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 76 | 9.47e-01 | 4.44e-03 | 9.99e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 9.83e-01 | 4.43e-03 | 9.99e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 148 | 9.26e-01 | -4.42e-03 | 9.98e-01 |
| GOBP DUCTUS ARTERIOSUS CLOSURE | 5 | 9.86e-01 | -4.42e-03 | 1.00e+00 |
| GOBP PEPTIDE CATABOLIC PROCESS | 22 | 9.71e-01 | 4.40e-03 | 9.99e-01 |
| GOBP DGMP METABOLIC PROCESS | 5 | 9.86e-01 | 4.40e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 37 | 9.63e-01 | -4.40e-03 | 9.99e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 24 | 9.70e-01 | -4.39e-03 | 9.99e-01 |
| GOBP RESPONSE TO CYTOKINE | 901 | 8.24e-01 | -4.38e-03 | 9.88e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 272 | 9.01e-01 | 4.36e-03 | 9.95e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 44 | 9.60e-01 | 4.36e-03 | 9.99e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 148 | 9.27e-01 | -4.35e-03 | 9.98e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 27 | 9.69e-01 | 4.35e-03 | 9.99e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 33 | 9.66e-01 | 4.34e-03 | 9.99e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 9.85e-01 | -4.33e-03 | 1.00e+00 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 111 | 9.38e-01 | 4.28e-03 | 9.98e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 9.82e-01 | -4.24e-03 | 9.99e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 67 | 9.52e-01 | -4.23e-03 | 9.99e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 36 | 9.65e-01 | -4.22e-03 | 9.99e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 70 | 9.51e-01 | 4.21e-03 | 9.99e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 46 | 9.61e-01 | -4.21e-03 | 9.99e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 19 | 9.75e-01 | 4.21e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 880 | 8.33e-01 | 4.20e-03 | 9.88e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 95 | 9.44e-01 | 4.20e-03 | 9.98e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 5 | 9.87e-01 | -4.18e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 167 | 9.26e-01 | -4.17e-03 | 9.98e-01 |
| GOCC NBAF COMPLEX | 16 | 9.77e-01 | 4.17e-03 | 9.99e-01 |
| GOBP MAINTENANCE OF LOCATION | 334 | 8.96e-01 | -4.14e-03 | 9.94e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 9.77e-01 | -4.13e-03 | 9.99e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 208 | 9.18e-01 | 4.12e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 9.75e-01 | -4.12e-03 | 9.99e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 9.86e-01 | 4.12e-03 | 1.00e+00 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 9.87e-01 | -4.11e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 155 | 9.30e-01 | -4.10e-03 | 9.98e-01 |
| GOBP DNA PROTECTION | 6 | 9.86e-01 | 4.09e-03 | 1.00e+00 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 20 | 9.75e-01 | 4.08e-03 | 9.99e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 44 | 9.63e-01 | 4.07e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 85 | 9.48e-01 | -4.06e-03 | 9.99e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 43 | 9.63e-01 | -4.06e-03 | 9.99e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 25 | 9.72e-01 | 4.04e-03 | 9.99e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 50 | 9.61e-01 | 4.02e-03 | 9.99e-01 |
| GOBP MISMATCH REPAIR | 32 | 9.69e-01 | -4.02e-03 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 126 | 9.38e-01 | -3.99e-03 | 9.98e-01 |
| GOBP CERAMIDE TRANSPORT | 17 | 9.77e-01 | -3.98e-03 | 9.99e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 41 | 9.65e-01 | 3.97e-03 | 9.99e-01 |
| GOBP AXON GUIDANCE | 223 | 9.19e-01 | -3.96e-03 | 9.97e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 316 | 9.04e-01 | 3.95e-03 | 9.96e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 9.82e-01 | 3.93e-03 | 9.99e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 9.77e-01 | 3.89e-03 | 9.99e-01 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 10 | 9.83e-01 | -3.88e-03 | 9.99e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 9.87e-01 | 3.87e-03 | 1.00e+00 |
| GOBP RESPONSE TO SALT STRESS | 24 | 9.74e-01 | -3.86e-03 | 9.99e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 16 | 9.79e-01 | 3.85e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 101 | 9.47e-01 | -3.83e-03 | 9.99e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 105 | 9.46e-01 | -3.83e-03 | 9.99e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 134 | 9.39e-01 | -3.82e-03 | 9.98e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 54 | 9.61e-01 | -3.81e-03 | 9.99e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 16 | 9.79e-01 | 3.81e-03 | 9.99e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 21 | 9.76e-01 | -3.75e-03 | 9.99e-01 |
| GOMF DYNEIN COMPLEX BINDING | 23 | 9.75e-01 | -3.75e-03 | 9.99e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 15 | 9.80e-01 | 3.74e-03 | 9.99e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 12 | 9.82e-01 | 3.71e-03 | 9.99e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 87 | 9.52e-01 | -3.70e-03 | 9.99e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 41 | 9.67e-01 | 3.70e-03 | 9.99e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 19 | 9.78e-01 | -3.70e-03 | 9.99e-01 |
| GOBP PLATELET MORPHOGENESIS | 22 | 9.76e-01 | 3.70e-03 | 9.99e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 9.80e-01 | 3.69e-03 | 9.99e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 148 | 9.38e-01 | 3.68e-03 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 13 | 9.82e-01 | -3.67e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 99 | 9.50e-01 | -3.66e-03 | 9.99e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 224 | 9.25e-01 | 3.64e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 30 | 9.72e-01 | -3.64e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 126 | 9.44e-01 | -3.61e-03 | 9.98e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 14 | 9.81e-01 | -3.61e-03 | 9.99e-01 |
| GOBP ENDOSOMAL TRANSPORT | 239 | 9.25e-01 | 3.56e-03 | 9.98e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 36 | 9.71e-01 | -3.55e-03 | 9.99e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 5 | 9.89e-01 | 3.55e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 67 | 9.60e-01 | -3.52e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 160 | 9.39e-01 | -3.52e-03 | 9.98e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 49 | 9.66e-01 | -3.49e-03 | 9.99e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 13 | 9.83e-01 | -3.49e-03 | 9.99e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 15 | 9.81e-01 | -3.49e-03 | 9.99e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 15 | 9.81e-01 | 3.48e-03 | 9.99e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 13 | 9.83e-01 | 3.47e-03 | 9.99e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 46 | 9.68e-01 | -3.46e-03 | 9.99e-01 |
| GOBP GENERATION OF NEURONS | 1416 | 8.28e-01 | -3.45e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 9.88e-01 | 3.45e-03 | 1.00e+00 |
| GOBP RESPONSE TO INSULIN | 262 | 9.24e-01 | -3.41e-03 | 9.98e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 248 | 9.27e-01 | 3.40e-03 | 9.98e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 164 | 9.40e-01 | -3.39e-03 | 9.98e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 24 | 9.77e-01 | -3.38e-03 | 9.99e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 61 | 9.64e-01 | -3.38e-03 | 9.99e-01 |
| GOCC MICROBODY | 143 | 9.45e-01 | 3.35e-03 | 9.99e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 208 | 9.34e-01 | 3.35e-03 | 9.98e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 317 | 9.19e-01 | -3.34e-03 | 9.97e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 246 | 9.28e-01 | -3.34e-03 | 9.98e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 136 | 9.47e-01 | -3.33e-03 | 9.99e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 9 | 9.86e-01 | 3.30e-03 | 1.00e+00 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 9.77e-01 | -3.29e-03 | 9.99e-01 |
| GOCC NURF COMPLEX | 5 | 9.90e-01 | 3.29e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION | 8 | 9.87e-01 | -3.25e-03 | 1.00e+00 |
| GOBP DENDRITE MORPHOGENESIS | 129 | 9.49e-01 | -3.24e-03 | 9.99e-01 |
| GOMF 7SK SNRNA BINDING | 9 | 9.87e-01 | -3.22e-03 | 1.00e+00 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 19 | 9.81e-01 | 3.21e-03 | 9.99e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 9.87e-01 | 3.21e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 38 | 9.73e-01 | -3.21e-03 | 9.99e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 79 | 9.61e-01 | -3.19e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 8 | 9.88e-01 | -3.17e-03 | 1.00e+00 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 8 | 9.88e-01 | 3.16e-03 | 1.00e+00 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 120 | 9.52e-01 | -3.16e-03 | 9.99e-01 |
| GOBP BEHAVIOR | 629 | 8.93e-01 | 3.16e-03 | 9.93e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 10 | 9.86e-01 | -3.15e-03 | 1.00e+00 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 16 | 9.83e-01 | 3.10e-03 | 9.99e-01 |
| GOBP HEMOPOIESIS | 911 | 8.74e-01 | -3.09e-03 | 9.93e-01 |
| GOMF FLIPPASE ACTIVITY | 15 | 9.84e-01 | -3.07e-03 | 9.99e-01 |
| GOBP SNRNA TRANSCRIPTION | 19 | 9.82e-01 | -3.04e-03 | 9.99e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 46 | 9.72e-01 | 3.02e-03 | 9.99e-01 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 12 | 9.86e-01 | 3.01e-03 | 1.00e+00 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 9.90e-01 | 2.99e-03 | 1.00e+00 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 116 | 9.56e-01 | -2.96e-03 | 9.99e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 27 | 9.79e-01 | -2.92e-03 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 9.84e-01 | 2.92e-03 | 9.99e-01 |
| GOBP VENTRAL MIDLINE DEVELOPMENT | 6 | 9.90e-01 | 2.92e-03 | 1.00e+00 |
| GOBP JNK CASCADE | 154 | 9.50e-01 | 2.91e-03 | 9.99e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 113 | 9.58e-01 | 2.88e-03 | 9.99e-01 |
| GOBP TELOMERE MAINTENANCE | 149 | 9.52e-01 | -2.87e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 9.90e-01 | -2.86e-03 | 1.00e+00 |
| GOBP HISTONE UBIQUITINATION | 8 | 9.89e-01 | -2.85e-03 | 1.00e+00 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 106 | 9.60e-01 | 2.82e-03 | 9.99e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 9.87e-01 | -2.80e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 6 | 9.91e-01 | 2.80e-03 | 1.00e+00 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 52 | 9.73e-01 | 2.76e-03 | 9.99e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 200 | 9.47e-01 | 2.75e-03 | 9.99e-01 |
| GOBP PHOSPHORYLATION | 1518 | 8.59e-01 | -2.73e-03 | 9.92e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 55 | 9.72e-01 | -2.72e-03 | 9.99e-01 |
| GOMF DYNEIN LIGHT CHAIN BINDING | 9 | 9.89e-01 | -2.72e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 146 | 9.55e-01 | -2.72e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1864 | 8.46e-01 | 2.72e-03 | 9.90e-01 |
| GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE | 6 | 9.91e-01 | 2.70e-03 | 1.00e+00 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 140 | 9.56e-01 | -2.68e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 151 | 9.55e-01 | 2.67e-03 | 9.99e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 9.77e-01 | -2.66e-03 | 9.99e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 100 | 9.63e-01 | 2.66e-03 | 9.99e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 87 | 9.66e-01 | 2.65e-03 | 9.99e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 29 | 9.80e-01 | -2.64e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 182 | 9.51e-01 | 2.64e-03 | 9.99e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 14 | 9.86e-01 | -2.62e-03 | 1.00e+00 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 20 | 9.84e-01 | 2.62e-03 | 9.99e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 52 | 9.74e-01 | 2.61e-03 | 9.99e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 35 | 9.79e-01 | -2.60e-03 | 9.99e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 85 | 9.67e-01 | -2.59e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 74 | 9.70e-01 | 2.52e-03 | 9.99e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 400 | 9.31e-01 | -2.51e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 231 | 9.48e-01 | -2.49e-03 | 9.99e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 14 | 9.87e-01 | -2.47e-03 | 1.00e+00 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 953 | 8.97e-01 | 2.47e-03 | 9.94e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 814 | 9.06e-01 | 2.44e-03 | 9.96e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 60 | 9.74e-01 | 2.39e-03 | 9.99e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 9.93e-01 | 2.38e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 573 | 9.23e-01 | -2.37e-03 | 9.98e-01 |
| GOMF COLLAGEN BINDING | 68 | 9.73e-01 | 2.36e-03 | 9.99e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 64 | 9.74e-01 | -2.35e-03 | 9.99e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 12 | 9.89e-01 | -2.34e-03 | 1.00e+00 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 39 | 9.80e-01 | 2.33e-03 | 9.99e-01 |
| GOBP NEURAL PLATE MORPHOGENESIS | 5 | 9.93e-01 | 2.32e-03 | 1.00e+00 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 9.88e-01 | -2.32e-03 | 1.00e+00 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 50 | 9.77e-01 | 2.31e-03 | 9.99e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 77 | 9.72e-01 | -2.31e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1240 | 8.92e-01 | 2.29e-03 | 9.93e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 19 | 9.86e-01 | -2.28e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING | 7 | 9.92e-01 | -2.27e-03 | 1.00e+00 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 9.92e-01 | 2.25e-03 | 1.00e+00 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 11 | 9.90e-01 | 2.23e-03 | 1.00e+00 |
| GOCC IMMUNOLOGICAL SYNAPSE | 45 | 9.79e-01 | 2.22e-03 | 9.99e-01 |
| GOBP RESPONSE TO FRUCTOSE | 8 | 9.91e-01 | -2.22e-03 | 1.00e+00 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 566 | 9.29e-01 | -2.19e-03 | 9.98e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 9.86e-01 | -2.16e-03 | 1.00e+00 |
| GOBP CELL PROJECTION ASSEMBLY | 586 | 9.30e-01 | 2.14e-03 | 9.98e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 13 | 9.89e-01 | -2.14e-03 | 1.00e+00 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 150 | 9.64e-01 | 2.11e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 546 | 9.35e-01 | -2.05e-03 | 9.98e-01 |
| GOBP NEUROGENESIS | 1643 | 8.90e-01 | -2.04e-03 | 9.93e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 873 | 9.19e-01 | 2.04e-03 | 9.97e-01 |
| GOMF LEUCINE BINDING | 6 | 9.93e-01 | -2.04e-03 | 1.00e+00 |
| GOBP RESPONSE TO UV B | 21 | 9.87e-01 | 2.03e-03 | 1.00e+00 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 9.91e-01 | -2.01e-03 | 1.00e+00 |
| GOBP VIRAL GENOME REPLICATION | 124 | 9.69e-01 | -2.00e-03 | 9.99e-01 |
| GOBP MICTURITION | 8 | 9.92e-01 | 1.98e-03 | 1.00e+00 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 12 | 9.91e-01 | 1.96e-03 | 1.00e+00 |
| GOBP CELLULAR CATABOLIC PROCESS | 1532 | 8.99e-01 | 1.95e-03 | 9.94e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 7 | 9.93e-01 | -1.92e-03 | 1.00e+00 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 9.93e-01 | 1.88e-03 | 1.00e+00 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 12 | 9.91e-01 | 1.86e-03 | 1.00e+00 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 98 | 9.75e-01 | 1.85e-03 | 9.99e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 115 | 9.73e-01 | 1.83e-03 | 9.99e-01 |
| GOMF U1 SNRNP BINDING | 6 | 9.94e-01 | -1.82e-03 | 1.00e+00 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 23 | 9.88e-01 | -1.81e-03 | 1.00e+00 |
| GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.94e-01 | 1.80e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 138 | 9.71e-01 | -1.77e-03 | 9.99e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 1037 | 9.24e-01 | -1.76e-03 | 9.98e-01 |
| GOBP ENDOCYTIC RECYCLING | 82 | 9.78e-01 | -1.76e-03 | 9.99e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 51 | 9.83e-01 | 1.69e-03 | 9.99e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 51 | 9.83e-01 | 1.69e-03 | 9.99e-01 |
| GOCC MULTIVESICULAR BODY | 65 | 9.81e-01 | -1.67e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 110 | 9.76e-01 | 1.64e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO L GLUTAMATE | 5 | 9.95e-01 | -1.63e-03 | 1.00e+00 |
| GOBP REGULATION OF MYELINATION | 45 | 9.85e-01 | -1.61e-03 | 1.00e+00 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 6 | 9.95e-01 | -1.61e-03 | 1.00e+00 |
| GOBP SYNAPTIC VESICLE RECYCLING | 76 | 9.81e-01 | 1.61e-03 | 9.99e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 1268 | 9.25e-01 | 1.57e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 941 | 9.35e-01 | 1.56e-03 | 9.98e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 16 | 9.91e-01 | 1.55e-03 | 1.00e+00 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 206 | 9.70e-01 | -1.53e-03 | 9.99e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 191 | 9.71e-01 | -1.51e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 60 | 9.84e-01 | 1.50e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 65 | 9.83e-01 | -1.50e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 12 | 9.93e-01 | 1.49e-03 | 1.00e+00 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 12 | 9.93e-01 | -1.49e-03 | 1.00e+00 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 11 | 9.93e-01 | -1.48e-03 | 1.00e+00 |
| GOBP CELL PART MORPHOGENESIS | 642 | 9.49e-01 | 1.47e-03 | 9.99e-01 |
| GOBP SEX DETERMINATION | 18 | 9.91e-01 | -1.47e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 59 | 9.84e-01 | -1.47e-03 | 9.99e-01 |
| GOBP RETINA HOMEOSTASIS | 75 | 9.83e-01 | 1.46e-03 | 9.99e-01 |
| GOBP RECEPTOR DIFFUSION TRAPPING | 10 | 9.94e-01 | -1.46e-03 | 1.00e+00 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 87 | 9.81e-01 | -1.44e-03 | 9.99e-01 |
| GOBP SINGLE FERTILIZATION | 158 | 9.75e-01 | 1.43e-03 | 9.99e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 36 | 9.88e-01 | -1.42e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 10 | 9.94e-01 | 1.41e-03 | 1.00e+00 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 46 | 9.87e-01 | 1.40e-03 | 1.00e+00 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 10 | 9.94e-01 | 1.39e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 10 | 9.94e-01 | 1.37e-03 | 1.00e+00 |
| GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT | 9 | 9.94e-01 | 1.36e-03 | 1.00e+00 |
| GOBP ERAD PATHWAY | 108 | 9.81e-01 | -1.36e-03 | 9.99e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 46 | 9.87e-01 | -1.36e-03 | 1.00e+00 |
| GOBP AXONAL TRANSPORT | 62 | 9.85e-01 | -1.36e-03 | 1.00e+00 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 8 | 9.95e-01 | -1.34e-03 | 1.00e+00 |
| GOBP LYMPH VESSEL DEVELOPMENT | 31 | 9.90e-01 | -1.32e-03 | 1.00e+00 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 9.96e-01 | -1.31e-03 | 1.00e+00 |
| GOBP ALCOHOL METABOLIC PROCESS | 355 | 9.66e-01 | 1.30e-03 | 9.99e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 5 | 9.96e-01 | -1.29e-03 | 1.00e+00 |
| GOMF ANTIPORTER ACTIVITY | 127 | 9.80e-01 | -1.26e-03 | 9.99e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 29 | 9.91e-01 | 1.23e-03 | 1.00e+00 |
| GOBP FLUID TRANSPORT | 37 | 9.90e-01 | -1.22e-03 | 1.00e+00 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 1078 | 9.46e-01 | 1.21e-03 | 9.99e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 152 | 9.80e-01 | 1.20e-03 | 9.99e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1616 | 9.37e-01 | -1.18e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 146 | 9.81e-01 | 1.15e-03 | 9.99e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 547 | 9.64e-01 | 1.14e-03 | 9.99e-01 |
| GOBP RUFFLE ORGANIZATION | 57 | 9.88e-01 | 1.13e-03 | 1.00e+00 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 945 | 9.54e-01 | 1.12e-03 | 9.99e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 118 | 9.83e-01 | -1.11e-03 | 9.99e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY | 13 | 9.95e-01 | 1.08e-03 | 1.00e+00 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 30 | 9.92e-01 | -1.07e-03 | 1.00e+00 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 9.89e-01 | 1.05e-03 | 1.00e+00 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 21 | 9.93e-01 | -1.05e-03 | 1.00e+00 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 208 | 9.79e-01 | 1.05e-03 | 9.99e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 35 | 9.92e-01 | -1.04e-03 | 1.00e+00 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 170 | 9.81e-01 | -1.04e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 79 | 9.87e-01 | -1.03e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 15 | 9.95e-01 | 1.02e-03 | 1.00e+00 |
| GOBP RESPONSE TO UV | 147 | 9.83e-01 | 1.02e-03 | 9.99e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 17 | 9.94e-01 | 1.02e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 247 | 9.78e-01 | -1.02e-03 | 9.99e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 503 | 9.69e-01 | 9.98e-04 | 9.99e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 837 | 9.62e-01 | -9.81e-04 | 9.99e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 930 | 9.60e-01 | -9.72e-04 | 9.99e-01 |
| GOBP REGULATION OF SECRETION | 601 | 9.68e-01 | -9.53e-04 | 9.99e-01 |
| GOMF ACTIN FILAMENT BINDING | 203 | 9.82e-01 | -9.42e-04 | 9.99e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 26 | 9.93e-01 | 9.41e-04 | 1.00e+00 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 276 | 9.79e-01 | -9.09e-04 | 9.99e-01 |
| GOBP RELAXATION OF MUSCLE | 33 | 9.93e-01 | 8.84e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION | 6 | 9.97e-01 | 8.66e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 15 | 9.95e-01 | -8.42e-04 | 1.00e+00 |
| GOMF AMP BINDING | 15 | 9.95e-01 | -8.42e-04 | 1.00e+00 |
| GOCC BLOOD MICROPARTICLE | 111 | 9.88e-01 | -8.39e-04 | 1.00e+00 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 42 | 9.93e-01 | 8.13e-04 | 1.00e+00 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 18 | 9.95e-01 | 8.06e-04 | 1.00e+00 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 28 | 9.94e-01 | 7.95e-04 | 1.00e+00 |
| GOBP CERAMIDE CATABOLIC PROCESS | 20 | 9.95e-01 | 7.89e-04 | 1.00e+00 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 63 | 9.91e-01 | 7.80e-04 | 1.00e+00 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 11 | 9.96e-01 | 7.67e-04 | 1.00e+00 |
| GOBP HEART PROCESS | 245 | 9.84e-01 | -7.54e-04 | 9.99e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 12 | 9.96e-01 | 7.52e-04 | 1.00e+00 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 75 | 9.91e-01 | 7.37e-04 | 1.00e+00 |
| GOCC AP 2 ADAPTOR COMPLEX | 10 | 9.97e-01 | -7.30e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 228 | 9.85e-01 | -7.23e-04 | 1.00e+00 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 17 | 9.96e-01 | 7.11e-04 | 1.00e+00 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 12 | 9.97e-01 | -7.07e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 31 | 9.95e-01 | -7.05e-04 | 1.00e+00 |
| GOBP AMINO ACID METABOLIC PROCESS | 277 | 9.84e-01 | -7.00e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 17 | 9.96e-01 | -6.95e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 9.98e-01 | -6.29e-04 | 1.00e+00 |
| GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 9.98e-01 | -6.11e-04 | 1.00e+00 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 38 | 9.95e-01 | -6.10e-04 | 1.00e+00 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 605 | 9.80e-01 | -5.91e-04 | 9.99e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 9.95e-01 | 5.53e-04 | 1.00e+00 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 65 | 9.94e-01 | -5.48e-04 | 1.00e+00 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 450 | 9.84e-01 | 5.44e-04 | 9.99e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 25 | 9.96e-01 | 5.24e-04 | 1.00e+00 |
| GOBP DOPAMINE METABOLIC PROCESS | 35 | 9.96e-01 | 4.50e-04 | 1.00e+00 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 9.96e-01 | 4.47e-04 | 1.00e+00 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 37 | 9.96e-01 | 4.40e-04 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 364 | 9.89e-01 | 4.33e-04 | 1.00e+00 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 39 | 9.96e-01 | 4.32e-04 | 1.00e+00 |
| GOBP FOREBRAIN DEVELOPMENT | 389 | 9.89e-01 | -4.14e-04 | 1.00e+00 |
| GOCC NUCLEAR PORE | 89 | 9.95e-01 | -3.96e-04 | 1.00e+00 |
| GOBP MESENCHYMAL CELL MIGRATION | 61 | 9.96e-01 | 3.63e-04 | 1.00e+00 |
| GOCC NUCLEOLUS | 1318 | 9.82e-01 | -3.62e-04 | 9.99e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 14 | 9.98e-01 | 3.52e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 139 | 9.94e-01 | -3.51e-04 | 1.00e+00 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 491 | 9.89e-01 | 3.50e-04 | 1.00e+00 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 19 | 9.98e-01 | -3.48e-04 | 1.00e+00 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 22 | 9.98e-01 | -3.46e-04 | 1.00e+00 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 17 | 9.98e-01 | -3.30e-04 | 1.00e+00 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 63 | 9.96e-01 | -3.27e-04 | 1.00e+00 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 53 | 9.97e-01 | -3.23e-04 | 1.00e+00 |
| GOBP NEURON PROJECTION ORGANIZATION | 84 | 9.96e-01 | 3.10e-04 | 1.00e+00 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 702 | 9.89e-01 | 2.94e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF GROWTH | 236 | 9.94e-01 | 2.79e-04 | 1.00e+00 |
| GOBP PROTEIN HYDROXYLATION | 23 | 9.99e-01 | 2.16e-04 | 1.00e+00 |
| GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT | 7 | 9.99e-01 | 2.02e-04 | 1.00e+00 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 72 | 9.98e-01 | -1.77e-04 | 1.00e+00 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 139 | 9.97e-01 | 1.58e-04 | 1.00e+00 |
| GOCC OUTER MEMBRANE | 229 | 9.97e-01 | -1.54e-04 | 1.00e+00 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 53 | 9.99e-01 | 1.30e-04 | 1.00e+00 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 59 | 9.99e-01 | 1.28e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 89 | 9.98e-01 | -1.19e-04 | 1.00e+00 |
| GOBP L GLUTAMATE IMPORT | 38 | 9.99e-01 | -1.11e-04 | 1.00e+00 |
| GOBP TRANSLATIONAL ELONGATION | 68 | 9.99e-01 | -1.04e-04 | 1.00e+00 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 19 | 9.99e-01 | 1.03e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 50 | 9.99e-01 | -8.95e-05 | 1.00e+00 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 9.99e-01 | 8.94e-05 | 1.00e+00 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 1.00e+00 | 8.21e-05 | 1.00e+00 |
| GOBP RESPONSE TO TYPE III INTERFERON | 11 | 1.00e+00 | 7.88e-05 | 1.00e+00 |
| GOBP NEURON APOPTOTIC PROCESS | 264 | 9.98e-01 | 7.62e-05 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 22 | 1.00e+00 | 7.47e-05 | 1.00e+00 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 13 | 1.00e+00 | 6.66e-05 | 1.00e+00 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 14 | 1.00e+00 | 6.51e-05 | 1.00e+00 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 59 | 9.99e-01 | 5.81e-05 | 1.00e+00 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 469 | 9.98e-01 | 5.45e-05 | 1.00e+00 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 17 | 1.00e+00 | 5.10e-05 | 1.00e+00 |
| GOBP VIRAL TRANSLATION | 20 | 1.00e+00 | -9.12e-06 | 1.00e+00 |
Detailed Gene set reports
GOBP_DISRUPTION_OF_PLASMA_MEMBRANE_INTEGRITY_IN_ANOTHER_ORGANISM
| set | GOBP_DISRUPTION_OF_PLASMA_MEMBRANE_INTEGRITY_IN_ANOTHER_ORGANISM |
| setSize | 6 |
| pANOVA | 3.24e-05 |
| s.dist | -0.979 |
| p.adjustANOVA | 0.0114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -17881 |
| DEFA1B | -17881 |
| DEFA3 | -17881 |
| DEFA6 | -17653 |
| DEFA4 | -17444 |
| DEFA5 | -17295 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -17881 |
| DEFA1B | -17881 |
| DEFA3 | -17881 |
| DEFA6 | -17653 |
| DEFA4 | -17444 |
| DEFA5 | -17295 |
GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION
| set | GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION |
| setSize | 5 |
| pANOVA | 0.000397 |
| s.dist | 0.915 |
| p.adjustANOVA | 0.0634 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UCN | 3838 |
| CRH | 3830 |
| CRHBP | 3139 |
| GHRL | 2725 |
| RAB8B | 1983 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UCN | 3838 |
| CRH | 3830 |
| CRHBP | 3139 |
| GHRL | 2725 |
| RAB8B | 1983 |
GOMF_PIRNA_BINDING
| set | GOMF_PIRNA_BINDING |
| setSize | 5 |
| pANOVA | 0.00506 |
| s.dist | -0.724 |
| p.adjustANOVA | 0.278 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PIWIL1 | -17621 |
| PIWIL3 | -16655 |
| PIWIL4 | -15520 |
| TEX19 | -12387 |
| PIWIL2 | -12165 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PIWIL1 | -17621 |
| PIWIL3 | -16655 |
| PIWIL4 | -15520 |
| TEX19 | -12387 |
| PIWIL2 | -12165 |
GOBP_PREVENTION_OF_POLYSPERMY
| set | GOBP_PREVENTION_OF_POLYSPERMY |
| setSize | 7 |
| pANOVA | 0.00122 |
| s.dist | -0.706 |
| p.adjustANOVA | 0.129 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ZP1 | -16855 |
| PLAT | -16464 |
| ASTL | -16427 |
| ZP2 | -16047 |
| ZP4 | -15287 |
| NLRP5 | -13741 |
| MYH9 | -7856 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ZP1 | -16855 |
| PLAT | -16464 |
| ASTL | -16427 |
| ZP2 | -16047 |
| ZP4 | -15287 |
| NLRP5 | -13741 |
| MYH9 | -7856 |
GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_ACTIVATION
| set | GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_ACTIVATION |
| setSize | 5 |
| pANOVA | 0.00829 |
| s.dist | -0.682 |
| p.adjustANOVA | 0.353 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPI1 | -16815 |
| MIR125A | -15460 |
| CD300A | -14139 |
| GRN | -13813 |
| BCR | -11805 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPI1 | -16815 |
| MIR125A | -15460 |
| CD300A | -14139 |
| GRN | -13813 |
| BCR | -11805 |
GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS
| set | GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS |
| setSize | 7 |
| pANOVA | 0.00325 |
| s.dist | 0.642 |
| p.adjustANOVA | 0.219 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TBX1 | 3159 |
| EYA1 | 2865 |
| CHD7 | 2051 |
| HOXA1 | 1993 |
| TBX3 | 1471 |
| FGF10 | -2067 |
| ZEB1 | -8667 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TBX1 | 3159 |
| EYA1 | 2865 |
| CHD7 | 2051 |
| HOXA1 | 1993 |
| TBX3 | 1471 |
| FGF10 | -2067 |
| ZEB1 | -8667 |
GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY
| set | GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0144 |
| s.dist | -0.632 |
| p.adjustANOVA | 0.454 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FMO3 | -16142 |
| FMO2 | -15553 |
| FMO1 | -14246 |
| FMO4 | -13842 |
| FMO5 | -9513 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FMO3 | -16142 |
| FMO2 | -15553 |
| FMO1 | -14246 |
| FMO4 | -13842 |
| FMO5 | -9513 |
GOBP_COMPARTMENT_PATTERN_SPECIFICATION
| set | GOBP_COMPARTMENT_PATTERN_SPECIFICATION |
| setSize | 5 |
| pANOVA | 0.015 |
| s.dist | 0.628 |
| p.adjustANOVA | 0.461 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DLL1 | 3671 |
| PBX3 | 2848 |
| NOTCH1 | 2275 |
| DLL3 | 2046 |
| LFNG | -11031 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DLL1 | 3671 |
| PBX3 | 2848 |
| NOTCH1 | 2275 |
| DLL3 | 2046 |
| LFNG | -11031 |
GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION
| set | GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.0153 |
| s.dist | 0.626 |
| p.adjustANOVA | 0.461 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DLL1 | 3671 |
| NOTCH1 | 2275 |
| HES1 | -82 |
| NODAL | -389 |
| JAG1 | -5787 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DLL1 | 3671 |
| NOTCH1 | 2275 |
| HES1 | -82 |
| NODAL | -389 |
| JAG1 | -5787 |
GOBP_EGG_ACTIVATION
| set | GOBP_EGG_ACTIVATION |
| setSize | 11 |
| pANOVA | 0.000395 |
| s.dist | -0.617 |
| p.adjustANOVA | 0.0634 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NPR2 | -16973 |
| ZP1 | -16855 |
| PLAT | -16464 |
| ASTL | -16427 |
| ZP2 | -16047 |
| ZP4 | -15287 |
| NLRP5 | -13741 |
| WBP2NL | -12552 |
| PLCB1 | -9746 |
| PLCZ1 | -8690 |
| MYH9 | -7856 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NPR2 | -16973 |
| ZP1 | -16855 |
| PLAT | -16464 |
| ASTL | -16427 |
| ZP2 | -16047 |
| ZP4 | -15287 |
| NLRP5 | -13741 |
| WBP2NL | -12552 |
| PLCB1 | -9746 |
| PLCZ1 | -8690 |
| MYH9 | -7856 |
GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY
| set | GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0179 |
| s.dist | 0.612 |
| p.adjustANOVA | 0.477 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RRN3 | 3728 |
| TAF1C | 1916 |
| RRN3P1 | -699 |
| RRN3P2 | -1220 |
| UBTF | -4832 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RRN3 | 3728 |
| TAF1C | 1916 |
| RRN3P1 | -699 |
| RRN3P2 | -1220 |
| UBTF | -4832 |
GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION
| set | GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.0181 |
| s.dist | -0.611 |
| p.adjustANOVA | 0.477 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LHX3 | -17463 |
| PROP1 | -15299 |
| GHRHR | -14505 |
| PITX2 | -10629 |
| WNT4 | -10233 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LHX3 | -17463 |
| PROP1 | -15299 |
| GHRHR | -14505 |
| PITX2 | -10629 |
| WNT4 | -10233 |
GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY
| set | GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY |
| setSize | 7 |
| pANOVA | 0.00528 |
| s.dist | -0.609 |
| p.adjustANOVA | 0.28 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL23A | -17754 |
| CCL5 | -17316 |
| AGT | -14831 |
| CD300A | -14139 |
| IL6R | -11192 |
| IL12B | -10302 |
| IL23R | -9707 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL23A | -17754 |
| CCL5 | -17316 |
| AGT | -14831 |
| CD300A | -14139 |
| IL6R | -11192 |
| IL12B | -10302 |
| IL23R | -9707 |
GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE
| set | GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE |
| setSize | 8 |
| pANOVA | 0.00287 |
| s.dist | -0.609 |
| p.adjustANOVA | 0.204 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KLK5 | -17467 |
| ACOD1 | -15926 |
| KLK7 | -15892 |
| IL17A | -15211 |
| IL17F | -14539 |
| KLK3 | -12344 |
| PGC | -9037 |
| NOD2 | -8425 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KLK5 | -17467 |
| ACOD1 | -15926 |
| KLK7 | -15892 |
| IL17A | -15211 |
| IL17F | -14539 |
| KLK3 | -12344 |
| PGC | -9037 |
| NOD2 | -8425 |
GOBP_REGULATION_OF_MESODERM_DEVELOPMENT
| set | GOBP_REGULATION_OF_MESODERM_DEVELOPMENT |
| setSize | 6 |
| pANOVA | 0.0102 |
| s.dist | -0.605 |
| p.adjustANOVA | 0.383 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CER1 | -16757 |
| MIR1-1 | -16478 |
| MIXL1 | -15922 |
| ETV2 | -14336 |
| TP63 | -10364 |
| PUS7 | -7556 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CER1 | -16757 |
| MIR1-1 | -16478 |
| MIXL1 | -15922 |
| ETV2 | -14336 |
| TP63 | -10364 |
| PUS7 | -7556 |
GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT
| set | GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.0198 |
| s.dist | 0.602 |
| p.adjustANOVA | 0.491 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDGFB | 2825 |
| NOTCH1 | 2275 |
| FOXC2 | -88 |
| GPR4 | -303 |
| ACTA2 | -6366 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDGFB | 2825 |
| NOTCH1 | 2275 |
| FOXC2 | -88 |
| GPR4 | -303 |
| ACTA2 | -6366 |
GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING
| set | GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING |
| setSize | 5 |
| pANOVA | 0.0198 |
| s.dist | -0.601 |
| p.adjustANOVA | 0.491 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CXCL9 | -17683 |
| PF4 | -17675 |
| CXCL11 | -17144 |
| CXCL13 | -16002 |
| CXCL10 | 870 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CXCL9 | -17683 |
| PF4 | -17675 |
| CXCL11 | -17144 |
| CXCL13 | -16002 |
| CXCL10 | 870 |
GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING
| set | GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING |
| setSize | 5 |
| pANOVA | 0.0203 |
| s.dist | -0.599 |
| p.adjustANOVA | 0.494 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCL26 | -16906 |
| NARS1 | -15951 |
| CCL24 | -14885 |
| CCL27 | -13335 |
| CCL11 | -6441 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCL26 | -16906 |
| NARS1 | -15951 |
| CCL24 | -14885 |
| CCL27 | -13335 |
| CCL11 | -6441 |
GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS
| set | GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS |
| setSize | 7 |
| pANOVA | 0.00614 |
| s.dist | -0.598 |
| p.adjustANOVA | 0.3 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMP4 | -17059 |
| TIMP2 | -15322 |
| TIMP3 | -14805 |
| PTPN3 | -13448 |
| LRIG2 | -12157 |
| ROCK1 | -11204 |
| IL10 | -10427 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMP4 | -17059 |
| TIMP2 | -15322 |
| TIMP3 | -14805 |
| PTPN3 | -13448 |
| LRIG2 | -12157 |
| ROCK1 | -11204 |
| IL10 | -10427 |
GOBP_SPERMIDINE_TRANSPORT
| set | GOBP_SPERMIDINE_TRANSPORT |
| setSize | 5 |
| pANOVA | 0.0208 |
| s.dist | 0.597 |
| p.adjustANOVA | 0.496 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC22A3 | 2333 |
| SLC22A2 | 2210 |
| SLC22A1 | 2163 |
| SLC18B1 | -2653 |
| SLC22A16 | -5976 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC22A3 | 2333 |
| SLC22A2 | 2210 |
| SLC22A1 | 2163 |
| SLC18B1 | -2653 |
| SLC22A16 | -5976 |
GOBP_SOFT_PALATE_DEVELOPMENT
| set | GOBP_SOFT_PALATE_DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.021 |
| s.dist | 0.596 |
| p.adjustANOVA | 0.496 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TBX1 | 3159 |
| FOXE1 | 1825 |
| SOX11 | 1112 |
| COL11A2 | 962 |
| TSHZ1 | -9015 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TBX1 | 3159 |
| FOXE1 | 1825 |
| SOX11 | 1112 |
| COL11A2 | 962 |
| TSHZ1 | -9015 |
GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS
| set | GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS |
| setSize | 6 |
| pANOVA | 0.013 |
| s.dist | -0.586 |
| p.adjustANOVA | 0.436 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BMP5 | -16558 |
| ATP1A1 | -16538 |
| REST | -13760 |
| PDE8B | -13564 |
| BMP2 | -12366 |
| DKK3 | -7342 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BMP5 | -16558 |
| ATP1A1 | -16538 |
| REST | -13760 |
| PDE8B | -13564 |
| BMP2 | -12366 |
| DKK3 | -7342 |
GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS
| set | GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS |
| setSize | 5 |
| pANOVA | 0.0242 |
| s.dist | -0.582 |
| p.adjustANOVA | 0.517 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BMP5 | -16558 |
| ATP1A1 | -16538 |
| REST | -13760 |
| BMP2 | -12366 |
| DKK3 | -7342 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BMP5 | -16558 |
| ATP1A1 | -16538 |
| REST | -13760 |
| BMP2 | -12366 |
| DKK3 | -7342 |
GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION
| set | GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION |
| setSize | 7 |
| pANOVA | 0.0078 |
| s.dist | 0.581 |
| p.adjustANOVA | 0.343 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IRGM | 2739 |
| CALCOCO2 | 1357 |
| FYCO1 | 1007 |
| SMCR8 | 589 |
| ADRB2 | -1317 |
| TOM1 | -1790 |
| UVRAG | -6512 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IRGM | 2739 |
| CALCOCO2 | 1357 |
| FYCO1 | 1007 |
| SMCR8 | 589 |
| ADRB2 | -1317 |
| TOM1 | -1790 |
| UVRAG | -6512 |
GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM
| set | GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM |
| setSize | 10 |
| pANOVA | 0.00158 |
| s.dist | -0.577 |
| p.adjustANOVA | 0.151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -17881 |
| DEFA1B | -17881 |
| DEFA3 | -17881 |
| DEFA6 | -17653 |
| REG1B | -17611 |
| DEFA4 | -17444 |
| DEFA5 | -17295 |
| REG3A | -6659 |
| REG1A | -2200 |
| REG3G | -55 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DEFA1 | -17881 |
| DEFA1B | -17881 |
| DEFA3 | -17881 |
| DEFA6 | -17653 |
| REG1B | -17611 |
| DEFA4 | -17444 |
| DEFA5 | -17295 |
| REG3A | -6659 |
| REG1A | -2200 |
| REG3G | -55 |
GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY
| set | GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0255 |
| s.dist | 0.577 |
| p.adjustANOVA | 0.525 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDHA2 | 1899 |
| DLD | 1556 |
| DLAT | -381 |
| PDHB | -1940 |
| PDHX | -4151 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDHA2 | 1899 |
| DLD | 1556 |
| DLAT | -381 |
| PDHB | -1940 |
| PDHX | -4151 |
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_FOOD
| set | GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_FOOD |
| setSize | 10 |
| pANOVA | 0.00167 |
| s.dist | 0.574 |
| p.adjustANOVA | 0.157 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UCN | 3838 |
| LEP | 2950 |
| SPX | 2490 |
| CARTPT | 2470 |
| PPARA | 212 |
| NENF | -2178 |
| BBS4 | -2302 |
| MKKS | -3848 |
| GHSR | -3885 |
| BBS2 | -6097 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UCN | 3838 |
| LEP | 2950 |
| SPX | 2490 |
| CARTPT | 2470 |
| PPARA | 212 |
| NENF | -2178 |
| BBS4 | -2302 |
| MKKS | -3848 |
| GHSR | -3885 |
| BBS2 | -6097 |
GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
| set | GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY |
| setSize | 7 |
| pANOVA | 0.00859 |
| s.dist | -0.574 |
| p.adjustANOVA | 0.358 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AQP3 | -16213 |
| AQP7 | -16088 |
| AQP10 | -15452 |
| AQP8 | -15106 |
| AQP9 | -14211 |
| SLC14A2 | -13349 |
| SLC14A1 | -2118 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AQP3 | -16213 |
| AQP7 | -16088 |
| AQP10 | -15452 |
| AQP8 | -15106 |
| AQP9 | -14211 |
| SLC14A2 | -13349 |
| SLC14A1 | -2118 |
GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY
| set | GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0266 |
| s.dist | 0.573 |
| p.adjustANOVA | 0.531 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| USP16 | 2966 |
| MYSM1 | 2253 |
| BAP1 | 332 |
| USP49 | -3671 |
| USP22 | -5116 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| USP16 | 2966 |
| MYSM1 | 2253 |
| BAP1 | 332 |
| USP49 | -3671 |
| USP22 | -5116 |
GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION
| set | GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION |
| setSize | 5 |
| pANOVA | 0.0274 |
| s.dist | -0.57 |
| p.adjustANOVA | 0.537 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD47 | -16461 |
| CCR2 | -16293 |
| PDGFD | -15219 |
| JAM3 | -13705 |
| AGER | -4209 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CD47 | -16461 |
| CCR2 | -16293 |
| PDGFD | -15219 |
| JAM3 | -13705 |
| AGER | -4209 |
GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS
| set | GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS |
| setSize | 6 |
| pANOVA | 0.0158 |
| s.dist | -0.569 |
| p.adjustANOVA | 0.466 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MIR145 | -17758 |
| MIR143 | -17282 |
| EFEMP2 | -13423 |
| COL3A1 | -12877 |
| MYLK | -12831 |
| PROX1 | -4860 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MIR145 | -17758 |
| MIR143 | -17282 |
| EFEMP2 | -13423 |
| COL3A1 | -12877 |
| MYLK | -12831 |
| PROX1 | -4860 |
GOBP_POSITIVE_REGULATION_OF_FERTILIZATION
| set | GOBP_POSITIVE_REGULATION_OF_FERTILIZATION |
| setSize | 5 |
| pANOVA | 0.0281 |
| s.dist | 0.567 |
| p.adjustANOVA | 0.545 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRSS37 | 3023 |
| CFAP69 | 2478 |
| PRDM9 | 1853 |
| LHFPL2 | -1360 |
| CCDC87 | -9550 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRSS37 | 3023 |
| CFAP69 | 2478 |
| PRDM9 | 1853 |
| LHFPL2 | -1360 |
| CCDC87 | -9550 |
GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY
| set | GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY |
| setSize | 6 |
| pANOVA | 0.0165 |
| s.dist | 0.565 |
| p.adjustANOVA | 0.468 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GDF15 | 3379 |
| GHRL | 2725 |
| LEPROT | -514 |
| LEPROTL1 | -802 |
| MBD5 | -4539 |
| JAK2 | -4630 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GDF15 | 3379 |
| GHRL | 2725 |
| LEPROT | -514 |
| LEPROTL1 | -802 |
| MBD5 | -4539 |
| JAK2 | -4630 |
GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS
| set | GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS |
| setSize | 5 |
| pANOVA | 0.03 |
| s.dist | 0.56 |
| p.adjustANOVA | 0.554 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTR1B | 1913 |
| HTR2B | 867 |
| TRPV1 | -693 |
| TRPM2 | -860 |
| KCNK4 | -5147 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTR1B | 1913 |
| HTR2B | 867 |
| TRPV1 | -693 |
| TRPM2 | -860 |
| KCNK4 | -5147 |
GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER
| set | GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER |
| setSize | 5 |
| pANOVA | 0.0312 |
| s.dist | 0.556 |
| p.adjustANOVA | 0.556 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TUBGCP5 | 2202 |
| TUBGCP2 | 775 |
| TUBGCP3 | -2270 |
| TUBGCP4 | -2285 |
| TUBGCP6 | -2551 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TUBGCP5 | 2202 |
| TUBGCP2 | 775 |
| TUBGCP3 | -2270 |
| TUBGCP4 | -2285 |
| TUBGCP6 | -2551 |
GOMF_LACTATE_DEHYDROGENASE_ACTIVITY
| set | GOMF_LACTATE_DEHYDROGENASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.019 |
| s.dist | 0.553 |
| p.adjustANOVA | 0.489 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LDHC | 3960 |
| LDHAL6A | 3315 |
| LDHD | 3162 |
| LDHAL6B | 2035 |
| LDHB | -6176 |
| LDHA | -11492 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LDHC | 3960 |
| LDHAL6A | 3315 |
| LDHD | 3162 |
| LDHAL6B | 2035 |
| LDHB | -6176 |
| LDHA | -11492 |
GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION
| set | GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION |
| setSize | 5 |
| pANOVA | 0.0324 |
| s.dist | 0.552 |
| p.adjustANOVA | 0.558 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| INSL4 | 3940 |
| BOK | 3805 |
| FZD5 | 1058 |
| NODAL | -389 |
| ACVR1C | -12767 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| INSL4 | 3940 |
| BOK | 3805 |
| FZD5 | 1058 |
| NODAL | -389 |
| ACVR1C | -12767 |
GOBP_ENDOCANNABINOID_SIGNALING_PATHWAY
| set | GOBP_ENDOCANNABINOID_SIGNALING_PATHWAY |
| setSize | 5 |
| pANOVA | 0.0324 |
| s.dist | -0.552 |
| p.adjustANOVA | 0.558 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ALOX15B | -16581 |
| ABHD6 | -15398 |
| DAGLA | -13162 |
| CAMK2A | -12917 |
| MGLL | -6882 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ALOX15B | -16581 |
| ABHD6 | -15398 |
| DAGLA | -13162 |
| CAMK2A | -12917 |
| MGLL | -6882 |
GOBP_ATRIOVENTRICULAR_VALVE_FORMATION
| set | GOBP_ATRIOVENTRICULAR_VALVE_FORMATION |
| setSize | 8 |
| pANOVA | 0.00704 |
| s.dist | 0.55 |
| p.adjustANOVA | 0.325 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HEY1 | 2655 |
| HEY2 | 2482 |
| NOTCH1 | 2275 |
| OLFM1 | 1698 |
| ZFPM1 | 946 |
| DCHS1 | -2742 |
| SMAD4 | -5864 |
| GATA4 | -8616 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HEY1 | 2655 |
| HEY2 | 2482 |
| NOTCH1 | 2275 |
| OLFM1 | 1698 |
| ZFPM1 | 946 |
| DCHS1 | -2742 |
| SMAD4 | -5864 |
| GATA4 | -8616 |
GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE
| set | GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE |
| setSize | 5 |
| pANOVA | 0.036 |
| s.dist | -0.542 |
| p.adjustANOVA | 0.575 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARL5C | -16233 |
| RAB6A | -14951 |
| ARL5B | -14800 |
| RAB6B | -13821 |
| ARL5A | -4547 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ARL5C | -16233 |
| RAB6A | -14951 |
| ARL5B | -14800 |
| RAB6B | -13821 |
| ARL5A | -4547 |
GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE
| set | GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE |
| setSize | 10 |
| pANOVA | 0.00316 |
| s.dist | -0.539 |
| p.adjustANOVA | 0.216 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TREM2 | -17552.0 |
| CCL2 | -17243.0 |
| C4A | -16746.5 |
| C4B | -16746.5 |
| HMGB1 | -16086.0 |
| C2 | -11448.0 |
| C3 | -10294.0 |
| TGM2 | -9691.0 |
| ABCA7 | -7097.0 |
| CD300LF | -5496.0 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TREM2 | -17552.0 |
| CCL2 | -17243.0 |
| C4A | -16746.5 |
| C4B | -16746.5 |
| HMGB1 | -16086.0 |
| C2 | -11448.0 |
| C3 | -10294.0 |
| TGM2 | -9691.0 |
| ABCA7 | -7097.0 |
| CD300LF | -5496.0 |
GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE
| set | GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE |
| setSize | 8 |
| pANOVA | 0.00843 |
| s.dist | -0.538 |
| p.adjustANOVA | 0.355 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TREM2 | -17552.0 |
| CCL2 | -17243.0 |
| C4A | -16746.5 |
| C4B | -16746.5 |
| C2 | -11448.0 |
| C3 | -10294.0 |
| ABCA7 | -7097.0 |
| CD300LF | -5496.0 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TREM2 | -17552.0 |
| CCL2 | -17243.0 |
| C4A | -16746.5 |
| C4B | -16746.5 |
| C2 | -11448.0 |
| C3 | -10294.0 |
| ABCA7 | -7097.0 |
| CD300LF | -5496.0 |
GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING
| set | GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING |
| setSize | 6 |
| pANOVA | 0.0226 |
| s.dist | 0.538 |
| p.adjustANOVA | 0.508 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BRSK2 | 3124 |
| CDH2 | 2345 |
| NLGN2 | 2168 |
| PCDH17 | -1869 |
| PTEN | -4189 |
| BRSK1 | -7771 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BRSK2 | 3124 |
| CDH2 | 2345 |
| NLGN2 | 2168 |
| PCDH17 | -1869 |
| PTEN | -4189 |
| BRSK1 | -7771 |
GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT
| set | GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT |
| setSize | 6 |
| pANOVA | 0.0242 |
| s.dist | 0.531 |
| p.adjustANOVA | 0.517 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC25A41 | 2714 |
| SLC25A31 | 1329 |
| SLC25A23 | -1189 |
| ADCY10 | -2836 |
| SLC25A24 | -3178 |
| SLC25A4 | -3449 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC25A41 | 2714 |
| SLC25A31 | 1329 |
| SLC25A23 | -1189 |
| ADCY10 | -2836 |
| SLC25A24 | -3178 |
| SLC25A4 | -3449 |
GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE
| set | GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE |
| setSize | 6 |
| pANOVA | 0.0245 |
| s.dist | 0.53 |
| p.adjustANOVA | 0.519 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| WNT7A | 3054 |
| NLGN2 | 2168 |
| CLSTN3 | -889 |
| DVL1 | -2886 |
| MAPT | -3494 |
| WNT5A | -4636 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| WNT7A | 3054 |
| NLGN2 | 2168 |
| CLSTN3 | -889 |
| DVL1 | -2886 |
| MAPT | -3494 |
| WNT5A | -4636 |
GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY
| set | GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0246 |
| s.dist | 0.53 |
| p.adjustANOVA | 0.519 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SCGB1A1 | 3662 |
| ANXA1 | 3186 |
| ANXA9 | 1849 |
| ANXA2 | -2832 |
| ANXA3 | -3256 |
| ANXA2P2 | -9318 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SCGB1A1 | 3662 |
| ANXA1 | 3186 |
| ANXA9 | 1849 |
| ANXA2 | -2832 |
| ANXA3 | -3256 |
| ANXA2P2 | -9318 |
GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY
| set | GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0404 |
| s.dist | 0.529 |
| p.adjustANOVA | 0.608 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PPIP5K1 | 2891 |
| IP6K3 | 2485 |
| IP6K2 | -638 |
| IP6K1 | -4078 |
| PPIP5K2 | -6284 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PPIP5K1 | 2891 |
| IP6K3 | 2485 |
| IP6K2 | -638 |
| IP6K1 | -4078 |
| PPIP5K2 | -6284 |
GOBP_CORTISOL_SECRETION
| set | GOBP_CORTISOL_SECRETION |
| setSize | 5 |
| pANOVA | 0.0407 |
| s.dist | 0.528 |
| p.adjustANOVA | 0.608 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CRH | 3830 |
| GALR1 | 3729 |
| GHRL | 2725 |
| GAL | -1174 |
| PTPN11 | -14777 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CRH | 3830 |
| GALR1 | 3729 |
| GHRL | 2725 |
| GAL | -1174 |
| PTPN11 | -14777 |
GOCC_TRANSLOCON_COMPLEX
| set | GOCC_TRANSLOCON_COMPLEX |
| setSize | 5 |
| pANOVA | 0.0412 |
| s.dist | 0.527 |
| p.adjustANOVA | 0.61 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SEC61G | 2221 |
| SEC61A2 | 769 |
| SEC61B | 695 |
| ARL6IP1 | -2225 |
| SEC61A1 | -7200 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SEC61G | 2221 |
| SEC61A2 | 769 |
| SEC61B | 695 |
| ARL6IP1 | -2225 |
| SEC61A1 | -7200 |
GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY
| set | GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY |
| setSize | 5 |
| pANOVA | 0.0414 |
| s.dist | -0.527 |
| p.adjustANOVA | 0.61 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MIR196A1 | -16247 |
| ABI3 | -15472 |
| MIR214 | -14905 |
| SLIT2 | -13044 |
| HRG | -3860 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MIR196A1 | -16247 |
| ABI3 | -15472 |
| MIR214 | -14905 |
| SLIT2 | -13044 |
| HRG | -3860 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.0 (2024-04-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4
## [2] GGally_2.2.1
## [3] ggplot2_3.5.1
## [4] reshape2_1.4.4
## [5] gplots_3.1.3.1
## [6] gtools_3.9.5
## [7] tibble_3.2.1
## [8] dplyr_1.1.4
## [9] echarts4r_0.4.5
## [10] plyr_1.8.9
## [11] png_0.1-8
## [12] gridExtra_2.3
## [13] missMethyl_1.36.0
## [14] beeswarm_0.4.0
## [15] kableExtra_1.4.0
## [16] mitch_1.15.6
## [17] tictoc_1.2.1
## [18] HGNChelper_0.8.1
## [19] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [20] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1
## [21] minfi_1.48.0
## [22] bumphunter_1.44.0
## [23] locfit_1.5-9.9
## [24] iterators_1.0.14
## [25] foreach_1.5.2
## [26] Biostrings_2.70.2
## [27] XVector_0.42.0
## [28] SummarizedExperiment_1.32.0
## [29] Biobase_2.62.0
## [30] MatrixGenerics_1.14.0
## [31] matrixStats_1.3.0
## [32] GenomicRanges_1.54.1
## [33] GenomeInfoDb_1.38.6
## [34] IRanges_2.36.0
## [35] S4Vectors_0.40.2
## [36] BiocGenerics_0.48.1
## [37] eulerr_7.0.2
## [38] limma_3.58.1
##
## loaded via a namespace (and not attached):
## [1] splines_4.4.0 later_1.3.2
## [3] BiocIO_1.12.0 bitops_1.0-7
## [5] filelock_1.0.3 preprocessCore_1.64.0
## [7] XML_3.99-0.16.1 lifecycle_1.0.4
## [9] lattice_0.22-6 MASS_7.3-60.2
## [11] base64_2.0.1 scrime_1.3.5
## [13] magrittr_2.0.3 sass_0.4.9
## [15] rmarkdown_2.26 jquerylib_0.1.4
## [17] yaml_2.3.8 httpuv_1.6.15
## [19] doRNG_1.8.6 askpass_1.2.0
## [21] DBI_1.2.2 RColorBrewer_1.1-3
## [23] abind_1.4-5 zlibbioc_1.48.0
## [25] quadprog_1.5-8 purrr_1.0.2
## [27] RCurl_1.98-1.14 rappdirs_0.3.3
## [29] GenomeInfoDbData_1.2.11 genefilter_1.84.0
## [31] annotate_1.80.0 svglite_2.1.3
## [33] DelayedMatrixStats_1.24.0 codetools_0.2-20
## [35] DelayedArray_0.28.0 xml2_1.3.6
## [37] tidyselect_1.2.1 farver_2.1.1
## [39] beanplot_1.3.1 BiocFileCache_2.10.1
## [41] illuminaio_0.44.0 GenomicAlignments_1.38.2
## [43] jsonlite_1.8.8 multtest_2.58.0
## [45] survival_3.6-4 systemfonts_1.0.6
## [47] tools_4.4.0 progress_1.2.3
## [49] Rcpp_1.0.12 glue_1.7.0
## [51] SparseArray_1.2.4 xfun_0.43
## [53] HDF5Array_1.30.1 withr_3.0.0
## [55] fastmap_1.1.1 rhdf5filters_1.14.1
## [57] fansi_1.0.6 openssl_2.1.2
## [59] caTools_1.18.2 digest_0.6.35
## [61] R6_2.5.1 mime_0.12
## [63] colorspace_2.1-0 biomaRt_2.58.2
## [65] RSQLite_2.3.6 utf8_1.2.4
## [67] tidyr_1.3.1 generics_0.1.3
## [69] data.table_1.15.4 rtracklayer_1.62.0
## [71] prettyunits_1.2.0 httr_1.4.7
## [73] htmlwidgets_1.6.4 S4Arrays_1.2.0
## [75] ggstats_0.6.0 pkgconfig_2.0.3
## [77] gtable_0.3.5 blob_1.2.4
## [79] siggenes_1.76.0 htmltools_0.5.8.1
## [81] scales_1.3.0 knitr_1.46
## [83] rstudioapi_0.16.0 tzdb_0.4.0
## [85] rjson_0.2.21 nlme_3.1-164
## [87] curl_5.2.1 org.Hs.eg.db_3.18.0
## [89] cachem_1.0.8 rhdf5_2.46.1
## [91] stringr_1.5.1 KernSmooth_2.23-22
## [93] AnnotationDbi_1.64.1 restfulr_0.0.15
## [95] GEOquery_2.70.0 pillar_1.9.0
## [97] grid_4.4.0 reshape_0.8.9
## [99] vctrs_0.6.5 promises_1.3.0
## [101] dbplyr_2.5.0 xtable_1.8-4
## [103] evaluate_0.23 readr_2.1.5
## [105] GenomicFeatures_1.54.3 cli_3.6.2
## [107] compiler_4.4.0 Rsamtools_2.18.0
## [109] rlang_1.1.3 crayon_1.5.2
## [111] rngtools_1.5.2 labeling_0.4.3
## [113] nor1mix_1.3-3 mclust_6.1.1
## [115] stringi_1.8.3 viridisLite_0.4.2
## [117] BiocParallel_1.36.0 munsell_0.5.1
## [119] Matrix_1.7-0 hms_1.1.3
## [121] sparseMatrixStats_1.14.0 bit64_4.0.5
## [123] Rhdf5lib_1.24.2 KEGGREST_1.42.0
## [125] statmod_1.5.0 shiny_1.8.1.1
## [127] highr_0.10 memoise_2.0.1.9000
## [129] bslib_0.7.0 bit_4.0.5END of report